{"drugId":"CHEMBL1096882","targetId":"ENSG00000167325","diseaseId":"EFO_0000094","phase":1,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02924753%22"}],"ancestors":["EFO_0007352","OTAR_0000006","EFO_0009676","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0000220","EFO_0002461","MONDO_0044881","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_1000068","MONDO_0004805","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0004095","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"B-cell acute lymphoblastic leukemia","approvedSymbol":"RRM1","approvedName":"ribonucleotide reductase catalytic subunit M1","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"Ribonucleoside-diphosphate reductase RR1 inhibitor","targetName":"Ribonucleoside-diphosphate reductase RR1"}
{"drugId":"CHEMBL1421","targetId":"ENSG00000136573","diseaseId":"EFO_0000095","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00872976%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00829647%22"}],"ancestors":["EFO_0007352","OTAR_0000006","EFO_0009676","MONDO_0001014","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0000220","EFO_0002461","MONDO_0044881","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_1000068","MONDO_0017594","MONDO_0004805","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0004095","EFO_0000096","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"chronic lymphocytic leukemia","approvedSymbol":"BLK","approvedName":"BLK proto-oncogene, Src family tyrosine kinase","targetClass":["Enzyme"],"prefName":"DASATINIB","tradeNames":["Dasatinib","Sprycel"],"synonyms":["BMS-354825","BMS-354825 HYDRATE","BMS-354825-03","Dasatinib","Dasatinib anhydrous","Dasatinib hydrate","Dasatinib monohydrate","NSC-759877"],"drugType":"Small molecule","mechanismOfAction":"SRC inhibitor","targetName":"SRC"}
{"drugId":"CHEMBL2107358","targetId":"ENSG00000129473","diseaseId":"EFO_0000095","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00538187%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00612612%22"}],"ancestors":["EFO_0007352","OTAR_0000006","EFO_0009676","MONDO_0001014","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0000220","EFO_0002461","MONDO_0044881","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_1000068","MONDO_0017594","MONDO_0004805","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0004095","EFO_0000096","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"chronic lymphocytic leukemia","approvedSymbol":"BCL2L2","approvedName":"BCL2 like 2","targetClass":["Other cytosolic protein"],"prefName":"OBATOCLAX MESYLATE","tradeNames":[],"synonyms":["GX-15-070MS","GX15-070MS","Obatoclax","Obatoclax mesilate","Obatoclax mesylate"],"drugType":"Small molecule","mechanismOfAction":"Apoptosis regulator Bcl-W inhibitor","targetName":"Apoptosis regulator Bcl-W"}
{"drugId":"CHEMBL3989869","targetId":"ENSG00000097007","diseaseId":"EFO_0000095","phase":3,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02612311%22"}],"ancestors":["EFO_0007352","OTAR_0000006","EFO_0009676","MONDO_0001014","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0000220","EFO_0002461","MONDO_0044881","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_1000068","MONDO_0017594","MONDO_0004805","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0004095","EFO_0000096","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"chronic lymphocytic leukemia","approvedSymbol":"ABL1","approvedName":"ABL proto-oncogene 1, non-receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"UMBRALISIB TOSYLATE","tradeNames":["Ukoniq"],"synonyms":["RP-5307","TGR-1202","TGR-1202 (4-METHYLBENZENESULFONATE)","Tgr-1202","Umbralisib tosylate"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase ABL inhibitor","targetName":"Tyrosine-protein kinase ABL"}
{"drugId":"CHEMBL408194","targetId":"ENSG00000171791","diseaseId":"EFO_0000095","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00612612%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00538187%22"}],"ancestors":["EFO_0007352","OTAR_0000006","EFO_0009676","MONDO_0001014","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0000220","EFO_0002461","MONDO_0044881","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_1000068","MONDO_0017594","MONDO_0004805","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0004095","EFO_0000096","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"chronic lymphocytic leukemia","approvedSymbol":"BCL2","approvedName":"BCL2 apoptosis regulator","targetClass":["Ion channel"],"prefName":"OBATOCLAX","tradeNames":[],"synonyms":["GX15-070","Obatoclax"],"drugType":"Small molecule","mechanismOfAction":"Apoptosis regulator Bcl-2 inhibitor","targetName":"Apoptosis regulator Bcl-2"}
{"drugId":"CHEMBL501867","targetId":"ENSG00000261456","diseaseId":"EFO_0000095","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003204%22"}],"ancestors":["EFO_0007352","OTAR_0000006","EFO_0009676","MONDO_0001014","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0000220","EFO_0002461","MONDO_0044881","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_1000068","MONDO_0017594","MONDO_0004805","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0004095","EFO_0000096","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"chronic lymphocytic leukemia","approvedSymbol":"TUBB8","approvedName":"tubulin beta 8 class VIII","targetClass":["Structural protein"],"prefName":"VINCRISTINE SULFATE","tradeNames":["Kyocristine","Leurocristine Sulfate","Marqibo kit","Oncovin","Vincasar","Vincasar pfs","Vincrex","Vincristine sulfate","Vincristine sulfate pfs"],"synonyms":["37231","Kyocristine","LILLY-37231","Marqibo","NSC-67574","Novopharm","Vincristine sulfate","Vincristine sulfate liposome","Vincristine sulphate","Vincristini sulfas","Vincrisul"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL848","targetId":"ENSG00000113851","diseaseId":"EFO_0000095","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02225275%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01465230%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00751296%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01600053%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01241786%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00899431%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01127542%22"}],"ancestors":["EFO_0007352","OTAR_0000006","EFO_0009676","MONDO_0001014","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0000220","EFO_0002461","MONDO_0044881","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_1000068","MONDO_0017594","MONDO_0004805","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0004095","EFO_0000096","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"chronic lymphocytic leukemia","approvedSymbol":"CRBN","approvedName":"cereblon","targetClass":["Enzyme","Unclassified protein","Transcription factor","Epigenetic regulator"],"prefName":"LENALIDOMIDE","tradeNames":["Revlimid"],"synonyms":["CC-5013","CDC-501","Lenalidomide","NSC-747972","SYP-1512"],"drugType":"Small molecule","mechanismOfAction":"CRL4(CRBN) E3 ubiquitin ligase inhibitor","targetName":"CRL4(CRBN) E3 ubiquitin ligase"}
{"drugId":"CHEMBL1389","targetId":"ENSG00000082175","diseaseId":"EFO_0000180","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03589027%22"}],"ancestors":["EFO_0000764","MONDO_0100336","MONDO_0100321","EFO_0000763","EFO_0005741","EFO_1001357","MONDO_0021681","MONDO_0100329","MONDO_0021682"],"label":"HIV-1 infection","approvedSymbol":"PGR","approvedName":"progesterone receptor","targetClass":["Transcription factor"],"prefName":"LEVONORGESTREL","tradeNames":["Athentia next","Emerres","Emerres una","Ezinelle","Fallback solo","Her style","Isteranda","Jadelle","Jaydess","Kyleena","Levonelle","Levonelle one step","Levonelle-2","Levonorgestrel","Levosert","Liletta","Microval","Mirena","Norgeston","Norplant","Norplant Ii","Norplant System","Opcicon one-step","Ovrette","Plan B","Plan b one-step","Postinor-2","Skyla","Upostelle"],"synonyms":["BAY86-5028","Levonorgestrel","Levonorgestrelum","NSC-744007","Norgestrel (-)-form","Norgestrel, (-)-","WY-5104"],"drugType":"Small molecule","mechanismOfAction":"Progesterone receptor agonist","targetName":"Progesterone receptor"}
{"drugId":"CHEMBL4297846","targetId":"ENSG00000010610","diseaseId":"EFO_0000180","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04041362%22"}],"ancestors":["EFO_0000764","MONDO_0100336","MONDO_0100321","EFO_0000763","EFO_0005741","EFO_1001357","MONDO_0021681","MONDO_0100329","MONDO_0021682"],"label":"HIV-1 infection","approvedSymbol":"CD4","approvedName":"CD4 molecule","targetClass":["Surface antigen"],"prefName":"UB-421","tradeNames":[],"synonyms":["Db4c7 mab","Mab db4c7","UB-421","UB-421 (DB4C7 MAB)","UB421","Ub-421"],"drugType":"Unknown","mechanismOfAction":"T-cell surface antigen CD4 inhibitor","targetName":"T-cell surface antigen CD4"}
{"drugId":"CHEMBL1289601","targetId":"ENSG00000102755","diseaseId":"EFO_0000181","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04428151%22"}],"ancestors":["EFO_0000313","MONDO_0002532","MONDO_0002038","MONDO_0023370","EFO_0005950","EFO_0000707","MONDO_0045024","EFO_0006858","MONDO_0004992","EFO_0006859","EFO_0000616"],"label":"head and neck squamous cell carcinoma","approvedSymbol":"FLT1","approvedName":"fms related receptor tyrosine kinase 1","targetClass":["Enzyme"],"prefName":"LENVATINIB","tradeNames":["Kisplyx","Lenvima"],"synonyms":["E-7080","ER-203492-00","Lenvatinib"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000164258","diseaseId":"EFO_0000181","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02949700%22"}],"ancestors":["EFO_0000313","MONDO_0002532","MONDO_0002038","MONDO_0023370","EFO_0005950","EFO_0000707","MONDO_0045024","EFO_0006858","MONDO_0004992","EFO_0006859","EFO_0000616"],"label":"head and neck squamous cell carcinoma","approvedSymbol":"NDUFS4","approvedName":"NADH:ubiquinone oxidoreductase subunit S4","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000004779","diseaseId":"EFO_0000181","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04414540%22"}],"ancestors":["EFO_0000313","MONDO_0002532","MONDO_0002038","MONDO_0023370","EFO_0005950","EFO_0000707","MONDO_0045024","EFO_0006858","MONDO_0004992","EFO_0006859","EFO_0000616"],"label":"head and neck squamous cell carcinoma","approvedSymbol":"NDUFAB1","approvedName":"NADH:ubiquinone oxidoreductase subunit AB1","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL189963","targetId":"ENSG00000105810","diseaseId":"EFO_0000181","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04966481%22"}],"ancestors":["EFO_0000313","MONDO_0002532","MONDO_0002038","MONDO_0023370","EFO_0005950","EFO_0000707","MONDO_0045024","EFO_0006858","MONDO_0004992","EFO_0006859","EFO_0000616"],"label":"head and neck squamous cell carcinoma","approvedSymbol":"CDK6","approvedName":"cyclin dependent kinase 6","targetClass":["Enzyme"],"prefName":"PALBOCICLIB","tradeNames":["Ibrance"],"synonyms":["PD-0332991","Palbociclib"],"drugType":"Small molecule","mechanismOfAction":"CDK6/cyclin D1 inhibitor","targetName":"CDK6/cyclin D1"}
{"drugId":"CHEMBL24828","targetId":"ENSG00000146904","diseaseId":"EFO_0000181","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00459043%22"}],"ancestors":["EFO_0000313","MONDO_0002532","MONDO_0002038","MONDO_0023370","EFO_0005950","EFO_0000707","MONDO_0045024","EFO_0006858","MONDO_0004992","EFO_0006859","EFO_0000616"],"label":"head and neck squamous cell carcinoma","approvedSymbol":"EPHA1","approvedName":"EPH receptor A1","targetClass":["Enzyme"],"prefName":"VANDETANIB","tradeNames":["Caprelsa","Zactima"],"synonyms":["GNF-PF-2188","NSC-744325","NSC-760766","Vandetanib","ZD-64","ZD-6474","ZD6474"],"drugType":"Small molecule","mechanismOfAction":"Ephrin receptor inhibitor","targetName":"Ephrin receptor"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000258947","diseaseId":"EFO_0000181","phase":1,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05376553%22"}],"ancestors":["EFO_0000313","MONDO_0002532","MONDO_0002038","MONDO_0023370","EFO_0005950","EFO_0000707","MONDO_0045024","EFO_0006858","MONDO_0004992","EFO_0006859","EFO_0000616"],"label":"head and neck squamous cell carcinoma","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000137285","diseaseId":"EFO_0000181","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05027204%22"}],"ancestors":["EFO_0000313","MONDO_0002532","MONDO_0002038","MONDO_0023370","EFO_0005950","EFO_0000707","MONDO_0045024","EFO_0006858","MONDO_0004992","EFO_0006859","EFO_0000616"],"label":"head and neck squamous cell carcinoma","approvedSymbol":"TUBB2B","approvedName":"tubulin beta 2B class IIb","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000137267","diseaseId":"EFO_0000181","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02124707%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00736944%22"}],"ancestors":["EFO_0000313","MONDO_0002532","MONDO_0002038","MONDO_0023370","EFO_0005950","EFO_0000707","MONDO_0045024","EFO_0006858","MONDO_0004992","EFO_0006859","EFO_0000616"],"label":"head and neck squamous cell carcinoma","approvedSymbol":"TUBB2A","approvedName":"tubulin beta 2A class IIa","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000137267","diseaseId":"EFO_0000181","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04766827%22"}],"ancestors":["EFO_0000313","MONDO_0002532","MONDO_0002038","MONDO_0023370","EFO_0005950","EFO_0000707","MONDO_0045024","EFO_0006858","MONDO_0004992","EFO_0006859","EFO_0000616"],"label":"head and neck squamous cell carcinoma","approvedSymbol":"TUBB2A","approvedName":"tubulin beta 2A class IIa","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL477772","targetId":"ENSG00000113721","diseaseId":"EFO_0000181","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01716416%22"}],"ancestors":["EFO_0000313","MONDO_0002532","MONDO_0002038","MONDO_0023370","EFO_0005950","EFO_0000707","MONDO_0045024","EFO_0006858","MONDO_0004992","EFO_0006859","EFO_0000616"],"label":"head and neck squamous cell carcinoma","approvedSymbol":"PDGFRB","approvedName":"platelet derived growth factor receptor beta","targetClass":["Enzyme"],"prefName":"PAZOPANIB","tradeNames":["Votrient"],"synonyms":["GW786034","NSC-752782","Pazopanib"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","targetName":"Platelet-derived growth factor receptor"}
{"drugId":"CHEMBL1336","targetId":"ENSG00000113721","diseaseId":"EFO_0000182","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02406508%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02908165%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00808145%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02129322%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03780634%22"}],"ancestors":["MONDO_0024276","MONDO_0023370","MONDO_0021069","MONDO_0045024","MONDO_0004992","MONDO_0024477","MONDO_0002691","EFO_0008550","EFO_0003769","EFO_0000313","EFO_1000218","EFO_0000228","EFO_0001379","EFO_0001421","EFO_0008549","MONDO_0002516","MONDO_0018532","EFO_0006858","MONDO_0018531","EFO_0010284","EFO_0000616","EFO_0010282"],"label":"hepatocellular carcinoma","approvedSymbol":"PDGFRB","approvedName":"platelet derived growth factor receptor beta","targetClass":["Enzyme"],"prefName":"SORAFENIB","tradeNames":["Nexavar"],"synonyms":["BAY 43-9006","BAY-43-9006","Sorafenib"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor beta inhibitor","targetName":"Platelet-derived growth factor receptor beta"}
{"drugId":"CHEMBL1456","targetId":"ENSG00000106348","diseaseId":"EFO_0000182","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02702960%22"}],"ancestors":["MONDO_0024276","MONDO_0023370","MONDO_0021069","MONDO_0045024","MONDO_0004992","MONDO_0024477","MONDO_0002691","EFO_0008550","EFO_0003769","EFO_0000313","EFO_1000218","EFO_0000228","EFO_0001379","EFO_0001421","EFO_0008549","MONDO_0002516","MONDO_0018532","EFO_0006858","MONDO_0018531","EFO_0010284","EFO_0000616","EFO_0010282"],"label":"hepatocellular carcinoma","approvedSymbol":"IMPDH1","approvedName":"inosine monophosphate dehydrogenase 1","targetClass":["Enzyme"],"prefName":"MYCOPHENOLATE MOFETIL","tradeNames":["Arzip","Cellcept","Mycophenolate mofetil","Myfenax"],"synonyms":["Myclausen","Mycophenolate mofetil","Mycophenolic acid 2-(4-morpholinyl)ethyl ester","Mycophenylate mofetil","NSC-724229","NSC-758905","RS-61443"],"drugType":"Small molecule","mechanismOfAction":"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor","targetName":"Inosine-5'-monophosphate dehydrogenase (IMPDH)"}
{"drugId":"CHEMBL1567","targetId":"ENSG00000128052","diseaseId":"EFO_0000182","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00699374%22"}],"ancestors":["MONDO_0024276","MONDO_0023370","MONDO_0021069","MONDO_0045024","MONDO_0004992","MONDO_0024477","MONDO_0002691","EFO_0008550","EFO_0003769","EFO_0000313","EFO_1000218","EFO_0000228","EFO_0001379","EFO_0001421","EFO_0008549","MONDO_0002516","MONDO_0018532","EFO_0006858","MONDO_0018531","EFO_0010284","EFO_0000616","EFO_0010282"],"label":"hepatocellular carcinoma","approvedSymbol":"KDR","approvedName":"kinase insert domain receptor","targetClass":["Enzyme"],"prefName":"SUNITINIB MALATE","tradeNames":["Sunitinib malate","Sutent"],"synonyms":["PHA-290940AD","SU-010398","SU-011248 L-MALATE SALT","SU010398","SU011248 L-MALATE SALT","Sunitinib l-malate","Sunitinib malate","Sutent"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL1946170","targetId":"ENSG00000142627","diseaseId":"EFO_0000182","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05048017%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04327700%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05134532%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03899428%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04183088%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04718909%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04310709%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04806243%22"}],"ancestors":["MONDO_0024276","MONDO_0023370","MONDO_0021069","MONDO_0045024","MONDO_0004992","MONDO_0024477","MONDO_0002691","EFO_0008550","EFO_0003769","EFO_0000313","EFO_1000218","EFO_0000228","EFO_0001379","EFO_0001421","EFO_0008549","MONDO_0002516","MONDO_0018532","EFO_0006858","MONDO_0018531","EFO_0010284","EFO_0000616","EFO_0010282"],"label":"hepatocellular carcinoma","approvedSymbol":"EPHA2","approvedName":"EPH receptor A2","targetClass":["Enzyme"],"prefName":"REGORAFENIB","tradeNames":["Stivarga"],"synonyms":["BAY 73-4506","BAY 73-4506 monohydrate","BAY-73-4506","BAY-734506","Regorafenib"],"drugType":"Small molecule","mechanismOfAction":"Ephrin type-A receptor 2","targetName":"Ephrin type-A receptor 2"}
{"drugId":"CHEMBL2103842","targetId":"ENSG00000146648","diseaseId":"EFO_0000182","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03499626%22"}],"ancestors":["MONDO_0024276","MONDO_0023370","MONDO_0021069","MONDO_0045024","MONDO_0004992","MONDO_0024477","MONDO_0002691","EFO_0008550","EFO_0003769","EFO_0000313","EFO_1000218","EFO_0000228","EFO_0001379","EFO_0001421","EFO_0008549","MONDO_0002516","MONDO_0018532","EFO_0006858","MONDO_0018531","EFO_0010284","EFO_0000616","EFO_0010282"],"label":"hepatocellular carcinoma","approvedSymbol":"EGFR","approvedName":"epidermal growth factor receptor","targetClass":["Enzyme"],"prefName":"VARLITINIB","tradeNames":[],"synonyms":["AR-00334543","ARRY-334543","ARRY-543","ASLAN-001","ASLAN001","Varlitinib"],"drugType":"Small molecule","mechanismOfAction":"Epidermal growth factor receptor erbB1 inhibitor","targetName":"Epidermal growth factor receptor erbB1"}
{"drugId":"CHEMBL3137343","targetId":"ENSG00000188389","diseaseId":"EFO_0000182","phase":1,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05440708%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05286320%22"}],"ancestors":["MONDO_0024276","MONDO_0023370","MONDO_0021069","MONDO_0045024","MONDO_0004992","MONDO_0024477","MONDO_0002691","EFO_0008550","EFO_0003769","EFO_0000313","EFO_1000218","EFO_0000228","EFO_0001379","EFO_0001421","EFO_0008549","MONDO_0002516","MONDO_0018532","EFO_0006858","MONDO_0018531","EFO_0010284","EFO_0000616","EFO_0010282"],"label":"hepatocellular carcinoma","approvedSymbol":"PDCD1","approvedName":"programmed cell death 1","targetClass":["Surface antigen"],"prefName":"PEMBROLIZUMAB","tradeNames":["Keytruda"],"synonyms":["KEYLYNK-010 COMPONENT PEMBROLIZUMAB","Lambrolizumab","MK-3475","PEMBROLIZUMAB COMPONENT OF KEYLYNK-010","Pembrolizumab","SCH-900475"],"drugType":"Antibody","mechanismOfAction":"Programmed cell death protein 1 inhibitor","targetName":"Programmed cell death protein 1"}
{"drugId":"CHEMBL4297163","targetId":"ENSG00000138685","diseaseId":"EFO_0000182","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01402908%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00568308%22"}],"ancestors":["MONDO_0024276","MONDO_0023370","MONDO_0021069","MONDO_0045024","MONDO_0004992","MONDO_0024477","MONDO_0002691","EFO_0008550","EFO_0003769","EFO_0000313","EFO_1000218","EFO_0000228","EFO_0001379","EFO_0001421","EFO_0008549","MONDO_0002516","MONDO_0018532","EFO_0006858","MONDO_0018531","EFO_0010284","EFO_0000616","EFO_0010282"],"label":"hepatocellular carcinoma","approvedSymbol":"FGF2","approvedName":"fibroblast growth factor 2","targetClass":["Secreted protein"],"prefName":"MUPARFOSTAT","tradeNames":[],"synonyms":["Muparfostat","PI-88"],"drugType":"Oligosaccharide","mechanismOfAction":"Basic fibroblast growth factor inhibitor","targetName":"Basic fibroblast growth factor"}
{"drugId":"CHEMBL468","targetId":"ENSG00000100387","diseaseId":"EFO_0000182","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00728078%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00384800%22"}],"ancestors":["MONDO_0024276","MONDO_0023370","MONDO_0021069","MONDO_0045024","MONDO_0004992","MONDO_0024477","MONDO_0002691","EFO_0008550","EFO_0003769","EFO_0000313","EFO_1000218","EFO_0000228","EFO_0001379","EFO_0001421","EFO_0008549","MONDO_0002516","MONDO_0018532","EFO_0006858","MONDO_0018531","EFO_0010284","EFO_0000616","EFO_0010282"],"label":"hepatocellular carcinoma","approvedSymbol":"RBX1","approvedName":"ring-box 1","targetClass":["Enzyme"],"prefName":"THALIDOMIDE","tradeNames":["Talidex","Thalomid"],"synonyms":[".alpha.-phthalimidoglutarimide","Celgene","Contergan","Distaval","K-17","Myrin","N-phthalylglutamic acid imide","NSC-527179","NSC-66847","Neurosedyn","Pantosediv","Pharmion","Softenon","Thaled","Thalidomide","Thalidomide "],"drugType":"Small molecule","mechanismOfAction":"CRL4(CRBN) E3 ubiquitin ligase inhibitor","targetName":"CRL4(CRBN) E3 ubiquitin ligase"}
{"drugId":"CHEMBL1201576","targetId":"ENSG00000156738","diseaseId":"EFO_0000183","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02408042%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0005741","MONDO_0044881","MONDO_0045024","Orphanet_322126","MONDO_0100336","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0100321","MONDO_0021669","EFO_0000508","MONDO_0019044","MONDO_0017342","MONDO_0017341","EFO_0005803","MONDO_0017343","EFO_0000616"],"label":"Hodgkins lymphoma","approvedSymbol":"MS4A1","approvedName":"membrane spanning 4-domains A1","targetClass":["Ion channel"],"prefName":"RITUXIMAB","tradeNames":["Mabthera","Mabthera rituxan","Rituxan"],"synonyms":["ABP-798","ABP798","Bi-695500","Blitzima","CT-P10","Gp2013","HS-006","HS-006 (RITUXIMAB BIOSIMILAR)","HS006","IDEC-102","IDEC-C2B8","Pf-05280586","R-105 IDEC-102","RG-105","RHCACD20MA","Riabni","Ritemvia","Rituximab","Rituximab (genetical recombination)","Rituximab biosimilar - celltrion","Rituximab-abbs","Rituximab-arrx","Rituximab-boehringer ingelheim","Rituximab-ct-p10","Rituximab-pfizer","Rituximab-pvvr","Ruxience","SAIT-101","SAIT101","Truxima","Tuxella","Usp mab 001, monoclonal igg1","Zuberitamab"],"drugType":"Antibody","mechanismOfAction":"B-lymphocyte antigen CD20 binding agent","targetName":"B-lymphocyte antigen CD20"}
{"drugId":"CHEMBL1750","targetId":"ENSG00000106628","diseaseId":"EFO_0000183","phase":1,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01701986%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0005741","MONDO_0044881","MONDO_0045024","Orphanet_322126","MONDO_0100336","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0100321","MONDO_0021669","EFO_0000508","MONDO_0019044","MONDO_0017342","MONDO_0017341","EFO_0005803","MONDO_0017343","EFO_0000616"],"label":"Hodgkins lymphoma","approvedSymbol":"POLD2","approvedName":"DNA polymerase delta 2, accessory subunit","targetClass":["Enzyme"],"prefName":"CLOFARABINE","tradeNames":["Clolar","Evoltra"],"synonyms":["Clofarabine","Clolar","NSC-759857"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL3813873","targetId":"ENSG00000182578","diseaseId":"EFO_0000183","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01217229%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0005741","MONDO_0044881","MONDO_0045024","Orphanet_322126","MONDO_0100336","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0100321","MONDO_0021669","EFO_0000508","MONDO_0019044","MONDO_0017342","MONDO_0017341","EFO_0005803","MONDO_0017343","EFO_0000616"],"label":"Hodgkins lymphoma","approvedSymbol":"CSF1R","approvedName":"colony stimulating factor 1 receptor","targetClass":["Enzyme"],"prefName":"PEXIDARTINIB","tradeNames":[],"synonyms":["CML-261","PLX-3397","PLX3397","Pexidartinib","Plx-3397"],"drugType":"Small molecule","mechanismOfAction":"Macrophage colony stimulating factor receptor inhibitor","targetName":"Macrophage colony stimulating factor receptor"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000104833","diseaseId":"EFO_0000183","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01555853%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01929941%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0005741","MONDO_0044881","MONDO_0045024","Orphanet_322126","MONDO_0100336","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0100321","MONDO_0021669","EFO_0000508","MONDO_0019044","MONDO_0017342","MONDO_0017341","EFO_0005803","MONDO_0017343","EFO_0000616"],"label":"Hodgkins lymphoma","approvedSymbol":"TUBB4A","approvedName":"tubulin beta 4A class IVa","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL803","targetId":"ENSG00000062822","diseaseId":"EFO_0000183","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01453504%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01321346%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0005741","MONDO_0044881","MONDO_0045024","Orphanet_322126","MONDO_0100336","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0100321","MONDO_0021669","EFO_0000508","MONDO_0019044","MONDO_0017342","MONDO_0017341","EFO_0005803","MONDO_0017343","EFO_0000616"],"label":"Hodgkins lymphoma","approvedSymbol":"POLD1","approvedName":"DNA polymerase delta 1, catalytic subunit","targetClass":["Enzyme"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL90555","targetId":"ENSG00000258947","diseaseId":"EFO_0000183","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04638790%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0005741","MONDO_0044881","MONDO_0045024","Orphanet_322126","MONDO_0100336","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0100321","MONDO_0021669","EFO_0000508","MONDO_0019044","MONDO_0017342","MONDO_0017341","EFO_0005803","MONDO_0017343","EFO_0000616"],"label":"Hodgkins lymphoma","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"VINCRISTINE","tradeNames":[],"synonyms":["22-oxovincaleukoblastine","Leucristine","Leurocristine","Oncotcs","Tecnocris","Vincaleukoblastine, 22-oxo-","Vincristin","Vincristine","Vinkristin"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1138","targetId":"ENSG00000015520","diseaseId":"EFO_0000195","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00409773%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01849068%22"}],"ancestors":["EFO_0000589","OTAR_0000020"],"label":"metabolic syndrome","approvedSymbol":"NPC1L1","approvedName":"NPC1 like intracellular cholesterol transporter 1","targetClass":["Other membrane protein"],"prefName":"EZETIMIBE","tradeNames":["Ezetimibe","Ezetrol","Zetia"],"synonyms":["Ezetimibe","MK0653","NSC-758923","SCH-58235","SCH58235"],"drugType":"Small molecule","mechanismOfAction":"Niemann-Pick C1-like protein 1 inhibitor","targetName":"Niemann-Pick C1-like protein 1"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198888","diseaseId":"EFO_0000195","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02629627%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00703755%22"}],"ancestors":["EFO_0000589","OTAR_0000020"],"label":"metabolic syndrome","approvedSymbol":"MT-ND1","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000164258","diseaseId":"EFO_0000195","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01342744%22"}],"ancestors":["EFO_0000589","OTAR_0000020"],"label":"metabolic syndrome","approvedSymbol":"NDUFS4","approvedName":"NADH:ubiquinone oxidoreductase subunit S4","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL434394","targetId":"ENSG00000043591","diseaseId":"EFO_0000195","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00775671%22"}],"ancestors":["EFO_0000589","OTAR_0000020"],"label":"metabolic syndrome","approvedSymbol":"ADRB1","approvedName":"adrenoceptor beta 1","targetClass":["Membrane receptor"],"prefName":"NEBIVOLOL","tradeNames":["Hypoloc","Nebilet"],"synonyms":["Narbivolol","Nebivolol","R-65824","R65,824"],"drugType":"Small molecule","mechanismOfAction":"Beta-1 adrenergic receptor antagonist","targetName":"Beta-1 adrenergic receptor"}
{"drugId":"CHEMBL1200511","targetId":"ENSG00000109163","diseaseId":"EFO_0000196","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04262154%22"}],"ancestors":["OTAR_0000017","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","MONDO_0008315","EFO_0000512","EFO_0000313","EFO_0001663","EFO_0006858","EFO_0000616"],"label":"metastatic prostate cancer","approvedSymbol":"GNRHR","approvedName":"gonadotropin releasing hormone receptor","targetClass":["Membrane receptor"],"prefName":"GONADORELIN ACETATE","tradeNames":["Cystorelin","Factrel","GnRH","Gonadotropin Releasing Hormone","Lh Releasing Factor","Lutrelef","Lutrepulse","Lutrepulse kit"],"synonyms":["ABBOTT-41070","Fertagyl","Gonadorelin acetate","Gonadorelin acetate mixture","Gonadorelin diacetate","Hypocrine","Luteinizing","Luteinizing hormone-releasing factor diacetate tetrahydrate"],"drugType":"Protein","mechanismOfAction":"Gonadotropin-releasing hormone receptor agonist","targetName":"Gonadotropin-releasing hormone receptor"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000106628","diseaseId":"EFO_0000198","phase":1,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02960646%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03393611%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","Orphanet_68336","MONDO_0015756","MONDO_0023370","MONDO_0021058","EFO_0000508","MONDO_0019044","MONDO_0045024","EFO_0005803","EFO_0000616","Orphanet_322126"],"label":"myelodysplastic syndrome","approvedSymbol":"POLD2","approvedName":"DNA polymerase delta 2, accessory subunit","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000177084","diseaseId":"EFO_0000198","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00004114%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","Orphanet_68336","MONDO_0015756","MONDO_0023370","MONDO_0021058","EFO_0000508","MONDO_0019044","MONDO_0045024","EFO_0005803","EFO_0000616","Orphanet_322126"],"label":"myelodysplastic syndrome","approvedSymbol":"POLE","approvedName":"DNA polymerase epsilon, catalytic subunit","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL2103847","targetId":"ENSG00000141279","diseaseId":"EFO_0000198","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02452346%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","Orphanet_68336","MONDO_0015756","MONDO_0023370","MONDO_0021058","EFO_0000508","MONDO_0019044","MONDO_0045024","EFO_0005803","EFO_0000616","Orphanet_322126"],"label":"myelodysplastic syndrome","approvedSymbol":"NPEPPS","approvedName":"aminopeptidase puromycin sensitive","targetClass":["Enzyme"],"prefName":"TOSEDOSTAT","tradeNames":[],"synonyms":["CHR 2797","CHR-2797","Tosedostat"],"drugType":"Small molecule","mechanismOfAction":"Aminopeptidase inhibitor","targetName":"Aminopeptidase"}
{"drugId":"CHEMBL3301622","targetId":"ENSG00000122025","diseaseId":"EFO_0000198","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02115295%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","Orphanet_68336","MONDO_0015756","MONDO_0023370","MONDO_0021058","EFO_0000508","MONDO_0019044","MONDO_0045024","EFO_0005803","EFO_0000616","Orphanet_322126"],"label":"myelodysplastic syndrome","approvedSymbol":"FLT3","approvedName":"fms related receptor tyrosine kinase 3","targetClass":["Enzyme"],"prefName":"GILTERITINIB","tradeNames":[],"synonyms":["ASP-2215","ASP2215","Asp-2215","Gilteritinib"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase receptor FLT3 inhibitor","targetName":"Tyrosine-protein kinase receptor FLT3"}
{"drugId":"CHEMBL34259","targetId":"ENSG00000228716","diseaseId":"EFO_0000198","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01749111%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","Orphanet_68336","MONDO_0015756","MONDO_0023370","MONDO_0021058","EFO_0000508","MONDO_0019044","MONDO_0045024","EFO_0005803","EFO_0000616","Orphanet_322126"],"label":"myelodysplastic syndrome","approvedSymbol":"DHFR","approvedName":"dihydrofolate reductase","targetClass":["Enzyme"],"prefName":"METHOTREXATE","tradeNames":["Amethopterin","Ebetrex","Emtexate high-pot","Emtexate pf","Folex","Maxtrex","Methotrexate","Metoject","Mexate","Otrexup","Otrexup pfs","Rasuvo","Reditrex","Rheumatrex","Trexall","Zlatal"],"synonyms":["(r)-methotrexate","ADX-2191","Abitrexate","Amethopterin","CL 14377","CL-14377","D-amethopterin","D-methotrexate","EMT-25299","Folex","Methotrexate","Methotrexate, (r)-","Methotrexate, d-","Methotrexatum","Methylaminopterin","Mexate","Mexate-AQ","NSC-740","R-9985","R-methotrexate","TCMDC-123832","TCMDC-125488","TCMDC-125858","Trexall"],"drugType":"Small molecule","mechanismOfAction":"Dihydrofolate reductase inhibitor","targetName":"Dihydrofolate reductase"}
{"drugId":"CHEMBL408513","targetId":"ENSG00000094631","diseaseId":"EFO_0000198","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00357162%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","Orphanet_68336","MONDO_0015756","MONDO_0023370","MONDO_0021058","EFO_0000508","MONDO_0019044","MONDO_0045024","EFO_0005803","EFO_0000616","Orphanet_322126"],"label":"myelodysplastic syndrome","approvedSymbol":"HDAC6","approvedName":"histone deacetylase 6","targetClass":["Epigenetic regulator"],"prefName":"BELINOSTAT","tradeNames":["Beleodaq"],"synonyms":["Belinostat","NSC726630","PX-105684","PXD-101","PXD101"],"drugType":"Small molecule","mechanismOfAction":"Histone deacetylase inhibitor","targetName":"Histone deacetylase"}
{"drugId":"CHEMBL2108738","targetId":"ENSG00000188389","diseaseId":"EFO_0000199","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03854032%22"}],"ancestors":["EFO_0005570","MONDO_0002038","MONDO_0002532","MONDO_0023370","EFO_0005950","MONDO_0023644","MONDO_0045024","MONDO_0004992","MONDO_0044710","EFO_0000181","EFO_0000313","EFO_0003868","EFO_1000218","MONDO_0044925","EFO_0008549","EFO_0000707","MONDO_0002516","EFO_0006858","EFO_0006859","EFO_1001047","EFO_0000616","EFO_0010282"],"label":"oral squamous cell carcinoma","approvedSymbol":"PDCD1","approvedName":"programmed cell death 1","targetClass":["Surface antigen"],"prefName":"NIVOLUMAB","tradeNames":["Opdivo"],"synonyms":["BMS-936558","BMS-986298","MDX-1106","Nivolumab","ONO-4538"],"drugType":"Antibody","mechanismOfAction":"Programmed cell death protein 1 inhibitor","targetName":"Programmed cell death protein 1"}
{"drugId":"CHEMBL1738","targetId":"ENSG00000077097","diseaseId":"EFO_0000209","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03007147%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0000220","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","EFO_1000068","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"T-cell acute lymphoblastic leukemia","approvedSymbol":"TOP2B","approvedName":"DNA topoisomerase II beta","targetClass":["Enzyme"],"prefName":"DEXRAZOXANE","tradeNames":["Cardioxane","Zinecard"],"synonyms":["ADR-529","Dexrazoxane","ICRF-187","NSC-169780","Razoxane, (s)-","Razoxane, d-"],"drugType":"Small molecule","mechanismOfAction":"DNA topoisomerase II inhibitor","targetName":"DNA topoisomerase II"}
{"drugId":"CHEMBL3545414","targetId":"ENSG00000128052","diseaseId":"EFO_0000211","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03631862%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0002426","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0024615","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"unspecified peripheral T-cell lymphoma","approvedSymbol":"KDR","approvedName":"kinase insert domain receptor","targetClass":["Enzyme"],"prefName":"RIVOCERANIB MESYLATE","tradeNames":["Aitan"],"synonyms":["Apatinib (registered name in China)","Apatinib mesylate","Rivoceranib mesylate","YN-968D1","Yn-968d1"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor 2 inhibitor","targetName":"Vascular endothelial growth factor receptor 2"}
{"drugId":"CHEMBL803","targetId":"ENSG00000014138","diseaseId":"EFO_0000211","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00791947%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0002426","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0024615","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"unspecified peripheral T-cell lymphoma","approvedSymbol":"POLA2","approvedName":"DNA polymerase alpha 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL480","targetId":"ENSG00000105675","diseaseId":"EFO_0000217","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00149084%22"}],"ancestors":["EFO_0009608","EFO_0010282"],"label":"gastritis","approvedSymbol":"ATP4A","approvedName":"ATPase H+/K+ transporting subunit alpha","targetClass":["Transporter"],"prefName":"LANSOPRAZOLE","tradeNames":["Lansoprazole","Opiren","Prevacid","Prevacid 24 hr","Prevacid Delayed Release","Prevacid Solutab","Prevacid iv","Zoton"],"synonyms":["A-65006","AG-1749","Agopton","Lansoprazole","Lansox","Lanzoprazole","Lanzor","Limpidex","NSC-758638","Ogast","Ogastoro","Prevonco","Takepron"],"drugType":"Small molecule","mechanismOfAction":"Potassium-transporting ATPase inhibitor","targetName":"Potassium-transporting ATPase"}
{"drugId":"CHEMBL574737","targetId":"ENSG00000135446","diseaseId":"EFO_0000218","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00301938%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","MONDO_0015756","EFO_0003820","EFO_1000068","EFO_0005803","EFO_0000616","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0002427","MONDO_0020703","EFO_0002428","MONDO_0015667","EFO_0000222","EFO_0000540","EFO_0000565","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"acute erythroleukemia","approvedSymbol":"CDK4","approvedName":"cyclin dependent kinase 4","targetClass":["Enzyme"],"prefName":"UCN-01","tradeNames":[],"synonyms":["7-hydroxystaurosporine","KRX-0601","KW-2401","NSC-638850","UCN-01","UCN-02","Ucn 01","Ucn-01"],"drugType":"Small molecule","mechanismOfAction":"Cyclin-dependent kinase 4 inhibitor","targetName":"Cyclin-dependent kinase 4"}
{"drugId":"CHEMBL803","targetId":"ENSG00000014138","diseaseId":"EFO_0000218","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00369317%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00006363%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003190%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002798%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","MONDO_0015756","EFO_0003820","EFO_1000068","EFO_0005803","EFO_0000616","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0002427","MONDO_0020703","EFO_0002428","MONDO_0015667","EFO_0000222","EFO_0000540","EFO_0000565","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"acute erythroleukemia","approvedSymbol":"POLA2","approvedName":"DNA polymerase alpha 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000148229","diseaseId":"EFO_0000220","phase":1,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02614066%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","EFO_1000068","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"acute lymphoblastic leukemia","approvedSymbol":"POLE3","approvedName":"DNA polymerase epsilon 3, accessory subunit","targetClass":["Unclassified protein"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000077514","diseaseId":"EFO_0000220","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00075478%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00412360%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00187083%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01564784%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","EFO_1000068","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"acute lymphoblastic leukemia","approvedSymbol":"POLD3","approvedName":"DNA polymerase delta 3, accessory subunit","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000014138","diseaseId":"EFO_0000220","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02894645%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","EFO_1000068","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"acute lymphoblastic leukemia","approvedSymbol":"POLA2","approvedName":"DNA polymerase alpha 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1873475","targetId":"ENSG00000010671","diseaseId":"EFO_0000220","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02815059%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","EFO_1000068","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"acute lymphoblastic leukemia","approvedSymbol":"BTK","approvedName":"Bruton tyrosine kinase","targetClass":["Enzyme"],"prefName":"IBRUTINIB","tradeNames":["Imbruvica"],"synonyms":["CRA-032765","Ibrutinib","PC-32765","PCI 32765","PCI-32765","PCI-32765-00"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase BTK inhibitor","targetName":"Tyrosine-protein kinase BTK"}
{"drugId":"CHEMBL389621","targetId":"ENSG00000113580","diseaseId":"EFO_0000220","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00131053%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","EFO_1000068","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"acute lymphoblastic leukemia","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"HYDROCORTISONE","tradeNames":["Acetasol hc","Acticort","Aeroseb-hc","Ala-cort","Ala-scalp","Alkindi sprinkle","Alphaderm","Anflam","Anucort-Hc","Anugesic hc","Anusol hc","Anusol plus hc","Anusol soothing relief","Anusol-Hc","Balneol-hc","Beta-hc","Calmurid hc","Canesten hc","Cetacort","Cipro hc","Cobadex","Colocort","Corlan","Cort-dome","Cortef","Cortenem","Cortenema","Cortril","Daktacort","Daktacort hydrocort","Derma care hydrocort","Dermacort","Dermaspray demang","Dioderm","Dome-cort","Econacort","Efcortelan p","Eldecort","Epicort","Eurax-hc","Eurax-hydrocort","Evacort","Exe-cort","Flexicort","Germoloids hc","Glycort","Gregoderm","H-cort","Hc #1","Hc #4","Hc (hydrocortisone)","Hi-cor","Hydro-rx","Hydrocort in calamine oily","Hydrocort in cetomacrogol for a","Hydrocort in wte soft paraf","Hydrocortisone","Hydrocortisone in absorbase","Hydrocortone","Hydroderm","Hydroderm hc","Hytone","Jungle for","Locoid","Medicort","Mildison lipocream","Nogenic hc","Nutracort","Nybadex","Nystaform-hc","Otoseptil","Otosporin","Penecort","Perinal","Plenadren","Proctocort","Proctocream hc","Proctofoam hc","Proctosedyl","Quinocort","Sential hc","Stie-cort","Synacort","Terra-cortril nystatin","Texacort","Timocort","Timodine","Topisone","Tri-cicatrin","Uniroid","Uniroid hc","Xyloproct","Zenoxone"],"synonyms":["Cor-Oticin","Cortifoam","Cortisol","FLEXICORT","Hydrocortisone","Micort-HC","NSC-10483","Neo-Cortef","Ophthocort","Terra-Cortril","U-Cort"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL501867","targetId":"ENSG00000261456","diseaseId":"EFO_0000220","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02877303%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","EFO_1000068","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"acute lymphoblastic leukemia","approvedSymbol":"TUBB8","approvedName":"tubulin beta 8 class VIII","targetClass":["Structural protein"],"prefName":"VINCRISTINE SULFATE","tradeNames":["Kyocristine","Leurocristine Sulfate","Marqibo kit","Oncovin","Vincasar","Vincasar pfs","Vincrex","Vincristine sulfate","Vincristine sulfate pfs"],"synonyms":["37231","Kyocristine","LILLY-37231","Marqibo","NSC-67574","Novopharm","Vincristine sulfate","Vincristine sulfate liposome","Vincristine sulphate","Vincristini sulfas","Vincrisul"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL628","targetId":"ENSG00000095464","diseaseId":"EFO_0000220","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02451774%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","EFO_1000068","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"acute lymphoblastic leukemia","approvedSymbol":"PDE6C","approvedName":"phosphodiesterase 6C","targetClass":["Enzyme"],"prefName":"PENTOXIFYLLINE","tradeNames":["Neotren mr","Pentoxifylline","Pentoxil","Trental","Trental 100","Trental 400"],"synonyms":["BL 191","BL-191","C04AD03","NSC-637086","NSC-758481","Oxpentifylline","Oxypentifylline","Pentoxifylline","Pentoxiphyllin"],"drugType":"Small molecule","mechanismOfAction":"3',5'-cyclic phosphodiesterase inhibitor","targetName":"3',5'-cyclic phosphodiesterase"}
{"drugId":"CHEMBL803","targetId":"ENSG00000100479","diseaseId":"EFO_0000220","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05157971%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02303821%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03571321%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01371630%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03817320%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","EFO_1000068","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"acute lymphoblastic leukemia","approvedSymbol":"POLE2","approvedName":"DNA polymerase epsilon 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL803","targetId":"ENSG00000106628","diseaseId":"EFO_0000220","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02776605%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03575325%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01593488%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00476190%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03384654%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02981628%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02828358%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00136435%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","EFO_1000068","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"acute lymphoblastic leukemia","approvedSymbol":"POLD2","approvedName":"DNA polymerase delta 2, accessory subunit","targetClass":["Enzyme"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL803","targetId":"ENSG00000062822","diseaseId":"EFO_0000220","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03860844%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02339350%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03117751%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03913559%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02877303%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03318419%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04845035%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","EFO_1000068","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"acute lymphoblastic leukemia","approvedSymbol":"POLD1","approvedName":"DNA polymerase delta 1, catalytic subunit","targetClass":["Enzyme"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL888","targetId":"ENSG00000014138","diseaseId":"EFO_0000220","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03339700%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","EFO_1000068","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"acute lymphoblastic leukemia","approvedSymbol":"POLA2","approvedName":"DNA polymerase alpha 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL90555","targetId":"ENSG00000196230","diseaseId":"EFO_0000220","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04747912%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02877303%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03117751%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03860844%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","EFO_1000068","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"acute lymphoblastic leukemia","approvedSymbol":"TUBB","approvedName":"tubulin beta class I","targetClass":["Structural protein"],"prefName":"VINCRISTINE","tradeNames":[],"synonyms":["22-oxovincaleukoblastine","Leucristine","Leurocristine","Oncotcs","Tecnocris","Vincaleukoblastine, 22-oxo-","Vincristin","Vincristine","Vinkristin"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000177084","diseaseId":"EFO_0000222","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00559221%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00529880%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02272478%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02275663%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","MONDO_0015756","EFO_0003820","EFO_1000068","EFO_0005803","EFO_0000616","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0002427","EFO_0002428","EFO_0000540","EFO_0000565","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"acute myeloid leukemia","approvedSymbol":"POLE","approvedName":"DNA polymerase epsilon, catalytic subunit","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1750","targetId":"ENSG00000014138","diseaseId":"EFO_0000222","phase":1,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01534702%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","MONDO_0015756","EFO_0003820","EFO_1000068","EFO_0005803","EFO_0000616","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0002427","EFO_0002428","EFO_0000540","EFO_0000565","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"acute myeloid leukemia","approvedSymbol":"POLA2","approvedName":"DNA polymerase alpha 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"CLOFARABINE","tradeNames":["Clolar","Evoltra"],"synonyms":["Clofarabine","Clolar","NSC-759857"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1750","targetId":"ENSG00000100479","diseaseId":"EFO_0000222","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05477589%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","MONDO_0015756","EFO_0003820","EFO_1000068","EFO_0005803","EFO_0000616","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0002427","EFO_0002428","EFO_0000540","EFO_0000565","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"acute myeloid leukemia","approvedSymbol":"POLE2","approvedName":"DNA polymerase epsilon 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"CLOFARABINE","tradeNames":["Clolar","Evoltra"],"synonyms":["Clofarabine","Clolar","NSC-759857"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL38","targetId":"ENSG00000131759","diseaseId":"EFO_0000222","phase":3,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01067274%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","MONDO_0015756","EFO_0003820","EFO_1000068","EFO_0005803","EFO_0000616","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0002427","EFO_0002428","EFO_0000540","EFO_0000565","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"acute myeloid leukemia","approvedSymbol":"RARA","approvedName":"retinoic acid receptor alpha","targetClass":["Transcription factor"],"prefName":"TRETINOIN","tradeNames":["Acticin","Altreno","Atralin","Avita","Renova","Retin-a","Retin-a micro","Retin-a-micro","Tretin-X","Tretinoin","Vesanoid"],"synonyms":["Aberel","All-trans retinoic acid","All-trans-retinoic acid","Eudyna","Kerlocal","NSC-122758","Oristar rna","Retin a","Retinoic acid","Tretinoin"],"drugType":"Small molecule","mechanismOfAction":"Retinoic acid receptor agonist","targetName":"Retinoic acid receptor"}
{"drugId":"CHEMBL3990038","targetId":"ENSG00000198851","diseaseId":"EFO_0000222","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05063123%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","MONDO_0015756","EFO_0003820","EFO_1000068","EFO_0005803","EFO_0000616","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0002427","EFO_0002428","EFO_0000540","EFO_0000565","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"acute myeloid leukemia","approvedSymbol":"CD3E","approvedName":"CD3 epsilon subunit of T-cell receptor complex","targetClass":["Membrane receptor"],"prefName":"FLOTETUZUMAB","tradeNames":[],"synonyms":["Flotetuzumab","MGD-006","MGD006","RES-234","RES234","S-80880","S80880"],"drugType":"Antibody","mechanismOfAction":"T cell surface glycoprotein CD3 binding agent","targetName":"T cell surface glycoprotein CD3"}
{"drugId":"CHEMBL4297599","targetId":"ENSG00000014138","diseaseId":"EFO_0000222","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02544438%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","MONDO_0015756","EFO_0003820","EFO_1000068","EFO_0005803","EFO_0000616","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0002427","EFO_0002428","EFO_0000540","EFO_0000565","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"acute myeloid leukemia","approvedSymbol":"POLA2","approvedName":"DNA polymerase alpha 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"ASPACYTARABINE","tradeNames":[],"synonyms":["Aspacytarabine","Astarabine","BST-236","Bst-236"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL477772","targetId":"ENSG00000102755","diseaseId":"EFO_0000222","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02638428%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","MONDO_0015756","EFO_0003820","EFO_1000068","EFO_0005803","EFO_0000616","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0002427","EFO_0002428","EFO_0000540","EFO_0000565","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"acute myeloid leukemia","approvedSymbol":"FLT1","approvedName":"fms related receptor tyrosine kinase 1","targetClass":["Enzyme"],"prefName":"PAZOPANIB","tradeNames":["Votrient"],"synonyms":["GW786034","NSC-752782","Pazopanib"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL483254","targetId":"ENSG00000163517","diseaseId":"EFO_0000222","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01242774%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00691938%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00840346%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01055483%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01321346%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00946647%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01463046%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","MONDO_0015756","EFO_0003820","EFO_1000068","EFO_0005803","EFO_0000616","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0002427","EFO_0002428","EFO_0000540","EFO_0000565","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"acute myeloid leukemia","approvedSymbol":"HDAC11","approvedName":"histone deacetylase 11","targetClass":["Epigenetic regulator"],"prefName":"PANOBINOSTAT","tradeNames":["Farydak"],"synonyms":["LBH-589","LBH589","Panobinostat","Panobinostat hydrate"],"drugType":"Small molecule","mechanismOfAction":"Histone deacetylase inhibitor","targetName":"Histone deacetylase"}
{"drugId":"CHEMBL576982","targetId":"ENSG00000157404","diseaseId":"EFO_0000222","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02039726%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","MONDO_0015756","EFO_0003820","EFO_1000068","EFO_0005803","EFO_0000616","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0002427","EFO_0002428","EFO_0000540","EFO_0000565","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"acute myeloid leukemia","approvedSymbol":"KIT","approvedName":"KIT proto-oncogene, receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"QUIZARTINIB","tradeNames":[],"synonyms":["AC-010220","AC-220","AC010220","AC220","ASP-2689","Ac-220","Quizartinib"],"drugType":"Small molecule","mechanismOfAction":"Stem cell growth factor receptor inhibitor","targetName":"Stem cell growth factor receptor"}
{"drugId":"CHEMBL608533","targetId":"ENSG00000154229","diseaseId":"EFO_0000222","phase":4,"urls":[{"niceName":"FDA","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207997s000lbl.pdf"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","MONDO_0015756","EFO_0003820","EFO_1000068","EFO_0005803","EFO_0000616","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0002427","EFO_0002428","EFO_0000540","EFO_0000565","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"acute myeloid leukemia","approvedSymbol":"PRKCA","approvedName":"protein kinase C alpha","targetClass":["Enzyme"],"prefName":"MIDOSTAURIN","tradeNames":["Rydapt"],"synonyms":["CGP 41251","CGP-41251","Midostaurin","NSC-656576","NVP-PKC412","PKC 412","PKC-412","Pkc-412"],"drugType":"Small molecule","mechanismOfAction":"Protein kinase C (PKC) inhibitor","targetName":"Protein kinase C (PKC)"}
{"drugId":"CHEMBL803","targetId":"ENSG00000062822","diseaseId":"EFO_0000222","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03897127%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05020665%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03384225%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05183035%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04778397%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03257241%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04293562%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05177731%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04174612%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04087967%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03250338%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03765541%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04083911%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02724163%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03384212%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03258931%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03021330%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03926624%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","MONDO_0015756","EFO_0003820","EFO_1000068","EFO_0005803","EFO_0000616","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0002427","EFO_0002428","EFO_0000540","EFO_0000565","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"acute myeloid leukemia","approvedSymbol":"POLD1","approvedName":"DNA polymerase delta 1, catalytic subunit","targetClass":["Enzyme"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL803","targetId":"ENSG00000198056","diseaseId":"EFO_0000224","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02200978%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00408278%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","MONDO_0015756","EFO_0003820","EFO_1000068","EFO_0005803","EFO_0000616","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0002427","EFO_0002428","EFO_0000222","EFO_0000540","EFO_0000565","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"acute promyelocytic leukemia","approvedSymbol":"PRIM1","approvedName":"DNA primase subunit 1","targetClass":["Enzyme"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1289601","targetId":"ENSG00000037280","diseaseId":"EFO_0000231","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02780310%22"}],"ancestors":["EFO_0000313","MONDO_0024276","EFO_0000228","MONDO_0023370","MONDO_0045024","EFO_0006858","MONDO_0004992","EFO_0000616"],"label":"adenoid cystic carcinoma","approvedSymbol":"FLT4","approvedName":"fms related receptor tyrosine kinase 4","targetClass":["Enzyme"],"prefName":"LENVATINIB","tradeNames":["Kisplyx","Lenvima"],"synonyms":["E-7080","ER-203492-00","Lenvatinib"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000188229","diseaseId":"EFO_0000233","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02186847%22"}],"ancestors":["EFO_0003060","MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0002532","MONDO_0056806","MONDO_0023370","MONDO_0008903","EFO_1000073","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0000707","EFO_0000708","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"adenosquamous lung carcinoma","approvedSymbol":"TUBB4B","approvedName":"tubulin beta 4B class IVb","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL553025","targetId":"ENSG00000258947","diseaseId":"EFO_0000233","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00005838%22"}],"ancestors":["EFO_0003060","MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0002532","MONDO_0056806","MONDO_0023370","MONDO_0008903","EFO_1000073","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0000707","EFO_0000708","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"adenosquamous lung carcinoma","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"VINORELBINE","tradeNames":[],"synonyms":["NSC-760087","Navelbin","Vinorelbine","Vinorelbine Base"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL501867","targetId":"ENSG00000261456","diseaseId":"EFO_0000248","phase":3,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00354835%22"}],"ancestors":["OTAR_0000006","EFO_0009676","MONDO_0023370","EFO_0000691","EFO_0002970","MONDO_0045024","MONDO_0004992","MONDO_0020120","MONDO_0044334","EFO_0007384","EFO_1001968","MONDO_0024637","MONDO_0002847","MONDO_0000637","EFO_0002918","MONDO_0002848","MONDO_0016123","MONDO_0003939","EFO_1000541","EFO_0000616"],"label":"alveolar rhabdomyosarcoma","approvedSymbol":"TUBB8","approvedName":"tubulin beta 8 class VIII","targetClass":["Structural protein"],"prefName":"VINCRISTINE SULFATE","tradeNames":["Kyocristine","Leurocristine Sulfate","Marqibo kit","Oncovin","Vincasar","Vincasar pfs","Vincrex","Vincristine sulfate","Vincristine sulfate pfs"],"synonyms":["37231","Kyocristine","LILLY-37231","Marqibo","NSC-67574","Novopharm","Vincristine sulfate","Vincristine sulfate liposome","Vincristine sulphate","Vincristini sulfas","Vincrisul"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL538943","targetId":"ENSG00000188229","diseaseId":"EFO_0000248","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01222715%22"}],"ancestors":["OTAR_0000006","EFO_0009676","MONDO_0023370","EFO_0000691","EFO_0002970","MONDO_0045024","MONDO_0004992","MONDO_0020120","MONDO_0044334","EFO_0007384","EFO_1001968","MONDO_0024637","MONDO_0002847","MONDO_0000637","EFO_0002918","MONDO_0002848","MONDO_0016123","MONDO_0003939","EFO_1000541","EFO_0000616"],"label":"alveolar rhabdomyosarcoma","approvedSymbol":"TUBB4B","approvedName":"tubulin beta 4B class IVb","targetClass":["Structural protein"],"prefName":"VINORELBINE TARTRATE","tradeNames":["Navelbine","Vinorelbine tartrate"],"synonyms":["Liposomal vinorelbine tartrate","TLC-178","TLC178","Vinorelbine (as tartrate)","Vinorelbine Ditartarate","Vinorelbine ditartrate","Vinorelbine liposomal","Vinorelbine tartrate","Vinorelbine tartrate (1:2)"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL553025","targetId":"ENSG00000196230","diseaseId":"EFO_0000248","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04994132%22"}],"ancestors":["OTAR_0000006","EFO_0009676","MONDO_0023370","EFO_0000691","EFO_0002970","MONDO_0045024","MONDO_0004992","MONDO_0020120","MONDO_0044334","EFO_0007384","EFO_1001968","MONDO_0024637","MONDO_0002847","MONDO_0000637","EFO_0002918","MONDO_0002848","MONDO_0016123","MONDO_0003939","EFO_1000541","EFO_0000616"],"label":"alveolar rhabdomyosarcoma","approvedSymbol":"TUBB","approvedName":"tubulin beta class I","targetClass":["Structural protein"],"prefName":"VINORELBINE","tradeNames":[],"synonyms":["NSC-760087","Navelbin","Vinorelbine","Vinorelbine Base"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1200699","targetId":"ENSG00000118113","diseaseId":"EFO_0000274","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01631617%22"}],"ancestors":["EFO_0000701","OTAR_0000018","EFO_1000636","MONDO_0005271","EFO_0000540","MONDO_0002406","EFO_0000508","EFO_0010285","EFO_1002003"],"label":"atopic eczema","approvedSymbol":"MMP8","approvedName":"matrix metallopeptidase 8","targetClass":["Enzyme"],"prefName":"DOXYCYCLINE","tradeNames":["Doxychel","Doxycycline","Monodox","Oracea","Vibramycin"],"synonyms":["Doxirobe","Doxycycline","Doxycycline monohydrate","Doxylin","GS-3065","Supracyclin","Xyrosa"],"drugType":"Small molecule","mechanismOfAction":"Matrix metalloproteinase 8 inhibitor","targetName":"Matrix metalloproteinase 8"}
{"drugId":"CHEMBL1075","targetId":"ENSG00000136531","diseaseId":"EFO_0000275","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00000556%22"}],"ancestors":["EFO_0003777","EFO_0004269","MONDO_0007263","EFO_0000319"],"label":"atrial fibrillation","approvedSymbol":"SCN2A","approvedName":"sodium voltage-gated channel alpha subunit 2","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"MORICIZINE","tradeNames":["Ethmozine"],"synonyms":["EN-313","EN-313 FREE BASE","Ethmozine","Moracizine","Moricizine"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL13","targetId":"ENSG00000043591","diseaseId":"EFO_0000275","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00783900%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00784316%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01655303%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02695992%22"}],"ancestors":["EFO_0003777","EFO_0004269","MONDO_0007263","EFO_0000319"],"label":"atrial fibrillation","approvedSymbol":"ADRB1","approvedName":"adrenoceptor beta 1","targetClass":["Membrane receptor"],"prefName":"METOPROLOL","tradeNames":[],"synonyms":["(rs)-metoprolol","Beatrolol","CGP-2175","Dl-metoprolol","Lopressidone","Metoprolol","Metoprolol slow release","Seroken","Toprol-XL"],"drugType":"Small molecule","mechanismOfAction":"Beta-1 adrenergic receptor antagonist","targetName":"Beta-1 adrenergic receptor"}
{"drugId":"CHEMBL1305","targetId":"ENSG00000196639","diseaseId":"EFO_0000275","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01527279%22"}],"ancestors":["EFO_0003777","EFO_0004269","MONDO_0007263","EFO_0000319"],"label":"atrial fibrillation","approvedSymbol":"HRH1","approvedName":"histamine receptor H1","targetClass":["Membrane receptor"],"prefName":"ANTAZOLINE","tradeNames":["Antaz sulf","Vasocon-a"],"synonyms":["Antazoline","Atazoline","Vasocon-A"],"drugType":"Small molecule","mechanismOfAction":"Histamine H1 receptor antagonist","targetName":"Histamine H1 receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000165264","diseaseId":"EFO_0000275","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03603912%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04625946%22"}],"ancestors":["EFO_0003777","EFO_0004269","MONDO_0007263","EFO_0000319"],"label":"atrial fibrillation","approvedSymbol":"NDUFB6","approvedName":"NADH:ubiquinone oxidoreductase subunit B6","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL184412","targetId":"ENSG00000007314","diseaseId":"EFO_0000275","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01522651%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01213368%22"}],"ancestors":["EFO_0003777","EFO_0004269","MONDO_0007263","EFO_0000319"],"label":"atrial fibrillation","approvedSymbol":"SCN4A","approvedName":"sodium voltage-gated channel alpha subunit 4","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"DRONEDARONE","tradeNames":[],"synonyms":["Dronedarone","SR-33589","SR33589"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL2111110","targetId":"ENSG00000151079","diseaseId":"EFO_0000275","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00126022%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00126061%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00126074%22"}],"ancestors":["EFO_0003777","EFO_0004269","MONDO_0007263","EFO_0000319"],"label":"atrial fibrillation","approvedSymbol":"KCNA6","approvedName":"potassium voltage-gated channel subfamily A member 6","targetClass":["Ion channel"],"prefName":"TEDISAMIL","tradeNames":[],"synonyms":["KC-8857","KC8857","Tedisamil"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated potassium channel blocker","targetName":"Voltage-gated potassium channel"}
{"drugId":"CHEMBL2111110","targetId":"ENSG00000162975","diseaseId":"EFO_0000275","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00126074%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00126022%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00126061%22"}],"ancestors":["EFO_0003777","EFO_0004269","MONDO_0007263","EFO_0000319"],"label":"atrial fibrillation","approvedSymbol":"KCNF1","approvedName":"potassium voltage-gated channel modifier subfamily F member 1","targetClass":["Ion channel"],"prefName":"TEDISAMIL","tradeNames":[],"synonyms":["KC-8857","KC8857","Tedisamil"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated potassium channel blocker","targetName":"Voltage-gated potassium channel"}
{"drugId":"CHEMBL2111112","targetId":"ENSG00000130037","diseaseId":"EFO_0000275","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00267930%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00526136%22"}],"ancestors":["EFO_0003777","EFO_0004269","MONDO_0007263","EFO_0000319"],"label":"atrial fibrillation","approvedSymbol":"KCNA5","approvedName":"potassium voltage-gated channel subfamily A member 5","targetClass":["Ion channel"],"prefName":"VERNAKALANT","tradeNames":[],"synonyms":["Vernakalant"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated potassium channel subunit Kv1.5 blocker","targetName":"Voltage-gated potassium channel subunit Kv1.5"}
{"drugId":"CHEMBL473","targetId":"ENSG00000055118","diseaseId":"EFO_0000275","phase":3,"status":"Suspended","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00392106%22"}],"ancestors":["EFO_0003777","EFO_0004269","MONDO_0007263","EFO_0000319"],"label":"atrial fibrillation","approvedSymbol":"KCNH2","approvedName":"potassium voltage-gated channel subfamily H member 2","targetClass":["Ion channel","Membrane receptor"],"prefName":"DOFETILIDE","tradeNames":["Dofetilide","Tikosyn"],"synonyms":["Dofetilide","UK-68,798","UK-68798"],"drugType":"Small molecule","mechanismOfAction":"HERG blocker","targetName":"HERG"}
{"drugId":"CHEMBL477","targetId":"ENSG00000170425","diseaseId":"EFO_0000275","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03032965%22"}],"ancestors":["EFO_0003777","EFO_0004269","MONDO_0007263","EFO_0000319"],"label":"atrial fibrillation","approvedSymbol":"ADORA2B","approvedName":"adenosine A2b receptor","targetClass":["Membrane receptor"],"prefName":"ADENOSINE","tradeNames":["Adenocard","Adenocor","Adenoscan","Adenosine"],"synonyms":["9-.beta.-d-ribofuranosyladenine","Adenosine","NSC-7652","SR 96225","SR-96225"],"drugType":"Small molecule","mechanismOfAction":"Adenosine receptor agonist","targetName":"Adenosine receptor"}
{"drugId":"CHEMBL836","targetId":"ENSG00000171873","diseaseId":"EFO_0000284","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02121613%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04107896%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02244229%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01294592%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00379067%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01604811%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02180789%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02245490%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02244255%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00701779%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01777269%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02244242%22"}],"ancestors":["EFO_0000512","OTAR_0000017","EFO_0009555","EFO_0000536","EFO_0009602","MONDO_0045024"],"label":"benign prostatic hyperplasia","approvedSymbol":"ADRA1D","approvedName":"adrenoceptor alpha 1D","targetClass":["Membrane receptor"],"prefName":"TAMSULOSIN","tradeNames":[],"synonyms":["HGP-0412","HIP-1402","HIP1402","Tamsulon","Tamsulosin"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor alpha-1 antagonist","targetName":"Adrenergic receptor alpha-1"}
{"drugId":"CHEMBL888","targetId":"ENSG00000077514","diseaseId":"EFO_0000294","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04640623%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04172675%22"}],"ancestors":["MONDO_0023370","EFO_0009690","MONDO_0045024","EFO_1000018","MONDO_0021066","EFO_0000616"],"label":"bladder tumor","approvedSymbol":"POLD3","approvedName":"DNA polymerase delta 3, accessory subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1201179","targetId":"ENSG00000146648","diseaseId":"EFO_0000305","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00684983%22"}],"ancestors":["OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0007254","MONDO_0045024","MONDO_0004992","EFO_0009483","MONDO_0003274","EFO_0003869","EFO_0000313","EFO_0010285","EFO_0006858","EFO_0000616"],"label":"breast carcinoma","approvedSymbol":"EGFR","approvedName":"epidermal growth factor receptor","targetClass":["Enzyme"],"prefName":"LAPATINIB DITOSYLATE","tradeNames":["Tykerb"],"synonyms":["GW-572016F","GW572016F","Lapatinib","Lapatinib ditoluenesulfonate monohydrate","Lapatinib ditosylate","Lapatinib ditosylate monohydrate","Lapatinib tosilate","Lapatinib tosilate hydrate","Tycerb"],"drugType":"Small molecule","mechanismOfAction":"Epidermal growth factor receptor erbB1 inhibitor","targetName":"Epidermal growth factor receptor erbB1"}
{"drugId":"CHEMBL1201752","targetId":"ENSG00000188229","diseaseId":"EFO_0000305","phase":4,"urls":[{"niceName":"FDA","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022065lbl.pdf"}],"ancestors":["OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0007254","MONDO_0045024","MONDO_0004992","EFO_0009483","MONDO_0003274","EFO_0003869","EFO_0000313","EFO_0010285","EFO_0006858","EFO_0000616"],"label":"breast carcinoma","approvedSymbol":"TUBB4B","approvedName":"tubulin beta 4B class IVb","targetClass":["Structural protein"],"prefName":"IXABEPILONE","tradeNames":["Ixempra","Ixempra kit"],"synonyms":["Azaepothilone b","BMS 247550-01","BMS-247550","BMS-247550-01","Ixabepilone","Ixempra","NSC-747973"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL2007641","targetId":"ENSG00000141736","diseaseId":"EFO_0000305","phase":1,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03101748%22"}],"ancestors":["OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0007254","MONDO_0045024","MONDO_0004992","EFO_0009483","MONDO_0003274","EFO_0003869","EFO_0000313","EFO_0010285","EFO_0006858","EFO_0000616"],"label":"breast carcinoma","approvedSymbol":"ERBB2","approvedName":"erb-b2 receptor tyrosine kinase 2","targetClass":["Enzyme"],"prefName":"PERTUZUMAB","tradeNames":["Omnitarg","Omnitarg Perjeta","Perjeta"],"synonyms":["Pertuzumab","Pertuzumab-zzxf","RG-1273","RHUMAB 2C4","RHUMAB-2C4"],"drugType":"Antibody","mechanismOfAction":"Receptor protein-tyrosine kinase erbB-2 inhibitor","targetName":"Receptor protein-tyrosine kinase erbB-2"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000188229","diseaseId":"EFO_0000305","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03606967%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03179904%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02593175%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05233696%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05177796%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04216472%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04266249%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02689427%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02436993%22"}],"ancestors":["OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0007254","MONDO_0045024","MONDO_0004992","EFO_0009483","MONDO_0003274","EFO_0003869","EFO_0000313","EFO_0010285","EFO_0006858","EFO_0000616"],"label":"breast carcinoma","approvedSymbol":"TUBB4B","approvedName":"tubulin beta 4B class IVb","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL92","targetId":"ENSG00000104833","diseaseId":"EFO_0000305","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03144947%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04001829%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02568839%22"}],"ancestors":["OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0007254","MONDO_0045024","MONDO_0004992","EFO_0009483","MONDO_0003274","EFO_0003869","EFO_0000313","EFO_0010285","EFO_0006858","EFO_0000616"],"label":"breast carcinoma","approvedSymbol":"TUBB4A","approvedName":"tubulin beta 4A class IVa","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":[],"synonyms":["RP-56976","Taxotere"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198840","diseaseId":"EFO_0000308","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02186847%22"}],"ancestors":["EFO_0003060","MONDO_0024276","MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","EFO_0000571","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000228","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"bronchoalveolar adenocarcinoma","approvedSymbol":"MT-ND3","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL359744","targetId":"ENSG00000131747","diseaseId":"EFO_0000309","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01092182%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02199184%22"}],"ancestors":["EFO_0007352","MONDO_0044881","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0100321","MONDO_0021669","MONDO_0017595","MONDO_0004805","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0005741","MONDO_0004095","EFO_0000096","MONDO_0045024","MONDO_0100336","EFO_0000540","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0017342","MONDO_0017341","MONDO_0017343"],"label":"Burkitts lymphoma","approvedSymbol":"TOP2A","approvedName":"DNA topoisomerase II alpha","targetClass":["Enzyme"],"prefName":"DOXORUBICIN HYDROCHLORIDE","tradeNames":["Adriamycin","Adriamycin Rdf","Adriamycin pfs","Caelyx","Doxil","Doxil (liposomal)","Doxorubicin hydrochloride","Doxorubicin hydrochloride (liposomal)","Myocet","Rubex"],"synonyms":["Adriablastina cs","Adriamycin, hydrochloride","Doxorubicin HCl","Doxorubicin citrate","Doxorubicin citric acid salt","Doxorubicin hcl","Doxorubicin hydrochloride","Doxorubicin liposomal complex of the hydrochloride","Doxorubicini hydrochloridum","Hydroxydaunomycin hydrochloride","Liposomal doxorubicin hydrochloride"],"drugType":"Small molecule","mechanismOfAction":"DNA topoisomerase II alpha inhibitor","targetName":"DNA topoisomerase II alpha"}
{"drugId":"CHEMBL803","targetId":"ENSG00000177084","diseaseId":"EFO_0000309","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01371630%22"}],"ancestors":["EFO_0007352","MONDO_0044881","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0100321","MONDO_0021669","MONDO_0017595","MONDO_0004805","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0005741","MONDO_0004095","EFO_0000096","MONDO_0045024","MONDO_0100336","EFO_0000540","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0017342","MONDO_0017341","MONDO_0017343"],"label":"Burkitts lymphoma","approvedSymbol":"POLE","approvedName":"DNA polymerase epsilon, catalytic subunit","targetClass":["Enzyme"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL2105717","targetId":"ENSG00000105976","diseaseId":"EFO_0000313","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05265988%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","EFO_0006858","MONDO_0004992","EFO_0000616"],"label":"carcinoma","approvedSymbol":"MET","approvedName":"MET proto-oncogene, receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"CABOZANTINIB","tradeNames":["Cabometyx","Cometriq"],"synonyms":["BMS-907351","BMS-907351 FREE BASE","Cabozantinib","XL-184","XL-184 FREE BASE","XL184"],"drugType":"Small molecule","mechanismOfAction":"Hepatocyte growth factor receptor inhibitor","targetName":"Hepatocyte growth factor receptor"}
{"drugId":"CHEMBL3545110","targetId":"ENSG00000135446","diseaseId":"EFO_0000313","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03673124%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","EFO_0006858","MONDO_0004992","EFO_0000616"],"label":"carcinoma","approvedSymbol":"CDK4","approvedName":"cyclin dependent kinase 4","targetClass":["Enzyme"],"prefName":"RIBOCICLIB","tradeNames":[],"synonyms":["LEE-011","LEE-011A","LEE011","LEE011A","Lee-011","NVP-LEE011","Ribociclib"],"drugType":"Small molecule","mechanismOfAction":"Cyclin-dependent kinase 4 inhibitor","targetName":"Cyclin-dependent kinase 4"}
{"drugId":"CHEMBL888","targetId":"ENSG00000177084","diseaseId":"EFO_0000313","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03092895%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","EFO_0006858","MONDO_0004992","EFO_0000616"],"label":"carcinoma","approvedSymbol":"POLE","approvedName":"DNA polymerase epsilon, catalytic subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000023228","diseaseId":"EFO_0000319","phase":0,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01037660%22"}],"ancestors":[],"label":"cardiovascular disease","approvedSymbol":"NDUFS1","approvedName":"NADH:ubiquinone oxidoreductase core subunit S1","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL249856","targetId":"ENSG00000172572","diseaseId":"EFO_0000319","phase":4,"urls":[{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=C01CE03"}],"ancestors":[],"label":"cardiovascular disease","approvedSymbol":"PDE3A","approvedName":"phosphodiesterase 3A","targetClass":["Enzyme"],"prefName":"ENOXIMONE","tradeNames":["Perfan"],"synonyms":["Enoximone","MDL 17,043","MDL-17043"],"drugType":"Small molecule","mechanismOfAction":"Phosphodiesterase 3 inhibitor","targetName":"Phosphodiesterase 3"}
{"drugId":"CHEMBL3990033","targetId":"ENSG00000169174","diseaseId":"EFO_0000319","phase":4,"urls":[{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=C10AX16"}],"ancestors":[],"label":"cardiovascular disease","approvedSymbol":"PCSK9","approvedName":"proprotein convertase subtilisin/kexin type 9","targetClass":["Membrane receptor","Enzyme"],"prefName":"INCLISIRAN","tradeNames":[],"synonyms":["ALN-60212","ALN-PCSSC","ALN-PSCsc","Inclisiran","Leqvio"],"drugType":"Oligonucleotide","mechanismOfAction":"PCSK9 mRNA RNAi inhibitor","targetName":"PCSK9 mRNA"}
{"drugId":"CHEMBL3184679","targetId":"ENSG00000066468","diseaseId":"EFO_0000326","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02824133%22"}],"ancestors":["MONDO_0023370","EFO_0000618","MONDO_0021248","MONDO_0045024","EFO_0007392","MONDO_0004992","EFO_0009386","EFO_1000158","EFO_0000616"],"label":"central nervous system cancer","approvedSymbol":"FGFR2","approvedName":"fibroblast growth factor receptor 2","targetClass":["Enzyme","Secreted protein"],"prefName":"AZD-4547","tradeNames":[],"synonyms":["AZD-4547","Azd 4547","Azd-4547","Azd4547","KB-74810"],"drugType":"Small molecule","mechanismOfAction":"Fibroblast growth factor receptor inhibitor","targetName":"Fibroblast growth factor receptor"}
{"drugId":"CHEMBL58323","targetId":"ENSG00000136531","diseaseId":"EFO_0000326","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03436433%22"}],"ancestors":["MONDO_0023370","EFO_0000618","MONDO_0021248","MONDO_0045024","EFO_0007392","MONDO_0004992","EFO_0009386","EFO_1000158","EFO_0000616"],"label":"central nervous system cancer","approvedSymbol":"SCN2A","approvedName":"sodium voltage-gated channel alpha subunit 2","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"ERLOSAMIDE","tradeNames":["Lacosamide","Vimpat"],"synonyms":["(r)-lacosamide 1","ADD 243037","ADD-243037","Erlosamide","Lacosamide","Lacosamide cv","SPM 927","SPM-927"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL101253","targetId":"ENSG00000128052","diseaseId":"EFO_0000339","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00088231%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","MONDO_0015756","EFO_0003820","MONDO_0023603","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0004251","EFO_0002427","EFO_0002428","EFO_0000540","EFO_0000565","EFO_0000508","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"chronic myelogenous leukemia","approvedSymbol":"KDR","approvedName":"kinase insert domain receptor","targetClass":["Enzyme"],"prefName":"VATALANIB","tradeNames":[],"synonyms":["BAY-86-5127","CGP-79787","K-222584","NVP-PTK787","PTK-787","PTK787","Ptk-787","Vatalanib","Vatalanib succinate","ZK-222584","ZK222584"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL1421","targetId":"ENSG00000182866","diseaseId":"EFO_0000339","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4764f37b-c9e6-4ede-bcc2-8a03b7c521df"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","MONDO_0015756","EFO_0003820","MONDO_0023603","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0004251","EFO_0002427","EFO_0002428","EFO_0000540","EFO_0000565","EFO_0000508","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"chronic myelogenous leukemia","approvedSymbol":"LCK","approvedName":"LCK proto-oncogene, Src family tyrosine kinase","targetClass":["Enzyme"],"prefName":"DASATINIB","tradeNames":["Dasatinib","Sprycel"],"synonyms":["BMS-354825","BMS-354825 HYDRATE","BMS-354825-03","Dasatinib","Dasatinib anhydrous","Dasatinib hydrate","Dasatinib monohydrate","NSC-759877"],"drugType":"Small molecule","mechanismOfAction":"SRC inhibitor","targetName":"SRC"}
{"drugId":"CHEMBL255863","targetId":"ENSG00000186716","diseaseId":"EFO_0000339","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01690065%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02001818%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01804985%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","MONDO_0015756","EFO_0003820","MONDO_0023603","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0004251","EFO_0002427","EFO_0002428","EFO_0000540","EFO_0000565","EFO_0000508","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"chronic myelogenous leukemia","approvedSymbol":"BCR","approvedName":"BCR activator of RhoGEF and GTPase","targetClass":["Other cytosolic protein"],"prefName":"NILOTINIB","tradeNames":["Tasigna"],"synonyms":["AMN 107","AMN-107","AMN107","NSC-747599","Nilotinib"],"drugType":"Small molecule","mechanismOfAction":"Bcr/Abl fusion protein","targetName":"Bcr/Abl fusion protein"}
{"drugId":"CHEMBL255863","targetId":"ENSG00000186716","diseaseId":"EFO_0000339","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01043874%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00786812%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01061177%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01368523%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00980018%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01227577%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01206088%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03332511%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02546674%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","MONDO_0015756","EFO_0003820","MONDO_0023603","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0004251","EFO_0002427","EFO_0002428","EFO_0000540","EFO_0000565","EFO_0000508","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"chronic myelogenous leukemia","approvedSymbol":"BCR","approvedName":"BCR activator of RhoGEF and GTPase","targetClass":["Other cytosolic protein"],"prefName":"NILOTINIB","tradeNames":["Tasigna"],"synonyms":["AMN 107","AMN-107","AMN107","NSC-747599","Nilotinib"],"drugType":"Small molecule","mechanismOfAction":"Bcr/Abl fusion protein","targetName":"Bcr/Abl fusion protein"}
{"drugId":"CHEMBL288441","targetId":"ENSG00000186716","diseaseId":"EFO_0000339","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03831776%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04626024%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03654768%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","MONDO_0015756","EFO_0003820","MONDO_0023603","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0004251","EFO_0002427","EFO_0002428","EFO_0000540","EFO_0000565","EFO_0000508","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"chronic myelogenous leukemia","approvedSymbol":"BCR","approvedName":"BCR activator of RhoGEF and GTPase","targetClass":["Other cytosolic protein"],"prefName":"BOSUTINIB","tradeNames":["Bosulif"],"synonyms":["Bosutinib","Bosutinib (as monohydrate)","Bosutinib hydrate","Bosutinib monohydrate","SK-606","SKI-606"],"drugType":"Small molecule","mechanismOfAction":"Bcr/Abl fusion protein","targetName":"Bcr/Abl fusion protein"}
{"drugId":"CHEMBL288441","targetId":"ENSG00000197122","diseaseId":"EFO_0000339","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adc84ad5-a04d-4fee-9ba8-91f7abd928e3"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","MONDO_0015756","EFO_0003820","MONDO_0023603","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0004251","EFO_0002427","EFO_0002428","EFO_0000540","EFO_0000565","EFO_0000508","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"chronic myelogenous leukemia","approvedSymbol":"SRC","approvedName":"SRC proto-oncogene, non-receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"BOSUTINIB","tradeNames":["Bosulif"],"synonyms":["Bosutinib","Bosutinib (as monohydrate)","Bosutinib hydrate","Bosutinib monohydrate","SK-606","SKI-606"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase SRC inhibitor","targetName":"Tyrosine-protein kinase SRC"}
{"drugId":"CHEMBL595","targetId":"ENSG00000132170","diseaseId":"EFO_0000339","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02889003%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02687425%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","MONDO_0015756","EFO_0003820","MONDO_0023603","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0004251","EFO_0002427","EFO_0002428","EFO_0000540","EFO_0000565","EFO_0000508","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"chronic myelogenous leukemia","approvedSymbol":"PPARG","approvedName":"peroxisome proliferator activated receptor gamma","targetClass":["Transcription factor","Unclassified protein","Epigenetic regulator"],"prefName":"PIOGLITAZONE","tradeNames":[],"synonyms":["AD-4833","Actos","Duetact","Glustin","Pioglitazone","U-72107","Zactos"],"drugType":"Small molecule","mechanismOfAction":"Peroxisome proliferator-activated receptor gamma agonist","targetName":"Peroxisome proliferator-activated receptor gamma"}
{"drugId":"CHEMBL803","targetId":"ENSG00000101868","diseaseId":"EFO_0000339","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00023920%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","MONDO_0015756","EFO_0003820","MONDO_0023603","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0004251","EFO_0002427","EFO_0002428","EFO_0000540","EFO_0000565","EFO_0000508","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"chronic myelogenous leukemia","approvedSymbol":"POLA1","approvedName":"DNA polymerase alpha 1, catalytic subunit","targetClass":["Enzyme"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1042","targetId":"ENSG00000111424","diseaseId":"EFO_0000341","phase":4,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01416701%22"}],"ancestors":["EFO_0009433","EFO_0000684","MONDO_0002567","EFO_0009910","MONDO_0004867","OTAR_0000010","EFO_0003818"],"label":"chronic obstructive pulmonary disease","approvedSymbol":"VDR","approvedName":"vitamin D receptor","targetClass":["Transcription factor"],"prefName":"CHOLECALCIFEROL","tradeNames":["Accrete d3","Aciferol d3","Adcal-d3","Aviticol","Bio-vitamin d3","Biolife vitamin d3","Cacit d3","Calceos","Calci-d","Calcichew d3","Calcichew d3 fte","Calcichew d3 once daily","Caldrink d3","Calfovit d3","Colecal d3","Colecalciferol","Colekal-d3","Colevit d3","Cubicole d3","D-max","D-tracetten","D-vit3","D3 lemon melts","D3-50","Dekristol","Desunin","Dihydrocholesterol","Dlux 400","E-d3","Evacal d3","Fultium daily d3","Fultium-d3","Hux d3","Invita d3","Iso d3","Kora liquid","Natecal d3","Nature's remedy vitamin d3","Neo-d","Nphd3","Osteocaps d3","Plenachol","Pro d3","Pro d3 folic","Pro d3 forte","Royalvit d3","Stexerol-d3","Stivit-d3","Sunvit-d3 1,000","Sunvit-d3 10,000","Sunvit-d3 2,000","Sunvit-d3 20,000","Sunvit-d3 3,000","Sunvit-d3 400","Sunvit-d3 5,000","Sunvit-d3 50,000","Sunvit-d3 800","Synervit-d3","Theical d-3","Thorens","Vigantol","Vigantoletten","Vigantoletten 500","Vit d3 streuli","Vita-d3","Vitamin D 3","Zymad"],"synonyms":["7-dehydrocholesterol, activated","AK R215 COMPONENT COLECALCIFEROL","AK-R215 COMPONENT COLECALCIFEROL","Cholecalciferol","Colecalciferol","Colecalciferolum","Delsterol","Delta-d","Deparal","Ebivit","NSC-375571","Provitina","Ricketon","Vitamin d","Vitamin d (cholecalciferol)","Vitamin d assay system suitability","Vitamin d-3","Vitamin d3","Vitamin d3 (as cholecalciferol)"],"drugType":"Small molecule","mechanismOfAction":"Vitamin D receptor agonist","targetName":"Vitamin D receptor"}
{"drugId":"CHEMBL1256786","targetId":"ENSG00000169252","diseaseId":"EFO_0000341","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02533505%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01186653%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04520230%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01748279%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01656005%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01787097%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00489853%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00542880%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03028701%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02988869%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00496470%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00239421%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03478696%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03478683%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00379028%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00139932%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00134979%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03081156%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02972476%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00996697%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01253473%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01853787%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01415518%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01794780%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01397890%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02424344%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01488019%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00561886%22"}],"ancestors":["EFO_0009433","EFO_0000684","MONDO_0002567","EFO_0009910","MONDO_0004867","OTAR_0000010","EFO_0003818"],"label":"chronic obstructive pulmonary disease","approvedSymbol":"ADRB2","approvedName":"adrenoceptor beta 2","targetClass":["Membrane receptor"],"prefName":"FORMOTEROL","tradeNames":[],"synonyms":["Foradil","Formoterol"],"drugType":"Small molecule","mechanismOfAction":"Beta-2 adrenergic receptor agonist","targetName":"Beta-2 adrenergic receptor"}
{"drugId":"CHEMBL193240","targetId":"ENSG00000105650","diseaseId":"EFO_0000341","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01443845%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01630200%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01329029%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01480661%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01849341%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01745848%22"}],"ancestors":["EFO_0009433","EFO_0000684","MONDO_0002567","EFO_0009910","MONDO_0004867","OTAR_0000010","EFO_0003818"],"label":"chronic obstructive pulmonary disease","approvedSymbol":"PDE4C","approvedName":"phosphodiesterase 4C","targetClass":["Enzyme"],"prefName":"ROFLUMILAST","tradeNames":["Daliresp","Daxas"],"synonyms":["B-9302-107","B9302-107","BY-217","BY217","BYK-20869","BYK20869","Roflumilast"],"drugType":"Small molecule","mechanismOfAction":"Phosphodiesterase 4 inhibitor","targetName":"Phosphodiesterase 4"}
{"drugId":"CHEMBL27810","targetId":"ENSG00000274286","diseaseId":"EFO_0000341","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02380053%22"}],"ancestors":["EFO_0009433","EFO_0000684","MONDO_0002567","EFO_0009910","MONDO_0004867","OTAR_0000010","EFO_0003818"],"label":"chronic obstructive pulmonary disease","approvedSymbol":"ADRA2B","approvedName":"adrenoceptor alpha 2B","targetClass":["Membrane receptor"],"prefName":"CELIPROLOL","tradeNames":[],"synonyms":["Celiprolol","Celiprolol pch"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor alpha-2 antagonist","targetName":"Adrenergic receptor alpha-2"}
{"drugId":"CHEMBL3039518","targetId":"ENSG00000133019","diseaseId":"EFO_0000341","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00478738%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00674817%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02570165%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02573870%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01319019%22"}],"ancestors":["EFO_0009433","EFO_0000684","MONDO_0002567","EFO_0009910","MONDO_0004867","OTAR_0000010","EFO_0003818"],"label":"chronic obstructive pulmonary disease","approvedSymbol":"CHRM3","approvedName":"cholinergic receptor muscarinic 3","targetClass":["Membrane receptor"],"prefName":"BATEFENTEROL","tradeNames":[],"synonyms":["Batefenterol","GSK-961081A","GSK961081","GSK961081A","TD-5959"],"drugType":"Small molecule","mechanismOfAction":"Muscarinic acetylcholine receptor M3 antagonist","targetName":"Muscarinic acetylcholine receptor M3"}
{"drugId":"CHEMBL1201733","targetId":"ENSG00000113721","diseaseId":"EFO_0000349","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01684397%22"}],"ancestors":["MONDO_0024276","MONDO_0002367","MONDO_0023370","EFO_0002890","EFO_0009690","EFO_0000681","MONDO_0045024","MONDO_0004992","MONDO_0021066","EFO_0003086","MONDO_0007763","EFO_0005708","EFO_0000313","EFO_0000228","EFO_0000348","EFO_0003865","EFO_1000363","EFO_0006858","EFO_0000616"],"label":"clear cell renal carcinoma","approvedSymbol":"PDGFRB","approvedName":"platelet derived growth factor receptor beta","targetClass":["Enzyme"],"prefName":"PAZOPANIB HYDROCHLORIDE","tradeNames":["Votrient"],"synonyms":["GW-786034B","GW786034B","Pazopanib (as hydrochloride)","Pazopanib hcl","Pazopanib hydrochloride","Pazopanib monohydrochloride"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","targetName":"Platelet-derived growth factor receptor"}
{"drugId":"CHEMBL2103868","targetId":"ENSG00000128052","diseaseId":"EFO_0000349","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05122546%22"}],"ancestors":["MONDO_0024276","MONDO_0002367","MONDO_0023370","EFO_0002890","EFO_0009690","EFO_0000681","MONDO_0045024","MONDO_0004992","MONDO_0021066","EFO_0003086","MONDO_0007763","EFO_0005708","EFO_0000313","EFO_0000228","EFO_0000348","EFO_0003865","EFO_1000363","EFO_0006858","EFO_0000616"],"label":"clear cell renal carcinoma","approvedSymbol":"KDR","approvedName":"kinase insert domain receptor","targetClass":["Enzyme"],"prefName":"CABOZANTINIB S-MALATE","tradeNames":["Cabometyx","Cometriq"],"synonyms":["BMS-907351","Cabozantinib s-malate","XL-184","XL184"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor 2 inhibitor","targetName":"Vascular endothelial growth factor receptor 2"}
{"drugId":"CHEMBL1278146","targetId":"ENSG00000134853","diseaseId":"EFO_0000365","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02390947%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0024276","MONDO_0023370","MONDO_0045024","MONDO_0024634","MONDO_0004992","EFO_0004142","EFO_0000313","EFO_1000218","EFO_0000228","MONDO_0021118","EFO_1001951","EFO_0008549","EFO_0005842","MONDO_0002516","EFO_0006858","EFO_0000616","EFO_0010282"],"label":"colorectal adenocarcinoma","approvedSymbol":"PDGFRA","approvedName":"platelet derived growth factor receptor alpha","targetClass":["Enzyme"],"prefName":"FAMITINIB","tradeNames":[],"synonyms":["Famitinib","SHR-1020","SHR1020","Shr-1020"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","targetName":"Platelet-derived growth factor receptor"}
{"drugId":"CHEMBL1946170","targetId":"ENSG00000128052","diseaseId":"EFO_0000365","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03377361%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0024276","MONDO_0023370","MONDO_0045024","MONDO_0024634","MONDO_0004992","EFO_0004142","EFO_0000313","EFO_1000218","EFO_0000228","MONDO_0021118","EFO_1001951","EFO_0008549","EFO_0005842","MONDO_0002516","EFO_0006858","EFO_0000616","EFO_0010282"],"label":"colorectal adenocarcinoma","approvedSymbol":"KDR","approvedName":"kinase insert domain receptor","targetClass":["Enzyme"],"prefName":"REGORAFENIB","tradeNames":["Stivarga"],"synonyms":["BAY 73-4506","BAY 73-4506 monohydrate","BAY-73-4506","BAY-734506","Regorafenib"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL1946170","targetId":"ENSG00000128052","diseaseId":"EFO_0000365","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02788006%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01929616%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0024276","MONDO_0023370","MONDO_0045024","MONDO_0024634","MONDO_0004992","EFO_0004142","EFO_0000313","EFO_1000218","EFO_0000228","MONDO_0021118","EFO_1001951","EFO_0008549","EFO_0005842","MONDO_0002516","EFO_0006858","EFO_0000616","EFO_0010282"],"label":"colorectal adenocarcinoma","approvedSymbol":"KDR","approvedName":"kinase insert domain receptor","targetClass":["Enzyme"],"prefName":"REGORAFENIB","tradeNames":["Stivarga"],"synonyms":["BAY 73-4506","BAY 73-4506 monohydrate","BAY-73-4506","BAY-734506","Regorafenib"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL223360","targetId":"ENSG00000182578","diseaseId":"EFO_0000365","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00707889%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0024276","MONDO_0023370","MONDO_0045024","MONDO_0024634","MONDO_0004992","EFO_0004142","EFO_0000313","EFO_1000218","EFO_0000228","MONDO_0021118","EFO_1001951","EFO_0008549","EFO_0005842","MONDO_0002516","EFO_0006858","EFO_0000616","EFO_0010282"],"label":"colorectal adenocarcinoma","approvedSymbol":"CSF1R","approvedName":"colony stimulating factor 1 receptor","targetClass":["Enzyme"],"prefName":"LINIFANIB","tradeNames":[],"synonyms":["A-741439","ABT-869","AL-39324","Linifanib","RG-3635"],"drugType":"Small molecule","mechanismOfAction":"Macrophage colony stimulating factor receptor inhibitor","targetName":"Macrophage colony stimulating factor receptor"}
{"drugId":"CHEMBL723","targetId":"ENSG00000170214","diseaseId":"EFO_0000373","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00123903%22"}],"ancestors":["EFO_0003777","EFO_0003144","EFO_0000319"],"label":"congestive heart failure","approvedSymbol":"ADRA1B","approvedName":"adrenoceptor alpha 1B","targetClass":["Membrane receptor"],"prefName":"CARVEDILOL","tradeNames":["Carvedilol","Coreg","Coreg CR","Eucardic 12.5","Eucardic 25","Eucardic 3.125","Eucardic 6.25"],"synonyms":["BM 14.190","BM-14-190","BM-14.190","BM-14190","C07AG02","Carvedilol","Coronis","DQ-2466","Dilatrend","Dimitone","Eucardic","Korvasan","Kredex","NSC-758694","SKF-105517","Talliton"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor alpha-1 antagonist","targetName":"Adrenergic receptor alpha-1"}
{"drugId":"CHEMBL1433","targetId":"ENSG00000137673","diseaseId":"EFO_0000384","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01783106%22"}],"ancestors":["EFO_0005140","EFO_0009431","OTAR_0000018","EFO_0003767","EFO_0000540","EFO_0000508","EFO_0010282"],"label":"Crohn's disease","approvedSymbol":"MMP7","approvedName":"matrix metallopeptidase 7","targetClass":["Enzyme"],"prefName":"DOXYCYCLINE ANHYDROUS","tradeNames":[],"synonyms":["Anhydrous doxycycline","Doxycycline (anhydrous)"],"drugType":"Small molecule","mechanismOfAction":"Matrix metalloproteinase 7 inhibitor","targetName":"Matrix metalloproteinase 7"}
{"drugId":"CHEMBL221959","targetId":"ENSG00000105639","diseaseId":"EFO_0000384","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01470599%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01393626%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01393899%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00615199%22"}],"ancestors":["EFO_0005140","EFO_0009431","OTAR_0000018","EFO_0003767","EFO_0000540","EFO_0000508","EFO_0010282"],"label":"Crohn's disease","approvedSymbol":"JAK3","approvedName":"Janus kinase 3","targetClass":["Enzyme"],"prefName":"TOFACITINIB","tradeNames":[],"synonyms":["550","CP 690550","CP- 690 550","CP-690","CP-690,550","CP-690,550 FREE BASE","CP-690-550","CP-690550","CP-690550 FREE BASE","CP690,550","CP690550","Cp-690 free base","Tasocitinib","Tofacitinib"],"drugType":"Small molecule","mechanismOfAction":"Janus Kinase (JAK) inhibitor","targetName":"Janus Kinase (JAK)"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000077514","diseaseId":"EFO_0000389","phase":0,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02652455%22"}],"ancestors":["MONDO_0002898","MONDO_0000653","MONDO_0023370","MONDO_0021069","MONDO_0045024","MONDO_0004992","EFO_0004198","MONDO_0021143","MONDO_0021583","EFO_0003769","EFO_0000701","EFO_0000756","EFO_0001379","EFO_1001901","EFO_0010285","EFO_0000616"],"label":"cutaneous melanoma","approvedSymbol":"POLD3","approvedName":"DNA polymerase delta 3, accessory subunit","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1908360","targetId":"ENSG00000088832","diseaseId":"EFO_0000389","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00098553%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00976573%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00521001%22"}],"ancestors":["MONDO_0002898","MONDO_0000653","MONDO_0023370","MONDO_0021069","MONDO_0045024","MONDO_0004992","EFO_0004198","MONDO_0021143","MONDO_0021583","EFO_0003769","EFO_0000701","EFO_0000756","EFO_0001379","EFO_1001901","EFO_0010285","EFO_0000616"],"label":"cutaneous melanoma","approvedSymbol":"FKBP1A","approvedName":"FKBP prolyl isomerase 1A","targetClass":["Enzyme"],"prefName":"EVEROLIMUS","tradeNames":["Afinitor","Afinitor disperz","Certican","Votubia","Zortress"],"synonyms":["40-o-(2-hydroxyethyl)-rapamycin","Everolimus","RAD 666","RAD-001","RAD-666","RAD001","SDZ-RAD","Sdz rad"],"drugType":"Small molecule","mechanismOfAction":"FK506-binding protein 1A inhibitor","targetName":"FK506-binding protein 1A"}
{"drugId":"CHEMBL1201630","targetId":"ENSG00000171105","diseaseId":"EFO_0000400","phase":4,"urls":[{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=A10AE03"},{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=A10AD03"},{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=A10AB03"},{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=A10AC03"}],"ancestors":["EFO_0000589","EFO_0001379","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"diabetes mellitus","approvedSymbol":"INSR","approvedName":"insulin receptor","targetClass":["Enzyme"],"prefName":"INSULIN PURIFIED PORK","tradeNames":["Iletin ii","Regular iletin ii (pork)","Regular purified pork insulin","Velosulin"],"synonyms":["Insulin (pork)","Insulin purified pork"],"drugType":"Protein","mechanismOfAction":"Insulin receptor agonist","targetName":"Insulin receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000130414","diseaseId":"EFO_0000400","phase":0,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02844803%22"}],"ancestors":["EFO_0000589","EFO_0001379","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"diabetes mellitus","approvedSymbol":"NDUFA10","approvedName":"NADH:ubiquinone oxidoreductase subunit A10","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198786","diseaseId":"EFO_0000400","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01929512%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01874080%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02011633%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01192152%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02249910%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01192139%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01775579%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02026817%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00279240%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00959101%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02956044%22"}],"ancestors":["EFO_0000589","EFO_0001379","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"diabetes mellitus","approvedSymbol":"MT-ND5","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000158864","diseaseId":"EFO_0000400","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04581447%22"}],"ancestors":["EFO_0000589","EFO_0001379","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"diabetes mellitus","approvedSymbol":"NDUFS2","approvedName":"NADH:ubiquinone oxidoreductase core subunit S2","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000158864","diseaseId":"EFO_0000400","phase":4,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01107717%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04288778%22"}],"ancestors":["EFO_0000589","EFO_0001379","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"diabetes mellitus","approvedSymbol":"NDUFS2","approvedName":"NADH:ubiquinone oxidoreductase core subunit S2","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000139180","diseaseId":"EFO_0000400","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02719756%22"}],"ancestors":["EFO_0000589","EFO_0001379","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"diabetes mellitus","approvedSymbol":"NDUFA9","approvedName":"NADH:ubiquinone oxidoreductase subunit A9","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1491","targetId":"ENSG00000157388","diseaseId":"EFO_0000400","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5562b3f5-8757-11de-8a39-0800200c9a66"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f48911e0-705f-11dc-afc9-0002a5d5c51b"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=01139e81-a4fa-4e13-acdf-c75c79a1aa9c"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b18686fa-be94-472e-8404-c69e6869ed10"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=18d7820d-471f-4ee2-9ec6-25d8d27c77de"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d0caec89-96ec-411d-a933-63eda74a6da7"}],"ancestors":["EFO_0000589","EFO_0001379","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"diabetes mellitus","approvedSymbol":"CACNA1D","approvedName":"calcium voltage-gated channel subunit alpha1 D","targetClass":["Ion channel"],"prefName":"AMLODIPINE","tradeNames":["Astudal 5","Istin","Norvas","Norvasc"],"synonyms":["Amlodipine","CKD-330 COMPONENT AMLODIPINE","HGP-0904","HGP0904"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated L-type calcium channel blocker","targetName":"Voltage-gated L-type calcium channel"}
{"drugId":"CHEMBL1703","targetId":"ENSG00000167792","diseaseId":"EFO_0000400","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01890122%22"}],"ancestors":["EFO_0000589","EFO_0001379","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"diabetes mellitus","approvedSymbol":"NDUFV1","approvedName":"NADH:ubiquinone oxidoreductase core subunit V1","targetClass":["Enzyme"],"prefName":"METFORMIN HYDROCHLORIDE","tradeNames":["Bolamyn sr","Diagemet xl","Fortamet","Glucamet 500","Glucamet 850","Glucient sr","Glucophage","Glucophage sr","Glucophage xr","Glumetza","Glyformin","Janumet","Ledermetin","Metabet sr","Metformin hydrochloride","Metsol","Milform","Orabet","Riomet","Riomet er","Sukkarto sr"],"synonyms":["Apophage","Benofomin","Diabefagos","Diabex","EX-404","EX404","Glucaminol","LA-6023","Metformin hcl","Metformin hydrochloride","NSC-91485","Neodipa","Siamformet","Walaphage"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1703","targetId":"ENSG00000198888","diseaseId":"EFO_0000400","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4383c6ec-53ad-4c79-b0af-316b3284b2fb"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f6dd9b86-0d18-95d4-2bc7-05591bfdd597"}],"ancestors":["EFO_0000589","EFO_0001379","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"diabetes mellitus","approvedSymbol":"MT-ND1","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1","targetClass":["Enzyme"],"prefName":"METFORMIN HYDROCHLORIDE","tradeNames":["Bolamyn sr","Diagemet xl","Fortamet","Glucamet 500","Glucamet 850","Glucient sr","Glucophage","Glucophage sr","Glucophage xr","Glumetza","Glyformin","Janumet","Ledermetin","Metabet sr","Metformin hydrochloride","Metsol","Milform","Orabet","Riomet","Riomet er","Sukkarto sr"],"synonyms":["Apophage","Benofomin","Diabefagos","Diabex","EX-404","EX404","Glucaminol","LA-6023","Metformin hcl","Metformin hydrochloride","NSC-91485","Neodipa","Siamformet","Walaphage"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1703","targetId":"ENSG00000267855","diseaseId":"EFO_0000400","phase":4,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04288778%22"}],"ancestors":["EFO_0000589","EFO_0001379","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"diabetes mellitus","approvedSymbol":"NDUFA7","approvedName":"NADH:ubiquinone oxidoreductase subunit A7","targetClass":["Enzyme"],"prefName":"METFORMIN HYDROCHLORIDE","tradeNames":["Bolamyn sr","Diagemet xl","Fortamet","Glucamet 500","Glucamet 850","Glucient sr","Glucophage","Glucophage sr","Glucophage xr","Glumetza","Glyformin","Janumet","Ledermetin","Metabet sr","Metformin hydrochloride","Metsol","Milform","Orabet","Riomet","Riomet er","Sukkarto sr"],"synonyms":["Apophage","Benofomin","Diabefagos","Diabex","EX-404","EX404","Glucaminol","LA-6023","Metformin hcl","Metformin hydrochloride","NSC-91485","Neodipa","Siamformet","Walaphage"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1703","targetId":"ENSG00000099795","diseaseId":"EFO_0000400","phase":4,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04287387%22"}],"ancestors":["EFO_0000589","EFO_0001379","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"diabetes mellitus","approvedSymbol":"NDUFB7","approvedName":"NADH:ubiquinone oxidoreductase subunit B7","targetClass":["Enzyme"],"prefName":"METFORMIN HYDROCHLORIDE","tradeNames":["Bolamyn sr","Diagemet xl","Fortamet","Glucamet 500","Glucamet 850","Glucient sr","Glucophage","Glucophage sr","Glucophage xr","Glumetza","Glyformin","Janumet","Ledermetin","Metabet sr","Metformin hydrochloride","Metsol","Milform","Orabet","Riomet","Riomet er","Sukkarto sr"],"synonyms":["Apophage","Benofomin","Diabefagos","Diabex","EX-404","EX404","Glucaminol","LA-6023","Metformin hcl","Metformin hydrochloride","NSC-91485","Neodipa","Siamformet","Walaphage"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000163873","diseaseId":"EFO_0000400","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00600067%22"}],"ancestors":["EFO_0000589","EFO_0001379","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"diabetes mellitus","approvedSymbol":"GRIK3","approvedName":"glutamate ionotropic receptor kainate type subunit 3","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"Glutamate receptor ionotropic kainate antagonist","targetName":"Glutamate receptor ionotropic kainate"}
{"drugId":"CHEMBL472","targetId":"ENSG00000187486","diseaseId":"EFO_0000400","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00494312%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00770835%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02201602%22"}],"ancestors":["EFO_0000589","EFO_0001379","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"diabetes mellitus","approvedSymbol":"KCNJ11","approvedName":"potassium inwardly rectifying channel subfamily J member 11","targetClass":["Transporter","Ion channel"],"prefName":"GLYBURIDE","tradeNames":["Calabren","Daonil","Diabeta","Diabetamide 2.5","Diabetamide 5","Euglucon","Gliken","Glyburide","Glyburide (micronized)","Glynase","Glynase Prestab","Lederglib","Libanil","Malix","Micronase","Semi-daonil"],"synonyms":["Cirara","Glibenclamide","Glibenclamidum","Glybenclamide","Glyburide","HB 419","HB-419","NSC-759618","U-26,45","U-26,452","U-26452"],"drugType":"Small molecule","mechanismOfAction":"Sulfonylurea receptor 1, Kir6.2 blocker","targetName":"Sulfonylurea receptor 1, Kir6.2"}
{"drugId":"CHEMBL932","targetId":"ENSG00000160191","diseaseId":"EFO_0000400","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01613755%22"}],"ancestors":["EFO_0000589","EFO_0001379","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"diabetes mellitus","approvedSymbol":"PDE9A","approvedName":"phosphodiesterase 9A","targetClass":["Enzyme"],"prefName":"DIPYRIDAMOLE","tradeNames":["Attia","Cerebrovase 100","Cerebrovase 25","Dipyridamole","Iv persantine","Modaplate","Ofcram pr","Persantin","Persantin ret","Persantine","Pyridantin","Vasyrol"],"synonyms":["B01AC07","Dipyridamole","NSC-515776","RA-8"],"drugType":"Small molecule","mechanismOfAction":"3',5'-cyclic phosphodiesterase inhibitor","targetName":"3',5'-cyclic phosphodiesterase"}
{"drugId":"CHEMBL1201179","targetId":"ENSG00000141736","diseaseId":"EFO_0000402","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00103324%22"}],"ancestors":["MONDO_0001056","MONDO_0024276","MONDO_0023370","MONDO_0021652","MONDO_0045024","MONDO_0004992","EFO_0000313","EFO_0000503","EFO_1000218","EFO_0000228","EFO_0000178","EFO_0003897","EFO_0008549","MONDO_0002516","EFO_0006858","EFO_0009608","EFO_0000616","EFO_0010282"],"label":"diffuse gastric adenocarcinoma","approvedSymbol":"ERBB2","approvedName":"erb-b2 receptor tyrosine kinase 2","targetClass":["Enzyme"],"prefName":"LAPATINIB DITOSYLATE","tradeNames":["Tykerb"],"synonyms":["GW-572016F","GW572016F","Lapatinib","Lapatinib ditoluenesulfonate monohydrate","Lapatinib ditosylate","Lapatinib ditosylate monohydrate","Lapatinib tosilate","Lapatinib tosilate hydrate","Tycerb"],"drugType":"Small molecule","mechanismOfAction":"Receptor protein-tyrosine kinase erbB-2 inhibitor","targetName":"Receptor protein-tyrosine kinase erbB-2"}
{"drugId":"CHEMBL1201568","targetId":"ENSG00000119535","diseaseId":"EFO_0000403","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00333008%22"}],"ancestors":["EFO_0007352","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0017595","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"diffuse large B-cell lymphoma","approvedSymbol":"CSF3R","approvedName":"colony stimulating factor 3 receptor","targetClass":["Membrane receptor"],"prefName":"PEGFILGRASTIM","tradeNames":["Neulasta","Neulasta sureclick"],"synonyms":["Chs-1701","Fulphila","Granulocyte colony-stimulating factor pegfilgrastim","Lupifil-p","MYL-1401H","Neupopeg","Nyvepria","Peg-filgrastim","Pegfilgrastim","Pegfilgrastim (neulasta)","Pegfilgrastim biosimilar - lupin","Pegfilgrastim for bioassay","Pegfilgrastim-apgf","Pegfilgrastim-bmez","Pegfilgrastim-cbqv","Pegfilgrastim-jmdb","Pegfilgrastim-ljfd","Ql-0605","Ql0605","TPI-120","Udenyca","Ziextenzo"],"drugType":"Protein","mechanismOfAction":"Granulocyte colony stimulating factor receptor agonist","targetName":"Granulocyte colony stimulating factor receptor"}
{"drugId":"CHEMBL1742992","targetId":"ENSG00000198851","diseaseId":"EFO_0000403","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03023878%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01741792%22"}],"ancestors":["EFO_0007352","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0017595","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"diffuse large B-cell lymphoma","approvedSymbol":"CD3E","approvedName":"CD3 epsilon subunit of T-cell receptor complex","targetClass":["Membrane receptor"],"prefName":"BLINATUMOMAB","tradeNames":[],"synonyms":["Blinatumomab","MEDI-538","MT-103"],"drugType":"Antibody","mechanismOfAction":"T cell surface glycoprotein CD3 cross-linking agent","targetName":"T cell surface glycoprotein CD3"}
{"drugId":"CHEMBL1742994","targetId":"ENSG00000176014","diseaseId":"EFO_0000403","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02086604%22"}],"ancestors":["EFO_0007352","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0017595","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"diffuse large B-cell lymphoma","approvedSymbol":"TUBB6","approvedName":"tubulin beta 6 class V","targetClass":["Structural protein"],"prefName":"BRENTUXIMAB VEDOTIN","tradeNames":["Adcetris"],"synonyms":["Brentuximab vedotin","Brentuximab vedotin brentuximab","CAC-10","CAC10","CAC10-VCMMAE","Cac10-1006(4)","Cac10-vcmmae(4)","Monoclonal antibody sgn-30","SGN-35"],"drugType":"Antibody","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL2108611","targetId":"ENSG00000012124","diseaseId":"EFO_0000403","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01679119%22"}],"ancestors":["EFO_0007352","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0017595","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"diffuse large B-cell lymphoma","approvedSymbol":"CD22","approvedName":"CD22 molecule","targetClass":["Adhesion"],"prefName":"INOTUZUMAB OZOGAMICIN","tradeNames":["Besponsa"],"synonyms":["CMC-544","Inotuzumab ozogamicin","PF-05208773","WAY-207294","WAY-207294 CMC-544"],"drugType":"Antibody","mechanismOfAction":"CD22 binding agent","targetName":"CD22"}
{"drugId":"CHEMBL3581647","targetId":"ENSG00000169925","diseaseId":"EFO_0000403","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02698189%22"}],"ancestors":["EFO_0007352","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0017595","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"diffuse large B-cell lymphoma","approvedSymbol":"BRD3","approvedName":"bromodomain containing 3","targetClass":["Epigenetic regulator"],"prefName":"BIRABRESIB","tradeNames":[],"synonyms":["Birabresib","MK-8628","OTX-015","OTX-015 ANHYDROUS","OTX015","OTX015 ANHYDROUS","Y-803 anhydrous"],"drugType":"Small molecule","mechanismOfAction":"Bromodomain and extra-terminal motif (BET) inhibitor","targetName":"Bromodomain and extra-terminal motif (BET)"}
{"drugId":"CHEMBL4297789","targetId":"ENSG00000142676","diseaseId":"EFO_0000403","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03488251%22"}],"ancestors":["EFO_0007352","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0017595","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"diffuse large B-cell lymphoma","approvedSymbol":"RPL11","approvedName":"ribosomal protein L11","targetClass":["Unclassified protein"],"prefName":"MT-3724","tradeNames":[],"synonyms":["Mt-3724"],"drugType":"Unknown","mechanismOfAction":"80S Ribosome inhibitor","targetName":"80S Ribosome"}
{"drugId":"CHEMBL4297789","targetId":"ENSG00000156482","diseaseId":"EFO_0000403","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03488251%22"}],"ancestors":["EFO_0007352","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0017595","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"diffuse large B-cell lymphoma","approvedSymbol":"RPL30","approvedName":"ribosomal protein L30","targetClass":["Unclassified protein"],"prefName":"MT-3724","tradeNames":[],"synonyms":["Mt-3724"],"drugType":"Unknown","mechanismOfAction":"80S Ribosome inhibitor","targetName":"80S Ribosome"}
{"drugId":"CHEMBL4297789","targetId":"ENSG00000231500","diseaseId":"EFO_0000403","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03488251%22"}],"ancestors":["EFO_0007352","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0017595","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"diffuse large B-cell lymphoma","approvedSymbol":"RPS18","approvedName":"ribosomal protein S18","targetClass":["Unclassified protein"],"prefName":"MT-3724","tradeNames":[],"synonyms":["Mt-3724"],"drugType":"Unknown","mechanismOfAction":"80S Ribosome inhibitor","targetName":"80S Ribosome"}
{"drugId":"CHEMBL501867","targetId":"ENSG00000101162","diseaseId":"EFO_0000403","phase":2,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04023916%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04842487%22"}],"ancestors":["EFO_0007352","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0017595","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"diffuse large B-cell lymphoma","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"VINCRISTINE SULFATE","tradeNames":["Kyocristine","Leurocristine Sulfate","Marqibo kit","Oncovin","Vincasar","Vincasar pfs","Vincrex","Vincristine sulfate","Vincristine sulfate pfs"],"synonyms":["37231","Kyocristine","LILLY-37231","Marqibo","NSC-67574","Novopharm","Vincristine sulfate","Vincristine sulfate liposome","Vincristine sulphate","Vincristini sulfas","Vincrisul"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL501867","targetId":"ENSG00000196230","diseaseId":"EFO_0000403","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04231448%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05018520%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05179733%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04332822%22"}],"ancestors":["EFO_0007352","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0017595","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"diffuse large B-cell lymphoma","approvedSymbol":"TUBB","approvedName":"tubulin beta class I","targetClass":["Structural protein"],"prefName":"VINCRISTINE SULFATE","tradeNames":["Kyocristine","Leurocristine Sulfate","Marqibo kit","Oncovin","Vincasar","Vincasar pfs","Vincrex","Vincristine sulfate","Vincristine sulfate pfs"],"synonyms":["37231","Kyocristine","LILLY-37231","Marqibo","NSC-67574","Novopharm","Vincristine sulfate","Vincristine sulfate liposome","Vincristine sulphate","Vincristini sulfas","Vincrisul"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL90555","targetId":"ENSG00000104833","diseaseId":"EFO_0000403","phase":2,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05290090%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05422066%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04842487%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04023916%22"}],"ancestors":["EFO_0007352","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0017595","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"diffuse large B-cell lymphoma","approvedSymbol":"TUBB4A","approvedName":"tubulin beta 4A class IVa","targetClass":["Structural protein"],"prefName":"VINCRISTINE","tradeNames":[],"synonyms":["22-oxovincaleukoblastine","Leucristine","Leurocristine","Oncotcs","Tecnocris","Vincaleukoblastine, 22-oxo-","Vincristin","Vincristine","Vinkristin"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL538943","targetId":"ENSG00000104833","diseaseId":"EFO_0000437","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04994132%22"}],"ancestors":["OTAR_0000006","EFO_0009676","MONDO_0023370","EFO_0000691","EFO_0002970","MONDO_0045024","MONDO_0004992","MONDO_0020120","MONDO_0044334","EFO_0007384","EFO_1001968","MONDO_0024637","MONDO_0002847","MONDO_0000637","EFO_0002918","MONDO_0002848","MONDO_0016123","MONDO_0003939","EFO_1000541","EFO_0000616"],"label":"embryonal rhabdomyosarcoma","approvedSymbol":"TUBB4A","approvedName":"tubulin beta 4A class IVa","targetClass":["Structural protein"],"prefName":"VINORELBINE TARTRATE","tradeNames":["Navelbine","Vinorelbine tartrate"],"synonyms":["Liposomal vinorelbine tartrate","TLC-178","TLC178","Vinorelbine (as tartrate)","Vinorelbine Ditartarate","Vinorelbine ditartrate","Vinorelbine liposomal","Vinorelbine tartrate","Vinorelbine tartrate (1:2)"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL90555","targetId":"ENSG00000188229","diseaseId":"EFO_0000437","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01055314%22"}],"ancestors":["OTAR_0000006","EFO_0009676","MONDO_0023370","EFO_0000691","EFO_0002970","MONDO_0045024","MONDO_0004992","MONDO_0020120","MONDO_0044334","EFO_0007384","EFO_1001968","MONDO_0024637","MONDO_0002847","MONDO_0000637","EFO_0002918","MONDO_0002848","MONDO_0016123","MONDO_0003939","EFO_1000541","EFO_0000616"],"label":"embryonal rhabdomyosarcoma","approvedSymbol":"TUBB4B","approvedName":"tubulin beta 4B class IVb","targetClass":["Structural protein"],"prefName":"VINCRISTINE","tradeNames":[],"synonyms":["22-oxovincaleukoblastine","Leucristine","Leurocristine","Oncotcs","Tecnocris","Vincaleukoblastine, 22-oxo-","Vincristin","Vincristine","Vinkristin"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1703","targetId":"ENSG00000198888","diseaseId":"EFO_0000466","phase":2,"status":"Suspended","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02122185%22"}],"ancestors":["OTAR_0000017","MONDO_0024276","MONDO_0002149","MONDO_0023370","EFO_1000051","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0000313","EFO_0000228","EFO_0009549","EFO_1001331","EFO_0006858","EFO_0000616"],"label":"endometrioid carcinoma","approvedSymbol":"MT-ND1","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1","targetClass":["Enzyme"],"prefName":"METFORMIN HYDROCHLORIDE","tradeNames":["Bolamyn sr","Diagemet xl","Fortamet","Glucamet 500","Glucamet 850","Glucient sr","Glucophage","Glucophage sr","Glucophage xr","Glumetza","Glyformin","Janumet","Ledermetin","Metabet sr","Metformin hydrochloride","Metsol","Milform","Orabet","Riomet","Riomet er","Sukkarto sr"],"synonyms":["Apophage","Benofomin","Diabefagos","Diabex","EX-404","EX404","Glucaminol","LA-6023","Metformin hcl","Metformin hydrochloride","NSC-91485","Neodipa","Siamformet","Walaphage"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1068","targetId":"ENSG00000168356","diseaseId":"EFO_0000474","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00275925%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01498822%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00275912%22"}],"ancestors":["EFO_0005774","EFO_0000618","EFO_0009386"],"label":"epilepsy","approvedSymbol":"SCN11A","approvedName":"sodium voltage-gated channel alpha subunit 11","targetClass":["Ion channel"],"prefName":"OXCARBAZEPINE","tradeNames":["Oxcarbazepine","Oxtellar xr","Trileptal"],"synonyms":["GP-47680","KIN-493","NSC-758693","Oxcarbamazepine","Oxcarbazepine","SPN-804"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000105737","diseaseId":"EFO_0000474","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00210574%22"}],"ancestors":["EFO_0005774","EFO_0000618","EFO_0009386"],"label":"epilepsy","approvedSymbol":"GRIK5","approvedName":"glutamate ionotropic receptor kainate type subunit 5","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"Glutamate receptor ionotropic kainate antagonist","targetName":"Glutamate receptor ionotropic kainate"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000105737","diseaseId":"EFO_0000474","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3d6b2a30-28c3-1735-e054-00144ff88e88"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=691f0102-5015-4303-9134-abb6e9b29c39"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89109cf7-404a-4949-9ef8-a1e749b37de4"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e883e5ac-4ee4-466e-bb6c-bff0a5ea8479"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=011eedbd-efb1-4d4e-99f0-b6bca81fb5ad"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a48b6716-cf81-e694-c0c7-92c87e9d37ce"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=38b4ef68-43d5-40fb-919c-2922e20ee367"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a02ad027-4e18-4a52-b2ad-d2899349381f"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=35312f49-decf-428d-bf5f-4215b762ed3c"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4adb812b-2c91-414b-a4f7-7c234a0d2d1e"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d3854fff-98ac-40a9-9929-7c4fdd223e82"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7f3d81cc-caec-47a0-b703-fdff6fbc3f6f"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2dc7957e-a3e5-46bb-aa66-f3250f872f5e"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f8bb1f7-74e4-31b5-e053-2995a90ae176"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4ce9b4dd-bcff-4157-a859-aa816e2b1226"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=98f178c8-7659-4b64-afcd-755a7387addd"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=711f0b6a-b167-46b2-b0c6-dc6dea01737b"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6c93b37f-0245-4299-a2f2-214f51b4f6b1"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=088811b2-a86a-40f4-b0d7-646aa5725807"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f9d59e3-d10d-48f3-af01-83ba3e1e3a2b"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=756e6ebc-36fa-b6ac-a228-9d86d0ab8256"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e9f64563-284b-465c-9873-44c1d3edc94e"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcbea233-0aa2-462e-9254-7c970936e44c"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3c909a53-ae66-4b28-a741-b60bb25a69cf"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d286d935-e409-452a-b7c2-84a446a6042b"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=38b8c4a5-710f-453c-b7c1-38f19e38e808"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac805bbd-26d5-456d-9ce8-cb91ed8703b6"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=88e7a888-1464-491a-a439-9a9c127c3702"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=32b48ea0-a215-43b8-83b4-a5435a686d68"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=efd1106b-d369-4651-b703-b0985ce93b79"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=13648371-f6c0-4567-a641-b074280edc96"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=39bd7142-9b39-993d-85f8-e538d4893ee5"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ed130acb-ee3c-4c93-853f-241a03749167"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c6fa0c7b-eea6-48f0-9ae9-c19eb088b271"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=950f70d4-69e6-42c0-9296-634118bbe7a9"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=21628112-0c47-11df-95b3-498d55d89593"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67dcdd6e-48bc-418e-a887-805929d83ce0"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cea5f748-3127-4d36-83af-9ab3cf58503c"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9bed0b5b-0876-49c7-9185-200b2825c6f7"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7874bf12-b05d-45ba-ac65-124ff9e20179"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4cd8947e-a20e-4d4e-8761-c45bc98899a3"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1f5f940c-d5b9-4d09-958d-246931e167af"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e9c4e279-0ef9-4e96-8741-dfe7556953d9"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1ddad60-26ab-49a7-b8a9-96442dc0ac87"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7f9eb38f-0dfa-4798-b3c1-32381d33affa"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=992d56e6-6a6e-48a2-85f1-f79a7903d8fe"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=48b2eb14-c9d5-48cb-bfc4-ddfa973db699"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0312ba87-6188-4695-8b2b-05c3da2f7a96"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=44db00eb-4ec7-47f9-82c9-4bb767f5ba3f"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3ac13777-45fb-45c2-84b8-d56aad796140"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8887de7e-eba5-4f00-97ca-5077cfaa361b"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a31cf5f7-4898-475f-a7b9-d9f8e493d9f8"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e608d164-5f77-40f5-a72b-26dd20ad7a8a"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=88c9d1ca-f3a8-4078-8de7-21fd9040dd20"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7694b8ef-74e9-474c-b9e2-f1aec42d6756"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e4886adf-199d-4b19-a4ef-75f8f94cb54e"},{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=N03AX11"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=202b1a2a-11dc-4c3d-aa53-27512a98a042"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e2a38cca-ce0e-4344-9fa1-11279c9f1aea"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b4e8ffce-7680-fd9d-df6b-5bd872ba3c09"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1f276ab2-a867-4843-8630-19792fb4da52"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d9513e0-2fb8-46c9-bbd6-b03efd31c3ef"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4690d08b-767a-40e2-979d-76f1bc742c32"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=79433bac-6142-488e-aa1b-8c9dd6aced32"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=57016639-89fe-43ad-89c4-5e7a756dddec"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e868925a-676d-469a-a18c-8162bbbb99a8"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=af3eb64f-edfb-470f-924b-ef592b5b88dc"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7dd162fc-f208-4746-b2da-92747fa2f3d5"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a712d050-d5de-4685-a80a-548ab080fdb7"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ad75cae9-1c05-4622-9941-f7116779b4e2"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17471bd6-4f48-40e0-952e-6a69bd0eeec9"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5c44de38-a291-471d-8335-abc65e04387d"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=546130a3-e5f2-422d-88f0-66de19540ecb"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b8b097e0-bfa3-4bc3-ba1f-a62a0330f689"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e5cea83a-d914-4e15-a54a-47d78ec2907b"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6ee00e82-799d-445e-b658-a9712c49a28e"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ef4cf6a8-6b40-488e-be57-6be464c8d5c5"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae63e0e2-ceb1-4cc7-88fa-92cfa4516960"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a4ff77b8-04bc-4edb-a085-8d6d8687f8d1"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=340d2619-4b29-456b-a3ac-0fa329e0b304"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1af94c80-2b17-409a-98f6-ce00f942351d"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=234076ca-0dca-4670-aa6a-6f7c1f74ff3a"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eddc5abc-ed77-46ba-94a2-ad666cf28e23"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ca4ec248-285d-4066-8f89-5ed0c538c4c9"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=48619df9-4bbd-4789-8d86-8646edb7daa5"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ca37556e-b7f9-4e36-b82e-10cc9d0feee8"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6b8d757f-8773-4513-b6be-179e0e6d0c1f"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=19f0ded7-c14a-4431-8881-7edd5c5c4e9c"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e999cb0a-8e45-4fdc-9b52-f3661f5dfc33"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=44754f78-a77c-4973-857b-e96dd413b69a"}],"ancestors":["EFO_0005774","EFO_0000618","EFO_0009386"],"label":"epilepsy","approvedSymbol":"GRIK5","approvedName":"glutamate ionotropic receptor kainate type subunit 5","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"Glutamate receptor ionotropic kainate antagonist","targetName":"Glutamate receptor ionotropic kainate"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000183873","diseaseId":"EFO_0000474","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02205931%22"}],"ancestors":["EFO_0005774","EFO_0000618","EFO_0009386"],"label":"epilepsy","approvedSymbol":"SCN5A","approvedName":"sodium voltage-gated channel alpha subunit 5","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL41355","targetId":"ENSG00000185760","diseaseId":"EFO_0000474","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01480609%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01462669%22"}],"ancestors":["EFO_0005774","EFO_0000618","EFO_0009386"],"label":"epilepsy","approvedSymbol":"KCNQ5","approvedName":"potassium voltage-gated channel subfamily Q member 5","targetClass":["Ion channel"],"prefName":"EZOGABINE","tradeNames":["Potiga","Trobalt"],"synonyms":["AWD-21360","AWD21-360","D-23129","Ezogabine","GKE-841","GW-582892X","GW582892X","Retigabine","WAY-143841"],"drugType":"Small molecule","mechanismOfAction":"KCNQ (Kv7) potassium channel opener","targetName":"KCNQ (Kv7) potassium channel"}
{"drugId":"CHEMBL452","targetId":"ENSG00000182256","diseaseId":"EFO_0000474","phase":4,"urls":[{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=N03AE01"}],"ancestors":["EFO_0005774","EFO_0000618","EFO_0009386"],"label":"epilepsy","approvedSymbol":"GABRG3","approvedName":"gamma-aminobutyric acid type A receptor subunit gamma3","targetClass":["Ion channel"],"prefName":"CLONAZEPAM","tradeNames":["Clonazepam","Klonopin","Klonopin rapidly disintegrating","Rivotril"],"synonyms":["Clonazepam","Clonazepam civ","NSC-179913","RO 5-4023","RO-5-4023","RO-54023","Ravotril","Rivatril"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL58323","targetId":"ENSG00000136531","diseaseId":"EFO_0000474","phase":3,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02408549%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04627285%22"}],"ancestors":["EFO_0005774","EFO_0000618","EFO_0009386"],"label":"epilepsy","approvedSymbol":"SCN2A","approvedName":"sodium voltage-gated channel alpha subunit 2","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"ERLOSAMIDE","tradeNames":["Lacosamide","Vimpat"],"synonyms":["(r)-lacosamide 1","ADD 243037","ADD-243037","Erlosamide","Lacosamide","Lacosamide cv","SPM 927","SPM-927"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL58323","targetId":"ENSG00000136546","diseaseId":"EFO_0000474","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04144218%22"}],"ancestors":["EFO_0005774","EFO_0000618","EFO_0009386"],"label":"epilepsy","approvedSymbol":"SCN7A","approvedName":"sodium voltage-gated channel alpha subunit 7","targetClass":["Ion channel"],"prefName":"ERLOSAMIDE","tradeNames":["Lacosamide","Vimpat"],"synonyms":["(r)-lacosamide 1","ADD 243037","ADD-243037","Erlosamide","Lacosamide","Lacosamide cv","SPM 927","SPM-927"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL741","targetId":"ENSG00000007314","diseaseId":"EFO_0000474","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02283801%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00605371%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00627575%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03695094%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02707965%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00412191%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01879423%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01357902%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02064465%22"}],"ancestors":["EFO_0005774","EFO_0000618","EFO_0009386"],"label":"epilepsy","approvedSymbol":"SCN4A","approvedName":"sodium voltage-gated channel alpha subunit 4","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"LAMOTRIGINE","tradeNames":["Lamictal","Lamictal cd","Lamictal odt","Lamictal xr","Lamotrigine"],"synonyms":["BW 430C","BW-430C","Lamotrigine","NSC-759171"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL750","targetId":"ENSG00000185313","diseaseId":"EFO_0000474","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f94b2ba4-024f-4068-8759-da6c8d31c546"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d049bfcf-0634-4649-a782-12976ee4c49e"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b20a51ef-255e-1eb0-c0e1-461cde46b887"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0ab183cf-51aa-402a-9351-53a4f112d1f9"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=902a17d4-ce4f-476a-81d8-bb518041c814"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5626e08c-de45-48ff-b85f-21abdfae6574"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=345efcc4-6a36-4ddf-8b6c-9c6c844dab0a"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3f8d493a-df64-4419-85b0-a5809219a9de"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f484218e-4265-7a3f-fda0-07e9c6f24dd5"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b40ec321-1181-4e8d-8914-d30772b30cad"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e99efc7-cf3f-4368-7afb-41d8dfaeffcf"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb81de7b-c542-495b-9278-bb8bbd6ff199"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=78ad1221-f07d-4afc-9ce7-5a0418101ff9"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=24284954-0c29-458f-a9f8-97a7ad418ca7"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4696e856-69c4-4e7e-b76d-d70d85c4b561"},{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=N03AX15"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3164d438-90bf-420a-9a56-5498b987f91c"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f89aba5c-bd19-4476-925c-bd7bd34723bb"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b2433b54-da24-45c7-9d48-35f098e15814"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6d2f9c84-a597-4055-8815-8fbcdf4c4876"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3676af6a-198b-4453-b43a-039fb26817dd"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f47f15fd-43b3-4599-9550-8efdfe36b689"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6690c2cf-1634-93c0-7b2e-0ad4ca70cd6d"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31b97f07-9783-479d-b448-b272610a2f36"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fe15e56e-8b86-4a65-825c-31d37dd81612"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0c160018-e3fb-4f04-9475-c4cf2cceb1b7"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c4c51de5-6cb3-46a5-906e-f2cb4562a52b"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=907c965e-8faf-53db-e053-2995a90a8cd1"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2b59734e-e070-4847-ae43-350eba867c33"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7acf80d2-566e-43b0-91d8-055b56a0eef6"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fef69fd6-427e-40f1-98d1-47ec35cfbdc4"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d12de43e-3ac3-4335-bc85-70d7366a91eb"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fe9efeaf-09e3-4836-9ade-995cd3e59e45"}],"ancestors":["EFO_0005774","EFO_0000618","EFO_0009386"],"label":"epilepsy","approvedSymbol":"SCN10A","approvedName":"sodium voltage-gated channel alpha subunit 10","targetClass":["Ion channel"],"prefName":"ZONISAMIDE","tradeNames":["Zonegran","Zonisamide"],"synonyms":["AD-810","CI-912","Excegran","N03AX15","PD-110843","Zonisamide"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL343448","targetId":"ENSG00000163517","diseaseId":"EFO_0000478","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00098527%22"}],"ancestors":["MONDO_0024276","EFO_0009544","MONDO_0021350","MONDO_0023370","MONDO_0021355","MONDO_0044991","MONDO_0045024","MONDO_0004992","MONDO_0003274","MONDO_0007576","EFO_0000313","EFO_1000218","EFO_0000228","EFO_0008549","MONDO_0002516","EFO_0006858","EFO_0002916","EFO_0010282","EFO_0000616"],"label":"esophageal adenocarcinoma","approvedSymbol":"HDAC11","approvedName":"histone deacetylase 11","targetClass":["Epigenetic regulator"],"prefName":"ROMIDEPSIN","tradeNames":["Chromadax","Istodax"],"synonyms":["Depsipeptide","FK-228","FK228","FR-901228","FR901228","NSC-630176","Romidepsin"],"drugType":"Protein","mechanismOfAction":"Histone deacetylase inhibitor","targetName":"Histone deacetylase"}
{"drugId":"CHEMBL481","targetId":"ENSG00000198900","diseaseId":"EFO_0000478","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00165490%22"}],"ancestors":["MONDO_0024276","EFO_0009544","MONDO_0021350","MONDO_0023370","MONDO_0021355","MONDO_0044991","MONDO_0045024","MONDO_0004992","MONDO_0003274","MONDO_0007576","EFO_0000313","EFO_1000218","EFO_0000228","EFO_0008549","MONDO_0002516","EFO_0006858","EFO_0002916","EFO_0010282","EFO_0000616"],"label":"esophageal adenocarcinoma","approvedSymbol":"TOP1","approvedName":"DNA topoisomerase I","targetClass":["Enzyme"],"prefName":"IRINOTECAN","tradeNames":[],"synonyms":["Biotecan","Camptosar","Irinotecan","NSC-728073"],"drugType":"Small molecule","mechanismOfAction":"DNA topoisomerase I inhibitor","targetName":"DNA topoisomerase I"}
{"drugId":"CHEMBL760","targetId":"ENSG00000172572","diseaseId":"EFO_0000479","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04285086%22"}],"ancestors":["EFO_0004260","MONDO_0002245","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0002249","MONDO_0000621","EFO_1000350","EFO_0009314","MONDO_0021181","MONDO_0005374","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","MONDO_0015756","EFO_0003820","MONDO_0023603","MONDO_0019111","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0004251","EFO_0002427","EFO_0002428","EFO_0000540","EFO_0000508","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"essential thrombocythemia","approvedSymbol":"PDE3A","approvedName":"phosphodiesterase 3A","targetClass":["Enzyme"],"prefName":"ANAGRELIDE","tradeNames":[],"synonyms":["Agrylin","Anagrelide","Xagrid"],"drugType":"Small molecule","mechanismOfAction":"Phosphodiesterase 3 inhibitor","targetName":"Phosphodiesterase 3"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000077514","diseaseId":"EFO_0000519","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00990496%22"}],"ancestors":["MONDO_0021193","EFO_0005543","MONDO_0023370","EFO_0000272","MONDO_0021248","MONDO_0045024","MONDO_0020665","EFO_0007392","MONDO_0004992","EFO_0009386","EFO_0000326","MONDO_0100342","MONDO_0021636","MONDO_0016680","EFO_0000618","EFO_0000616","EFO_1000158"],"label":"glioblastoma multiforme","approvedSymbol":"POLD3","approvedName":"DNA polymerase delta 3, accessory subunit","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1421","targetId":"ENSG00000097007","diseaseId":"EFO_0000519","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00892177%22"}],"ancestors":["MONDO_0021193","EFO_0005543","MONDO_0023370","EFO_0000272","MONDO_0021248","MONDO_0045024","MONDO_0020665","EFO_0007392","MONDO_0004992","EFO_0009386","EFO_0000326","MONDO_0100342","MONDO_0021636","MONDO_0016680","EFO_0000618","EFO_0000616","EFO_1000158"],"label":"glioblastoma multiforme","approvedSymbol":"ABL1","approvedName":"ABL proto-oncogene 1, non-receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"DASATINIB","tradeNames":["Dasatinib","Sprycel"],"synonyms":["BMS-354825","BMS-354825 HYDRATE","BMS-354825-03","Dasatinib","Dasatinib anhydrous","Dasatinib hydrate","Dasatinib monohydrate","NSC-759877"],"drugType":"Small molecule","mechanismOfAction":"Bcr/Abl fusion protein","targetName":"Bcr/Abl fusion protein"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000164182","diseaseId":"EFO_0000519","phase":0,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03151772%22"}],"ancestors":["MONDO_0021193","EFO_0005543","MONDO_0023370","EFO_0000272","MONDO_0021248","MONDO_0045024","MONDO_0020665","EFO_0007392","MONDO_0004992","EFO_0009386","EFO_0000326","MONDO_0100342","MONDO_0021636","MONDO_0016680","EFO_0000618","EFO_0000616","EFO_1000158"],"label":"glioblastoma multiforme","approvedSymbol":"NDUFAF2","approvedName":"NADH:ubiquinone oxidoreductase complex assembly factor 2","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198695","diseaseId":"EFO_0000519","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02780024%22"}],"ancestors":["MONDO_0021193","EFO_0005543","MONDO_0023370","EFO_0000272","MONDO_0021248","MONDO_0045024","MONDO_0020665","EFO_0007392","MONDO_0004992","EFO_0009386","EFO_0000326","MONDO_0100342","MONDO_0021636","MONDO_0016680","EFO_0000618","EFO_0000616","EFO_1000158"],"label":"glioblastoma multiforme","approvedSymbol":"MT-ND6","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000213619","diseaseId":"EFO_0000519","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02780024%22"}],"ancestors":["MONDO_0021193","EFO_0005543","MONDO_0023370","EFO_0000272","MONDO_0021248","MONDO_0045024","MONDO_0020665","EFO_0007392","MONDO_0004992","EFO_0009386","EFO_0000326","MONDO_0100342","MONDO_0021636","MONDO_0016680","EFO_0000618","EFO_0000616","EFO_1000158"],"label":"glioblastoma multiforme","approvedSymbol":"NDUFS3","approvedName":"NADH:ubiquinone oxidoreductase core subunit S3","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1642","targetId":"ENSG00000097007","diseaseId":"EFO_0000519","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00171938%22"}],"ancestors":["MONDO_0021193","EFO_0005543","MONDO_0023370","EFO_0000272","MONDO_0021248","MONDO_0045024","MONDO_0020665","EFO_0007392","MONDO_0004992","EFO_0009386","EFO_0000326","MONDO_0100342","MONDO_0021636","MONDO_0016680","EFO_0000618","EFO_0000616","EFO_1000158"],"label":"glioblastoma multiforme","approvedSymbol":"ABL1","approvedName":"ABL proto-oncogene 1, non-receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"IMATINIB MESYLATE","tradeNames":["Gleevec","Glivec","Imatinib mesylate"],"synonyms":["Gleevec","Imatinib (as mesilate)","Imatinib accord","Imatinib medac","Imatinib mesilate","Imatinib mesylate","Imatinib methane sulfonate","Imatinib methanesulfonate","NSC-716051","QTI-571","QTI571","Qti571","STI 571","STI-571","STI571"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase ABL inhibitor","targetName":"Tyrosine-protein kinase ABL"}
{"drugId":"CHEMBL2105728","targetId":"ENSG00000113721","diseaseId":"EFO_0000519","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02626364%22"}],"ancestors":["MONDO_0021193","EFO_0005543","MONDO_0023370","EFO_0000272","MONDO_0021248","MONDO_0045024","MONDO_0020665","EFO_0007392","MONDO_0004992","EFO_0009386","EFO_0000326","MONDO_0100342","MONDO_0021636","MONDO_0016680","EFO_0000618","EFO_0000616","EFO_1000158"],"label":"glioblastoma multiforme","approvedSymbol":"PDGFRB","approvedName":"platelet derived growth factor receptor beta","targetClass":["Enzyme"],"prefName":"CRENOLANIB","tradeNames":[],"synonyms":["ARO 002","ARO-002","CP 868596","CP-868,596","CP-868596","Crenolanib"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","targetName":"Platelet-derived growth factor receptor"}
{"drugId":"CHEMBL79","targetId":"ENSG00000153253","diseaseId":"EFO_0000519","phase":1,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04716699%22"}],"ancestors":["MONDO_0021193","EFO_0005543","MONDO_0023370","EFO_0000272","MONDO_0021248","MONDO_0045024","MONDO_0020665","EFO_0007392","MONDO_0004992","EFO_0009386","EFO_0000326","MONDO_0100342","MONDO_0021636","MONDO_0016680","EFO_0000618","EFO_0000616","EFO_1000158"],"label":"glioblastoma multiforme","approvedSymbol":"SCN3A","approvedName":"sodium voltage-gated channel alpha subunit 3","targetClass":["Ion channel"],"prefName":"LIDOCAINE","tradeNames":["Alphacaine","Anestacon","Dentipatch","Lidocaine","Lidoderm","Lignocaine Hcl","Lignostab","Lmx 4","Oraqix","Vagisil","Xylocaine","Xylodase","Xylotox","Ztlido"],"synonyms":["ALGRX 3268","ALGRX-3268","Anestacon","Embolex","Iontocaine","Lidocaine","Lidocainum","Lidocaton","Lidopen","Lignocaine","NSC-40030","Octocaine","Solarcaine","Xylestesin"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL803","targetId":"ENSG00000198056","diseaseId":"EFO_0000519","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01044966%22"}],"ancestors":["MONDO_0021193","EFO_0005543","MONDO_0023370","EFO_0000272","MONDO_0021248","MONDO_0045024","MONDO_0020665","EFO_0007392","MONDO_0004992","EFO_0009386","EFO_0000326","MONDO_0100342","MONDO_0021636","MONDO_0016680","EFO_0000618","EFO_0000616","EFO_1000158"],"label":"glioblastoma multiforme","approvedSymbol":"PRIM1","approvedName":"DNA primase subunit 1","targetClass":["Enzyme"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL84","targetId":"ENSG00000184428","diseaseId":"EFO_0000519","phase":1,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00452959%22"}],"ancestors":["MONDO_0021193","EFO_0005543","MONDO_0023370","EFO_0000272","MONDO_0021248","MONDO_0045024","MONDO_0020665","EFO_0007392","MONDO_0004992","EFO_0009386","EFO_0000326","MONDO_0100342","MONDO_0021636","MONDO_0016680","EFO_0000618","EFO_0000616","EFO_1000158"],"label":"glioblastoma multiforme","approvedSymbol":"TOP1MT","approvedName":"DNA topoisomerase I mitochondrial","targetClass":["Enzyme"],"prefName":"TOPOTECAN","tradeNames":["Hycamtin","Potactasol"],"synonyms":["Hycamptamine","Hycamptin","Hycamtin","NSC-609699","NSC-641007","Nogitecan","SKF-104864","Topotecan"],"drugType":"Small molecule","mechanismOfAction":"DNA topoisomerase I, mitochondrial inhibitor","targetName":"DNA topoisomerase I, mitochondrial"}
{"drugId":"CHEMBL118","targetId":"ENSG00000073756","diseaseId":"EFO_0000537","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00624559%22"}],"ancestors":["MONDO_0000473","EFO_0004264","EFO_0000319"],"label":"hypertension","approvedSymbol":"PTGS2","approvedName":"prostaglandin-endoperoxide synthase 2","targetClass":["Enzyme"],"prefName":"CELECOXIB","tradeNames":["Celebra","Celebrex","Celecoxib","Elyxyb","Onsenal"],"synonyms":["Celecoxib","DFN-15","DFN15","NSC-719627","NSC-758624","SC-58635"],"drugType":"Small molecule","mechanismOfAction":"Cyclooxygenase-2 inhibitor","targetName":"Cyclooxygenase-2"}
{"drugId":"CHEMBL1200561","targetId":"ENSG00000171873","diseaseId":"EFO_0000537","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8a4a732-39cc-4436-b004-202c9a2b5af1"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bd637448-fc45-466d-af90-20e1560bc293"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1354cefd-b275-4e3c-bda2-666d21ac3109"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=05e29a60-ebf9-470a-b565-40a6f1f6e102"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1ef407ee-6487-428e-8d4e-1a896aa15e43"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b57cf33b-e0bd-54e9-e053-2a95a90a5a6a"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=45c2b44b-c76b-4d03-8986-65ffe61fa154"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2dc814a4-1bb2-497b-987d-c3ebe444994e"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2630f595-05ba-439e-a85e-7a7d5c4e58ae"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a86e1731-0044-492f-9d78-c0f9ddc7b889"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17d13f2e-6b0e-4b66-8351-6c590f79536b"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2892f3c2-bff6-4411-adf3-fa065ac7c362"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f6646d19-2e74-49b6-99dc-1edf260fa2f2"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be67ff48-8e43-4589-800b-7c67d0c36cea"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7d5b94bd-bd39-414d-855e-b8e6f22e593e"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=df695e29-59ac-4063-9263-26c6decebea5"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=724f5dbc-da28-4d6b-bd4d-e6d024fc00aa"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=54ea9131-b6b9-4e49-8834-a1f056313843"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3cc4f65a-6eed-4a4b-ba93-e716c95feb05"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4abe1804-ae5f-4401-b84c-8ca6a71fbf74"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c2a89626-308c-4c4b-9aa1-4d6253ede486"}],"ancestors":["MONDO_0000473","EFO_0004264","EFO_0000319"],"label":"hypertension","approvedSymbol":"ADRA1D","approvedName":"adrenoceptor alpha 1D","targetClass":["Membrane receptor"],"prefName":"DOXAZOSIN MESYLATE","tradeNames":["Cardozin xl","Cardura","Cardura xl","Cascor","Colixil xl","Doxadura","Doxazosin mesylate","Doxzogen xl","Larbex xl","Oxandosin xl","Raporsin xl","Slocinx xl"],"synonyms":["Alfadil","Doxazosin (as mesilate)","Doxazosin mesilate","Doxazosin mesylate","Doxazosin methanesulfonate","NSC-759284","UK-33,274-27","UK-33274-27"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor alpha-1 antagonist","targetName":"Adrenergic receptor alpha-1"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000065518","diseaseId":"EFO_0000537","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00000620%22"}],"ancestors":["MONDO_0000473","EFO_0004264","EFO_0000319"],"label":"hypertension","approvedSymbol":"NDUFB4","approvedName":"NADH:ubiquinone oxidoreductase subunit B4","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198886","diseaseId":"EFO_0000537","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02072382%22"}],"ancestors":["MONDO_0000473","EFO_0004264","EFO_0000319"],"label":"hypertension","approvedSymbol":"MT-ND4","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL191","targetId":"ENSG00000144891","diseaseId":"EFO_0000537","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02958631%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03578042%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00533858%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00813722%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00198562%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03626259%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00669435%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01271374%22"}],"ancestors":["MONDO_0000473","EFO_0004264","EFO_0000319"],"label":"hypertension","approvedSymbol":"AGTR1","approvedName":"angiotensin II receptor type 1","targetClass":["Membrane receptor"],"prefName":"LOSARTAN","tradeNames":[],"synonyms":["Allisartan","Angizaar","Dup-89","HGP-1405","HGP1405","Losartan","Losartic","Lozap","NSC-758699"],"drugType":"Small molecule","mechanismOfAction":"Type-1 angiotensin II receptor antagonist","targetName":"Type-1 angiotensin II receptor"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000120251","diseaseId":"EFO_0000537","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00236665%22"}],"ancestors":["MONDO_0000473","EFO_0004264","EFO_0000319"],"label":"hypertension","approvedSymbol":"GRIA2","approvedName":"glutamate ionotropic receptor AMPA type subunit 2","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"Glutamate receptor ionotropic AMPA antagonist","targetName":"Glutamate receptor ionotropic AMPA"}
{"drugId":"CHEMBL256087","targetId":"ENSG00000104321","diseaseId":"EFO_0000537","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01408446%22"}],"ancestors":["MONDO_0000473","EFO_0004264","EFO_0000319"],"label":"hypertension","approvedSymbol":"TRPA1","approvedName":"transient receptor potential cation channel subfamily A member 1","targetClass":["Ion channel"],"prefName":"MENTHOL","tradeNames":["Aqua-cool","Aquasoothe","Arjun","Catarrh","Dermacool","Fisherman's friend lozenges","Halls","Karvol","Lockets","Meggezones","Muirs","Therapeutic mineral ice","Tixylix decongestant inh","Vocalzone"],"synonyms":["Dl-menthol","FEMA NO. 2665","Menthol","Menthol racemate","NSC-2603","Racementhol"],"drugType":"Small molecule","mechanismOfAction":"Transient receptor potential cation channel subfamily A member 1 opener","targetName":"Transient receptor potential cation channel subfamily A member 1"}
{"drugId":"CHEMBL723","targetId":"ENSG00000170214","diseaseId":"EFO_0000537","phase":3,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04121299%22"}],"ancestors":["MONDO_0000473","EFO_0004264","EFO_0000319"],"label":"hypertension","approvedSymbol":"ADRA1B","approvedName":"adrenoceptor alpha 1B","targetClass":["Membrane receptor"],"prefName":"CARVEDILOL","tradeNames":["Carvedilol","Coreg","Coreg CR","Eucardic 12.5","Eucardic 25","Eucardic 3.125","Eucardic 6.25"],"synonyms":["BM 14.190","BM-14-190","BM-14.190","BM-14190","C07AG02","Carvedilol","Coronis","DQ-2466","Dilatrend","Dimitone","Eucardic","Korvasan","Kredex","NSC-758694","SKF-105517","Talliton"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor alpha-1 antagonist","targetName":"Adrenergic receptor alpha-1"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198840","diseaseId":"EFO_0000545","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02848950%22"}],"ancestors":["EFO_0000512","OTAR_0000017"],"label":"infertility","approvedSymbol":"MT-ND3","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL2110824","targetId":"ENSG00000109163","diseaseId":"EFO_0000545","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00823602%22"}],"ancestors":["EFO_0000512","OTAR_0000017"],"label":"infertility","approvedSymbol":"GNRHR","approvedName":"gonadotropin releasing hormone receptor","targetClass":["Membrane receptor"],"prefName":"BUSERELIN","tradeNames":["Suprecur","Suprefact"],"synonyms":["Buserelin"],"drugType":"Protein","mechanismOfAction":"Gonadotropin-releasing hormone receptor agonist","targetName":"Gonadotropin-releasing hormone receptor"}
{"drugId":"CHEMBL1200699","targetId":"ENSG00000137673","diseaseId":"EFO_0000546","phase":2,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05411484%22"}],"ancestors":["OTAR_0000009"],"label":"injury","approvedSymbol":"MMP7","approvedName":"matrix metallopeptidase 7","targetClass":["Enzyme"],"prefName":"DOXYCYCLINE","tradeNames":["Doxychel","Doxycycline","Monodox","Oracea","Vibramycin"],"synonyms":["Doxirobe","Doxycycline","Doxycycline monohydrate","Doxylin","GS-3065","Supracyclin","Xyrosa"],"drugType":"Small molecule","mechanismOfAction":"Matrix metalloproteinase 7 inhibitor","targetName":"Matrix metalloproteinase 7"}
{"drugId":"CHEMBL1714","targetId":"ENSG00000161509","diseaseId":"EFO_0000546","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00834730%22"}],"ancestors":["OTAR_0000009"],"label":"injury","approvedSymbol":"GRIN2C","approvedName":"glutamate ionotropic receptor NMDA type subunit 2C","targetClass":["Ion channel"],"prefName":"KETAMINE HYDROCHLORIDE","tradeNames":["Anaket-V","Ketalar","Ketamine hydrochloride","Ketanest","Ketavet","Vetalar"],"synonyms":["CI-581","CL 369","CL-369","CN-52,372-2","CN-52372-2","CN-523722","Ketamine (as hydrochloride)","Ketamine hcl","Ketamine hydrochloride","Ketamine hydrochloride ciii","Ketamini hydrochloridum","Special k","Vetalar"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor negative allosteric modulator","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL499","targetId":"ENSG00000043591","diseaseId":"EFO_0000546","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03452072%22"}],"ancestors":["OTAR_0000009"],"label":"injury","approvedSymbol":"ADRB1","approvedName":"adrenoceptor beta 1","targetClass":["Membrane receptor"],"prefName":"TIMOLOL","tradeNames":["Betim","Betimol","Blocadren","Glau-opt","Glaucol","Nyogel","Timolol","Timoptic","Tiopex"],"synonyms":["Blocadren","Istalol","Timolol","Timolol anhydrous","Timolol hemihydrate","Timoptic","Timoptic-XE"],"drugType":"Small molecule","mechanismOfAction":"Beta-1 adrenergic receptor antagonist","targetName":"Beta-1 adrenergic receptor"}
{"drugId":"CHEMBL655","targetId":"ENSG00000113327","diseaseId":"EFO_0000546","phase":3,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05383495%22"}],"ancestors":["OTAR_0000009"],"label":"injury","approvedSymbol":"GABRG2","approvedName":"gamma-aminobutyric acid type A receptor subunit gamma2","targetClass":["Ion channel"],"prefName":"MIDAZOLAM","tradeNames":["Midazolam in 0.9% sodium chloride","Nayzilam"],"synonyms":["Midazolam","Midazolam civ","USL-261","USL261"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL79","targetId":"ENSG00000183873","diseaseId":"EFO_0000546","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03676556%22"}],"ancestors":["OTAR_0000009"],"label":"injury","approvedSymbol":"SCN5A","approvedName":"sodium voltage-gated channel alpha subunit 5","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"LIDOCAINE","tradeNames":["Alphacaine","Anestacon","Dentipatch","Lidocaine","Lidoderm","Lignocaine Hcl","Lignostab","Lmx 4","Oraqix","Vagisil","Xylocaine","Xylodase","Xylotox","Ztlido"],"synonyms":["ALGRX 3268","ALGRX-3268","Anestacon","Embolex","Iontocaine","Lidocaine","Lidocainum","Lidocaton","Lidopen","Lignocaine","NSC-40030","Octocaine","Solarcaine","Xylestesin"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL79","targetId":"ENSG00000136546","diseaseId":"EFO_0000546","phase":4,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02584335%22"}],"ancestors":["OTAR_0000009"],"label":"injury","approvedSymbol":"SCN7A","approvedName":"sodium voltage-gated channel alpha subunit 7","targetClass":["Ion channel"],"prefName":"LIDOCAINE","tradeNames":["Alphacaine","Anestacon","Dentipatch","Lidocaine","Lidoderm","Lignocaine Hcl","Lignostab","Lmx 4","Oraqix","Vagisil","Xylocaine","Xylodase","Xylotox","Ztlido"],"synonyms":["ALGRX 3268","ALGRX-3268","Anestacon","Embolex","Iontocaine","Lidocaine","Lidocainum","Lidocaton","Lidopen","Lignocaine","NSC-40030","Octocaine","Solarcaine","Xylestesin"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000196230","diseaseId":"EFO_0000556","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02835586%22"}],"ancestors":["EFO_0000651","HP_0000118","HP_0001626"],"label":"ischemia","approvedSymbol":"TUBB","approvedName":"tubulin beta class I","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL34259","targetId":"ENSG00000228716","diseaseId":"EFO_0000557","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00323960%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0009433","MONDO_0600023","EFO_0009690","EFO_0004145","EFO_0002461","EFO_0004244","MONDO_0016105","EFO_0000398","MONDO_0002406","EFO_0000618","EFO_1002003","MONDO_0003939","EFO_1002049","EFO_0009387","EFO_0002970","EFO_0003100","OTAR_0000010","EFO_0003086","MONDO_0020120","EFO_0003063","MONDO_0020122","EFO_0000701","MONDO_0019724","EFO_0000783","EFO_0000684","EFO_0000540","MONDO_0015923","EFO_1001902","EFO_0004149","EFO_0005755","MONDO_0018010","EFO_1001986","EFO_0010285","EFO_0003818"],"label":"juvenile dermatomyositis","approvedSymbol":"DHFR","approvedName":"dihydrofolate reductase","targetClass":["Enzyme"],"prefName":"METHOTREXATE","tradeNames":["Amethopterin","Ebetrex","Emtexate high-pot","Emtexate pf","Folex","Maxtrex","Methotrexate","Metoject","Mexate","Otrexup","Otrexup pfs","Rasuvo","Reditrex","Rheumatrex","Trexall","Zlatal"],"synonyms":["(r)-methotrexate","ADX-2191","Abitrexate","Amethopterin","CL 14377","CL-14377","D-amethopterin","D-methotrexate","EMT-25299","Folex","Methotrexate","Methotrexate, (r)-","Methotrexate, d-","Methotrexatum","Methylaminopterin","Mexate","Mexate-AQ","NSC-740","R-9985","R-methotrexate","TCMDC-123832","TCMDC-125488","TCMDC-125858","Trexall"],"drugType":"Small molecule","mechanismOfAction":"Dihydrofolate reductase inhibitor","targetName":"Dihydrofolate reductase"}
{"drugId":"CHEMBL1201265","targetId":"ENSG00000113580","diseaseId":"EFO_0000565","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1447b82-9e72-4e93-97c3-51fe7484517f"}],"ancestors":["OTAR_0000006","EFO_0009676","MONDO_0003225","MONDO_0002334","EFO_0000540","MONDO_0023370","MONDO_0005374","EFO_0002461","MONDO_0045024","MONDO_0044881","EFO_0005803","EFO_0000616"],"label":"leukemia","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"METHYLPREDNISOLONE HEMISUCCINATE","tradeNames":[],"synonyms":["Methylprednisolone hemisuccinate","Methylprednisolone succinate"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL1201605","targetId":"ENSG00000134460","diseaseId":"EFO_0000565","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00006350%22"}],"ancestors":["OTAR_0000006","EFO_0009676","MONDO_0003225","MONDO_0002334","EFO_0000540","MONDO_0023370","MONDO_0005374","EFO_0002461","MONDO_0045024","MONDO_0044881","EFO_0005803","EFO_0000616"],"label":"leukemia","approvedSymbol":"IL2RA","approvedName":"interleukin 2 receptor subunit alpha","targetClass":["Membrane receptor"],"prefName":"DACLIZUMAB","tradeNames":["Zenapax","Zinbryta"],"synonyms":["Daclizumab","Daclizumab beta","RO 24-7375","RO-24-7375"],"drugType":"Antibody","mechanismOfAction":"Interleukin-2 receptor inhibitor","targetName":"Interleukin-2 receptor"}
{"drugId":"CHEMBL1421","targetId":"ENSG00000182866","diseaseId":"EFO_0000565","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00978731%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00816283%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00345826%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01218477%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00064233%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00306202%22"}],"ancestors":["OTAR_0000006","EFO_0009676","MONDO_0003225","MONDO_0002334","EFO_0000540","MONDO_0023370","MONDO_0005374","EFO_0002461","MONDO_0045024","MONDO_0044881","EFO_0005803","EFO_0000616"],"label":"leukemia","approvedSymbol":"LCK","approvedName":"LCK proto-oncogene, Src family tyrosine kinase","targetClass":["Enzyme"],"prefName":"DASATINIB","tradeNames":["Dasatinib","Sprycel"],"synonyms":["BMS-354825","BMS-354825 HYDRATE","BMS-354825-03","Dasatinib","Dasatinib anhydrous","Dasatinib hydrate","Dasatinib monohydrate","NSC-759877"],"drugType":"Small molecule","mechanismOfAction":"SRC inhibitor","targetName":"SRC"}
{"drugId":"CHEMBL1742994","targetId":"ENSG00000101162","diseaseId":"EFO_0000565","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02096042%22"}],"ancestors":["OTAR_0000006","EFO_0009676","MONDO_0003225","MONDO_0002334","EFO_0000540","MONDO_0023370","MONDO_0005374","EFO_0002461","MONDO_0045024","MONDO_0044881","EFO_0005803","EFO_0000616"],"label":"leukemia","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"BRENTUXIMAB VEDOTIN","tradeNames":["Adcetris"],"synonyms":["Brentuximab vedotin","Brentuximab vedotin brentuximab","CAC-10","CAC10","CAC10-VCMMAE","Cac10-1006(4)","Cac10-vcmmae(4)","Monoclonal antibody sgn-30","SGN-35"],"drugType":"Antibody","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL34259","targetId":"ENSG00000228716","diseaseId":"EFO_0000565","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003868%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00025545%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003671%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00039130%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002471%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01319981%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00536978%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01162551%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00553202%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002598%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00276601%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00018954%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002494%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00787761%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002756%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002785%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003700%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00133991%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003783%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002805%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01323920%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002768%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00038610%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01020734%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00005854%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00458848%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00053196%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002704%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00317785%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00448201%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00857389%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003187%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002865%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003870%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00040690%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00070174%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00022126%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00618501%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00551460%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002547%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00109837%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01490723%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002554%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002809%22"}],"ancestors":["OTAR_0000006","EFO_0009676","MONDO_0003225","MONDO_0002334","EFO_0000540","MONDO_0023370","MONDO_0005374","EFO_0002461","MONDO_0045024","MONDO_0044881","EFO_0005803","EFO_0000616"],"label":"leukemia","approvedSymbol":"DHFR","approvedName":"dihydrofolate reductase","targetClass":["Enzyme"],"prefName":"METHOTREXATE","tradeNames":["Amethopterin","Ebetrex","Emtexate high-pot","Emtexate pf","Folex","Maxtrex","Methotrexate","Metoject","Mexate","Otrexup","Otrexup pfs","Rasuvo","Reditrex","Rheumatrex","Trexall","Zlatal"],"synonyms":["(r)-methotrexate","ADX-2191","Abitrexate","Amethopterin","CL 14377","CL-14377","D-amethopterin","D-methotrexate","EMT-25299","Folex","Methotrexate","Methotrexate, (r)-","Methotrexate, d-","Methotrexatum","Methylaminopterin","Mexate","Mexate-AQ","NSC-740","R-9985","R-methotrexate","TCMDC-123832","TCMDC-125488","TCMDC-125858","Trexall"],"drugType":"Small molecule","mechanismOfAction":"Dihydrofolate reductase inhibitor","targetName":"Dihydrofolate reductase"}
{"drugId":"CHEMBL38","targetId":"ENSG00000077092","diseaseId":"EFO_0000565","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002701%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002658%22"}],"ancestors":["OTAR_0000006","EFO_0009676","MONDO_0003225","MONDO_0002334","EFO_0000540","MONDO_0023370","MONDO_0005374","EFO_0002461","MONDO_0045024","MONDO_0044881","EFO_0005803","EFO_0000616"],"label":"leukemia","approvedSymbol":"RARB","approvedName":"retinoic acid receptor beta","targetClass":["Transcription factor"],"prefName":"TRETINOIN","tradeNames":["Acticin","Altreno","Atralin","Avita","Renova","Retin-a","Retin-a micro","Retin-a-micro","Tretin-X","Tretinoin","Vesanoid"],"synonyms":["Aberel","All-trans retinoic acid","All-trans-retinoic acid","Eudyna","Kerlocal","NSC-122758","Oristar rna","Retin a","Retinoic acid","Tretinoin"],"drugType":"Small molecule","mechanismOfAction":"Retinoic acid receptor agonist","targetName":"Retinoic acid receptor"}
{"drugId":"CHEMBL803","targetId":"ENSG00000014138","diseaseId":"EFO_0000565","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00882206%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01005914%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003729%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00022490%22"}],"ancestors":["OTAR_0000006","EFO_0009676","MONDO_0003225","MONDO_0002334","EFO_0000540","MONDO_0023370","MONDO_0005374","EFO_0002461","MONDO_0045024","MONDO_0044881","EFO_0005803","EFO_0000616"],"label":"leukemia","approvedSymbol":"POLA2","approvedName":"DNA polymerase alpha 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1703","targetId":"ENSG00000147123","diseaseId":"EFO_0000571","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03709147%22"}],"ancestors":["EFO_0003060","MONDO_0024276","MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000228","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"lung adenocarcinoma","approvedSymbol":"NDUFB11","approvedName":"NADH:ubiquinone oxidoreductase subunit B11","targetClass":["Enzyme"],"prefName":"METFORMIN HYDROCHLORIDE","tradeNames":["Bolamyn sr","Diagemet xl","Fortamet","Glucamet 500","Glucamet 850","Glucient sr","Glucophage","Glucophage sr","Glucophage xr","Glumetza","Glyformin","Janumet","Ledermetin","Metabet sr","Metformin hydrochloride","Metsol","Milform","Orabet","Riomet","Riomet er","Sukkarto sr"],"synonyms":["Apophage","Benofomin","Diabefagos","Diabex","EX-404","EX404","Glucaminol","LA-6023","Metformin hcl","Metformin hydrochloride","NSC-91485","Neodipa","Siamformet","Walaphage"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL2108738","targetId":"ENSG00000188389","diseaseId":"EFO_0000571","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02466568%22"}],"ancestors":["EFO_0003060","MONDO_0024276","MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000228","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"lung adenocarcinoma","approvedSymbol":"PDCD1","approvedName":"programmed cell death 1","targetClass":["Surface antigen"],"prefName":"NIVOLUMAB","tradeNames":["Opdivo"],"synonyms":["BMS-936558","BMS-986298","MDX-1106","Nivolumab","ONO-4538"],"drugType":"Antibody","mechanismOfAction":"Programmed cell death protein 1 inhibitor","targetName":"Programmed cell death protein 1"}
{"drugId":"CHEMBL92","targetId":"ENSG00000188229","diseaseId":"EFO_0000571","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00042835%22"}],"ancestors":["EFO_0003060","MONDO_0024276","MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000228","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"lung adenocarcinoma","approvedSymbol":"TUBB4B","approvedName":"tubulin beta 4B class IVb","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":[],"synonyms":["RP-56976","Taxotere"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1201746","targetId":"ENSG00000228716","diseaseId":"EFO_0000574","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00052442%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoma","approvedSymbol":"DHFR","approvedName":"dihydrofolate reductase","targetClass":["Enzyme"],"prefName":"PRALATREXATE","tradeNames":["Folotyn"],"synonyms":["NSC-754230","PDX","Pralatrexate"],"drugType":"Small molecule","mechanismOfAction":"Dihydrofolate reductase inhibitor","targetName":"Dihydrofolate reductase"}
{"drugId":"CHEMBL131","targetId":"ENSG00000113580","diseaseId":"EFO_0000574","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00275106%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoma","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"PREDNISOLONE","tradeNames":["Cortalone","Dekotil","Delta-cortef","Deltacortril","Deltalone","Dilacort","Fernisolone-p","Hydeltra","Meti-derm","Meticortelone","Pevanti","Precortisyl","Precortisyl fte","Prednisolone","Prelone","Scheriproct","Servisone","Sterane"],"synonyms":["Desowen","Hydeltra-Tba","Meticortelone","NSC-9120","NSC-9900","Neo-Delta-Cortef","Poly-Pred","Pred-G","Prednisolone","Servisone","Tridesilon","Verdeso"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL159","targetId":"ENSG00000101162","diseaseId":"EFO_0000574","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02343718%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoma","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"VINBLASTINE","tradeNames":[],"synonyms":["NSC-47842","Velban","Vinblastine","[3H]-Vinblastine"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL159","targetId":"ENSG00000261456","diseaseId":"EFO_0000574","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00041210%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoma","approvedSymbol":"TUBB8","approvedName":"tubulin beta 8 class VIII","targetClass":["Structural protein"],"prefName":"VINBLASTINE","tradeNames":[],"synonyms":["NSC-47842","Velban","Vinblastine","[3H]-Vinblastine"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1742994","targetId":"ENSG00000196230","diseaseId":"EFO_0000574","phase":4,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05442554%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoma","approvedSymbol":"TUBB","approvedName":"tubulin beta class I","targetClass":["Structural protein"],"prefName":"BRENTUXIMAB VEDOTIN","tradeNames":["Adcetris"],"synonyms":["Brentuximab vedotin","Brentuximab vedotin brentuximab","CAC-10","CAC10","CAC10-VCMMAE","Cac10-1006(4)","Cac10-vcmmae(4)","Monoclonal antibody sgn-30","SGN-35"],"drugType":"Antibody","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL343448","targetId":"ENSG00000171720","diseaseId":"EFO_0000574","phase":0,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01913119%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoma","approvedSymbol":"HDAC3","approvedName":"histone deacetylase 3","targetClass":["Epigenetic regulator"],"prefName":"ROMIDEPSIN","tradeNames":["Chromadax","Istodax"],"synonyms":["Depsipeptide","FK-228","FK228","FR-901228","FR901228","NSC-630176","Romidepsin"],"drugType":"Protein","mechanismOfAction":"Histone deacetylase inhibitor","targetName":"Histone deacetylase"}
{"drugId":"CHEMBL343448","targetId":"ENSG00000108840","diseaseId":"EFO_0000574","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01456039%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00024180%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00963274%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03770000%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01902225%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00019318%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01324310%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01324323%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoma","approvedSymbol":"HDAC5","approvedName":"histone deacetylase 5","targetClass":["Epigenetic regulator"],"prefName":"ROMIDEPSIN","tradeNames":["Chromadax","Istodax"],"synonyms":["Depsipeptide","FK-228","FK228","FR-901228","FR901228","NSC-630176","Romidepsin"],"drugType":"Protein","mechanismOfAction":"Histone deacetylase inhibitor","targetName":"Histone deacetylase"}
{"drugId":"CHEMBL343448","targetId":"ENSG00000068024","diseaseId":"EFO_0000574","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04233697%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoma","approvedSymbol":"HDAC4","approvedName":"histone deacetylase 4","targetClass":["Epigenetic regulator"],"prefName":"ROMIDEPSIN","tradeNames":["Chromadax","Istodax"],"synonyms":["Depsipeptide","FK-228","FK228","FR-901228","FR901228","NSC-630176","Romidepsin"],"drugType":"Protein","mechanismOfAction":"Histone deacetylase inhibitor","targetName":"Histone deacetylase"}
{"drugId":"CHEMBL378544","targetId":"ENSG00000137285","diseaseId":"EFO_0000574","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00041210%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoma","approvedSymbol":"TUBB2B","approvedName":"tubulin beta 2B class IIb","targetClass":["Structural protein"],"prefName":"VINBLASTINE SULFATE","tradeNames":["Velban","Velbe","Vinblast,lederle","Vinblastine sulfate"],"synonyms":["29060-LE","29060LE","Alkaban-aq","NSC-49842","Vinblastine sulfate","Vinblastine sulphate","Vinblastini sulfas","Vincaleukoblastine sulfate","Vlb monosulfate"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL378544","targetId":"ENSG00000137267","diseaseId":"EFO_0000574","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f073b58e-56d6-4c8d-a2ce-b37719402d77"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoma","approvedSymbol":"TUBB2A","approvedName":"tubulin beta 2A class IIa","targetClass":["Structural protein"],"prefName":"VINBLASTINE SULFATE","tradeNames":["Velban","Velbe","Vinblast,lederle","Vinblastine sulfate"],"synonyms":["29060-LE","29060LE","Alkaban-aq","NSC-49842","Vinblastine sulfate","Vinblastine sulphate","Vinblastini sulfas","Vincaleukoblastine sulfate","Vlb monosulfate"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL39541","targetId":"ENSG00000167552","diseaseId":"EFO_0000574","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00005579%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoma","approvedSymbol":"TUBA1A","approvedName":"tubulin alpha 1a","targetClass":["Structural protein"],"prefName":"DOLASTATIN-10","tradeNames":[],"synonyms":["Dolastatin 10","Dolastatin-10","Dolostatin 10"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL44657","targetId":"ENSG00000077097","diseaseId":"EFO_0000574","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00006669%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00983944%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00801918%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00723658%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00005998%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoma","approvedSymbol":"TOP2B","approvedName":"DNA topoisomerase II beta","targetClass":["Enzyme"],"prefName":"ETOPOSIDE","tradeNames":["Etoposide","Toposar","Vepesid"],"synonyms":["Etoposide","Etoposide resolution mixture","Etoposidum","NSC-141540","Sintopozid","VP-16-213"],"drugType":"Small molecule","mechanismOfAction":"DNA topoisomerase II inhibitor","targetName":"DNA topoisomerase II"}
{"drugId":"CHEMBL468","targetId":"ENSG00000100387","diseaseId":"EFO_0000574","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00450801%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoma","approvedSymbol":"RBX1","approvedName":"ring-box 1","targetClass":["Enzyme"],"prefName":"THALIDOMIDE","tradeNames":["Talidex","Thalomid"],"synonyms":[".alpha.-phthalimidoglutarimide","Celgene","Contergan","Distaval","K-17","Myrin","N-phthalylglutamic acid imide","NSC-527179","NSC-66847","Neurosedyn","Pantosediv","Pharmion","Softenon","Thaled","Thalidomide","Thalidomide "],"drugType":"Small molecule","mechanismOfAction":"CRL4(CRBN) E3 ubiquitin ligase inhibitor","targetName":"CRL4(CRBN) E3 ubiquitin ligase"}
{"drugId":"CHEMBL501867","targetId":"ENSG00000196230","diseaseId":"EFO_0000574","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003215%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00053768%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002700%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003150%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003421%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00005578%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00059839%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00646854%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002835%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002827%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00005977%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00004228%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00004179%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002576%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002618%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00005867%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003650%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00278408%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00004112%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00052936%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00004031%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002565%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002757%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003595%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00433459%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00278421%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002766%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoma","approvedSymbol":"TUBB","approvedName":"tubulin beta class I","targetClass":["Structural protein"],"prefName":"VINCRISTINE SULFATE","tradeNames":["Kyocristine","Leurocristine Sulfate","Marqibo kit","Oncovin","Vincasar","Vincasar pfs","Vincrex","Vincristine sulfate","Vincristine sulfate pfs"],"synonyms":["37231","Kyocristine","LILLY-37231","Marqibo","NSC-67574","Novopharm","Vincristine sulfate","Vincristine sulfate liposome","Vincristine sulphate","Vincristini sulfas","Vincrisul"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL538943","targetId":"ENSG00000261456","diseaseId":"EFO_0000574","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00070304%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00574496%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003963%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00006760%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoma","approvedSymbol":"TUBB8","approvedName":"tubulin beta 8 class VIII","targetClass":["Structural protein"],"prefName":"VINORELBINE TARTRATE","tradeNames":["Navelbine","Vinorelbine tartrate"],"synonyms":["Liposomal vinorelbine tartrate","TLC-178","TLC178","Vinorelbine (as tartrate)","Vinorelbine Ditartarate","Vinorelbine ditartrate","Vinorelbine liposomal","Vinorelbine tartrate","Vinorelbine tartrate (1:2)"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL565612","targetId":"ENSG00000065675","diseaseId":"EFO_0000574","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01854606%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoma","approvedSymbol":"PRKCQ","approvedName":"protein kinase C theta","targetClass":["Enzyme"],"prefName":"SOTRASTAURIN","tradeNames":[],"synonyms":["AEB-071","AEB071","Aeb-071","NVP-AEB071","Sotrastaurin"],"drugType":"Small molecule","mechanismOfAction":"Protein kinase C (PKC) inhibitor","targetName":"Protein kinase C (PKC)"}
{"drugId":"CHEMBL650","targetId":"ENSG00000113580","diseaseId":"EFO_0000574","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00920153%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoma","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"METHYLPREDNISOLONE","tradeNames":["Medrol","Medrone","Methylprednisolone"],"synonyms":["J3.872E","Methylprednisolone","NSC-19987","U-67,590A"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL803","targetId":"ENSG00000014138","diseaseId":"EFO_0000574","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003217%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003079%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00299182%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00244946%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01538472%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00058292%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoma","approvedSymbol":"POLA2","approvedName":"DNA polymerase alpha 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL803","targetId":"ENSG00000148229","diseaseId":"EFO_0000574","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00244946%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01538472%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003217%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00058292%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00299182%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003079%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoma","approvedSymbol":"POLE3","approvedName":"DNA polymerase epsilon 3, accessory subunit","targetClass":["Unclassified protein"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL803","targetId":"ENSG00000062822","diseaseId":"EFO_0000574","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00723658%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00005998%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoma","approvedSymbol":"POLD1","approvedName":"DNA polymerase delta 1, catalytic subunit","targetClass":["Enzyme"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL888","targetId":"ENSG00000077514","diseaseId":"EFO_0000574","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02533323%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00216164%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoma","approvedSymbol":"POLD3","approvedName":"DNA polymerase delta 3, accessory subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL225072","targetId":"ENSG00000176890","diseaseId":"EFO_0000588","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00668499%22"}],"ancestors":["EFO_1001044","MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"mesothelioma","approvedSymbol":"TYMS","approvedName":"thymidylate synthetase","targetClass":["Enzyme"],"prefName":"PEMETREXED","tradeNames":["Alimta","Pemfexy"],"synonyms":["LY-2315","LY-231514","LY231514","NSC-698037","Pemetrexed"],"drugType":"Small molecule","mechanismOfAction":"Thymidylate synthase inhibitor","targetName":"Thymidylate synthase"}
{"drugId":"CHEMBL491473","targetId":"ENSG00000134853","diseaseId":"EFO_0000588","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00243074%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00309946%22"}],"ancestors":["EFO_1001044","MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"mesothelioma","approvedSymbol":"PDGFRA","approvedName":"platelet derived growth factor receptor alpha","targetClass":["Enzyme"],"prefName":"CEDIRANIB","tradeNames":["Recentin"],"synonyms":["AZD-2171","AZD2171","Azd-2171","Cediranib","ZD-2171"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","targetName":"Platelet-derived growth factor receptor"}
{"drugId":"CHEMBL1487","targetId":"ENSG00000113161","diseaseId":"EFO_0000589","phase":4,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05238012%22"}],"ancestors":["OTAR_0000020"],"label":"metabolic disease","approvedSymbol":"HMGCR","approvedName":"3-hydroxy-3-methylglutaryl-CoA reductase","targetClass":["Enzyme"],"prefName":"ATORVASTATIN","tradeNames":["Cardyl","Lipitor","Prevencor","Sortis","Tahor","Zarator"],"synonyms":["Atorvastatin"],"drugType":"Small molecule","mechanismOfAction":"HMG-CoA reductase inhibitor","targetName":"HMG-CoA reductase"}
{"drugId":"CHEMBL1089636","targetId":"ENSG00000101162","diseaseId":"EFO_0000616","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00539383%22"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"ANG1005","tradeNames":[],"synonyms":["ANG-1005","ANG1005","Ang1005","Paclitaxel trevatide"],"drugType":"Protein","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1232461","targetId":"ENSG00000141867","diseaseId":"EFO_0000616","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01943851%22"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"BRD4","approvedName":"bromodomain containing 4","targetClass":["Other nuclear protein","Epigenetic regulator","Other cytosolic protein"],"prefName":"MOLIBRESIB","tradeNames":[],"synonyms":["Bet inhibitor gsk525762","GSK-525762","GSK-525762A","GSK525762","GSK525762A","I-BET 762","Molibresib"],"drugType":"Small molecule","mechanismOfAction":"Bromodomain and extra-terminal motif (BET) inhibitor","targetName":"Bromodomain and extra-terminal motif (BET)"}
{"drugId":"CHEMBL1287853","targetId":"ENSG00000096968","diseaseId":"EFO_0000616","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01437787%22"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"JAK2","approvedName":"Janus kinase 2","targetClass":["Enzyme","Other cytosolic protein"],"prefName":"FEDRATINIB","tradeNames":[],"synonyms":["Fedratinib","SAR-302503","SAR302503","Sar-302503","TG-101348","TG101348"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase JAK2 inhibitor","targetName":"Tyrosine-protein kinase JAK2"}
{"drugId":"CHEMBL159","targetId":"ENSG00000101162","diseaseId":"EFO_0000616","phase":4,"urls":[{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=L01CA01"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"VINBLASTINE","tradeNames":[],"synonyms":["NSC-47842","Velban","Vinblastine","[3H]-Vinblastine"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1614766","targetId":"ENSG00000169032","diseaseId":"EFO_0000616","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00817518%22"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"MAP2K1","approvedName":"mitogen-activated protein kinase kinase 1","targetClass":["Enzyme"],"prefName":"RO-4987655","tradeNames":[],"synonyms":["CH-4987655","RO4987655","Ro 4987655","Ro-4987655"],"drugType":"Small molecule","mechanismOfAction":"Dual specificity mitogen-activated protein kinase kinase 1 inhibitor","targetName":"Dual specificity mitogen-activated protein kinase kinase 1"}
{"drugId":"CHEMBL2029988","targetId":"ENSG00000165731","diseaseId":"EFO_0000616","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01877811%22"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"RET","approvedName":"ret proto-oncogene","targetClass":["Unclassified protein","Enzyme","Other cytosolic protein"],"prefName":"CEP-32496","tradeNames":[],"synonyms":["AB-024","AC-013773","Agerafenib","CEP-32496","Cep-32496","RXDX-105","Rxdx 105"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase receptor RET inhibitor","targetName":"Tyrosine-protein kinase receptor RET"}
{"drugId":"CHEMBL2108029","targetId":"ENSG00000198851","diseaseId":"EFO_0000616","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01569412%22"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"CD3E","approvedName":"CD3 epsilon subunit of T-cell receptor complex","targetClass":["Membrane receptor"],"prefName":"ERTUMAXOMAB","tradeNames":["Rexomun"],"synonyms":["Ertumaxomab"],"drugType":"Antibody","mechanismOfAction":"T-cell surface glycoprotein CD3 epsilon chain cross-linking agent","targetName":"T-cell surface glycoprotein CD3 epsilon chain"}
{"drugId":"CHEMBL2109500","targetId":"ENSG00000275546","diseaseId":"EFO_0000616","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03347123%22"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"KIR2DL2","approvedName":"killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 2 ","prefName":"LIRILUMAB","tradeNames":[],"synonyms":["Anti-KIR Antibody","BMS-986015","BMS-986015-01","BMS-98601501","IPH-2102","IPH2102","Lirilumab"],"drugType":"Antibody","mechanismOfAction":"Killer cell immunoglobulin-like receptor 2DL2 inhibitor","targetName":"Killer cell immunoglobulin-like receptor 2DL2"}
{"drugId":"CHEMBL2109629","targetId":"ENSG00000102854","diseaseId":"EFO_0000616","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02485119%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03102320%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02696642%22"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"MSLN","approvedName":"mesothelin","targetClass":["Unclassified protein"],"prefName":"ANETUMAB RAVTANSINE","tradeNames":[],"synonyms":["Anetumab ravtansine","BAY 94-9343","BAY-94-9343","BAY-949343","BAY94-9343"],"drugType":"Antibody","mechanismOfAction":"Mesothelin binding agent","targetName":"Mesothelin"}
{"drugId":"CHEMBL2396661","targetId":"ENSG00000121879","diseaseId":"EFO_0000616","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02620839%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01708161%22"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"PIK3CA","approvedName":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha","targetClass":["Enzyme"],"prefName":"ALPELISIB","tradeNames":["Piqray"],"synonyms":["Alpelisib","BYL-719","BYL719","Byl-719","NVP-BYL719"],"drugType":"Small molecule","mechanismOfAction":"PI3-kinase p110-alpha subunit inhibitor","targetName":"PI3-kinase p110-alpha subunit"}
{"drugId":"CHEMBL24828","targetId":"ENSG00000120156","diseaseId":"EFO_0000616","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00667147%22"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"TEK","approvedName":"TEK receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"VANDETANIB","tradeNames":["Caprelsa","Zactima"],"synonyms":["GNF-PF-2188","NSC-744325","NSC-760766","Vandetanib","ZD-64","ZD-6474","ZD6474"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase TIE-2 inhibitor","targetName":"Tyrosine-protein kinase TIE-2"}
{"drugId":"CHEMBL252164","targetId":"ENSG00000080824","diseaseId":"EFO_0000616","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01132625%22"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"HSP90AA1","approvedName":"heat shock protein 90 alpha family class A member 1","targetClass":["Unclassified protein","Other cytosolic protein"],"prefName":"LUMINESPIB","tradeNames":[],"synonyms":["Luminespib","NVP-AUY-922","NVP-AUY922","NVP-AUY922-NX","VER-52296"],"drugType":"Small molecule","mechanismOfAction":"Heat shock protein HSP90 inhibitor","targetName":"Heat shock protein HSP90"}
{"drugId":"CHEMBL254328","targetId":"ENSG00000277893","diseaseId":"EFO_0000616","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01771458%22"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"SRD5A2","approvedName":"steroid 5 alpha-reductase 2","targetClass":["Enzyme"],"prefName":"ABIRATERONE","tradeNames":["Zytiga"],"synonyms":["Abiraterone","CB 7598","CB-7598","NSC-741232"],"drugType":"Small molecule","mechanismOfAction":"Steroid 5-alpha-reductase inhibitor","targetName":"Steroid 5-alpha-reductase"}
{"drugId":"CHEMBL27759","targetId":"ENSG00000116478","diseaseId":"EFO_0000616","phase":3,"urls":[{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=L01XH05"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"HDAC1","approvedName":"histone deacetylase 1","targetClass":["Epigenetic regulator"],"prefName":"ENTINOSTAT","tradeNames":[],"synonyms":["Entinostat","MS-27-275","MS-275","MS-275-27","SNDX-275"],"drugType":"Small molecule","mechanismOfAction":"Histone deacetylase inhibitor","targetName":"Histone deacetylase"}
{"drugId":"CHEMBL3186534","targetId":"ENSG00000128052","diseaseId":"EFO_0000616","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02836171%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02836821%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04428086%22"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"KDR","approvedName":"kinase insert domain receptor","targetClass":["Enzyme"],"prefName":"RIVOCERANIB","tradeNames":[],"synonyms":["Apatinib","Apatinib free base","Rivoceranib","YN968D1","YN968D1 FREE BASE"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor 2 inhibitor","targetName":"Vascular endothelial growth factor receptor 2"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000176014","diseaseId":"EFO_0000616","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02283424%22"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"TUBB6","approvedName":"tubulin beta 6 class V","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL411","targetId":"ENSG00000091831","diseaseId":"EFO_0000616","phase":4,"urls":[{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=L02AA01"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"ESR1","approvedName":"estrogen receptor 1","targetClass":["Transcription factor","Unclassified protein"],"prefName":"DIETHYLSTILBESTROL","tradeNames":["Apstil","Diethylstilbestrol","Distilbene","Stilbestrol","Stilbetin","Stilboesterol","Tampovagan"],"synonyms":["Cyren a","Diethylstilbestrol","Estrobene","Estrogenine","Estromenin","Fonatol","NSC-3070","New-estranol 1","Palestrol","Stilbestro","Stilbestroform","Stilbestrol","Stilboestrol","Synestrin","Synthestrin"],"drugType":"Small molecule","mechanismOfAction":"Estrogen receptor alpha agonist","targetName":"Estrogen receptor alpha"}
{"drugId":"CHEMBL4442620","targetId":"ENSG00000164885","diseaseId":"EFO_0000616","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01188252%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02047890%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01335256%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02390154%22"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"CDK5","approvedName":"cyclin dependent kinase 5","targetClass":["Enzyme"],"prefName":"RONICICLIB","tradeNames":[],"synonyms":["BAY10-00394","Bay 1000394","Bay-1000394","Roniciclib"],"drugType":"Small molecule","mechanismOfAction":"Cyclin-dependent kinase inhibitor","targetName":"Cyclin-dependent kinase"}
{"drugId":"CHEMBL4442620","targetId":"ENSG00000185324","diseaseId":"EFO_0000616","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01335256%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01188252%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02047890%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02390154%22"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"CDK10","approvedName":"cyclin dependent kinase 10","targetClass":["Enzyme"],"prefName":"RONICICLIB","tradeNames":[],"synonyms":["BAY10-00394","Bay 1000394","Bay-1000394","Roniciclib"],"drugType":"Small molecule","mechanismOfAction":"Cyclin-dependent kinase inhibitor","targetName":"Cyclin-dependent kinase"}
{"drugId":"CHEMBL477772","targetId":"ENSG00000113721","diseaseId":"EFO_0000616","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00788580%22"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"PDGFRB","approvedName":"platelet derived growth factor receptor beta","targetClass":["Enzyme"],"prefName":"PAZOPANIB","tradeNames":["Votrient"],"synonyms":["GW786034","NSC-752782","Pazopanib"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","targetName":"Platelet-derived growth factor receptor"}
{"drugId":"CHEMBL558752","targetId":"ENSG00000128052","diseaseId":"EFO_0000616","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01352273%22"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"KDR","approvedName":"kinase insert domain receptor","targetClass":["Enzyme"],"prefName":"RAF-265","tradeNames":[],"synonyms":["CHIR-265","NVP-RAF265","RAF265","Raf 265","Raf-265"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor 2 inhibitor","targetName":"Vascular endothelial growth factor receptor 2"}
{"drugId":"CHEMBL574737","targetId":"ENSG00000163558","diseaseId":"EFO_0000616","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00012194%22"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"PRKCI","approvedName":"protein kinase C iota","targetClass":["Enzyme"],"prefName":"UCN-01","tradeNames":[],"synonyms":["7-hydroxystaurosporine","KRX-0601","KW-2401","NSC-638850","UCN-01","UCN-02","Ucn 01","Ucn-01"],"drugType":"Small molecule","mechanismOfAction":"Protein kinase C (PKC) inhibitor","targetName":"Protein kinase C (PKC)"}
{"drugId":"CHEMBL601719","targetId":"ENSG00000171094","diseaseId":"EFO_0000616","phase":4,"urls":[{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=L01ED01"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"ALK","approvedName":"ALK receptor tyrosine kinase","targetClass":["Other nuclear protein","Enzyme","Unclassified protein"],"prefName":"CRIZOTINIB","tradeNames":["Xalkori"],"synonyms":["Crizotinib","NSC-756645","PF-02341066","PF-2341066","Pf-2341066"],"drugType":"Small molecule","mechanismOfAction":"NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)","targetName":"NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)"}
{"drugId":"CHEMBL888","targetId":"ENSG00000062822","diseaseId":"EFO_0000616","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00072228%22"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"POLD1","approvedName":"DNA polymerase delta 1, catalytic subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL98","targetId":"ENSG00000171720","diseaseId":"EFO_0000616","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00424775%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00801151%22"}],"ancestors":["MONDO_0023370","MONDO_0045024"],"label":"neoplasm","approvedSymbol":"HDAC3","approvedName":"histone deacetylase 3","targetClass":["Epigenetic regulator"],"prefName":"VORINOSTAT","tradeNames":["Zolinza"],"synonyms":["MK-0683","MK0683","NSC-701852","NSC-748799","NSC-759852","Suberoylanilide hydroxamic acid","Vorinostat"],"drugType":"Small molecule","mechanismOfAction":"Histone deacetylase 3 inhibitor","targetName":"Histone deacetylase 3"}
{"drugId":"CHEMBL501867","targetId":"ENSG00000137267","diseaseId":"EFO_0000621","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00281905%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00024193%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00392340%22"}],"ancestors":["MONDO_0021193","EFO_0005784","EFO_1000393","EFO_0005235","MONDO_0023370","EFO_0000618","MONDO_0016708","MONDO_0021248","MONDO_0045024","EFO_0009386","EFO_0000616"],"label":"neuroblastoma","approvedSymbol":"TUBB2A","approvedName":"tubulin beta 2A class IIa","targetClass":["Structural protein"],"prefName":"VINCRISTINE SULFATE","tradeNames":["Kyocristine","Leurocristine Sulfate","Marqibo kit","Oncovin","Vincasar","Vincasar pfs","Vincrex","Vincristine sulfate","Vincristine sulfate pfs"],"synonyms":["37231","Kyocristine","LILLY-37231","Marqibo","NSC-67574","Novopharm","Vincristine sulfate","Vincristine sulfate liposome","Vincristine sulphate","Vincristini sulfas","Vincrisul"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL553025","targetId":"ENSG00000137285","diseaseId":"EFO_0000621","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003234%22"}],"ancestors":["MONDO_0021193","EFO_0005784","EFO_1000393","EFO_0005235","MONDO_0023370","EFO_0000618","MONDO_0016708","MONDO_0021248","MONDO_0045024","EFO_0009386","EFO_0000616"],"label":"neuroblastoma","approvedSymbol":"TUBB2B","approvedName":"tubulin beta 2B class IIb","targetClass":["Structural protein"],"prefName":"VINORELBINE","tradeNames":[],"synonyms":["NSC-760087","Navelbin","Vinorelbine","Vinorelbine Base"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000198056","diseaseId":"EFO_0000637","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03721068%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03635632%22"}],"ancestors":["EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0023370","EFO_0000691","EFO_0002461","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"osteosarcoma","approvedSymbol":"PRIM1","approvedName":"DNA primase subunit 1","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL535","targetId":"ENSG00000037280","diseaseId":"EFO_0000640","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05043090%22"}],"ancestors":["MONDO_0024276","MONDO_0021096","MONDO_0002367","MONDO_0002512","MONDO_0023370","EFO_0002890","EFO_0009690","EFO_0000681","MONDO_0045024","MONDO_0004992","MONDO_0021066","EFO_0003086","EFO_0005708","EFO_0000313","EFO_0000228","EFO_0003865","EFO_1000646","EFO_1000363","EFO_0006858","EFO_0000616"],"label":"papillary renal cell carcinoma","approvedSymbol":"FLT4","approvedName":"fms related receptor tyrosine kinase 4","targetClass":["Enzyme"],"prefName":"SUNITINIB","tradeNames":["Sutent"],"synonyms":["NSC-736511","NSC-750690","SU-011248","SU-11248","SU011248","Sunitinib","Sutent"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL1201733","targetId":"ENSG00000113721","diseaseId":"EFO_0000641","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01413113%22"}],"ancestors":["MONDO_0024276","MONDO_0021096","MONDO_0002512","MONDO_0002108","MONDO_0023370","EFO_0002892","MONDO_0021069","MONDO_0024622","MONDO_0045024","MONDO_0004992","EFO_0003769","EFO_0000313","EFO_0000228","EFO_1000646","EFO_0001379","EFO_0003841","EFO_1000627","EFO_1002017","EFO_0006858","EFO_0000616"],"label":"papillary thyroid carcinoma","approvedSymbol":"PDGFRB","approvedName":"platelet derived growth factor receptor beta","targetClass":["Enzyme"],"prefName":"PAZOPANIB HYDROCHLORIDE","tradeNames":["Votrient"],"synonyms":["GW-786034B","GW786034B","Pazopanib (as hydrochloride)","Pazopanib hcl","Pazopanib hydrochloride","Pazopanib monohydrochloride"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","targetName":"Platelet-derived growth factor receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198888","diseaseId":"EFO_0000649","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03204058%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02461667%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02283554%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02372656%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03204071%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02274090%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02580331%22"}],"ancestors":["OTAR_0000006","EFO_0009676","MONDO_0002635","EFO_1001216","EFO_0002461","EFO_1001047","EFO_0010282"],"label":"periodontitis","approvedSymbol":"MT-ND1","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL679","targetId":"ENSG00000171873","diseaseId":"EFO_0000649","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03354312%22"}],"ancestors":["OTAR_0000006","EFO_0009676","MONDO_0002635","EFO_1001216","EFO_0002461","EFO_1001047","EFO_0010282"],"label":"periodontitis","approvedSymbol":"ADRA1D","approvedName":"adrenoceptor alpha 1D","targetClass":["Membrane receptor"],"prefName":"EPINEPHRINE","tradeNames":["Adren co","Adrenaclick","Adrenalin","Ana-Kit","Ana-guard","Anapen","Anaphylactic shock drug kit","Asma-vydrin","Asthmahaler","Auvi-q","Bronkaid mist","Brovon","Emerade","Epi e z pen jr","Epinephrine","Epinephrine (copackaged)","Epipen","Epipen e z pen","Epipen jr","Epipen jr.","Eppy","Gppe inh soln","Jext","Medihaler-epi","Primatene","Primatene mist","Riddobron","Riddofan","Rybarvin","Simplene","Soln made to rybarvin for","Sus-Phrine","Sus-Phrine Sulfite-Free","Sus-phrine sulfite free","Symjepi","Twinject 0.15","Twinject 0.3"],"synonyms":["(-)-(r)-epinephrine","(-)-epinephrine","Adrenaline","Adrenalinum","Epinephrine","Epinephrine hcl","Epinephrine hydrochloride","Epinephrinum","Glauposine","L-epinephrine hydrochloride","Levo-methylaminoethanolcatechol","NSC-62786","Nephridine","Racepinefrine, (r)-","Sus-phrine sulphite-free","Susphrine","Tonogen","Twinject"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor agonist","targetName":"Adrenergic receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000147123","diseaseId":"EFO_0000660","phase":0,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02689843%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02498522%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03117517%22"}],"ancestors":["EFO_0000512","OTAR_0000017","OTAR_0000018","EFO_0005771","MONDO_0002259","EFO_0001379","EFO_0000508","EFO_0009549"],"label":"polycystic ovary syndrome","approvedSymbol":"NDUFB11","approvedName":"NADH:ubiquinone oxidoreductase subunit B11","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000099795","diseaseId":"EFO_0000660","phase":0,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03905941%22"}],"ancestors":["EFO_0000512","OTAR_0000017","OTAR_0000018","EFO_0005771","MONDO_0002259","EFO_0001379","EFO_0000508","EFO_0009549"],"label":"polycystic ovary syndrome","approvedSymbol":"NDUFB7","approvedName":"NADH:ubiquinone oxidoreductase subunit B7","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000178057","diseaseId":"EFO_0000660","phase":0,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02026869%22"}],"ancestors":["EFO_0000512","OTAR_0000017","OTAR_0000018","EFO_0005771","MONDO_0002259","EFO_0001379","EFO_0000508","EFO_0009549"],"label":"polycystic ovary syndrome","approvedSymbol":"NDUFAF3","approvedName":"NADH:ubiquinone oxidoreductase complex assembly factor 3","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000183648","diseaseId":"EFO_0000660","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01798875%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03486626%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00461643%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01366391%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00378729%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00501904%22"}],"ancestors":["EFO_0000512","OTAR_0000017","OTAR_0000018","EFO_0005771","MONDO_0002259","EFO_0001379","EFO_0000508","EFO_0009549"],"label":"polycystic ovary syndrome","approvedSymbol":"NDUFB1","approvedName":"NADH:ubiquinone oxidoreductase subunit B1","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198786","diseaseId":"EFO_0000660","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03486626%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00501904%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00378729%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01798875%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00461643%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01366391%22"}],"ancestors":["EFO_0000512","OTAR_0000017","OTAR_0000018","EFO_0005771","MONDO_0002259","EFO_0001379","EFO_0000508","EFO_0009549"],"label":"polycystic ovary syndrome","approvedSymbol":"MT-ND5","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1703","targetId":"ENSG00000178127","diseaseId":"EFO_0000660","phase":0,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04204044%22"}],"ancestors":["EFO_0000512","OTAR_0000017","OTAR_0000018","EFO_0005771","MONDO_0002259","EFO_0001379","EFO_0000508","EFO_0009549"],"label":"polycystic ovary syndrome","approvedSymbol":"NDUFV2","approvedName":"NADH:ubiquinone oxidoreductase core subunit V2","targetClass":["Enzyme"],"prefName":"METFORMIN HYDROCHLORIDE","tradeNames":["Bolamyn sr","Diagemet xl","Fortamet","Glucamet 500","Glucamet 850","Glucient sr","Glucophage","Glucophage sr","Glucophage xr","Glumetza","Glyformin","Janumet","Ledermetin","Metabet sr","Metformin hydrochloride","Metsol","Milform","Orabet","Riomet","Riomet er","Sukkarto sr"],"synonyms":["Apophage","Benofomin","Diabefagos","Diabex","EX-404","EX404","Glucaminol","LA-6023","Metformin hcl","Metformin hydrochloride","NSC-91485","Neodipa","Siamformet","Walaphage"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL211456","targetId":"ENSG00000120907","diseaseId":"EFO_0000668","phase":3,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01451060%22"}],"ancestors":["MONDO_0000473","OTAR_0000018","OTAR_0000014","MONDO_0045048","EFO_0009690","EFO_0004264","MONDO_0024664","EFO_0003086","EFO_0009682","MONDO_0015512","EFO_0000508","MONDO_0100191","EFO_0000537","MONDO_0700003","EFO_0000319"],"label":"preeclampsia","approvedSymbol":"ADRA1A","approvedName":"adrenoceptor alpha 1A","targetClass":["Membrane receptor"],"prefName":"EPHEDRINE","tradeNames":[],"synonyms":["(-)-ephedrine","Ephedrine","Ephedrine, anhydrous","Ephedrinum, anhydrous","L-ephedrine","NSC-170951","NSC-8971","Xenadrine"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor agonist","targetName":"Adrenergic receptor"}
{"drugId":"CHEMBL1201748","targetId":"ENSG00000104833","diseaseId":"EFO_0000673","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01981668%22"}],"ancestors":["OTAR_0000017","MONDO_0024276","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","MONDO_0008315","EFO_0000512","EFO_0000313","EFO_0000228","EFO_0001663","EFO_0006858","EFO_0000616"],"label":"prostate adenocarcinoma","approvedSymbol":"TUBB4A","approvedName":"tubulin beta 4A class IVa","targetClass":["Structural protein"],"prefName":"CABAZITAXEL","tradeNames":["Jevtana","Jevtana kit"],"synonyms":["Cabazitaxel","Cabazitaxel acetonate","Jevtana","NSC-761432","TXD 258","TXD-258","XRP 6258","XRP-6258"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1274","targetId":"ENSG00000169083","diseaseId":"EFO_0000673","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00512668%22"}],"ancestors":["OTAR_0000017","MONDO_0024276","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","MONDO_0008315","EFO_0000512","EFO_0000313","EFO_0000228","EFO_0001663","EFO_0006858","EFO_0000616"],"label":"prostate adenocarcinoma","approvedSymbol":"AR","approvedName":"androgen receptor","targetClass":["Transcription factor","Unclassified protein"],"prefName":"NILUTAMIDE","tradeNames":["Anadron","Nilandron","Nilutamide"],"synonyms":["NSC-758683","Nilutamide","RU 23908","RU-23908"],"drugType":"Small molecule","mechanismOfAction":"Androgen Receptor antagonist","targetName":"Androgen Receptor"}
{"drugId":"CHEMBL2108628","targetId":"ENSG00000188229","diseaseId":"EFO_0000673","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00446836%22"}],"ancestors":["OTAR_0000017","MONDO_0024276","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","MONDO_0008315","EFO_0000512","EFO_0000313","EFO_0000228","EFO_0001663","EFO_0006858","EFO_0000616"],"label":"prostate adenocarcinoma","approvedSymbol":"TUBB4B","approvedName":"tubulin beta 4B class IVb","targetClass":["Structural protein"],"prefName":"PACLITAXEL POLIGLUMEX","tradeNames":["Xyotax"],"synonyms":["CT-2103","L-polyglutamic paclitaxel","Opaxio","PG-TXL","Paclitaxel conjugate with poly-l-glutamic acid","Paclitaxel poliglumex"],"drugType":"Small molecule","mechanismOfAction":"Tubulin stabiliser","targetName":"Tubulin"}
{"drugId":"CHEMBL254328","targetId":"ENSG00000128039","diseaseId":"EFO_0000673","phase":0,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03511196%22"}],"ancestors":["OTAR_0000017","MONDO_0024276","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","MONDO_0008315","EFO_0000512","EFO_0000313","EFO_0000228","EFO_0001663","EFO_0006858","EFO_0000616"],"label":"prostate adenocarcinoma","approvedSymbol":"SRD5A3","approvedName":"steroid 5 alpha-reductase 3","targetClass":["Enzyme"],"prefName":"ABIRATERONE","tradeNames":["Zytiga"],"synonyms":["Abiraterone","CB 7598","CB-7598","NSC-741232"],"drugType":"Small molecule","mechanismOfAction":"Steroid 5-alpha-reductase inhibitor","targetName":"Steroid 5-alpha-reductase"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000188229","diseaseId":"EFO_0000673","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00598858%22"}],"ancestors":["OTAR_0000017","MONDO_0024276","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","MONDO_0008315","EFO_0000512","EFO_0000313","EFO_0000228","EFO_0001663","EFO_0006858","EFO_0000616"],"label":"prostate adenocarcinoma","approvedSymbol":"TUBB4B","approvedName":"tubulin beta 4B class IVb","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000261456","diseaseId":"EFO_0000673","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00764166%22"}],"ancestors":["OTAR_0000017","MONDO_0024276","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","MONDO_0008315","EFO_0000512","EFO_0000313","EFO_0000228","EFO_0001663","EFO_0006858","EFO_0000616"],"label":"prostate adenocarcinoma","approvedSymbol":"TUBB8","approvedName":"tubulin beta 8 class VIII","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL655","targetId":"ENSG00000022355","diseaseId":"EFO_0000673","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03237416%22"}],"ancestors":["OTAR_0000017","MONDO_0024276","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","MONDO_0008315","EFO_0000512","EFO_0000313","EFO_0000228","EFO_0001663","EFO_0006858","EFO_0000616"],"label":"prostate adenocarcinoma","approvedSymbol":"GABRA1","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha1","targetClass":["Ion channel"],"prefName":"MIDAZOLAM","tradeNames":["Midazolam in 0.9% sodium chloride","Nayzilam"],"synonyms":["Midazolam","Midazolam civ","USL-261","USL261"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL98","targetId":"ENSG00000171720","diseaseId":"EFO_0000673","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00589472%22"}],"ancestors":["OTAR_0000017","MONDO_0024276","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","MONDO_0008315","EFO_0000512","EFO_0000313","EFO_0000228","EFO_0001663","EFO_0006858","EFO_0000616"],"label":"prostate adenocarcinoma","approvedSymbol":"HDAC3","approvedName":"histone deacetylase 3","targetClass":["Epigenetic regulator"],"prefName":"VORINOSTAT","tradeNames":["Zolinza"],"synonyms":["MK-0683","MK0683","NSC-701852","NSC-748799","NSC-759852","Suberoylanilide hydroxamic acid","Vorinostat"],"drugType":"Small molecule","mechanismOfAction":"Histone deacetylase 3 inhibitor","targetName":"Histone deacetylase 3"}
{"drugId":"CHEMBL1743069","targetId":"ENSG00000214042","diseaseId":"EFO_0000676","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00472758%22"}],"ancestors":["EFO_0000701","OTAR_0000018","EFO_0000540","EFO_1000636","EFO_0000508","MONDO_0002406","EFO_0010285"],"label":"psoriasis","approvedSymbol":"IFNA7","approvedName":"interferon alpha 7","targetClass":["Secreted protein"],"prefName":"SIFALIMUMAB","tradeNames":[],"synonyms":["MDX-1103","MEDI-545","Sifalimumab"],"drugType":"Antibody","mechanismOfAction":"Interferon alpha inhibitor","targetName":"Interferon alpha"}
{"drugId":"CHEMBL3707374","targetId":"ENSG00000180739","diseaseId":"EFO_0000676","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01987843%22"}],"ancestors":["EFO_0000701","OTAR_0000018","EFO_0000540","EFO_1000636","EFO_0000508","MONDO_0002406","EFO_0010285"],"label":"psoriasis","approvedSymbol":"S1PR5","approvedName":"sphingosine-1-phosphate receptor 5","targetClass":["Membrane receptor"],"prefName":"AMISELIMOD HYDROCHLORIDE","tradeNames":[],"synonyms":["Amiselimod hydrochloride","MT-1303"],"drugType":"Small molecule","mechanismOfAction":"Sphingosine 1-phosphate receptor modulator","targetName":"Sphingosine 1-phosphate receptor"}
{"drugId":"CHEMBL4297700","targetId":"ENSG00000112116","diseaseId":"EFO_0000676","phase":3,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03598790%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05020249%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03536884%22"}],"ancestors":["EFO_0000701","OTAR_0000018","EFO_0000540","EFO_1000636","EFO_0000508","MONDO_0002406","EFO_0010285"],"label":"psoriasis","approvedSymbol":"IL17F","approvedName":"interleukin 17F","targetClass":["Unclassified protein"],"prefName":"BIMEKIZUMAB","tradeNames":[],"synonyms":["Bimekizumab","UCB-4940","UCB4940","Ucb4940"],"drugType":"Antibody","mechanismOfAction":"Interleukin-17F inhibitor","targetName":"Interleukin-17F"}
{"drugId":"CHEMBL4596392","targetId":"ENSG00000105397","diseaseId":"EFO_0000676","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02931838%22"}],"ancestors":["EFO_0000701","OTAR_0000018","EFO_0000540","EFO_1000636","EFO_0000508","MONDO_0002406","EFO_0010285"],"label":"psoriasis","approvedSymbol":"TYK2","approvedName":"tyrosine kinase 2","targetClass":["Enzyme"],"prefName":"DEUCRAVACITINIB","tradeNames":[],"synonyms":[],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase TYK2 negative allosteric modulator","targetName":"Tyrosine-protein kinase TYK2"}
{"drugId":"CHEMBL514800","targetId":"ENSG00000065989","diseaseId":"EFO_0000676","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02412644%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03000309%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03441789%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03774875%22"}],"ancestors":["EFO_0000701","OTAR_0000018","EFO_0000540","EFO_1000636","EFO_0000508","MONDO_0002406","EFO_0010285"],"label":"psoriasis","approvedSymbol":"PDE4A","approvedName":"phosphodiesterase 4A","targetClass":["Enzyme"],"prefName":"APREMILAST","tradeNames":["Otezla"],"synonyms":["Apremilast","CC-10004","CC10004"],"drugType":"Small molecule","mechanismOfAction":"Phosphodiesterase 4 inhibitor","targetName":"Phosphodiesterase 4"}
{"drugId":"CHEMBL632","targetId":"ENSG00000113580","diseaseId":"EFO_0000676","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03122353%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02940002%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03469336%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03004339%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03880357%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00578370%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04221906%22"}],"ancestors":["EFO_0000701","OTAR_0000018","EFO_0000540","EFO_1000636","EFO_0000508","MONDO_0002406","EFO_0010285"],"label":"psoriasis","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"BETAMETHASONE","tradeNames":["Alphatrex","Betasolan","Betatrex","Betnelan","Celestone","Dermabet","Uticort"],"synonyms":["BETA-VAL","Betamethasone","Betatrex","Dermabet","Flubenisolone","Lotrisone","NSC-39470","SCH 4831","SCH-4831","Taclonex","Uticort","VISUBETA"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL393220","targetId":"ENSG00000113161","diseaseId":"EFO_0000681","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00490698%22"}],"ancestors":["MONDO_0024276","MONDO_0002367","MONDO_0023370","EFO_0002890","EFO_0009690","MONDO_0045024","MONDO_0004992","MONDO_0021066","EFO_0003086","EFO_0000313","EFO_0000228","EFO_0003865","EFO_1000363","EFO_0006858","EFO_0000616"],"label":"renal cell carcinoma","approvedSymbol":"HMGCR","approvedName":"3-hydroxy-3-methylglutaryl-CoA reductase","targetClass":["Enzyme"],"prefName":"ATORVASTATIN CALCIUM","tradeNames":["Atorvastatin calcium","Lipitor"],"synonyms":["Atorvastatin calcium","Atorvastatin calcium (anhydrous)","Atorvastatin calcium anhydrous","Atorvastatin calcium hydrate","Atorvastatin calcium salt anhydrous","Atorvastatin calcium salt trihydrate","Atorvastatin calcium trihydrate","CI-981","NSC-758617"],"drugType":"Small molecule","mechanismOfAction":"HMG-CoA reductase inhibitor","targetName":"HMG-CoA reductase"}
{"drugId":"CHEMBL4650419","targetId":"ENSG00000163599","diseaseId":"EFO_0000681","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04736706%22"}],"ancestors":["MONDO_0024276","MONDO_0002367","MONDO_0023370","EFO_0002890","EFO_0009690","MONDO_0045024","MONDO_0004992","MONDO_0021066","EFO_0003086","EFO_0000313","EFO_0000228","EFO_0003865","EFO_1000363","EFO_0006858","EFO_0000616"],"label":"renal cell carcinoma","approvedSymbol":"CTLA4","approvedName":"cytotoxic T-lymphocyte associated protein 4","targetClass":["Surface antigen"],"prefName":"QUAVONLIMAB","tradeNames":[],"synonyms":["MK-1308A COMPONENT QUAVONLIMAB","Quavonlimab"],"drugType":"Antibody","mechanismOfAction":"Cytotoxic T-lymphocyte protein 4 inhibitor","targetName":"Cytotoxic T-lymphocyte protein 4"}
{"drugId":"CHEMBL477772","targetId":"ENSG00000113721","diseaseId":"EFO_0000681","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00720941%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01064310%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00387764%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00334282%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01235962%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01613846%22"}],"ancestors":["MONDO_0024276","MONDO_0002367","MONDO_0023370","EFO_0002890","EFO_0009690","MONDO_0045024","MONDO_0004992","MONDO_0021066","EFO_0003086","EFO_0000313","EFO_0000228","EFO_0003865","EFO_1000363","EFO_0006858","EFO_0000616"],"label":"renal cell carcinoma","approvedSymbol":"PDGFRB","approvedName":"platelet derived growth factor receptor beta","targetClass":["Enzyme"],"prefName":"PAZOPANIB","tradeNames":["Votrient"],"synonyms":["GW786034","NSC-752782","Pazopanib"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","targetName":"Platelet-derived growth factor receptor"}
{"drugId":"CHEMBL477772","targetId":"ENSG00000157404","diseaseId":"EFO_0000681","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02535351%22"}],"ancestors":["MONDO_0024276","MONDO_0002367","MONDO_0023370","EFO_0002890","EFO_0009690","MONDO_0045024","MONDO_0004992","MONDO_0021066","EFO_0003086","EFO_0000313","EFO_0000228","EFO_0003865","EFO_1000363","EFO_0006858","EFO_0000616"],"label":"renal cell carcinoma","approvedSymbol":"KIT","approvedName":"KIT proto-oncogene, receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"PAZOPANIB","tradeNames":["Votrient"],"synonyms":["GW786034","NSC-752782","Pazopanib"],"drugType":"Small molecule","mechanismOfAction":"Stem cell growth factor receptor inhibitor","targetName":"Stem cell growth factor receptor"}
{"drugId":"CHEMBL113","targetId":"ENSG00000282608","diseaseId":"EFO_0000685","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03131973%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01636557%22"}],"ancestors":["EFO_0004260","EFO_0005140","OTAR_0000006","EFO_0009676","MONDO_0002614","MONDO_0000589","EFO_0002461","EFO_0005809","EFO_1000999","EFO_0000540","EFO_0005755","EFO_1001986","EFO_0005856","EFO_1002003"],"label":"rheumatoid arthritis","approvedSymbol":"ADORA3","approvedName":"adenosine A3 receptor","targetClass":["Membrane receptor"],"prefName":"CAFFEINE","tradeNames":["Nodoz","Nodoz caplets and chewable tablets","Pro-plus","Yeast-vite","Zanthine"],"synonyms":["Anhydrous caffeine","Cafcit","Caffeine","Caffeine anhydrous","Caffeine melting point standard","Caffeinum","Coffeine","Coffeinum","Durvitan","FEMA NO. 2224","Guaranine","Methyltheobromine","NSC-5036","Synalgos","Theine","Vivarin"],"drugType":"Small molecule","mechanismOfAction":"Adenosine receptor antagonist","targetName":"Adenosine receptor"}
{"drugId":"CHEMBL1201823","targetId":"ENSG00000121594","diseaseId":"EFO_0000685","phase":3,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05428488%22"}],"ancestors":["EFO_0004260","EFO_0005140","OTAR_0000006","EFO_0009676","MONDO_0002614","MONDO_0000589","EFO_0002461","EFO_0005809","EFO_1000999","EFO_0000540","EFO_0005755","EFO_1001986","EFO_0005856","EFO_1002003"],"label":"rheumatoid arthritis","approvedSymbol":"CD80","approvedName":"CD80 molecule","targetClass":["Surface antigen"],"prefName":"ABATACEPT","tradeNames":["Orencia","Orencia clickject"],"synonyms":["Abatacept","Abatacept (genetical recombination)","Abatacept recombinant","BMS-188667","CTLA4-IGG4M","RG-1046","RG-2077"],"drugType":"Protein","mechanismOfAction":"T-lymphocyte activation antigen CD80 inhibitor","targetName":"T-lymphocyte activation antigen CD80"}
{"drugId":"CHEMBL1535","targetId":"ENSG00000239732","diseaseId":"EFO_0000685","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02603146%22"}],"ancestors":["EFO_0004260","EFO_0005140","OTAR_0000006","EFO_0009676","MONDO_0002614","MONDO_0000589","EFO_0002461","EFO_0005809","EFO_1000999","EFO_0000540","EFO_0005755","EFO_1001986","EFO_0005856","EFO_1002003"],"label":"rheumatoid arthritis","approvedSymbol":"TLR9","approvedName":"toll like receptor 9","targetClass":["Membrane receptor"],"prefName":"HYDROXYCHLOROQUINE","tradeNames":[],"synonyms":["Hydroxychloroquine","Polirreumin"],"drugType":"Small molecule","mechanismOfAction":"Toll-like receptor 9 antagonist","targetName":"Toll-like receptor 9"}
{"drugId":"CHEMBL1743039","targetId":"ENSG00000198223","diseaseId":"EFO_0000685","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01050998%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01715896%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01706926%22"}],"ancestors":["EFO_0004260","EFO_0005140","OTAR_0000006","EFO_0009676","MONDO_0002614","MONDO_0000589","EFO_0002461","EFO_0005809","EFO_1000999","EFO_0000540","EFO_0005755","EFO_1001986","EFO_0005856","EFO_1002003"],"label":"rheumatoid arthritis","approvedSymbol":"CSF2RA","approvedName":"colony stimulating factor 2 receptor subunit alpha","targetClass":["Membrane receptor"],"prefName":"MAVRILIMUMAB","tradeNames":[],"synonyms":["CAM-3001","CAM3001","KPL-301","Mavrilimumab"],"drugType":"Antibody","mechanismOfAction":"Granulocyte-macrophage colony-stimulating factor receptor antagonist","targetName":"Granulocyte-macrophage colony-stimulating factor receptor"}
{"drugId":"CHEMBL4085457","targetId":"ENSG00000102010","diseaseId":"EFO_0000685","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04413617%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02969044%22"}],"ancestors":["EFO_0004260","EFO_0005140","OTAR_0000006","EFO_0009676","MONDO_0002614","MONDO_0000589","EFO_0002461","EFO_0005809","EFO_1000999","EFO_0000540","EFO_0005755","EFO_1001986","EFO_0005856","EFO_1002003"],"label":"rheumatoid arthritis","approvedSymbol":"BMX","approvedName":"BMX non-receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"PF-06651600","tradeNames":[],"synonyms":["PF-06651600","Pf-06651600","Ritlecitinib"],"drugType":"Small molecule","mechanismOfAction":"TEC family kinase inhibitor","targetName":"TEC family kinase"}
{"drugId":"CHEMBL1535","targetId":"ENSG00000239732","diseaseId":"EFO_0000691","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01842594%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"sarcoma","approvedSymbol":"TLR9","approvedName":"toll like receptor 9","targetClass":["Membrane receptor"],"prefName":"HYDROXYCHLOROQUINE","tradeNames":[],"synonyms":["Hydroxychloroquine","Polirreumin"],"drugType":"Small molecule","mechanismOfAction":"Toll-like receptor 9 antagonist","targetName":"Toll-like receptor 9"}
{"drugId":"CHEMBL359744","targetId":"ENSG00000131747","diseaseId":"EFO_0000691","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002516%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00020566%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00379457%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"sarcoma","approvedSymbol":"TOP2A","approvedName":"DNA topoisomerase II alpha","targetClass":["Enzyme"],"prefName":"DOXORUBICIN HYDROCHLORIDE","tradeNames":["Adriamycin","Adriamycin Rdf","Adriamycin pfs","Caelyx","Doxil","Doxil (liposomal)","Doxorubicin hydrochloride","Doxorubicin hydrochloride (liposomal)","Myocet","Rubex"],"synonyms":["Adriablastina cs","Adriamycin, hydrochloride","Doxorubicin HCl","Doxorubicin citrate","Doxorubicin citric acid salt","Doxorubicin hcl","Doxorubicin hydrochloride","Doxorubicin liposomal complex of the hydrochloride","Doxorubicini hydrochloridum","Hydroxydaunomycin hydrochloride","Liposomal doxorubicin hydrochloride"],"drugType":"Small molecule","mechanismOfAction":"DNA topoisomerase II alpha inhibitor","targetName":"DNA topoisomerase II alpha"}
{"drugId":"CHEMBL44657","targetId":"ENSG00000077097","diseaseId":"EFO_0000691","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00014313%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00072280%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"sarcoma","approvedSymbol":"TOP2B","approvedName":"DNA topoisomerase II beta","targetClass":["Enzyme"],"prefName":"ETOPOSIDE","tradeNames":["Etoposide","Toposar","Vepesid"],"synonyms":["Etoposide","Etoposide resolution mixture","Etoposidum","NSC-141540","Sintopozid","VP-16-213"],"drugType":"Small molecule","mechanismOfAction":"DNA topoisomerase II inhibitor","targetName":"DNA topoisomerase II"}
{"drugId":"CHEMBL477772","targetId":"ENSG00000102755","diseaseId":"EFO_0000691","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03798106%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"sarcoma","approvedSymbol":"FLT1","approvedName":"fms related receptor tyrosine kinase 1","targetClass":["Enzyme"],"prefName":"PAZOPANIB","tradeNames":["Votrient"],"synonyms":["GW786034","NSC-752782","Pazopanib"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL477772","targetId":"ENSG00000128052","diseaseId":"EFO_0000691","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04741438%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"sarcoma","approvedSymbol":"KDR","approvedName":"kinase insert domain receptor","targetClass":["Enzyme"],"prefName":"PAZOPANIB","tradeNames":["Votrient"],"synonyms":["GW786034","NSC-752782","Pazopanib"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL501867","targetId":"ENSG00000258947","diseaseId":"EFO_0000691","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00020566%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002516%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00379457%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"sarcoma","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"VINCRISTINE SULFATE","tradeNames":["Kyocristine","Leurocristine Sulfate","Marqibo kit","Oncovin","Vincasar","Vincasar pfs","Vincrex","Vincristine sulfate","Vincristine sulfate pfs"],"synonyms":["37231","Kyocristine","LILLY-37231","Marqibo","NSC-67574","Novopharm","Vincristine sulfate","Vincristine sulfate liposome","Vincristine sulphate","Vincristini sulfas","Vincrisul"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL888","targetId":"ENSG00000106628","diseaseId":"EFO_0000691","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003316%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"sarcoma","approvedSymbol":"POLD2","approvedName":"DNA polymerase delta 2, accessory subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL107","targetId":"ENSG00000104833","diseaseId":"EFO_0000694","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04516941%22"}],"ancestors":["EFO_0007396","MONDO_0100336","EFO_0007223","EFO_0000684","MONDO_0100321","EFO_0000763","EFO_0005741","OTAR_0000010","MONDO_0020753","MONDO_0100329"],"label":"severe acute respiratory syndrome","approvedSymbol":"TUBB4A","approvedName":"tubulin beta 4A class IVa","targetClass":["Structural protein"],"prefName":"COLCHICINE","tradeNames":["Colchicine","Colcrys","Gloperba","Mitigare"],"synonyms":["(-)-colchicine","Colchcine","Colchicine","Colchicinum","Colchineos","Colchisol","NSC-757"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1200694","targetId":"ENSG00000145888","diseaseId":"EFO_0000694","phase":3,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04530188%22"}],"ancestors":["EFO_0007396","MONDO_0100336","EFO_0007223","EFO_0000684","MONDO_0100321","EFO_0000763","EFO_0005741","OTAR_0000010","MONDO_0020753","MONDO_0100329"],"label":"severe acute respiratory syndrome","approvedSymbol":"GLRA1","approvedName":"glycine receptor alpha 1","targetClass":["Ion channel"],"prefName":"SEVOFLURANE","tradeNames":["Sevoflurane","Sojourn","Ultane"],"synonyms":["MR-6S4","MR6S4","NSC-760367","Sevocalm","Sevoflo","Sevoflurane","Sevorane"],"drugType":"Small molecule","mechanismOfAction":"Glycine receptor (alpha-1/beta) positive modulator","targetName":"Glycine receptor (alpha-1/beta)"}
{"drugId":"CHEMBL1643","targetId":"ENSG00000106348","diseaseId":"EFO_0000694","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04605588%22"}],"ancestors":["EFO_0007396","MONDO_0100336","EFO_0007223","EFO_0000684","MONDO_0100321","EFO_0000763","EFO_0005741","OTAR_0000010","MONDO_0020753","MONDO_0100329"],"label":"severe acute respiratory syndrome","approvedSymbol":"IMPDH1","approvedName":"inosine monophosphate dehydrogenase 1","targetClass":["Enzyme"],"prefName":"RIBAVIRIN","tradeNames":["Copegus","Rebetol","Ribapak","Ribasphere","Ribavarin","Ribavirin","Ribofluranosyl Carboxamide","Tribavirin","Viramid","Virazid","Virazole"],"synonyms":["Cotronak","NSC-163039","Ribavirin","Ribavirin biopartners","Ribavirin mylan","Ribavirin teva","SCH 18908","SCH-18908","Tribavirin"],"drugType":"Small molecule","mechanismOfAction":"Inosine-5'-monophosphate dehydrogenase 1 inhibitor","targetName":"Inosine-5'-monophosphate dehydrogenase 1"}
{"drugId":"CHEMBL1194","targetId":"ENSG00000136531","diseaseId":"EFO_0000701","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04523961%22"}],"ancestors":["EFO_0010285"],"label":"skin disease","approvedSymbol":"SCN2A","approvedName":"sodium voltage-gated channel alpha subunit 2","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"PRILOCAINE","tradeNames":[],"synonyms":["ASTRA-1512","ASTRA-1515","Citanest","NSC-40027","Prilocaine","Propitocaine"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL1173655","targetId":"ENSG00000178568","diseaseId":"EFO_0000702","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02876081%22"}],"ancestors":["Orphanet_271847","EFO_0009433","EFO_0008524","MONDO_0008903","MONDO_0021069","MONDO_0002120","MONDO_0003274","EFO_0001071","EFO_0003769","EFO_0000313","Orphanet_68336","EFO_0006858","EFO_0000616","OTAR_0000018","MONDO_0000376","EFO_0005220","MONDO_0021350","MONDO_0023370","OTAR_0000010","MONDO_0045024","MONDO_0025511","MONDO_0004992","EFO_0000684","MONDO_0021117","EFO_1001901","EFO_0001379","EFO_0003853","EFO_0000508","EFO_0003818"],"label":"small cell lung carcinoma","approvedSymbol":"ERBB4","approvedName":"erb-b2 receptor tyrosine kinase 4","targetClass":["Enzyme"],"prefName":"AFATINIB","tradeNames":["Gilotrif","Giotrif"],"synonyms":["Afatinib","BIBW-2992","BIBW2992","Bibw 2992","NSC-750691","Tomtovok","Tovok"],"drugType":"Small molecule","mechanismOfAction":"Receptor protein-tyrosine kinase erbB-4 inhibitor","targetName":"Receptor protein-tyrosine kinase erbB-4"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000158864","diseaseId":"EFO_0000702","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03994744%22"}],"ancestors":["Orphanet_271847","EFO_0009433","EFO_0008524","MONDO_0008903","MONDO_0021069","MONDO_0002120","MONDO_0003274","EFO_0001071","EFO_0003769","EFO_0000313","Orphanet_68336","EFO_0006858","EFO_0000616","OTAR_0000018","MONDO_0000376","EFO_0005220","MONDO_0021350","MONDO_0023370","OTAR_0000010","MONDO_0045024","MONDO_0025511","MONDO_0004992","EFO_0000684","MONDO_0021117","EFO_1001901","EFO_0001379","EFO_0003853","EFO_0000508","EFO_0003818"],"label":"small cell lung carcinoma","approvedSymbol":"NDUFS2","approvedName":"NADH:ubiquinone oxidoreductase core subunit S2","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000258947","diseaseId":"EFO_0000702","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04757779%22"}],"ancestors":["Orphanet_271847","EFO_0009433","EFO_0008524","MONDO_0008903","MONDO_0021069","MONDO_0002120","MONDO_0003274","EFO_0001071","EFO_0003769","EFO_0000313","Orphanet_68336","EFO_0006858","EFO_0000616","OTAR_0000018","MONDO_0000376","EFO_0005220","MONDO_0021350","MONDO_0023370","OTAR_0000010","MONDO_0045024","MONDO_0025511","MONDO_0004992","EFO_0000684","MONDO_0021117","EFO_1001901","EFO_0001379","EFO_0003853","EFO_0000508","EFO_0003818"],"label":"small cell lung carcinoma","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1131","targetId":"ENSG00000186350","diseaseId":"EFO_0000707","phase":4,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00488384%22"}],"ancestors":["EFO_0000313","MONDO_0002532","MONDO_0023370","MONDO_0045024","EFO_0006858","MONDO_0004992","EFO_0000616"],"label":"squamous cell carcinoma","approvedSymbol":"RXRA","approvedName":"retinoid X receptor alpha","targetClass":["Transcription factor"],"prefName":"ACITRETIN","tradeNames":["Acitretin","Neotigason","Soriatane"],"synonyms":["Acitretin","Etretin","RO 10-1670","RO 10-1670/000","RO-101670000"],"drugType":"Small molecule","mechanismOfAction":"Retinoid receptor agonist","targetName":"Retinoid receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000137806","diseaseId":"EFO_0000707","phase":0,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02083692%22"}],"ancestors":["EFO_0000313","MONDO_0002532","MONDO_0023370","MONDO_0045024","EFO_0006858","MONDO_0004992","EFO_0000616"],"label":"squamous cell carcinoma","approvedSymbol":"NDUFAF1","approvedName":"NADH:ubiquinone oxidoreductase complex assembly factor 1","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL3833373","targetId":"ENSG00000120217","diseaseId":"EFO_0000707","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02938273%22"}],"ancestors":["EFO_0000313","MONDO_0002532","MONDO_0023370","MONDO_0045024","EFO_0006858","MONDO_0004992","EFO_0000616"],"label":"squamous cell carcinoma","approvedSymbol":"CD274","approvedName":"CD274 molecule","targetClass":["Unclassified protein"],"prefName":"AVELUMAB","tradeNames":["Bavencio"],"synonyms":["Avelumab","MSB-0010682","MSB0010682","MSB0010718C","Msb-0010718c"],"drugType":"Antibody","mechanismOfAction":"Programmed cell death 1 ligand 1 other","targetName":"Programmed cell death 1 ligand 1"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000101162","diseaseId":"EFO_0000708","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03041181%22"}],"ancestors":["MONDO_0000376","MONDO_0002532","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0000707","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"squamous cell lung carcinoma","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL3545414","targetId":"ENSG00000128052","diseaseId":"EFO_0000708","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03725423%22"}],"ancestors":["MONDO_0000376","MONDO_0002532","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0000707","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"squamous cell lung carcinoma","approvedSymbol":"KDR","approvedName":"kinase insert domain receptor","targetClass":["Enzyme"],"prefName":"RIVOCERANIB MESYLATE","tradeNames":["Aitan"],"synonyms":["Apatinib (registered name in China)","Apatinib mesylate","Rivoceranib mesylate","YN-968D1","Yn-968d1"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor 2 inhibitor","targetName":"Vascular endothelial growth factor receptor 2"}
{"drugId":"CHEMBL888","targetId":"ENSG00000167325","diseaseId":"EFO_0000708","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02423590%22"}],"ancestors":["MONDO_0000376","MONDO_0002532","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0000707","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"squamous cell lung carcinoma","approvedSymbol":"RRM1","approvedName":"ribonucleotide reductase catalytic subunit M1","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"Ribonucleoside-diphosphate reductase RR1 inhibitor","targetName":"Ribonucleoside-diphosphate reductase RR1"}
{"drugId":"CHEMBL92","targetId":"ENSG00000258947","diseaseId":"EFO_0000708","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01824901%22"}],"ancestors":["MONDO_0000376","MONDO_0002532","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0000707","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"squamous cell lung carcinoma","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":[],"synonyms":["RP-56976","Taxotere"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL92","targetId":"ENSG00000258947","diseaseId":"EFO_0000708","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02513342%22"}],"ancestors":["MONDO_0000376","MONDO_0002532","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0000707","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"squamous cell lung carcinoma","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":[],"synonyms":["RP-56976","Taxotere"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL2107386","targetId":"ENSG00000181104","diseaseId":"EFO_0000712","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=45d79217-53cf-4240-9c43-19ee54a1dc3a"}],"ancestors":["MONDO_0043218","EFO_0005774","EFO_0003763","EFO_0000618","EFO_0004264","EFO_0009386","EFO_0000319"],"label":"stroke","approvedSymbol":"F2R","approvedName":"coagulation factor II thrombin receptor","targetClass":["Membrane receptor"],"prefName":"VORAPAXAR SULFATE","tradeNames":["Zontivity"],"synonyms":["SCH 530348","SCH-530348","Vorapaxar sulfate"],"drugType":"Small molecule","mechanismOfAction":"Proteinase-activated receptor 1 antagonist","targetName":"Proteinase-activated receptor 1"}
{"drugId":"CHEMBL502835","targetId":"ENSG00000113721","diseaseId":"EFO_0000717","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03675581%22"}],"ancestors":["OTAR_0000006","EFO_0009676","MONDO_0000589","EFO_0002461","EFO_0009690","MONDO_0024458","EFO_0003966","EFO_0005809","MONDO_0023603","EFO_0002630","MONDO_0000603","MONDO_0016340","EFO_0000318","EFO_1002003","MONDO_0003939","EFO_1001993","EFO_0000319","EFO_1002049","MONDO_0030701","OTAR_0000018","EFO_1001473","EFO_0002970","OTAR_0000010","MONDO_0000591","EFO_0003086","EFO_0002945","Orphanet_101435","EFO_0000701","MONDO_0019724","EFO_0003777","EFO_0000684","EFO_0000540","Orphanet_98702","EFO_0005755","EFO_0000508","EFO_1001986","EFO_0010285","MONDO_0100191"],"label":"systemic scleroderma","approvedSymbol":"PDGFRB","approvedName":"platelet derived growth factor receptor beta","targetClass":["Enzyme"],"prefName":"NINTEDANIB","tradeNames":["Ofev","Vargatef"],"synonyms":["BIBF 1120","BIBF-1120","BIBF1120","Bibf-1120","Intedanib","Nintedanib"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","targetName":"Platelet-derived growth factor receptor"}
{"drugId":"CHEMBL1201581","targetId":"ENSG00000232810","diseaseId":"EFO_0000729","phase":3,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04205643%22"}],"ancestors":["EFO_0005140","EFO_0009431","OTAR_0000018","EFO_0003767","EFO_0000540","EFO_0003872","EFO_0000508","MONDO_0003409","MONDO_0024634","EFO_1001463","EFO_0010282"],"label":"ulcerative colitis","approvedSymbol":"TNF","approvedName":"tumor necrosis factor","targetClass":["Secreted protein"],"prefName":"INFLIXIMAB","tradeNames":["Inflectra","Remicade","Remsima"],"synonyms":["ABP 710","Abp-710","Avsola","BOW015","Bow-015","Ct-p-13","Ct-p13","Infimab","Infliximab","Infliximab (janssen)","Infliximab (remicade)","Infliximab-abda","Infliximab-axxq","Infliximab-dyyb","Infliximab-hjmt","Infliximab-pfizer","Infliximab-qbtx","Ixifi","NI-071","Pf-06438179","TA-650","Zessly","cA2"],"drugType":"Antibody","mechanismOfAction":"TNF-alpha inhibitor","targetName":"TNF-alpha"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000212907","diseaseId":"EFO_0000729","phase":2,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04750135%22"}],"ancestors":["EFO_0005140","EFO_0009431","OTAR_0000018","EFO_0003767","EFO_0000540","EFO_0003872","EFO_0000508","MONDO_0003409","MONDO_0024634","EFO_1001463","EFO_0010282"],"label":"ulcerative colitis","approvedSymbol":"MT-ND4L","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL635","targetId":"ENSG00000113580","diseaseId":"EFO_0000729","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03804931%22"}],"ancestors":["EFO_0005140","EFO_0009431","OTAR_0000018","EFO_0003767","EFO_0000540","EFO_0003872","EFO_0000508","MONDO_0003409","MONDO_0024634","EFO_1001463","EFO_0010282"],"label":"ulcerative colitis","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"PREDNISONE","tradeNames":["Cortan","Cortancyl","Decortisyl","Delta-dome","Deltasone","Fernisone","Liquid pred","Lodotra","Meticorten","Orasone","Paracort","Prednicen-m","Prednisone","Prednisone intensol","Rayos","Servisone","Sterapred"],"synonyms":["3en3hg4wsw","Decortin","Dehydrocortisone","Metacortandracin","NSC-10023","Prednisone","Prednisone anhydrous","Prednisone tablets","Supercortil"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL1336","targetId":"ENSG00000113721","diseaseId":"EFO_0000756","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00329641%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00483301%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00119249%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00492297%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00110994%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00498836%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00794235%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00281957%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00623402%22"}],"ancestors":["EFO_0003769","EFO_1001901","EFO_0001379","MONDO_0023370","MONDO_0045024","MONDO_0021143","EFO_0000616"],"label":"melanoma","approvedSymbol":"PDGFRB","approvedName":"platelet derived growth factor receptor beta","targetClass":["Enzyme"],"prefName":"SORAFENIB","tradeNames":["Nexavar"],"synonyms":["BAY 43-9006","BAY-43-9006","Sorafenib"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor beta inhibitor","targetName":"Platelet-derived growth factor receptor beta"}
{"drugId":"CHEMBL2028663","targetId":"ENSG00000157764","diseaseId":"EFO_0000756","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02296996%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01619774%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01266967%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01682213%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03352947%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02039947%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01153763%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01726738%22"}],"ancestors":["EFO_0003769","EFO_1001901","EFO_0001379","MONDO_0023370","MONDO_0045024","MONDO_0021143","EFO_0000616"],"label":"melanoma","approvedSymbol":"BRAF","approvedName":"B-Raf proto-oncogene, serine/threonine kinase","targetClass":["Enzyme"],"prefName":"DABRAFENIB","tradeNames":["Tafinlar"],"synonyms":["Dabrafenib","GSK-2118436","GSK-2118436A","GSK2118436A","Gsk2118436"],"drugType":"Small molecule","mechanismOfAction":"Serine/threonine-protein kinase B-raf inhibitor","targetName":"Serine/threonine-protein kinase B-raf"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000101162","diseaseId":"EFO_0000756","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02223884%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01009775%22"}],"ancestors":["EFO_0003769","EFO_1001901","EFO_0001379","MONDO_0023370","MONDO_0045024","MONDO_0021143","EFO_0000616"],"label":"melanoma","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000104833","diseaseId":"EFO_0000756","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01256359%22"}],"ancestors":["EFO_0003769","EFO_1001901","EFO_0001379","MONDO_0023370","MONDO_0045024","MONDO_0021143","EFO_0000616"],"label":"melanoma","approvedSymbol":"TUBB4A","approvedName":"tubulin beta 4A class IVa","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL3809489","targetId":"ENSG00000167601","diseaseId":"EFO_0000756","phase":1,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02872259%22"}],"ancestors":["EFO_0003769","EFO_1001901","EFO_0001379","MONDO_0023370","MONDO_0045024","MONDO_0021143","EFO_0000616"],"label":"melanoma","approvedSymbol":"AXL","approvedName":"AXL receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"BEMCENTINIB","tradeNames":[],"synonyms":["BGB 324","BGB-324","BGB324","Bemcentinib","CS-1046","HY-15150","KB-80319","QC-11751","R 428","R-428","R428","SYN-1131","SYN1131","W-5845"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase receptor UFO inhibitor","targetName":"Tyrosine-protein kinase receptor UFO"}
{"drugId":"CHEMBL941","targetId":"ENSG00000113721","diseaseId":"EFO_0000756","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04598009%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05274438%22"}],"ancestors":["EFO_0003769","EFO_1001901","EFO_0001379","MONDO_0023370","MONDO_0045024","MONDO_0021143","EFO_0000616"],"label":"melanoma","approvedSymbol":"PDGFRB","approvedName":"platelet derived growth factor receptor beta","targetClass":["Enzyme"],"prefName":"IMATINIB","tradeNames":[],"synonyms":["Glamox","Gleevec","Imatinib","NSC-743414","NSC-759854","STI-571"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor beta inhibitor","targetName":"Platelet-derived growth factor receptor beta"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000189043","diseaseId":"EFO_0000764","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02064374%22"}],"ancestors":["MONDO_0100336","MONDO_0100321","EFO_0000763","EFO_0005741","EFO_1001357","MONDO_0021681","MONDO_0100329","MONDO_0021682"],"label":"HIV infection","approvedSymbol":"NDUFA4","approvedName":"NDUFA4 mitochondrial complex associated","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1535","targetId":"ENSG00000239732","diseaseId":"EFO_0000764","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01067417%22"}],"ancestors":["MONDO_0100336","MONDO_0100321","EFO_0000763","EFO_0005741","EFO_1001357","MONDO_0021681","MONDO_0100329","MONDO_0021682"],"label":"HIV infection","approvedSymbol":"TLR9","approvedName":"toll like receptor 9","targetClass":["Membrane receptor"],"prefName":"HYDROXYCHLOROQUINE","tradeNames":[],"synonyms":["Hydroxychloroquine","Polirreumin"],"drugType":"Small molecule","mechanismOfAction":"Toll-like receptor 9 antagonist","targetName":"Toll-like receptor 9"}
{"drugId":"CHEMBL1789844","targetId":"ENSG00000163599","diseaseId":"EFO_0000764","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03407105%22"}],"ancestors":["MONDO_0100336","MONDO_0100321","EFO_0000763","EFO_0005741","EFO_1001357","MONDO_0021681","MONDO_0100329","MONDO_0021682"],"label":"HIV infection","approvedSymbol":"CTLA4","approvedName":"cytotoxic T-lymphocyte associated protein 4","targetClass":["Surface antigen"],"prefName":"IPILIMUMAB","tradeNames":["Yervoy"],"synonyms":["BMS-734016","BMS734016","Ipilimumab","MDX-010","MDX-010 MDX-CTLA4","MDX-101","MDX-CTLA-4","MDX010"],"drugType":"Antibody","mechanismOfAction":"Cytotoxic T-lymphocyte protein 4 inhibitor","targetName":"Cytotoxic T-lymphocyte protein 4"}
{"drugId":"CHEMBL2095208","targetId":"ENSG00000106258","diseaseId":"EFO_0000764","phase":1,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05458102%22"}],"ancestors":["MONDO_0100336","MONDO_0100321","EFO_0000763","EFO_0005741","EFO_1001357","MONDO_0021681","MONDO_0100329","MONDO_0021682"],"label":"HIV infection","approvedSymbol":"CYP3A5","approvedName":"cytochrome P450 family 3 subfamily A member 5","targetClass":["Enzyme"],"prefName":"COBICISTAT","tradeNames":["Tybost"],"synonyms":["Cobicistat","Cobicistat on silicon dioxide","GS-9350"],"drugType":"Small molecule","mechanismOfAction":"Cytochrome P450 3A inhibitor","targetName":"Cytochrome P450 3A"}
{"drugId":"CHEMBL1201561","targetId":"ENSG00000159110","diseaseId":"EFO_0000765","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00035360%22"}],"ancestors":["MONDO_0021094","OTAR_0000017","OTAR_0000018","EFO_0005741","MONDO_0021681","MONDO_0003780","MONDO_0100329","MONDO_0021682","EFO_0000512","EFO_0000764","MONDO_0100336","EFO_0000540","MONDO_0100321","EFO_0000763","EFO_1001357","EFO_0000508"],"label":"AIDS","approvedSymbol":"IFNAR2","approvedName":"interferon alpha and beta receptor subunit 2","targetClass":["Membrane receptor"],"prefName":"PEGINTERFERON ALFA-2B","tradeNames":["Peg-Intron","Pegintron"],"synonyms":["Peg-interferon alfa-2b","Pegifn alfa-2b","Peginterferon alfa-2b","Peginterferon-alfa-2b","Pegylated interferon alpha 2b","Sylatron"],"drugType":"Protein","mechanismOfAction":"Interferon alpha/beta receptor agonist","targetName":"Interferon alpha/beta receptor"}
{"drugId":"CHEMBL163","targetId":"ENSG00000160868","diseaseId":"EFO_0000765","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00855088%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00001968%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00985543%22"}],"ancestors":["MONDO_0021094","OTAR_0000017","OTAR_0000018","EFO_0005741","MONDO_0021681","MONDO_0003780","MONDO_0100329","MONDO_0021682","EFO_0000512","EFO_0000764","MONDO_0100336","EFO_0000540","MONDO_0100321","EFO_0000763","EFO_1001357","EFO_0000508"],"label":"AIDS","approvedSymbol":"CYP3A4","approvedName":"cytochrome P450 family 3 subfamily A member 4","targetClass":["Enzyme"],"prefName":"RITONAVIR","tradeNames":["Norvir","Ritonavir"],"synonyms":["A-84538","ABBOTT-84538","ABT-538","Empetus","NSC-693184","Norvir","Ritomune","Ritonavir","Ritonavir related compounds mixture","Ritonavirum","Ritovir","Viekirax","Viriton"],"drugType":"Small molecule","mechanismOfAction":"Cytochrome P450 3A inhibitor","targetName":"Cytochrome P450 3A"}
{"drugId":"CHEMBL2142592","targetId":"ENSG00000128602","diseaseId":"EFO_0000768","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04968574%22"}],"ancestors":["EFO_0006890","EFO_0009433","EFO_0000684","MONDO_0023370","EFO_0009448","EFO_0004244","OTAR_0000010","MONDO_0045024","EFO_0003818","EFO_0000616"],"label":"idiopathic pulmonary fibrosis","approvedSymbol":"SMO","approvedName":"smoothened, frizzled class receptor","targetClass":["Membrane receptor"],"prefName":"TALADEGIB","tradeNames":[],"synonyms":["LY-2940680","LY2940680","Taladegib"],"drugType":"Small molecule","mechanismOfAction":"Smoothened homolog antagonist","targetName":"Smoothened homolog"}
{"drugId":"CHEMBL2364648","targetId":"ENSG00000110944","diseaseId":"EFO_0001060","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04704843%22"}],"ancestors":["EFO_0009431","OTAR_0000018","EFO_0009554","EFO_0005809","MONDO_0000588","EFO_0000540","MONDO_0024635","EFO_0000508","EFO_1002003","EFO_0010282"],"label":"celiac disease","approvedSymbol":"IL23A","approvedName":"interleukin 23 subunit alpha","targetClass":["Secreted protein"],"prefName":"GUSELKUMAB","tradeNames":["Tremfya"],"synonyms":["CNTO 1959","CNTO-1959","Guselkumab"],"drugType":"Antibody","mechanismOfAction":"Interleukin-23 inhibitor","targetName":"Interleukin-23"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000176014","diseaseId":"EFO_0001061","phase":1,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02492503%22"}],"ancestors":["MONDO_0002256","OTAR_0000017","MONDO_0002654","MONDO_0002974","MONDO_0002149","MONDO_0023370","EFO_1000051","MONDO_0021148","MONDO_0045024","MONDO_0004992","MONDO_0021230","EFO_0000512","EFO_0000313","MONDO_0002715","EFO_0002919","EFO_0009549","EFO_1001331","EFO_0006858","EFO_0000616","EFO_0003859"],"label":"cervical carcinoma","approvedSymbol":"TUBB6","approvedName":"tubulin beta 6 class V","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1200437","targetId":"ENSG00000185313","diseaseId":"EFO_0001068","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3af30c3b-944e-4293-baa5-38965b1d1137"}],"ancestors":["MONDO_0100336","EFO_0001379","EFO_0005741","EFO_0001421","MONDO_0002428","EFO_0001067","MONDO_0100120","MONDO_0044347","EFO_0005803","EFO_0010284","MONDO_0043424","EFO_0010282"],"label":"malaria","approvedSymbol":"SCN10A","approvedName":"sodium voltage-gated channel alpha subunit 10","targetClass":["Ion channel"],"prefName":"QUINIDINE GLUCONATE","tradeNames":["Duraquin","Quinact","Quinaglute","Quinalan","Quinatime","Quinidine gluconate"],"synonyms":["Dura-tab","Gluconic acid quinidine salt","Gluquinate","NSC-757297","Quinidine gluconate","Quinidine mono-d-gluconate","Quinidine monogluconate, d-"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL1200437","targetId":"ENSG00000196876","diseaseId":"EFO_0001068","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3af30c3b-944e-4293-baa5-38965b1d1137"}],"ancestors":["MONDO_0100336","EFO_0001379","EFO_0005741","EFO_0001421","MONDO_0002428","EFO_0001067","MONDO_0100120","MONDO_0044347","EFO_0005803","EFO_0010284","MONDO_0043424","EFO_0010282"],"label":"malaria","approvedSymbol":"SCN8A","approvedName":"sodium voltage-gated channel alpha subunit 8","targetClass":["Unclassified protein","Auxiliary transport protein","Ion channel"],"prefName":"QUINIDINE GLUCONATE","tradeNames":["Duraquin","Quinact","Quinaglute","Quinalan","Quinatime","Quinidine gluconate"],"synonyms":["Dura-tab","Gluconic acid quinidine salt","Gluquinate","NSC-757297","Quinidine gluconate","Quinidine mono-d-gluconate","Quinidine monogluconate, d-"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000164182","diseaseId":"EFO_0001068","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05236530%22"}],"ancestors":["MONDO_0100336","EFO_0001379","EFO_0005741","EFO_0001421","MONDO_0002428","EFO_0001067","MONDO_0100120","MONDO_0044347","EFO_0005803","EFO_0010284","MONDO_0043424","EFO_0010282"],"label":"malaria","approvedSymbol":"NDUFAF2","approvedName":"NADH:ubiquinone oxidoreductase complex assembly factor 2","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL2103792","targetId":"ENSG00000239732","diseaseId":"EFO_0001068","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01351948%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00414336%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00427167%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00320658%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00889616%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00984763%22"}],"ancestors":["MONDO_0100336","EFO_0001379","EFO_0005741","EFO_0001421","MONDO_0002428","EFO_0001067","MONDO_0100120","MONDO_0044347","EFO_0005803","EFO_0010284","MONDO_0043424","EFO_0010282"],"label":"malaria","approvedSymbol":"TLR9","approvedName":"toll like receptor 9","targetClass":["Membrane receptor"],"prefName":"AGATOLIMOD","tradeNames":[],"synonyms":["Agatolimod","PF-3512676","Pf-3512676 free acid"],"drugType":"Oligonucleotide","mechanismOfAction":"Toll-like receptor 9 agonist","targetName":"Toll-like receptor 9"}
{"drugId":"CHEMBL1703","targetId":"ENSG00000178127","diseaseId":"EFO_0001071","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04931017%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"lung carcinoma","approvedSymbol":"NDUFV2","approvedName":"NADH:ubiquinone oxidoreductase core subunit V2","targetClass":["Enzyme"],"prefName":"METFORMIN HYDROCHLORIDE","tradeNames":["Bolamyn sr","Diagemet xl","Fortamet","Glucamet 500","Glucamet 850","Glucient sr","Glucophage","Glucophage sr","Glucophage xr","Glumetza","Glyformin","Janumet","Ledermetin","Metabet sr","Metformin hydrochloride","Metsol","Milform","Orabet","Riomet","Riomet er","Sukkarto sr"],"synonyms":["Apophage","Benofomin","Diabefagos","Diabex","EX-404","EX404","Glucaminol","LA-6023","Metformin hcl","Metformin hydrochloride","NSC-91485","Neodipa","Siamformet","Walaphage"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1201618","targetId":"ENSG00000215644","diseaseId":"EFO_0001073","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00929812%22"}],"ancestors":["EFO_0000589","EFO_0001069","OTAR_0000020","MONDO_0003916"],"label":"obesity","approvedSymbol":"GCGR","approvedName":"glucagon receptor","targetClass":["Membrane receptor"],"prefName":"GLUCAGON HYDROCHLORIDE","tradeNames":["Glucagen","Glucagon"],"synonyms":["Glucagon chloride","Glucagon hcl","Glucagon hydrochloride","Glucagon, monohydrochloride"],"drugType":"Protein","mechanismOfAction":"Glucagon receptor agonist","targetName":"Glucagon receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000123545","diseaseId":"EFO_0001073","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00842400%22"}],"ancestors":["EFO_0000589","EFO_0001069","OTAR_0000020","MONDO_0003916"],"label":"obesity","approvedSymbol":"NDUFAF4","approvedName":"NADH:ubiquinone oxidoreductase complex assembly factor 4","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL2105635","targetId":"ENSG00000004948","diseaseId":"EFO_0001073","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00785408%22"}],"ancestors":["EFO_0000589","EFO_0001069","OTAR_0000020","MONDO_0003916"],"label":"obesity","approvedSymbol":"CALCR","approvedName":"calcitonin receptor","targetClass":["Membrane receptor"],"prefName":"DAVALINTIDE","tradeNames":[],"synonyms":["AC-2307","AC2307","Ac2307","Davalintide"],"drugType":"Protein","mechanismOfAction":"Amylin receptor AMY1, CALCR/RAMP1 agonist","targetName":"Amylin receptor AMY1, CALCR/RAMP1"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000113327","diseaseId":"EFO_0001073","phase":0,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04881799%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04986631%22"}],"ancestors":["EFO_0000589","EFO_0001069","OTAR_0000020","MONDO_0003916"],"label":"obesity","approvedSymbol":"GABRG2","approvedName":"gamma-aminobutyric acid type A receptor subunit gamma2","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000105737","diseaseId":"EFO_0001073","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04298203%22"}],"ancestors":["EFO_0000589","EFO_0001069","OTAR_0000020","MONDO_0003916"],"label":"obesity","approvedSymbol":"GRIK5","approvedName":"glutamate ionotropic receptor kainate type subunit 5","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"Glutamate receptor ionotropic kainate antagonist","targetName":"Glutamate receptor ionotropic kainate"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000011677","diseaseId":"EFO_0001073","phase":4,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04408586%22"}],"ancestors":["EFO_0000589","EFO_0001069","OTAR_0000020","MONDO_0003916"],"label":"obesity","approvedSymbol":"GABRA3","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha3","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL741","targetId":"ENSG00000144285","diseaseId":"EFO_0001073","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00277641%22"}],"ancestors":["EFO_0000589","EFO_0001069","OTAR_0000020","MONDO_0003916"],"label":"obesity","approvedSymbol":"SCN1A","approvedName":"sodium voltage-gated channel alpha subunit 1","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"LAMOTRIGINE","tradeNames":["Lamictal","Lamictal cd","Lamictal odt","Lamictal xr","Lamotrigine"],"synonyms":["BW 430C","BW-430C","Lamotrigine","NSC-759171"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL778","targetId":"ENSG00000274286","diseaseId":"EFO_0001073","phase":0,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04436731%22"}],"ancestors":["EFO_0000589","EFO_0001069","OTAR_0000020","MONDO_0003916"],"label":"obesity","approvedSymbol":"ADRA2B","approvedName":"adrenoceptor alpha 2B","targetClass":["Membrane receptor"],"prefName":"DEXMEDETOMIDINE","tradeNames":["Precedex"],"synonyms":["Dexmedetomidine","MPV-1440","Medetomidine, (s)-"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor alpha-2 agonist","targetName":"Adrenergic receptor alpha-2"}
{"drugId":"CHEMBL911","targetId":"ENSG00000113327","diseaseId":"EFO_0001073","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00976105%22"}],"ancestors":["EFO_0000589","EFO_0001069","OTAR_0000020","MONDO_0003916"],"label":"obesity","approvedSymbol":"GABRG2","approvedName":"gamma-aminobutyric acid type A receptor subunit gamma2","targetClass":["Ion channel"],"prefName":"ZOLPIDEM","tradeNames":[],"synonyms":["Ambien","Sanval","Zolpidem","Zolpidem civ"],"drugType":"Small molecule","mechanismOfAction":"GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator","targetName":"GABA A receptor alpha-1/beta-1/gamma-2"}
{"drugId":"CHEMBL112","targetId":"ENSG00000196689","diseaseId":"EFO_0001074","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02778958%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01764555%22"}],"ancestors":["EFO_0000589","EFO_0001069","OTAR_0000020","MONDO_0003916","EFO_0001073"],"label":"morbid obesity","approvedSymbol":"TRPV1","approvedName":"transient receptor potential cation channel subfamily V member 1","targetClass":["Ion channel"],"prefName":"ACETAMINOPHEN","tradeNames":["Abdine","Acephen","Acetaminophen","Alvedon","Angiers","Calpol","Calpol six plus","Calpol six plus fastmelts","Child lemsip","Cupanol","Dafalgan","Datril","Disprol","Disprol infant","Disprol jnr","Disprol paed","Fennings","Galpamol","Hedex","Infadrops","Infants' feverall","Injectapap","Junior parapaed","Mandanol","Medinol","Medinol for children","Medinol over 6","Medinol under 6","Medised plain","Miradol","Neopap","Ofirmev","Paldesic","Panadol","Panadol actifast","Panadol actifast solb","Panadol advan","Panadol jnr","Panadol oa","Panaleve","Panaleve 6 plus","Paracetamol","Paramin","Parapaed jnr","Parapaed six plus","Paravict","Perfalgan","Phenaphen","Placidex","Rimadol","Salzone","Tixymol","Tramil 500","Tylenol"],"synonyms":["Acetaminophen","Apap","Biocetamol","Doliprane","Efferalgan","N-acetyl-p-aminophenol","NSC-109028","NSC-3991","P-hydroxy-acetanilid","Paracetamol","Paracetamolum","Vermidon"],"drugType":"Small molecule","mechanismOfAction":"Vanilloid receptor opener","targetName":"Vanilloid receptor"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000176014","diseaseId":"EFO_0001075","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00474669%22"}],"ancestors":["OTAR_0000017","EFO_0005771","MONDO_0002259","MONDO_0002149","MONDO_0023370","MONDO_0002229","EFO_1000051","EFO_0003893","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0000313","MONDO_0008170","EFO_0001379","EFO_0009549","MONDO_0018364","EFO_0006858","EFO_1001331","EFO_0000616"],"label":"ovarian carcinoma","approvedSymbol":"TUBB6","approvedName":"tubulin beta 6 class V","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000187730","diseaseId":"EFO_0001358","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00204386%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004257","EFO_0006788","EFO_0000618","EFO_0010098","EFO_0009386"],"label":"post-traumatic stress disorder","approvedSymbol":"GABRD","approvedName":"gamma-aminobutyric acid type A receptor subunit delta","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL27","targetId":"ENSG00000169252","diseaseId":"EFO_0001358","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03151681%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004257","EFO_0006788","EFO_0000618","EFO_0010098","EFO_0009386"],"label":"post-traumatic stress disorder","approvedSymbol":"ADRB2","approvedName":"adrenoceptor beta 2","targetClass":["Membrane receptor"],"prefName":"PROPRANOLOL","tradeNames":[],"synonyms":[".beta.-propranolol","AY-64043-","Betalong","Dl-propranolol","Euprovasin","Inderal","Inderide-40/25","Inderide-80/25","Propranolol","Proprasylyt","Reducor"],"drugType":"Small molecule","mechanismOfAction":"Beta-2 adrenergic receptor antagonist","targetName":"Beta-2 adrenergic receptor"}
{"drugId":"CHEMBL1139","targetId":"ENSG00000160013","diseaseId":"EFO_0001361","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05427162%22"}],"ancestors":["MONDO_0000473","MONDO_0005149","EFO_0000684","OTAR_0000010","EFO_0004264","EFO_0000537","EFO_0000319"],"label":"pulmonary arterial hypertension","approvedSymbol":"PTGIR","approvedName":"prostaglandin I2 receptor","targetClass":["Membrane receptor"],"prefName":"EPOPROSTENOL","tradeNames":[],"synonyms":["ACT-385781A","Epoprostenol","Flolan","PG-I2","Pgi2","Pgx","Prostacyclin","Prostaglandin i2","Prostaglandin x","U-53,217","U-53217"],"drugType":"Small molecule","mechanismOfAction":"Prostanoid IP receptor agonist","targetName":"Prostanoid IP receptor"}
{"drugId":"CHEMBL1201583","targetId":"ENSG00000112715","diseaseId":"EFO_0001365","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04101877%22"}],"ancestors":["MONDO_0021084","OTAR_0000018","EFO_0008624","MONDO_0004580","MONDO_0024458","MONDO_0002175","EFO_0003966","MONDO_0019118","MONDO_0020238","MONDO_0024417","EFO_0000618","EFO_0000508","EFO_0009606","EFO_0003839"],"label":"age-related macular degeneration","approvedSymbol":"VEGFA","approvedName":"vascular endothelial growth factor A","targetClass":["Secreted protein"],"prefName":"BEVACIZUMAB","tradeNames":["Avastin"],"synonyms":["12-IGG1","AVA-1","Abp-215","BI 695502","BS-503A","Bevacizumab","Bevacizumab beta","Bevacizumab biosimilar (fkb-238)","Bevacizumab-awwb","Bevacizumab-bvzr","Bi-695502","Bs-503","Byvasda","CHS-5217","CT-16","CT-P16","CT-P16 (BIOSIMILAR OF BEVACIZUMAB)","Ct-16","Ct-p16","FKB-238","Fkb238","HLX-04","HLX04","Ibi-305","Ibi305","Mvasi","PF-06439535","Pf-06439535","R-435","RG-435","RHUMAB-","RHUMAB-VEGF","Usp mab 002, monoclonal igg1","Zirabev"],"drugType":"Antibody","mechanismOfAction":"Vascular endothelial growth factor A inhibitor","targetName":"Vascular endothelial growth factor A"}
{"drugId":"CHEMBL1742982","targetId":"ENSG00000112715","diseaseId":"EFO_0001365","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04820452%22"}],"ancestors":["MONDO_0021084","OTAR_0000018","EFO_0008624","MONDO_0004580","MONDO_0024458","MONDO_0002175","EFO_0003966","MONDO_0019118","MONDO_0020238","MONDO_0024417","EFO_0000618","EFO_0000508","EFO_0009606","EFO_0003839"],"label":"age-related macular degeneration","approvedSymbol":"VEGFA","approvedName":"vascular endothelial growth factor A","targetClass":["Secreted protein"],"prefName":"AFLIBERCEPT","tradeNames":["Eylea","Zaltrap"],"synonyms":["ABP-938","AVE-0005","AVE0005","Aflibercept","Aflibercept (genetical recombination)","Aflibercept beta","Aflibercept biosimilar (amgen)","Aflibercept recombinant","BAY-86-5321","BAY-865321","BAY86-5321","VEGF TRAP","Vegf trap-eye","Ziv-aflibercept"],"drugType":"Protein","mechanismOfAction":"Vascular endothelial growth factor A inhibitor","targetName":"Vascular endothelial growth factor A"}
{"drugId":"CHEMBL1742982","targetId":"ENSG00000119630","diseaseId":"EFO_0001365","phase":4,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02002377%22"}],"ancestors":["MONDO_0021084","OTAR_0000018","EFO_0008624","MONDO_0004580","MONDO_0024458","MONDO_0002175","EFO_0003966","MONDO_0019118","MONDO_0020238","MONDO_0024417","EFO_0000618","EFO_0000508","EFO_0009606","EFO_0003839"],"label":"age-related macular degeneration","approvedSymbol":"PGF","approvedName":"placental growth factor","targetClass":["Secreted protein"],"prefName":"AFLIBERCEPT","tradeNames":["Eylea","Zaltrap"],"synonyms":["ABP-938","AVE-0005","AVE0005","Aflibercept","Aflibercept (genetical recombination)","Aflibercept beta","Aflibercept biosimilar (amgen)","Aflibercept recombinant","BAY-86-5321","BAY-865321","BAY86-5321","VEGF TRAP","Vegf trap-eye","Ziv-aflibercept"],"drugType":"Protein","mechanismOfAction":"Placenta growth factor inhibitor","targetName":"Placenta growth factor"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000101868","diseaseId":"EFO_0001378","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03128359%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0000621","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0004992","Orphanet_322126","EFO_0002427","Orphanet_68336","EFO_0000200","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0000508","MONDO_0019044","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"multiple myeloma","approvedSymbol":"POLA1","approvedName":"DNA polymerase alpha 1, catalytic subunit","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1456","targetId":"ENSG00000178035","diseaseId":"EFO_0001378","phase":1,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01619761%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0000621","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0004992","Orphanet_322126","EFO_0002427","Orphanet_68336","EFO_0000200","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0000508","MONDO_0019044","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"multiple myeloma","approvedSymbol":"IMPDH2","approvedName":"inosine monophosphate dehydrogenase 2","targetClass":["Enzyme"],"prefName":"MYCOPHENOLATE MOFETIL","tradeNames":["Arzip","Cellcept","Mycophenolate mofetil","Myfenax"],"synonyms":["Myclausen","Mycophenolate mofetil","Mycophenolic acid 2-(4-morpholinyl)ethyl ester","Mycophenylate mofetil","NSC-724229","NSC-758905","RS-61443"],"drugType":"Small molecule","mechanismOfAction":"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor","targetName":"Inosine-5'-monophosphate dehydrogenase (IMPDH)"}
{"drugId":"CHEMBL325041","targetId":"ENSG00000100804","diseaseId":"EFO_0001378","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01470131%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00574080%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00657553%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00256776%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01002248%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00522392%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0000621","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0004992","Orphanet_322126","EFO_0002427","Orphanet_68336","EFO_0000200","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0000508","MONDO_0019044","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"multiple myeloma","approvedSymbol":"PSMB5","approvedName":"proteasome 20S subunit beta 5","targetClass":["Enzyme"],"prefName":"BORTEZOMIB","tradeNames":["Velcade"],"synonyms":["Bortezomib","Bortezomib accord","Bortezomib hydrate","LDP-341","NSC-681239","PS-341","Velcade"],"drugType":"Small molecule","mechanismOfAction":"26S proteosome inhibitor","targetName":"26S proteasome"}
{"drugId":"CHEMBL371405","targetId":"ENSG00000204264","diseaseId":"EFO_0001378","phase":2,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05050305%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0000621","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0004992","Orphanet_322126","EFO_0002427","Orphanet_68336","EFO_0000200","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0000508","MONDO_0019044","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"multiple myeloma","approvedSymbol":"PSMB8","approvedName":"proteasome 20S subunit beta 8","targetClass":["Enzyme"],"prefName":"MARIZOMIB","tradeNames":[],"synonyms":["Marizomib","NPI-0052","Salinosporamide a"],"drugType":"Small molecule","mechanismOfAction":"20S proteosome inhibitor","targetName":"20S proteasome"}
{"drugId":"CHEMBL4297562","targetId":"ENSG00000107984","diseaseId":"EFO_0001378","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01711671%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0000621","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0004992","Orphanet_322126","EFO_0002427","Orphanet_68336","EFO_0000200","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0000508","MONDO_0019044","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"multiple myeloma","approvedSymbol":"DKK1","approvedName":"dickkopf WNT signaling pathway inhibitor 1","targetClass":["Secreted protein"],"prefName":"DKN-01","tradeNames":[],"synonyms":["DKN-01","Dkn-01","LY-2812176","LY2812176","Sirexatamab"],"drugType":"Unknown","mechanismOfAction":"Dickkopf-related protein 1 inhibitor","targetName":"Dickkopf-related protein 1"}
{"drugId":"CHEMBL451887","targetId":"ENSG00000100804","diseaseId":"EFO_0001378","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04096066%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03742297%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03651128%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03729804%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0000621","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0004992","Orphanet_322126","EFO_0002427","Orphanet_68336","EFO_0000200","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0000508","MONDO_0019044","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"multiple myeloma","approvedSymbol":"PSMB5","approvedName":"proteasome 20S subunit beta 5","targetClass":["Enzyme"],"prefName":"CARFILZOMIB","tradeNames":["Kyprolis"],"synonyms":["Carfilzomib","NSC-758252","PR-171"],"drugType":"Protein","mechanismOfAction":"26S proteosome inhibitor","targetName":"26S proteasome"}
{"drugId":"CHEMBL468","targetId":"ENSG00000113851","diseaseId":"EFO_0001378","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00367185%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00057564%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00232934%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00633542%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00083876%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00111748%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00083915%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00075829%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01070862%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00602511%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03402295%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00222053%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01971658%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00934154%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01296503%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00049673%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00443235%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01539083%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00461747%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00083551%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00033332%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00097981%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00218855%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00689936%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00452569%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00432458%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00038233%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01063179%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00507416%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0000621","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0004992","Orphanet_322126","EFO_0002427","Orphanet_68336","EFO_0000200","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0000508","MONDO_0019044","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"multiple myeloma","approvedSymbol":"CRBN","approvedName":"cereblon","targetClass":["Enzyme","Unclassified protein","Transcription factor","Epigenetic regulator"],"prefName":"THALIDOMIDE","tradeNames":["Talidex","Thalomid"],"synonyms":[".alpha.-phthalimidoglutarimide","Celgene","Contergan","Distaval","K-17","Myrin","N-phthalylglutamic acid imide","NSC-527179","NSC-66847","Neurosedyn","Pantosediv","Pharmion","Softenon","Thaled","Thalidomide","Thalidomide "],"drugType":"Small molecule","mechanismOfAction":"CRL4(CRBN) E3 ubiquitin ligase inhibitor","targetName":"CRL4(CRBN) E3 ubiquitin ligase"}
{"drugId":"CHEMBL803","targetId":"ENSG00000148229","diseaseId":"EFO_0001378","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002502%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002657%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002552%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0000621","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0004992","Orphanet_322126","EFO_0002427","Orphanet_68336","EFO_0000200","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0000508","MONDO_0019044","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"multiple myeloma","approvedSymbol":"POLE3","approvedName":"DNA polymerase epsilon 3, accessory subunit","targetClass":["Unclassified protein"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL553025","targetId":"ENSG00000258947","diseaseId":"EFO_0001416","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00064077%22"}],"ancestors":["MONDO_0002256","OTAR_0000017","MONDO_0024276","MONDO_0002654","MONDO_0002974","MONDO_0002149","MONDO_0023370","EFO_1000051","MONDO_0021148","MONDO_0045024","MONDO_0004992","MONDO_0021230","EFO_0001061","EFO_0000512","EFO_0000313","EFO_0000228","MONDO_0002715","EFO_0002919","EFO_0009549","EFO_1001331","EFO_0006858","EFO_0000616","EFO_0003859"],"label":"cervical adenocarcinoma","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"VINORELBINE","tradeNames":[],"synonyms":["NSC-760087","Navelbin","Vinorelbine","Vinorelbine Base"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1289494","targetId":"ENSG00000128052","diseaseId":"EFO_0001421","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01631097%22"}],"ancestors":["EFO_0001379","EFO_0010284","EFO_0010282"],"label":"liver disease","approvedSymbol":"KDR","approvedName":"kinase insert domain receptor","targetClass":["Enzyme"],"prefName":"TIVOZANIB","tradeNames":["Fotivda"],"synonyms":["ASP-4130","AV-951","KIL8951","KRN-951","Kil-8951","Krn-951","Tivozanib"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000145863","diseaseId":"EFO_0001421","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00768209%22"}],"ancestors":["EFO_0001379","EFO_0010284","EFO_0010282"],"label":"liver disease","approvedSymbol":"GABRA6","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha6","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL4297590","targetId":"ENSG00000121764","diseaseId":"EFO_0001421","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03713242%22"}],"ancestors":["EFO_0001379","EFO_0010284","EFO_0010282"],"label":"liver disease","approvedSymbol":"HCRTR1","approvedName":"hypocretin receptor 1","targetClass":["Membrane receptor"],"prefName":"DARIDOREXANT","tradeNames":[],"synonyms":["ACT-541468","Act-541468","Daridorexant","Nemorexant"],"drugType":"Small molecule","mechanismOfAction":"Orexin receptor antagonist","targetName":"Orexin receptor"}
{"drugId":"CHEMBL461101","targetId":"ENSG00000117400","diseaseId":"EFO_0001642","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03844360%22"}],"ancestors":["MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","EFO_0005803","EFO_0000616"],"label":"lymphoid neoplasm","approvedSymbol":"MPL","approvedName":"MPL proto-oncogene, thrombopoietin receptor","targetClass":["Membrane receptor"],"prefName":"ELTROMBOPAG","tradeNames":["Revolade"],"synonyms":["Eltrombopag","SB497115"],"drugType":"Small molecule","mechanismOfAction":"Thrombopoietin receptor agonist","targetName":"Thrombopoietin receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000166136","diseaseId":"EFO_0001645","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00000620%22"}],"ancestors":["MONDO_0000473","EFO_0003777","EFO_0004264","EFO_0000319"],"label":"coronary artery disease","approvedSymbol":"NDUFB8","approvedName":"NADH:ubiquinone oxidoreductase subunit B8","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198786","diseaseId":"EFO_0001645","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01438723%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00723307%22"}],"ancestors":["MONDO_0000473","EFO_0003777","EFO_0004264","EFO_0000319"],"label":"coronary artery disease","approvedSymbol":"MT-ND5","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL317052","targetId":"ENSG00000128271","diseaseId":"EFO_0001645","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03236311%22"}],"ancestors":["MONDO_0000473","EFO_0003777","EFO_0004264","EFO_0000319"],"label":"coronary artery disease","approvedSymbol":"ADORA2A","approvedName":"adenosine A2a receptor","targetClass":["Membrane receptor"],"prefName":"REGADENOSON","tradeNames":["Lexiscan"],"synonyms":["Regadenoson monohydrate"],"drugType":"Small molecule","mechanismOfAction":"Adenosine A2a receptor agonist","targetName":"Adenosine A2a receptor"}
{"drugId":"CHEMBL1201670","targetId":"ENSG00000198223","diseaseId":"EFO_0001663","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00108732%22"}],"ancestors":["OTAR_0000017","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","MONDO_0008315","EFO_0000512","EFO_0000313","EFO_0006858","EFO_0000616"],"label":"prostate carcinoma","approvedSymbol":"CSF2RA","approvedName":"colony stimulating factor 2 receptor subunit alpha","targetClass":["Membrane receptor"],"prefName":"SARGRAMOSTIM","tradeNames":["Leukine"],"synonyms":["B1 61.012","B1-61012","Granulocyte-macrophage colony-stimulating factor sargramostim","RHU GM-CSF","RHU-GM-CSF","Sargramostim","Sargramostim rdna"],"drugType":"Protein","mechanismOfAction":"Granulocyte-macrophage colony-stimulating factor receptor agonist","targetName":"Granulocyte-macrophage colony-stimulating factor receptor"}
{"drugId":"CHEMBL131","targetId":"ENSG00000113580","diseaseId":"EFO_0001663","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00473746%22"}],"ancestors":["OTAR_0000017","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","MONDO_0008315","EFO_0000512","EFO_0000313","EFO_0006858","EFO_0000616"],"label":"prostate carcinoma","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"PREDNISOLONE","tradeNames":["Cortalone","Dekotil","Delta-cortef","Deltacortril","Deltalone","Dilacort","Fernisolone-p","Hydeltra","Meti-derm","Meticortelone","Pevanti","Precortisyl","Precortisyl fte","Prednisolone","Prelone","Scheriproct","Servisone","Sterane"],"synonyms":["Desowen","Hydeltra-Tba","Meticortelone","NSC-9120","NSC-9900","Neo-Delta-Cortef","Poly-Pred","Pred-G","Prednisolone","Servisone","Tridesilon","Verdeso"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000101868","diseaseId":"EFO_0002428","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00069992%22"}],"ancestors":["EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0002334","MONDO_0003225","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0023370","MONDO_0005374","EFO_0002461","MONDO_0044881","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0002427","MONDO_0015756","EFO_0000540","EFO_0003820","EFO_1001986","MONDO_0000637","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"chronic myeloproliferative disorder","approvedSymbol":"POLA1","approvedName":"DNA polymerase alpha 1, catalytic subunit","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1789941","targetId":"ENSG00000096968","diseaseId":"EFO_0002429","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04116502%22"}],"ancestors":["EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0001115","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","MONDO_0015756","MONDO_0023603","EFO_0003820","EFO_0005803","EFO_0005804","EFO_0000616","OTAR_0000018","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0004251","EFO_0002427","MONDO_0020703","EFO_0002428","EFO_0000540","EFO_0000508","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"polycythemia vera","approvedSymbol":"JAK2","approvedName":"Janus kinase 2","targetClass":["Enzyme","Other cytosolic protein"],"prefName":"RUXOLITINIB","tradeNames":["Jakavi"],"synonyms":["INC-424","INC424","INCB-018424","INCB-18424","INCB018424","Ruxolitinib"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase JAK2 inhibitor","targetName":"Tyrosine-protein kinase JAK2"}
{"drugId":"CHEMBL61872","targetId":"ENSG00000120251","diseaseId":"EFO_0002499","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00062504%22"}],"ancestors":["MONDO_0021193","EFO_0005543","MONDO_0023370","EFO_0000272","MONDO_0021248","MONDO_0045024","MONDO_0020665","MONDO_0004992","EFO_0007392","EFO_0009386","EFO_0000326","MONDO_0020633","MONDO_0100342","MONDO_0021636","EFO_0000618","MONDO_0016680","EFO_0000616","EFO_1000158"],"label":"anaplastic astrocytoma","approvedSymbol":"GRIA2","approvedName":"glutamate ionotropic receptor AMPA type subunit 2","targetClass":["Ion channel"],"prefName":"TALAMPANEL","tradeNames":[],"synonyms":["GYKI-53773","LY-300164","Talampanel"],"drugType":"Small molecule","mechanismOfAction":"Glutamate receptor ionotropic, AMPA 2 antagonist","targetName":"Glutamate receptor ionotropic, AMPA 2"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000176014","diseaseId":"EFO_0002517","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02101021%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02715804%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04329949%22"}],"ancestors":["MONDO_0024276","MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0000228","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_1000044","EFO_0002618","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic ductal adenocarcinoma","approvedSymbol":"TUBB6","approvedName":"tubulin beta 6 class V","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL888","targetId":"ENSG00000014138","diseaseId":"EFO_0002517","phase":1,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05257993%22"}],"ancestors":["MONDO_0024276","MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0000228","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_1000044","EFO_0002618","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic ductal adenocarcinoma","approvedSymbol":"POLA2","approvedName":"DNA polymerase alpha 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL888","targetId":"ENSG00000101868","diseaseId":"EFO_0002517","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01526135%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00471146%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02993731%22"}],"ancestors":["MONDO_0024276","MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0000228","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_1000044","EFO_0002618","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic ductal adenocarcinoma","approvedSymbol":"POLA1","approvedName":"DNA polymerase alpha 1, catalytic subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000004779","diseaseId":"EFO_0002546","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01234649%22"}],"ancestors":["EFO_0000651","HP_0000118","HP_0011014","HP_0001939"],"label":"abnormal glucose tolerance","approvedSymbol":"NDUFAB1","approvedName":"NADH:ubiquinone oxidoreductase subunit AB1","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL3622821","targetId":"ENSG00000096968","diseaseId":"EFO_0002609","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03725007%22"}],"ancestors":["EFO_0005140","EFO_0004260","OTAR_0000006","EFO_0009676","EFO_0000540","EFO_1000999","MONDO_0002614","EFO_0005755","EFO_0002461","EFO_1001986","EFO_0005856"],"label":"juvenile idiopathic arthritis","approvedSymbol":"JAK2","approvedName":"Janus kinase 2","targetClass":["Enzyme","Other cytosolic protein"],"prefName":"UPADACITINIB","tradeNames":["Rinvoq"],"synonyms":["ABT-494","Upadacitinib","Upadacitinib anhydrous","Upadacitinib hemihydrate"],"drugType":"Small molecule","mechanismOfAction":"Janus Kinase (JAK) inhibitor","targetName":"Janus Kinase (JAK)"}
{"drugId":"CHEMBL1201293","targetId":"ENSG00000116032","diseaseId":"EFO_0002610","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00385268%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","MONDO_0004938","EFO_0000618","EFO_0003890","MONDO_0002494","EFO_0009386"],"label":"cocaine dependence","approvedSymbol":"GRIN3B","approvedName":"glutamate ionotropic receptor NMDA type subunit 3B","targetClass":["Ion channel"],"prefName":"ACAMPROSATE","tradeNames":[],"synonyms":["Acamprosate"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor antagonist","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL370805","targetId":"ENSG00000168356","diseaseId":"EFO_0002610","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01978457%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","MONDO_0004938","EFO_0000618","EFO_0003890","MONDO_0002494","EFO_0009386"],"label":"cocaine dependence","approvedSymbol":"SCN11A","approvedName":"sodium voltage-gated channel alpha subunit 11","targetClass":["Ion channel"],"prefName":"COCAINE","tradeNames":[],"synonyms":["(r)-(-)-cocaine","Benzoylmethylecgonine","Cocaine","Cocainum","IDS-NC-004","Neurocaine","RX-0041","RX0041"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL531","targetId":"ENSG00000151577","diseaseId":"EFO_0002610","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00000248%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","MONDO_0004938","EFO_0000618","EFO_0003890","MONDO_0002494","EFO_0009386"],"label":"cocaine dependence","approvedSymbol":"DRD3","approvedName":"dopamine receptor D3","targetClass":["Membrane receptor"],"prefName":"PERGOLIDE","tradeNames":[],"synonyms":["Pergolide"],"drugType":"Small molecule","mechanismOfAction":"Dopamine receptor agonist","targetName":"Dopamine receptor"}
{"drugId":"CHEMBL87493","targetId":"ENSG00000179546","diseaseId":"EFO_0002610","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00000313%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","MONDO_0004938","EFO_0000618","EFO_0003890","MONDO_0002494","EFO_0009386"],"label":"cocaine dependence","approvedSymbol":"HTR1D","approvedName":"5-hydroxytryptamine receptor 1D","targetClass":["Membrane receptor"],"prefName":"FENFLURAMINE","tradeNames":[],"synonyms":["Acino","Brabafen","Fenfluramin","Fenfluramine","J5.760F","Obedrex","Pesos","Phenfluramine","Ponderax pa","Rotondin","S-768","Z-008","Z008","ZX-008","ZX008"],"drugType":"Small molecule","mechanismOfAction":"Serotonin 1d (5-HT1d) receptor agonist","targetName":"Serotonin 1d (5-HT1d) receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000137806","diseaseId":"EFO_0002614","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04264897%22"}],"ancestors":["EFO_0000651","HP_0000118","HP_0001939"],"label":"insulin resistance","approvedSymbol":"NDUFAF1","approvedName":"NADH:ubiquinone oxidoreductase complex assembly factor 1","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL526","targetId":"ENSG00000022355","diseaseId":"EFO_0002615","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03996148%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02609087%22"}],"ancestors":["MONDO_0000473","MONDO_0043218","EFO_0005774","EFO_0003763","EFO_0000618","EFO_0003781","EFO_0004264","EFO_0009386","EFO_0000319"],"label":"internal carotid artery stenosis","approvedSymbol":"GABRA1","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha1","targetClass":["Ion channel"],"prefName":"PROPOFOL","tradeNames":["Diprivan","Disoprivan","Propofol","Rapinovet"],"synonyms":["Disoprofol","Fresofol","ICI 35,868","ICI 35-868","ICI-35868","ICI35,868","Lipuro","NSC-5105","Phenol, 2,6-bis(1-methylethyl)","Propofol"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000077514","diseaseId":"EFO_0002617","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01995344%22"}],"ancestors":["EFO_0003769","EFO_0000756","EFO_1001901","EFO_0001379","MONDO_0023370","MONDO_0045024","MONDO_0021143","EFO_0000616"],"label":"metastatic melanoma","approvedSymbol":"POLD3","approvedName":"DNA polymerase delta 3, accessory subunit","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1201438","targetId":"ENSG00000134460","diseaseId":"EFO_0002617","phase":4,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01856023%22"}],"ancestors":["EFO_0003769","EFO_0000756","EFO_1001901","EFO_0001379","MONDO_0023370","MONDO_0045024","MONDO_0021143","EFO_0000616"],"label":"metastatic melanoma","approvedSymbol":"IL2RA","approvedName":"interleukin 2 receptor subunit alpha","targetClass":["Membrane receptor"],"prefName":"ALDESLEUKIN","tradeNames":["Proleukin"],"synonyms":["Aldesleukin","Human interleukin-2","Human interleukin-2 125-serine","ILT-101","Ilt-101","Ilt-101 (low dose il-2)","Interleukin 2","Interleukin-2","Interleukin-2 aldesleukin","Interleukin-2(2-133),125-ser","Recombinant interleukin-2 human"],"drugType":"Protein","mechanismOfAction":"Interleukin-2 receptor agonist","targetName":"Interleukin-2 receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000128609","diseaseId":"EFO_0002617","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01840007%22"}],"ancestors":["EFO_0003769","EFO_0000756","EFO_1001901","EFO_0001379","MONDO_0023370","MONDO_0045024","MONDO_0021143","EFO_0000616"],"label":"metastatic melanoma","approvedSymbol":"NDUFA5","approvedName":"NADH:ubiquinone oxidoreductase subunit A5","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1567","targetId":"ENSG00000122025","diseaseId":"EFO_0002617","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01005472%22"}],"ancestors":["EFO_0003769","EFO_0000756","EFO_1001901","EFO_0001379","MONDO_0023370","MONDO_0045024","MONDO_0021143","EFO_0000616"],"label":"metastatic melanoma","approvedSymbol":"FLT3","approvedName":"fms related receptor tyrosine kinase 3","targetClass":["Enzyme"],"prefName":"SUNITINIB MALATE","tradeNames":["Sunitinib malate","Sutent"],"synonyms":["PHA-290940AD","SU-010398","SU-011248 L-MALATE SALT","SU010398","SU011248 L-MALATE SALT","Sunitinib l-malate","Sunitinib malate","Sutent"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase receptor FLT3 inhibitor","targetName":"Tyrosine-protein kinase receptor FLT3"}
{"drugId":"CHEMBL2105729","targetId":"ENSG00000157764","diseaseId":"EFO_0002617","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=803beaaa-33f9-48cc-9a95-c2e887e095b4"}],"ancestors":["EFO_0003769","EFO_0000756","EFO_1001901","EFO_0001379","MONDO_0023370","MONDO_0045024","MONDO_0021143","EFO_0000616"],"label":"metastatic melanoma","approvedSymbol":"BRAF","approvedName":"B-Raf proto-oncogene, serine/threonine kinase","targetClass":["Enzyme"],"prefName":"DABRAFENIB MESYLATE","tradeNames":["Tafinlar"],"synonyms":["Dabrafenib mesilate","Dabrafenib mesylate","GSK-2118436 METHANESULFONATE SALT","GSK-2118436B","GSK-2118436B MESYLATE","GSK-2118436B METHANESULFONATE SALT","GSK2118436B","GSK2118436B, METHANE SULFONATE SALT","METHANE SULFONATE SALT"],"drugType":"Small molecule","mechanismOfAction":"Serine/threonine-protein kinase B-raf inhibitor","targetName":"Serine/threonine-protein kinase B-raf"}
{"drugId":"CHEMBL2108738","targetId":"ENSG00000188389","diseaseId":"EFO_0002617","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01721746%22"}],"ancestors":["EFO_0003769","EFO_0000756","EFO_1001901","EFO_0001379","MONDO_0023370","MONDO_0045024","MONDO_0021143","EFO_0000616"],"label":"metastatic melanoma","approvedSymbol":"PDCD1","approvedName":"programmed cell death 1","targetClass":["Surface antigen"],"prefName":"NIVOLUMAB","tradeNames":["Opdivo"],"synonyms":["BMS-936558","BMS-986298","MDX-1106","Nivolumab","ONO-4538"],"drugType":"Antibody","mechanismOfAction":"Programmed cell death protein 1 inhibitor","targetName":"Programmed cell death protein 1"}
{"drugId":"CHEMBL1201583","targetId":"ENSG00000112715","diseaseId":"EFO_0002618","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00222469%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00126633%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00365144%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00100815%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00602602%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00112528%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00417976%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00460174%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00305877%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00557492%22"}],"ancestors":["MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic carcinoma","approvedSymbol":"VEGFA","approvedName":"vascular endothelial growth factor A","targetClass":["Secreted protein"],"prefName":"BEVACIZUMAB","tradeNames":["Avastin"],"synonyms":["12-IGG1","AVA-1","Abp-215","BI 695502","BS-503A","Bevacizumab","Bevacizumab beta","Bevacizumab biosimilar (fkb-238)","Bevacizumab-awwb","Bevacizumab-bvzr","Bi-695502","Bs-503","Byvasda","CHS-5217","CT-16","CT-P16","CT-P16 (BIOSIMILAR OF BEVACIZUMAB)","Ct-16","Ct-p16","FKB-238","Fkb238","HLX-04","HLX04","Ibi-305","Ibi305","Mvasi","PF-06439535","Pf-06439535","R-435","RG-435","RHUMAB-","RHUMAB-VEGF","Usp mab 002, monoclonal igg1","Zirabev"],"drugType":"Antibody","mechanismOfAction":"Vascular endothelial growth factor A inhibitor","targetName":"Vascular endothelial growth factor A"}
{"drugId":"CHEMBL1201670","targetId":"ENSG00000198223","diseaseId":"EFO_0002618","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04810910%22"}],"ancestors":["MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic carcinoma","approvedSymbol":"CSF2RA","approvedName":"colony stimulating factor 2 receptor subunit alpha","targetClass":["Membrane receptor"],"prefName":"SARGRAMOSTIM","tradeNames":["Leukine"],"synonyms":["B1 61.012","B1-61012","Granulocyte-macrophage colony-stimulating factor sargramostim","RHU GM-CSF","RHU-GM-CSF","Sargramostim","Sargramostim rdna"],"drugType":"Protein","mechanismOfAction":"Granulocyte-macrophage colony-stimulating factor receptor agonist","targetName":"Granulocyte-macrophage colony-stimulating factor receptor"}
{"drugId":"CHEMBL1421","targetId":"ENSG00000157404","diseaseId":"EFO_0002618","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01395017%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01652976%22"}],"ancestors":["MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic carcinoma","approvedSymbol":"KIT","approvedName":"KIT proto-oncogene, receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"DASATINIB","tradeNames":["Dasatinib","Sprycel"],"synonyms":["BMS-354825","BMS-354825 HYDRATE","BMS-354825-03","Dasatinib","Dasatinib anhydrous","Dasatinib hydrate","Dasatinib monohydrate","NSC-759877"],"drugType":"Small molecule","mechanismOfAction":"Stem cell growth factor receptor inhibitor","targetName":"Stem cell growth factor receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000184983","diseaseId":"EFO_0002618","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01488552%22"}],"ancestors":["MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic carcinoma","approvedSymbol":"NDUFA6","approvedName":"NADH:ubiquinone oxidoreductase subunit A6","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL16","targetId":"ENSG00000168356","diseaseId":"EFO_0002618","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03512756%22"}],"ancestors":["MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic carcinoma","approvedSymbol":"SCN11A","approvedName":"sodium voltage-gated channel alpha subunit 11","targetClass":["Ion channel"],"prefName":"PHENYTOIN","tradeNames":["Dilabid","Dilantin","Dilantin-125","Dilantin-30","Diphenylhydantoin","Hydantol","Phentytoin","Phenytoin"],"synonyms":["Diphenylhydantoin","Epamin","Lepitoin","NSC-8722","Phenytek","Phenytex","Phenytoin","Phenytoinum","SM-88 COMPONENT PHENYTOIN","Zentropil"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL1637","targetId":"ENSG00000101868","diseaseId":"EFO_0002618","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00082862%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003780%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003797%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00275119%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00006117%22"}],"ancestors":["MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic carcinoma","approvedSymbol":"POLA1","approvedName":"DNA polymerase alpha 1, catalytic subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE HYDROCHLORIDE","tradeNames":["Gemcitabine hydrochloride","Gemzar","Infugem"],"synonyms":["Gemcitabine (as hydrochloride)","Gemcitabine hcl","Gemcitabine hydrochloride","Gemzar","LY-188011","LY-188011 HYDROCHLORIDE","LY188011 HYDROCHLORIDE"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1637","targetId":"ENSG00000014138","diseaseId":"EFO_0002618","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00024427%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00032175%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00026338%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003216%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00425360%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00058201%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00634725%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00075686%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00303758%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00058149%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00023972%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00416507%22"}],"ancestors":["MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic carcinoma","approvedSymbol":"POLA2","approvedName":"DNA polymerase alpha 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"GEMCITABINE HYDROCHLORIDE","tradeNames":["Gemcitabine hydrochloride","Gemzar","Infugem"],"synonyms":["Gemcitabine (as hydrochloride)","Gemcitabine hcl","Gemcitabine hydrochloride","Gemzar","LY-188011","LY-188011 HYDROCHLORIDE","LY188011 HYDROCHLORIDE"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1637","targetId":"ENSG00000175482","diseaseId":"EFO_0002618","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00075452%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00268411%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00005870%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00541021%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00005869%22"}],"ancestors":["MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic carcinoma","approvedSymbol":"POLD4","approvedName":"DNA polymerase delta 4, accessory subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE HYDROCHLORIDE","tradeNames":["Gemcitabine hydrochloride","Gemzar","Infugem"],"synonyms":["Gemcitabine (as hydrochloride)","Gemcitabine hcl","Gemcitabine hydrochloride","Gemzar","LY-188011","LY-188011 HYDROCHLORIDE","LY188011 HYDROCHLORIDE"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1946170","targetId":"ENSG00000185386","diseaseId":"EFO_0002618","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02080260%22"}],"ancestors":["MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic carcinoma","approvedSymbol":"MAPK11","approvedName":"mitogen-activated protein kinase 11","targetClass":["Enzyme"],"prefName":"REGORAFENIB","tradeNames":["Stivarga"],"synonyms":["BAY 73-4506","BAY 73-4506 monohydrate","BAY-73-4506","BAY-734506","Regorafenib"],"drugType":"Small molecule","mechanismOfAction":"MAP kinase p38 beta inhibitor","targetName":"MAP kinase p38 beta"}
{"drugId":"CHEMBL235191","targetId":"ENSG00000094631","diseaseId":"EFO_0002618","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00004861%22"}],"ancestors":["MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic carcinoma","approvedSymbol":"HDAC6","approvedName":"histone deacetylase 6","targetClass":["Epigenetic regulator"],"prefName":"TACEDINALINE","tradeNames":[],"synonyms":["CI-994","GOE 5549","GOE-5549","PD 123654","PD-123654","Tacedinaline"],"drugType":"Small molecule","mechanismOfAction":"Histone deacetylase inhibitor","targetName":"Histone deacetylase"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000176014","diseaseId":"EFO_0002618","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00320749%22"}],"ancestors":["MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic carcinoma","approvedSymbol":"TUBB6","approvedName":"tubulin beta 6 class V","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL3833373","targetId":"ENSG00000120217","diseaseId":"EFO_0002618","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03563144%22"}],"ancestors":["MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic carcinoma","approvedSymbol":"CD274","approvedName":"CD274 molecule","targetClass":["Unclassified protein"],"prefName":"AVELUMAB","tradeNames":["Bavencio"],"synonyms":["Avelumab","MSB-0010682","MSB0010682","MSB0010718C","Msb-0010718c"],"drugType":"Antibody","mechanismOfAction":"Programmed cell death 1 ligand 1 other","targetName":"Programmed cell death 1 ligand 1"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000137267","diseaseId":"EFO_0002618","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03502343%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01964534%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03278015%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02135822%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00024375%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00323583%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03825328%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02124317%22"}],"ancestors":["MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic carcinoma","approvedSymbol":"TUBB2A","approvedName":"tubulin beta 2A class IIa","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL574737","targetId":"ENSG00000166501","diseaseId":"EFO_0002618","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00031681%22"}],"ancestors":["MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic carcinoma","approvedSymbol":"PRKCB","approvedName":"protein kinase C beta","targetClass":["Enzyme"],"prefName":"UCN-01","tradeNames":[],"synonyms":["7-hydroxystaurosporine","KRX-0601","KW-2401","NSC-638850","UCN-01","UCN-02","Ucn 01","Ucn-01"],"drugType":"Small molecule","mechanismOfAction":"Protein kinase C (PKC) inhibitor","targetName":"Protein kinase C (PKC)"}
{"drugId":"CHEMBL888","targetId":"ENSG00000106628","diseaseId":"EFO_0002618","phase":1,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05497778%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05193604%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05141149%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05251038%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03417921%22"}],"ancestors":["MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic carcinoma","approvedSymbol":"POLD2","approvedName":"DNA polymerase delta 2, accessory subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL888","targetId":"ENSG00000062822","diseaseId":"EFO_0002618","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00024427%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00498225%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03200821%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00634725%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00303758%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003216%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01072981%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00416507%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00030732%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00057876%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00075686%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00844649%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00425360%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00058149%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03766295%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00058201%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00032175%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00023972%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00644618%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00026338%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00789633%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02694536%22"}],"ancestors":["MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic carcinoma","approvedSymbol":"POLD1","approvedName":"DNA polymerase delta 1, catalytic subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL112","targetId":"ENSG00000073756","diseaseId":"EFO_0002756","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04625608%22"}],"ancestors":["GO_0008150","GO_0007610"],"label":"fasting","approvedSymbol":"PTGS2","approvedName":"prostaglandin-endoperoxide synthase 2","targetClass":["Enzyme"],"prefName":"ACETAMINOPHEN","tradeNames":["Abdine","Acephen","Acetaminophen","Alvedon","Angiers","Calpol","Calpol six plus","Calpol six plus fastmelts","Child lemsip","Cupanol","Dafalgan","Datril","Disprol","Disprol infant","Disprol jnr","Disprol paed","Fennings","Galpamol","Hedex","Infadrops","Infants' feverall","Injectapap","Junior parapaed","Mandanol","Medinol","Medinol for children","Medinol over 6","Medinol under 6","Medised plain","Miradol","Neopap","Ofirmev","Paldesic","Panadol","Panadol actifast","Panadol actifast solb","Panadol advan","Panadol jnr","Panadol oa","Panaleve","Panaleve 6 plus","Paracetamol","Paramin","Parapaed jnr","Parapaed six plus","Paravict","Perfalgan","Phenaphen","Placidex","Rimadol","Salzone","Tixymol","Tramil 500","Tylenol"],"synonyms":["Acetaminophen","Apap","Biocetamol","Doliprane","Efferalgan","N-acetyl-p-aminophenol","NSC-109028","NSC-3991","P-hydroxy-acetanilid","Paracetamol","Paracetamolum","Vermidon"],"drugType":"Small molecule","mechanismOfAction":"Cyclooxygenase inhibitor","targetName":"Cyclooxygenase"}
{"drugId":"CHEMBL2107333","targetId":"ENSG00000079999","diseaseId":"EFO_0002913","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02546440%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0002898","MONDO_0000653","MONDO_0023370","MONDO_0044881","MONDO_0045024","MONDO_0004992","EFO_0004198","Orphanet_322126","MONDO_0018898","MONDO_0017207","EFO_0000701","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0010285","EFO_0005803","EFO_0000616"],"label":"Cutaneous T-cell lymphoma","approvedSymbol":"KEAP1","approvedName":"kelch like ECH associated protein 1","targetClass":["Unclassified protein"],"prefName":"DIMETHYL FUMARATE","tradeNames":["Tecfidera"],"synonyms":["AZL 0 211089","AZL O 211089","AZL-0211089","AZL-O-211089","BG 00012","BG 12","BG-00012","BG-12","BG00012","Dimethyl fumar","Dimethyl fumarate","FAG-201","FP-187","FP187","Fumaric acid dimethyl ester","LAS-41008","LAS41008","Las41008","NSC-167432","NSC-25942","Panaclar"],"drugType":"Small molecule","mechanismOfAction":"Kelch-like ECH-associated protein 1 inhibitor","targetName":"Kelch-like ECH-associated protein 1"}
{"drugId":"CHEMBL3137343","targetId":"ENSG00000188389","diseaseId":"EFO_0002913","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03240211%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0002898","MONDO_0000653","MONDO_0023370","MONDO_0044881","MONDO_0045024","MONDO_0004992","EFO_0004198","Orphanet_322126","MONDO_0018898","MONDO_0017207","EFO_0000701","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0010285","EFO_0005803","EFO_0000616"],"label":"Cutaneous T-cell lymphoma","approvedSymbol":"PDCD1","approvedName":"programmed cell death 1","targetClass":["Surface antigen"],"prefName":"PEMBROLIZUMAB","tradeNames":["Keytruda"],"synonyms":["KEYLYNK-010 COMPONENT PEMBROLIZUMAB","Lambrolizumab","MK-3475","PEMBROLIZUMAB COMPONENT OF KEYLYNK-010","Pembrolizumab","SCH-900475"],"drugType":"Antibody","mechanismOfAction":"Programmed cell death protein 1 inhibitor","targetName":"Programmed cell death protein 1"}
{"drugId":"CHEMBL1642","targetId":"ENSG00000186716","diseaseId":"EFO_0002914","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00075400%22"}],"ancestors":["OTAR_0000017","MONDO_0002654","EFO_0007532","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0000691","MONDO_0021148","MONDO_0045024","MONDO_0004992","MONDO_0021254","EFO_0000512","MONDO_0002715","EFO_0009549","EFO_1001331","EFO_0000616","EFO_0003859"],"label":"uterine sarcoma","approvedSymbol":"BCR","approvedName":"BCR activator of RhoGEF and GTPase","targetClass":["Other cytosolic protein"],"prefName":"IMATINIB MESYLATE","tradeNames":["Gleevec","Glivec","Imatinib mesylate"],"synonyms":["Gleevec","Imatinib (as mesilate)","Imatinib accord","Imatinib medac","Imatinib mesilate","Imatinib mesylate","Imatinib methane sulfonate","Imatinib methanesulfonate","NSC-716051","QTI-571","QTI571","Qti571","STI 571","STI-571","STI571"],"drugType":"Small molecule","mechanismOfAction":"Bcr/Abl fusion protein","targetName":"Bcr/Abl fusion protein"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000137285","diseaseId":"EFO_0002916","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01608464%22"}],"ancestors":["EFO_0009544","MONDO_0021350","MONDO_0023370","MONDO_0021355","MONDO_0044991","MONDO_0045024","MONDO_0004992","MONDO_0003274","MONDO_0007576","EFO_0000313","EFO_1000218","EFO_0008549","MONDO_0002516","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"esophageal carcinoma","approvedSymbol":"TUBB2B","approvedName":"tubulin beta 2B class IIb","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000258947","diseaseId":"EFO_0002916","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03099382%22"}],"ancestors":["EFO_0009544","MONDO_0021350","MONDO_0023370","MONDO_0021355","MONDO_0044991","MONDO_0045024","MONDO_0004992","MONDO_0003274","MONDO_0007576","EFO_0000313","EFO_1000218","EFO_0008549","MONDO_0002516","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"esophageal carcinoma","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000101162","diseaseId":"EFO_0002917","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02020707%22"}],"ancestors":["MONDO_0024276","EFO_0005771","MONDO_0002149","MONDO_0002229","EFO_1000051","EFO_0003893","MONDO_0021148","EFO_0001075","EFO_0006460","EFO_0000512","EFO_0003825","EFO_0000313","MONDO_0008170","EFO_0009549","MONDO_0018364","EFO_0006858","EFO_1001331","EFO_0000616","OTAR_0000017","MONDO_0002259","MONDO_0023370","MONDO_0045024","MONDO_0004992","MONDO_0024885","MONDO_0037256","EFO_0000228","MONDO_0037255","EFO_0001379"],"label":"ovarian serous adenocarcinoma","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1179047","targetId":"ENSG00000007314","diseaseId":"EFO_0002950","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03993314%22"}],"ancestors":["GO_0008150","GO_0000003"],"label":"pregnancy","approvedSymbol":"SCN4A","approvedName":"sodium voltage-gated channel alpha subunit 4","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"CHLOROPROCAINE","tradeNames":[],"synonyms":["2-chloroprocaine","Chloroprocaine"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198763","diseaseId":"EFO_0002950","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05479214%22"}],"ancestors":["GO_0008150","GO_0000003"],"label":"pregnancy","approvedSymbol":"MT-ND2","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1201733","targetId":"ENSG00000113721","diseaseId":"EFO_0003016","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01767636%22"}],"ancestors":["MONDO_0024276","MONDO_0002367","MONDO_0023370","EFO_0002890","EFO_0009690","EFO_0000681","MONDO_0045024","MONDO_0004992","MONDO_0021066","EFO_0003086","EFO_0000313","EFO_0000228","EFO_0003865","EFO_1000363","EFO_0006858","EFO_0000616"],"label":"collecting duct carcinoma","approvedSymbol":"PDGFRB","approvedName":"platelet derived growth factor receptor beta","targetClass":["Enzyme"],"prefName":"PAZOPANIB HYDROCHLORIDE","tradeNames":["Votrient"],"synonyms":["GW-786034B","GW786034B","Pazopanib (as hydrochloride)","Pazopanib hcl","Pazopanib hydrochloride","Pazopanib monohydrochloride"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","targetName":"Platelet-derived growth factor receptor"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000101868","diseaseId":"EFO_0003025","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01823198%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","MONDO_0015756","EFO_0003820","EFO_1000068","EFO_0005803","EFO_0000616","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0002427","EFO_0002428","MONDO_0015667","EFO_0000222","EFO_0000540","EFO_0000565","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"acute megakaryoblastic leukaemia","approvedSymbol":"POLA1","approvedName":"DNA polymerase alpha 1, catalytic subunit","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL574737","targetId":"ENSG00000184304","diseaseId":"EFO_0003027","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00301938%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","MONDO_0015756","EFO_0003820","EFO_1000068","EFO_0005803","EFO_0000616","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0002427","EFO_0002428","MONDO_0015667","EFO_0000222","EFO_0000540","EFO_0000565","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"acute myeloblastic leukemia without maturation","approvedSymbol":"PRKD1","approvedName":"protein kinase D1","targetClass":["Enzyme"],"prefName":"UCN-01","tradeNames":[],"synonyms":["7-hydroxystaurosporine","KRX-0601","KW-2401","NSC-638850","UCN-01","UCN-02","Ucn 01","Ucn-01"],"drugType":"Small molecule","mechanismOfAction":"Protein kinase C (PKC) inhibitor","targetName":"Protein kinase C (PKC)"}
{"drugId":"CHEMBL1200485","targetId":"ENSG00000128052","diseaseId":"EFO_0003032","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00278382%22"}],"ancestors":["MONDO_0000430","OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","EFO_0002426","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","MONDO_0024615","EFO_0005952","EFO_0000508","MONDO_0019044","EFO_0005803","MONDO_0015760","EFO_0000616"],"label":"anaplastic large cell lymphoma","approvedSymbol":"KDR","approvedName":"kinase insert domain receptor","targetClass":["Enzyme"],"prefName":"SORAFENIB TOSYLATE","tradeNames":["Nexavar"],"synonyms":["BAY 54-9085","BAY-54-9085","Sorafenib tosilate","Sorafenib tosylate"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL461101","targetId":"ENSG00000117400","diseaseId":"EFO_0003047","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00996216%22"}],"ancestors":["MONDO_0100336","MONDO_0100321","EFO_0001379","EFO_0000763","EFO_0005741","EFO_0001421","MONDO_0100329","EFO_0010284","EFO_0004196","MONDO_0043424","EFO_0010282","EFO_0007274"],"label":"hepatitis C virus infection","approvedSymbol":"MPL","approvedName":"MPL proto-oncogene, thrombopoietin receptor","targetClass":["Membrane receptor"],"prefName":"ELTROMBOPAG","tradeNames":["Revolade"],"synonyms":["Eltrombopag","SB497115"],"drugType":"Small molecule","mechanismOfAction":"Thrombopoietin receptor agonist","targetName":"Thrombopoietin receptor"}
{"drugId":"CHEMBL1738797","targetId":"ENSG00000143924","diseaseId":"EFO_0003060","phase":3,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02271139%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02075840%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"non-small cell lung carcinoma","approvedSymbol":"EML4","approvedName":"EMAP like 4","targetClass":["Enzyme"],"prefName":"ALECTINIB","tradeNames":["Alecensa"],"synonyms":["AF-802","AF802","Alectinib","CH-5424802","CH5424802","RO-5424802","RO5424802"],"drugType":"Small molecule","mechanismOfAction":"EML4-ALK","targetName":"EML4-ALK "}
{"drugId":"CHEMBL1983268","targetId":"ENSG00000140538","diseaseId":"EFO_0003060","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04302025%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03178552%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"non-small cell lung carcinoma","approvedSymbol":"NTRK3","approvedName":"neurotrophic receptor tyrosine kinase 3","targetClass":["Enzyme"],"prefName":"ENTRECTINIB","tradeNames":["Rozlytrek"],"synonyms":["Entrectinib","NMS-E628","RXDX-101","Rxdx-101"],"drugType":"Small molecule","mechanismOfAction":"Neurotrophic tyrosine kinase receptor inhibitor","targetName":"Neurotrophic tyrosine kinase receptor"}
{"drugId":"CHEMBL225072","targetId":"ENSG00000159131","diseaseId":"EFO_0003060","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02148380%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"non-small cell lung carcinoma","approvedSymbol":"GART","approvedName":"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase","targetClass":["Enzyme"],"prefName":"PEMETREXED","tradeNames":["Alimta","Pemfexy"],"synonyms":["LY-2315","LY-231514","LY231514","NSC-698037","Pemetrexed"],"drugType":"Small molecule","mechanismOfAction":"GAR transformylase inhibitor","targetName":"GAR transformylase"}
{"drugId":"CHEMBL24828","targetId":"ENSG00000154928","diseaseId":"EFO_0003060","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00807170%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00745732%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"non-small cell lung carcinoma","approvedSymbol":"EPHB1","approvedName":"EPH receptor B1","targetClass":["Enzyme"],"prefName":"VANDETANIB","tradeNames":["Caprelsa","Zactima"],"synonyms":["GNF-PF-2188","NSC-744325","NSC-760766","Vandetanib","ZD-64","ZD-6474","ZD6474"],"drugType":"Small molecule","mechanismOfAction":"Ephrin receptor inhibitor","targetName":"Ephrin receptor"}
{"drugId":"CHEMBL3188267","targetId":"ENSG00000105976","diseaseId":"EFO_0003060","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02414139%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04323436%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04139317%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"non-small cell lung carcinoma","approvedSymbol":"MET","approvedName":"MET proto-oncogene, receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"CAPMATINIB","tradeNames":[],"synonyms":["Capmatinib","INC-280","INC280","INCB-28060","INCB-28060 FREE BASE","Incb-28060","NVP-INC280","NVP-INC280-NX","NYP-INC280-NX"],"drugType":"Small molecule","mechanismOfAction":"Hepatocyte growth factor receptor inhibitor","targetName":"Hepatocyte growth factor receptor"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000188229","diseaseId":"EFO_0003060","phase":2,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05500092%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04846634%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04181372%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"non-small cell lung carcinoma","approvedSymbol":"TUBB4B","approvedName":"tubulin beta 4B class IVb","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL3545396","targetId":"ENSG00000102755","diseaseId":"EFO_0003060","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00743938%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01167244%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"non-small cell lung carcinoma","approvedSymbol":"FLT1","approvedName":"fms related receptor tyrosine kinase 1","targetClass":["Enzyme"],"prefName":"BMS-690514","tradeNames":[],"synonyms":["Bms 6690514","Bms 690514","Bms-690514"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL3963485","targetId":"ENSG00000068078","diseaseId":"EFO_0003060","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03762122%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"non-small cell lung carcinoma","approvedSymbol":"FGFR3","approvedName":"fibroblast growth factor receptor 3","targetClass":["Enzyme"],"prefName":"ROGARATINIB","tradeNames":[],"synonyms":["BAY-1163877","Bay-1163877","Rogaratinib"],"drugType":"Small molecule","mechanismOfAction":"Fibroblast growth factor receptor inhibitor","targetName":"Fibroblast growth factor receptor"}
{"drugId":"CHEMBL3990032","targetId":"ENSG00000258947","diseaseId":"EFO_0003060","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04928846%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"non-small cell lung carcinoma","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"TELISOTUZUMAB VEDOTIN","tradeNames":[],"synonyms":["ABBV-399","ABT-399","Abbv 399","Abt-700-vcmmae","PR-1420682","Telisotuzumab vedotin"],"drugType":"Antibody","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL4297181","targetId":"ENSG00000105647","diseaseId":"EFO_0003060","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02079636%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01655225%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"non-small cell lung carcinoma","approvedSymbol":"PIK3R2","approvedName":"phosphoinositide-3-kinase regulatory subunit 2","targetClass":["Enzyme"],"prefName":"SAMOTOLISIB","tradeNames":[],"synonyms":["LY 3023414","LY-3023414","LY3023414","Ly-3023414","Samotolisib"],"drugType":"Small molecule","mechanismOfAction":"PI3-kinase class I inhibitor","targetName":"PI3-kinase class I"}
{"drugId":"CHEMBL4297939","targetId":"ENSG00000198900","diseaseId":"EFO_0003060","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04656652%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05215340%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"non-small cell lung carcinoma","approvedSymbol":"TOP1","approvedName":"DNA topoisomerase I","targetClass":["Enzyme"],"prefName":"DS-1062","tradeNames":[],"synonyms":["ADC DS-1062A","DATO-DXD","DS-1062","DS-1062A","DS1062","Datopotamab deruxtecan","Ds-1062","Ds-1062a"],"drugType":"Unknown","mechanismOfAction":"DNA topoisomerase I inhibitor","targetName":"DNA topoisomerase I"}
{"drugId":"CHEMBL4298098","targetId":"ENSG00000105388","diseaseId":"EFO_0003060","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04154956%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"non-small cell lung carcinoma","approvedSymbol":"CEACAM5","approvedName":"CEA cell adhesion molecule 5","targetClass":["Adhesion"],"prefName":"SAR-408701","tradeNames":[],"synonyms":["SAR-408701","SAR408701","Sar 408701","Sar-408701","Sar408701","Tusamitamab ravtansine"],"drugType":"Unknown","mechanismOfAction":"Carcinoembryonic antigen-related cell adhesion molecule 5 binding agent","targetName":"Carcinoembryonic antigen-related cell adhesion molecule 5"}
{"drugId":"CHEMBL429876","targetId":"ENSG00000082781","diseaseId":"EFO_0003060","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01118676%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"non-small cell lung carcinoma","approvedSymbol":"ITGB5","approvedName":"integrin subunit beta 5","targetClass":["Membrane receptor"],"prefName":"CILENGITIDE","tradeNames":[],"synonyms":["Cilengitide","EMD 121974","EMD-12192","EMD-121974"],"drugType":"Protein","mechanismOfAction":"Integrin alpha-V/beta-5 antagonist","targetName":"Integrin alpha-V/beta-5"}
{"drugId":"CHEMBL553","targetId":"ENSG00000146648","diseaseId":"EFO_0003060","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00466089%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01410214%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02006043%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01796288%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00678964%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01955421%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02738983%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02037997%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01130779%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03123484%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02146118%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01714908%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00620269%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01091376%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00466284%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01131429%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00977470%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00722969%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03074864%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00908336%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02036359%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"non-small cell lung carcinoma","approvedSymbol":"EGFR","approvedName":"epidermal growth factor receptor","targetClass":["Enzyme"],"prefName":"ERLOTINIB","tradeNames":["Tarceva"],"synonyms":["CP-358,774","CP-358774","CP-35877401","Erlotinib","OSI-774","R-1415","RG-1415","Ro-508231"],"drugType":"Small molecule","mechanismOfAction":"Epidermal growth factor receptor erbB1 inhibitor","targetName":"Epidermal growth factor receptor erbB1"}
{"drugId":"CHEMBL553025","targetId":"ENSG00000101162","diseaseId":"EFO_0003060","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00683514%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00441922%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01454934%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00148395%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00148798%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00737867%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00499109%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00298415%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00686959%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00441740%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"non-small cell lung carcinoma","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"VINORELBINE","tradeNames":[],"synonyms":["NSC-760087","Navelbin","Vinorelbine","Vinorelbine Base"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL75133","targetId":"ENSG00000204231","diseaseId":"EFO_0003060","phase":1,"status":"Suspended","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02991651%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"non-small cell lung carcinoma","approvedSymbol":"RXRB","approvedName":"retinoid X receptor beta","targetClass":["Transcription factor"],"prefName":"IRX-4204","tradeNames":[],"synonyms":["AGN-194204","AGN194204","Irx-4204","KB-145960","NRX-194204","NRX194204","VTP-194204"],"drugType":"Small molecule","mechanismOfAction":"Retinoid X receptor agonist","targetName":"Retinoid X receptor"}
{"drugId":"CHEMBL888","targetId":"ENSG00000148229","diseaseId":"EFO_0003060","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01631357%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00881296%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00075751%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00600587%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00489996%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01395758%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00199758%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00191139%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00154739%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00212043%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00842712%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00191620%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00191256%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00055757%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00517595%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00385606%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00191230%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00434135%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00112346%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00069875%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00061464%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01185847%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01236716%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00424853%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00695994%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00192036%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01194453%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00215930%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00536640%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01998919%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00401492%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03717155%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00518011%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00193921%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00490659%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01770795%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00753714%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00034606%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00330746%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00264498%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00247416%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00828841%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00655850%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00077350%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01077713%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00191841%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01788566%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00191490%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00620971%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00217282%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01810367%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00735904%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00191763%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01086254%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00198367%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00259675%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00323869%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00198393%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01633645%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00489983%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00173888%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01951157%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00870870%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00042679%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00425191%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00061451%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01797913%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01844791%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00400803%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00994097%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01160744%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00271271%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00701558%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01652820%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"non-small cell lung carcinoma","approvedSymbol":"POLE3","approvedName":"DNA polymerase epsilon 3, accessory subunit","targetClass":["Unclassified protein"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL92","targetId":"ENSG00000137267","diseaseId":"EFO_0003060","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03269162%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02643407%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00637910%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01630733%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02076477%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","MONDO_0008903","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0001071","EFO_0000313","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0006858","EFO_0003818","EFO_0000616"],"label":"non-small cell lung carcinoma","approvedSymbol":"TUBB2A","approvedName":"tubulin beta 2A class IIa","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":[],"synonyms":["RP-56976","Taxotere"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000189043","diseaseId":"EFO_0003095","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02457286%22"}],"ancestors":["EFO_0001379","EFO_0001421","MONDO_0004790","EFO_0010284","EFO_0010282"],"label":"non-alcoholic fatty liver disease","approvedSymbol":"NDUFA4","approvedName":"NDUFA4 mitochondrial complex associated","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000023228","diseaseId":"EFO_0003095","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02147925%22"}],"ancestors":["EFO_0001379","EFO_0001421","MONDO_0004790","EFO_0010284","EFO_0010282"],"label":"non-alcoholic fatty liver disease","approvedSymbol":"NDUFS1","approvedName":"NADH:ubiquinone oxidoreductase core subunit S1","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL3261331","targetId":"ENSG00000151090","diseaseId":"EFO_0003095","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02912260%22"}],"ancestors":["EFO_0001379","EFO_0001421","MONDO_0004790","EFO_0010284","EFO_0010282"],"label":"non-alcoholic fatty liver disease","approvedSymbol":"THRB","approvedName":"thyroid hormone receptor beta","targetClass":["Transcription factor"],"prefName":"RESMETIROM","tradeNames":[],"synonyms":["MGL-3196","Mgl-3196","Resmetirom","VIA-3196"],"drugType":"Small molecule","mechanismOfAction":"Thyroid hormone receptor beta-1 agonist","targetName":"Thyroid hormone receptor beta-1"}
{"drugId":"CHEMBL4524066","targetId":"ENSG00000112164","diseaseId":"EFO_0003095","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02147925%22"}],"ancestors":["EFO_0001379","EFO_0001421","MONDO_0004790","EFO_0010284","EFO_0010282"],"label":"non-alcoholic fatty liver disease","approvedSymbol":"GLP1R","approvedName":"glucagon like peptide 1 receptor","targetClass":["Membrane receptor"],"prefName":"LIRAGLUTIDE","tradeNames":["Saxenda","Victoza"],"synonyms":["Liraglutide","Liraglutide (rdna origin)","Liraglutide recombinant","NN-2211","NN-9924","NN2211","NN9924","NNC 90-1170","NNC-90-1170"],"drugType":"Protein","mechanismOfAction":"Glucagon-like peptide 1 receptor agonist","targetName":"Glucagon-like peptide 1 receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198695","diseaseId":"EFO_0003100","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04780854%22"}],"ancestors":["EFO_0009387","EFO_1001902","EFO_0004149","EFO_0000618"],"label":"peripheral neuropathy","approvedSymbol":"MT-ND6","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL79","targetId":"ENSG00000136531","diseaseId":"EFO_0003103","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01690767%22"}],"ancestors":["MONDO_0100336","EFO_0000771","EFO_0005741"],"label":"urinary tract infection","approvedSymbol":"SCN2A","approvedName":"sodium voltage-gated channel alpha subunit 2","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"LIDOCAINE","tradeNames":["Alphacaine","Anestacon","Dentipatch","Lidocaine","Lidoderm","Lignocaine Hcl","Lignostab","Lmx 4","Oraqix","Vagisil","Xylocaine","Xylodase","Xylotox","Ztlido"],"synonyms":["ALGRX 3268","ALGRX-3268","Anestacon","Embolex","Iontocaine","Lidocaine","Lidocainum","Lidocaton","Lidopen","Lignocaine","NSC-40030","Octocaine","Solarcaine","Xylestesin"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL2103830","targetId":"ENSG00000165025","diseaseId":"EFO_0003106","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04581954%22"}],"ancestors":["MONDO_0100336","EFO_0009433","EFO_0000684","EFO_0005741","OTAR_0000010","EFO_1001991","EFO_0003818","MONDO_0024355"],"label":"pneumonia","approvedSymbol":"SYK","approvedName":"spleen associated tyrosine kinase","targetClass":["Enzyme"],"prefName":"FOSTAMATINIB","tradeNames":[],"synonyms":["Fostamatinib","R-788","R-788 FREE ACID","R-935788","R-935788 FREE ACID","R788 FREE ACID","R935788 FREE ACID"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase SYK inhibitor","targetName":"Tyrosine-protein kinase SYK"}
{"drugId":"CHEMBL1144","targetId":"ENSG00000113161","diseaseId":"EFO_0003144","phase":4,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00402376%22"}],"ancestors":["EFO_0003777","EFO_0000319"],"label":"heart failure","approvedSymbol":"HMGCR","approvedName":"3-hydroxy-3-methylglutaryl-CoA reductase","targetClass":["Enzyme"],"prefName":"PRAVASTATIN","tradeNames":[],"synonyms":["C10AA03","Pravachol","Pravastatin","Pravator"],"drugType":"Small molecule","mechanismOfAction":"HMG-CoA reductase inhibitor","targetName":"HMG-CoA reductase"}
{"drugId":"CHEMBL1215","targetId":"ENSG00000120907","diseaseId":"EFO_0003144","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03421860%22"}],"ancestors":["EFO_0003777","EFO_0000319"],"label":"heart failure","approvedSymbol":"ADRA1A","approvedName":"adrenoceptor alpha 1A","targetClass":["Membrane receptor"],"prefName":"PHENYLEPHRINE","tradeNames":[],"synonyms":["(-)-phenylephrine","(r)-phenylephrine","AB-101 (PHENYLEPHRINE)","Cyclomydril","Duo-Medihaler","J8.601K","M-oxedrine","M-sympathol","M-sympatol","M-synephrine","Meta-synephrine","Metasynephrine","Phenylephrine","Phenylephrine minims","Phenylephrine, (r)-","R(-)-mezaton"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor alpha-1 agonist","targetName":"Adrenergic receptor alpha-1"}
{"drugId":"CHEMBL1560","targetId":"ENSG00000159640","diseaseId":"EFO_0003144","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01437371%22"}],"ancestors":["EFO_0003777","EFO_0000319"],"label":"heart failure","approvedSymbol":"ACE","approvedName":"angiotensin I converting enzyme","targetClass":["Enzyme"],"prefName":"CAPTOPRIL","tradeNames":["Acepril","Capoten","Captomex","Captopril","Ecopace","Hyteneze 12.5","Hyteneze 25","Hyteneze 50","Kaplon","Lopril","Noyada","Tensobon"],"synonyms":["Apopril","C09AA01","Capoten","Captomax","Captopril","Captoprilum","Farcopril","Garranil","Hypopress","Mepha","NSC-757419","SA-333","SQ -14225","SQ 14,225","SQ-14225","Tensiomin","Zapto"],"drugType":"Small molecule","mechanismOfAction":"Angiotensin-converting enzyme inhibitor","targetName":"Angiotensin-converting enzyme"}
{"drugId":"CHEMBL2051955","targetId":"ENSG00000172572","diseaseId":"EFO_0003144","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00166127%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01290146%22"}],"ancestors":["EFO_0003777","EFO_0000319"],"label":"heart failure","approvedSymbol":"PDE3A","approvedName":"phosphodiesterase 3A","targetClass":["Enzyme"],"prefName":"LEVOSIMENDAN","tradeNames":["Simdax"],"synonyms":["(-)-OR-1259","(r)-simendan","Levosimendan","NSC-759644","OR-1259","Simendan, (r)-"],"drugType":"Small molecule","mechanismOfAction":"Phosphodiesterase 3 inhibitor","targetName":"Phosphodiesterase 3"}
{"drugId":"CHEMBL3137301","targetId":"ENSG00000196549","diseaseId":"EFO_0003144","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02970669%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02554890%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02874794%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03506412%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03168568%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02887183%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02754518%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04688294%22"}],"ancestors":["EFO_0003777","EFO_0000319"],"label":"heart failure","approvedSymbol":"MME","approvedName":"membrane metalloendopeptidase","targetClass":["Enzyme"],"prefName":"SACUBITRIL","tradeNames":[],"synonyms":["AHU-377","AHU377","Sacubitril"],"drugType":"Small molecule","mechanismOfAction":"Neprilysin inhibitor","targetName":"Neprilysin"}
{"drugId":"CHEMBL723","targetId":"ENSG00000043591","diseaseId":"EFO_0003144","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00517725%22"}],"ancestors":["EFO_0003777","EFO_0000319"],"label":"heart failure","approvedSymbol":"ADRB1","approvedName":"adrenoceptor beta 1","targetClass":["Membrane receptor"],"prefName":"CARVEDILOL","tradeNames":["Carvedilol","Coreg","Coreg CR","Eucardic 12.5","Eucardic 25","Eucardic 3.125","Eucardic 6.25"],"synonyms":["BM 14.190","BM-14-190","BM-14.190","BM-14190","C07AG02","Carvedilol","Coronis","DQ-2466","Dilatrend","Dimitone","Eucardic","Korvasan","Kredex","NSC-758694","SKF-105517","Talliton"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor beta antagonist","targetName":"Adrenergic receptor beta"}
{"drugId":"CHEMBL842","targetId":"ENSG00000070915","diseaseId":"EFO_0003144","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02606253%22"}],"ancestors":["EFO_0003777","EFO_0000319"],"label":"heart failure","approvedSymbol":"SLC12A3","approvedName":"solute carrier family 12 member 3","targetClass":["Transporter"],"prefName":"CHLOROTHIAZIDE","tradeNames":["Chlorothiazide","Diuril","Saluric"],"synonyms":["Chlorothiazide","Chlorthiazide","Hydrochlorothiazide impurity, chlorothiazide-","NSC-25693"],"drugType":"Small molecule","mechanismOfAction":"Thiazide-sensitive sodium-chloride cotransporter inhibitor","targetName":"Thiazide-sensitive sodium-chloride cotransporter"}
{"drugId":"CHEMBL3","targetId":"ENSG00000160716","diseaseId":"EFO_0003768","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02048852%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04590404%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04126135%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","MONDO_0004938","EFO_0000618","EFO_0003890","MONDO_0002494","EFO_0009386"],"label":"nicotine dependence","approvedSymbol":"CHRNB2","approvedName":"cholinergic receptor nicotinic beta 2 subunit","targetClass":["Ion channel"],"prefName":"NICOTINE","tradeNames":["Habitrol","Nicabate","Nicoderm","Nicoderm cq","Nicopass","Nicopatch","Nicorette invisi","Nicotine","Nicotinell classic","Nicotinell support","Nicotinell tts 10","Nicotinell tts 20","Nicotinell tts 30","Nicotrol","Nicotrol Inhaler","Nicotrol NS","Niquitin","Niquitin clr","Niquitin minis cherry","Niquitin minis mint","Niquitin minis orange","Niquitin mint","Niquitin pre-quit","Niquitin strips mint","Prostep","Stoppers","Stubit"],"synonyms":["Nicotine"],"drugType":"Small molecule","mechanismOfAction":"Neuronal acetylcholine receptor; alpha4/beta2 agonist","targetName":"Neuronal acetylcholine receptor; alpha4/beta2"}
{"drugId":"CHEMBL360328","targetId":"ENSG00000147246","diseaseId":"EFO_0003768","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02906644%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","MONDO_0004938","EFO_0000618","EFO_0003890","MONDO_0002494","EFO_0009386"],"label":"nicotine dependence","approvedSymbol":"HTR2C","approvedName":"5-hydroxytryptamine receptor 2C","targetClass":["Ion channel","Membrane receptor"],"prefName":"LORCASERIN","tradeNames":[],"synonyms":["Lorcaserin"],"drugType":"Small molecule","mechanismOfAction":"Serotonin 2c (5-HT2c) receptor agonist","targetName":"Serotonin 2c (5-HT2c) receptor"}
{"drugId":"CHEMBL1200694","targetId":"ENSG00000163288","diseaseId":"EFO_0003777","phase":4,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02664922%22"}],"ancestors":["EFO_0000319"],"label":"heart disease","approvedSymbol":"GABRB1","approvedName":"gamma-aminobutyric acid type A receptor subunit beta1","targetClass":["Ion channel"],"prefName":"SEVOFLURANE","tradeNames":["Sevoflurane","Sojourn","Ultane"],"synonyms":["MR-6S4","MR6S4","NSC-760367","Sevocalm","Sevoflo","Sevoflurane","Sevorane"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL526","targetId":"ENSG00000163288","diseaseId":"EFO_0003777","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02481791%22"}],"ancestors":["EFO_0000319"],"label":"heart disease","approvedSymbol":"GABRB1","approvedName":"gamma-aminobutyric acid type A receptor subunit beta1","targetClass":["Ion channel"],"prefName":"PROPOFOL","tradeNames":["Diprivan","Disoprivan","Propofol","Rapinovet"],"synonyms":["Disoprofol","Fresofol","ICI 35,868","ICI 35-868","ICI-35868","ICI35,868","Lipuro","NSC-5105","Phenol, 2,6-bis(1-methylethyl)","Propofol"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL107","targetId":"ENSG00000258947","diseaseId":"EFO_0003780","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00700297%22"}],"ancestors":["EFO_0005140","EFO_0005774","MONDO_0019293","EFO_0009690","EFO_0004264","EFO_0003086","EFO_0009386","EFO_0000701","EFO_0000474","EFO_0000540","EFO_0000618","EFO_0010285","EFO_0000319"],"label":"Behcet's syndrome","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"COLCHICINE","tradeNames":["Colchicine","Colcrys","Gloperba","Mitigare"],"synonyms":["(-)-colchicine","Colchcine","Colchicine","Colchicinum","Colchineos","Colchisol","NSC-757"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000167325","diseaseId":"EFO_0003802","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002798%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0021058","EFO_0000198","MONDO_0045024","Orphanet_322126","Orphanet_68336","MONDO_0015756","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"refractory anemia","approvedSymbol":"RRM1","approvedName":"ribonucleotide reductase catalytic subunit M1","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"Ribonucleoside-diphosphate reductase RR1 inhibitor","targetName":"Ribonucleoside-diphosphate reductase RR1"}
{"drugId":"CHEMBL803","targetId":"ENSG00000148229","diseaseId":"EFO_0003812","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002798%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0021058","MONDO_0002280","EFO_0000198","MONDO_0045024","MONDO_0020099","Orphanet_322126","Orphanet_68336","MONDO_0015756","MONDO_0015194","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"refractory anemia with ringed sideroblasts","approvedSymbol":"POLE3","approvedName":"DNA polymerase epsilon 3, accessory subunit","targetClass":["Unclassified protein"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL35","targetId":"ENSG00000074803","diseaseId":"EFO_0003818","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00618852%22"}],"ancestors":["EFO_0009433","EFO_0000684","OTAR_0000010"],"label":"lung disease","approvedSymbol":"SLC12A1","approvedName":"solute carrier family 12 member 1","targetClass":["Transporter"],"prefName":"FUROSEMIDE","tradeNames":["Aluzine 20","Aluzine 40","Aluzine 500","Aquamed","Disal","Diuresal","Dryptal","Froop","Frumax","Frumil","Frusemide","Frusetic","Frusid","Frusol","Furosemide","Hydroled","Lasix","Lasix ret","Rusyde","Tenkofruse"],"synonyms":["Frusemide","Furosemide","Furosemidum","LB-502","Logirene","Marsemide","Mirfat","NSC-269420","Oedemex"],"drugType":"Small molecule","mechanismOfAction":"Sodium-(potassium)-chloride cotransporter 2 inhibitor","targetName":"Sodium-(potassium)-chloride cotransporter 2"}
{"drugId":"CHEMBL655","targetId":"ENSG00000186297","diseaseId":"EFO_0003819","phase":4,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04068948%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_1001216","EFO_0002461","EFO_1001047","MONDO_0002220","EFO_0010282"],"label":"dental caries","approvedSymbol":"GABRA5","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha5","targetClass":["Ion channel"],"prefName":"MIDAZOLAM","tradeNames":["Midazolam in 0.9% sodium chloride","Nayzilam"],"synonyms":["Midazolam","Midazolam civ","USL-261","USL261"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL761","targetId":"ENSG00000274286","diseaseId":"EFO_0003822","phase":1,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05470868%22"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"hyperemia","approvedSymbol":"ADRA2B","approvedName":"adrenoceptor alpha 2B","targetClass":["Membrane receptor"],"prefName":"NAPHAZOLINE","tradeNames":[],"synonyms":["Nafazair","Nafazolin","Naphazoline"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor alpha agonist","targetName":"Adrenergic receptor alpha"}
{"drugId":"CHEMBL526","targetId":"ENSG00000094755","diseaseId":"EFO_0003832","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01709422%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01540084%22"}],"ancestors":["OTAR_0000018","EFO_0001379","EFO_0009534","EFO_0001421","EFO_0000508","MONDO_0015509","EFO_0010284","EFO_0010282"],"label":"gallbladder disease","approvedSymbol":"GABRP","approvedName":"gamma-aminobutyric acid type A receptor subunit pi","targetClass":["Ion channel"],"prefName":"PROPOFOL","tradeNames":["Diprivan","Disoprivan","Propofol","Rapinovet"],"synonyms":["Disoprofol","Fresofol","ICI 35,868","ICI 35-868","ICI-35868","ICI35,868","Lipuro","NSC-5105","Phenol, 2,6-bis(1-methylethyl)","Propofol"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL1336","targetId":"ENSG00000132155","diseaseId":"EFO_0003833","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01817751%22"}],"ancestors":["MONDO_0023370","EFO_0005774","EFO_0000618","MONDO_0021248","MONDO_0045024","EFO_0009386","EFO_1000158","EFO_0000616"],"label":"brain neoplasm","approvedSymbol":"RAF1","approvedName":"Raf-1 proto-oncogene, serine/threonine kinase","targetClass":["Enzyme"],"prefName":"SORAFENIB","tradeNames":["Nexavar"],"synonyms":["BAY 43-9006","BAY-43-9006","Sorafenib"],"drugType":"Small molecule","mechanismOfAction":"Serine/threonine-protein kinase RAF inhibitor","targetName":"Serine/threonine-protein kinase RAF"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000136521","diseaseId":"EFO_0003833","phase":1,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01528046%22"}],"ancestors":["MONDO_0023370","EFO_0005774","EFO_0000618","MONDO_0021248","MONDO_0045024","EFO_0009386","EFO_1000158","EFO_0000616"],"label":"brain neoplasm","approvedSymbol":"NDUFB5","approvedName":"NADH:ubiquinone oxidoreductase subunit B5","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1722","targetId":"ENSG00000142319","diseaseId":"EFO_0003840","phase":1,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00220493%22"}],"ancestors":["EFO_0005140","EFO_0005772","EFO_0005774","MONDO_0002977","MONDO_0000568","MONDO_0005301","EFO_0009386","MONDO_0002562","EFO_0005809","EFO_0000540","EFO_0000618","EFO_1002003","EFO_1000870"],"label":"chronic progressive multiple sclerosis","approvedSymbol":"SLC6A3","approvedName":"solute carrier family 6 member 3","targetClass":["Transporter"],"prefName":"METHYLPHENIDATE HYDROCHLORIDE","tradeNames":["Adhansia xr","Aptensio xr","Concerta","Delmosart","Equasym","Equasym xl","Jornay pm","Matoride xl","Medikinet","Medikinet xl","Metadate cd","Metadate er","Methylin","Methylin er","Methylphenidate hydrochloride","Quillichew er","Quillivant xr","Ritalin","Ritalin la","Ritalin sr","Ritalin-sr","Tranquilyn","Xenidate xl"],"synonyms":["Aptensio","Aptensio xr","Foquest","Metadate","Methylphenidate HCl","Methylphenidate hcl","Methylphenidate hydrochloride","Methylphenidate hydrochloride cii","NSC-169868","Oros mph","Quillichew","Quillivant","SPD-544","SPD544"],"drugType":"Small molecule","mechanismOfAction":"Dopamine transporter inhibitor","targetName":"Dopamine transporter"}
{"drugId":"CHEMBL406","targetId":"ENSG00000070915","diseaseId":"EFO_0003840","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05013463%22"}],"ancestors":["EFO_0005140","EFO_0005772","EFO_0005774","MONDO_0002977","MONDO_0000568","MONDO_0005301","EFO_0009386","MONDO_0002562","EFO_0005809","EFO_0000540","EFO_0000618","EFO_1002003","EFO_1000870"],"label":"chronic progressive multiple sclerosis","approvedSymbol":"SLC12A3","approvedName":"solute carrier family 12 member 3","targetClass":["Transporter"],"prefName":"INDAPAMIDE","tradeNames":["Cardide sr","Ethibide xl","Indapamide","Indaxa 2.5","Indipam xl","Lozol","Mapemid xl","Natrilix","Natrilix sr","Nindaxa 2.5","Opumide 2.5","Rawel xl","Tensaid xl","Varbim xl"],"synonyms":["Arifon","Bajaten","Damide","Flubest","Fludex","Fludin","Flupamid","Indaflex","Indamide","Indamol","Indapamide","Ipamix","KYD-041","Lorvas","NSC-757075","Natrix","Noranat","S-1520","SE-1520","Tandix","Tertensif","Veroxil"],"drugType":"Small molecule","mechanismOfAction":"Thiazide-sensitive sodium-chloride cotransporter inhibitor","targetName":"Thiazide-sensitive sodium-chloride cotransporter"}
{"drugId":"CHEMBL1336","targetId":"ENSG00000122025","diseaseId":"EFO_0003841","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00984282%22"}],"ancestors":["EFO_0003769","EFO_0001379","MONDO_0023370","EFO_1000627","MONDO_0045024","EFO_0000616"],"label":"thyroid neoplasm","approvedSymbol":"FLT3","approvedName":"fms related receptor tyrosine kinase 3","targetClass":["Enzyme"],"prefName":"SORAFENIB","tradeNames":["Nexavar"],"synonyms":["BAY 43-9006","BAY-43-9006","Sorafenib"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase receptor FLT3 inhibitor","targetName":"Tyrosine-protein kinase receptor FLT3"}
{"drugId":"CHEMBL1093","targetId":"ENSG00000153253","diseaseId":"EFO_0003843","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01912755%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03470532%22"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"pain","approvedSymbol":"SCN3A","approvedName":"sodium voltage-gated channel alpha subunit 3","targetClass":["Ion channel"],"prefName":"ARTICAINE","tradeNames":[],"synonyms":["40 045","40-045","Articaine","Carticaine","HOE 045","HOE-045","Septocaine"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL112","targetId":"ENSG00000117480","diseaseId":"EFO_0003843","phase":0,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05122351%22"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"pain","approvedSymbol":"FAAH","approvedName":"fatty acid amide hydrolase","targetClass":["Enzyme"],"prefName":"ACETAMINOPHEN","tradeNames":["Abdine","Acephen","Acetaminophen","Alvedon","Angiers","Calpol","Calpol six plus","Calpol six plus fastmelts","Child lemsip","Cupanol","Dafalgan","Datril","Disprol","Disprol infant","Disprol jnr","Disprol paed","Fennings","Galpamol","Hedex","Infadrops","Infants' feverall","Injectapap","Junior parapaed","Mandanol","Medinol","Medinol for children","Medinol over 6","Medinol under 6","Medised plain","Miradol","Neopap","Ofirmev","Paldesic","Panadol","Panadol actifast","Panadol actifast solb","Panadol advan","Panadol jnr","Panadol oa","Panaleve","Panaleve 6 plus","Paracetamol","Paramin","Parapaed jnr","Parapaed six plus","Paravict","Perfalgan","Phenaphen","Placidex","Rimadol","Salzone","Tixymol","Tramil 500","Tylenol"],"synonyms":["Acetaminophen","Apap","Biocetamol","Doliprane","Efferalgan","N-acetyl-p-aminophenol","NSC-109028","NSC-3991","P-hydroxy-acetanilid","Paracetamol","Paracetamolum","Vermidon"],"drugType":"Small molecule","mechanismOfAction":"Anandamide amidohydrolase inhibitor","targetName":"Anandamide amidohydrolase"}
{"drugId":"CHEMBL112","targetId":"ENSG00000196689","diseaseId":"EFO_0003843","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01568749%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01592227%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05022810%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01562704%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00750347%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02654860%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00750048%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04265456%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01551797%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01880125%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00802087%22"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"pain","approvedSymbol":"TRPV1","approvedName":"transient receptor potential cation channel subfamily V member 1","targetClass":["Ion channel"],"prefName":"ACETAMINOPHEN","tradeNames":["Abdine","Acephen","Acetaminophen","Alvedon","Angiers","Calpol","Calpol six plus","Calpol six plus fastmelts","Child lemsip","Cupanol","Dafalgan","Datril","Disprol","Disprol infant","Disprol jnr","Disprol paed","Fennings","Galpamol","Hedex","Infadrops","Infants' feverall","Injectapap","Junior parapaed","Mandanol","Medinol","Medinol for children","Medinol over 6","Medinol under 6","Medised plain","Miradol","Neopap","Ofirmev","Paldesic","Panadol","Panadol actifast","Panadol actifast solb","Panadol advan","Panadol jnr","Panadol oa","Panaleve","Panaleve 6 plus","Paracetamol","Paramin","Parapaed jnr","Parapaed six plus","Paravict","Perfalgan","Phenaphen","Placidex","Rimadol","Salzone","Tixymol","Tramil 500","Tylenol"],"synonyms":["Acetaminophen","Apap","Biocetamol","Doliprane","Efferalgan","N-acetyl-p-aminophenol","NSC-109028","NSC-3991","P-hydroxy-acetanilid","Paracetamol","Paracetamolum","Vermidon"],"drugType":"Small molecule","mechanismOfAction":"Vanilloid receptor opener","targetName":"Vanilloid receptor"}
{"drugId":"CHEMBL12","targetId":"ENSG00000113327","diseaseId":"EFO_0003843","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01790555%22"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"pain","approvedSymbol":"GABRG2","approvedName":"gamma-aminobutyric acid type A receptor subunit gamma2","targetClass":["Ion channel"],"prefName":"DIAZEPAM","tradeNames":["Alupram 10","Alupram 2","Alupram 5","Apozepam","Atensine","Dialar","Dialar fte","Diastat","Diastat acudial","Diazepam","Diazepam intensol","Dizac","E-Pam","Paxel","Q-pam","Relanium","Scriptopam","Serenack","Solis","Stesolid","Tensium","Tranimul","Valclair","Valium","Valrelease","Valtoco","Vivol"],"synonyms":["Ansiolisina","Centrazepam","Diacepin","Diazepam","Diazepam civ","LA III","LA-III","NRL-1","NSC-169897","NSC-77518","Nrl-1","RO 5-2807","RO-5-2807","RO-52807","Servizepam","Tranquase","WY-3467"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL1201132","targetId":"ENSG00000112038","diseaseId":"EFO_0003843","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03786887%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03296488%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03288428%22"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"pain","approvedSymbol":"OPRM1","approvedName":"opioid receptor mu 1","targetClass":["Membrane receptor"],"prefName":"NALBUPHINE HYDROCHLORIDE","tradeNames":["Nalbuphine","Nalbuphine hydrochloride","Nubain"],"synonyms":["EN-2234A","NSC-757829","Nalbufine hydrochloride","Nalbuphine hcl","Nalbuphine hydrochloride"],"drugType":"Small molecule","mechanismOfAction":"Opioid receptors; mu/kappa/delta agonist","targetName":"Opioid receptors; mu/kappa/delta"}
{"drugId":"CHEMBL1201180","targetId":"ENSG00000095303","diseaseId":"EFO_0003843","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4bca1472-9a43-4510-a2de-5a2d80edbfbc"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f8b489ee-b48f-41b6-a759-c910e531576f"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=56caa44c-cc65-4500-ae05-ed508e52075d"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f103f7e8-1253-43cb-9667-cd0d8f4d5500"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"pain","approvedSymbol":"PTGS1","approvedName":"prostaglandin-endoperoxide synthase 1","targetClass":["Enzyme"],"prefName":"DICLOFENAC EPOLAMINE","tradeNames":["Flector","Flector Patch","Licart"],"synonyms":["Diclofenac epolamine","Diclofenac epolaminum"],"drugType":"Small molecule","mechanismOfAction":"Cyclooxygenase inhibitor","targetName":"Cyclooxygenase"}
{"drugId":"CHEMBL1201570","targetId":"ENSG00000115594","diseaseId":"EFO_0003843","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05074485%22"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"pain","approvedSymbol":"IL1R1","approvedName":"interleukin 1 receptor type 1","targetClass":["Membrane receptor"],"prefName":"ANAKINRA","tradeNames":["Antril","Kineret"],"synonyms":["AMG-719","Alta-2530","Alta2530","Anakinra","Interleukin-1 receptor antagonist anakinra","Osp-101"],"drugType":"Protein","mechanismOfAction":"Interleukin-1 receptor antagonist","targetName":"Interleukin-1 receptor"}
{"drugId":"CHEMBL1341","targetId":"ENSG00000109158","diseaseId":"EFO_0003843","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05137184%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03215056%22"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"pain","approvedSymbol":"GABRA4","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha4","targetClass":["Ion channel","Enzyme"],"prefName":"METHOXYFLURANE","tradeNames":["Metofane","Penthrane","Pentrane"],"synonyms":["Analgizer","Anecotan","DA-759","Inhalan","Methoxiflurane","Methoxy flurane","Methoxyflurane","NSC-110432","Penthrox"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL1685","targetId":"ENSG00000112038","diseaseId":"EFO_0003843","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03014713%22"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"pain","approvedSymbol":"OPRM1","approvedName":"opioid receptor mu 1","targetClass":["Membrane receptor"],"prefName":"DEZOCINE","tradeNames":["Dalgan"],"synonyms":["Dezocine","Docozine","Dozocine","WY-16,225","WY-16225"],"drugType":"Small molecule","mechanismOfAction":"Mu opioid receptor partial agonist","targetName":"Mu opioid receptor"}
{"drugId":"CHEMBL2103744","targetId":"ENSG00000112038","diseaseId":"EFO_0003843","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05186454%22"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"pain","approvedSymbol":"OPRM1","approvedName":"opioid receptor mu 1","targetClass":["Membrane receptor"],"prefName":"MORPHINE SULFATE","tradeNames":["Arymo er","Astramorph pf","Avinza","Depodur","Duramorph","Duramorph pf","Duromorph","Filnarine sr","Infumorph","Kadian","Moraxen","Morcap sr","Morphabond","Morphabond er","Morphgesic sr","Morphine sulfate","Morphine sulfate (autoinjector)","Ms contin","Mst continus","Oramorph","Oramorph sr","Oramorph udv","Rhotard","Sevredol","Srm-rhotard","Zomorph"],"synonyms":["Arymo","Astramorph","Dolcontin","Kapanol","Morcap","Morphine sulfate","Morphine sulfate anhydrous","Morphine sulfate cii","Morphine sulfate hydrate","Morphine sulfate pentahydrate","Morphine sulfate,anhydrous","Morphine sulphate","Morphine sulphate anhydrous","Morphine sulphate pentahydrate","Morphini sulfas","Moscontin","NSC-11441"],"drugType":"Small molecule","mechanismOfAction":"Mu opioid receptor agonist","targetName":"Mu opioid receptor"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000151834","diseaseId":"EFO_0003843","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00432549%22"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"pain","approvedSymbol":"GABRA2","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha2","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL3186993","targetId":"ENSG00000196639","diseaseId":"EFO_0003843","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01151696%22"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"pain","approvedSymbol":"HRH1","approvedName":"histamine receptor H1","targetClass":["Membrane receptor"],"prefName":"HYDROXYZINE HYDROCHLORIDE","tradeNames":["Atarax","Hydroxyzine","Hydroxyzine hydrochloride","Orgatrax","Ucerax","Vistaril"],"synonyms":["Hydroxizine chloride","Hydroxyzine dihydrochloride","Hydroxyzine hydrochloride"],"drugType":"Small molecule","mechanismOfAction":"Histamine H1 receptor antagonist","targetName":"Histamine H1 receptor"}
{"drugId":"CHEMBL3545125","targetId":"ENSG00000007402","diseaseId":"EFO_0003843","phase":3,"urls":[{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=N02BG11"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"pain","approvedSymbol":"CACNA2D2","approvedName":"calcium voltage-gated channel auxiliary subunit alpha2delta 2","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"MIROGABALIN","tradeNames":[],"synonyms":["A-200-0700","A200-0700","Mirogabalin"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated calcium channel alpha2/delta subunit 2 modulator","targetName":"Voltage-gated calcium channel alpha2/delta subunit 2"}
{"drugId":"CHEMBL461522","targetId":"ENSG00000095303","diseaseId":"EFO_0003843","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02445599%22"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"pain","approvedSymbol":"PTGS1","approvedName":"prostaglandin-endoperoxide synthase 1","targetClass":["Enzyme"],"prefName":"DIPYRONE","tradeNames":["Diprofarn","Novaldin"],"synonyms":["Dipyrone"],"drugType":"Small molecule","mechanismOfAction":"Cyclooxygenase inhibitor","targetName":"Cyclooxygenase"}
{"drugId":"CHEMBL526","targetId":"ENSG00000102287","diseaseId":"EFO_0003843","phase":0,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05486819%22"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"pain","approvedSymbol":"GABRE","approvedName":"gamma-aminobutyric acid type A receptor subunit epsilon","targetClass":["Ion channel"],"prefName":"PROPOFOL","tradeNames":["Diprivan","Disoprivan","Propofol","Rapinovet"],"synonyms":["Disoprofol","Fresofol","ICI 35,868","ICI 35-868","ICI-35868","ICI35,868","Lipuro","NSC-5105","Phenol, 2,6-bis(1-methylethyl)","Propofol"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL526","targetId":"ENSG00000094755","diseaseId":"EFO_0003843","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02203175%22"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"pain","approvedSymbol":"GABRP","approvedName":"gamma-aminobutyric acid type A receptor subunit pi","targetClass":["Ion channel"],"prefName":"PROPOFOL","tradeNames":["Diprivan","Disoprivan","Propofol","Rapinovet"],"synonyms":["Disoprofol","Fresofol","ICI 35,868","ICI 35-868","ICI-35868","ICI35,868","Lipuro","NSC-5105","Phenol, 2,6-bis(1-methylethyl)","Propofol"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL679","targetId":"ENSG00000170214","diseaseId":"EFO_0003843","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04577690%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04814433%22"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"pain","approvedSymbol":"ADRA1B","approvedName":"adrenoceptor alpha 1B","targetClass":["Membrane receptor"],"prefName":"EPINEPHRINE","tradeNames":["Adren co","Adrenaclick","Adrenalin","Ana-Kit","Ana-guard","Anapen","Anaphylactic shock drug kit","Asma-vydrin","Asthmahaler","Auvi-q","Bronkaid mist","Brovon","Emerade","Epi e z pen jr","Epinephrine","Epinephrine (copackaged)","Epipen","Epipen e z pen","Epipen jr","Epipen jr.","Eppy","Gppe inh soln","Jext","Medihaler-epi","Primatene","Primatene mist","Riddobron","Riddofan","Rybarvin","Simplene","Soln made to rybarvin for","Sus-Phrine","Sus-Phrine Sulfite-Free","Sus-phrine sulfite free","Symjepi","Twinject 0.15","Twinject 0.3"],"synonyms":["(-)-(r)-epinephrine","(-)-epinephrine","Adrenaline","Adrenalinum","Epinephrine","Epinephrine hcl","Epinephrine hydrochloride","Epinephrinum","Glauposine","L-epinephrine hydrochloride","Levo-methylaminoethanolcatechol","NSC-62786","Nephridine","Racepinefrine, (r)-","Sus-phrine sulphite-free","Susphrine","Tonogen","Twinject"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor agonist","targetName":"Adrenergic receptor"}
{"drugId":"CHEMBL741","targetId":"ENSG00000168356","diseaseId":"EFO_0003843","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04523935%22"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"pain","approvedSymbol":"SCN11A","approvedName":"sodium voltage-gated channel alpha subunit 11","targetClass":["Ion channel"],"prefName":"LAMOTRIGINE","tradeNames":["Lamictal","Lamictal cd","Lamictal odt","Lamictal xr","Lamotrigine"],"synonyms":["BW 430C","BW-430C","Lamotrigine","NSC-759171"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL79","targetId":"ENSG00000007314","diseaseId":"EFO_0003843","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e9fdb9c9-fd00-443d-acc4-516fa8265c00"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=481aeef5-01cb-4567-a67f-896e6929b2ed"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a80355e6-c235-4770-a2cd-240486874eaf"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7bb482ba-632b-4d8f-a7d4-3fc857bdeef7"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8debb03e-a237-4e0d-be06-8ae17eaa14fa"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3e1cfe73-1d7f-4807-a26d-0d4c2b4894d9"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fd1caa1c-ae4f-488a-a624-41cecd533388"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9bcc1392-a679-4430-afd3-7893f3091cf7"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9378d186-5b25-49bc-8563-a659fa1194c2"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b3eee508-8bf3-4bd3-9a71-47ee6ea87f95"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b61c6a09-7764-4a92-93a9-a1356aeeaa9c"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0cd42a2f-d202-447d-998e-8877ac3c0d38"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b466c7eb-bca3-4686-ada6-325103ab06f3"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e495f18f-4c42-4126-a4c2-f5641aa163a7"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5f86a348-2274-4945-8694-4c1f0050bf02"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=11f724d8-63cd-10d9-e054-00144ff8d46c"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c913688b-c51d-44c2-8ce6-5200f1ea0bab"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=625c2437-2999-4b82-8331-51cd32aa3292"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=833cd52c-6470-49c4-937f-1393971f4db9"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1972d657-2d5a-4697-bba9-80caffc2f2d7"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a4eeb3f-ab3d-477c-86d6-f933affb20b4"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=829e3bd1-fb1c-4613-9db3-9a89ef8e2c0c"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c05f3803-92ae-42b7-8248-933bd92d6116"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ea5416d6-5988-413b-8682-6835b359eb78"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b6c88c84-cd82-4390-aea5-b04f15f57143"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2a9976e3-4595-4bc5-b7f9-f4a9bd59e55d"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=82b5bf2c-7dc9-40bd-9fb4-b5b1b5be0470"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4219aa16-026a-4919-b4ac-97ff21b7a005"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=823c2d42-d00d-401d-4081-fc1d434455e0"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=08990ac8-3215-4b84-b2be-23298edbddf4"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e942a88a-7cb1-4c99-b70f-4c48994bb84e"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"pain","approvedSymbol":"SCN4A","approvedName":"sodium voltage-gated channel alpha subunit 4","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"LIDOCAINE","tradeNames":["Alphacaine","Anestacon","Dentipatch","Lidocaine","Lidoderm","Lignocaine Hcl","Lignostab","Lmx 4","Oraqix","Vagisil","Xylocaine","Xylodase","Xylotox","Ztlido"],"synonyms":["ALGRX 3268","ALGRX-3268","Anestacon","Embolex","Iontocaine","Lidocaine","Lidocainum","Lidocaton","Lidopen","Lignocaine","NSC-40030","Octocaine","Solarcaine","Xylestesin"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL807","targetId":"ENSG00000161509","diseaseId":"EFO_0003843","phase":4,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01032759%22"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"pain","approvedSymbol":"GRIN2C","approvedName":"glutamate ionotropic receptor NMDA type subunit 2C","targetClass":["Ion channel"],"prefName":"MEMANTINE","tradeNames":[],"synonyms":["D-145","DRG-0267","Memantine","NSC-757843","Namenda"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor negative allosteric modulator","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL888","targetId":"ENSG00000101868","diseaseId":"EFO_0003860","phase":1,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01852890%22"}],"ancestors":["EFO_0001379","MONDO_0023370","EFO_0009605","EFO_0008549","MONDO_0045024","EFO_0010282","EFO_0000616"],"label":"pancreatic neoplasm","approvedSymbol":"POLA1","approvedName":"DNA polymerase alpha 1, catalytic subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL888","targetId":"ENSG00000077514","diseaseId":"EFO_0003860","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00574275%22"}],"ancestors":["EFO_0001379","MONDO_0023370","EFO_0009605","EFO_0008549","MONDO_0045024","EFO_0010282","EFO_0000616"],"label":"pancreatic neoplasm","approvedSymbol":"POLD3","approvedName":"DNA polymerase delta 3, accessory subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000101162","diseaseId":"EFO_0003863","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02256436%22"}],"ancestors":["MONDO_0023370","EFO_0009690","MONDO_0045024","MONDO_0021066","EFO_0000616"],"label":"urogenital neoplasm","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL3137320","targetId":"ENSG00000143799","diseaseId":"EFO_0003869","phase":4,"urls":[{"niceName":"FDA","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211651s000lbl.pdf"}],"ancestors":["OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","EFO_0010285","EFO_0009483","EFO_0000616"],"label":"breast neoplasm","approvedSymbol":"PARP1","approvedName":"poly(ADP-ribose) polymerase 1","targetClass":["Enzyme"],"prefName":"TALAZOPARIB","tradeNames":[],"synonyms":["BMN 673","BMN-673","LT-673","Talazoparib"],"drugType":"Small molecule","mechanismOfAction":"Poly [ADP-ribose] polymerase-1 inhibitor","targetName":"Poly [ADP-ribose] polymerase-1"}
{"drugId":"CHEMBL4279455","targetId":"ENSG00000258947","diseaseId":"EFO_0003869","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00386685%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00485979%22"}],"ancestors":["OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","EFO_0010285","EFO_0009483","EFO_0000616"],"label":"breast neoplasm","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"LAROTAXEL","tradeNames":[],"synonyms":["Larotaxel","XRP-9881","XRP9881","Xrp9881"],"drugType":"Small molecule","mechanismOfAction":"Tubulin stabiliser","targetName":"Tubulin"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000104833","diseaseId":"EFO_0003869","phase":3,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03036488%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03705429%22"}],"ancestors":["OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","EFO_0010285","EFO_0009483","EFO_0000616"],"label":"breast neoplasm","approvedSymbol":"TUBB4A","approvedName":"tubulin beta 4A class IVa","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL553025","targetId":"ENSG00000137267","diseaseId":"EFO_0003869","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01137994%22"}],"ancestors":["OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","EFO_0010285","EFO_0009483","EFO_0000616"],"label":"breast neoplasm","approvedSymbol":"TUBB2A","approvedName":"tubulin beta 2A class IIa","targetClass":["Structural protein"],"prefName":"VINORELBINE","tradeNames":[],"synonyms":["NSC-760087","Navelbin","Vinorelbine","Vinorelbine Base"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL628","targetId":"ENSG00000123360","diseaseId":"EFO_0003869","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00188669%22"}],"ancestors":["OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","EFO_0010285","EFO_0009483","EFO_0000616"],"label":"breast neoplasm","approvedSymbol":"PDE1B","approvedName":"phosphodiesterase 1B","targetClass":["Enzyme"],"prefName":"PENTOXIFYLLINE","tradeNames":["Neotren mr","Pentoxifylline","Pentoxil","Trental","Trental 100","Trental 400"],"synonyms":["BL 191","BL-191","C04AD03","NSC-637086","NSC-758481","Oxpentifylline","Oxypentifylline","Pentoxifylline","Pentoxiphyllin"],"drugType":"Small molecule","mechanismOfAction":"3',5'-cyclic phosphodiesterase inhibitor","targetName":"3',5'-cyclic phosphodiesterase"}
{"drugId":"CHEMBL924","targetId":"ENSG00000160752","diseaseId":"EFO_0003869","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00050011%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02181101%22"}],"ancestors":["OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","EFO_0010285","EFO_0009483","EFO_0000616"],"label":"breast neoplasm","approvedSymbol":"FDPS","approvedName":"farnesyl diphosphate synthase","targetClass":["Enzyme"],"prefName":"ZOLEDRONIC ACID","tradeNames":["Aclasta","Reclast","Zerlinda","Zoledronic acid","Zometa"],"synonyms":["AK-156","Anhydrous zoledronic acid","CGP 42446","CGP-42446","CGP-42446A","NSC-721517","Zoladrona acid mylan","Zoledronate","Zoledronate hydrate","Zoledronic","Zoledronic acid","Zoledronic acid accord","Zoledronic acid anhydrous","Zoledronic acid hydrate","Zoledronic acid medac","Zoledronic acid monohydrate","Zoledronic acid teva","Zometa"],"drugType":"Small molecule","mechanismOfAction":"Farnesyl diphosphate synthase inhibitor","targetName":"Farnesyl diphosphate synthase"}
{"drugId":"CHEMBL1200485","targetId":"ENSG00000132155","diseaseId":"EFO_0003871","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00939627%22"}],"ancestors":["MONDO_0023370","EFO_0005950","EFO_0008549","MONDO_0045024","EFO_1001047","MONDO_0001165","EFO_0010282","EFO_0000616"],"label":"tongue neoplasm","approvedSymbol":"RAF1","approvedName":"Raf-1 proto-oncogene, serine/threonine kinase","targetClass":["Enzyme"],"prefName":"SORAFENIB TOSYLATE","tradeNames":["Nexavar"],"synonyms":["BAY 54-9085","BAY-54-9085","Sorafenib tosilate","Sorafenib tosylate"],"drugType":"Small molecule","mechanismOfAction":"Serine/threonine-protein kinase RAF inhibitor","targetName":"Serine/threonine-protein kinase RAF"}
{"drugId":"CHEMBL1201775","targetId":"ENSG00000171759","diseaseId":"EFO_0003876","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00403494%22"}],"ancestors":["MONDO_0000473","MONDO_0002277","EFO_0003875","EFO_0004264","EFO_0000319"],"label":"intermittent vascular claudication","approvedSymbol":"PAH","approvedName":"phenylalanine hydroxylase","targetClass":["Enzyme"],"prefName":"SAPROPTERIN DIHYDROCHLORIDE","tradeNames":["Kuvan"],"synonyms":["Biopten","Dapropterin hydrochloride","Phenoptin","SUN-0588","SUN-0588 (SHIRATORI)","Sapropterin dihydrochloride","Sapropterin hydrochloride","T-1401","T1401","T1401 (BIOMARIN)"],"drugType":"Small molecule","mechanismOfAction":"Phenylalanine-4-hydroxylase activator","targetName":"Phenylalanine-4-hydroxylase"}
{"drugId":"CHEMBL1536","targetId":"ENSG00000111424","diseaseId":"EFO_0003882","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00663221%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00752557%22"}],"ancestors":["EFO_0004260","OTAR_0000006","EFO_0005571","EFO_0009676","OTAR_0000018","EFO_0005541","EFO_0002461","MONDO_0800064","MONDO_0019019","MONDO_0000833","MONDO_0018230","EFO_0000508","MONDO_0000837"],"label":"osteoporosis","approvedSymbol":"VDR","approvedName":"vitamin D receptor","targetClass":["Transcription factor"],"prefName":"ERGOCALCIFEROL","tradeNames":["Calciferol","Calciferol in arach oil","Caltrate","D-forte","Deltalin","Drisdol","Eciferol d2","Ergo-d2","Ergocalciferol","Ergoral d2","Lanes","Oleovitamin D","Osto-d2","Sterogyl","Sterogyl 15h","Sterogyl-15","Uvesterol d","Vitamin D 2","Vitamin d"],"synonyms":["Calciferol","Ergocalciferol","Ergocalciferolum","Ergorone","NSC-62792","Oleovitamin d, synthetic","Ostelin","Viosterol","Viosterol in oil","Vitamin d (ergocalciferol)","Vitamin d2"],"drugType":"Small molecule","mechanismOfAction":"Vitamin D receptor agonist","targetName":"Vitamin D receptor"}
{"drugId":"CHEMBL870","targetId":"ENSG00000160752","diseaseId":"EFO_0003882","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05091099%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05387200%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05151484%22"}],"ancestors":["EFO_0004260","OTAR_0000006","EFO_0005571","EFO_0009676","OTAR_0000018","EFO_0005541","EFO_0002461","MONDO_0800064","MONDO_0019019","MONDO_0000833","MONDO_0018230","EFO_0000508","MONDO_0000837"],"label":"osteoporosis","approvedSymbol":"FDPS","approvedName":"farnesyl diphosphate synthase","targetClass":["Enzyme"],"prefName":"ALENDRONIC ACID","tradeNames":["Binosto","Fosamax"],"synonyms":["Alendronate","Alendronic Acid","Alendronic acid","Fosamax"],"drugType":"Small molecule","mechanismOfAction":"Farnesyl diphosphate synthase inhibitor","targetName":"Farnesyl diphosphate synthase"}
{"drugId":"CHEMBL1168","targetId":"ENSG00000159640","diseaseId":"EFO_0003884","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01485978%22"}],"ancestors":["EFO_0009690","EFO_0003086"],"label":"chronic kidney disease","approvedSymbol":"ACE","approvedName":"angiotensin I converting enzyme","targetClass":["Enzyme"],"prefName":"RAMIPRIL","tradeNames":["Altace","Lopace","Ramipril","Ranace","Tritace"],"synonyms":["C09AA05","Cardace","Corpril","Delix","Ecator","HOE 498","HOE-498","Hopace","NSC-758933","Pramace","Ramace","Ramipres","Ramipril","Triatec","Unipril","Vesdil"],"drugType":"Small molecule","mechanismOfAction":"Angiotensin-converting enzyme inhibitor","targetName":"Angiotensin-converting enzyme"}
{"drugId":"CHEMBL554","targetId":"ENSG00000146648","diseaseId":"EFO_0003884","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02581124%22"}],"ancestors":["EFO_0009690","EFO_0003086"],"label":"chronic kidney disease","approvedSymbol":"EGFR","approvedName":"epidermal growth factor receptor","targetClass":["Enzyme"],"prefName":"LAPATINIB","tradeNames":["Tyverb"],"synonyms":["GSK-572016","GW-2016","GW-572016","GW-572016X","GW572016","Lapatinib"],"drugType":"Small molecule","mechanismOfAction":"Epidermal growth factor receptor erbB1 inhibitor","targetName":"Epidermal growth factor receptor erbB1"}
{"drugId":"CHEMBL1200494","targetId":"ENSG00000184160","diseaseId":"EFO_0003888","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3a171942-37af-430d-8b9d-bb678ca2be4b"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=301f01a7-2b0a-cfba-9c3d-a1dd831785a3"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b972af81-3a37-40be-9fe1-3ddf59852528"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1bb3fac5-11e8-4d1c-a5e4-2520abcdeb47"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0000618","EFO_0005548","MONDO_0000592","EFO_0009386"],"label":"attention deficit hyperactivity disorder","approvedSymbol":"ADRA2C","approvedName":"adrenoceptor alpha 2C","targetClass":["Membrane receptor"],"prefName":"GUANFACINE HYDROCHLORIDE","tradeNames":["Akfen","Estulic","Guanfacine hydrochloride","Intuniv","Tenex"],"synonyms":["BS 100-141","BS-100-141","Guafacine hydrochloride","Guanfacine hcl","Guanfacine hydrochloride","SPD503"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor alpha-2 agonist","targetName":"Adrenergic receptor alpha-2"}
{"drugId":"CHEMBL1201192","targetId":"ENSG00000142319","diseaseId":"EFO_0003888","phase":4,"urls":[{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=N06BA13"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0000618","EFO_0005548","MONDO_0000592","EFO_0009386"],"label":"attention deficit hyperactivity disorder","approvedSymbol":"SLC6A3","approvedName":"solute carrier family 6 member 3","targetClass":["Transporter"],"prefName":"ARMODAFINIL","tradeNames":["Armodafinil","Nuvigil"],"synonyms":["Armodafinil","CEP-10952","CEP-10953","CRL-40982","Modafinil, (r)-","NSC-751850","NSC-758711","R-(-)-modafinil"],"drugType":"Small molecule","mechanismOfAction":"Dopamine transporter inhibitor","targetName":"Dopamine transporter"}
{"drugId":"CHEMBL405","targetId":"ENSG00000103546","diseaseId":"EFO_0003888","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03153488%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0000618","EFO_0005548","MONDO_0000592","EFO_0009386"],"label":"attention deficit hyperactivity disorder","approvedSymbol":"SLC6A2","approvedName":"solute carrier family 6 member 2","targetClass":["Transporter"],"prefName":"AMPHETAMINE","tradeNames":["Adzenys er","Adzenys xr-odt","Dyanavel xr"],"synonyms":["Amfetamin","Amfetamine","Amphetamine","Amphetamine resin complex","Amphetamine, dl-","Dyanavel","NSC-27159","Norephedrane"],"drugType":"Small molecule","mechanismOfAction":"Norepinephrine transporter releasing agent","targetName":"Norepinephrine transporter"}
{"drugId":"CHEMBL526","targetId":"ENSG00000166206","diseaseId":"EFO_0003890","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01852539%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","MONDO_0004938","EFO_0000618","MONDO_0002494","EFO_0009386"],"label":"drug dependence","approvedSymbol":"GABRB3","approvedName":"gamma-aminobutyric acid type A receptor subunit beta3","targetClass":["Ion channel"],"prefName":"PROPOFOL","tradeNames":["Diprivan","Disoprivan","Propofol","Rapinovet"],"synonyms":["Disoprofol","Fresofol","ICI 35,868","ICI 35-868","ICI-35868","ICI35,868","Lipuro","NSC-5105","Phenol, 2,6-bis(1-methylethyl)","Propofol"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL79","targetId":"ENSG00000196876","diseaseId":"EFO_0003890","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03921567%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","MONDO_0004938","EFO_0000618","MONDO_0002494","EFO_0009386"],"label":"drug dependence","approvedSymbol":"SCN8A","approvedName":"sodium voltage-gated channel alpha subunit 8","targetClass":["Unclassified protein","Auxiliary transport protein","Ion channel"],"prefName":"LIDOCAINE","tradeNames":["Alphacaine","Anestacon","Dentipatch","Lidocaine","Lidoderm","Lignocaine Hcl","Lignostab","Lmx 4","Oraqix","Vagisil","Xylocaine","Xylodase","Xylotox","Ztlido"],"synonyms":["ALGRX 3268","ALGRX-3268","Anestacon","Embolex","Iontocaine","Lidocaine","Lidocainum","Lidocaton","Lidopen","Lignocaine","NSC-40030","Octocaine","Solarcaine","Xylestesin"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL477772","targetId":"ENSG00000128052","diseaseId":"EFO_0003893","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01608009%22"}],"ancestors":["EFO_0000512","OTAR_0000017","EFO_0005771","MONDO_0002259","EFO_0001379","MONDO_0023370","EFO_1000051","EFO_0009549","MONDO_0021148","MONDO_0045024","EFO_0000616"],"label":"ovarian neoplasm","approvedSymbol":"KDR","approvedName":"kinase insert domain receptor","targetClass":["Enzyme"],"prefName":"PAZOPANIB","tradeNames":["Votrient"],"synonyms":["GW786034","NSC-752782","Pazopanib"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL1433","targetId":"ENSG00000137673","diseaseId":"EFO_0003894","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03457636%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00837213%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02899000%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05399290%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01885910%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04451330%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00635609%22"}],"ancestors":["EFO_0000701","OTAR_0000018","MONDO_0024481","EFO_1000636","EFO_1000763","EFO_0000508","MONDO_0002406","EFO_0010285","MONDO_0002917"],"label":"acne","approvedSymbol":"MMP7","approvedName":"matrix metallopeptidase 7","targetClass":["Enzyme"],"prefName":"DOXYCYCLINE ANHYDROUS","tradeNames":[],"synonyms":["Anhydrous doxycycline","Doxycycline (anhydrous)"],"drugType":"Small molecule","mechanismOfAction":"Matrix metalloproteinase 7 inhibitor","targetName":"Matrix metalloproteinase 7"}
{"drugId":"CHEMBL3989740","targetId":"ENSG00000118113","diseaseId":"EFO_0003894","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00688064%22"}],"ancestors":["EFO_0000701","OTAR_0000018","MONDO_0024481","EFO_1000636","EFO_1000763","EFO_0000508","MONDO_0002406","EFO_0010285","MONDO_0002917"],"label":"acne","approvedSymbol":"MMP8","approvedName":"matrix metallopeptidase 8","targetClass":["Enzyme"],"prefName":"DOXYCYCLINE HYCLATE","tradeNames":["Acticlate","Acticlate cap","Alodox","Atridox","Cyclodox","Demix 100","Demix 50","Doryx","Doryx mpc","Doxatet","Doxy","Doxy 100","Doxy 200","Doxy-Caps","Doxy-lemmon","Doxychel hyclate","Doxycycline hyclate","Doxylar","Lymepak","Nordox","Periostat","Ramysis","Vibra-tabs","Vibramycin","Vibramycin 50","Vibramycin Hyclate","Vibramycin acne pack","Vibramycin-d","Vibrox"],"synonyms":["Azudoxat","Clinofug","Diocimex","Doxicrisol","Doxycycline hyclate","Doxycycline hydrochloride hemiethanolate hemihydrate","Doxycyclini hyclas","Doxyprex","Duradoxal","Granudoxy","Mespafin","Monodoks","NSC-741421","Retens","Ronaxan","Spanor","Tetraclean","Tetradox","Unacil","Vibraveineuse","Vibravenos","Zadorin"],"drugType":"Small molecule","mechanismOfAction":"Matrix metalloproteinase 8 inhibitor","targetName":"Matrix metalloproteinase 8"}
{"drugId":"CHEMBL2108581","targetId":"ENSG00000160654","diseaseId":"EFO_0003897","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04222114%22"}],"ancestors":["MONDO_0023370","EFO_0008549","MONDO_0045024","EFO_0009608","EFO_0010282","EFO_0000616"],"label":"stomach neoplasm","approvedSymbol":"CD3G","approvedName":"CD3 gamma subunit of T-cell receptor complex","targetClass":["Unclassified protein"],"prefName":"CATUMAXOMAB","tradeNames":["Removab"],"synonyms":["Catumaxomab"],"drugType":"Antibody","mechanismOfAction":"T cell surface glycoprotein CD3 cross-linking agent","targetName":"T cell surface glycoprotein CD3"}
{"drugId":"CHEMBL3545414","targetId":"ENSG00000128052","diseaseId":"EFO_0003897","phase":3,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03889626%22"}],"ancestors":["MONDO_0023370","EFO_0008549","MONDO_0045024","EFO_0009608","EFO_0010282","EFO_0000616"],"label":"stomach neoplasm","approvedSymbol":"KDR","approvedName":"kinase insert domain receptor","targetClass":["Enzyme"],"prefName":"RIVOCERANIB MESYLATE","tradeNames":["Aitan"],"synonyms":["Apatinib (registered name in China)","Apatinib mesylate","Rivoceranib mesylate","YN-968D1","Yn-968d1"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor 2 inhibitor","targetName":"Vascular endothelial growth factor receptor 2"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000188229","diseaseId":"EFO_0003897","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02486601%22"}],"ancestors":["MONDO_0023370","EFO_0008549","MONDO_0045024","EFO_0009608","EFO_0010282","EFO_0000616"],"label":"stomach neoplasm","approvedSymbol":"TUBB4B","approvedName":"tubulin beta 4B class IVb","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1088750","targetId":"ENSG00000112062","diseaseId":"EFO_0003898","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00811499%22"}],"ancestors":["EFO_0004260","EFO_0005140","OTAR_0000006","EFO_0009676","EFO_0009477","MONDO_0002614","MONDO_0000589","EFO_0002461","MONDO_0045002","EFO_0005809","EFO_0000540","EFO_1000999","EFO_0000685","EFO_0000706","EFO_0005755","MONDO_0000812","EFO_1001986","EFO_0005856","MONDO_0003937","EFO_1002003"],"label":"ankylosing spondylitis","approvedSymbol":"MAPK14","approvedName":"mitogen-activated protein kinase 14","targetClass":["Enzyme"],"prefName":"ARRY-797","tradeNames":[],"synonyms":["ARRY-371797","ARRY-797","Arry-797"],"drugType":"Small molecule","mechanismOfAction":"MAP kinase p38 alpha inhibitor","targetName":"MAP kinase p38 alpha"}
{"drugId":"CHEMBL221959","targetId":"ENSG00000096968","diseaseId":"EFO_0003898","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03504072%22"}],"ancestors":["EFO_0004260","EFO_0005140","OTAR_0000006","EFO_0009676","EFO_0009477","MONDO_0002614","MONDO_0000589","EFO_0002461","MONDO_0045002","EFO_0005809","EFO_0000540","EFO_1000999","EFO_0000685","EFO_0000706","EFO_0005755","MONDO_0000812","EFO_1001986","EFO_0005856","MONDO_0003937","EFO_1002003"],"label":"ankylosing spondylitis","approvedSymbol":"JAK2","approvedName":"Janus kinase 2","targetClass":["Enzyme","Other cytosolic protein"],"prefName":"TOFACITINIB","tradeNames":[],"synonyms":["550","CP 690550","CP- 690 550","CP-690","CP-690,550","CP-690,550 FREE BASE","CP-690-550","CP-690550","CP-690550 FREE BASE","CP690,550","CP690550","Cp-690 free base","Tasocitinib","Tofacitinib"],"drugType":"Small molecule","mechanismOfAction":"Janus Kinase (JAK) inhibitor","targetName":"Janus Kinase (JAK)"}
{"drugId":"CHEMBL4297700","targetId":"ENSG00000112115","diseaseId":"EFO_0003898","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03355573%22"}],"ancestors":["EFO_0004260","EFO_0005140","OTAR_0000006","EFO_0009676","EFO_0009477","MONDO_0002614","MONDO_0000589","EFO_0002461","MONDO_0045002","EFO_0005809","EFO_0000540","EFO_1000999","EFO_0000685","EFO_0000706","EFO_0005755","MONDO_0000812","EFO_1001986","EFO_0005856","MONDO_0003937","EFO_1002003"],"label":"ankylosing spondylitis","approvedSymbol":"IL17A","approvedName":"interleukin 17A","targetClass":["Secreted protein"],"prefName":"BIMEKIZUMAB","tradeNames":[],"synonyms":["Bimekizumab","UCB-4940","UCB4940","Ucb4940"],"drugType":"Antibody","mechanismOfAction":"Interleukin 17A inhibitor","targetName":"Interleukin 17A"}
{"drugId":"CHEMBL723","targetId":"ENSG00000120907","diseaseId":"EFO_0003913","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02547597%22"}],"ancestors":["EFO_0000651","HP_0000118","HP_0001626"],"label":"angina pectoris","approvedSymbol":"ADRA1A","approvedName":"adrenoceptor alpha 1A","targetClass":["Membrane receptor"],"prefName":"CARVEDILOL","tradeNames":["Carvedilol","Coreg","Coreg CR","Eucardic 12.5","Eucardic 25","Eucardic 3.125","Eucardic 6.25"],"synonyms":["BM 14.190","BM-14-190","BM-14.190","BM-14190","C07AG02","Carvedilol","Coronis","DQ-2466","Dilatrend","Dimitone","Eucardic","Korvasan","Kredex","NSC-758694","SKF-105517","Talliton"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor alpha-1 antagonist","targetName":"Adrenergic receptor alpha-1"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198763","diseaseId":"EFO_0003914","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00000620%22"}],"ancestors":["MONDO_0000473","MONDO_0002277","EFO_0009085","EFO_0004264","EFO_0009086","EFO_0000319"],"label":"atherosclerosis","approvedSymbol":"MT-ND2","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL723","targetId":"ENSG00000188778","diseaseId":"EFO_0003914","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00000620%22"}],"ancestors":["MONDO_0000473","MONDO_0002277","EFO_0009085","EFO_0004264","EFO_0009086","EFO_0000319"],"label":"atherosclerosis","approvedSymbol":"ADRB3","approvedName":"adrenoceptor beta 3","targetClass":["Membrane receptor"],"prefName":"CARVEDILOL","tradeNames":["Carvedilol","Coreg","Coreg CR","Eucardic 12.5","Eucardic 25","Eucardic 3.125","Eucardic 6.25"],"synonyms":["BM 14.190","BM-14-190","BM-14.190","BM-14190","C07AG02","Carvedilol","Coronis","DQ-2466","Dilatrend","Dimitone","Eucardic","Korvasan","Kredex","NSC-758694","SKF-105517","Talliton"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor beta antagonist","targetName":"Adrenergic receptor beta"}
{"drugId":"CHEMBL1201468","targetId":"ENSG00000140009","diseaseId":"EFO_0003922","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e0141598-0bb2-4cf0-c9b8-6867b34bbb17"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"menopause","approvedSymbol":"ESR2","approvedName":"estrogen receptor 2","targetClass":["Transcription factor"],"prefName":"ESTROGENS, ESTERIFIED","tradeNames":["Amnestrogen","Esterified estrogens","Estratab","Evex","Femogen","Menest"],"synonyms":["Esterified estrogens","Estrogens esterified","Estrogens, esterified","Estrogens,esterified"],"drugType":"Small molecule","mechanismOfAction":"Estrogen receptor agonist","targetName":"Estrogen receptor"}
{"drugId":"CHEMBL1201607","targetId":"ENSG00000115232","diseaseId":"EFO_0003929","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00306592%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00027300%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00030966%22"}],"ancestors":["EFO_0005140","EFO_0005772","EFO_0005774","MONDO_0002977","MONDO_0000568","MONDO_0005301","EFO_0009386","MONDO_0002562","EFO_0005809","EFO_0000540","EFO_0000618","EFO_1002003","EFO_1000870"],"label":"relapsing-remitting multiple sclerosis","approvedSymbol":"ITGA4","approvedName":"integrin subunit alpha 4","targetClass":["Membrane receptor"],"prefName":"NATALIZUMAB","tradeNames":["Tysabri"],"synonyms":["AN100226M","ANTEGRAN","Antegren","Natalizumab"],"drugType":"Antibody","mechanismOfAction":"Integrin alpha-4/beta-7 inhibitor","targetName":"Integrin alpha-4/beta-7"}
{"drugId":"CHEMBL2108041","targetId":"ENSG00000156738","diseaseId":"EFO_0003929","phase":4,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04261790%22"}],"ancestors":["EFO_0005140","EFO_0005772","EFO_0005774","MONDO_0002977","MONDO_0000568","MONDO_0005301","EFO_0009386","MONDO_0002562","EFO_0005809","EFO_0000540","EFO_0000618","EFO_1002003","EFO_1000870"],"label":"relapsing-remitting multiple sclerosis","approvedSymbol":"MS4A1","approvedName":"membrane spanning 4-domains A1","targetClass":["Ion channel"],"prefName":"OCRELIZUMAB","tradeNames":["Ocrevus"],"synonyms":["2H7","Ocrelizumab","PR-070769","PR070769","R-1594","RG-1594"],"drugType":"Antibody","mechanismOfAction":"B-lymphocyte antigen CD20 binding agent","targetName":"B-lymphocyte antigen CD20"}
{"drugId":"CHEMBL284348","targetId":"ENSG00000151079","diseaseId":"EFO_0003929","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01917019%22"}],"ancestors":["EFO_0005140","EFO_0005772","EFO_0005774","MONDO_0002977","MONDO_0000568","MONDO_0005301","EFO_0009386","MONDO_0002562","EFO_0005809","EFO_0000540","EFO_0000618","EFO_1002003","EFO_1000870"],"label":"relapsing-remitting multiple sclerosis","approvedSymbol":"KCNA6","approvedName":"potassium voltage-gated channel subfamily A member 6","targetClass":["Ion channel"],"prefName":"DALFAMPRIDINE","tradeNames":["Ampyra","Ampyra Extended Release","Fampyra","Neurelan"],"synonyms":["Dalfampridine","EL-970","Fampridine","Fampridine (4-aminopyridine)","NSC-15041"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated potassium channel blocker","targetName":"Voltage-gated potassium channel"}
{"drugId":"CHEMBL655","targetId":"ENSG00000022355","diseaseId":"EFO_0003931","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00416039%22"}],"ancestors":["EFO_0004260","OTAR_0000006","EFO_0009676","EFO_0000546","EFO_0002461","OTAR_0000009"],"label":"bone fracture","approvedSymbol":"GABRA1","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha1","targetClass":["Ion channel"],"prefName":"MIDAZOLAM","tradeNames":["Midazolam in 0.9% sodium chloride","Nayzilam"],"synonyms":["Midazolam","Midazolam civ","USL-261","USL261"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL112","targetId":"ENSG00000073756","diseaseId":"EFO_0003943","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04905563%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03759028%22"}],"ancestors":["EFO_0004260","OTAR_0000006","EFO_0009676","EFO_0000546","EFO_0003931","EFO_0009514","EFO_0002461","OTAR_0000009"],"label":"humerus fracture","approvedSymbol":"PTGS2","approvedName":"prostaglandin-endoperoxide synthase 2","targetClass":["Enzyme"],"prefName":"ACETAMINOPHEN","tradeNames":["Abdine","Acephen","Acetaminophen","Alvedon","Angiers","Calpol","Calpol six plus","Calpol six plus fastmelts","Child lemsip","Cupanol","Dafalgan","Datril","Disprol","Disprol infant","Disprol jnr","Disprol paed","Fennings","Galpamol","Hedex","Infadrops","Infants' feverall","Injectapap","Junior parapaed","Mandanol","Medinol","Medinol for children","Medinol over 6","Medinol under 6","Medised plain","Miradol","Neopap","Ofirmev","Paldesic","Panadol","Panadol actifast","Panadol actifast solb","Panadol advan","Panadol jnr","Panadol oa","Panaleve","Panaleve 6 plus","Paracetamol","Paramin","Parapaed jnr","Parapaed six plus","Paravict","Perfalgan","Phenaphen","Placidex","Rimadol","Salzone","Tixymol","Tramil 500","Tylenol"],"synonyms":["Acetaminophen","Apap","Biocetamol","Doliprane","Efferalgan","N-acetyl-p-aminophenol","NSC-109028","NSC-3991","P-hydroxy-acetanilid","Paracetamol","Paracetamolum","Vermidon"],"drugType":"Small molecule","mechanismOfAction":"Cyclooxygenase inhibitor","targetName":"Cyclooxygenase"}
{"drugId":"CHEMBL38","targetId":"ENSG00000172819","diseaseId":"EFO_0003963","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a35fa709-5eb5-4429-b38f-f1e0019bf0ee"}],"ancestors":["EFO_0000651","EFO_0003784"],"label":"freckles","approvedSymbol":"RARG","approvedName":"retinoic acid receptor gamma","targetClass":["Transcription factor"],"prefName":"TRETINOIN","tradeNames":["Acticin","Altreno","Atralin","Avita","Renova","Retin-a","Retin-a micro","Retin-a-micro","Tretin-X","Tretinoin","Vesanoid"],"synonyms":["Aberel","All-trans retinoic acid","All-trans-retinoic acid","Eudyna","Kerlocal","NSC-122758","Oristar rna","Retin a","Retinoic acid","Tretinoin"],"drugType":"Small molecule","mechanismOfAction":"Retinoic acid receptor agonist","targetName":"Retinoic acid receptor"}
{"drugId":"CHEMBL2105717","targetId":"ENSG00000105976","diseaseId":"EFO_0003968","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04339738%22"}],"ancestors":["MONDO_0024296","MONDO_0021080","MONDO_0023370","EFO_0000691","MONDO_0024757","MONDO_0002095","MONDO_0045024","MONDO_0004992","EFO_0004264","MONDO_0002100","MONDO_0044334","EFO_0003967","EFO_1001968","MONDO_0024637","EFO_1000541","EFO_0000616","EFO_0000319"],"label":"angiosarcoma","approvedSymbol":"MET","approvedName":"MET proto-oncogene, receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"CABOZANTINIB","tradeNames":["Cabometyx","Cometriq"],"synonyms":["BMS-907351","BMS-907351 FREE BASE","Cabozantinib","XL-184","XL-184 FREE BASE","XL184"],"drugType":"Small molecule","mechanismOfAction":"Hepatocyte growth factor receptor inhibitor","targetName":"Hepatocyte growth factor receptor"}
{"drugId":"CHEMBL27","targetId":"ENSG00000169252","diseaseId":"EFO_0003968","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04518124%22"}],"ancestors":["MONDO_0024296","MONDO_0021080","MONDO_0023370","EFO_0000691","MONDO_0024757","MONDO_0002095","MONDO_0045024","MONDO_0004992","EFO_0004264","MONDO_0002100","MONDO_0044334","EFO_0003967","EFO_1001968","MONDO_0024637","EFO_1000541","EFO_0000616","EFO_0000319"],"label":"angiosarcoma","approvedSymbol":"ADRB2","approvedName":"adrenoceptor beta 2","targetClass":["Membrane receptor"],"prefName":"PROPRANOLOL","tradeNames":[],"synonyms":[".beta.-propranolol","AY-64043-","Betalong","Dl-propranolol","Euprovasin","Inderal","Inderide-40/25","Inderide-80/25","Propranolol","Proprasylyt","Reducor"],"drugType":"Small molecule","mechanismOfAction":"Beta-2 adrenergic receptor antagonist","targetName":"Beta-2 adrenergic receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000119013","diseaseId":"EFO_0004142","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01632020%22"}],"ancestors":["EFO_0009431","MONDO_0021118","MONDO_0023370","EFO_0008549","MONDO_0024634","MONDO_0045024","EFO_0010282","EFO_0000616"],"label":"colorectal neoplasm","approvedSymbol":"NDUFB3","approvedName":"NADH:ubiquinone oxidoreductase subunit B3","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL940","targetId":"ENSG00000153956","diseaseId":"EFO_0004143","phase":4,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04285281%22"}],"ancestors":["EFO_0009487","EFO_0009387","OTAR_0000018","MONDO_0020127","EFO_1001902","EFO_0004149","EFO_0000618","EFO_0000508","EFO_0003100"],"label":"carpal tunnel syndrome","approvedSymbol":"CACNA2D1","approvedName":"calcium voltage-gated channel auxiliary subunit alpha2delta 1","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"GABAPENTIN","tradeNames":["Gabapentin","Gralise","Neurontin"],"synonyms":["CI-945","DM-1796","GOE 3450","GOE-3450","Gabapentin","NSC-742194","NSC-759254"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated calcium channel modulator","targetName":"Voltage-gated calcium channel"}
{"drugId":"CHEMBL3545153","targetId":"ENSG00000134318","diseaseId":"EFO_0004190","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00868894%22"}],"ancestors":["EFO_0003966","MONDO_0005041","MONDO_0024458"],"label":"open-angle glaucoma","approvedSymbol":"ROCK2","approvedName":"Rho associated coiled-coil containing protein kinase 2","targetClass":["Enzyme"],"prefName":"DE-104","tradeNames":[],"synonyms":["De-104"],"drugType":"Small molecule","mechanismOfAction":"Rho-associated protein kinase inhibitor","targetName":"Rho-associated protein kinase"}
{"drugId":"CHEMBL1282","targetId":"ENSG00000196664","diseaseId":"EFO_0004193","phase":3,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02242929%22"}],"ancestors":["EFO_0010176","MONDO_0002898","MONDO_0000653","EFO_0009259","MONDO_0023370","EFO_0009260","MONDO_0045024","MONDO_0004992","EFO_0004198","EFO_0000313","EFO_0000701","MONDO_0021634","EFO_0010285","EFO_0006858","EFO_0000616","EFO_1001763"],"label":"basal cell carcinoma","approvedSymbol":"TLR7","approvedName":"toll like receptor 7","targetClass":["Membrane receptor"],"prefName":"IMIQUIMOD","tradeNames":["Aldara","Imiquimod","Zyclara"],"synonyms":["Aldara","Imiquimod","NSC-369100","NSC-759651","R-837","S-26308","S26308"],"drugType":"Small molecule","mechanismOfAction":"Toll-like receptor 7 agonist","targetName":"Toll-like receptor 7"}
{"drugId":"CHEMBL473417","targetId":"ENSG00000128602","diseaseId":"EFO_0004193","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02639117%22"}],"ancestors":["EFO_0010176","MONDO_0002898","MONDO_0000653","EFO_0009259","MONDO_0023370","EFO_0009260","MONDO_0045024","MONDO_0004992","EFO_0004198","EFO_0000313","EFO_0000701","MONDO_0021634","EFO_0010285","EFO_0006858","EFO_0000616","EFO_1001763"],"label":"basal cell carcinoma","approvedSymbol":"SMO","approvedName":"smoothened, frizzled class receptor","targetClass":["Membrane receptor"],"prefName":"VISMODEGIB","tradeNames":["Erivedge"],"synonyms":["GDC-0449","NSC-747691","NSC-755986","Vismodegib"],"drugType":"Small molecule","mechanismOfAction":"Smoothened homolog inhibitor","targetName":"Smoothened homolog"}
{"drugId":"CHEMBL574737","targetId":"ENSG00000140992","diseaseId":"EFO_0004193","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00031681%22"}],"ancestors":["EFO_0010176","MONDO_0002898","MONDO_0000653","EFO_0009259","MONDO_0023370","EFO_0009260","MONDO_0045024","MONDO_0004992","EFO_0004198","EFO_0000313","EFO_0000701","MONDO_0021634","EFO_0010285","EFO_0006858","EFO_0000616","EFO_1001763"],"label":"basal cell carcinoma","approvedSymbol":"PDPK1","approvedName":"3-phosphoinositide dependent protein kinase 1","targetClass":["Enzyme"],"prefName":"UCN-01","tradeNames":[],"synonyms":["7-hydroxystaurosporine","KRX-0601","KW-2401","NSC-638850","UCN-01","UCN-02","Ucn 01","Ucn-01"],"drugType":"Small molecule","mechanismOfAction":"3-phosphoinositide dependent protein kinase-1 inhibitor","targetName":"3-phosphoinositide dependent protein kinase-1"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000113327","diseaseId":"EFO_0004211","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00231621%22"}],"ancestors":["EFO_0000589","OTAR_0000020"],"label":"Hypertriglyceridemia","approvedSymbol":"GABRG2","approvedName":"gamma-aminobutyric acid type A receptor subunit gamma2","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL1714","targetId":"ENSG00000176884","diseaseId":"EFO_0004215","phase":1,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04714541%22"}],"ancestors":["EFO_0000589","EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0005203","EFO_0001069","OTAR_0000020","EFO_0000618","EFO_0009386"],"label":"anorexia nervosa","approvedSymbol":"GRIN1","approvedName":"glutamate ionotropic receptor NMDA type subunit 1","targetClass":["Ion channel"],"prefName":"KETAMINE HYDROCHLORIDE","tradeNames":["Anaket-V","Ketalar","Ketamine hydrochloride","Ketanest","Ketavet","Vetalar"],"synonyms":["CI-581","CL 369","CL-369","CN-52,372-2","CN-52372-2","CN-523722","Ketamine (as hydrochloride)","Ketamine hcl","Ketamine hydrochloride","Ketamine hydrochloride ciii","Ketamini hydrochloridum","Special k","Vetalar"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor negative allosteric modulator","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL163","targetId":"ENSG00000160868","diseaseId":"EFO_0004220","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01081158%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01813552%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01185860%22"}],"ancestors":["EFO_0005741","EFO_0003047","MONDO_0100329","EFO_0004196","MONDO_0043424","EFO_0007274","MONDO_0100336","MONDO_0100321","EFO_0001379","EFO_0000763","EFO_0001421","EFO_0010284","EFO_0010282"],"label":"chronic hepatitis C virus infection","approvedSymbol":"CYP3A4","approvedName":"cytochrome P450 family 3 subfamily A member 4","targetClass":["Enzyme"],"prefName":"RITONAVIR","tradeNames":["Norvir","Ritonavir"],"synonyms":["A-84538","ABBOTT-84538","ABT-538","Empetus","NSC-693184","Norvir","Ritomune","Ritonavir","Ritonavir related compounds mixture","Ritonavirum","Ritovir","Viekirax","Viriton"],"drugType":"Small molecule","mechanismOfAction":"Cytochrome P450 3A inhibitor","targetName":"Cytochrome P450 3A"}
{"drugId":"CHEMBL2107842","targetId":"ENSG00000142166","diseaseId":"EFO_0004220","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00402428%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00411385%22"}],"ancestors":["EFO_0005741","EFO_0003047","MONDO_0100329","EFO_0004196","MONDO_0043424","EFO_0007274","MONDO_0100336","MONDO_0100321","EFO_0001379","EFO_0000763","EFO_0001421","EFO_0010284","EFO_0010282"],"label":"chronic hepatitis C virus infection","approvedSymbol":"IFNAR1","approvedName":"interferon alpha and beta receptor subunit 1","targetClass":["Membrane receptor"],"prefName":"ALBINTERFERON ALFA-2B","tradeNames":["Albuferon"],"synonyms":["Albinterferon alfa-2b","Interferon-alfa-2b"],"drugType":"Protein","mechanismOfAction":"Interferon alpha/beta receptor agonist","targetName":"Interferon alpha/beta receptor"}
{"drugId":"CHEMBL2108709","targetId":"ENSG00000080573","diseaseId":"EFO_0004229","phase":4,"status":"Enrolling by invitation","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03406338%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0003899","EFO_0002970"],"label":"Dupuytren Contracture","approvedSymbol":"COL5A3","approvedName":"collagen type V alpha 3 chain","targetClass":["Structural protein"],"prefName":"COLLAGENASE CLOSTRIDIUM HISTOLYTICUM","tradeNames":["Santyl","Xiaflex"],"synonyms":["AA-4500","AA4500","Clostridial collagenase","Clostridium histolyticum enzymes","Collagenase","Collagenase (clostridium histolyticum)","Collagenase clostridium histolyticum","Cordase","Iruxol","MZ-004","Plaquase"],"drugType":"Enzyme","mechanismOfAction":"Collagen hydrolytic enzyme","targetName":"Collagen"}
{"drugId":"CHEMBL1289601","targetId":"ENSG00000102755","diseaseId":"EFO_0004230","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03005015%22"}],"ancestors":["EFO_0000512","OTAR_0000017","MONDO_0002654","MONDO_0023370","EFO_1000051","EFO_0009549","MONDO_0021148","MONDO_0045024","EFO_0003859","EFO_0000616"],"label":"endometrial neoplasm","approvedSymbol":"FLT1","approvedName":"fms related receptor tyrosine kinase 1","targetClass":["Enzyme"],"prefName":"LENVATINIB","tradeNames":["Kisplyx","Lenvima"],"synonyms":["E-7080","ER-203492-00","Lenvatinib"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL1667969","targetId":"ENSG00000067900","diseaseId":"EFO_0004234","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00914277%22"}],"ancestors":["EFO_0000512","MONDO_0002134","OTAR_0000017","MONDO_0002036","EFO_0009555"],"label":"erectile dysfunction","approvedSymbol":"ROCK1","approvedName":"Rho associated coiled-coil containing protein kinase 1","targetClass":["Enzyme"],"prefName":"SAR-407899","tradeNames":[],"synonyms":["SAR-407899"],"drugType":"Small molecule","mechanismOfAction":"Rho-associated protein kinase inhibitor","targetName":"Rho-associated protein kinase"}
{"drugId":"CHEMBL655","targetId":"ENSG00000022355","diseaseId":"EFO_0004242","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02206776%22"}],"ancestors":["EFO_0000677","MONDO_0002025","OTAR_0000018","EFO_0005774","EFO_0006788","EFO_0000618","EFO_0000508","EFO_0009386"],"label":"obsessive-compulsive disorder","approvedSymbol":"GABRA1","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha1","targetClass":["Ion channel"],"prefName":"MIDAZOLAM","tradeNames":["Midazolam in 0.9% sodium chloride","Nayzilam"],"synonyms":["Midazolam","Midazolam civ","USL-261","USL261"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL1201185","targetId":"ENSG00000162009","diseaseId":"EFO_0004243","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01731925%22"}],"ancestors":["EFO_0003769","EFO_1001901","EFO_0001379","MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"carcinoid tumor","approvedSymbol":"SSTR5","approvedName":"somatostatin receptor 5","targetClass":["Membrane receptor"],"prefName":"LANREOTIDE","tradeNames":["Somatuline autogel","Somatuline la"],"synonyms":["Angiopeptin","Lanreotide"],"drugType":"Protein","mechanismOfAction":"Somatostatin receptor 5 agonist","targetName":"Somatostatin receptor 5"}
{"drugId":"CHEMBL1680","targetId":"ENSG00000180616","diseaseId":"EFO_0004243","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00427349%22"}],"ancestors":["EFO_0003769","EFO_1001901","EFO_0001379","MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"carcinoid tumor","approvedSymbol":"SSTR2","approvedName":"somatostatin receptor 2","targetClass":["Membrane receptor"],"prefName":"OCTREOTIDE","tradeNames":["Sandostatin"],"synonyms":["Octreotide","SMS 201-995","SMS-201-995","SMS-995","SMS995"],"drugType":"Protein","mechanismOfAction":"Somatostatin receptor agonist","targetName":"Somatostatin receptor"}
{"drugId":"CHEMBL3039583","targetId":"ENSG00000162009","diseaseId":"EFO_0004243","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00088595%22"}],"ancestors":["EFO_0003769","EFO_1001901","EFO_0001379","MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"carcinoid tumor","approvedSymbol":"SSTR5","approvedName":"somatostatin receptor 5","targetClass":["Membrane receptor"],"prefName":"PASIREOTIDE","tradeNames":["Signifor"],"synonyms":["Pasireotide","SOM 230","SOM-230","SOM230"],"drugType":"Protein","mechanismOfAction":"Somatostatin receptor 5 agonist","targetName":"Somatostatin receptor 5"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000148229","diseaseId":"EFO_0004251","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00053196%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00028730%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00787761%22"}],"ancestors":["EFO_0002427","OTAR_0000018","Orphanet_68336","MONDO_0002334","MONDO_0023370","EFO_0000508","MONDO_0045024","MONDO_0044881","MONDO_0004992","EFO_0005803","Orphanet_322126","EFO_0000616"],"label":"myeloproliferative disorder","approvedSymbol":"POLE3","approvedName":"DNA polymerase epsilon 3, accessory subunit","targetClass":["Unclassified protein"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL467","targetId":"ENSG00000171848","diseaseId":"EFO_0004251","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00005823%22"}],"ancestors":["EFO_0002427","OTAR_0000018","Orphanet_68336","MONDO_0002334","MONDO_0023370","EFO_0000508","MONDO_0045024","MONDO_0044881","MONDO_0004992","EFO_0005803","Orphanet_322126","EFO_0000616"],"label":"myeloproliferative disorder","approvedSymbol":"RRM2","approvedName":"ribonucleotide reductase regulatory subunit M2","targetClass":["Enzyme"],"prefName":"HYDROXYUREA","tradeNames":["Droxia","Hydrea","Hydroxyurea","Siklos"],"synonyms":["Hydroxycarbamide","Hydroxyurea","NSC-32065","SQ 1089","SQ-1089"],"drugType":"Small molecule","mechanismOfAction":"Ribonucleoside-diphosphate reductase RR1 inhibitor","targetName":"Ribonucleoside-diphosphate reductase RR1"}
{"drugId":"CHEMBL225072","targetId":"ENSG00000176890","diseaseId":"EFO_0004252","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00630149%22"}],"ancestors":["MONDO_0004821","EFO_0000684","EFO_0003853","MONDO_0023370","EFO_0005950","MONDO_0004867","EFO_0008549","MONDO_0021246","OTAR_0000010","MONDO_0045024","MONDO_0020592","EFO_0000616"],"label":"nasopharyngeal neoplasm","approvedSymbol":"TYMS","approvedName":"thymidylate synthetase","targetClass":["Enzyme"],"prefName":"PEMETREXED","tradeNames":["Alimta","Pemfexy"],"synonyms":["LY-2315","LY-231514","LY231514","NSC-698037","Pemetrexed"],"drugType":"Small molecule","mechanismOfAction":"Thymidylate synthase inhibitor","targetName":"Thymidylate synthase"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000188229","diseaseId":"EFO_0004252","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03708822%22"}],"ancestors":["MONDO_0004821","EFO_0000684","EFO_0003853","MONDO_0023370","EFO_0005950","MONDO_0004867","EFO_0008549","MONDO_0021246","OTAR_0000010","MONDO_0045024","MONDO_0020592","EFO_0000616"],"label":"nasopharyngeal neoplasm","approvedSymbol":"TUBB4B","approvedName":"tubulin beta 4B class IVb","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000261456","diseaseId":"EFO_0004252","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02012062%22"}],"ancestors":["MONDO_0004821","EFO_0000684","EFO_0003853","MONDO_0023370","EFO_0005950","MONDO_0004867","EFO_0008549","MONDO_0021246","OTAR_0000010","MONDO_0045024","MONDO_0020592","EFO_0000616"],"label":"nasopharyngeal neoplasm","approvedSymbol":"TUBB8","approvedName":"tubulin beta 8 class VIII","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL4297829","targetId":"ENSG00000188389","diseaseId":"EFO_0004252","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04872582%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04072107%22"}],"ancestors":["MONDO_0004821","EFO_0000684","EFO_0003853","MONDO_0023370","EFO_0005950","MONDO_0004867","EFO_0008549","MONDO_0021246","OTAR_0000010","MONDO_0045024","MONDO_0020592","EFO_0000616"],"label":"nasopharyngeal neoplasm","approvedSymbol":"PDCD1","approvedName":"programmed cell death 1","targetClass":["Surface antigen"],"prefName":"SINTILIMAB","tradeNames":["Tyvyt"],"synonyms":["ANTI-PD-1 MONOCLONAL ANTIBODY IBI308","IBI-308","IBI308","Ibi308","Sintilimab"],"drugType":"Antibody","mechanismOfAction":"Programmed cell death protein 1 antagonist","targetName":"Programmed cell death protein 1"}
{"drugId":"CHEMBL571","targetId":"ENSG00000073756","diseaseId":"EFO_0004253","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00599664%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00857090%22"}],"ancestors":["MONDO_0024647","EFO_0009690","EFO_0003086"],"label":"nephrolithiasis","approvedSymbol":"PTGS2","approvedName":"prostaglandin-endoperoxide synthase 2","targetClass":["Enzyme"],"prefName":"KETOPROFEN","tradeNames":["Actron","Alrheumat","Axorid","Fenoket 200","Jomethid xl","Ketocid 200","Ketonal","Ketoprofen","Ketotard 200 xl","Ketovail","Ketozip 200 xl","Larafen","Larafen cr","Nexcede","Orudis","Orudis 100","Orudis kt","Oruvail","Oruvail 100","Oruvail 150","Oruvail 200","Oruvail im","Powergel","Tiloket","Tiloket cr","Valket 200 retard"],"synonyms":["(rs)-ketoprofen","19583RP","Actron ketoprofen","Aneol","Capisten","Hydratropic acid, m-benzoyl-","IDEA-033","Iso-k","Ketoprofen","Ketorin","NSC-758144","R.P. 19,583","R.P. 19583","RP-19583","RU-4733","Sector"],"drugType":"Small molecule","mechanismOfAction":"Cyclooxygenase inhibitor","targetName":"Cyclooxygenase"}
{"drugId":"CHEMBL1364144","targetId":"ENSG00000113580","diseaseId":"EFO_0004255","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40e871a8-98ea-46bd-a593-ab800da186b4"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=18dacdba-793c-490d-aa73-9e76bec41fae"}],"ancestors":["EFO_0009690","EFO_0003086","MONDO_0002331"],"label":"nephrotic syndrome","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"METHYLPREDNISOLONE ACETATE","tradeNames":["Depmedalone","Depo-medrol","Depo-medrone","M-predrol","Medrol","Medrol acetate","Methylprednisolone acetate","Neo-medrone"],"synonyms":["Methyl prednisolone acetate","Methylprednisolone 21-acetate","Methylprednisolone acetate","NSC-48985"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL637","targetId":"ENSG00000103546","diseaseId":"EFO_0004262","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5745dd13-8e25-f87e-e053-2991aa0af01d"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=516e7566-35c2-4a25-88d8-54d9dbc8f6be"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0006788","EFO_0000618","EFO_0009386"],"label":"panic disorder","approvedSymbol":"SLC6A2","approvedName":"solute carrier family 6 member 2","targetClass":["Transporter"],"prefName":"VENLAFAXINE","tradeNames":["Alventa xl","Amphero xl","Bonilux xl","Depefex xl","Efexor","Efexor xl","Foraven xl","Mentaven xl","Politid xl","Ranfaxine xl","Rodomel xl","Sunveniz xl","Tardcaps xl","Tifaxin xl","Tonpular xl","Trixat xl","Vaxalin xl","Venaxx xl","Venlablue xl","Venladex xl","Venlalic xl","Venlaneo xl","Vensir xl","Vexarin xl","Viepax","Viepax xl","Winfex xl"],"synonyms":["Efectin","Effexor","Kanghong","NSC-758676","Trevilor","Velafax","Venlafaxine","Venlor"],"drugType":"Small molecule","mechanismOfAction":"Norepinephrine transporter inhibitor","targetName":"Norepinephrine transporter"}
{"drugId":"CHEMBL1068","targetId":"ENSG00000183873","diseaseId":"EFO_0004263","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00050934%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00908349%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00772603%22"}],"ancestors":["EFO_0000474","EFO_0005774","EFO_0000618","EFO_0009386"],"label":"partial epilepsy","approvedSymbol":"SCN5A","approvedName":"sodium voltage-gated channel alpha subunit 5","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"OXCARBAZEPINE","tradeNames":["Oxcarbazepine","Oxtellar xr","Trileptal"],"synonyms":["GP-47680","KIN-493","NSC-758693","Oxcarbamazepine","Oxcarbazepine","SPN-804"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL1451","targetId":"ENSG00000113580","diseaseId":"EFO_0004264","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00370630%22"}],"ancestors":["EFO_0000319"],"label":"vascular disease","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"TRIAMCINOLONE","tradeNames":["Aristocort","Aristocort A","Delphicort","Kenacort","Kenalog","Triamcinolone","Volon"],"synonyms":["Fluoxiprednisolone","NSC-13397","Triamcinolone"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL1201182","targetId":"ENSG00000088832","diseaseId":"EFO_0004265","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03942601%22"}],"ancestors":["MONDO_0000473","MONDO_0002277","EFO_0003875","EFO_0009085","EFO_0004264","EFO_0009086","EFO_0000319","EFO_0003914"],"label":"peripheral arterial disease","approvedSymbol":"FKBP1A","approvedName":"FKBP prolyl isomerase 1A","targetClass":["Enzyme"],"prefName":"TEMSIROLIMUS","tradeNames":["Torisel"],"synonyms":["CCI-779","Temsirolimus"],"drugType":"Small molecule","mechanismOfAction":"FK506-binding protein 1A inhibitor","targetName":"FK506-binding protein 1A"}
{"drugId":"CHEMBL1280","targetId":"ENSG00000151067","diseaseId":"EFO_0004269","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=92f7adf1-cb8c-4c6e-95d1-9afd28fe5116"}],"ancestors":["EFO_0003777","EFO_0000319"],"label":"cardiac arrhythmia","approvedSymbol":"CACNA1C","approvedName":"calcium voltage-gated channel subunit alpha1 C","targetClass":["Ion channel"],"prefName":"VERAPAMIL HYDROCHLORIDE","tradeNames":["Berkatens","Calan","Calan sr","Cordilox","Cordilox i.v.","Cordilox mr 240","Covera","Covera-hs","Ethimil mr 240","Geangin","Half securon sr","Isoptin","Isoptin Sr","Manidon sr","Ranvera mr","Securon","Securon iv","Securon mid","Securon sr","Univer","Vera-til sr","Verapamil hydrochloride","Verapress mr 240","Verelan","Verelan pm","Vertab sr 240","Zolvera"],"synonyms":["CP-16533-1","LU-20175","NSC-272366","NSC-657799","Verapamil hcl","Verapamil hydrochloride","Verapamili hydrochloridum"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated L-type calcium channel blocker","targetName":"Voltage-gated L-type calcium channel"}
{"drugId":"CHEMBL2111110","targetId":"ENSG00000140015","diseaseId":"EFO_0004269","phase":0,"urls":[{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=C01BD06"}],"ancestors":["EFO_0003777","EFO_0000319"],"label":"cardiac arrhythmia","approvedSymbol":"KCNH5","approvedName":"potassium voltage-gated channel subfamily H member 5","targetClass":["Ion channel"],"prefName":"TEDISAMIL","tradeNames":[],"synonyms":["KC-8857","KC8857","Tedisamil"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated potassium channel blocker","targetName":"Voltage-gated potassium channel"}
{"drugId":"CHEMBL558","targetId":"ENSG00000136546","diseaseId":"EFO_0004269","phase":4,"urls":[{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=C01BB02"}],"ancestors":["EFO_0003777","EFO_0000319"],"label":"cardiac arrhythmia","approvedSymbol":"SCN7A","approvedName":"sodium voltage-gated channel alpha subunit 7","targetClass":["Ion channel"],"prefName":"MEXILETINE","tradeNames":[],"synonyms":["(rs)-mexiletine","Dl-mexiletine","Mexiletine"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL1164729","targetId":"ENSG00000158125","diseaseId":"EFO_0004274","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02246673%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02287818%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01712204%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04155918%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00174941%22"}],"ancestors":["EFO_0000589","EFO_0004260","OTAR_0000006","EFO_0009676","EFO_1000999","MONDO_0002614","OTAR_0000020","EFO_0005755","EFO_0002461","EFO_1001986","EFO_0005856"],"label":"gout","approvedSymbol":"XDH","approvedName":"xanthine dehydrogenase","targetClass":["Enzyme"],"prefName":"FEBUXOSTAT","tradeNames":["Adenuric","Uloric"],"synonyms":["Febuxostat","NSC-758874","TMX-67"],"drugType":"Small molecule","mechanismOfAction":"Xanthine dehydrogenase inhibitor","targetName":"Xanthine dehydrogenase"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000137267","diseaseId":"EFO_0004281","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002903%22"}],"ancestors":["EFO_0003863","MONDO_0023370","EFO_0009690","MONDO_0045024","MONDO_0021066","EFO_0000616"],"label":"testicular neoplasm","approvedSymbol":"TUBB2A","approvedName":"tubulin beta 2A class IIa","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL553025","targetId":"ENSG00000104833","diseaseId":"EFO_0004284","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01020864%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"upper aerodigestive tract neoplasm","approvedSymbol":"TUBB4A","approvedName":"tubulin beta 4A class IVa","targetClass":["Structural protein"],"prefName":"VINORELBINE","tradeNames":[],"synonyms":["NSC-760087","Navelbin","Vinorelbine","Vinorelbine Base"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1201657","targetId":"ENSG00000117601","diseaseId":"EFO_0004286","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01072955%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01072747%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01448746%22"}],"ancestors":["EFO_0004264","EFO_0000319"],"label":"venous thromboembolism","approvedSymbol":"SERPINC1","approvedName":"serpin family C member 1","targetClass":["Enzyme","Secreted protein"],"prefName":"HEPARIN SODIUM","tradeNames":["Heparin lock flush","Heparin sodium","Heparin sodium preservative free","Lipo-hepin","Liquaemin lock flush","Liquaemin sodium","Liquaemin sodium preservative free","Multiparin","Panheprin","Pump-hep","Sodium heparin","Thrombophob","Unihep","Uniparin","Uniparin fte"],"synonyms":["Crude heparin","Crude heparin porcine","Heparin sodium","Heparin sodium porcine","Heparin sodium unfractionated","Heparin sodium, porcine","Heparinum natricum","Liquemin sodium","S01XA14","Sodium heparin"],"drugType":"Oligosaccharide","mechanismOfAction":"Antithrombin-III activator","targetName":"Antithrombin-III"}
{"drugId":"CHEMBL1421","targetId":"ENSG00000125508","diseaseId":"EFO_0004289","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01643603%22"}],"ancestors":["OTAR_0000006","EFO_0009676","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0005374","EFO_0002461","MONDO_0044881","MONDO_0045024","EFO_0001642","EFO_0000540","EFO_0000565","EFO_0005803","EFO_0000616"],"label":"lymphoid leukemia","approvedSymbol":"SRMS","approvedName":"src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites","targetClass":["Enzyme"],"prefName":"DASATINIB","tradeNames":["Dasatinib","Sprycel"],"synonyms":["BMS-354825","BMS-354825 HYDRATE","BMS-354825-03","Dasatinib","Dasatinib anhydrous","Dasatinib hydrate","Dasatinib monohydrate","NSC-759877"],"drugType":"Small molecule","mechanismOfAction":"SRC inhibitor","targetName":"SRC"}
{"drugId":"CHEMBL3","targetId":"ENSG00000160716","diseaseId":"EFO_0004319","phase":4,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02918500%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03072511%22"}],"ancestors":["GO_0008150","GO_0007610"],"label":"smoking cessation","approvedSymbol":"CHRNB2","approvedName":"cholinergic receptor nicotinic beta 2 subunit","targetClass":["Ion channel"],"prefName":"NICOTINE","tradeNames":["Habitrol","Nicabate","Nicoderm","Nicoderm cq","Nicopass","Nicopatch","Nicorette invisi","Nicotine","Nicotinell classic","Nicotinell support","Nicotinell tts 10","Nicotinell tts 20","Nicotinell tts 30","Nicotrol","Nicotrol Inhaler","Nicotrol NS","Niquitin","Niquitin clr","Niquitin minis cherry","Niquitin minis mint","Niquitin minis orange","Niquitin mint","Niquitin pre-quit","Niquitin strips mint","Prostep","Stoppers","Stubit"],"synonyms":["Nicotine"],"drugType":"Small molecule","mechanismOfAction":"Neuronal acetylcholine receptor; alpha4/beta2 agonist","targetName":"Neuronal acetylcholine receptor; alpha4/beta2"}
{"drugId":"CHEMBL1714","targetId":"ENSG00000161509","diseaseId":"EFO_0004321","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04763343%22"}],"ancestors":["GO_0008150","EFO_0007623","GO_0007610"],"label":"attempted suicide","approvedSymbol":"GRIN2C","approvedName":"glutamate ionotropic receptor NMDA type subunit 2C","targetClass":["Ion channel"],"prefName":"KETAMINE HYDROCHLORIDE","tradeNames":["Anaket-V","Ketalar","Ketamine hydrochloride","Ketanest","Ketavet","Vetalar"],"synonyms":["CI-581","CL 369","CL-369","CN-52,372-2","CN-52372-2","CN-523722","Ketamine (as hydrochloride)","Ketamine hcl","Ketamine hydrochloride","Ketamine hydrochloride ciii","Ketamini hydrochloridum","Special k","Vetalar"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor negative allosteric modulator","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL1200694","targetId":"ENSG00000100433","diseaseId":"EFO_0004337","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02123355%22"}],"ancestors":["GO_0008150","EFO_0004323","EFO_0003925"],"label":"intelligence","approvedSymbol":"KCNK10","approvedName":"potassium two pore domain channel subfamily K member 10","targetClass":["Ion channel"],"prefName":"SEVOFLURANE","tradeNames":["Sevoflurane","Sojourn","Ultane"],"synonyms":["MR-6S4","MR6S4","NSC-760367","Sevocalm","Sevoflo","Sevoflurane","Sevorane"],"drugType":"Small molecule","mechanismOfAction":"Potassium channel subfamily K member 10 opener","targetName":"Potassium channel subfamily K member 10"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000004779","diseaseId":"EFO_0004566","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00617240%22"}],"ancestors":["HP_0004323","EFO_0000651","HP_0000118","HP_0001507"],"label":"body weight gain","approvedSymbol":"NDUFAB1","approvedName":"NADH:ubiquinone oxidoreductase subunit AB1","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000158864","diseaseId":"EFO_0004593","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03841591%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03320694%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01215331%22"}],"ancestors":["EFO_0000589","EFO_0001379","OTAR_0000014","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","MONDO_0700003","EFO_0009682","EFO_0010282"],"label":"gestational diabetes","approvedSymbol":"NDUFS2","approvedName":"NADH:ubiquinone oxidoreductase core subunit S2","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000137806","diseaseId":"EFO_0004593","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01280409%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01240785%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01563120%22"}],"ancestors":["EFO_0000589","EFO_0001379","OTAR_0000014","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","MONDO_0700003","EFO_0009682","EFO_0010282"],"label":"gestational diabetes","approvedSymbol":"NDUFAF1","approvedName":"NADH:ubiquinone oxidoreductase complex assembly factor 1","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1703","targetId":"ENSG00000185633","diseaseId":"EFO_0004593","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02980276%22"}],"ancestors":["EFO_0000589","EFO_0001379","OTAR_0000014","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","MONDO_0700003","EFO_0009682","EFO_0010282"],"label":"gestational diabetes","approvedSymbol":"NDUFA4L2","approvedName":"NDUFA4 mitochondrial complex associated like 2","targetClass":["Enzyme"],"prefName":"METFORMIN HYDROCHLORIDE","tradeNames":["Bolamyn sr","Diagemet xl","Fortamet","Glucamet 500","Glucamet 850","Glucient sr","Glucophage","Glucophage sr","Glucophage xr","Glumetza","Glyformin","Janumet","Ledermetin","Metabet sr","Metformin hydrochloride","Metsol","Milform","Orabet","Riomet","Riomet er","Sukkarto sr"],"synonyms":["Apophage","Benofomin","Diabefagos","Diabex","EX-404","EX404","Glucaminol","LA-6023","Metformin hcl","Metformin hydrochloride","NSC-91485","Neodipa","Siamformet","Walaphage"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1077896","targetId":"ENSG00000196876","diseaseId":"EFO_0004616","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00562627%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00901628%22"}],"ancestors":["EFO_0004260","OTAR_0000006","EFO_0009676","EFO_1000999","MONDO_0002614","EFO_0005755","EFO_0002461","EFO_1001986","EFO_0005856","MONDO_0005178"],"label":"osteoarthritis, knee","approvedSymbol":"SCN8A","approvedName":"sodium voltage-gated channel alpha subunit 8","targetClass":["Unclassified protein","Auxiliary transport protein","Ion channel"],"prefName":"ROPIVACAINE","tradeNames":[],"synonyms":["Ropivacaine","Ropivicaine","TLC-590","TLC590","Tlc590"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL1077896","targetId":"ENSG00000136531","diseaseId":"EFO_0004616","phase":4,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05336968%22"}],"ancestors":["EFO_0004260","OTAR_0000006","EFO_0009676","EFO_1000999","MONDO_0002614","EFO_0005755","EFO_0002461","EFO_1001986","EFO_0005856","MONDO_0005178"],"label":"osteoarthritis, knee","approvedSymbol":"SCN2A","approvedName":"sodium voltage-gated channel alpha subunit 2","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"ROPIVACAINE","tradeNames":[],"synonyms":["Ropivacaine","Ropivicaine","TLC-590","TLC590","Tlc590"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL679","targetId":"ENSG00000171873","diseaseId":"EFO_0004616","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00901628%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02462148%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00562627%22"}],"ancestors":["EFO_0004260","OTAR_0000006","EFO_0009676","EFO_1000999","MONDO_0002614","EFO_0005755","EFO_0002461","EFO_1001986","EFO_0005856","MONDO_0005178"],"label":"osteoarthritis, knee","approvedSymbol":"ADRA1D","approvedName":"adrenoceptor alpha 1D","targetClass":["Membrane receptor"],"prefName":"EPINEPHRINE","tradeNames":["Adren co","Adrenaclick","Adrenalin","Ana-Kit","Ana-guard","Anapen","Anaphylactic shock drug kit","Asma-vydrin","Asthmahaler","Auvi-q","Bronkaid mist","Brovon","Emerade","Epi e z pen jr","Epinephrine","Epinephrine (copackaged)","Epipen","Epipen e z pen","Epipen jr","Epipen jr.","Eppy","Gppe inh soln","Jext","Medihaler-epi","Primatene","Primatene mist","Riddobron","Riddofan","Rybarvin","Simplene","Soln made to rybarvin for","Sus-Phrine","Sus-Phrine Sulfite-Free","Sus-phrine sulfite free","Symjepi","Twinject 0.15","Twinject 0.3"],"synonyms":["(-)-(r)-epinephrine","(-)-epinephrine","Adrenaline","Adrenalinum","Epinephrine","Epinephrine hcl","Epinephrine hydrochloride","Epinephrinum","Glauposine","L-epinephrine hydrochloride","Levo-methylaminoethanolcatechol","NSC-62786","Nephridine","Racepinefrine, (r)-","Sus-phrine sulphite-free","Susphrine","Tonogen","Twinject"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor agonist","targetName":"Adrenergic receptor"}
{"drugId":"CHEMBL312443","targetId":"ENSG00000166206","diseaseId":"EFO_0004698","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00266344%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0008568","EFO_0000618","EFO_0009386"],"label":"insomnia","approvedSymbol":"GABRB3","approvedName":"gamma-aminobutyric acid type A receptor subunit beta3","targetClass":["Ion channel"],"prefName":"GABOXADOL","tradeNames":[],"synonyms":["Gaboxadol","LU 02-030","LU-02-030","LU-02030","MK-0928","NSC-759585"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; agonist GABA site agonist","targetName":"GABA-A receptor; agonist GABA site"}
{"drugId":"CHEMBL778","targetId":"ENSG00000184160","diseaseId":"EFO_0004698","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02818569%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0008568","EFO_0000618","EFO_0009386"],"label":"insomnia","approvedSymbol":"ADRA2C","approvedName":"adrenoceptor alpha 2C","targetClass":["Membrane receptor"],"prefName":"DEXMEDETOMIDINE","tradeNames":["Precedex"],"synonyms":["Dexmedetomidine","MPV-1440","Medetomidine, (s)-"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor alpha-2 agonist","targetName":"Adrenergic receptor alpha-2"}
{"drugId":"CHEMBL2103741","targetId":"ENSG00000151090","diseaseId":"EFO_0004705","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02917863%22"}],"ancestors":["EFO_0001379","EFO_1000627"],"label":"hypothyroidism","approvedSymbol":"THRB","approvedName":"thyroid hormone receptor beta","targetClass":["Transcription factor"],"prefName":"LEVOTHYROXINE SODIUM","tradeNames":["Eltroxin","Euthyrox","Evotrox","L-thyroxine henning","Levo-t","Levolet","Levothroid","Levothyroid","Levothyroxine sodium","Levoxine","Levoxyl","Novothyrox","Soloxine","Synthroid","Thyquidity","Thyro-tabs","Thyrol L","Thyroxine","Tirosint","Tirosint-sol","Unithroid"],"synonyms":["Eferox","Levaxin","Levothyrox","Levothyroxine sodium","Levothyroxine sodium anhydrous","Levothyroxine sodium hydrate","Liotrix (t4)","Monosodium l-thyroxine hydrate","NSC-259940","Oroxine","Soloxine","T4","T4 (liotrix)","Thyroxine","Thyroxine sodium","Thyroxine sodium salt"],"drugType":"Small molecule","mechanismOfAction":"Thyroid hormone receptor agonist","targetName":"Thyroid hormone receptor"}
{"drugId":"CHEMBL538943","targetId":"ENSG00000188229","diseaseId":"EFO_0004708","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00302003%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0005741","MONDO_0009348","MONDO_0044881","MONDO_0045024","EFO_0000183","Orphanet_322126","MONDO_0100336","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0100321","MONDO_0021669","EFO_0000508","MONDO_0019044","MONDO_0017342","MONDO_0017341","EFO_0005803","MONDO_0017343","EFO_0000616"],"label":"nodular sclerosis Hodgkin lymphoma","approvedSymbol":"TUBB4B","approvedName":"tubulin beta 4B class IVb","targetClass":["Structural protein"],"prefName":"VINORELBINE TARTRATE","tradeNames":["Navelbine","Vinorelbine tartrate"],"synonyms":["Liposomal vinorelbine tartrate","TLC-178","TLC178","Vinorelbine (as tartrate)","Vinorelbine Ditartarate","Vinorelbine ditartrate","Vinorelbine liposomal","Vinorelbine tartrate","Vinorelbine tartrate (1:2)"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1201101","targetId":"ENSG00000169083","diseaseId":"EFO_0004714","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01096329%22"}],"ancestors":["HP_0000708","HP_0012638","EFO_0000651","HP_0000118","HP_0000707"],"label":"sexual dysfunction","approvedSymbol":"AR","approvedName":"androgen receptor","targetClass":["Transcription factor","Unclassified protein"],"prefName":"TESTOSTERONE CYPIONATE","tradeNames":["Andro-Cyp","Depandro","Depo-testosterone","Depotest","Testosterone","Testosterone cypionate"],"synonyms":["Depo-Testadiol","NSC-9157","Testosterone 17.beta.-cyclopentanepropionate","Testosterone cipionate","Testosterone cyclopentylpropionate","Testosterone cypionate","Testosterone cypionate ciii"],"drugType":"Small molecule","mechanismOfAction":"Androgen Receptor agonist","targetName":"Androgen Receptor"}
{"drugId":"CHEMBL1201823","targetId":"ENSG00000121594","diseaseId":"EFO_0004719","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05303272%22"}],"ancestors":["EFO_1000749","EFO_0005140","EFO_0008598","EFO_0000701","EFO_0005809","EFO_0000540","EFO_1000774","MONDO_0002406","EFO_0010285","EFO_1002003"],"label":"pemphigus vulgaris","approvedSymbol":"CD80","approvedName":"CD80 molecule","targetClass":["Surface antigen"],"prefName":"ABATACEPT","tradeNames":["Orencia","Orencia clickject"],"synonyms":["Abatacept","Abatacept (genetical recombination)","Abatacept recombinant","BMS-188667","CTLA4-IGG4M","RG-1046","RG-2077"],"drugType":"Protein","mechanismOfAction":"T-lymphocyte activation antigen CD80 inhibitor","targetName":"T-lymphocyte activation antigen CD80"}
{"drugId":"CHEMBL1643895","targetId":"ENSG00000178084","diseaseId":"EFO_0004888","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02478645%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02480088%22"}],"ancestors":["HP_0025031","HP_0002017","EFO_0000651","EFO_0003765","EFO_0005323","HP_0011458","HP_0000118"],"label":"post operative nausea and vomiting","approvedSymbol":"HTR3C","approvedName":"5-hydroxytryptamine receptor 3C","targetClass":["Ion channel"],"prefName":"RAMOSETRON","tradeNames":[],"synonyms":["Ramosetron"],"drugType":"Small molecule","mechanismOfAction":"Serotonin 3 (5-HT3) receptor antagonist","targetName":"Serotonin 3 (5-HT3) receptor"}
{"drugId":"CHEMBL354077","targetId":"ENSG00000156486","diseaseId":"EFO_0004991","phase":3,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03579966%22"}],"ancestors":["EFO_0005140","EFO_0009387","MONDO_0002977","MONDO_0020124","EFO_0003100","MONDO_0020125","MONDO_0000590","EFO_0005809","EFO_0000540","MONDO_0015923","EFO_1001902","EFO_0004149","EFO_0000618","EFO_1002003","MONDO_0018743"],"label":"Myasthenia gravis","approvedSymbol":"KCNS2","approvedName":"potassium voltage-gated channel modifier subfamily S member 2","targetClass":["Ion channel"],"prefName":"AMIFAMPRIDINE","tradeNames":["Ruzurgi"],"synonyms":["3,4-DAP","3,4-Diammoniopyridinium","4-DAP","Amifampridine","DAP","Dynamine","NSC-521760","Pyridine-3,4-Diamine"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated potassium channel blocker","targetName":"Voltage-gated potassium channel"}
{"drugId":"CHEMBL628","targetId":"ENSG00000105650","diseaseId":"EFO_0004997","phase":3,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05487755%22"}],"ancestors":["EFO_0000589","EFO_0000401","EFO_0003884","OTAR_0000020","EFO_0009690","EFO_0003086"],"label":"type 2 diabetes nephropathy","approvedSymbol":"PDE4C","approvedName":"phosphodiesterase 4C","targetClass":["Enzyme"],"prefName":"PENTOXIFYLLINE","tradeNames":["Neotren mr","Pentoxifylline","Pentoxil","Trental","Trental 100","Trental 400"],"synonyms":["BL 191","BL-191","C04AD03","NSC-637086","NSC-758481","Oxpentifylline","Oxypentifylline","Pentoxifylline","Pentoxiphyllin"],"drugType":"Small molecule","mechanismOfAction":"3',5'-cyclic phosphodiesterase inhibitor","targetName":"3',5'-cyclic phosphodiesterase"}
{"drugId":"CHEMBL888","targetId":"ENSG00000146143","diseaseId":"EFO_0005088","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00936936%22"}],"ancestors":["OTAR_0000017","EFO_0009555","MONDO_0024582","EFO_0007355","EFO_0009601","MONDO_0002259","MONDO_0002149","MONDO_0023370","EFO_1000051","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0000313","MONDO_0021348","EFO_0001379","EFO_0006858","EFO_0000616"],"label":"testicular carcinoma","approvedSymbol":"PRIM2","approvedName":"DNA primase subunit 2","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL3301595","targetId":"ENSG00000103546","diseaseId":"EFO_0005203","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02564588%22"}],"ancestors":["EFO_0000589","EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0001069","OTAR_0000020","EFO_0000618","EFO_0009386"],"label":"eating disorder","approvedSymbol":"SLC6A2","approvedName":"solute carrier family 6 member 2","targetClass":["Transporter"],"prefName":"DASOTRALINE","tradeNames":[],"synonyms":["(1r,4s)-trans-norsertraline","Dasotraline","Norsertraline, (1r,4s)-trans-","SEP-225289"],"drugType":"Small molecule","mechanismOfAction":"Monoamine transporter inhibitor","targetName":"Monoamine transporter"}
{"drugId":"CHEMBL778","targetId":"ENSG00000150594","diseaseId":"EFO_0005207","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03425734%22"}],"ancestors":["OTAR_0000018","EFO_0003777","MONDO_0024239","EFO_0000319"],"label":"congenital heart disease","approvedSymbol":"ADRA2A","approvedName":"adrenoceptor alpha 2A","targetClass":["Membrane receptor"],"prefName":"DEXMEDETOMIDINE","tradeNames":["Precedex"],"synonyms":["Dexmedetomidine","MPV-1440","Medetomidine, (s)-"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor alpha-2 agonist","targetName":"Adrenergic receptor alpha-2"}
{"drugId":"CHEMBL888","targetId":"ENSG00000100479","diseaseId":"EFO_0005221","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04480190%22"}],"ancestors":["MONDO_0003059","MONDO_0024276","MONDO_0002665","MONDO_0002887","EFO_0009534","MONDO_0021069","MONDO_0003193","EFO_0003891","MONDO_0024477","MONDO_0021385","MONDO_0021662","MONDO_0021321","EFO_0003769","EFO_0000313","MONDO_0003060","EFO_0001421","EFO_0006858","EFO_0000616","EFO_0005540","MONDO_0023370","MONDO_0018918","MONDO_0045024","MONDO_0004992","MONDO_0002691","EFO_0008550","MONDO_0018536","EFO_1000218","EFO_0000228","EFO_0001379","MONDO_0003090","EFO_0008549","MONDO_0002516","MONDO_0018532","EFO_0010284","MONDO_0018531","EFO_0010282"],"label":"cholangiocarcinoma","approvedSymbol":"POLE2","approvedName":"DNA polymerase epsilon 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL888","targetId":"ENSG00000106628","diseaseId":"EFO_0005221","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02548195%22"}],"ancestors":["MONDO_0003059","MONDO_0024276","MONDO_0002665","MONDO_0002887","EFO_0009534","MONDO_0021069","MONDO_0003193","EFO_0003891","MONDO_0024477","MONDO_0021385","MONDO_0021662","MONDO_0021321","EFO_0003769","EFO_0000313","MONDO_0003060","EFO_0001421","EFO_0006858","EFO_0000616","EFO_0005540","MONDO_0023370","MONDO_0018918","MONDO_0045024","MONDO_0004992","MONDO_0002691","EFO_0008550","MONDO_0018536","EFO_1000218","EFO_0000228","EFO_0001379","MONDO_0003090","EFO_0008549","MONDO_0002516","MONDO_0018532","EFO_0010284","MONDO_0018531","EFO_0010282"],"label":"cholangiocarcinoma","approvedSymbol":"POLD2","approvedName":"DNA polymerase delta 2, accessory subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1175","targetId":"ENSG00000103546","diseaseId":"EFO_0005230","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00475969%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00122850%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00122837%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00122863%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00122824%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00114127%22"}],"ancestors":["HP_0000708","HP_0012638","EFO_0000651","HP_0000118","HP_0000707"],"label":"anxiety","approvedSymbol":"SLC6A2","approvedName":"solute carrier family 6 member 2","targetClass":["Transporter"],"prefName":"DULOXETINE","tradeNames":[],"synonyms":["Cymbalta","Duloxetine","LY-248686","LY248686"],"drugType":"Small molecule","mechanismOfAction":"Norepinephrine transporter inhibitor","targetName":"Norepinephrine transporter"}
{"drugId":"CHEMBL2103836","targetId":"ENSG00000081248","diseaseId":"EFO_0005230","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00820794%22"}],"ancestors":["HP_0000708","HP_0012638","EFO_0000651","HP_0000118","HP_0000707"],"label":"anxiety","approvedSymbol":"CACNA1S","approvedName":"calcium voltage-gated channel subunit alpha1 S","targetClass":["Ion channel"],"prefName":"IMAGABALIN","tradeNames":[],"synonyms":["Imagabalin","PD 0332334","PD-0332334","PF-00195889"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated calcium channel modulator","targetName":"Voltage-gated calcium channel"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000125675","diseaseId":"EFO_0005230","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02374567%22"}],"ancestors":["HP_0000708","HP_0012638","EFO_0000651","HP_0000118","HP_0000707"],"label":"anxiety","approvedSymbol":"GRIA3","approvedName":"glutamate ionotropic receptor AMPA type subunit 3","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"Glutamate receptor ionotropic AMPA antagonist","targetName":"Glutamate receptor ionotropic AMPA"}
{"drugId":"CHEMBL655","targetId":"ENSG00000151834","diseaseId":"EFO_0005230","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00942539%22"}],"ancestors":["HP_0000708","HP_0012638","EFO_0000651","HP_0000118","HP_0000707"],"label":"anxiety","approvedSymbol":"GABRA2","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha2","targetClass":["Ion channel"],"prefName":"MIDAZOLAM","tradeNames":["Midazolam in 0.9% sodium chloride","Nayzilam"],"synonyms":["Midazolam","Midazolam civ","USL-261","USL261"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL888","targetId":"ENSG00000101868","diseaseId":"EFO_0005230","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01598584%22"}],"ancestors":["HP_0000708","HP_0012638","EFO_0000651","HP_0000118","HP_0000707"],"label":"anxiety","approvedSymbol":"POLA1","approvedName":"DNA polymerase alpha 1, catalytic subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL888","targetId":"ENSG00000106628","diseaseId":"EFO_0005230","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01598584%22"}],"ancestors":["HP_0000708","HP_0012638","EFO_0000651","HP_0000118","HP_0000707"],"label":"anxiety","approvedSymbol":"POLD2","approvedName":"DNA polymerase delta 2, accessory subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL968","targetId":"ENSG00000151834","diseaseId":"EFO_0005230","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02374567%22"}],"ancestors":["HP_0000708","HP_0012638","EFO_0000651","HP_0000118","HP_0000707"],"label":"anxiety","approvedSymbol":"GABRA2","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha2","targetClass":["Ion channel"],"prefName":"FLURAZEPAM","tradeNames":[],"synonyms":["Dalmane","Flurazepam","Insumin"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL1201752","targetId":"ENSG00000101162","diseaseId":"EFO_0005232","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00095979%22"}],"ancestors":["MONDO_0024276","OTAR_0000017","MONDO_0002654","MONDO_0021251","MONDO_0002149","MONDO_0023370","EFO_1000051","MONDO_0000931","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0000313","EFO_0000228","EFO_0002919","MONDO_0002715","EFO_1001512","EFO_0009549","MONDO_0011962","EFO_0006858","EFO_1001331","EFO_0000616","EFO_0003859"],"label":"endometrium adenocarcinoma","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"IXABEPILONE","tradeNames":["Ixempra","Ixempra kit"],"synonyms":["Azaepothilone b","BMS 247550-01","BMS-247550","BMS-247550-01","Ixabepilone","Ixempra","NSC-747973"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL877","targetId":"ENSG00000122194","diseaseId":"EFO_0005251","phase":0,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03580590%22"}],"ancestors":["MONDO_0000473","EFO_0004264","EFO_0000319"],"label":"hypotension","approvedSymbol":"PLG","approvedName":"plasminogen","targetClass":["Enzyme"],"prefName":"TRANEXAMIC ACID","tradeNames":["Cyklo-f heavy period relief","Cyklokapron","Exacyl","Lysteda","Menstralite","Tranexamic acid"],"synonyms":["Amcha","CL 65336","CL-65336","Cyclo-f","Cyclocapron","Cyclokapron","Espercil","Femstrual","Haematrix","LB-1148","LB1148","NSC-291305","RP-18429","Rikavarin","TRANS AMCHA","TRANS-AMCHA","Tranexamic acid","Trans AMCHA","Transamin"],"drugType":"Small molecule","mechanismOfAction":"Plasminogen inhibitor","targetName":"Plasminogen"}
{"drugId":"CHEMBL1200461","targetId":"ENSG00000171873","diseaseId":"EFO_0005252","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01515865%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00555880%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00046475%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01518946%22"}],"ancestors":["EFO_0005251","MONDO_0000473","EFO_0004264","EFO_0000319"],"label":"orthostatic hypotension","approvedSymbol":"ADRA1D","approvedName":"adrenoceptor alpha 1D","targetClass":["Membrane receptor"],"prefName":"MIDODRINE HYDROCHLORIDE","tradeNames":["Bramox","Gutron","Midodrine hydrochloride","Midon","Orvaten","Proamatine"],"synonyms":["A-4020 LINZ","Amatine","Hipertan","Metligine","Midodrine hcl","Midodrine hydrochloride","Midodrine monohydrochloride","NSC-758429","ST 1085 HYDROCHLORIDE","ST 1085 [AS THE BASE]","ST-1085","ST-1085 BASE","ST-1085 HYDROCHLORIDE","ST-PETER-224","ST. PETER 224","ST1085 HYDROCHLORIDE"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor alpha-1 agonist","targetName":"Adrenergic receptor alpha-1"}
{"drugId":"CHEMBL86","targetId":"ENSG00000164270","diseaseId":"EFO_0005252","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00748059%22"}],"ancestors":["EFO_0005251","MONDO_0000473","EFO_0004264","EFO_0000319"],"label":"orthostatic hypotension","approvedSymbol":"HTR4","approvedName":"5-hydroxytryptamine receptor 4","targetClass":["Membrane receptor"],"prefName":"METOCLOPRAMIDE","tradeNames":[],"synonyms":["Clopra","Clopra-\"Yellow\"","Elieten","Maxolon","Methoxyclopramide","Metoclopramide","Reglan","Terperan"],"drugType":"Small molecule","mechanismOfAction":"Serotonin 4 (5-HT4) receptor agonist","targetName":"Serotonin 4 (5-HT4) receptor"}
{"drugId":"CHEMBL681","targetId":"ENSG00000094755","diseaseId":"EFO_0005323","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02224443%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02134093%22"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"post-operative sign or symptom","approvedSymbol":"GABRP","approvedName":"gamma-aminobutyric acid type A receptor subunit pi","targetClass":["Ion channel"],"prefName":"ETOMIDATE","tradeNames":["Amidate","Etomidate"],"synonyms":["Etomidate","Hypnomidate","NSC-759160"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL1112","targetId":"ENSG00000178394","diseaseId":"EFO_0005407","phase":4,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01844700%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02357849%22"}],"ancestors":["EFO_0000677","MONDO_0002025","MONDO_0002039","EFO_0005774","EFO_0000618","EFO_0009386"],"label":"psychosis","approvedSymbol":"HTR1A","approvedName":"5-hydroxytryptamine receptor 1A","targetClass":["Membrane receptor"],"prefName":"ARIPIPRAZOLE","tradeNames":["Abilify","Abilify maintena","Abilify maintena kit","Abilify mycite kit","Aripiprazole"],"synonyms":["Abilify mycite","Aripiprazole","Aripiprex","NSC-759266","OPC-14597","OPC-31"],"drugType":"Small molecule","mechanismOfAction":"Serotonin 1a (5-HT1a) receptor partial agonist","targetName":"Serotonin 1a (5-HT1a) receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000267855","diseaseId":"EFO_0005411","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00401973%22"}],"ancestors":["EFO_0000677","MONDO_0002025","MONDO_0002039","EFO_0005774","EFO_0000618","EFO_0005407","EFO_0009386"],"label":"schizoaffective disorder","approvedSymbol":"NDUFA7","approvedName":"NADH:ubiquinone oxidoreductase subunit A7","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL14376","targetId":"ENSG00000149295","diseaseId":"EFO_0005411","phase":4,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01929889%22"}],"ancestors":["EFO_0000677","MONDO_0002025","MONDO_0002039","EFO_0005774","EFO_0000618","EFO_0005407","EFO_0009386"],"label":"schizoaffective disorder","approvedSymbol":"DRD2","approvedName":"dopamine receptor D2","targetClass":["Membrane receptor"],"prefName":"ILOPERIDONE","tradeNames":["Fanapt","Iloperidone"],"synonyms":["HP 873","HP-873","Iloperidone"],"drugType":"Small molecule","mechanismOfAction":"Dopamine D2 receptor antagonist","targetName":"Dopamine D2 receptor"}
{"drugId":"CHEMBL3188993","targetId":"ENSG00000102468","diseaseId":"EFO_0005411","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00206102%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00325689%22"}],"ancestors":["EFO_0000677","MONDO_0002025","MONDO_0002039","EFO_0005774","EFO_0000618","EFO_0005407","EFO_0009386"],"label":"schizoaffective disorder","approvedSymbol":"HTR2A","approvedName":"5-hydroxytryptamine receptor 2A","targetClass":["Membrane receptor"],"prefName":"QUETIAPINE FUMARATE","tradeNames":["Quetiapine fumarate","Seroquel","Seroquel xr"],"synonyms":["FK-947E","FK947E","ICI 204,636","ICI-204636","Quetiapine (as fumarate)","Quetiapine fumarate","Quetiapine hemifumarate","Utapine","ZD-5077","ZD5077","ZM 204,636","ZM-204636"],"drugType":"Small molecule","mechanismOfAction":"Serotonin 2a (5-HT2a) receptor antagonist","targetName":"Serotonin 2a (5-HT2a) receptor"}
{"drugId":"CHEMBL429317","targetId":"ENSG00000175344","diseaseId":"EFO_0005411","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02978599%22"}],"ancestors":["EFO_0000677","MONDO_0002025","MONDO_0002039","EFO_0005774","EFO_0000618","EFO_0005407","EFO_0009386"],"label":"schizoaffective disorder","approvedSymbol":"CHRNA7","approvedName":"cholinergic receptor nicotinic alpha 7 subunit","targetClass":["Ion channel"],"prefName":"AVL-3288","tradeNames":[],"synonyms":["Anvylic-3288","Avl-3288","CCMI","UCI-4083","XY-4083"],"drugType":"Small molecule","mechanismOfAction":"Neuronal acetylcholine receptor protein alpha-7 subunit positive allosteric modulator","targetName":"Neuronal acetylcholine receptor protein alpha-7 subunit"}
{"drugId":"CHEMBL660","targetId":"ENSG00000105464","diseaseId":"EFO_0005411","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00401973%22"}],"ancestors":["EFO_0000677","MONDO_0002025","MONDO_0002039","EFO_0005774","EFO_0000618","EFO_0005407","EFO_0009386"],"label":"schizoaffective disorder","approvedSymbol":"GRIN2D","approvedName":"glutamate ionotropic receptor NMDA type subunit 2D","targetClass":["Ion channel"],"prefName":"AMANTADINE","tradeNames":[],"synonyms":["Amantadine","Amantidine","NSC-341865","Symadine","Symmetrel","TCMDC-125869"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor antagonist","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL864","targetId":"ENSG00000196639","diseaseId":"EFO_0005532","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1741b4f2-af49-43fe-8319-7b8a38fa25d2"}],"ancestors":["EFO_0000701","EFO_0005531","MONDO_0019293","MONDO_0002406","EFO_0010285","EFO_0004264","EFO_0000319"],"label":"angioedema","approvedSymbol":"HRH1","approvedName":"histamine receptor H1","targetClass":["Membrane receptor"],"prefName":"CARBINOXAMINE","tradeNames":[],"synonyms":["Carbinoxamine","Clistin","Palgic"],"drugType":"Small molecule","mechanismOfAction":"Histamine H1 receptor antagonist","targetName":"Histamine H1 receptor"}
{"drugId":"CHEMBL1946170","targetId":"ENSG00000128052","diseaseId":"EFO_0005540","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02115542%22"}],"ancestors":["MONDO_0003059","MONDO_0002887","EFO_0009534","MONDO_0021069","EFO_0003891","MONDO_0024477","MONDO_0021662","EFO_0003769","EFO_0000313","MONDO_0003060","EFO_0001421","EFO_0006858","EFO_0000616","MONDO_0023370","MONDO_0045024","MONDO_0004992","MONDO_0002691","EFO_0008550","EFO_1000218","EFO_0001379","EFO_0008549","MONDO_0002516","MONDO_0018531","EFO_0010284","EFO_0010282"],"label":"bile duct carcinoma","approvedSymbol":"KDR","approvedName":"kinase insert domain receptor","targetClass":["Enzyme"],"prefName":"REGORAFENIB","tradeNames":["Stivarga"],"synonyms":["BAY 73-4506","BAY 73-4506 monohydrate","BAY-73-4506","BAY-734506","Regorafenib"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL92","targetId":"ENSG00000261456","diseaseId":"EFO_0005577","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00169182%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00117572%22"}],"ancestors":["MONDO_0000376","MONDO_0023370","EFO_0005950","MONDO_0021246","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0020592","MONDO_0021351","MONDO_0021310","EFO_0000684","EFO_0008549","MONDO_0002516","EFO_0006859","EFO_0000616","EFO_0010282"],"label":"pharynx cancer","approvedSymbol":"TUBB8","approvedName":"tubulin beta 8 class VIII","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":[],"synonyms":["RP-56976","Taxotere"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1200323","targetId":"ENSG00000274286","diseaseId":"EFO_0005669","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00963976%22"}],"ancestors":["MONDO_0043218","EFO_0000551","EFO_0005774","EFO_0003763","EFO_0000618","EFO_0004264","EFO_0009386","EFO_0000319"],"label":"intracerebral hemorrhage","approvedSymbol":"ADRA2B","approvedName":"adrenoceptor alpha 2B","targetClass":["Membrane receptor"],"prefName":"LABETALOL HYDROCHLORIDE","tradeNames":["Labetalol Hydrocloride","Labetalol hydrochloride","Labetalol hydrochloride in dextrose","Labetalol hydrochloride in sodium chloride","Labrocol","Normodyne","Trandate"],"synonyms":["AH 5158A","AH-5158A","AH-5158A HYDROCHLORIDE","Ibidomide hydrochloride","Labetalol hcl","Labetalol hydrochloride","NSC-290312","SCH 15719W","SCH-15719W","SCH-15719W HYDROCHLORIDE"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor antagonist","targetName":"Adrenergic receptor"}
{"drugId":"CHEMBL595","targetId":"ENSG00000132170","diseaseId":"EFO_0005669","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00827892%22"}],"ancestors":["MONDO_0043218","EFO_0000551","EFO_0005774","EFO_0003763","EFO_0000618","EFO_0004264","EFO_0009386","EFO_0000319"],"label":"intracerebral hemorrhage","approvedSymbol":"PPARG","approvedName":"peroxisome proliferator activated receptor gamma","targetClass":["Transcription factor","Unclassified protein","Epigenetic regulator"],"prefName":"PIOGLITAZONE","tradeNames":[],"synonyms":["AD-4833","Actos","Duetact","Glustin","Pioglitazone","U-72107","Zactos"],"drugType":"Small molecule","mechanismOfAction":"Peroxisome proliferator-activated receptor gamma agonist","targetName":"Peroxisome proliferator-activated receptor gamma"}
{"drugId":"CHEMBL2103749","targetId":"ENSG00000180210","diseaseId":"EFO_0005672","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01642238%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03588611%22"}],"ancestors":["MONDO_0000473","EFO_0001645","EFO_0003777","MONDO_0005053","EFO_1001375","EFO_0004264","MONDO_0024643","EFO_0000319"],"label":"acute coronary syndrome","approvedSymbol":"F2","approvedName":"coagulation factor II, thrombin","targetClass":["Enzyme"],"prefName":"BIVALIRUDIN","tradeNames":["Angiomax","Angiomax rtu","Bivalirudin","Bivalirudin in 0.9% sodium chloride"],"synonyms":["BG-8967","BG8967","Bivalirudin"],"drugType":"Protein","mechanismOfAction":"Thrombin inhibitor","targetName":"Thrombin"}
{"drugId":"CHEMBL1690","targetId":"ENSG00000239732","diseaseId":"EFO_0005755","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00946790%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0002461","EFO_1001986"],"label":"rheumatic disease","approvedSymbol":"TLR9","approvedName":"toll like receptor 9","targetClass":["Membrane receptor"],"prefName":"HYDROXYCHLOROQUINE SULFATE","tradeNames":["Ercoquin","Hydroxychloroquine sulfate","Oxichlorochine","Plaquenil","Quensyl","Quinoric"],"synonyms":["Ercoquin","Hydroxychloroquine Sulfate","Hydroxychloroquine sulfate","Hydroxychloroquine sulphate","NSC-4375","Oxichlorochine sulfate","Oxiklorin","Quensyl","TCMDC-123987"],"drugType":"Small molecule","mechanismOfAction":"Toll-like receptor 9 antagonist","targetName":"Toll-like receptor 9"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000164258","diseaseId":"EFO_0005761","phase":4,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04145687%22"}],"ancestors":["EFO_0000540","EFO_1002050","EFO_0009690","EFO_1002003","EFO_0003086","MONDO_0002462","EFO_1002049"],"label":"lupus nephritis","approvedSymbol":"NDUFS4","approvedName":"NADH:ubiquinone oxidoreductase subunit S4","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000178127","diseaseId":"EFO_0005762","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00971295%22"}],"ancestors":["EFO_0003843","EFO_0000651","EFO_0003765"],"label":"neuropathic pain","approvedSymbol":"NDUFV2","approvedName":"NADH:ubiquinone oxidoreductase core subunit V2","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL651","targetId":"ENSG00000112038","diseaseId":"EFO_0005762","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05235191%22"}],"ancestors":["EFO_0003843","EFO_0000651","EFO_0003765"],"label":"neuropathic pain","approvedSymbol":"OPRM1","approvedName":"opioid receptor mu 1","targetClass":["Membrane receptor"],"prefName":"METHADONE","tradeNames":[],"synonyms":["Amidone","Diaminon","Dl-methadone","Dolophin","Dolophine","Heptadon","Heptadone","IDS-NM-002","Metasedin","Methadone","Methadose","Phenadone","Phy","Physeptone","Symoron","Westadone"],"drugType":"Small molecule","mechanismOfAction":"Mu opioid receptor agonist","targetName":"Mu opioid receptor"}
{"drugId":"CHEMBL1504","targetId":"ENSG00000113580","diseaseId":"EFO_0005773","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04701593%22"}],"ancestors":["OTAR_0000018","EFO_0003966","EFO_0000508","EFO_0000618","MONDO_0024458","EFO_0003839"],"label":"retinal detachment","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"TRIAMCINOLONE ACETONIDE","tradeNames":["Adcortyl","Adcortyl in orabase","Allernaze","Aristocort","Aristocort a","Aristogel","Audicort","Aureocort","Azmacort","Flutex","Gppe ear dps cap","Gppe ear oint","Kenacort","Kenalog","Kenalog in orabase","Kenalog-10","Kenalog-40","Kenalog-80","Kenalog-h","Nasacort","Nasacort allergy 24 hour","Nasacort aq","Nasacort hfa","Nystadermal","Oracort","Oralone","Pevaryl t.c.","Remiderm","Remotic","Silderm","Tri-Nasal","Tri-adcortyl","Triacet","Triacort","Triamcinolone acetonide","Triamcinolone acetonide in absorbase","Triatex","Triderm","Triesence","Trivaris","Trymex","Vetalog","Zilretta"],"synonyms":["FX-006","FX006","Kenacourt","NSC-21916","Triamcinolone Acetonide","Triamcinolone acetonide"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL1473","targetId":"ENSG00000113580","diseaseId":"EFO_0005854","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02885025%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00929968%22"}],"ancestors":["MONDO_0000771","EFO_0008521","EFO_0000684","MONDO_0005271","EFO_0000540","MONDO_0004867","OTAR_0000010","EFO_1002003","MONDO_0002232"],"label":"allergic rhinitis","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"FLUTICASONE PROPIONATE","tradeNames":["Aerivio spiromax","Airflusal forspiro","Armonair digihaler","Armonair respiclick","Cutivate","Flixonase","Flixotide","Flonase","Flonase allergy relief","Flovent","Flovent diskus 100","Flovent diskus 250","Flovent diskus 50","Flovent hfa","Fluticasone propionate","Flutiform","Nasofan","Pirinase","Sereflo","Seretide 100","Seretide 125","Seretide 250","Seretide 50","Seretide 500","Sirdupla","Xhance"],"synonyms":["CCI 18781","CCI-18781","FLOVENT","Fluticaps","Fluticasone","Fluticasone propionate","Fluticasone propionate ","Fluticasone-17-propionate","NSC-759889","Opn-375","Optinose","PF-00241939","R01AD08"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL1289601","targetId":"ENSG00000102755","diseaseId":"EFO_0005922","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04949256%22"}],"ancestors":["EFO_0009544","MONDO_0021350","MONDO_0002532","MONDO_0023370","MONDO_0021355","MONDO_0044991","MONDO_0045024","MONDO_0004992","MONDO_0003274","MONDO_0007576","EFO_0000313","EFO_1000218","EFO_0008549","EFO_0000707","MONDO_0002516","EFO_0006858","EFO_0002916","EFO_0010282","EFO_0000616"],"label":"esophageal squamous cell carcinoma","approvedSymbol":"FLT1","approvedName":"fms related receptor tyrosine kinase 1","targetClass":["Enzyme"],"prefName":"LENVATINIB","tradeNames":["Kisplyx","Lenvima"],"synonyms":["E-7080","ER-203492-00","Lenvatinib"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000258947","diseaseId":"EFO_0005922","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01591135%22"}],"ancestors":["EFO_0009544","MONDO_0021350","MONDO_0002532","MONDO_0023370","MONDO_0021355","MONDO_0044991","MONDO_0045024","MONDO_0004992","MONDO_0003274","MONDO_0007576","EFO_0000313","EFO_1000218","EFO_0008549","EFO_0000707","MONDO_0002516","EFO_0006858","EFO_0002916","EFO_0010282","EFO_0000616"],"label":"esophageal squamous cell carcinoma","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000077514","diseaseId":"EFO_0005952","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00825149%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00802113%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"non-Hodgkins lymphoma","approvedSymbol":"POLD3","approvedName":"DNA polymerase delta 3, accessory subunit","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000198056","diseaseId":"EFO_0005952","phase":1,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05400109%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"non-Hodgkins lymphoma","approvedSymbol":"PRIM1","approvedName":"DNA primase subunit 1","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1201576","targetId":"ENSG00000156738","diseaseId":"EFO_0005952","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02356159%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04074330%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03467373%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04673617%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03930953%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"non-Hodgkins lymphoma","approvedSymbol":"MS4A1","approvedName":"membrane spanning 4-domains A1","targetClass":["Ion channel"],"prefName":"RITUXIMAB","tradeNames":["Mabthera","Mabthera rituxan","Rituxan"],"synonyms":["ABP-798","ABP798","Bi-695500","Blitzima","CT-P10","Gp2013","HS-006","HS-006 (RITUXIMAB BIOSIMILAR)","HS006","IDEC-102","IDEC-C2B8","Pf-05280586","R-105 IDEC-102","RG-105","RHCACD20MA","Riabni","Ritemvia","Rituximab","Rituximab (genetical recombination)","Rituximab biosimilar - celltrion","Rituximab-abbs","Rituximab-arrx","Rituximab-boehringer ingelheim","Rituximab-ct-p10","Rituximab-pfizer","Rituximab-pvvr","Ruxience","SAIT-101","SAIT101","Truxima","Tuxella","Usp mab 001, monoclonal igg1","Zuberitamab"],"drugType":"Antibody","mechanismOfAction":"B-lymphocyte antigen CD20 binding agent","targetName":"B-lymphocyte antigen CD20"}
{"drugId":"CHEMBL4297789","targetId":"ENSG00000142676","diseaseId":"EFO_0005952","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03645395%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"non-Hodgkins lymphoma","approvedSymbol":"RPL11","approvedName":"ribosomal protein L11","targetClass":["Unclassified protein"],"prefName":"MT-3724","tradeNames":[],"synonyms":["Mt-3724"],"drugType":"Unknown","mechanismOfAction":"80S Ribosome inhibitor","targetName":"80S Ribosome"}
{"drugId":"CHEMBL888","targetId":"ENSG00000148229","diseaseId":"EFO_0005952","phase":1,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02953509%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"non-Hodgkins lymphoma","approvedSymbol":"POLE3","approvedName":"DNA polymerase epsilon 3, accessory subunit","targetClass":["Unclassified protein"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL888","targetId":"ENSG00000177084","diseaseId":"EFO_0005952","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00163761%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00163748%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00491127%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00276003%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00280878%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"non-Hodgkins lymphoma","approvedSymbol":"POLE","approvedName":"DNA polymerase epsilon, catalytic subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1256786","targetId":"ENSG00000169252","diseaseId":"EFO_0006505","phase":4,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00633776%22"}],"ancestors":["MONDO_0021925","EFO_0009433","EFO_0000684","MONDO_0002567","EFO_0009910","MONDO_0004867","EFO_1002018","OTAR_0000010","EFO_0000341","EFO_0003818","EFO_0009661"],"label":"chronic bronchitis","approvedSymbol":"ADRB2","approvedName":"adrenoceptor beta 2","targetClass":["Membrane receptor"],"prefName":"FORMOTEROL","tradeNames":[],"synonyms":["Foradil","Formoterol"],"drugType":"Small molecule","mechanismOfAction":"Beta-2 adrenergic receptor agonist","targetName":"Beta-2 adrenergic receptor"}
{"drugId":"CHEMBL1201670","targetId":"ENSG00000198223","diseaseId":"EFO_0006544","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00072137%22"}],"ancestors":["MONDO_0004986","MONDO_0023370","EFO_0000294","EFO_0009690","MONDO_0024337","MONDO_0045024","MONDO_0004992","MONDO_0021066","MONDO_0001187","MONDO_0037254","EFO_0000313","EFO_0008528","EFO_1000363","EFO_1000601","EFO_0006858","EFO_1000018","EFO_0000616"],"label":"bladder transitional cell carcinoma","approvedSymbol":"CSF2RA","approvedName":"colony stimulating factor 2 receptor subunit alpha","targetClass":["Membrane receptor"],"prefName":"SARGRAMOSTIM","tradeNames":["Leukine"],"synonyms":["B1 61.012","B1-61012","Granulocyte-macrophage colony-stimulating factor sargramostim","RHU GM-CSF","RHU-GM-CSF","Sargramostim","Sargramostim rdna"],"drugType":"Protein","mechanismOfAction":"Granulocyte-macrophage colony-stimulating factor receptor agonist","targetName":"Granulocyte-macrophage colony-stimulating factor receptor"}
{"drugId":"CHEMBL1637","targetId":"ENSG00000175482","diseaseId":"EFO_0006544","phase":1,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02420847%22"}],"ancestors":["MONDO_0004986","MONDO_0023370","EFO_0000294","EFO_0009690","MONDO_0024337","MONDO_0045024","MONDO_0004992","MONDO_0021066","MONDO_0001187","MONDO_0037254","EFO_0000313","EFO_0008528","EFO_1000363","EFO_1000601","EFO_0006858","EFO_1000018","EFO_0000616"],"label":"bladder transitional cell carcinoma","approvedSymbol":"POLD4","approvedName":"DNA polymerase delta 4, accessory subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE HYDROCHLORIDE","tradeNames":["Gemcitabine hydrochloride","Gemzar","Infugem"],"synonyms":["Gemcitabine (as hydrochloride)","Gemcitabine hcl","Gemcitabine hydrochloride","Gemzar","LY-188011","LY-188011 HYDROCHLORIDE","LY188011 HYDROCHLORIDE"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL185","targetId":"ENSG00000176890","diseaseId":"EFO_0006544","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00154687%22"}],"ancestors":["MONDO_0004986","MONDO_0023370","EFO_0000294","EFO_0009690","MONDO_0024337","MONDO_0045024","MONDO_0004992","MONDO_0021066","MONDO_0001187","MONDO_0037254","EFO_0000313","EFO_0008528","EFO_1000363","EFO_1000601","EFO_0006858","EFO_1000018","EFO_0000616"],"label":"bladder transitional cell carcinoma","approvedSymbol":"TYMS","approvedName":"thymidylate synthetase","targetClass":["Enzyme"],"prefName":"FLUOROURACIL","tradeNames":["5.f.u.","Accusite","Actikerall","Adrucil","Carac","Efudex","Efudix","Fluoro-uracil roche","Fluoroplex","Fluorouracil","Tolak"],"synonyms":["5 FU","5-FU","5-Fluorouracil","5-fluoruracil","Fluorouracil","Fluorouracilum","Fluorouricil","Fluracil","NSC-19893","Phthoruracil","Queroplex","RO 2-9757","RO-2-9757","RO-29757"],"drugType":"Small molecule","mechanismOfAction":"Thymidylate synthase inhibitor","targetName":"Thymidylate synthase"}
{"drugId":"CHEMBL24828","targetId":"ENSG00000165731","diseaseId":"EFO_0006544","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00880334%22"}],"ancestors":["MONDO_0004986","MONDO_0023370","EFO_0000294","EFO_0009690","MONDO_0024337","MONDO_0045024","MONDO_0004992","MONDO_0021066","MONDO_0001187","MONDO_0037254","EFO_0000313","EFO_0008528","EFO_1000363","EFO_1000601","EFO_0006858","EFO_1000018","EFO_0000616"],"label":"bladder transitional cell carcinoma","approvedSymbol":"RET","approvedName":"ret proto-oncogene","targetClass":["Unclassified protein","Enzyme","Other cytosolic protein"],"prefName":"VANDETANIB","tradeNames":["Caprelsa","Zactima"],"synonyms":["GNF-PF-2188","NSC-744325","NSC-760766","Vandetanib","ZD-64","ZD-6474","ZD6474"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase receptor RET inhibitor","targetName":"Tyrosine-protein kinase receptor RET"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000101162","diseaseId":"EFO_0006544","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02401542%22"}],"ancestors":["MONDO_0004986","MONDO_0023370","EFO_0000294","EFO_0009690","MONDO_0024337","MONDO_0045024","MONDO_0004992","MONDO_0021066","MONDO_0001187","MONDO_0037254","EFO_0000313","EFO_0008528","EFO_1000363","EFO_1000601","EFO_0006858","EFO_1000018","EFO_0000616"],"label":"bladder transitional cell carcinoma","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000137285","diseaseId":"EFO_0006544","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04579224%22"}],"ancestors":["MONDO_0004986","MONDO_0023370","EFO_0000294","EFO_0009690","MONDO_0024337","MONDO_0045024","MONDO_0004992","MONDO_0021066","MONDO_0001187","MONDO_0037254","EFO_0000313","EFO_0008528","EFO_1000363","EFO_1000601","EFO_0006858","EFO_1000018","EFO_0000616"],"label":"bladder transitional cell carcinoma","approvedSymbol":"TUBB2B","approvedName":"tubulin beta 2B class IIb","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1437","targetId":"ENSG00000171873","diseaseId":"EFO_0006834","phase":3,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05207280%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04295993%22"}],"ancestors":["EFO_0000651","HP_0000118","HP_0001626"],"label":"septic shock","approvedSymbol":"ADRA1D","approvedName":"adrenoceptor alpha 1D","targetClass":["Membrane receptor"],"prefName":"NOREPINEPHRINE","tradeNames":[],"synonyms":["(-)-noradrenaline","Levophed","NSC-757246","Nor adrenalin","Norepinephrine","R-norepinephrine"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor agonist","targetName":"Adrenergic receptor"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000106628","diseaseId":"EFO_0006859","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01310179%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00004246%22"}],"ancestors":["EFO_0005950","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"head and neck malignant neoplasia","approvedSymbol":"POLD2","approvedName":"DNA polymerase delta 2, accessory subunit","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000090266","diseaseId":"EFO_0006859","phase":0,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03109873%22"}],"ancestors":["EFO_0005950","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"head and neck malignant neoplasia","approvedSymbol":"NDUFB2","approvedName":"NADH:ubiquinone oxidoreductase subunit B2","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1773","targetId":"ENSG00000176890","diseaseId":"EFO_0006859","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00101075%22"}],"ancestors":["EFO_0005950","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"head and neck malignant neoplasia","approvedSymbol":"TYMS","approvedName":"thymidylate synthetase","targetClass":["Enzyme"],"prefName":"CAPECITABINE","tradeNames":["Capecitabine","Xeloda"],"synonyms":["Capecitabine","Capecitabine accord","Capecitabine medac","Capecitabine sun","Capecitabine teva","Capecitibine","Capecytabine","Capiibine","Captabin","Ecansya","NSC-759853","RO 09-1978/000","RO-09-1978000","RO-091978000","Xeloda"],"drugType":"Small molecule","mechanismOfAction":"Thymidylate synthase inhibitor","targetName":"Thymidylate synthase"}
{"drugId":"CHEMBL24828","targetId":"ENSG00000065361","diseaseId":"EFO_0006859","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00720083%22"}],"ancestors":["EFO_0005950","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"head and neck malignant neoplasia","approvedSymbol":"ERBB3","approvedName":"erb-b2 receptor tyrosine kinase 3","targetClass":["Enzyme"],"prefName":"VANDETANIB","tradeNames":["Caprelsa","Zactima"],"synonyms":["GNF-PF-2188","NSC-744325","NSC-760766","Vandetanib","ZD-64","ZD-6474","ZD6474"],"drugType":"Small molecule","mechanismOfAction":"Epidermal growth factor receptor inhibitor","targetName":"Epidermal growth factor receptor"}
{"drugId":"CHEMBL24828","targetId":"ENSG00000101213","diseaseId":"EFO_0006859","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00720083%22"}],"ancestors":["EFO_0005950","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"head and neck malignant neoplasia","approvedSymbol":"PTK6","approvedName":"protein tyrosine kinase 6","targetClass":["Enzyme"],"prefName":"VANDETANIB","tradeNames":["Caprelsa","Zactima"],"synonyms":["GNF-PF-2188","NSC-744325","NSC-760766","Vandetanib","ZD-64","ZD-6474","ZD6474"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase BRK inhibitor","targetName":"Tyrosine-protein kinase BRK"}
{"drugId":"CHEMBL289351","targetId":"ENSG00000196230","diseaseId":"EFO_0006859","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00060242%22"}],"ancestors":["EFO_0005950","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"head and neck malignant neoplasia","approvedSymbol":"TUBB","approvedName":"tubulin beta class I","targetClass":["Structural protein"],"prefName":"FOSBRETABULIN DISODIUM","tradeNames":[],"synonyms":["CA 4P","CA-4DP","CA4DP","Fosbretabulin disodium","Fosbretabulin disodium salt"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000196230","diseaseId":"EFO_0006859","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01927744%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03894891%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02126969%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00076310%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00544414%22"}],"ancestors":["EFO_0005950","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"head and neck malignant neoplasia","approvedSymbol":"TUBB","approvedName":"tubulin beta class I","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000137267","diseaseId":"EFO_0006859","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00352118%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00646659%22"}],"ancestors":["EFO_0005950","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"head and neck malignant neoplasia","approvedSymbol":"TUBB2A","approvedName":"tubulin beta 2A class IIa","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000176014","diseaseId":"EFO_0006859","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00113399%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01126216%22"}],"ancestors":["EFO_0005950","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"head and neck malignant neoplasia","approvedSymbol":"TUBB6","approvedName":"tubulin beta 6 class V","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL90555","targetId":"ENSG00000104833","diseaseId":"EFO_0006859","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002476%22"}],"ancestors":["EFO_0005950","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"head and neck malignant neoplasia","approvedSymbol":"TUBB4A","approvedName":"tubulin beta 4A class IVa","targetClass":["Structural protein"],"prefName":"VINCRISTINE","tradeNames":[],"synonyms":["22-oxovincaleukoblastine","Leucristine","Leurocristine","Oncotcs","Tecnocris","Vincaleukoblastine, 22-oxo-","Vincristin","Vincristine","Vinkristin"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL92","targetId":"ENSG00000137285","diseaseId":"EFO_0006859","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00076310%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00544414%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03894891%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01927744%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02126969%22"}],"ancestors":["EFO_0005950","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"head and neck malignant neoplasia","approvedSymbol":"TUBB2B","approvedName":"tubulin beta 2B class IIb","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":[],"synonyms":["RP-56976","Taxotere"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL92","targetId":"ENSG00000258947","diseaseId":"EFO_0006859","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02057107%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04356170%22"}],"ancestors":["EFO_0005950","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"head and neck malignant neoplasia","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":[],"synonyms":["RP-56976","Taxotere"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1201733","targetId":"ENSG00000134853","diseaseId":"EFO_0006861","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01394211%22"}],"ancestors":["OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0007254","MONDO_0045024","MONDO_0004992","EFO_0009483","MONDO_0003274","EFO_0003869","EFO_0000313","EFO_0000305","EFO_0010285","EFO_0006858","EFO_0000616"],"label":"male breast carcinoma","approvedSymbol":"PDGFRA","approvedName":"platelet derived growth factor receptor alpha","targetClass":["Enzyme"],"prefName":"PAZOPANIB HYDROCHLORIDE","tradeNames":["Votrient"],"synonyms":["GW-786034B","GW786034B","Pazopanib (as hydrochloride)","Pazopanib hcl","Pazopanib hydrochloride","Pazopanib monohydrochloride"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","targetName":"Platelet-derived growth factor receptor"}
{"drugId":"CHEMBL108","targetId":"ENSG00000168356","diseaseId":"EFO_0006911","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01581918%22"}],"ancestors":["HP_0025031","HP_0002017","EFO_0000651","HP_0011458","HP_0000118"],"label":"Chemotherapy-induced nausea and vomiting","approvedSymbol":"SCN11A","approvedName":"sodium voltage-gated channel alpha subunit 11","targetClass":["Ion channel"],"prefName":"CARBAMAZEPINE","tradeNames":["Arbil mr","Carbagen sr","Carbamazepine","Carbatrol","Carnexiv","Epimaz","Epimaz ret","Epitol","Equetro","Sirtal ret","Tegretol","Tegretol Xr","Tegretol chewtab","Tegretol prolonged release","Tegretol-xr","Teril","Teril ret","Timonil 200 ret","Timonil 400 ret"],"synonyms":["Biston","Carbamazepine","Carbamazepine anhydrous","Carbamazepine extended release","Carbamazepinum","Finlepsin","G-32883","GEIGY 32883","Karbamazepin","Karbelex","NSC-169864","Neurotol","Neurotop","Sirtal","Stazepine","Tegretal","Telesmin","Timonil"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL1672054","targetId":"ENSG00000115353","diseaseId":"EFO_0006911","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00437229%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00404274%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00511823%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00405080%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00440128%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00404378%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00460707%22"}],"ancestors":["HP_0025031","HP_0002017","EFO_0000651","HP_0011458","HP_0000118"],"label":"Chemotherapy-induced nausea and vomiting","approvedSymbol":"TACR1","approvedName":"tachykinin receptor 1","targetClass":["Membrane receptor"],"prefName":"CASOPITANT","tradeNames":["Rezonic","Zunrisa"],"synonyms":["Casopitant","GW-679769","GW679769","Gw679769"],"drugType":"Small molecule","mechanismOfAction":"Neurokinin 1 receptor antagonist","targetName":"Neurokinin 1 receptor"}
{"drugId":"CHEMBL1720","targetId":"ENSG00000166736","diseaseId":"EFO_0006911","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00895245%22"}],"ancestors":["HP_0025031","HP_0002017","EFO_0000651","HP_0011458","HP_0000118"],"label":"Chemotherapy-induced nausea and vomiting","approvedSymbol":"HTR3A","approvedName":"5-hydroxytryptamine receptor 3A","targetClass":["Ion channel"],"prefName":"PALONOSETRON HYDROCHLORIDE","tradeNames":["Aloxi","Palonosetron hydrochloride"],"synonyms":["Palonocetron hydrochloride","Palonosetron (as hydrochloride)","Palonosetron hcl","Palonosetron hydrochloride","RS-25259-197"],"drugType":"Small molecule","mechanismOfAction":"Serotonin 3a (5-HT3a) receptor antagonist","targetName":"Serotonin 3a (5-HT3a) receptor"}
{"drugId":"CHEMBL160","targetId":"ENSG00000196262","diseaseId":"EFO_0006926","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03413306%22"}],"ancestors":["HP_0001871","EFO_0000651","HP_0001876","HP_0001877","HP_0000118","HP_0001915","EFO_0004272"],"label":"acquired aplastic anemia","approvedSymbol":"PPIA","approvedName":"peptidylprolyl isomerase A","targetClass":["Enzyme"],"prefName":"CYCLOSPORINE","tradeNames":["Capimune","Capsorin","Cequa","Cyclosporine","Deximune","Gengraf","Ikervis","Neoral","Optimmune","Restasis","Restasis multidose","Sandimmun","Sandimmune","Sangcya","Vanquoral","Verkazia"],"synonyms":["27-400","ANTIBIOTIC S-7481F1","Atopica","Ciclosporin","Ciclosporin a","Ciclosporinum","Cyclosporin","Cyclosporin a","Cyclosporine","Cyclosporine a","Cyclosporine microemulsion","Cyclosporine, modified","Equoral","Mitogard","NSC-290193","Neoplanta","Neurostat","OL-27-400","Ramihyphin a","SANG-35","SDZ-OXL-400","Zinograf me"],"drugType":"Protein","mechanismOfAction":"Cyclophilin A modulator","targetName":"Cyclophilin A"}
{"drugId":"CHEMBL1201567","targetId":"ENSG00000119535","diseaseId":"EFO_0006927","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02918292%22"}],"ancestors":["HP_0001871","EFO_0000651","HP_0001876","HP_0001877","HP_0000118","HP_0001915","EFO_0004272"],"label":"severe aplastic anemia","approvedSymbol":"CSF3R","approvedName":"colony stimulating factor 3 receptor","targetClass":["Membrane receptor"],"prefName":"FILGRASTIM","tradeNames":["Accofil","Neupogen","Neupogen 30","Neupogen 48","Nivestim","Zarzio"],"synonyms":["Filgrastim","Filgrastim for bioassay","Filgrastim-sndz","Granulocyte colony-stimulating factor filgrastim","KRN-8601","MBRI-9901","R-METHUG-CSF","TX-01","TX01","Tbo-filgrastim","XM-02","XM02"],"drugType":"Protein","mechanismOfAction":"Granulocyte colony stimulating factor receptor agonist","targetName":"Granulocyte colony stimulating factor receptor"}
{"drugId":"CHEMBL762","targetId":"ENSG00000184160","diseaseId":"EFO_0007141","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01275105%22"}],"ancestors":["EFO_0003966","EFO_0009546","MONDO_0002314","EFO_0005751","MONDO_0005271","EFO_0000540","MONDO_0024458","EFO_0009450","EFO_1002003","EFO_1000203"],"label":"allergic conjunctivitis","approvedSymbol":"ADRA2C","approvedName":"adrenoceptor alpha 2C","targetClass":["Membrane receptor"],"prefName":"OXYMETAZOLINE","tradeNames":[],"synonyms":["Nasacon","Ocuclear","Operil","Oxymetazoline"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor alpha agonist","targetName":"Adrenergic receptor alpha"}
{"drugId":"CHEMBL160","targetId":"ENSG00000196262","diseaseId":"EFO_0007183","phase":0,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00378677%22"}],"ancestors":["MONDO_0002465","MONDO_0100336","EFO_0009433","EFO_0000684","EFO_0003106","EFO_0005741","OTAR_0000010","EFO_0004244","EFO_0003818","EFO_1001991","MONDO_0024355"],"label":"bronchiolitis obliterans","approvedSymbol":"PPIA","approvedName":"peptidylprolyl isomerase A","targetClass":["Enzyme"],"prefName":"CYCLOSPORINE","tradeNames":["Capimune","Capsorin","Cequa","Cyclosporine","Deximune","Gengraf","Ikervis","Neoral","Optimmune","Restasis","Restasis multidose","Sandimmun","Sandimmune","Sangcya","Vanquoral","Verkazia"],"synonyms":["27-400","ANTIBIOTIC S-7481F1","Atopica","Ciclosporin","Ciclosporin a","Ciclosporinum","Cyclosporin","Cyclosporin a","Cyclosporine","Cyclosporine a","Cyclosporine microemulsion","Cyclosporine, modified","Equoral","Mitogard","NSC-290193","Neoplanta","Neurostat","OL-27-400","Ramihyphin a","SANG-35","SDZ-OXL-400","Zinograf me"],"drugType":"Protein","mechanismOfAction":"Cyclophilin A modulator","targetName":"Cyclophilin A"}
{"drugId":"CHEMBL452","targetId":"ENSG00000163285","diseaseId":"EFO_0007191","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02913924%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","MONDO_0004938","EFO_0000618","EFO_0003890","MONDO_0002494","EFO_0009386"],"label":"cannabis dependence","approvedSymbol":"GABRG1","approvedName":"gamma-aminobutyric acid type A receptor subunit gamma1","targetClass":["Ion channel"],"prefName":"CLONAZEPAM","tradeNames":["Clonazepam","Klonopin","Klonopin rapidly disintegrating","Rivotril"],"synonyms":["Clonazepam","Clonazepam civ","NSC-179913","RO 5-4023","RO-5-4023","RO-54023","Ravotril","Rivatril"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL1201302","targetId":"ENSG00000113580","diseaseId":"EFO_0007257","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a760c03f-c675-4d63-a20e-0600a980130b"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dff598e8-e662-411f-978d-4ba3fb8ef7db"}],"ancestors":["MONDO_0100336","EFO_0009433","EFO_0003106","EFO_0000684","EFO_0005741","OTAR_0000010","EFO_1001991","EFO_0003818","MONDO_0024355"],"label":"eosinophilic pneumonia","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"DEXAMETHASONE PHOSPHORIC ACID","tradeNames":[],"synonyms":["Dexamethasone phosphate","Dexamethasone phosphoric acid"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL112","targetId":"ENSG00000196689","diseaseId":"EFO_0007328","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01389518%22"}],"ancestors":["MONDO_0024352","MONDO_0100336","EFO_0000684","MONDO_0100321","EFO_0000763","EFO_0005741","OTAR_0000010","MONDO_0100329","MONDO_0024355"],"label":"influenza","approvedSymbol":"TRPV1","approvedName":"transient receptor potential cation channel subfamily V member 1","targetClass":["Ion channel"],"prefName":"ACETAMINOPHEN","tradeNames":["Abdine","Acephen","Acetaminophen","Alvedon","Angiers","Calpol","Calpol six plus","Calpol six plus fastmelts","Child lemsip","Cupanol","Dafalgan","Datril","Disprol","Disprol infant","Disprol jnr","Disprol paed","Fennings","Galpamol","Hedex","Infadrops","Infants' feverall","Injectapap","Junior parapaed","Mandanol","Medinol","Medinol for children","Medinol over 6","Medinol under 6","Medised plain","Miradol","Neopap","Ofirmev","Paldesic","Panadol","Panadol actifast","Panadol actifast solb","Panadol advan","Panadol jnr","Panadol oa","Panaleve","Panaleve 6 plus","Paracetamol","Paramin","Parapaed jnr","Parapaed six plus","Paravict","Perfalgan","Phenaphen","Placidex","Rimadol","Salzone","Tixymol","Tramil 500","Tylenol"],"synonyms":["Acetaminophen","Apap","Biocetamol","Doliprane","Efferalgan","N-acetyl-p-aminophenol","NSC-109028","NSC-3991","P-hydroxy-acetanilid","Paracetamol","Paracetamolum","Vermidon"],"drugType":"Small molecule","mechanismOfAction":"Vanilloid receptor opener","targetName":"Vanilloid receptor"}
{"drugId":"CHEMBL655","targetId":"ENSG00000182256","diseaseId":"EFO_0007328","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02888327%22"}],"ancestors":["MONDO_0024352","MONDO_0100336","EFO_0000684","MONDO_0100321","EFO_0000763","EFO_0005741","OTAR_0000010","MONDO_0100329","MONDO_0024355"],"label":"influenza","approvedSymbol":"GABRG3","approvedName":"gamma-aminobutyric acid type A receptor subunit gamma3","targetClass":["Ion channel"],"prefName":"MIDAZOLAM","tradeNames":["Midazolam in 0.9% sodium chloride","Nayzilam"],"synonyms":["Midazolam","Midazolam civ","USL-261","USL261"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL1077896","targetId":"ENSG00000153253","diseaseId":"EFO_0007355","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02740127%22"}],"ancestors":["EFO_0000512","OTAR_0000017","EFO_0009555","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"male reproductive organ cancer","approvedSymbol":"SCN3A","approvedName":"sodium voltage-gated channel alpha subunit 3","targetClass":["Ion channel"],"prefName":"ROPIVACAINE","tradeNames":[],"synonyms":["Ropivacaine","Ropivicaine","TLC-590","TLC590","Tlc590"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL1433","targetId":"ENSG00000137673","diseaseId":"EFO_0007357","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00340691%22"}],"ancestors":["MONDO_0100336","EFO_0000701","EFO_0005741","MONDO_0016075","EFO_0001067","EFO_0010285","EFO_1001342"],"label":"mansonelliasis","approvedSymbol":"MMP7","approvedName":"matrix metallopeptidase 7","targetClass":["Enzyme"],"prefName":"DOXYCYCLINE ANHYDROUS","tradeNames":[],"synonyms":["Anhydrous doxycycline","Doxycycline (anhydrous)"],"drugType":"Small molecule","mechanismOfAction":"Matrix metalloproteinase 7 inhibitor","targetName":"Matrix metalloproteinase 7"}
{"drugId":"CHEMBL284348","targetId":"ENSG00000075043","diseaseId":"EFO_0007405","phase":0,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04148781%22"}],"ancestors":["MONDO_0002135","EFO_0003966","MONDO_0003569","EFO_0001423","EFO_0000618","MONDO_0024458","EFO_0009386"],"label":"optic neuritis","approvedSymbol":"KCNQ2","approvedName":"potassium voltage-gated channel subfamily Q member 2","targetClass":["Ion channel"],"prefName":"DALFAMPRIDINE","tradeNames":["Ampyra","Ampyra Extended Release","Fampyra","Neurelan"],"synonyms":["Dalfampridine","EL-970","Fampridine","Fampridine (4-aminopyridine)","NSC-15041"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated potassium channel blocker","targetName":"Voltage-gated potassium channel"}
{"drugId":"CHEMBL284348","targetId":"ENSG00000173826","diseaseId":"EFO_0007405","phase":0,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04148781%22"}],"ancestors":["MONDO_0002135","EFO_0003966","MONDO_0003569","EFO_0001423","EFO_0000618","MONDO_0024458","EFO_0009386"],"label":"optic neuritis","approvedSymbol":"KCNH6","approvedName":"potassium voltage-gated channel subfamily H member 6","targetClass":["Ion channel"],"prefName":"DALFAMPRIDINE","tradeNames":["Ampyra","Ampyra Extended Release","Fampyra","Neurelan"],"synonyms":["Dalfampridine","EL-970","Fampridine","Fampridine (4-aminopyridine)","NSC-15041"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated potassium channel blocker","targetName":"Voltage-gated potassium channel"}
{"drugId":"CHEMBL535","targetId":"ENSG00000113721","diseaseId":"EFO_0007416","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00428597%22"}],"ancestors":["EFO_0007331","MONDO_0023370","MONDO_0021069","MONDO_0024503","EFO_0003860","MONDO_0045024","MONDO_0004992","MONDO_0002120","EFO_0000313","EFO_0003769","EFO_1000218","EFO_0001379","EFO_1001901","EFO_0008549","EFO_0009605","MONDO_0001933","MONDO_0002516","EFO_0006858","EFO_1000359","EFO_0000616","EFO_0010282"],"label":"pancreatic endocrine carcinoma","approvedSymbol":"PDGFRB","approvedName":"platelet derived growth factor receptor beta","targetClass":["Enzyme"],"prefName":"SUNITINIB","tradeNames":["Sutent"],"synonyms":["NSC-736511","NSC-750690","SU-011248","SU-11248","SU011248","Sunitinib","Sutent"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","targetName":"Platelet-derived growth factor receptor"}
{"drugId":"CHEMBL207538","targetId":"ENSG00000187730","diseaseId":"EFO_0007453","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05059600%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","OTAR_0000014","EFO_0004247","MONDO_0002050","EFO_0000618","EFO_0003761","EFO_0009386","EFO_0009683","MONDO_0700003"],"label":"postpartum depression","approvedSymbol":"GABRD","approvedName":"gamma-aminobutyric acid type A receptor subunit delta","targetClass":["Ion channel"],"prefName":"BREXANOLONE","tradeNames":["Zulresso"],"synonyms":["Allopregnan-3.alpha.-ol-20-one","Allopregnanolone","Allotetrahydroprogesterone","Brexanolone","SAGE-547","SGE-102"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL452","targetId":"ENSG00000113327","diseaseId":"EFO_0007462","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02312908%22"}],"ancestors":["EFO_0000677","MONDO_0002025","MONDO_0003406","EFO_0005774","EFO_0008568","EFO_0000618","EFO_0009386"],"label":"REM sleep behavior disorder","approvedSymbol":"GABRG2","approvedName":"gamma-aminobutyric acid type A receptor subunit gamma2","targetClass":["Ion channel"],"prefName":"CLONAZEPAM","tradeNames":["Clonazepam","Klonopin","Klonopin rapidly disintegrating","Rivotril"],"synonyms":["Clonazepam","Clonazepam civ","NSC-179913","RO 5-4023","RO-5-4023","RO-54023","Ravotril","Rivatril"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL1504","targetId":"ENSG00000113580","diseaseId":"EFO_0007490","phase":4,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03245671%22"}],"ancestors":["EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0000812","EFO_0002461","MONDO_0000836"],"label":"spinal stenosis","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"TRIAMCINOLONE ACETONIDE","tradeNames":["Adcortyl","Adcortyl in orabase","Allernaze","Aristocort","Aristocort a","Aristogel","Audicort","Aureocort","Azmacort","Flutex","Gppe ear dps cap","Gppe ear oint","Kenacort","Kenalog","Kenalog in orabase","Kenalog-10","Kenalog-40","Kenalog-80","Kenalog-h","Nasacort","Nasacort allergy 24 hour","Nasacort aq","Nasacort hfa","Nystadermal","Oracort","Oralone","Pevaryl t.c.","Remiderm","Remotic","Silderm","Tri-Nasal","Tri-adcortyl","Triacet","Triacort","Triamcinolone acetonide","Triamcinolone acetonide in absorbase","Triatex","Triderm","Triesence","Trivaris","Trymex","Vetalog","Zilretta"],"synonyms":["FX-006","FX006","Kenacourt","NSC-21916","Triamcinolone Acetonide","Triamcinolone acetonide"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL803","targetId":"ENSG00000077514","diseaseId":"EFO_0007498","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00716066%22"}],"ancestors":["EFO_0000589","EFO_0004280","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0000618","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"Stiff-Person syndrome","approvedSymbol":"POLD3","approvedName":"DNA polymerase delta 3, accessory subunit","targetClass":["Enzyme"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL4297422","targetId":"ENSG00000162736","diseaseId":"EFO_0008515","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01120275%22"}],"ancestors":["MONDO_0002898","MONDO_0000653","MONDO_0023370","MONDO_0021069","MONDO_0045024","MONDO_0004992","EFO_0004198","MONDO_0021143","MONDO_0021583","EFO_0003769","EFO_0000701","EFO_0000756","EFO_0001379","EFO_1001901","EFO_0000389","EFO_0010285","EFO_0000616"],"label":"nodular melanoma","approvedSymbol":"NCSTN","approvedName":"nicastrin","targetClass":["Enzyme"],"prefName":"RG-4733","tradeNames":[],"synonyms":["RO 4929097","RO-4929097","Rg 4733","Rg-4733","Ro4929097"],"drugType":"Small molecule","mechanismOfAction":"Gamma-secretase inhibitor","targetName":"Gamma-secretase"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000151366","diseaseId":"EFO_0008522","phase":0,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05349474%22"}],"ancestors":["EFO_0005140","EFO_0005772","EFO_0005774","MONDO_0002977","MONDO_0000568","MONDO_0005301","EFO_0009386","MONDO_0002562","EFO_0005809","EFO_0000540","EFO_0003840","EFO_0000618","EFO_1002003","EFO_1000870"],"label":"secondary progressive multiple sclerosis","approvedSymbol":"NDUFC2","approvedName":"NADH:ubiquinone oxidoreductase subunit C2","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL354077","targetId":"ENSG00000089558","diseaseId":"EFO_0008525","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03781479%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0009488","EFO_0005772","MONDO_0003182","EFO_0002970","EFO_0004145","EFO_0003782","EFO_0009386","EFO_1001902","EFO_0004149","EFO_0000618","MONDO_0003939"],"label":"spinal muscular atrophy","approvedSymbol":"KCNH4","approvedName":"potassium voltage-gated channel subfamily H member 4","targetClass":["Ion channel"],"prefName":"AMIFAMPRIDINE","tradeNames":["Ruzurgi"],"synonyms":["3,4-DAP","3,4-Diammoniopyridinium","4-DAP","Amifampridine","DAP","Dynamine","NSC-521760","Pyridine-3,4-Diamine"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated potassium channel blocker","targetName":"Voltage-gated potassium channel"}
{"drugId":"CHEMBL3301589","targetId":"ENSG00000258947","diseaseId":"EFO_0008528","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03869190%22"}],"ancestors":["MONDO_0037254","EFO_0000313","MONDO_0023370","EFO_0009690","MONDO_0024337","MONDO_0045024","EFO_1000363","EFO_1000601","EFO_0006858","MONDO_0004992","MONDO_0021066","EFO_0000616"],"label":"urothelial carcinoma","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"ENFORTUMAB VEDOTIN","tradeNames":["Padcev"],"synonyms":["AGS-22CE","AGS-22M6E","AGS-22ME","AGS-22MSE","ASG-22ME","Enfortumab vedotin","Enfortumab vedotin-ejfv"],"drugType":"Antibody","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL92","targetId":"ENSG00000188229","diseaseId":"EFO_0008528","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03209206%22"}],"ancestors":["MONDO_0037254","EFO_0000313","MONDO_0023370","EFO_0009690","MONDO_0024337","MONDO_0045024","EFO_1000363","EFO_1000601","EFO_0006858","MONDO_0004992","MONDO_0021066","EFO_0000616"],"label":"urothelial carcinoma","approvedSymbol":"TUBB4B","approvedName":"tubulin beta 4B class IVb","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":[],"synonyms":["RP-56976","Taxotere"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL2107457","targetId":"ENSG00000149295","diseaseId":"EFO_0008533","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04647955%22"}],"ancestors":["MONDO_0001318","EFO_0009608","EFO_0010282"],"label":"dyspepsia","approvedSymbol":"DRD2","approvedName":"dopamine receptor D2","targetClass":["Membrane receptor"],"prefName":"ITOPRIDE","tradeNames":[],"synonyms":["Itopride","NSC-759643"],"drugType":"Small molecule","mechanismOfAction":"Dopamine D2 receptor antagonist","targetName":"Dopamine D2 receptor"}
{"drugId":"CHEMBL2108427","targetId":"ENSG00000138039","diseaseId":"EFO_0008560","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01477073%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01354886%22"}],"ancestors":["EFO_0000545","EFO_0000512","OTAR_0000017","EFO_0009549"],"label":"female infertility","approvedSymbol":"LHCGR","approvedName":"luteinizing hormone/choriogonadotropin receptor","targetClass":["Membrane receptor"],"prefName":"MENOTROPINS","tradeNames":["Humegon","Menopur","Merional","Normegon","Pergonal","Pergonal low lh"],"synonyms":["FSH","Follicle stimulating hormone","Follotropin","HMG","Human follicle stimulating hormone","Menotrophin","Menotropins","Menotropins (fsh;lh)"],"drugType":"Protein","mechanismOfAction":"Luteinizing hormone/Choriogonadotropin receptor agonist","targetName":"Luteinizing hormone/Choriogonadotropin receptor"}
{"drugId":"CHEMBL1069","targetId":"ENSG00000144891","diseaseId":"EFO_0008583","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02924727%22"}],"ancestors":["EFO_0000612","EFO_0003777","MONDO_0024643","EFO_0000319"],"label":"acute myocardial infarction","approvedSymbol":"AGTR1","approvedName":"angiotensin II receptor type 1","targetClass":["Membrane receptor"],"prefName":"VALSARTAN","tradeNames":["Diovan","Exforge","Prexxartan","Valsartan"],"synonyms":["CGP 48933","CGP-48933","NSC-758927","Valsartan"],"drugType":"Small molecule","mechanismOfAction":"Type-1 angiotensin II receptor antagonist","targetName":"Type-1 angiotensin II receptor"}
{"drugId":"CHEMBL4297879","targetId":"ENSG00000197561","diseaseId":"EFO_0008583","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01936896%22"}],"ancestors":["EFO_0000612","EFO_0003777","MONDO_0024643","EFO_0000319"],"label":"acute myocardial infarction","approvedSymbol":"ELANE","approvedName":"elastase, neutrophil expressed","targetClass":["Enzyme"],"prefName":".ALPHA.1-PROTEINASE INHIBITOR HUMAN","tradeNames":[],"synonyms":[".alpha.-1 protease inhibitor",".alpha.1-antitrypsin",".alpha.1-proteinase inhibitor human","Alfa1 antitrypsin","Alpha 1-antitrypsin","Alpha-1 protease inhibitor","Alpha-1 proteinase inhibitor (human)","Alpha-1-antiproteinase","Alpha-1-antitrypsin","Alpha1-proteinase inhibitor","Alpha1-proteinase inhibitor (human)","Aralast","Atc-b02ab02","Glassia","Prolastin","Prolastin-c","Zemaira"],"drugType":"Protein","mechanismOfAction":"Leukocyte elastase inhibitor","targetName":"Leukocyte elastase"}
{"drugId":"CHEMBL742","targetId":"ENSG00000198785","diseaseId":"EFO_0008590","phase":3,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03338205%22"}],"ancestors":["EFO_0009433","EFO_0000684","MONDO_0004979","EFO_1002018","OTAR_0000010"],"label":"Status Asthmaticus","approvedSymbol":"GRIN3A","approvedName":"glutamate ionotropic receptor NMDA type subunit 3A","targetClass":["Ion channel"],"prefName":"KETAMINE","tradeNames":["Ketalar"],"synonyms":["Anaket v","Calypsol","Clorketam 1000","Dl-ketamine","Imalgene 1000","Ketamine","Ketasol 100","NSC-70151","Narketan","PMI-150","Tekam","Ursotamin","Vetaket"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor negative allosteric modulator","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL1908391","targetId":"ENSG00000157404","diseaseId":"EFO_0009001","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00831974%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01266369%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","EFO_0009000","Orphanet_322126","EFO_0002427","Orphanet_68336","EFO_0000540","EFO_0000508","MONDO_0019044","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"Mastocytosis","approvedSymbol":"KIT","approvedName":"KIT proto-oncogene, receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"MASITINIB","tradeNames":["Kinavet","Masivet"],"synonyms":["AB-1010","AB1010","Ab-1010","Masican","Masitinib","Masitinib mesilate","Masitinib mesylate","Masitinib methanesulfonate","Masiviera"],"drugType":"Small molecule","mechanismOfAction":"Stem cell growth factor receptor inhibitor","targetName":"Stem cell growth factor receptor"}
{"drugId":"CHEMBL650","targetId":"ENSG00000113580","diseaseId":"EFO_0009104","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05302388%22"}],"ancestors":["EFO_0000589","Orphanet_79191","OTAR_0000018","Orphanet_79224","MONDO_0019052","EFO_0000508","OTAR_0000020"],"label":"hyperuricemia","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"METHYLPREDNISOLONE","tradeNames":["Medrol","Medrone","Methylprednisolone"],"synonyms":["J3.872E","Methylprednisolone","NSC-19987","U-67,590A"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL4297526","targetId":"ENSG00000022355","diseaseId":"EFO_0009267","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04621305%22"}],"ancestors":["EFO_0000677","MONDO_0002025","MONDO_0002039","EFO_0005774","EFO_0000618","EFO_0009386"],"label":"delirium","approvedSymbol":"GABRA1","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha1","targetClass":["Ion channel"],"prefName":"REMIMAZOLAM","tradeNames":["Byfavo"],"synonyms":["CNS 7056","CNS-7056","Cns 7056","ONO-2745","Remimazolam"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL526","targetId":"ENSG00000151834","diseaseId":"EFO_0009267","phase":4,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02366299%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02394418%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02119806%22"}],"ancestors":["EFO_0000677","MONDO_0002025","MONDO_0002039","EFO_0005774","EFO_0000618","EFO_0009386"],"label":"delirium","approvedSymbol":"GABRA2","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha2","targetClass":["Ion channel"],"prefName":"PROPOFOL","tradeNames":["Diprivan","Disoprivan","Propofol","Rapinovet"],"synonyms":["Disoprofol","Fresofol","ICI 35,868","ICI 35-868","ICI-35868","ICI35,868","Lipuro","NSC-5105","Phenol, 2,6-bis(1-methylethyl)","Propofol"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL211456","targetId":"ENSG00000171873","diseaseId":"EFO_0009314","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02622126%22"}],"ancestors":["EFO_0005803"],"label":"blood coagulation disease","approvedSymbol":"ADRA1D","approvedName":"adrenoceptor alpha 1D","targetClass":["Membrane receptor"],"prefName":"EPHEDRINE","tradeNames":[],"synonyms":["(-)-ephedrine","Ephedrine","Ephedrine, anhydrous","Ephedrinum, anhydrous","L-ephedrine","NSC-170951","NSC-8971","Xenadrine"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor agonist","targetName":"Adrenergic receptor"}
{"drugId":"CHEMBL1421","targetId":"ENSG00000186716","diseaseId":"EFO_0009441","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00608361%22"}],"ancestors":["EFO_0007352","OTAR_0000020","MONDO_0044881","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0017594","MONDO_0004805","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0000432","MONDO_0023370","MONDO_0019052","MONDO_0004095","MONDO_0045024","EFO_0000589","EFO_0000540","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"Waldenstrom macroglobulinemia","approvedSymbol":"BCR","approvedName":"BCR activator of RhoGEF and GTPase","targetClass":["Other cytosolic protein"],"prefName":"DASATINIB","tradeNames":["Dasatinib","Sprycel"],"synonyms":["BMS-354825","BMS-354825 HYDRATE","BMS-354825-03","Dasatinib","Dasatinib anhydrous","Dasatinib hydrate","Dasatinib monohydrate","NSC-759877"],"drugType":"Small molecule","mechanismOfAction":"Bcr/Abl fusion protein","targetName":"Bcr/Abl fusion protein"}
{"drugId":"CHEMBL2103792","targetId":"ENSG00000239732","diseaseId":"EFO_0009441","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00438880%22"}],"ancestors":["EFO_0007352","OTAR_0000020","MONDO_0044881","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0017594","MONDO_0004805","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0000432","MONDO_0023370","MONDO_0019052","MONDO_0004095","MONDO_0045024","EFO_0000589","EFO_0000540","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"Waldenstrom macroglobulinemia","approvedSymbol":"TLR9","approvedName":"toll like receptor 9","targetClass":["Membrane receptor"],"prefName":"AGATOLIMOD","tradeNames":[],"synonyms":["Agatolimod","PF-3512676","Pf-3512676 free acid"],"drugType":"Oligonucleotide","mechanismOfAction":"Toll-like receptor 9 agonist","targetName":"Toll-like receptor 9"}
{"drugId":"CHEMBL2108404","targetId":"ENSG00000012124","diseaseId":"EFO_0009441","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00113802%22"}],"ancestors":["EFO_0007352","OTAR_0000020","MONDO_0044881","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0017594","MONDO_0004805","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0000432","MONDO_0023370","MONDO_0019052","MONDO_0004095","MONDO_0045024","EFO_0000589","EFO_0000540","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"Waldenstrom macroglobulinemia","approvedSymbol":"CD22","approvedName":"CD22 molecule","targetClass":["Adhesion"],"prefName":"EPRATUZUMAB","tradeNames":["Lymphocide"],"synonyms":["AMG-412","Epratuzumab","IMMU-HLL2","hLL2"],"drugType":"Antibody","mechanismOfAction":"CD22 inhibitor","targetName":"CD22"}
{"drugId":"CHEMBL325041","targetId":"ENSG00000100804","diseaseId":"EFO_0009441","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00492050%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03620903%22"}],"ancestors":["EFO_0007352","OTAR_0000020","MONDO_0044881","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0017594","MONDO_0004805","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0000432","MONDO_0023370","MONDO_0019052","MONDO_0004095","MONDO_0045024","EFO_0000589","EFO_0000540","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"Waldenstrom macroglobulinemia","approvedSymbol":"PSMB5","approvedName":"proteasome 20S subunit beta 5","targetClass":["Enzyme"],"prefName":"BORTEZOMIB","tradeNames":["Velcade"],"synonyms":["Bortezomib","Bortezomib accord","Bortezomib hydrate","LDP-341","NSC-681239","PS-341","Velcade"],"drugType":"Small molecule","mechanismOfAction":"26S proteosome inhibitor","targetName":"26S proteasome"}
{"drugId":"CHEMBL4650321","targetId":"ENSG00000010671","diseaseId":"EFO_0009441","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04440059%22"}],"ancestors":["EFO_0007352","OTAR_0000020","MONDO_0044881","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0017594","MONDO_0004805","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0000432","MONDO_0023370","MONDO_0019052","MONDO_0004095","MONDO_0045024","EFO_0000589","EFO_0000540","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"Waldenstrom macroglobulinemia","approvedSymbol":"BTK","approvedName":"Bruton tyrosine kinase","targetClass":["Enzyme"],"prefName":"ORELABRUTINIB","tradeNames":["Innobruka"],"synonyms":["ICP-022","Icp-022","Orelabrutinib"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase BTK inhibitor","targetName":"Tyrosine-protein kinase BTK"}
{"drugId":"CHEMBL650","targetId":"ENSG00000113580","diseaseId":"EFO_0009492","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00729794%22"}],"ancestors":["EFO_0003777","EFO_0004269","EFO_0000319"],"label":"cardiac arrest","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"METHYLPREDNISOLONE","tradeNames":["Medrol","Medrone","Methylprednisolone"],"synonyms":["J3.872E","Methylprednisolone","NSC-19987","U-67,590A"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL679","targetId":"ENSG00000120907","diseaseId":"EFO_0009552","phase":4,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02104414%22"}],"ancestors":["MONDO_0008638","MONDO_0004634","MONDO_0004869","EFO_0004264","EFO_0000319"],"label":"hemorrhoid","approvedSymbol":"ADRA1A","approvedName":"adrenoceptor alpha 1A","targetClass":["Membrane receptor"],"prefName":"EPINEPHRINE","tradeNames":["Adren co","Adrenaclick","Adrenalin","Ana-Kit","Ana-guard","Anapen","Anaphylactic shock drug kit","Asma-vydrin","Asthmahaler","Auvi-q","Bronkaid mist","Brovon","Emerade","Epi e z pen jr","Epinephrine","Epinephrine (copackaged)","Epipen","Epipen e z pen","Epipen jr","Epipen jr.","Eppy","Gppe inh soln","Jext","Medihaler-epi","Primatene","Primatene mist","Riddobron","Riddofan","Rybarvin","Simplene","Soln made to rybarvin for","Sus-Phrine","Sus-Phrine Sulfite-Free","Sus-phrine sulfite free","Symjepi","Twinject 0.15","Twinject 0.3"],"synonyms":["(-)-(r)-epinephrine","(-)-epinephrine","Adrenaline","Adrenalinum","Epinephrine","Epinephrine hcl","Epinephrine hydrochloride","Epinephrinum","Glauposine","L-epinephrine hydrochloride","Levo-methylaminoethanolcatechol","NSC-62786","Nephridine","Racepinefrine, (r)-","Sus-phrine sulphite-free","Susphrine","Tonogen","Twinject"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor agonist","targetName":"Adrenergic receptor"}
{"drugId":"CHEMBL79","targetId":"ENSG00000196876","diseaseId":"EFO_0009552","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02689856%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04276298%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04031131%22"}],"ancestors":["MONDO_0008638","MONDO_0004634","MONDO_0004869","EFO_0004264","EFO_0000319"],"label":"hemorrhoid","approvedSymbol":"SCN8A","approvedName":"sodium voltage-gated channel alpha subunit 8","targetClass":["Unclassified protein","Auxiliary transport protein","Ion channel"],"prefName":"LIDOCAINE","tradeNames":["Alphacaine","Anestacon","Dentipatch","Lidocaine","Lidoderm","Lignocaine Hcl","Lignostab","Lmx 4","Oraqix","Vagisil","Xylocaine","Xylodase","Xylotox","Ztlido"],"synonyms":["ALGRX 3268","ALGRX-3268","Anestacon","Embolex","Iontocaine","Lidocaine","Lidocainum","Lidocaton","Lidopen","Lignocaine","NSC-40030","Octocaine","Solarcaine","Xylestesin"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL558","targetId":"ENSG00000169432","diseaseId":"EFO_0009562","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02260388%22"}],"ancestors":["EFO_0009387","EFO_1001902","EFO_0004149","EFO_0000618","EFO_0003100"],"label":"polyneuropathy","approvedSymbol":"SCN9A","approvedName":"sodium voltage-gated channel alpha subunit 9","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"MEXILETINE","tradeNames":[],"synonyms":["(rs)-mexiletine","Dl-mexiletine","Mexiletine"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL139","targetId":"ENSG00000095303","diseaseId":"EFO_0009582","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01255423%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01066520%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01272934%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00955513%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02324270%22"}],"ancestors":["EFO_0000546","OTAR_0000009"],"label":"sprain","approvedSymbol":"PTGS1","approvedName":"prostaglandin-endoperoxide synthase 1","targetClass":["Enzyme"],"prefName":"DICLOFENAC","tradeNames":["Cambia","Voltaren","Voltaren Ophthalmic","Voltaren Xr","Zorvolex","Zorvolex capsules"],"synonyms":["Arthrotec","Cataflam","Diclofenac","Diclofenac free acid","LAS-41007","LAS41007","Las41007","Solaraze","Voltaren","Voltaren-XR"],"drugType":"Small molecule","mechanismOfAction":"Cyclooxygenase inhibitor","targetName":"Cyclooxygenase"}
{"drugId":"CHEMBL284348","targetId":"ENSG00000130037","diseaseId":"EFO_0009602","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03658408%22"}],"ancestors":["EFO_0000512","OTAR_0000017","EFO_0009555"],"label":"prostate disease","approvedSymbol":"KCNA5","approvedName":"potassium voltage-gated channel subfamily A member 5","targetClass":["Ion channel"],"prefName":"DALFAMPRIDINE","tradeNames":["Ampyra","Ampyra Extended Release","Fampyra","Neurelan"],"synonyms":["Dalfampridine","EL-970","Fampridine","Fampridine (4-aminopyridine)","NSC-15041"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated potassium channel blocker","targetName":"Voltage-gated potassium channel"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198886","diseaseId":"EFO_0009637","phase":2,"status":"Suspended","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02122185%22"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"pleural effusion","approvedSymbol":"MT-ND4","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL821","targetId":"ENSG00000182674","diseaseId":"EFO_0009708","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00037869%22"}],"ancestors":["GO_0008150","OBI_1110122"],"label":"metastasis","approvedSymbol":"KCNB2","approvedName":"potassium voltage-gated channel subfamily B member 2","targetClass":["Ion channel"],"prefName":"GUANIDINE","tradeNames":[],"synonyms":["Guanidine"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated potassium channel blocker","targetName":"Voltage-gated potassium channel"}
{"drugId":"CHEMBL70","targetId":"ENSG00000112038","diseaseId":"EFO_0009727","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04188418%22"}],"ancestors":["EFO_0000651","EFO_0003765"],"label":"shortness of breath","approvedSymbol":"OPRM1","approvedName":"opioid receptor mu 1","targetClass":["Membrane receptor"],"prefName":"MORPHINE","tradeNames":[],"synonyms":["Anhydrous morphine","Avinza","Depodur","Hydromorphone hydrochloride impurity, morphine-","IDS-NM-009","Infumorph","Kadian","Morphia","Morphine","Morphine (anhydrous)","Morphine anhydrous","Morphine extended release","Morphine polistirex","Morphium","N02AA01","Nepenthe","Ospalivina"],"drugType":"Small molecule","mechanismOfAction":"Mu opioid receptor agonist","targetName":"Mu opioid receptor"}
{"drugId":"CHEMBL660","targetId":"ENSG00000161509","diseaseId":"EFO_0009854","phase":4,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04936126%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0003761","EFO_0000618","EFO_0009386"],"label":"treatment resistant depression","approvedSymbol":"GRIN2C","approvedName":"glutamate ionotropic receptor NMDA type subunit 2C","targetClass":["Ion channel"],"prefName":"AMANTADINE","tradeNames":[],"synonyms":["Amantadine","Amantidine","NSC-341865","Symadine","Symmetrel","TCMDC-125869"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor antagonist","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL108","targetId":"ENSG00000196876","diseaseId":"EFO_0009963","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00266630%22"}],"ancestors":["MONDO_0004985","EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0000618","EFO_0009386"],"label":"bipolar I disorder","approvedSymbol":"SCN8A","approvedName":"sodium voltage-gated channel alpha subunit 8","targetClass":["Unclassified protein","Auxiliary transport protein","Ion channel"],"prefName":"CARBAMAZEPINE","tradeNames":["Arbil mr","Carbagen sr","Carbamazepine","Carbatrol","Carnexiv","Epimaz","Epimaz ret","Epitol","Equetro","Sirtal ret","Tegretol","Tegretol Xr","Tegretol chewtab","Tegretol prolonged release","Tegretol-xr","Teril","Teril ret","Timonil 200 ret","Timonil 400 ret"],"synonyms":["Biston","Carbamazepine","Carbamazepine anhydrous","Carbamazepine extended release","Carbamazepinum","Finlepsin","G-32883","GEIGY 32883","Karbamazepin","Karbelex","NSC-169864","Neurotol","Neurotop","Sirtal","Stazepine","Tegretal","Telesmin","Timonil"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL2105760","targetId":"ENSG00000178394","diseaseId":"EFO_0009963","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03257865%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03259555%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03287869%22"}],"ancestors":["MONDO_0004985","EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0000618","EFO_0009386"],"label":"bipolar I disorder","approvedSymbol":"HTR1A","approvedName":"5-hydroxytryptamine receptor 1A","targetClass":["Membrane receptor"],"prefName":"BREXPIPRAZOLE","tradeNames":["Rexulti"],"synonyms":["Brexpiprazole","OPC-34712"],"drugType":"Small molecule","mechanismOfAction":"Serotonin 1a (5-HT1a) receptor partial agonist","targetName":"Serotonin 1a (5-HT1a) receptor"}
{"drugId":"CHEMBL433","targetId":"ENSG00000112294","diseaseId":"EFO_0009963","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01977300%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00266630%22"}],"ancestors":["MONDO_0004985","EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0000618","EFO_0009386"],"label":"bipolar I disorder","approvedSymbol":"ALDH5A1","approvedName":"aldehyde dehydrogenase 5 family member A1","targetClass":["Enzyme"],"prefName":"VALPROATE SODIUM","tradeNames":["Delepsine","Depacon","Depakine","Depakote","Depakote CP","Depakote ER","Epilim","Epilim 200","Epilim 500","Epilim chrono 200","Epilim chrono 300","Epilim chrono 500","Epilim chronosphere","Epilim iv","Episenta","Kentilim","Orfiril","Orlept","Valproate sodium"],"synonyms":["A-44090","ABBOTT 44090","ABBOTT-44090","KW-6066N","NSC-732626","NSC-757376","Natrii valproas","Selenica","Sodium 2-propylpentanoate","Sodium valproate","Valproate sodium","Valproic acid sodium salt (1:1)","Valproic acid, sodium","Valproic acid, sodium salt"],"drugType":"Small molecule","mechanismOfAction":"Succinate semialdehyde dehydrogenase inhibitor","targetName":"Succinate semialdehyde dehydrogenase"}
{"drugId":"CHEMBL112","targetId":"ENSG00000095303","diseaseId":"EFO_0010072","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02862691%22"}],"ancestors":["EFO_0003843","EFO_0000651","EFO_0003765"],"label":"toothache","approvedSymbol":"PTGS1","approvedName":"prostaglandin-endoperoxide synthase 1","targetClass":["Enzyme"],"prefName":"ACETAMINOPHEN","tradeNames":["Abdine","Acephen","Acetaminophen","Alvedon","Angiers","Calpol","Calpol six plus","Calpol six plus fastmelts","Child lemsip","Cupanol","Dafalgan","Datril","Disprol","Disprol infant","Disprol jnr","Disprol paed","Fennings","Galpamol","Hedex","Infadrops","Infants' feverall","Injectapap","Junior parapaed","Mandanol","Medinol","Medinol for children","Medinol over 6","Medinol under 6","Medised plain","Miradol","Neopap","Ofirmev","Paldesic","Panadol","Panadol actifast","Panadol actifast solb","Panadol advan","Panadol jnr","Panadol oa","Panaleve","Panaleve 6 plus","Paracetamol","Paramin","Parapaed jnr","Parapaed six plus","Paravict","Perfalgan","Phenaphen","Placidex","Rimadol","Salzone","Tixymol","Tramil 500","Tylenol"],"synonyms":["Acetaminophen","Apap","Biocetamol","Doliprane","Efferalgan","N-acetyl-p-aminophenol","NSC-109028","NSC-3991","P-hydroxy-acetanilid","Paracetamol","Paracetamolum","Vermidon"],"drugType":"Small molecule","mechanismOfAction":"Cyclooxygenase inhibitor","targetName":"Cyclooxygenase"}
{"drugId":"CHEMBL112","targetId":"ENSG00000095303","diseaseId":"EFO_0010072","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02735122%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01920386%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01420653%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03224403%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00694369%22"}],"ancestors":["EFO_0003843","EFO_0000651","EFO_0003765"],"label":"toothache","approvedSymbol":"PTGS1","approvedName":"prostaglandin-endoperoxide synthase 1","targetClass":["Enzyme"],"prefName":"ACETAMINOPHEN","tradeNames":["Abdine","Acephen","Acetaminophen","Alvedon","Angiers","Calpol","Calpol six plus","Calpol six plus fastmelts","Child lemsip","Cupanol","Dafalgan","Datril","Disprol","Disprol infant","Disprol jnr","Disprol paed","Fennings","Galpamol","Hedex","Infadrops","Infants' feverall","Injectapap","Junior parapaed","Mandanol","Medinol","Medinol for children","Medinol over 6","Medinol under 6","Medised plain","Miradol","Neopap","Ofirmev","Paldesic","Panadol","Panadol actifast","Panadol actifast solb","Panadol advan","Panadol jnr","Panadol oa","Panaleve","Panaleve 6 plus","Paracetamol","Paramin","Parapaed jnr","Parapaed six plus","Paravict","Perfalgan","Phenaphen","Placidex","Rimadol","Salzone","Tixymol","Tramil 500","Tylenol"],"synonyms":["Acetaminophen","Apap","Biocetamol","Doliprane","Efferalgan","N-acetyl-p-aminophenol","NSC-109028","NSC-3991","P-hydroxy-acetanilid","Paracetamol","Paracetamolum","Vermidon"],"drugType":"Small molecule","mechanismOfAction":"Cyclooxygenase inhibitor","targetName":"Cyclooxygenase"}
{"drugId":"CHEMBL1180725","targetId":"ENSG00000168539","diseaseId":"EFO_0010282","phase":4,"urls":[{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=A03AB05"}],"ancestors":[],"label":"gastrointestinal disease","approvedSymbol":"CHRM1","approvedName":"cholinergic receptor muscarinic 1","targetClass":["Membrane receptor"],"prefName":"PROPANTHELINE","tradeNames":[],"synonyms":["Propantheline","Propantheline cation","Propantheline ion"],"drugType":"Small molecule","mechanismOfAction":"Muscarinic acetylcholine receptor M1 antagonist","targetName":"Muscarinic acetylcholine receptor M1"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000125675","diseaseId":"EFO_0010445","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02239913%22"}],"ancestors":["MONDO_0002025","MONDO_0002494"],"label":"cocaine use disorder","approvedSymbol":"GRIA3","approvedName":"glutamate ionotropic receptor AMPA type subunit 3","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"Glutamate receptor ionotropic AMPA antagonist","targetName":"Glutamate receptor ionotropic AMPA"}
{"drugId":"CHEMBL888","targetId":"ENSG00000148229","diseaseId":"EFO_1000026","phase":0,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02992015%22"}],"ancestors":["EFO_0005774","MONDO_0001657","MONDO_0021248","EFO_0007392","MONDO_0005499","MONDO_0100342","EFO_0000618","EFO_0000616","MONDO_0021193","EFO_1000142","MONDO_0003107","MONDO_0023370","EFO_0005543","MONDO_0045024","MONDO_0020665","MONDO_0004992","EFO_0009386","MONDO_0021079","EFO_0000326","EFO_0003833","MONDO_0003869","MONDO_0002912","EFO_1000654","MONDO_0002915","EFO_1001767","MONDO_0002914","MONDO_0037736","EFO_1000158"],"label":"diffuse intrinsic pontine glioma","approvedSymbol":"POLE3","approvedName":"DNA polymerase epsilon 3, accessory subunit","targetClass":["Unclassified protein"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL44657","targetId":"ENSG00000131747","diseaseId":"EFO_1000028","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02502708%22"}],"ancestors":["MONDO_0021193","MONDO_0021639","EFO_0005543","MONDO_0023370","MONDO_0021637","EFO_0000618","MONDO_0021248","MONDO_0045024","EFO_1000027","EFO_0009386","EFO_0000616"],"label":"ependymoma","approvedSymbol":"TOP2A","approvedName":"DNA topoisomerase II alpha","targetClass":["Enzyme"],"prefName":"ETOPOSIDE","tradeNames":["Etoposide","Toposar","Vepesid"],"synonyms":["Etoposide","Etoposide resolution mixture","Etoposidum","NSC-141540","Sintopozid","VP-16-213"],"drugType":"Small molecule","mechanismOfAction":"DNA topoisomerase II inhibitor","targetName":"DNA topoisomerase II"}
{"drugId":"CHEMBL1703","targetId":"ENSG00000212907","diseaseId":"EFO_1000043","phase":2,"status":"Suspended","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02122185%22"}],"ancestors":["MONDO_0024276","EFO_0005771","EFO_0006387","MONDO_0002149","MONDO_0002229","EFO_1000051","EFO_0003893","MONDO_0021148","EFO_0001075","EFO_0006460","EFO_0000512","EFO_0003825","EFO_0000313","MONDO_0008170","EFO_0009549","EFO_0002917","MONDO_0018364","EFO_0006858","EFO_1001331","EFO_0000616","OTAR_0000017","MONDO_0002259","MONDO_0023370","MONDO_0045024","MONDO_0004992","MONDO_0024885","MONDO_0021077","MONDO_0024621","MONDO_0037256","EFO_0000228","MONDO_0037255","EFO_0001379","EFO_1001962"],"label":"ovarian serous cystadenocarcinoma","approvedSymbol":"MT-ND4L","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L","targetClass":["Enzyme"],"prefName":"METFORMIN HYDROCHLORIDE","tradeNames":["Bolamyn sr","Diagemet xl","Fortamet","Glucamet 500","Glucamet 850","Glucient sr","Glucophage","Glucophage sr","Glucophage xr","Glumetza","Glyformin","Janumet","Ledermetin","Metabet sr","Metformin hydrochloride","Metsol","Milform","Orabet","Riomet","Riomet er","Sukkarto sr"],"synonyms":["Apophage","Benofomin","Diabefagos","Diabex","EX-404","EX404","Glucaminol","LA-6023","Metformin hcl","Metformin hydrochloride","NSC-91485","Neodipa","Siamformet","Walaphage"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1703","targetId":"ENSG00000213619","diseaseId":"EFO_1000043","phase":2,"status":"Suspended","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02122185%22"}],"ancestors":["MONDO_0024276","EFO_0005771","EFO_0006387","MONDO_0002149","MONDO_0002229","EFO_1000051","EFO_0003893","MONDO_0021148","EFO_0001075","EFO_0006460","EFO_0000512","EFO_0003825","EFO_0000313","MONDO_0008170","EFO_0009549","EFO_0002917","MONDO_0018364","EFO_0006858","EFO_1001331","EFO_0000616","OTAR_0000017","MONDO_0002259","MONDO_0023370","MONDO_0045024","MONDO_0004992","MONDO_0024885","MONDO_0021077","MONDO_0024621","MONDO_0037256","EFO_0000228","MONDO_0037255","EFO_0001379","EFO_1001962"],"label":"ovarian serous cystadenocarcinoma","approvedSymbol":"NDUFS3","approvedName":"NADH:ubiquinone oxidoreductase core subunit S3","targetClass":["Enzyme"],"prefName":"METFORMIN HYDROCHLORIDE","tradeNames":["Bolamyn sr","Diagemet xl","Fortamet","Glucamet 500","Glucamet 850","Glucient sr","Glucophage","Glucophage sr","Glucophage xr","Glumetza","Glyformin","Janumet","Ledermetin","Metabet sr","Metformin hydrochloride","Metsol","Milform","Orabet","Riomet","Riomet er","Sukkarto sr"],"synonyms":["Apophage","Benofomin","Diabefagos","Diabex","EX-404","EX404","Glucaminol","LA-6023","Metformin hcl","Metformin hydrochloride","NSC-91485","Neodipa","Siamformet","Walaphage"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1237022","targetId":"ENSG00000160712","diseaseId":"EFO_1000044","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03193190%22"}],"ancestors":["MONDO_0024276","MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0000228","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_0002618","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic adenocarcinoma","approvedSymbol":"IL6R","approvedName":"interleukin 6 receptor","targetClass":["Membrane receptor","Secreted protein"],"prefName":"TOCILIZUMAB","tradeNames":["Actemra","Actemra roactemra","Roactemra"],"synonyms":["ATLIZUMAB","Actemra","BAT-1806","BAT1806","Bat1806","MRA","MSB-11456","MSB11456","R-1569","RG-1569","RHPM-1","RO-4877533","Tocilizumab"],"drugType":"Antibody","mechanismOfAction":"Interleukin-6 receptor alpha subunit inhibitor","targetName":"Interleukin-6 receptor alpha subunit"}
{"drugId":"CHEMBL1637","targetId":"ENSG00000175482","diseaseId":"EFO_1000044","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02383433%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01897454%22"}],"ancestors":["MONDO_0024276","MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0000228","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_0002618","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic adenocarcinoma","approvedSymbol":"POLD4","approvedName":"DNA polymerase delta 4, accessory subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE HYDROCHLORIDE","tradeNames":["Gemcitabine hydrochloride","Gemzar","Infugem"],"synonyms":["Gemcitabine (as hydrochloride)","Gemcitabine hcl","Gemcitabine hydrochloride","Gemzar","LY-188011","LY-188011 HYDROCHLORIDE","LY188011 HYDROCHLORIDE"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1743006","targetId":"ENSG00000140443","diseaseId":"EFO_1000044","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00769483%22"}],"ancestors":["MONDO_0024276","MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0000228","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_0002618","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic adenocarcinoma","approvedSymbol":"IGF1R","approvedName":"insulin like growth factor 1 receptor","targetClass":["Enzyme"],"prefName":"DALOTUZUMAB","tradeNames":[],"synonyms":["Dalotuzumab","MK 0646","MK-0646","MK0646"],"drugType":"Antibody","mechanismOfAction":"Insulin-like growth factor I receptor antagonist","targetName":"Insulin-like growth factor I receptor"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000261456","diseaseId":"EFO_1000044","phase":1,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01971281%22"}],"ancestors":["MONDO_0024276","MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0000228","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_0002618","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic adenocarcinoma","approvedSymbol":"TUBB8","approvedName":"tubulin beta 8 class VIII","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL888","targetId":"ENSG00000146143","diseaseId":"EFO_1000044","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01360853%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01746979%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02436668%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00088894%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03943667%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03126435%22"}],"ancestors":["MONDO_0024276","MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0000228","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_0002618","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic adenocarcinoma","approvedSymbol":"PRIM2","approvedName":"DNA primase subunit 2","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL888","targetId":"ENSG00000077514","diseaseId":"EFO_1000044","phase":3,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04835064%22"}],"ancestors":["MONDO_0024276","MONDO_0002116","MONDO_0023370","EFO_0003860","MONDO_0045024","MONDO_0021076","MONDO_0004992","EFO_0000313","EFO_1000218","EFO_0000228","EFO_0001379","EFO_0009605","EFO_0008549","MONDO_0002516","EFO_0002618","EFO_1000359","EFO_0006858","EFO_0010282","EFO_0000616"],"label":"pancreatic adenocarcinoma","approvedSymbol":"POLD3","approvedName":"DNA polymerase delta 3, accessory subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000090266","diseaseId":"EFO_1000045","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02294006%22"}],"ancestors":["EFO_0007331","MONDO_0000386","MONDO_0023370","MONDO_0024503","EFO_0003860","MONDO_0045024","EFO_0003769","EFO_1001901","EFO_0001379","EFO_0008549","EFO_0009605","MONDO_0001933","EFO_0010282","EFO_0000616"],"label":"pancreatic neuroendocrine tumor","approvedSymbol":"NDUFB2","approvedName":"NADH:ubiquinone oxidoreductase subunit B2","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL3991432","targetId":"ENSG00000278195","diseaseId":"EFO_1000045","phase":2,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05247905%22"}],"ancestors":["EFO_0007331","MONDO_0000386","MONDO_0023370","MONDO_0024503","EFO_0003860","MONDO_0045024","EFO_0003769","EFO_1001901","EFO_0001379","EFO_0008549","EFO_0009605","MONDO_0001933","EFO_0010282","EFO_0000616"],"label":"pancreatic neuroendocrine tumor","approvedSymbol":"SSTR3","approvedName":"somatostatin receptor 3","targetClass":["Membrane receptor"],"prefName":"LUTETIUM DOTATATE","tradeNames":[],"synonyms":[],"drugType":"Unknown","mechanismOfAction":"Somatostatin receptor binding agent","targetName":"Somatostatin receptor"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000101162","diseaseId":"EFO_1000052","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01770301%22"}],"ancestors":["EFO_0000512","OTAR_0000017","MONDO_0023370","EFO_1000051","MONDO_0045024","EFO_0000616"],"label":"sex cord-stromal tumor","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000146143","diseaseId":"EFO_1000142","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03396575%22"}],"ancestors":["MONDO_0021193","MONDO_0003107","MONDO_0023370","EFO_0005543","EFO_0005774","MONDO_0001657","MONDO_0021248","MONDO_0045024","MONDO_0020665","EFO_0007392","MONDO_0004992","MONDO_0005499","EFO_0009386","EFO_0000326","EFO_0003833","MONDO_0100342","EFO_0000618","MONDO_0002912","EFO_1001767","EFO_1000158","EFO_0000616"],"label":"Brain Stem Glioma","approvedSymbol":"PRIM2","approvedName":"DNA primase subunit 2","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL547","targetId":"ENSG00000077092","diseaseId":"EFO_1000158","phase":3,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003564%22"}],"ancestors":["MONDO_0023370","EFO_0000618","MONDO_0021248","MONDO_0045024","EFO_0009386","EFO_0000616"],"label":"Central Nervous System Neoplasm","approvedSymbol":"RARB","approvedName":"retinoic acid receptor beta","targetClass":["Transcription factor"],"prefName":"ISOTRETINOIN","tradeNames":["Absorica","Absorica ld","Accutane","Amnesteem","Claravis","Isotrex","Myorisan","Roaccutane","Sotret","Zenatane"],"synonyms":["13 Cis-Retinoic Acid","13-cis-retinoic acid","Isotretinoin","NSC-758156","PAT-001","RO 4-3780","RO-4-3780","RO-43780","Retinoic acid 13-cis-form","Retinoic acid, 13-cis-","Vitamin a acid, 13-cis"],"drugType":"Small molecule","mechanismOfAction":"Retinoic acid receptor agonist","targetName":"Retinoic acid receptor"}
{"drugId":"CHEMBL1201752","targetId":"ENSG00000258947","diseaseId":"EFO_1000231","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00977574%22"}],"ancestors":["MONDO_0024276","EFO_0005232","MONDO_0002149","EFO_1000051","MONDO_0021148","EFO_0000512","EFO_0000313","EFO_0002919","EFO_1001512","EFO_0009549","EFO_0006858","EFO_1001331","EFO_0000616","OTAR_0000017","MONDO_0002654","MONDO_0021251","MONDO_0023370","MONDO_0000931","MONDO_0045024","MONDO_0004992","EFO_0000228","EFO_0000348","MONDO_0002715","MONDO_0011962","EFO_0003859"],"label":"Endometrial Clear Cell Adenocarcinoma","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"IXABEPILONE","tradeNames":["Ixempra","Ixempra kit"],"synonyms":["Azaepothilone b","BMS 247550-01","BMS-247550","BMS-247550-01","Ixabepilone","Ixempra","NSC-747973"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1703","targetId":"ENSG00000023228","diseaseId":"EFO_1000235","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04576104%22"}],"ancestors":["EFO_0000512","OTAR_0000017","MONDO_0002654","MONDO_0023370","EFO_1000051","EFO_0009549","MONDO_0021148","MONDO_0045024","EFO_0004230","EFO_0003859","EFO_0000616"],"label":"Endometrial Intraepithelial Neoplasia","approvedSymbol":"NDUFS1","approvedName":"NADH:ubiquinone oxidoreductase core subunit S1","targetClass":["Enzyme"],"prefName":"METFORMIN HYDROCHLORIDE","tradeNames":["Bolamyn sr","Diagemet xl","Fortamet","Glucamet 500","Glucamet 850","Glucient sr","Glucophage","Glucophage sr","Glucophage xr","Glumetza","Glyformin","Janumet","Ledermetin","Metabet sr","Metformin hydrochloride","Metsol","Milform","Orabet","Riomet","Riomet er","Sukkarto sr"],"synonyms":["Apophage","Benofomin","Diabefagos","Diabex","EX-404","EX404","Glucaminol","LA-6023","Metformin hcl","Metformin hydrochloride","NSC-91485","Neodipa","Siamformet","Walaphage"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000196230","diseaseId":"EFO_1000242","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02020707%22"}],"ancestors":["OTAR_0000017","MONDO_0002654","MONDO_0021251","EFO_0006772","MONDO_0002149","MONDO_0023370","EFO_1000051","MONDO_0000931","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0000313","EFO_0002919","MONDO_0002715","EFO_1001512","EFO_0009549","MONDO_0011962","EFO_0006858","EFO_1001331","EFO_0000616","EFO_0003859"],"label":"Endometrial Undifferentiated Carcinoma","approvedSymbol":"TUBB","approvedName":"tubulin beta class I","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1201438","targetId":"ENSG00000100385","diseaseId":"EFO_1000251","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02470559%22"}],"ancestors":["OTAR_0000017","MONDO_0002158","MONDO_0002149","MONDO_0023370","MONDO_0021092","EFO_0009548","EFO_1000051","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0000313","EFO_0009549","EFO_0006858","EFO_1001331","EFO_0000616"],"label":"Fallopian Tube Carcinoma","approvedSymbol":"IL2RB","approvedName":"interleukin 2 receptor subunit beta","targetClass":["Membrane receptor"],"prefName":"ALDESLEUKIN","tradeNames":["Proleukin"],"synonyms":["Aldesleukin","Human interleukin-2","Human interleukin-2 125-serine","ILT-101","Ilt-101","Ilt-101 (low dose il-2)","Interleukin 2","Interleukin-2","Interleukin-2 aldesleukin","Interleukin-2(2-133),125-ser","Recombinant interleukin-2 human"],"drugType":"Protein","mechanismOfAction":"Interleukin-2 receptor agonist","targetName":"Interleukin-2 receptor"}
{"drugId":"CHEMBL1637","targetId":"ENSG00000198056","diseaseId":"EFO_1000314","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03587662%22"}],"ancestors":["MONDO_0024276","MONDO_0002367","MONDO_0023370","EFO_0002890","EFO_0009690","EFO_0000681","MONDO_0045024","MONDO_0004992","MONDO_0021066","EFO_0003086","EFO_0000313","EFO_0000228","EFO_0003865","EFO_1000363","EFO_0006858","EFO_0000616"],"label":"Kidney Medullary Carcinoma","approvedSymbol":"PRIM1","approvedName":"DNA primase subunit 1","targetClass":["Enzyme"],"prefName":"GEMCITABINE HYDROCHLORIDE","tradeNames":["Gemcitabine hydrochloride","Gemzar","Infugem"],"synonyms":["Gemcitabine (as hydrochloride)","Gemcitabine hcl","Gemcitabine hydrochloride","Gemzar","LY-188011","LY-188011 HYDROCHLORIDE","LY188011 HYDROCHLORIDE"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL477772","targetId":"ENSG00000157404","diseaseId":"EFO_1000314","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01767636%22"}],"ancestors":["MONDO_0024276","MONDO_0002367","MONDO_0023370","EFO_0002890","EFO_0009690","EFO_0000681","MONDO_0045024","MONDO_0004992","MONDO_0021066","EFO_0003086","EFO_0000313","EFO_0000228","EFO_0003865","EFO_1000363","EFO_0006858","EFO_0000616"],"label":"Kidney Medullary Carcinoma","approvedSymbol":"KIT","approvedName":"KIT proto-oncogene, receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"PAZOPANIB","tradeNames":["Votrient"],"synonyms":["GW786034","NSC-752782","Pazopanib"],"drugType":"Small molecule","mechanismOfAction":"Stem cell growth factor receptor inhibitor","targetName":"Stem cell growth factor receptor"}
{"drugId":"CHEMBL888","targetId":"ENSG00000167325","diseaseId":"EFO_1000314","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03587662%22"}],"ancestors":["MONDO_0024276","MONDO_0002367","MONDO_0023370","EFO_0002890","EFO_0009690","EFO_0000681","MONDO_0045024","MONDO_0004992","MONDO_0021066","EFO_0003086","EFO_0000313","EFO_0000228","EFO_0003865","EFO_1000363","EFO_0006858","EFO_0000616"],"label":"Kidney Medullary Carcinoma","approvedSymbol":"RRM1","approvedName":"ribonucleotide reductase catalytic subunit M1","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"Ribonucleoside-diphosphate reductase RR1 inhibitor","targetName":"Ribonucleoside-diphosphate reductase RR1"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000147123","diseaseId":"EFO_1000357","phase":2,"status":"Suspended","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02122185%22"}],"ancestors":["EFO_0000512","OTAR_0000017","EFO_0005771","MONDO_0002259","EFO_0001379","MONDO_0023370","EFO_1000051","EFO_0003893","EFO_0009549","MONDO_0021148","MONDO_0045024","EFO_0000616"],"label":"Malignant Ovarian Brenner Tumor","approvedSymbol":"NDUFB11","approvedName":"NADH:ubiquinone oxidoreductase subunit B11","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL2108628","targetId":"ENSG00000188229","diseaseId":"EFO_1000357","phase":3,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00108745%22"}],"ancestors":["EFO_0000512","OTAR_0000017","EFO_0005771","MONDO_0002259","EFO_0001379","MONDO_0023370","EFO_1000051","EFO_0003893","EFO_0009549","MONDO_0021148","MONDO_0045024","EFO_0000616"],"label":"Malignant Ovarian Brenner Tumor","approvedSymbol":"TUBB4B","approvedName":"tubulin beta 4B class IVb","targetClass":["Structural protein"],"prefName":"PACLITAXEL POLIGLUMEX","tradeNames":["Xyotax"],"synonyms":["CT-2103","L-polyglutamic paclitaxel","Opaxio","PG-TXL","Paclitaxel conjugate with poly-l-glutamic acid","Paclitaxel poliglumex"],"drugType":"Small molecule","mechanismOfAction":"Tubulin stabiliser","targetName":"Tubulin"}
{"drugId":"CHEMBL679","targetId":"ENSG00000169252","diseaseId":"EFO_1000391","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03228914%22"}],"ancestors":["EFO_0000684","EFO_0000662","MONDO_0004867","OTAR_0000010","MONDO_0045024","MONDO_0002232"],"label":"Nasal Cavity Polyp","approvedSymbol":"ADRB2","approvedName":"adrenoceptor beta 2","targetClass":["Membrane receptor"],"prefName":"EPINEPHRINE","tradeNames":["Adren co","Adrenaclick","Adrenalin","Ana-Kit","Ana-guard","Anapen","Anaphylactic shock drug kit","Asma-vydrin","Asthmahaler","Auvi-q","Bronkaid mist","Brovon","Emerade","Epi e z pen jr","Epinephrine","Epinephrine (copackaged)","Epipen","Epipen e z pen","Epipen jr","Epipen jr.","Eppy","Gppe inh soln","Jext","Medihaler-epi","Primatene","Primatene mist","Riddobron","Riddofan","Rybarvin","Simplene","Soln made to rybarvin for","Sus-Phrine","Sus-Phrine Sulfite-Free","Sus-phrine sulfite free","Symjepi","Twinject 0.15","Twinject 0.3"],"synonyms":["(-)-(r)-epinephrine","(-)-epinephrine","Adrenaline","Adrenalinum","Epinephrine","Epinephrine hcl","Epinephrine hydrochloride","Epinephrinum","Glauposine","L-epinephrine hydrochloride","Levo-methylaminoethanolcatechol","NSC-62786","Nephridine","Racepinefrine, (r)-","Sus-phrine sulphite-free","Susphrine","Tonogen","Twinject"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor agonist","targetName":"Adrenergic receptor"}
{"drugId":"CHEMBL762","targetId":"ENSG00000150594","diseaseId":"EFO_1000391","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03228914%22"}],"ancestors":["EFO_0000684","EFO_0000662","MONDO_0004867","OTAR_0000010","MONDO_0045024","MONDO_0002232"],"label":"Nasal Cavity Polyp","approvedSymbol":"ADRA2A","approvedName":"adrenoceptor alpha 2A","targetClass":["Membrane receptor"],"prefName":"OXYMETAZOLINE","tradeNames":[],"synonyms":["Nasacon","Ocuclear","Operil","Oxymetazoline"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor alpha agonist","targetName":"Adrenergic receptor alpha"}
{"drugId":"CHEMBL1201583","targetId":"ENSG00000112715","diseaseId":"EFO_1000412","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00085358%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00989651%22"}],"ancestors":["EFO_0005771","MONDO_0002149","MONDO_0002229","EFO_1000051","MONDO_0003812","EFO_0003893","EFO_0001075","MONDO_0021148","MONDO_0002480","MONDO_0021043","EFO_0000512","EFO_0000313","MONDO_0008170","EFO_0009549","MONDO_0018364","MONDO_0002928","EFO_0006858","EFO_1001331","EFO_0000616","OTAR_0000017","MONDO_0002259","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0001379","EFO_1000356"],"label":"Ovarian Carcinosarcoma","approvedSymbol":"VEGFA","approvedName":"vascular endothelial growth factor A","targetClass":["Secreted protein"],"prefName":"BEVACIZUMAB","tradeNames":["Avastin"],"synonyms":["12-IGG1","AVA-1","Abp-215","BI 695502","BS-503A","Bevacizumab","Bevacizumab beta","Bevacizumab biosimilar (fkb-238)","Bevacizumab-awwb","Bevacizumab-bvzr","Bi-695502","Bs-503","Byvasda","CHS-5217","CT-16","CT-P16","CT-P16 (BIOSIMILAR OF BEVACIZUMAB)","Ct-16","Ct-p16","FKB-238","Fkb238","HLX-04","HLX04","Ibi-305","Ibi305","Mvasi","PF-06439535","Pf-06439535","R-435","RG-435","RHUMAB-","RHUMAB-VEGF","Usp mab 002, monoclonal igg1","Zirabev"],"drugType":"Antibody","mechanismOfAction":"Vascular endothelial growth factor A inhibitor","targetName":"Vascular endothelial growth factor A"}
{"drugId":"CHEMBL2108628","targetId":"ENSG00000176014","diseaseId":"EFO_1000435","phase":3,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00108745%22"}],"ancestors":["OTAR_0000017","EFO_0005771","MONDO_0002259","MONDO_0002149","MONDO_0023370","MONDO_0002229","EFO_1000051","EFO_0003893","EFO_0001075","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0000313","MONDO_0008170","EFO_0001379","EFO_0009549","EFO_1000601","MONDO_0018364","EFO_0006858","EFO_1001331","EFO_0000616"],"label":"Ovarian Transitional Cell Carcinoma","approvedSymbol":"TUBB6","approvedName":"tubulin beta 6 class V","targetClass":["Structural protein"],"prefName":"PACLITAXEL POLIGLUMEX","tradeNames":["Xyotax"],"synonyms":["CT-2103","L-polyglutamic paclitaxel","Opaxio","PG-TXL","Paclitaxel conjugate with poly-l-glutamic acid","Paclitaxel poliglumex"],"drugType":"Small molecule","mechanismOfAction":"Tubulin stabiliser","targetName":"Tubulin"}
{"drugId":"CHEMBL1614701","targetId":"ENSG00000169032","diseaseId":"EFO_1000489","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02393690%22"}],"ancestors":["EFO_0000313","MONDO_0024276","EFO_0000228","EFO_0001379","MONDO_0023370","MONDO_0045024","EFO_0006858","MONDO_0004992","EFO_0000616"],"label":"Poorly Differentiated Thyroid Gland Carcinoma","approvedSymbol":"MAP2K1","approvedName":"mitogen-activated protein kinase kinase 1","targetClass":["Enzyme"],"prefName":"SELUMETINIB","tradeNames":[],"synonyms":["ARRY-142886","ARRY-886","AZD-6244","AZD6244","Azd-6244","Selumetinib"],"drugType":"Small molecule","mechanismOfAction":"Dual specificity mitogen-activated protein kinase kinase 1 inhibitor","targetName":"Dual specificity mitogen-activated protein kinase kinase 1"}
{"drugId":"CHEMBL535","targetId":"ENSG00000113721","diseaseId":"EFO_1000581","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03449173%22"}],"ancestors":["EFO_0002626","EFO_0003769","MONDO_0002334","EFO_0001379","EFO_0000540","MONDO_0023370","MONDO_0018079","MONDO_0045024","MONDO_0003393","EFO_0006858","EFO_0005803","EFO_0000616"],"label":"Thymoma","approvedSymbol":"PDGFRB","approvedName":"platelet derived growth factor receptor beta","targetClass":["Enzyme"],"prefName":"SUNITINIB","tradeNames":["Sutent"],"synonyms":["NSC-736511","NSC-750690","SU-011248","SU-11248","SU011248","Sunitinib","Sutent"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","targetName":"Platelet-derived growth factor receptor"}
{"drugId":"CHEMBL2108738","targetId":"ENSG00000188389","diseaseId":"EFO_1000616","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02626962%22"}],"ancestors":["MONDO_0002236","EFO_1001230","MONDO_0023370","EFO_0005950","MONDO_0021069","MONDO_0021225","MONDO_0045024","MONDO_0024458","MONDO_0021248","MONDO_0004992","EFO_0007392","MONDO_0021143","MONDO_0002661","EFO_0003769","EFO_0003824","EFO_0000756","EFO_0003966","EFO_1001901","EFO_0001379","EFO_0000618","MONDO_0000649","EFO_1000403","EFO_0006859","EFO_0000616"],"label":"Uveal Melanoma","approvedSymbol":"PDCD1","approvedName":"programmed cell death 1","targetClass":["Surface antigen"],"prefName":"NIVOLUMAB","tradeNames":["Opdivo"],"synonyms":["BMS-936558","BMS-986298","MDX-1106","Nivolumab","ONO-4538"],"drugType":"Antibody","mechanismOfAction":"Programmed cell death protein 1 inhibitor","targetName":"Programmed cell death protein 1"}
{"drugId":"CHEMBL3590106","targetId":"ENSG00000100030","diseaseId":"EFO_1000616","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03417739%22"}],"ancestors":["MONDO_0002236","EFO_1001230","MONDO_0023370","EFO_0005950","MONDO_0021069","MONDO_0021225","MONDO_0045024","MONDO_0024458","MONDO_0021248","MONDO_0004992","EFO_0007392","MONDO_0021143","MONDO_0002661","EFO_0003769","EFO_0003824","EFO_0000756","EFO_0003966","EFO_1001901","EFO_0001379","EFO_0000618","MONDO_0000649","EFO_1000403","EFO_0006859","EFO_0000616"],"label":"Uveal Melanoma","approvedSymbol":"MAPK1","approvedName":"mitogen-activated protein kinase 1","targetClass":["Enzyme"],"prefName":"ULIXERTINIB","tradeNames":[],"synonyms":["BVD-ERK","Bvd-523","Ulixertinib","VRT-752271"],"drugType":"Small molecule","mechanismOfAction":"MAP kinase ERK2 inhibitor","targetName":"MAP kinase ERK2"}
{"drugId":"CHEMBL284348","targetId":"ENSG00000183960","diseaseId":"EFO_1000632","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01468350%22"}],"ancestors":["EFO_0005774","EFO_1000631","EFO_0000618","MONDO_0044996","EFO_0009386"],"label":"cerebral palsy","approvedSymbol":"KCNH8","approvedName":"potassium voltage-gated channel subfamily H member 8","targetClass":["Ion channel"],"prefName":"DALFAMPRIDINE","tradeNames":["Ampyra","Ampyra Extended Release","Fampyra","Neurelan"],"synonyms":["Dalfampridine","EL-970","Fampridine","Fampridine (4-aminopyridine)","NSC-15041"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated potassium channel blocker","targetName":"Voltage-gated potassium channel"}
{"drugId":"CHEMBL660","targetId":"ENSG00000273079","diseaseId":"EFO_1000632","phase":4,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04273737%22"}],"ancestors":["EFO_0005774","EFO_1000631","EFO_0000618","MONDO_0044996","EFO_0009386"],"label":"cerebral palsy","approvedSymbol":"GRIN2B","approvedName":"glutamate ionotropic receptor NMDA type subunit 2B","targetClass":["Ion channel"],"prefName":"AMANTADINE","tradeNames":[],"synonyms":["Amantadine","Amantidine","NSC-341865","Symadine","Symmetrel","TCMDC-125869"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor antagonist","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL112","targetId":"ENSG00000095303","diseaseId":"EFO_1000652","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02126332%22"}],"ancestors":["EFO_0001379","EFO_0000278","EFO_0009605","EFO_0010282"],"label":"acute pancreatitis","approvedSymbol":"PTGS1","approvedName":"prostaglandin-endoperoxide synthase 1","targetClass":["Enzyme"],"prefName":"ACETAMINOPHEN","tradeNames":["Abdine","Acephen","Acetaminophen","Alvedon","Angiers","Calpol","Calpol six plus","Calpol six plus fastmelts","Child lemsip","Cupanol","Dafalgan","Datril","Disprol","Disprol infant","Disprol jnr","Disprol paed","Fennings","Galpamol","Hedex","Infadrops","Infants' feverall","Injectapap","Junior parapaed","Mandanol","Medinol","Medinol for children","Medinol over 6","Medinol under 6","Medised plain","Miradol","Neopap","Ofirmev","Paldesic","Panadol","Panadol actifast","Panadol actifast solb","Panadol advan","Panadol jnr","Panadol oa","Panaleve","Panaleve 6 plus","Paracetamol","Paramin","Parapaed jnr","Parapaed six plus","Paravict","Perfalgan","Phenaphen","Placidex","Rimadol","Salzone","Tixymol","Tramil 500","Tylenol"],"synonyms":["Acetaminophen","Apap","Biocetamol","Doliprane","Efferalgan","N-acetyl-p-aminophenol","NSC-109028","NSC-3991","P-hydroxy-acetanilid","Paracetamol","Paracetamolum","Vermidon"],"drugType":"Small molecule","mechanismOfAction":"Cyclooxygenase inhibitor","targetName":"Cyclooxygenase"}
{"drugId":"CHEMBL1079175","targetId":"ENSG00000117020","diseaseId":"EFO_1000657","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01186705%22"}],"ancestors":["EFO_0009685","EFO_0007330","EFO_0009431","MONDO_0023370","MONDO_0024634","MONDO_0045024","MONDO_0004992","EFO_0004142","MONDO_0002165","MONDO_0021118","EFO_0008549","EFO_0005842","MONDO_0002516","EFO_0010282","EFO_0000616"],"label":"rectum cancer","approvedSymbol":"AKT3","approvedName":"AKT serine/threonine kinase 3","targetClass":["Enzyme"],"prefName":"MK-2206","tradeNames":[],"synonyms":["MK-2206","MK2206","Mk-2206"],"drugType":"Small molecule","mechanismOfAction":"Serine/threonine-protein kinase AKT inhibitor","targetName":"Serine/threonine-protein kinase AKT"}
{"drugId":"CHEMBL1336","targetId":"ENSG00000102755","diseaseId":"EFO_1000657","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00134069%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01376453%22"}],"ancestors":["EFO_0009685","EFO_0007330","EFO_0009431","MONDO_0023370","MONDO_0024634","MONDO_0045024","MONDO_0004992","EFO_0004142","MONDO_0002165","MONDO_0021118","EFO_0008549","EFO_0005842","MONDO_0002516","EFO_0010282","EFO_0000616"],"label":"rectum cancer","approvedSymbol":"FLT1","approvedName":"fms related receptor tyrosine kinase 1","targetClass":["Enzyme"],"prefName":"SORAFENIB","tradeNames":["Nexavar"],"synonyms":["BAY 43-9006","BAY-43-9006","Sorafenib"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000004779","diseaseId":"EFO_1000657","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02473094%22"}],"ancestors":["EFO_0009685","EFO_0007330","EFO_0009431","MONDO_0023370","MONDO_0024634","MONDO_0045024","MONDO_0004992","EFO_0004142","MONDO_0002165","MONDO_0021118","EFO_0008549","EFO_0005842","MONDO_0002516","EFO_0010282","EFO_0000616"],"label":"rectum cancer","approvedSymbol":"NDUFAB1","approvedName":"NADH:ubiquinone oxidoreductase subunit AB1","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1946170","targetId":"ENSG00000077782","diseaseId":"EFO_1000657","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02287727%22"}],"ancestors":["EFO_0009685","EFO_0007330","EFO_0009431","MONDO_0023370","MONDO_0024634","MONDO_0045024","MONDO_0004992","EFO_0004142","MONDO_0002165","MONDO_0021118","EFO_0008549","EFO_0005842","MONDO_0002516","EFO_0010282","EFO_0000616"],"label":"rectum cancer","approvedSymbol":"FGFR1","approvedName":"fibroblast growth factor receptor 1","targetClass":["Enzyme"],"prefName":"REGORAFENIB","tradeNames":["Stivarga"],"synonyms":["BAY 73-4506","BAY 73-4506 monohydrate","BAY-73-4506","BAY-734506","Regorafenib"],"drugType":"Small molecule","mechanismOfAction":"Fibroblast growth factor receptor 1 inhibitor","targetName":"Fibroblast growth factor receptor 1"}
{"drugId":"CHEMBL888","targetId":"ENSG00000175482","diseaseId":"EFO_1000657","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02919878%22"}],"ancestors":["EFO_0009685","EFO_0007330","EFO_0009431","MONDO_0023370","MONDO_0024634","MONDO_0045024","MONDO_0004992","EFO_0004142","MONDO_0002165","MONDO_0021118","EFO_0008549","EFO_0005842","MONDO_0002516","EFO_0010282","EFO_0000616"],"label":"rectum cancer","approvedSymbol":"POLD4","approvedName":"DNA polymerase delta 4, accessory subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198695","diseaseId":"EFO_1000710","phase":3,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04649502%22"}],"ancestors":["EFO_0000701","MONDO_0002260","EFO_1002046","EFO_0010285","EFO_1000772"],"label":"hidradenitis suppurativa","approvedSymbol":"MT-ND6","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198888","diseaseId":"EFO_1000710","phase":3,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04649502%22"}],"ancestors":["EFO_0000701","MONDO_0002260","EFO_1002046","EFO_0010285","EFO_1000772"],"label":"hidradenitis suppurativa","approvedSymbol":"MT-ND1","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL705","targetId":"ENSG00000204231","diseaseId":"EFO_1000726","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01538732%22"}],"ancestors":["EFO_0000701","EFO_1000724","MONDO_0002406","EFO_0010285"],"label":"lichen planus","approvedSymbol":"RXRB","approvedName":"retinoid X receptor beta","targetClass":["Transcription factor"],"prefName":"ALITRETINOIN","tradeNames":["Panretin","Toctino"],"synonyms":["9-cis retinoic acid","9-cis-retinoic acid","AGN 192013","AGN-192013","ALRT-1057","ALRT1057","Alitretinoin","BAL-4079","LG-100057","LG100057","LGD-1057","LGD1057","NSC-659772","Panretin","Retinoic acid 9-cis-form"],"drugType":"Small molecule","mechanismOfAction":"Retinoid receptor agonist","targetName":"Retinoid receptor"}
{"drugId":"CHEMBL1046","targetId":"ENSG00000104368","diseaseId":"EFO_1000760","phase":0,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01398280%22"}],"ancestors":["EFO_0000701","EFO_0010285"],"label":"rosacea","approvedSymbol":"PLAT","approvedName":"plasminogen activator, tissue type","targetClass":["Enzyme"],"prefName":"AMINOCAPROIC ACID","tradeNames":["Amicar","Aminocaproic","Aminocaproic acid","Epsikapron"],"synonyms":[".epsilon.-aminocaproic acid","177 J.D","177 J.D.","177 JD","177-JD","6-aminocaproic acid","Aminocaproic acid","CL 10304","CL-10304","CY-116","EACA","Epsilcapramin","Epsilon-aminocaproic acid","Hexanoic acid, 6-amino-","NSC-26154","NSC-400230"],"drugType":"Small molecule","mechanismOfAction":"Tissue-type plasminogen activator inhibitor","targetName":"Tissue-type plasminogen activator"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198763","diseaseId":"EFO_1000782","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02463357%22"}],"ancestors":["EFO_0000546","EFO_0000684","OTAR_0000010","OTAR_0000009"],"label":"altitude sickness","approvedSymbol":"MT-ND2","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL79","targetId":"ENSG00000168356","diseaseId":"EFO_1000783","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04106050%22"}],"ancestors":["EFO_0009387","EFO_0009532","EFO_1001902","EFO_0004149","EFO_0000618","EFO_0003100","EFO_0009386"],"label":"diabetic neuropathy","approvedSymbol":"SCN11A","approvedName":"sodium voltage-gated channel alpha subunit 11","targetClass":["Ion channel"],"prefName":"LIDOCAINE","tradeNames":["Alphacaine","Anestacon","Dentipatch","Lidocaine","Lidoderm","Lignocaine Hcl","Lignostab","Lmx 4","Oraqix","Vagisil","Xylocaine","Xylodase","Xylotox","Ztlido"],"synonyms":["ALGRX 3268","ALGRX-3268","Anestacon","Embolex","Iontocaine","Lidocaine","Lidocainum","Lidocaton","Lidopen","Lignocaine","NSC-40030","Octocaine","Solarcaine","Xylestesin"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000146143","diseaseId":"EFO_1000785","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00047060%22"}],"ancestors":["MONDO_0015817","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0015758","EFO_0005803","EFO_0002913","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0002898","MONDO_0000653","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0004198","MONDO_0018898","MONDO_0017207","EFO_0000701","EFO_0005952","EFO_0000508","MONDO_0019044","EFO_0010285","MONDO_0015760"],"label":"Sezary's disease","approvedSymbol":"PRIM2","approvedName":"DNA primase subunit 2","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL79","targetId":"ENSG00000168356","diseaseId":"EFO_1000789","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02102620%22"}],"ancestors":["EFO_0004260","OTAR_0000006","EFO_0009676","EFO_1000999","MONDO_0002614","EFO_0005755","EFO_0002461","EFO_1001986","EFO_0005856","MONDO_0005178"],"label":"osteoarthritis, hand","approvedSymbol":"SCN11A","approvedName":"sodium voltage-gated channel alpha subunit 11","targetClass":["Ion channel"],"prefName":"LIDOCAINE","tradeNames":["Alphacaine","Anestacon","Dentipatch","Lidocaine","Lidoderm","Lignocaine Hcl","Lignostab","Lmx 4","Oraqix","Vagisil","Xylocaine","Xylodase","Xylotox","Ztlido"],"synonyms":["ALGRX 3268","ALGRX-3268","Anestacon","Embolex","Iontocaine","Lidocaine","Lidocainum","Lidocaton","Lidopen","Lignocaine","NSC-40030","Octocaine","Solarcaine","Xylestesin"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL413376","targetId":"ENSG00000113578","diseaseId":"EFO_1000796","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002921%22"}],"ancestors":["MONDO_0024276","MONDO_0024296","MONDO_0002367","MONDO_0021080","EFO_0003850","MONDO_0021069","MONDO_0024757","EFO_0009690","EFO_0000681","EFO_0004264","MONDO_0021066","MONDO_0002100","EFO_0003769","EFO_0000313","EFO_0003865","MONDO_0036591","EFO_1000363","EFO_0006858","MONDO_0015077","EFO_0000616","EFO_0000319","EFO_0007466","MONDO_0023370","MONDO_0001502","MONDO_0021312","EFO_0002890","MONDO_0024645","MONDO_0045024","MONDO_0002095","MONDO_0004992","EFO_0003086","EFO_0000228","EFO_0001379","MONDO_0002814","MONDO_0002816","MONDO_0002817","EFO_0005539"],"label":"adrenal cortex carcinoma","approvedSymbol":"FGF1","approvedName":"fibroblast growth factor 1","targetClass":["Enzyme","Unclassified protein","Secreted protein"],"prefName":"SURAMIN HEXASODIUM","tradeNames":[],"synonyms":["BAY-205","BAYER-205","CI-1003","FOURNEAU 309","FOURNEAU-309","NF-060","NSC-758165","Nagananinum","Naphuride","Suramin hexasodium","Suramin sodium","Suraminum natricum"],"drugType":"Small molecule","mechanismOfAction":"Acidic fibroblast growth factor inhibitor","targetName":"Acidic fibroblast growth factor"}
{"drugId":"CHEMBL284348","targetId":"ENSG00000053918","diseaseId":"EFO_1000809","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01975324%22"}],"ancestors":["MONDO_0002135","MONDO_0003569","EFO_0004149","EFO_0000618","MONDO_0024458","EFO_0009386"],"label":"anterior ischemic optic neuropathy","approvedSymbol":"KCNQ1","approvedName":"potassium voltage-gated channel subfamily Q member 1","targetClass":["Ion channel","Auxiliary transport protein","Enzyme"],"prefName":"DALFAMPRIDINE","tradeNames":["Ampyra","Ampyra Extended Release","Fampyra","Neurelan"],"synonyms":["Dalfampridine","EL-970","Fampridine","Fampridine (4-aminopyridine)","NSC-15041"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated potassium channel blocker","targetName":"Voltage-gated potassium channel"}
{"drugId":"CHEMBL1152","targetId":"ENSG00000113580","diseaseId":"EFO_1000906","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04184999%22"}],"ancestors":["EFO_0009464","EFO_0003966","EFO_0009455","EFO_0009546","EFO_0009449","MONDO_0004768","EFO_0009547","MONDO_0024458","EFO_0009450","EFO_1000203"],"label":"dry eye syndrome","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"PREDNISOLONE ACETATE","tradeNames":["Econopred","Flo-pred","Meticortelone","Omnipred","Pred forte","Pred fte","Pred mild","Prednisolone acetate","Sterane","Ultracortenol"],"synonyms":["NSC-10966","Prednisolone 21-acetate","Prednisolone Acetate","Prednisolone acetate","Prednisoloni acetas"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL160","targetId":"ENSG00000196262","diseaseId":"EFO_1000906","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00399061%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04342988%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04555694%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00349440%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00477763%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04426240%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00407043%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04127851%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02121847%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00567177%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00405457%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02554981%22"}],"ancestors":["EFO_0009464","EFO_0003966","EFO_0009455","EFO_0009546","EFO_0009449","MONDO_0004768","EFO_0009547","MONDO_0024458","EFO_0009450","EFO_1000203"],"label":"dry eye syndrome","approvedSymbol":"PPIA","approvedName":"peptidylprolyl isomerase A","targetClass":["Enzyme"],"prefName":"CYCLOSPORINE","tradeNames":["Capimune","Capsorin","Cequa","Cyclosporine","Deximune","Gengraf","Ikervis","Neoral","Optimmune","Restasis","Restasis multidose","Sandimmun","Sandimmune","Sangcya","Vanquoral","Verkazia"],"synonyms":["27-400","ANTIBIOTIC S-7481F1","Atopica","Ciclosporin","Ciclosporin a","Ciclosporinum","Cyclosporin","Cyclosporin a","Cyclosporine","Cyclosporine a","Cyclosporine microemulsion","Cyclosporine, modified","Equoral","Mitogard","NSC-290193","Neoplanta","Neurostat","OL-27-400","Ramihyphin a","SANG-35","SDZ-OXL-400","Zinograf me"],"drugType":"Protein","mechanismOfAction":"Cyclophilin A modulator","targetName":"Cyclophilin A"}
{"drugId":"CHEMBL2104753","targetId":"ENSG00000132170","diseaseId":"EFO_1000906","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01118754%22"}],"ancestors":["EFO_0009464","EFO_0003966","EFO_0009455","EFO_0009546","EFO_0009449","MONDO_0004768","EFO_0009547","MONDO_0024458","EFO_0009450","EFO_1000203"],"label":"dry eye syndrome","approvedSymbol":"PPARG","approvedName":"peroxisome proliferator activated receptor gamma","targetClass":["Transcription factor","Unclassified protein","Epigenetic regulator"],"prefName":"RIVOGLITAZONE","tradeNames":[],"synonyms":["CS-011","DE-101","R 106056","R-106056","Rivoglitazone"],"drugType":"Small molecule","mechanismOfAction":"Peroxisome proliferator-activated receptor gamma agonist","targetName":"Peroxisome proliferator-activated receptor gamma"}
{"drugId":"CHEMBL2105741","targetId":"ENSG00000169032","diseaseId":"EFO_1000926","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03794297%22"}],"ancestors":["EFO_0007352","OTAR_0000006","MONDO_0017955","EFO_0009676","EFO_0000540","MONDO_0019751","EFO_0005755","EFO_0002461","EFO_1001986","MONDO_0044986","EFO_0005803","MONDO_0015531"],"label":"Erdheim-Chester disease","approvedSymbol":"MAP2K1","approvedName":"mitogen-activated protein kinase kinase 1","targetClass":["Enzyme"],"prefName":"TRAMETINIB DIMETHYL SULFOXIDE","tradeNames":["Mekinist"],"synonyms":["GSK-1120212B","GSK1120212B","Trametinib dimethyl sulfoxide"],"drugType":"Small molecule","mechanismOfAction":"Dual specificity mitogen-activated protein kinase kinase 1 inhibitor","targetName":"Dual specificity mitogen-activated protein kinase kinase 1"}
{"drugId":"CHEMBL1504","targetId":"ENSG00000113580","diseaseId":"EFO_1000941","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04347733%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0002970","EFO_1001986"],"label":"frozen shoulder","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"TRIAMCINOLONE ACETONIDE","tradeNames":["Adcortyl","Adcortyl in orabase","Allernaze","Aristocort","Aristocort a","Aristogel","Audicort","Aureocort","Azmacort","Flutex","Gppe ear dps cap","Gppe ear oint","Kenacort","Kenalog","Kenalog in orabase","Kenalog-10","Kenalog-40","Kenalog-80","Kenalog-h","Nasacort","Nasacort allergy 24 hour","Nasacort aq","Nasacort hfa","Nystadermal","Oracort","Oralone","Pevaryl t.c.","Remiderm","Remotic","Silderm","Tri-Nasal","Tri-adcortyl","Triacet","Triacort","Triamcinolone acetonide","Triamcinolone acetonide in absorbase","Triatex","Triderm","Triesence","Trivaris","Trymex","Vetalog","Zilretta"],"synonyms":["FX-006","FX006","Kenacourt","NSC-21916","Triamcinolone Acetonide","Triamcinolone acetonide"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL2108709","targetId":"ENSG00000196739","diseaseId":"EFO_1000941","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00261196%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0002970","EFO_1001986"],"label":"frozen shoulder","approvedSymbol":"COL27A1","approvedName":"collagen type XXVII alpha 1 chain","targetClass":["Structural protein"],"prefName":"COLLAGENASE CLOSTRIDIUM HISTOLYTICUM","tradeNames":["Santyl","Xiaflex"],"synonyms":["AA-4500","AA4500","Clostridial collagenase","Clostridium histolyticum enzymes","Collagenase","Collagenase (clostridium histolyticum)","Collagenase clostridium histolyticum","Cordase","Iruxol","MZ-004","Plaquase"],"drugType":"Enzyme","mechanismOfAction":"Collagen hydrolytic enzyme","targetName":"Collagen"}
{"drugId":"CHEMBL960","targetId":"ENSG00000102967","diseaseId":"EFO_1000965","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02532777%22"}],"ancestors":["EFO_0000540","EFO_1002003"],"label":"Henoch-Schoenlein purpura","approvedSymbol":"DHODH","approvedName":"dihydroorotate dehydrogenase (quinone)","targetClass":["Enzyme"],"prefName":"LEFLUNOMIDE","tradeNames":["Arava","Leflunomide"],"synonyms":["HWA-486","L04AA13","Leflunomide","Leflunomide medac","Leflunomide ratiopharm","Leflunomide teva","Leflunomide winthrop","NSC-677411","NSC-759864","Repso","SU-101","SU101","SULOL"],"drugType":"Small molecule","mechanismOfAction":"Dihydroorotate dehydrogenase inhibitor","targetName":"Dihydroorotate dehydrogenase"}
{"drugId":"CHEMBL1289601","targetId":"ENSG00000037280","diseaseId":"EFO_1001012","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04729348%22"}],"ancestors":["MONDO_0023370","EFO_0003851","EFO_0000618","MONDO_0021248","MONDO_0045024","EFO_0009386","MONDO_0024882","EFO_1000158","EFO_0000616","EFO_0009709"],"label":"leptomeningeal metastasis","approvedSymbol":"FLT4","approvedName":"fms related receptor tyrosine kinase 4","targetClass":["Enzyme"],"prefName":"LENVATINIB","tradeNames":["Kisplyx","Lenvima"],"synonyms":["E-7080","ER-203492-00","Lenvatinib"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000167325","diseaseId":"EFO_1001051","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00047060%22"}],"ancestors":["MONDO_0015816","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0015758","EFO_0005803","EFO_0002913","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0002898","MONDO_0000653","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0004198","MONDO_0018898","MONDO_0017207","EFO_0000701","MONDO_0015821","EFO_0005952","EFO_0000508","MONDO_0019044","EFO_0010285","MONDO_0015760"],"label":"mycosis fungoides","approvedSymbol":"RRM1","approvedName":"ribonucleotide reductase catalytic subunit M1","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"Ribonucleoside-diphosphate reductase RR1 inhibitor","targetName":"Ribonucleoside-diphosphate reductase RR1"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000077514","diseaseId":"EFO_1001051","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02548468%22"}],"ancestors":["MONDO_0015816","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0015758","EFO_0005803","EFO_0002913","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0002898","MONDO_0000653","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0004198","MONDO_0018898","MONDO_0017207","EFO_0000701","MONDO_0015821","EFO_0005952","EFO_0000508","MONDO_0019044","EFO_0010285","MONDO_0015760"],"label":"mycosis fungoides","approvedSymbol":"POLD3","approvedName":"DNA polymerase delta 3, accessory subunit","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1051","targetId":"ENSG00000122420","diseaseId":"EFO_1001069","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01987323%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02531152%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00868894%22"}],"ancestors":["MONDO_0000473","EFO_0003966","MONDO_0024458","EFO_0004264","EFO_0000537","EFO_0000319"],"label":"ocular hypertension","approvedSymbol":"PTGFR","approvedName":"prostaglandin F receptor","targetClass":["Membrane receptor"],"prefName":"LATANOPROST","tradeNames":["Latanoprost","Monopost","Xalatan","Xelpros"],"synonyms":["Latanoprost","Latanoprost (isopropyl ester)","PHXA-41","PHXA41","T-2345","T2345","XA-41","XA41"],"drugType":"Small molecule","mechanismOfAction":"Prostanoid FP receptor agonist","targetName":"Prostanoid FP receptor"}
{"drugId":"CHEMBL79","targetId":"ENSG00000136546","diseaseId":"EFO_1001087","phase":0,"status":"Enrolling by invitation","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04085913%22"}],"ancestors":["MONDO_0021360","MONDO_0023370","MONDO_0045024","MONDO_0021463","EFO_0003769","EFO_0000232","EFO_0001379","EFO_0002422","EFO_0005754","MONDO_0036976","MONDO_0000627","EFO_0006858","EFO_0000616"],"label":"parathyroid adenoma","approvedSymbol":"SCN7A","approvedName":"sodium voltage-gated channel alpha subunit 7","targetClass":["Ion channel"],"prefName":"LIDOCAINE","tradeNames":["Alphacaine","Anestacon","Dentipatch","Lidocaine","Lidoderm","Lignocaine Hcl","Lignostab","Lmx 4","Oraqix","Vagisil","Xylocaine","Xylodase","Xylotox","Ztlido"],"synonyms":["ALGRX 3268","ALGRX-3268","Anestacon","Embolex","Iontocaine","Lidocaine","Lidocainum","Lidocaton","Lidopen","Lignocaine","NSC-40030","Octocaine","Solarcaine","Xylestesin"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL3545110","targetId":"ENSG00000135446","diseaseId":"EFO_1001100","phase":1,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03056833%22"}],"ancestors":["EFO_0009541","MONDO_0023370","MONDO_0045024","EFO_0010282","EFO_0000616"],"label":"peritoneal neoplasm","approvedSymbol":"CDK4","approvedName":"cyclin dependent kinase 4","targetClass":["Enzyme"],"prefName":"RIBOCICLIB","tradeNames":[],"synonyms":["LEE-011","LEE-011A","LEE011","LEE011A","Lee-011","NVP-LEE011","Ribociclib"],"drugType":"Small molecule","mechanismOfAction":"Cyclin-dependent kinase 4 inhibitor","targetName":"Cyclin-dependent kinase 4"}
{"drugId":"CHEMBL131","targetId":"ENSG00000113580","diseaseId":"EFO_1001110","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03111810%22"}],"ancestors":["EFO_0001379","EFO_0005774","EFO_1000973","EFO_0000618","MONDO_0024468","EFO_0009607","EFO_0003099","MONDO_0100070","EFO_0005539","EFO_0009386"],"label":"pituitary-dependent Cushing's disease","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"PREDNISOLONE","tradeNames":["Cortalone","Dekotil","Delta-cortef","Deltacortril","Deltalone","Dilacort","Fernisolone-p","Hydeltra","Meti-derm","Meticortelone","Pevanti","Precortisyl","Precortisyl fte","Prednisolone","Prelone","Scheriproct","Servisone","Sterane"],"synonyms":["Desowen","Hydeltra-Tba","Meticortelone","NSC-9120","NSC-9900","Neo-Delta-Cortef","Poly-Pred","Pred-G","Prednisolone","Servisone","Tridesilon","Verdeso"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL384467","targetId":"ENSG00000113580","diseaseId":"EFO_1001115","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01639898%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02193698%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01816620%22"}],"ancestors":["EFO_0009387","EFO_0000540","MONDO_0015923","EFO_1001902","EFO_0004149","EFO_0000618","EFO_0003100","MONDO_0004805","EFO_0005803","MONDO_0018215","MONDO_0016169"],"label":"POEMS syndrome","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"DEXAMETHASONE","tradeNames":["Aeroseb-dex","Dalalone","Decaderm","Decadron","Decadron-75","Decaspray","Dexacortisyl","Dexafree","Dexamethasone","Dexamethasone intensol","Dexone","Dexone 0.5","Dexone 0.75","Dexone 1.5","Dexone 4","Dexsol","Dextenza","Dexycu kit","Dropodex","Gppe ear spy","Hemady","Hexadrol","Kortico Injection","Martapan","Maxidex","Maxitrol","Oradexon","Otomize","Ozurdex","Sofradex","Spersadex comp","Tobradex"],"synonyms":["Decadron-LA","Dexacen-4","Dexacort","Dexair","Dexamethasone","Dexamethasone metasulfobenzoate sodium","Dexamethasone palmitate","Dexamethasone valerate","Dexycu","Fluormethylprednisolone","ISV-305","Mymethasone","NSC-34521","Neodecadron","OTO-104"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL384467","targetId":"ENSG00000113580","diseaseId":"EFO_1001119","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02049476%22"}],"ancestors":["EFO_0003966","EFO_1001231","EFO_1001082","MONDO_0024458","MONDO_0002661"],"label":"posterior uveitis","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"DEXAMETHASONE","tradeNames":["Aeroseb-dex","Dalalone","Decaderm","Decadron","Decadron-75","Decaspray","Dexacortisyl","Dexafree","Dexamethasone","Dexamethasone intensol","Dexone","Dexone 0.5","Dexone 0.75","Dexone 1.5","Dexone 4","Dexsol","Dextenza","Dexycu kit","Dropodex","Gppe ear spy","Hemady","Hexadrol","Kortico Injection","Martapan","Maxidex","Maxitrol","Oradexon","Otomize","Ozurdex","Sofradex","Spersadex comp","Tobradex"],"synonyms":["Decadron-LA","Dexacen-4","Dexacort","Dexair","Dexamethasone","Dexamethasone metasulfobenzoate sodium","Dexamethasone palmitate","Dexamethasone valerate","Dexycu","Fluormethylprednisolone","ISV-305","Mymethasone","NSC-34521","Neodecadron","OTO-104"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL565612","targetId":"ENSG00000163558","diseaseId":"EFO_1001119","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00615693%22"}],"ancestors":["EFO_0003966","EFO_1001231","EFO_1001082","MONDO_0024458","MONDO_0002661"],"label":"posterior uveitis","approvedSymbol":"PRKCI","approvedName":"protein kinase C iota","targetClass":["Enzyme"],"prefName":"SOTRASTAURIN","tradeNames":[],"synonyms":["AEB-071","AEB071","Aeb-071","NVP-AEB071","Sotrastaurin"],"drugType":"Small molecule","mechanismOfAction":"Protein kinase C (PKC) inhibitor","targetName":"Protein kinase C (PKC)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000110717","diseaseId":"EFO_1001121","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01779362%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"prediabetes syndrome","approvedSymbol":"NDUFS8","approvedName":"NADH:ubiquinone oxidoreductase core subunit S8","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL3647536","targetId":"ENSG00000145863","diseaseId":"EFO_1001146","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02564029%22"}],"ancestors":["EFO_0000474","MONDO_0100036","EFO_0005774","EFO_0000618","EFO_0009386"],"label":"reflex epilepsy","approvedSymbol":"GABRA6","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha6","targetClass":["Ion channel"],"prefName":"DARIGABAT","tradeNames":[],"synonyms":["CVL-865","Cvl-865","Darigabat","PF-06372865","Pf-06372865"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel agonist","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL469","targetId":"ENSG00000095303","diseaseId":"EFO_1001178","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03913702%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_1000999","EFO_0002461"],"label":"shoulder impingement syndrome","approvedSymbol":"PTGS1","approvedName":"prostaglandin-endoperoxide synthase 1","targetClass":["Enzyme"],"prefName":"KETOROLAC","tradeNames":[],"synonyms":["Ketorolac"],"drugType":"Small molecule","mechanismOfAction":"Cyclooxygenase inhibitor","targetName":"Cyclooxygenase"}
{"drugId":"CHEMBL1068","targetId":"ENSG00000196876","diseaseId":"EFO_1001219","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04996199%22"}],"ancestors":["EFO_0009387","MONDO_0003569","MONDO_0015923","EFO_1001902","EFO_0004149","EFO_0009569","EFO_0000618","MONDO_0700057","EFO_0003100","MONDO_0016374","EFO_0009386","EFO_0009430"],"label":"trigeminal neuralgia","approvedSymbol":"SCN8A","approvedName":"sodium voltage-gated channel alpha subunit 8","targetClass":["Unclassified protein","Auxiliary transport protein","Ion channel"],"prefName":"OXCARBAZEPINE","tradeNames":["Oxcarbazepine","Oxtellar xr","Trileptal"],"synonyms":["GP-47680","KIN-493","NSC-758693","Oxcarbamazepine","Oxcarbazepine","SPN-804"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL679","targetId":"ENSG00000184160","diseaseId":"EFO_1001222","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3ed35d7d-616c-43cd-9776-705821afc1f0"}],"ancestors":["EFO_0005809","EFO_0000540","EFO_1002003"],"label":"type III hypersensitivity reaction disease","approvedSymbol":"ADRA2C","approvedName":"adrenoceptor alpha 2C","targetClass":["Membrane receptor"],"prefName":"EPINEPHRINE","tradeNames":["Adren co","Adrenaclick","Adrenalin","Ana-Kit","Ana-guard","Anapen","Anaphylactic shock drug kit","Asma-vydrin","Asthmahaler","Auvi-q","Bronkaid mist","Brovon","Emerade","Epi e z pen jr","Epinephrine","Epinephrine (copackaged)","Epipen","Epipen e z pen","Epipen jr","Epipen jr.","Eppy","Gppe inh soln","Jext","Medihaler-epi","Primatene","Primatene mist","Riddobron","Riddofan","Rybarvin","Simplene","Soln made to rybarvin for","Sus-Phrine","Sus-Phrine Sulfite-Free","Sus-phrine sulfite free","Symjepi","Twinject 0.15","Twinject 0.3"],"synonyms":["(-)-(r)-epinephrine","(-)-epinephrine","Adrenaline","Adrenalinum","Epinephrine","Epinephrine hcl","Epinephrine hydrochloride","Epinephrinum","Glauposine","L-epinephrine hydrochloride","Levo-methylaminoethanolcatechol","NSC-62786","Nephridine","Racepinefrine, (r)-","Sus-phrine sulphite-free","Susphrine","Tonogen","Twinject"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor agonist","targetName":"Adrenergic receptor"}
{"drugId":"CHEMBL118","targetId":"ENSG00000073756","diseaseId":"EFO_1001250","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02850211%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03540030%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0002970"],"label":"rotator cuff tear","approvedSymbol":"PTGS2","approvedName":"prostaglandin-endoperoxide synthase 2","targetClass":["Enzyme"],"prefName":"CELECOXIB","tradeNames":["Celebra","Celebrex","Celecoxib","Elyxyb","Onsenal"],"synonyms":["Celecoxib","DFN-15","DFN15","NSC-719627","NSC-758624","SC-58635"],"drugType":"Small molecule","mechanismOfAction":"Cyclooxygenase-2 inhibitor","targetName":"Cyclooxygenase-2"}
{"drugId":"CHEMBL1200694","targetId":"ENSG00000171303","diseaseId":"EFO_1001250","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03540030%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0002970"],"label":"rotator cuff tear","approvedSymbol":"KCNK3","approvedName":"potassium two pore domain channel subfamily K member 3","targetClass":["Ion channel"],"prefName":"SEVOFLURANE","tradeNames":["Sevoflurane","Sojourn","Ultane"],"synonyms":["MR-6S4","MR6S4","NSC-760367","Sevocalm","Sevoflo","Sevoflurane","Sevorane"],"drugType":"Small molecule","mechanismOfAction":"Potassium channel subfamily K member 3 opener","targetName":"Potassium channel subfamily K member 3"}
{"drugId":"CHEMBL1457","targetId":"ENSG00000112038","diseaseId":"EFO_1001250","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03818919%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0002970"],"label":"rotator cuff tear","approvedSymbol":"OPRM1","approvedName":"opioid receptor mu 1","targetClass":["Membrane receptor"],"prefName":"HYDROCODONE","tradeNames":[],"synonyms":["Hydrocodone"],"drugType":"Small molecule","mechanismOfAction":"Opioid receptors; mu/kappa/delta agonist","targetName":"Opioid receptors; mu/kappa/delta"}
{"drugId":"CHEMBL1650","targetId":"ENSG00000113580","diseaseId":"EFO_1001250","phase":1,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02918136%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0002970"],"label":"rotator cuff tear","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"CORTISONE ACETATE","tradeNames":["Cortate","Cortelan","Cortisone acetate","Cortistab","Cortisyl","Cortone"],"synonyms":["Cortisone","Cortisone 21-acetate","Cortisone Acetate","Cortisone acetate","Cortisone aceticum","NSC-49420"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL3039583","targetId":"ENSG00000180616","diseaseId":"EFO_1001256","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02780882%22"}],"ancestors":["EFO_0003769","EFO_0001379","MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"ACTH Syndrome, Ectopic","approvedSymbol":"SSTR2","approvedName":"somatostatin receptor 2","targetClass":["Membrane receptor"],"prefName":"PASIREOTIDE","tradeNames":["Signifor"],"synonyms":["Pasireotide","SOM 230","SOM-230","SOM230"],"drugType":"Protein","mechanismOfAction":"Somatostatin receptor 2 agonist","targetName":"Somatostatin receptor 2"}
{"drugId":"CHEMBL704","targetId":"ENSG00000132170","diseaseId":"EFO_1001294","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01209208%22"}],"ancestors":["EFO_0005140","EFO_1001295","EFO_0009431","OTAR_0000018","EFO_0003767","EFO_0000540","EFO_0003872","EFO_0000508","MONDO_0003409","MONDO_0024634","EFO_1001463","EFO_0010282"],"label":"lymphocytic colitis","approvedSymbol":"PPARG","approvedName":"peroxisome proliferator activated receptor gamma","targetClass":["Transcription factor","Unclassified protein","Epigenetic regulator"],"prefName":"MESALAMINE","tradeNames":["Apriso","Asacol","Asacol hd","Canasa","Coltec ec","Delzicol","Ipocol","Lialda","Mesalamine","Mesren mr","Mezavant xl","Octasa","Pentasa","Pentasa sr","Rowasa","Salofalk","Sfrowasa"],"synonyms":["Benzoic acid, 5-amino-2-hydroxy-","Fisalamine","Iialda","MAX-002","Mesalamine","Mesalazine","Mesalazine ","NSC-38877"],"drugType":"Small molecule","mechanismOfAction":"Peroxisome proliferator-activated receptor gamma agonist","targetName":"Peroxisome proliferator-activated receptor gamma"}
{"drugId":"CHEMBL803","targetId":"ENSG00000198056","diseaseId":"EFO_1001365","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002571%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002524%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"Lymphoma, AIDS-Related","approvedSymbol":"PRIM1","approvedName":"DNA primase subunit 1","targetClass":["Enzyme"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL79","targetId":"ENSG00000183873","diseaseId":"EFO_1001366","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00382083%22"}],"ancestors":["EFO_0003843","EFO_0000651","EFO_0003765"],"label":"mastodynia","approvedSymbol":"SCN5A","approvedName":"sodium voltage-gated channel alpha subunit 5","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"LIDOCAINE","tradeNames":["Alphacaine","Anestacon","Dentipatch","Lidocaine","Lidoderm","Lignocaine Hcl","Lignostab","Lmx 4","Oraqix","Vagisil","Xylocaine","Xylodase","Xylotox","Ztlido"],"synonyms":["ALGRX 3268","ALGRX-3268","Anestacon","Embolex","Iontocaine","Lidocaine","Lidocainum","Lidocaton","Lidopen","Lignocaine","NSC-40030","Octocaine","Solarcaine","Xylestesin"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL131","targetId":"ENSG00000113580","diseaseId":"EFO_1001373","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00127985%22"}],"ancestors":["EFO_0009518","OTAR_0000009"],"label":"Multiple Organ Failure","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"PREDNISOLONE","tradeNames":["Cortalone","Dekotil","Delta-cortef","Deltacortril","Deltalone","Dilacort","Fernisolone-p","Hydeltra","Meti-derm","Meticortelone","Pevanti","Precortisyl","Precortisyl fte","Prednisolone","Prelone","Scheriproct","Servisone","Sterane"],"synonyms":["Desowen","Hydeltra-Tba","Meticortelone","NSC-9120","NSC-9900","Neo-Delta-Cortef","Poly-Pred","Pred-G","Prednisolone","Servisone","Tridesilon","Verdeso"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL112","targetId":"ENSG00000196689","diseaseId":"EFO_1001412","phase":4,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01685658%22"}],"ancestors":["EFO_0003843","EFO_0000651","EFO_0003765"],"label":"renal colic","approvedSymbol":"TRPV1","approvedName":"transient receptor potential cation channel subfamily V member 1","targetClass":["Ion channel"],"prefName":"ACETAMINOPHEN","tradeNames":["Abdine","Acephen","Acetaminophen","Alvedon","Angiers","Calpol","Calpol six plus","Calpol six plus fastmelts","Child lemsip","Cupanol","Dafalgan","Datril","Disprol","Disprol infant","Disprol jnr","Disprol paed","Fennings","Galpamol","Hedex","Infadrops","Infants' feverall","Injectapap","Junior parapaed","Mandanol","Medinol","Medinol for children","Medinol over 6","Medinol under 6","Medised plain","Miradol","Neopap","Ofirmev","Paldesic","Panadol","Panadol actifast","Panadol actifast solb","Panadol advan","Panadol jnr","Panadol oa","Panaleve","Panaleve 6 plus","Paracetamol","Paramin","Parapaed jnr","Parapaed six plus","Paravict","Perfalgan","Phenaphen","Placidex","Rimadol","Salzone","Tixymol","Tramil 500","Tylenol"],"synonyms":["Acetaminophen","Apap","Biocetamol","Doliprane","Efferalgan","N-acetyl-p-aminophenol","NSC-109028","NSC-3991","P-hydroxy-acetanilid","Paracetamol","Paracetamolum","Vermidon"],"drugType":"Small molecule","mechanismOfAction":"Vanilloid receptor opener","targetName":"Vanilloid receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000164258","diseaseId":"EFO_1001461","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00169624%22"}],"ancestors":["EFO_0004264","EFO_0000319"],"label":"endothelial dysfunction","approvedSymbol":"NDUFS4","approvedName":"NADH:ubiquinone oxidoreductase subunit S4","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL124660","targetId":"ENSG00000122025","diseaseId":"EFO_1001465","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00379080%22"}],"ancestors":["MONDO_0021193","EFO_0005543","MONDO_0023370","EFO_0005774","EFO_0006545","MONDO_0001657","EFO_0000272","MONDO_0021248","MONDO_0045024","MONDO_0020665","EFO_0007392","MONDO_0004992","MONDO_0005499","EFO_0009386","EFO_0000326","EFO_0003833","MONDO_0100342","MONDO_0021636","EFO_0000519","MONDO_0016680","EFO_0000618","EFO_0000616","EFO_1000158"],"label":"gliosarcoma","approvedSymbol":"FLT3","approvedName":"fms related receptor tyrosine kinase 3","targetClass":["Enzyme"],"prefName":"TANDUTINIB","tradeNames":[],"synonyms":["CT 53518","CT-53518","CT53518","MLN-518","Mln-0518","NSC-759851","Tandutinib"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase receptor FLT3 inhibitor","targetName":"Tyrosine-protein kinase receptor FLT3"}
{"drugId":"CHEMBL24828","targetId":"ENSG00000133216","diseaseId":"EFO_1001465","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00995007%22"}],"ancestors":["MONDO_0021193","EFO_0005543","MONDO_0023370","EFO_0005774","EFO_0006545","MONDO_0001657","EFO_0000272","MONDO_0021248","MONDO_0045024","MONDO_0020665","EFO_0007392","MONDO_0004992","MONDO_0005499","EFO_0009386","EFO_0000326","EFO_0003833","MONDO_0100342","MONDO_0021636","EFO_0000519","MONDO_0016680","EFO_0000618","EFO_0000616","EFO_1000158"],"label":"gliosarcoma","approvedSymbol":"EPHB2","approvedName":"EPH receptor B2","targetClass":["Enzyme"],"prefName":"VANDETANIB","tradeNames":["Caprelsa","Zactima"],"synonyms":["GNF-PF-2188","NSC-744325","NSC-760766","Vandetanib","ZD-64","ZD-6474","ZD6474"],"drugType":"Small molecule","mechanismOfAction":"Ephrin receptor inhibitor","targetName":"Ephrin receptor"}
{"drugId":"CHEMBL24828","targetId":"ENSG00000197122","diseaseId":"EFO_1001465","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00995007%22"}],"ancestors":["MONDO_0021193","EFO_0005543","MONDO_0023370","EFO_0005774","EFO_0006545","MONDO_0001657","EFO_0000272","MONDO_0021248","MONDO_0045024","MONDO_0020665","EFO_0007392","MONDO_0004992","MONDO_0005499","EFO_0009386","EFO_0000326","EFO_0003833","MONDO_0100342","MONDO_0021636","EFO_0000519","MONDO_0016680","EFO_0000618","EFO_0000616","EFO_1000158"],"label":"gliosarcoma","approvedSymbol":"SRC","approvedName":"SRC proto-oncogene, non-receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"VANDETANIB","tradeNames":["Caprelsa","Zactima"],"synonyms":["GNF-PF-2188","NSC-744325","NSC-760766","Vandetanib","ZD-64","ZD-6474","ZD6474"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase SRC inhibitor","targetName":"Tyrosine-protein kinase SRC"}
{"drugId":"CHEMBL289228","targetId":"ENSG00000257365","diseaseId":"EFO_1001465","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00058097%22"}],"ancestors":["MONDO_0021193","EFO_0005543","MONDO_0023370","EFO_0005774","EFO_0006545","MONDO_0001657","EFO_0000272","MONDO_0021248","MONDO_0045024","MONDO_0020665","EFO_0007392","MONDO_0004992","MONDO_0005499","EFO_0009386","EFO_0000326","EFO_0003833","MONDO_0100342","MONDO_0021636","EFO_0000519","MONDO_0016680","EFO_0000618","EFO_0000616","EFO_1000158"],"label":"gliosarcoma","approvedSymbol":"FNTB","approvedName":"farnesyltransferase, CAAX box, beta","targetClass":["Enzyme"],"prefName":"TIPIFARNIB","tradeNames":[],"synonyms":["NSC-702818","R-11577","R-115777","R115777","Tipifarnib","Zarnestra"],"drugType":"Small molecule","mechanismOfAction":"Protein farnesyltransferase inhibitor","targetName":"Protein farnesyltransferase"}
{"drugId":"CHEMBL3125702","targetId":"ENSG00000141510","diseaseId":"EFO_1001465","phase":1,"status":"Suspended","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03107780%22"}],"ancestors":["MONDO_0021193","EFO_0005543","MONDO_0023370","EFO_0005774","EFO_0006545","MONDO_0001657","EFO_0000272","MONDO_0021248","MONDO_0045024","MONDO_0020665","EFO_0007392","MONDO_0004992","MONDO_0005499","EFO_0009386","EFO_0000326","EFO_0003833","MONDO_0100342","MONDO_0021636","EFO_0000519","MONDO_0016680","EFO_0000618","EFO_0000616","EFO_1000158"],"label":"gliosarcoma","approvedSymbol":"TP53","approvedName":"tumor protein p53","targetClass":["Unclassified protein","Transcription factor"],"prefName":"AMG-232","tradeNames":[],"synonyms":["AMG 232","AMG-232","Amg 232","Amg-232","KRT-232","Krt-232","Mdm2 inhibitor amg-232","Navtemadlin"],"drugType":"Small molecule","mechanismOfAction":"Tumour suppressor p53/oncoprotein Mdm2 inhibitor","targetName":"Tumour suppressor p53/oncoprotein Mdm2"}
{"drugId":"CHEMBL343448","targetId":"ENSG00000196591","diseaseId":"EFO_1001469","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00383565%22"}],"ancestors":["EFO_0007352","OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_0000540","EFO_0005952","EFO_0000508","MONDO_0017595","MONDO_0019044","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"Mantle cell lymphoma","approvedSymbol":"HDAC2","approvedName":"histone deacetylase 2","targetClass":["Unclassified protein","Epigenetic regulator"],"prefName":"ROMIDEPSIN","tradeNames":["Chromadax","Istodax"],"synonyms":["Depsipeptide","FK-228","FK228","FR-901228","FR901228","NSC-630176","Romidepsin"],"drugType":"Protein","mechanismOfAction":"Histone deacetylase inhibitor","targetName":"Histone deacetylase"}
{"drugId":"CHEMBL501867","targetId":"ENSG00000176014","diseaseId":"EFO_1001469","phase":3,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05051891%22"}],"ancestors":["EFO_0007352","OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_0000540","EFO_0005952","EFO_0000508","MONDO_0017595","MONDO_0019044","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"Mantle cell lymphoma","approvedSymbol":"TUBB6","approvedName":"tubulin beta 6 class V","targetClass":["Structural protein"],"prefName":"VINCRISTINE SULFATE","tradeNames":["Kyocristine","Leurocristine Sulfate","Marqibo kit","Oncovin","Vincasar","Vincasar pfs","Vincrex","Vincristine sulfate","Vincristine sulfate pfs"],"synonyms":["37231","Kyocristine","LILLY-37231","Marqibo","NSC-67574","Novopharm","Vincristine sulfate","Vincristine sulfate liposome","Vincristine sulphate","Vincristini sulfas","Vincrisul"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL803","targetId":"ENSG00000146143","diseaseId":"EFO_1001469","phase":1,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02728531%22"}],"ancestors":["EFO_0007352","OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_0000540","EFO_0005952","EFO_0000508","MONDO_0017595","MONDO_0019044","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"Mantle cell lymphoma","approvedSymbol":"PRIM2","approvedName":"DNA primase subunit 2","targetClass":["Enzyme"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL3125702","targetId":"ENSG00000135679","diseaseId":"EFO_1001471","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03787602%22"}],"ancestors":["EFO_0000701","MONDO_0023370","MONDO_0045024","EFO_0004198","EFO_0010285","EFO_0000616"],"label":"Merkel cell skin cancer","approvedSymbol":"MDM2","approvedName":"MDM2 proto-oncogene","targetClass":["Other nuclear protein","Epigenetic regulator","Enzyme"],"prefName":"AMG-232","tradeNames":[],"synonyms":["AMG 232","AMG-232","Amg 232","Amg-232","KRT-232","Krt-232","Mdm2 inhibitor amg-232","Navtemadlin"],"drugType":"Small molecule","mechanismOfAction":"Tumour suppressor p53/oncoprotein Mdm2 inhibitor","targetName":"Tumour suppressor p53/oncoprotein Mdm2"}
{"drugId":"CHEMBL1278146","targetId":"ENSG00000113721","diseaseId":"EFO_1001480","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02390947%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0023370","MONDO_0045024","MONDO_0024634","MONDO_0004992","EFO_0004142","MONDO_0024882","MONDO_0021118","EFO_0005842","EFO_0008549","MONDO_0002516","EFO_0009709","EFO_0010282","EFO_0000616"],"label":"metastatic colorectal cancer","approvedSymbol":"PDGFRB","approvedName":"platelet derived growth factor receptor beta","targetClass":["Enzyme"],"prefName":"FAMITINIB","tradeNames":[],"synonyms":["Famitinib","SHR-1020","SHR1020","Shr-1020"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","targetName":"Platelet-derived growth factor receptor"}
{"drugId":"CHEMBL1946170","targetId":"ENSG00000198400","diseaseId":"EFO_1001480","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03081494%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03305913%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01896856%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0023370","MONDO_0045024","MONDO_0024634","MONDO_0004992","EFO_0004142","MONDO_0024882","MONDO_0021118","EFO_0005842","EFO_0008549","MONDO_0002516","EFO_0009709","EFO_0010282","EFO_0000616"],"label":"metastatic colorectal cancer","approvedSymbol":"NTRK1","approvedName":"neurotrophic receptor tyrosine kinase 1","targetClass":["Enzyme"],"prefName":"REGORAFENIB","tradeNames":["Stivarga"],"synonyms":["BAY 73-4506","BAY 73-4506 monohydrate","BAY-73-4506","BAY-734506","Regorafenib"],"drugType":"Small molecule","mechanismOfAction":"Nerve growth factor receptor Trk-A","targetName":"Nerve growth factor receptor Trk-A"}
{"drugId":"CHEMBL20883","targetId":"ENSG00000176890","diseaseId":"EFO_1001480","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03380689%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0023370","MONDO_0045024","MONDO_0024634","MONDO_0004992","EFO_0004142","MONDO_0024882","MONDO_0021118","EFO_0005842","EFO_0008549","MONDO_0002516","EFO_0009709","EFO_0010282","EFO_0000616"],"label":"metastatic colorectal cancer","approvedSymbol":"TYMS","approvedName":"thymidylate synthetase","targetClass":["Enzyme"],"prefName":"TEGAFUR","tradeNames":["Citofur","Uftoral"],"synonyms":["Atillon","BMS-200604","Coparogin","Exonal","FT-207","Fental","Franrose","Ftorafur","Fulaid","Fulfeel","Furafluor","Furofutran","Futraful","J356.722B","Lamar","Lifril","MJF-12264","NSC-148958","Neberk","Nitobanil","Sinoflurol","Sunfural","Tefsiel c","Tegafur","Tegafur-uracil","Youfuding"],"drugType":"Small molecule","mechanismOfAction":"Thymidylate synthase inhibitor","targetName":"Thymidylate synthase"}
{"drugId":"CHEMBL3544923","targetId":"ENSG00000105388","diseaseId":"EFO_1001480","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01915472%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0023370","MONDO_0045024","MONDO_0024634","MONDO_0004992","EFO_0004142","MONDO_0024882","MONDO_0021118","EFO_0005842","EFO_0008549","MONDO_0002516","EFO_0009709","EFO_0010282","EFO_0000616"],"label":"metastatic colorectal cancer","approvedSymbol":"CEACAM5","approvedName":"CEA cell adhesion molecule 5","targetClass":["Adhesion"],"prefName":"LABETUZUMAB GOVITECAN","tradeNames":[],"synonyms":["Anti-ceacam5-sn 38","IMMU-130","Labetuzumab govitecan"],"drugType":"Antibody","mechanismOfAction":"Carcinoembryonic antigen-related cell adhesion molecule 5 binding agent","targetName":"Carcinoembryonic antigen-related cell adhesion molecule 5"}
{"drugId":"CHEMBL3833373","targetId":"ENSG00000120217","diseaseId":"EFO_1001480","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03150706%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0023370","MONDO_0045024","MONDO_0024634","MONDO_0004992","EFO_0004142","MONDO_0024882","MONDO_0021118","EFO_0005842","EFO_0008549","MONDO_0002516","EFO_0009709","EFO_0010282","EFO_0000616"],"label":"metastatic colorectal cancer","approvedSymbol":"CD274","approvedName":"CD274 molecule","targetClass":["Unclassified protein"],"prefName":"AVELUMAB","tradeNames":["Bavencio"],"synonyms":["Avelumab","MSB-0010682","MSB0010682","MSB0010718C","Msb-0010718c"],"drugType":"Antibody","mechanismOfAction":"Programmed cell death 1 ligand 1 other","targetName":"Programmed cell death 1 ligand 1"}
{"drugId":"CHEMBL554","targetId":"ENSG00000146648","diseaseId":"EFO_1001480","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00574171%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0023370","MONDO_0045024","MONDO_0024634","MONDO_0004992","EFO_0004142","MONDO_0024882","MONDO_0021118","EFO_0005842","EFO_0008549","MONDO_0002516","EFO_0009709","EFO_0010282","EFO_0000616"],"label":"metastatic colorectal cancer","approvedSymbol":"EGFR","approvedName":"epidermal growth factor receptor","targetClass":["Enzyme"],"prefName":"LAPATINIB","tradeNames":["Tyverb"],"synonyms":["GSK-572016","GW-2016","GW-572016","GW-572016X","GW572016","Lapatinib"],"drugType":"Small molecule","mechanismOfAction":"Epidermal growth factor receptor erbB1 inhibitor","targetName":"Epidermal growth factor receptor erbB1"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198888","diseaseId":"EFO_1001496","phase":3,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03764605%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04939935%22"}],"ancestors":["Orphanet_98056","OTAR_0000017","EFO_0008620","OTAR_0000018","EFO_0009555","EFO_0009690","EFO_0003086","EFO_0000512","EFO_0000545","EFO_0004248","EFO_0008615","MONDO_0000426","EFO_0000508","MONDO_0000429","MONDO_0100191","MONDO_0019741"],"label":"Autosomal dominant polycystic kidney disease","approvedSymbol":"MT-ND1","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL3137343","targetId":"ENSG00000188389","diseaseId":"EFO_1001512","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02630823%22"}],"ancestors":["OTAR_0000017","MONDO_0002654","MONDO_0021251","MONDO_0002149","MONDO_0023370","EFO_1000051","MONDO_0000931","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0000313","EFO_0002919","MONDO_0002715","EFO_0009549","MONDO_0011962","EFO_0006858","EFO_1001331","EFO_0000616","EFO_0003859"],"label":"endometrial carcinoma","approvedSymbol":"PDCD1","approvedName":"programmed cell death 1","targetClass":["Surface antigen"],"prefName":"PEMBROLIZUMAB","tradeNames":["Keytruda"],"synonyms":["KEYLYNK-010 COMPONENT PEMBROLIZUMAB","Lambrolizumab","MK-3475","PEMBROLIZUMAB COMPONENT OF KEYLYNK-010","Pembrolizumab","SCH-900475"],"drugType":"Antibody","mechanismOfAction":"Programmed cell death protein 1 inhibitor","targetName":"Programmed cell death protein 1"}
{"drugId":"CHEMBL1699","targetId":"ENSG00000176884","diseaseId":"EFO_1001801","phase":0,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04966546%22"}],"ancestors":["MONDO_0043218","EFO_0005774","EFO_0003763","EFO_0000618","EFO_0004264","EFO_0009386","EFO_0000319"],"label":"intracranial subdural hematoma","approvedSymbol":"GRIN1","approvedName":"glutamate ionotropic receptor NMDA type subunit 1","targetClass":["Ion channel"],"prefName":"MEMANTINE HYDROCHLORIDE","tradeNames":["Akatinol","Ebixa","Marixino","Memantine","Memantine hydrochloride","Namenda","Namenda xr","Nemdatine","Valios"],"synonyms":["Acrescent","Auxura","Balaxur","FP-01","Memantine accord","Memantine hcl","Memantine hydrochloride","Memantine lek","Memantine merz","Memantine mylan","Memantine ratiopharm","Memary","NSC-102290","SUN-Y7017"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor negative allosteric modulator","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL112","targetId":"ENSG00000117480","diseaseId":"EFO_1001891","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01822665%22"}],"ancestors":["MP_0001845","EFO_0000651","HP_0000118","EFO_1001898","HP_0002715"],"label":"gastrointestinal mucositis","approvedSymbol":"FAAH","approvedName":"fatty acid amide hydrolase","targetClass":["Enzyme"],"prefName":"ACETAMINOPHEN","tradeNames":["Abdine","Acephen","Acetaminophen","Alvedon","Angiers","Calpol","Calpol six plus","Calpol six plus fastmelts","Child lemsip","Cupanol","Dafalgan","Datril","Disprol","Disprol infant","Disprol jnr","Disprol paed","Fennings","Galpamol","Hedex","Infadrops","Infants' feverall","Injectapap","Junior parapaed","Mandanol","Medinol","Medinol for children","Medinol over 6","Medinol under 6","Medised plain","Miradol","Neopap","Ofirmev","Paldesic","Panadol","Panadol actifast","Panadol actifast solb","Panadol advan","Panadol jnr","Panadol oa","Panaleve","Panaleve 6 plus","Paracetamol","Paramin","Parapaed jnr","Parapaed six plus","Paravict","Perfalgan","Phenaphen","Placidex","Rimadol","Salzone","Tixymol","Tramil 500","Tylenol"],"synonyms":["Acetaminophen","Apap","Biocetamol","Doliprane","Efferalgan","N-acetyl-p-aminophenol","NSC-109028","NSC-3991","P-hydroxy-acetanilid","Paracetamol","Paracetamolum","Vermidon"],"drugType":"Small molecule","mechanismOfAction":"Anandamide amidohydrolase inhibitor","targetName":"Anandamide amidohydrolase"}
{"drugId":"CHEMBL661","targetId":"ENSG00000011677","diseaseId":"EFO_1001892","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c4520457-0b0e-493f-805c-c04a788268ee"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=68d8b8d1-00a4-42c4-a796-90211fee1a6d"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d7e80af-2290-53e4-e053-2a95a90a4e3f"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=388e249d-b9b6-44c3-9f8f-880eced0239f"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ff1630b4-2044-433c-96bc-0bb4ae8d42a0"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0006788","EFO_0000618","EFO_0009386"],"label":"generalized anxiety disorder","approvedSymbol":"GABRA3","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha3","targetClass":["Ion channel"],"prefName":"ALPRAZOLAM","tradeNames":["Alprazolam","Niravam","Xanax","Xanax xr"],"synonyms":["Alprazolam","Alprazolam civ","NSC-760140","U 31,889","U-31,889","U-31889"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL844","targetId":"ENSG00000274286","diseaseId":"EFO_1001893","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03173365%22"}],"ancestors":["EFO_0000701","EFO_0010285"],"label":"Hand-foot syndrome","approvedSymbol":"ADRA2B","approvedName":"adrenoceptor alpha 2B","targetClass":["Membrane receptor"],"prefName":"BRIMONIDINE","tradeNames":[],"synonyms":["AGN-190342 FREE BASE","Brimonidine","NSC-318825","UK-14304","UK-1430418 FREE BASE"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor alpha-2 agonist","targetName":"Adrenergic receptor alpha-2"}
{"drugId":"CHEMBL79","targetId":"ENSG00000168356","diseaseId":"EFO_1001896","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04201249%22"}],"ancestors":["EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0002614","EFO_1001434","EFO_1001887","EFO_0002461","EFO_1001986"],"label":"lateral epicondylitis","approvedSymbol":"SCN11A","approvedName":"sodium voltage-gated channel alpha subunit 11","targetClass":["Ion channel"],"prefName":"LIDOCAINE","tradeNames":["Alphacaine","Anestacon","Dentipatch","Lidocaine","Lidoderm","Lignocaine Hcl","Lignostab","Lmx 4","Oraqix","Vagisil","Xylocaine","Xylodase","Xylotox","Ztlido"],"synonyms":["ALGRX 3268","ALGRX-3268","Anestacon","Embolex","Iontocaine","Lidocaine","Lidocainum","Lidocaton","Lidopen","Lignocaine","NSC-40030","Octocaine","Solarcaine","Xylestesin"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000189043","diseaseId":"EFO_1001901","phase":0,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02823691%22"}],"ancestors":["EFO_0003769","EFO_0001379","MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"neuroendocrine neoplasm","approvedSymbol":"NDUFA4","approvedName":"NDUFA4 mitochondrial complex associated","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL661","targetId":"ENSG00000022355","diseaseId":"EFO_1001917","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00555139%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0006788","EFO_0000618","EFO_1001908","EFO_0009386"],"label":"social anxiety disorder","approvedSymbol":"GABRA1","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha1","targetClass":["Ion channel"],"prefName":"ALPRAZOLAM","tradeNames":["Alprazolam","Niravam","Xanax","Xanax xr"],"synonyms":["Alprazolam","Alprazolam civ","NSC-760140","U 31,889","U-31,889","U-31889"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL284348","targetId":"ENSG00000173826","diseaseId":"EFO_1001919","phase":0,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05447676%22"}],"ancestors":["EFO_0000546","EFO_0009490","EFO_0000618","OTAR_0000009"],"label":"Spinal cord injury","approvedSymbol":"KCNH6","approvedName":"potassium voltage-gated channel subfamily H member 6","targetClass":["Ion channel"],"prefName":"DALFAMPRIDINE","tradeNames":["Ampyra","Ampyra Extended Release","Fampyra","Neurelan"],"synonyms":["Dalfampridine","EL-970","Fampridine","Fampridine (4-aminopyridine)","NSC-15041"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated potassium channel blocker","targetName":"Voltage-gated potassium channel"}
{"drugId":"CHEMBL284348","targetId":"ENSG00000111262","diseaseId":"EFO_1001919","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01621113%22"}],"ancestors":["EFO_0000546","EFO_0009490","EFO_0000618","OTAR_0000009"],"label":"Spinal cord injury","approvedSymbol":"KCNA1","approvedName":"potassium voltage-gated channel subfamily A member 1","targetClass":["Ion channel","Auxiliary transport protein"],"prefName":"DALFAMPRIDINE","tradeNames":["Ampyra","Ampyra Extended Release","Fampyra","Neurelan"],"synonyms":["Dalfampridine","EL-970","Fampridine","Fampridine (4-aminopyridine)","NSC-15041"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated potassium channel blocker","targetName":"Voltage-gated potassium channel"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000148229","diseaseId":"EFO_1001945","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002798%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","MONDO_0015756","EFO_0003028","EFO_0003820","EFO_1000068","EFO_0005803","EFO_0000616","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0002427","EFO_0002428","MONDO_0015667","EFO_0000222","EFO_0000540","EFO_0000565","EFO_1001986","MONDO_0000637","MONDO_0019044","EFO_0010283"],"label":"childhood acute myeloid leukemia with maturation","approvedSymbol":"POLE3","approvedName":"DNA polymerase epsilon 3, accessory subunit","targetClass":["Unclassified protein"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1642","targetId":"ENSG00000097007","diseaseId":"EFO_1001946","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00061945%22"}],"ancestors":["EFO_0007352","OTAR_0000006","MONDO_0021581","MONDO_0005374","EFO_0004289","EFO_0002461","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0001642","EFO_0003820","MONDO_0023603","MONDO_0017595","MONDO_0004805","EFO_0005803","MONDO_0000870","OTAR_0000018","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","MONDO_0004992","MONDO_0004355","MONDO_0021079","EFO_0000540","EFO_0005952","EFO_1000654","EFO_0000508","EFO_1001986","MONDO_0000637","MONDO_0019044","EFO_0004260","EFO_0009676","MONDO_0000621","EFO_1000350","EFO_0009119","MONDO_0003659","EFO_0000220","MONDO_0044881","MONDO_0020511","EFO_0000574","MONDO_0017814","MONDO_0015757","EFO_1000068","EFO_0000616","MONDO_0004095","MONDO_0021138","EFO_0002425","MONDO_0017207","EFO_0000565","EFO_0010283"],"label":"childhood B acute lymphoblastic leukemia","approvedSymbol":"ABL1","approvedName":"ABL proto-oncogene 1, non-receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"IMATINIB MESYLATE","tradeNames":["Gleevec","Glivec","Imatinib mesylate"],"synonyms":["Gleevec","Imatinib (as mesilate)","Imatinib accord","Imatinib medac","Imatinib mesilate","Imatinib mesylate","Imatinib methane sulfonate","Imatinib methanesulfonate","NSC-716051","QTI-571","QTI571","Qti571","STI 571","STI-571","STI571"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase ABL inhibitor","targetName":"Tyrosine-protein kinase ABL"}
{"drugId":"CHEMBL1175","targetId":"ENSG00000108576","diseaseId":"EFO_1001951","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04137107%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0023370","MONDO_0045024","MONDO_0024634","MONDO_0004992","EFO_0004142","EFO_0000313","EFO_1000218","MONDO_0021118","EFO_0008549","EFO_0005842","MONDO_0002516","EFO_0006858","EFO_0000616","EFO_0010282"],"label":"colorectal carcinoma","approvedSymbol":"SLC6A4","approvedName":"solute carrier family 6 member 4","targetClass":["Transporter"],"prefName":"DULOXETINE","tradeNames":[],"synonyms":["Cymbalta","Duloxetine","LY-248686","LY248686"],"drugType":"Small molecule","mechanismOfAction":"Serotonin transporter inhibitor","targetName":"Serotonin transporter"}
{"drugId":"CHEMBL118","targetId":"ENSG00000073756","diseaseId":"EFO_1001951","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00305643%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00087256%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0023370","MONDO_0045024","MONDO_0024634","MONDO_0004992","EFO_0004142","EFO_0000313","EFO_1000218","MONDO_0021118","EFO_0008549","EFO_0005842","MONDO_0002516","EFO_0006858","EFO_0000616","EFO_0010282"],"label":"colorectal carcinoma","approvedSymbol":"PTGS2","approvedName":"prostaglandin-endoperoxide synthase 2","targetClass":["Enzyme"],"prefName":"CELECOXIB","tradeNames":["Celebra","Celebrex","Celecoxib","Elyxyb","Onsenal"],"synonyms":["Celecoxib","DFN-15","DFN15","NSC-719627","NSC-758624","SC-58635"],"drugType":"Small molecule","mechanismOfAction":"Cyclooxygenase-2 inhibitor","targetName":"Cyclooxygenase-2"}
{"drugId":"CHEMBL1289926","targetId":"ENSG00000037280","diseaseId":"EFO_1001951","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01483638%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0023370","MONDO_0045024","MONDO_0024634","MONDO_0004992","EFO_0004142","EFO_0000313","EFO_1000218","MONDO_0021118","EFO_0008549","EFO_0005842","MONDO_0002516","EFO_0006858","EFO_0000616","EFO_0010282"],"label":"colorectal carcinoma","approvedSymbol":"FLT4","approvedName":"fms related receptor tyrosine kinase 4","targetClass":["Enzyme"],"prefName":"AXITINIB","tradeNames":["Inlyta"],"synonyms":["AG-013736","AG-13736","Axitinib","NSC-757441"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL1697","targetId":"ENSG00000102001","diseaseId":"EFO_1001951","phase":0,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04017845%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0023370","MONDO_0045024","MONDO_0024634","MONDO_0004992","EFO_0004142","EFO_0000313","EFO_1000218","MONDO_0021118","EFO_0008549","EFO_0005842","MONDO_0002516","EFO_0006858","EFO_0000616","EFO_0010282"],"label":"colorectal carcinoma","approvedSymbol":"CACNA1F","approvedName":"calcium voltage-gated channel subunit alpha1 F","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"DILTIAZEM HYDROCHLORIDE","tradeNames":["Adizem-60","Adizem-sr","Adizem-xl","Angiozem 60","Angiozem cr 120","Angiozem cr 90","Angitil sr 120","Angitil sr 180","Angitil sr 90","Angitil xl 240","Angitil xl 300","Anoheal","Bi-carzem sr","Bi-carzem xl","Britiazim","Calazem","Calcicard","Calcicard cr","Cardizem","Cardizem cd","Cardizem la","Cardizem sr","Cartia xt","Dilacor","Dilacor xr","Dilcardia sr","Dilcardia xl","Dilt-cd","Diltiazem hydrochloride","Diltzac","Dilzem sr 120","Dilzem sr 60","Dilzem sr 90","Dilzem xl 120","Dilzem xl 180","Dilzem xl 240","Disogram sr","Horizem sr 120","Horizem sr 60","Horizem sr 90","Kentiazem","Kenzem sr","Optil","Optil sr 120","Optil sr 180","Optil sr 90","Optil xl 240","Optil xl 300","Retalzem 60","Slozem","Slozem 120","Slozem 180","Slozem 240","Taztia xt","Tiamex","Tiazac","Tildiem","Tildiem la 200","Tildiem la 300","Tildiem ret 120","Tildiem ret 90","Uard 120xl","Uard 180xl","Uard 240xl","Uard 300xl","Viazem xl","Zemret 180 xl","Zemret 240 xl","Zemret 300 xl","Zemtard 120 xl","Zemtard 180 xl","Zemtard 240 xl","Zemtard 300 xl","Zildil sr"],"synonyms":["Adizem","Altiazem","CRD-401","Cartia","Deltazen","Diladel","Dilpral","Dilrene","Diltiazem hcl","Diltiazem hydrochloride","Dilzem","Dilzene","Masdil","NSC-759576","RG 83606","RG-83606","Taztia","Zilden"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated L-type calcium channel blocker","targetName":"Voltage-gated L-type calcium channel"}
{"drugId":"CHEMBL1946170","targetId":"ENSG00000134853","diseaseId":"EFO_1001951","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02316340%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04126733%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0023370","MONDO_0045024","MONDO_0024634","MONDO_0004992","EFO_0004142","EFO_0000313","EFO_1000218","MONDO_0021118","EFO_0008549","EFO_0005842","MONDO_0002516","EFO_0006858","EFO_0000616","EFO_0010282"],"label":"colorectal carcinoma","approvedSymbol":"PDGFRA","approvedName":"platelet derived growth factor receptor alpha","targetClass":["Enzyme"],"prefName":"REGORAFENIB","tradeNames":["Stivarga"],"synonyms":["BAY 73-4506","BAY 73-4506 monohydrate","BAY-73-4506","BAY-734506","Regorafenib"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","targetName":"Platelet-derived growth factor receptor"}
{"drugId":"CHEMBL343448","targetId":"ENSG00000061273","diseaseId":"EFO_1001951","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00077337%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0023370","MONDO_0045024","MONDO_0024634","MONDO_0004992","EFO_0004142","EFO_0000313","EFO_1000218","MONDO_0021118","EFO_0008549","EFO_0005842","MONDO_0002516","EFO_0006858","EFO_0000616","EFO_0010282"],"label":"colorectal carcinoma","approvedSymbol":"HDAC7","approvedName":"histone deacetylase 7","targetClass":["Epigenetic regulator"],"prefName":"ROMIDEPSIN","tradeNames":["Chromadax","Istodax"],"synonyms":["Depsipeptide","FK-228","FK228","FR-901228","FR901228","NSC-630176","Romidepsin"],"drugType":"Protein","mechanismOfAction":"Histone deacetylase inhibitor","targetName":"Histone deacetylase"}
{"drugId":"CHEMBL4303214","targetId":"ENSG00000037280","diseaseId":"EFO_1001951","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02314819%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0023370","MONDO_0045024","MONDO_0024634","MONDO_0004992","EFO_0004142","EFO_0000313","EFO_1000218","MONDO_0021118","EFO_0008549","EFO_0005842","MONDO_0002516","EFO_0006858","EFO_0000616","EFO_0010282"],"label":"colorectal carcinoma","approvedSymbol":"FLT4","approvedName":"fms related receptor tyrosine kinase 4","targetClass":["Enzyme"],"prefName":"FRUQUINTINIB","tradeNames":[],"synonyms":["Fruquintinib","HMPL-013","HMPL013","Hmpl-013"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL491473","targetId":"ENSG00000134853","diseaseId":"EFO_1001951","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00588900%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0023370","MONDO_0045024","MONDO_0024634","MONDO_0004992","EFO_0004142","EFO_0000313","EFO_1000218","MONDO_0021118","EFO_0008549","EFO_0005842","MONDO_0002516","EFO_0006858","EFO_0000616","EFO_0010282"],"label":"colorectal carcinoma","approvedSymbol":"PDGFRA","approvedName":"platelet derived growth factor receptor alpha","targetClass":["Enzyme"],"prefName":"CEDIRANIB","tradeNames":["Recentin"],"synonyms":["AZD-2171","AZD2171","Azd-2171","Cediranib","ZD-2171"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","targetName":"Platelet-derived growth factor receptor"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000261456","diseaseId":"EFO_1001952","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00977574%22"}],"ancestors":["MONDO_0002149","EFO_1000051","EFO_1000073","MONDO_0021148","EFO_0000512","EFO_0000313","EFO_0002919","EFO_1001512","EFO_0009549","EFO_0006858","EFO_1001331","EFO_0000616","OTAR_0000017","MONDO_0002654","MONDO_0021251","MONDO_0002532","EFO_1000240","MONDO_0023370","MONDO_0000931","MONDO_0045024","MONDO_0004992","MONDO_0002715","EFO_0000707","MONDO_0011962","EFO_0003859"],"label":"endometrial adenosquamous carcinoma","approvedSymbol":"TUBB8","approvedName":"tubulin beta 8 class VIII","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1637","targetId":"ENSG00000106628","diseaseId":"EFO_1001961","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02392637%22"}],"ancestors":["MONDO_0003059","MONDO_0024276","MONDO_0002665","MONDO_0002887","EFO_0009534","MONDO_0021069","MONDO_0003193","EFO_0003891","MONDO_0024477","MONDO_0021385","MONDO_0021662","MONDO_0021321","EFO_0003769","EFO_0000313","MONDO_0003060","EFO_0001421","EFO_0006858","EFO_0000616","MONDO_0001487","EFO_0005221","EFO_0005540","MONDO_0023370","MONDO_0018918","MONDO_0045024","MONDO_0004992","MONDO_0002691","EFO_0008550","MONDO_0018536","EFO_1000218","EFO_0000228","EFO_0001379","MONDO_0003090","EFO_0008549","MONDO_0002516","MONDO_0018532","EFO_0010284","MONDO_0018531","EFO_0010282"],"label":"intrahepatic cholangiocarcinoma","approvedSymbol":"POLD2","approvedName":"DNA polymerase delta 2, accessory subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE HYDROCHLORIDE","tradeNames":["Gemcitabine hydrochloride","Gemzar","Infugem"],"synonyms":["Gemcitabine (as hydrochloride)","Gemcitabine hcl","Gemcitabine hydrochloride","Gemzar","LY-188011","LY-188011 HYDROCHLORIDE","LY188011 HYDROCHLORIDE"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1637","targetId":"ENSG00000146143","diseaseId":"EFO_1001961","phase":3,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05342194%22"}],"ancestors":["MONDO_0003059","MONDO_0024276","MONDO_0002665","MONDO_0002887","EFO_0009534","MONDO_0021069","MONDO_0003193","EFO_0003891","MONDO_0024477","MONDO_0021385","MONDO_0021662","MONDO_0021321","EFO_0003769","EFO_0000313","MONDO_0003060","EFO_0001421","EFO_0006858","EFO_0000616","MONDO_0001487","EFO_0005221","EFO_0005540","MONDO_0023370","MONDO_0018918","MONDO_0045024","MONDO_0004992","MONDO_0002691","EFO_0008550","MONDO_0018536","EFO_1000218","EFO_0000228","EFO_0001379","MONDO_0003090","EFO_0008549","MONDO_0002516","MONDO_0018532","EFO_0010284","MONDO_0018531","EFO_0010282"],"label":"intrahepatic cholangiocarcinoma","approvedSymbol":"PRIM2","approvedName":"DNA primase subunit 2","targetClass":["Enzyme"],"prefName":"GEMCITABINE HYDROCHLORIDE","tradeNames":["Gemcitabine hydrochloride","Gemzar","Infugem"],"synonyms":["Gemcitabine (as hydrochloride)","Gemcitabine hcl","Gemcitabine hydrochloride","Gemzar","LY-188011","LY-188011 HYDROCHLORIDE","LY188011 HYDROCHLORIDE"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000137267","diseaseId":"EFO_1001961","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02392637%22"}],"ancestors":["MONDO_0003059","MONDO_0024276","MONDO_0002665","MONDO_0002887","EFO_0009534","MONDO_0021069","MONDO_0003193","EFO_0003891","MONDO_0024477","MONDO_0021385","MONDO_0021662","MONDO_0021321","EFO_0003769","EFO_0000313","MONDO_0003060","EFO_0001421","EFO_0006858","EFO_0000616","MONDO_0001487","EFO_0005221","EFO_0005540","MONDO_0023370","MONDO_0018918","MONDO_0045024","MONDO_0004992","MONDO_0002691","EFO_0008550","MONDO_0018536","EFO_1000218","EFO_0000228","EFO_0001379","MONDO_0003090","EFO_0008549","MONDO_0002516","MONDO_0018532","EFO_0010284","MONDO_0018531","EFO_0010282"],"label":"intrahepatic cholangiocarcinoma","approvedSymbol":"TUBB2A","approvedName":"tubulin beta 2A class IIa","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1683590","targetId":"ENSG00000261456","diseaseId":"EFO_1001968","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01458249%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00413192%22"}],"ancestors":["MONDO_0023370","MONDO_0024637","EFO_0000691","MONDO_0045024","MONDO_0004992","EFO_1000541","MONDO_0044334","EFO_0000616"],"label":"soft tissue sarcoma","approvedSymbol":"TUBB8","approvedName":"tubulin beta 8 class VIII","targetClass":["Structural protein"],"prefName":"ERIBULIN","tradeNames":["Halaven"],"synonyms":["ER-086526","Eribulin"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL53463","targetId":"ENSG00000131747","diseaseId":"EFO_1001968","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05100628%22"}],"ancestors":["MONDO_0023370","MONDO_0024637","EFO_0000691","MONDO_0045024","MONDO_0004992","EFO_1000541","MONDO_0044334","EFO_0000616"],"label":"soft tissue sarcoma","approvedSymbol":"TOP2A","approvedName":"DNA topoisomerase II alpha","targetClass":["Enzyme"],"prefName":"DOXORUBICIN","tradeNames":["Adriblastina"],"synonyms":["Adriablastin","Adriamycin","Doxil","Doxorubicin","Epirubicin hydrochloride impurity, doxorubicin-","Hydroxydaunorubicin","NSC-123127","NSC-759155","Rubex","Valrubicin impurity, doxorubicin"],"drugType":"Small molecule","mechanismOfAction":"DNA topoisomerase II alpha inhibitor","targetName":"DNA topoisomerase II alpha"}
{"drugId":"CHEMBL888","targetId":"ENSG00000101868","diseaseId":"EFO_1001968","phase":1,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03524898%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01803152%22"}],"ancestors":["MONDO_0023370","MONDO_0024637","EFO_0000691","MONDO_0045024","MONDO_0004992","EFO_1000541","MONDO_0044334","EFO_0000616"],"label":"soft tissue sarcoma","approvedSymbol":"POLA1","approvedName":"DNA polymerase alpha 1, catalytic subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL888","targetId":"ENSG00000167325","diseaseId":"EFO_1001968","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01812018%22"}],"ancestors":["MONDO_0023370","MONDO_0024637","EFO_0000691","MONDO_0045024","MONDO_0004992","EFO_1000541","MONDO_0044334","EFO_0000616"],"label":"soft tissue sarcoma","approvedSymbol":"RRM1","approvedName":"ribonucleotide reductase catalytic subunit M1","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"Ribonucleoside-diphosphate reductase RR1 inhibitor","targetName":"Ribonucleoside-diphosphate reductase RR1"}
{"drugId":"CHEMBL1433","targetId":"ENSG00000137745","diseaseId":"EFO_1001984","phase":3,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03481972%22"}],"ancestors":["EFO_0000589","EFO_1000639","MONDO_0021179","EFO_1001875","OTAR_0000020"],"label":"cardiac amyloidosis","approvedSymbol":"MMP13","approvedName":"matrix metallopeptidase 13","targetClass":["Enzyme"],"prefName":"DOXYCYCLINE ANHYDROUS","tradeNames":[],"synonyms":["Anhydrous doxycycline","Doxycycline (anhydrous)"],"drugType":"Small molecule","mechanismOfAction":"Matrix metalloproteinase 13 inhibitor","targetName":"Matrix metalloproteinase 13"}
{"drugId":"CHEMBL1200480","targetId":"ENSG00000139874","diseaseId":"EFO_1002048","phase":2,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04941911%22"}],"ancestors":["EFO_0009690","EFO_0003086"],"label":"kidney failure","approvedSymbol":"SSTR1","approvedName":"somatostatin receptor 1","targetClass":["Membrane receptor"],"prefName":"OCTREOTIDE ACETATE","tradeNames":["Bynfezia pen","Mycapssa","Octreotide acetate","Octreotide acetate (preservative free)","Octreotide acetate preservative free","Sandostatin","Sandostatin lar"],"synonyms":["Octreolin","Octreotide (as acetate)","Octreotide acetate","SMS 201-995 AC","SMS-201-995 AC","SMS-201995-AC"],"drugType":"Protein","mechanismOfAction":"Somatostatin receptor agonist","targetName":"Somatostatin receptor"}
{"drugId":"CHEMBL526","targetId":"ENSG00000022355","diseaseId":"EFO_1002048","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02571426%22"}],"ancestors":["EFO_0009690","EFO_0003086"],"label":"kidney failure","approvedSymbol":"GABRA1","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha1","targetClass":["Ion channel"],"prefName":"PROPOFOL","tradeNames":["Diprivan","Disoprivan","Propofol","Rapinovet"],"synonyms":["Disoprofol","Fresofol","ICI 35,868","ICI 35-868","ICI-35868","ICI35,868","Lipuro","NSC-5105","Phenol, 2,6-bis(1-methylethyl)","Propofol"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000212907","diseaseId":"GO_0007568","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03072485%22"}],"ancestors":["GO_0008150"],"label":"aging","approvedSymbol":"MT-ND4L","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL363295","targetId":"ENSG00000151062","diseaseId":"HP_0000020","phase":4,"urls":[{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=G04BD05"}],"ancestors":["HP_0025142","HP_0000079","HP_0000014","EFO_0000651","HP_0000118"],"label":"Urinary incontinence","approvedSymbol":"CACNA2D4","approvedName":"calcium voltage-gated channel auxiliary subunit alpha2delta 4","targetClass":["Ion channel"],"prefName":"TERODILINE","tradeNames":[],"synonyms":["Terodiline"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated calcium channel blocker","targetName":"Voltage-gated calcium channel"}
{"drugId":"CHEMBL742","targetId":"ENSG00000198785","diseaseId":"HP_0000023","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02646709%22"}],"ancestors":["HP_0025031","EFO_0000651","HP_0000118","HP_0003549","HP_0100790","HP_0004299"],"label":"Inguinal hernia","approvedSymbol":"GRIN3A","approvedName":"glutamate ionotropic receptor NMDA type subunit 3A","targetClass":["Ion channel"],"prefName":"KETAMINE","tradeNames":["Ketalar"],"synonyms":["Anaket v","Calypsol","Clorketam 1000","Dl-ketamine","Imalgene 1000","Ketamine","Ketasol 100","NSC-70151","Narketan","PMI-150","Tekam","Ursotamin","Vetaket"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor negative allosteric modulator","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL1014","targetId":"ENSG00000144891","diseaseId":"HP_0000093","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00242346%22"}],"ancestors":["HP_0000079","EFO_0000651","HP_0000118","HP_0003110","HP_0011277","HP_0001939"],"label":"Proteinuria","approvedSymbol":"AGTR1","approvedName":"angiotensin II receptor type 1","targetClass":["Membrane receptor"],"prefName":"CANDESARTAN CILEXETIL","tradeNames":["Amias","Atacand","Candesartan cilexetil","Ratacand"],"synonyms":["Candesartan","Candesartan 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester","Candesartan cilexetil","NSC-758697","TCV-116"],"drugType":"Small molecule","mechanismOfAction":"Type-1 angiotensin II receptor antagonist","targetName":"Type-1 angiotensin II receptor"}
{"drugId":"CHEMBL1200409","targetId":"ENSG00000136531","diseaseId":"HP_0000360","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02266160%22"}],"ancestors":["HP_0000364","EFO_0000651","HP_0000598","HP_0000118"],"label":"Tinnitus","approvedSymbol":"SCN2A","approvedName":"sodium voltage-gated channel alpha subunit 2","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"LIDOCAINE HYDROCHLORIDE","tradeNames":["Akten","Alphacaine hydrochloride","Anestacon","Anodesyn","Bismodyne","Bradosol plus","Calgel","Co-phenylcaine fte","Denela","Dequaspray","Emla","Germoloids","Germoloids complete","Glydo","Hemocane","Iglu","Instillagel","Laryng-o-jet kit","Laryngojet","Laryngotracheal anesthesia kit","Lido hcl","Lidocaine hydrochloride","Lidocaine hydrochloride preservative free","Lidocaine hydrochloride viscous","Lidocaine viscous","Lidocaton","Lidopen","Lignokent","Lignospan special","Lignostab","Lignostab a 100","Lignostab n","Lignostab-a","Lta ii kit","Medijel","Oragard","Pediatric lta kit","Preparation h","Rexocaine","Versatis","Xylocaine","Xylocaine dental","Xylocaine preservative free","Xylocaine viscous","Xylotox e80","Zingo"],"synonyms":["Lidocaine hcl","Lidocaine hydrochloride","Lidocaine hydrochloride monohydrate","Lidocaine hydrochloride usp","Lidocaini hydrochloridum","Lignocaine (as hydrochloride)","Lignocaine hydrochloride","NSC-757420","Xylocaine hydrochloride"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000104267","diseaseId":"HP_0000360","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04404439%22"}],"ancestors":["HP_0000364","EFO_0000651","HP_0000598","HP_0000118"],"label":"Tinnitus","approvedSymbol":"CA2","approvedName":"carbonic anhydrase 2","targetClass":["Enzyme"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"Carbonic anhydrase II inhibitor","targetName":"Carbonic anhydrase II"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000105737","diseaseId":"HP_0000360","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04404439%22"}],"ancestors":["HP_0000364","EFO_0000651","HP_0000598","HP_0000118"],"label":"Tinnitus","approvedSymbol":"GRIK5","approvedName":"glutamate ionotropic receptor kainate type subunit 5","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"Glutamate receptor ionotropic kainate antagonist","targetName":"Glutamate receptor ionotropic kainate"}
{"drugId":"CHEMBL517712","targetId":"ENSG00000181072","diseaseId":"HP_0000545","phase":4,"status":"Enrolling by invitation","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03949101%22"}],"ancestors":["EFO_0000651","HP_0000478","HP_0000118","HP_0000539"],"label":"Myopia","approvedSymbol":"CHRM2","approvedName":"cholinergic receptor muscarinic 2","targetClass":["Membrane receptor"],"prefName":"ATROPINE","tradeNames":["Atroject","Atropen","Atrophate","Atropine","Atropine (autoinjector)","Isopto Atropine"],"synonyms":["Atropine","Atropinum","Dl-hyoscyamine"],"drugType":"Small molecule","mechanismOfAction":"Muscarinic acetylcholine receptor M2 antagonist","targetName":"Muscarinic acetylcholine receptor M2"}
{"drugId":"CHEMBL655","targetId":"ENSG00000113327","diseaseId":"HP_0000713","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02022488%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02909465%22"}],"ancestors":["HP_0000708","HP_0012638","EFO_0000651","HP_0000118","HP_0000707"],"label":"Agitation","approvedSymbol":"GABRG2","approvedName":"gamma-aminobutyric acid type A receptor subunit gamma2","targetClass":["Ion channel"],"prefName":"MIDAZOLAM","tradeNames":["Midazolam in 0.9% sodium chloride","Nayzilam"],"synonyms":["Midazolam","Midazolam civ","USL-261","USL261"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL778","targetId":"ENSG00000150594","diseaseId":"HP_0000713","phase":0,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05264077%22"}],"ancestors":["HP_0000708","HP_0012638","EFO_0000651","HP_0000118","HP_0000707"],"label":"Agitation","approvedSymbol":"ADRA2A","approvedName":"adrenoceptor alpha 2A","targetClass":["Membrane receptor"],"prefName":"DEXMEDETOMIDINE","tradeNames":["Precedex"],"synonyms":["Dexmedetomidine","MPV-1440","Medetomidine, (s)-"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor alpha-2 agonist","targetName":"Adrenergic receptor alpha-2"}
{"drugId":"CHEMBL243712","targetId":"ENSG00000135312","diseaseId":"HP_0000726","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02374567%22"}],"ancestors":["HP_0100543","HP_0012638","EFO_0000651","HP_0001268","HP_0011446","HP_0000118","HP_0000707"],"label":"Dementia","approvedSymbol":"HTR1B","approvedName":"5-hydroxytryptamine receptor 1B","targetClass":["Ion channel","Membrane receptor"],"prefName":"AMISULPRIDE","tradeNames":["Barhemsys","Solian","Solian 100","Solian 200","Solian 400","Solian 50"],"synonyms":["APD-421","APD421","Aminosultopride","Amisulpride","DAN-2163","Deniban","NSC-760085","Socian","Sulamid"],"drugType":"Small molecule","mechanismOfAction":"Serotonin (5-HT) receptor antagonist","targetName":"Serotonin (5-HT) receptor"}
{"drugId":"CHEMBL445","targetId":"ENSG00000103546","diseaseId":"HP_0000726","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02374567%22"}],"ancestors":["HP_0100543","HP_0012638","EFO_0000651","HP_0001268","HP_0011446","HP_0000118","HP_0000707"],"label":"Dementia","approvedSymbol":"SLC6A2","approvedName":"solute carrier family 6 member 2","targetClass":["Transporter"],"prefName":"NORTRIPTYLINE","tradeNames":["Allegron","Aventyl","Motipress","Motival"],"synonyms":["Desitriptilina","Lumbeck","NCI-169453","NSC-757234","Noramitriptyline","Nortrilen","Nortriptyline","Pamelor","Sesaval"],"drugType":"Small molecule","mechanismOfAction":"Norepinephrine transporter inhibitor","targetName":"Norepinephrine transporter"}
{"drugId":"CHEMBL1703","targetId":"ENSG00000140990","diseaseId":"HP_0000842","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00005669%22"}],"ancestors":["HP_0000818","EFO_0000651","HP_0003117","HP_0000118","HP_0011014","HP_0001939"],"label":"Hyperinsulinemia","approvedSymbol":"NDUFB10","approvedName":"NADH:ubiquinone oxidoreductase subunit B10","targetClass":["Enzyme"],"prefName":"METFORMIN HYDROCHLORIDE","tradeNames":["Bolamyn sr","Diagemet xl","Fortamet","Glucamet 500","Glucamet 850","Glucient sr","Glucophage","Glucophage sr","Glucophage xr","Glumetza","Glyformin","Janumet","Ledermetin","Metabet sr","Metformin hydrochloride","Metsol","Milform","Orabet","Riomet","Riomet er","Sukkarto sr"],"synonyms":["Apophage","Benofomin","Diabefagos","Diabex","EX-404","EX404","Glucaminol","LA-6023","Metformin hcl","Metformin hydrochloride","NSC-91485","Neodipa","Siamformet","Walaphage"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1703","targetId":"ENSG00000184983","diseaseId":"HP_0000842","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00005669%22"}],"ancestors":["HP_0000818","EFO_0000651","HP_0003117","HP_0000118","HP_0011014","HP_0001939"],"label":"Hyperinsulinemia","approvedSymbol":"NDUFA6","approvedName":"NADH:ubiquinone oxidoreductase subunit A6","targetClass":["Enzyme"],"prefName":"METFORMIN HYDROCHLORIDE","tradeNames":["Bolamyn sr","Diagemet xl","Fortamet","Glucamet 500","Glucamet 850","Glucient sr","Glucophage","Glucophage sr","Glucophage xr","Glumetza","Glyformin","Janumet","Ledermetin","Metabet sr","Metformin hydrochloride","Metsol","Milform","Orabet","Riomet","Riomet er","Sukkarto sr"],"synonyms":["Apophage","Benofomin","Diabefagos","Diabex","EX-404","EX404","Glucaminol","LA-6023","Metformin hcl","Metformin hydrochloride","NSC-91485","Neodipa","Siamformet","Walaphage"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1429","targetId":"ENSG00000166148","diseaseId":"HP_0000863","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6d55baa9-2b62-469c-93ae-3909ab249332"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=86f040d0-a073-4fa5-8997-b2fecc4a3205"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9d8442a-4722-4b41-9faa-1ee853a4cc3b"}],"ancestors":["HP_0000818","EFO_0000651","HP_0000118","HP_0012443","HP_0002011","HP_0000707"],"label":"Central diabetes insipidus","approvedSymbol":"AVPR1A","approvedName":"arginine vasopressin receptor 1A","targetClass":["Membrane receptor"],"prefName":"DESMOPRESSIN","tradeNames":[],"synonyms":["Desmopressin","H01BA02"],"drugType":"Protein","mechanismOfAction":"Vasopressin receptor agonist","targetName":"Vasopressin receptor"}
{"drugId":"CHEMBL730","targetId":"ENSG00000061918","diseaseId":"HP_0000938","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00043719%22"}],"ancestors":["EFO_0000651","HP_0004348","HP_0004349","HP_0011842","HP_0000118","HP_0000924"],"label":"Osteopenia","approvedSymbol":"GUCY1B1","approvedName":"guanylate cyclase 1 soluble subunit beta 1","targetClass":["Enzyme"],"prefName":"NITROGLYCERIN","tradeNames":["Coro-nitro","Deponit 10","Deponit 5","Glytrin","Gonitro","Lenitral 7.5","Minitran","Minitran 10","Minitran 15","Minitran 5","Natirose","Nitriderm tts","Nitro iv","Nitro-bid","Nitro-dur","Nitro-mack ret","Nitrocine","Nitrocontin continus","Nitroglycerin","Nitrol","Nitrolingual","Nitrolingual pumpspray","Nitromin","Nitromist","Nitronal","Nitrostat","Percutol","Rectiv","Rectogesic","Suscard buccal","Sustac","Transderm-nitro","Transiderm-nitro 10","Transiderm-nitro 5","Tridil","Trintek 10","Trintek 15","Trintek 5"],"synonyms":["C01DA02","Chlormethine oxide hydrochloride","Diluted nitroglycerin","Glonoinum","Glyceryl Trinitrate","Glyceryl trinitrate","Glyceryl trinitrate solution","Imx-150","Mechlorethamine oxide hcl","Mitomen","Mustron","Nitora","Nitroglycerin","Nitroglycerin tablets","Nitromin hydrochloride","Transderm-Nitro","Trinitrin","Trinitrin tablets","Trinitrine"],"drugType":"Small molecule","mechanismOfAction":"Soluble guanylate cyclase activator","targetName":"Soluble guanylate cyclase"}
{"drugId":"CHEMBL3989887","targetId":"ENSG00000088832","diseaseId":"HP_0000964","phase":4,"urls":[{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=D11AH01"}],"ancestors":["HP_0001574","EFO_0000651","HP_0012649","HP_0000951","HP_0012647","HP_0000118","HP_0002715","HP_0011123"],"label":"Eczema","approvedSymbol":"FKBP1A","approvedName":"FKBP prolyl isomerase 1A","targetClass":["Enzyme"],"prefName":"TACROLIMUS","tradeNames":["Adoport","Advagraf","Astagraf xl","Capexion","Envarsus","Envarsus xr","Modigraf","Perixis","Prograf","Protopic","Tacni","Tacrolimus","Vivadex"],"synonyms":["FK 506","FR900506","Tacrolimus","Tacrolimus hydrate"],"drugType":"Small molecule","mechanismOfAction":"FK506-binding protein 1A inhibitor","targetName":"FK506-binding protein 1A"}
{"drugId":"CHEMBL4594569","targetId":"ENSG00000117586","diseaseId":"HP_0000964","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05131477%22"}],"ancestors":["HP_0001574","EFO_0000651","HP_0012649","HP_0000951","HP_0012647","HP_0000118","HP_0002715","HP_0011123"],"label":"Eczema","approvedSymbol":"TNFSF4","approvedName":"TNF superfamily member 4","targetClass":["Secreted protein"],"prefName":"KY-1005","tradeNames":[],"synonyms":["Amlitelimab","KY-1005","KY-1005-2D10","KY1005","KY1005-2D10","Ky-1005","Ky1005"],"drugType":"Unknown","mechanismOfAction":"Tumor necrosis factor ligand superfamily member 4 inhibitor","targetName":"Tumor necrosis factor ligand superfamily member 4"}
{"drugId":"CHEMBL22108","targetId":"ENSG00000196639","diseaseId":"HP_0000989","phase":4,"urls":[{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=D04AA13"}],"ancestors":["HP_0001574","EFO_0000651","HP_0000951","HP_0000118"],"label":"Pruritus","approvedSymbol":"HRH1","approvedName":"histamine receptor H1","targetClass":["Membrane receptor"],"prefName":"DIMETHINDENE","tradeNames":[],"synonyms":["Dimethpyrindene","Dimetindene","Feniallerg","Forhistal"],"drugType":"Small molecule","mechanismOfAction":"Histamine H1 receptor antagonist","targetName":"Histamine H1 receptor"}
{"drugId":"CHEMBL698","targetId":"ENSG00000136546","diseaseId":"HP_0000989","phase":4,"urls":[{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=D04AB06"}],"ancestors":["HP_0001574","EFO_0000651","HP_0000951","HP_0000118"],"label":"Pruritus","approvedSymbol":"SCN7A","approvedName":"sodium voltage-gated channel alpha subunit 7","targetClass":["Ion channel"],"prefName":"TETRACAINE","tradeNames":["Ametop","Dicaine","Medihaler-tetracaine","Metraspray","Pontocaine"],"synonyms":["Amethocaine","Tetracaine"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL79","targetId":"ENSG00000169432","diseaseId":"HP_0001082","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01833819%22"}],"ancestors":["HP_0002012","HP_0025031","EFO_0000651","HP_0012438","HP_0000118","HP_0001392"],"label":"Cholecystitis","approvedSymbol":"SCN9A","approvedName":"sodium voltage-gated channel alpha subunit 9","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"LIDOCAINE","tradeNames":["Alphacaine","Anestacon","Dentipatch","Lidocaine","Lidoderm","Lignocaine Hcl","Lignostab","Lmx 4","Oraqix","Vagisil","Xylocaine","Xylodase","Xylotox","Ztlido"],"synonyms":["ALGRX 3268","ALGRX-3268","Anestacon","Embolex","Iontocaine","Lidocaine","Lidocainum","Lidocaton","Lidopen","Lignocaine","NSC-40030","Octocaine","Solarcaine","Xylestesin"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000140990","diseaseId":"HP_0001249","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03862950%22"}],"ancestors":["HP_0100543","HP_0012638","EFO_0000651","HP_0012759","HP_0011446","HP_0000118","HP_0000707"],"label":"Intellectual disability","approvedSymbol":"NDUFB10","approvedName":"NADH:ubiquinone oxidoreductase subunit B10","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1068","targetId":"ENSG00000196876","diseaseId":"HP_0001250","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01051193%22"}],"ancestors":["HP_0012638","EFO_0000651","HP_0000118","HP_0000707"],"label":"Seizure","approvedSymbol":"SCN8A","approvedName":"sodium voltage-gated channel alpha subunit 8","targetClass":["Unclassified protein","Auxiliary transport protein","Ion channel"],"prefName":"OXCARBAZEPINE","tradeNames":["Oxcarbazepine","Oxtellar xr","Trileptal"],"synonyms":["GP-47680","KIN-493","NSC-758693","Oxcarbamazepine","Oxcarbazepine","SPN-804"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000166206","diseaseId":"HP_0001250","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00231556%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00236756%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00236717%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00236886%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00113815%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00236743%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00266591%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00236418%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00236704%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00230698%22"}],"ancestors":["HP_0012638","EFO_0000651","HP_0000118","HP_0000707"],"label":"Seizure","approvedSymbol":"GABRB3","approvedName":"gamma-aminobutyric acid type A receptor subunit beta3","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL741","targetId":"ENSG00000196876","diseaseId":"HP_0001250","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00144872%22"}],"ancestors":["HP_0012638","EFO_0000651","HP_0000118","HP_0000707"],"label":"Seizure","approvedSymbol":"SCN8A","approvedName":"sodium voltage-gated channel alpha subunit 8","targetClass":["Unclassified protein","Auxiliary transport protein","Ion channel"],"prefName":"LAMOTRIGINE","tradeNames":["Lamictal","Lamictal cd","Lamictal odt","Lamictal xr","Lamotrigine"],"synonyms":["BW 430C","BW-430C","Lamotrigine","NSC-759171"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL3545042","targetId":"ENSG00000149403","diseaseId":"HP_0001257","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01649050%22"}],"ancestors":["HP_0001276","HP_0011804","EFO_0000651","HP_0012638","HP_0000118","HP_0003808","HP_0003011","HP_0011442","HP_0000707"],"label":"Spasticity","approvedSymbol":"GRIK4","approvedName":"glutamate ionotropic receptor kainate type subunit 4","targetClass":["Ion channel"],"prefName":"SELURAMPANEL","tradeNames":[],"synonyms":["BGG-492","BGG492","Bgg492","Selurampanel"],"drugType":"Small molecule","mechanismOfAction":"Glutamate receptor ionotropic kainate antagonist","targetName":"Glutamate receptor ionotropic kainate"}
{"drugId":"CHEMBL112","targetId":"ENSG00000117480","diseaseId":"HP_0001643","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03103022%22"}],"ancestors":["HP_0002597","EFO_0000651","HP_0000118","HP_0030680","HP_0001626"],"label":"Patent ductus arteriosus","approvedSymbol":"FAAH","approvedName":"fatty acid amide hydrolase","targetClass":["Enzyme"],"prefName":"ACETAMINOPHEN","tradeNames":["Abdine","Acephen","Acetaminophen","Alvedon","Angiers","Calpol","Calpol six plus","Calpol six plus fastmelts","Child lemsip","Cupanol","Dafalgan","Datril","Disprol","Disprol infant","Disprol jnr","Disprol paed","Fennings","Galpamol","Hedex","Infadrops","Infants' feverall","Injectapap","Junior parapaed","Mandanol","Medinol","Medinol for children","Medinol over 6","Medinol under 6","Medised plain","Miradol","Neopap","Ofirmev","Paldesic","Panadol","Panadol actifast","Panadol actifast solb","Panadol advan","Panadol jnr","Panadol oa","Panaleve","Panaleve 6 plus","Paracetamol","Paramin","Parapaed jnr","Parapaed six plus","Paravict","Perfalgan","Phenaphen","Placidex","Rimadol","Salzone","Tixymol","Tramil 500","Tylenol"],"synonyms":["Acetaminophen","Apap","Biocetamol","Doliprane","Efferalgan","N-acetyl-p-aminophenol","NSC-109028","NSC-3991","P-hydroxy-acetanilid","Paracetamol","Paracetamolum","Vermidon"],"drugType":"Small molecule","mechanismOfAction":"Anandamide amidohydrolase inhibitor","targetName":"Anandamide amidohydrolase"}
{"drugId":"CHEMBL3989691","targetId":"ENSG00000117400","diseaseId":"HP_0001873","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7714a0ed-34bb-46e6-a0a5-b363908b22c2"}],"ancestors":["HP_0001871","EFO_0000651","HP_0000118"],"label":"Thrombocytopenia","approvedSymbol":"MPL","approvedName":"MPL proto-oncogene, thrombopoietin receptor","targetClass":["Membrane receptor"],"prefName":"ELTROMBOPAG OLAMINE","tradeNames":["Promacta","Promacta kit"],"synonyms":["Eltrombopag (as olamine)","Eltrombopag compd with 2-aminoethanol (1:2)","Eltrombopag olamine","SB-497115-GR"],"drugType":"Small molecule","mechanismOfAction":"Thrombopoietin receptor agonist","targetName":"Thrombopoietin receptor"}
{"drugId":"CHEMBL1422","targetId":"ENSG00000197635","diseaseId":"HP_0001952","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00740363%22"}],"ancestors":["EFO_0000651","HP_0000118","HP_0011014","HP_0001939"],"label":"Glucose intolerance","approvedSymbol":"DPP4","approvedName":"dipeptidyl peptidase 4","targetClass":["Enzyme"],"prefName":"SITAGLIPTIN","tradeNames":["Januvia"],"synonyms":["LEZ-763","LEZ763","MK-0431","Sitagliptin"],"drugType":"Small molecule","mechanismOfAction":"Dipeptidyl peptidase IV inhibitor","targetName":"Dipeptidyl peptidase IV"}
{"drugId":"CHEMBL1437","targetId":"ENSG00000274286","diseaseId":"HP_0002140","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00227448%22"}],"ancestors":["EFO_0000556","HP_0002597","EFO_0000651","HP_0002637","HP_0030680","HP_0000118","HP_0001626","HP_0011025","HP_0012443","HP_0002011","HP_0100659","HP_0000707"],"label":"Ischemic stroke","approvedSymbol":"ADRA2B","approvedName":"adrenoceptor alpha 2B","targetClass":["Membrane receptor"],"prefName":"NOREPINEPHRINE","tradeNames":[],"synonyms":["(-)-noradrenaline","Levophed","NSC-757246","Nor adrenalin","Norepinephrine","R-norepinephrine"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor agonist","targetName":"Adrenergic receptor"}
{"drugId":"CHEMBL742","targetId":"ENSG00000105464","diseaseId":"HP_0002140","phase":2,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03223220%22"}],"ancestors":["EFO_0000556","HP_0002597","EFO_0000651","HP_0002637","HP_0030680","HP_0000118","HP_0001626","HP_0011025","HP_0012443","HP_0002011","HP_0100659","HP_0000707"],"label":"Ischemic stroke","approvedSymbol":"GRIN2D","approvedName":"glutamate ionotropic receptor NMDA type subunit 2D","targetClass":["Ion channel"],"prefName":"KETAMINE","tradeNames":["Ketalar"],"synonyms":["Anaket v","Calypsol","Clorketam 1000","Dl-ketamine","Imalgene 1000","Ketamine","Ketasol 100","NSC-70151","Narketan","PMI-150","Tekam","Ursotamin","Vetaket"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor negative allosteric modulator","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL113","targetId":"ENSG00000163485","diseaseId":"HP_0002315","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01172405%22"}],"ancestors":["HP_0012638","EFO_0000651","HP_0000118","HP_0000707"],"label":"Headache","approvedSymbol":"ADORA1","approvedName":"adenosine A1 receptor","targetClass":["Membrane receptor"],"prefName":"CAFFEINE","tradeNames":["Nodoz","Nodoz caplets and chewable tablets","Pro-plus","Yeast-vite","Zanthine"],"synonyms":["Anhydrous caffeine","Cafcit","Caffeine","Caffeine anhydrous","Caffeine melting point standard","Caffeinum","Coffeine","Coffeinum","Durvitan","FEMA NO. 2224","Guaranine","Methyltheobromine","NSC-5036","Synalgos","Theine","Vivarin"],"drugType":"Small molecule","mechanismOfAction":"Adenosine receptor antagonist","targetName":"Adenosine receptor"}
{"drugId":"CHEMBL190","targetId":"ENSG00000170425","diseaseId":"HP_0002315","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03997006%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04257851%22"}],"ancestors":["HP_0012638","EFO_0000651","HP_0000118","HP_0000707"],"label":"Headache","approvedSymbol":"ADORA2B","approvedName":"adenosine A2b receptor","targetClass":["Membrane receptor"],"prefName":"THEOPHYLLINE","tradeNames":["Accurbron","Aerolate","Aerolate iii","Aerolate jr","Aerolate sr","Aquaphyllin","Bronkodyl","Duraphyl","Elixicon","Elixomin","Elixophyllin","Elixophyllin sr","Labid","Lanophyllin","Lasma","Nuelin","Nuelin sa","Nuelin sa-250","Pro-vent","Quibron","Quibron-t","Quibron-t/sr","Respbid","Slo-bid","Slo-phyllin","Somophyllin-crt","Somophyllin-t","Sustaire","T-phyl","Theo-24","Theo-dur","Theobid","Theobid jr.","Theochron","Theocin","Theoclear l.a.-130","Theoclear l.a.-260","Theoclear-100","Theoclear-200","Theoclear-80","Theograd","Theolair","Theolair-sr","Theolixir","Theophyl","Theophyl-225","Theophyl-sr","Theophylline","Theophylline-sr","Theovent","Uni-dur","Uniphyl","Uniphyllin continus"],"synonyms":["Dimethylxanthine","Doxophylline metabolite m3","NSC-2066","NSC-757346","Theophylline","Theophylline anhydrous","Theophylline melting point standard","Theophylline monohydrate","Theophylline, anhydrous","Theophylline,anhydrous"],"drugType":"Small molecule","mechanismOfAction":"Adenosine receptor antagonist","targetName":"Adenosine receptor"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000163873","diseaseId":"HP_0002315","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00261469%22"}],"ancestors":["HP_0012638","EFO_0000651","HP_0000118","HP_0000707"],"label":"Headache","approvedSymbol":"GRIK3","approvedName":"glutamate ionotropic receptor kainate type subunit 3","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"Glutamate receptor ionotropic kainate antagonist","targetName":"Glutamate receptor ionotropic kainate"}
{"drugId":"CHEMBL1487","targetId":"ENSG00000113161","diseaseId":"HP_0003124","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00758004%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00777517%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01859455%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02374047%22"}],"ancestors":["EFO_0000651","HP_0003119","HP_0000118","HP_0001939"],"label":"Hypercholesterolemia","approvedSymbol":"HMGCR","approvedName":"3-hydroxy-3-methylglutaryl-CoA reductase","targetClass":["Enzyme"],"prefName":"ATORVASTATIN","tradeNames":["Cardyl","Lipitor","Prevencor","Sortis","Tahor","Zarator"],"synonyms":["Atorvastatin"],"drugType":"Small molecule","mechanismOfAction":"HMG-CoA reductase inhibitor","targetName":"HMG-CoA reductase"}
{"drugId":"CHEMBL1228","targetId":"ENSG00000095303","diseaseId":"HP_0003326","phase":4,"urls":[{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=M02AA04"}],"ancestors":["HP_0025142","EFO_0000651","HP_0000118"],"label":"Myalgia","approvedSymbol":"PTGS1","approvedName":"prostaglandin-endoperoxide synthase 1","targetClass":["Enzyme"],"prefName":"OXYPHENBUTAZONE","tradeNames":["Oxyphenbutazone","Tandearil"],"synonyms":["Oxyphenbutazone"],"drugType":"Small molecule","mechanismOfAction":"Cyclooxygenase inhibitor","targetName":"Cyclooxygenase"}
{"drugId":"CHEMBL25","targetId":"ENSG00000095303","diseaseId":"HP_0003394","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=03cdc2f8-78d1-11dc-8314-0800200c9a66"}],"ancestors":["HP_0011804","EFO_0000651","HP_0000118","HP_0003011"],"label":"Muscle spasm","approvedSymbol":"PTGS1","approvedName":"prostaglandin-endoperoxide synthase 1","targetClass":["Enzyme"],"prefName":"ASPIRIN","tradeNames":["8-hour bayer","Acetosalic Acid","Acetylsalic acid","Acetylsalicylic Acid","Alka rapid","Anadin all night","Angettes 75","Aspirin","Aspro clr","Bayer extra strength aspirin for migraine pain","Danamep","Disprin cv","Disprin direct","Durlaza","Ecotrin","Enprin","Equi-Prin","Gencardia","Levius","Max strgh aspro clr","Measurin","Micropirin ec","Nu-seals 300","Nu-seals 600","Nu-seals 75","Nu-seals cardio 75","Paynocil","Platet","Platet 300","Postmi 300","Postmi 75","Salicylic Acid Acetate","Vazalore"],"synonyms":["Acetyl salicylate","Acetylsalicylic Acid","Acetylsalicylic acid","Acetylsalicylic acid (who-ip)","Acetylsalicylicum acidum","Acidum acetylsalicylicum","Aspirin","BAY1019036","Benzoic acid, 2-(acetyloxy)-","NSC-27223","NSC-406186"],"drugType":"Small molecule","mechanismOfAction":"Cyclooxygenase inhibitor","targetName":"Cyclooxygenase"}
{"drugId":"CHEMBL112","targetId":"ENSG00000073756","diseaseId":"HP_0003418","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03825198%22"}],"ancestors":["HP_0025142","EFO_0000651","EFO_0003843","EFO_0003765","HP_0011842","HP_0000118","HP_0000924","HP_0000925"],"label":"Back pain","approvedSymbol":"PTGS2","approvedName":"prostaglandin-endoperoxide synthase 2","targetClass":["Enzyme"],"prefName":"ACETAMINOPHEN","tradeNames":["Abdine","Acephen","Acetaminophen","Alvedon","Angiers","Calpol","Calpol six plus","Calpol six plus fastmelts","Child lemsip","Cupanol","Dafalgan","Datril","Disprol","Disprol infant","Disprol jnr","Disprol paed","Fennings","Galpamol","Hedex","Infadrops","Infants' feverall","Injectapap","Junior parapaed","Mandanol","Medinol","Medinol for children","Medinol over 6","Medinol under 6","Medised plain","Miradol","Neopap","Ofirmev","Paldesic","Panadol","Panadol actifast","Panadol actifast solb","Panadol advan","Panadol jnr","Panadol oa","Panaleve","Panaleve 6 plus","Paracetamol","Paramin","Parapaed jnr","Parapaed six plus","Paravict","Perfalgan","Phenaphen","Placidex","Rimadol","Salzone","Tixymol","Tramil 500","Tylenol"],"synonyms":["Acetaminophen","Apap","Biocetamol","Doliprane","Efferalgan","N-acetyl-p-aminophenol","NSC-109028","NSC-3991","P-hydroxy-acetanilid","Paracetamol","Paracetamolum","Vermidon"],"drugType":"Small molecule","mechanismOfAction":"Cyclooxygenase inhibitor","targetName":"Cyclooxygenase"}
{"drugId":"CHEMBL112","targetId":"ENSG00000117480","diseaseId":"HP_0003418","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5ea858e-76d9-4777-b3dc-5d614f66d485"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=852e5822-9bc0-06ed-e053-2a91aa0a5f1b"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dd7b5ba3-652a-443f-b0b9-17abda148e67"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dad63da3-cd1f-42a8-93d5-44b39aae1268"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9d384e88-5c11-4600-ac6c-a38371570138"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=889c5b6a-879e-425c-a25a-435766e9d601"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42e4219a-a4ef-f090-f6a4-2fd2e213d397"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=55768b45-fd98-4779-85b6-6a50c628677e"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=affddef4-c724-4bf6-8608-6eeffa38d684"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=853012b8-d3b7-78d3-e053-2a91aa0ab0f2"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f1bb6e5-3de5-48b4-bf44-d4e881be5ab0"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=97c99b40-bcd9-710b-e053-2a95a90a10a7"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4b04b21b-ee68-4c59-91ad-57c3d84e2b09"}],"ancestors":["HP_0025142","EFO_0000651","EFO_0003843","EFO_0003765","HP_0011842","HP_0000118","HP_0000924","HP_0000925"],"label":"Back pain","approvedSymbol":"FAAH","approvedName":"fatty acid amide hydrolase","targetClass":["Enzyme"],"prefName":"ACETAMINOPHEN","tradeNames":["Abdine","Acephen","Acetaminophen","Alvedon","Angiers","Calpol","Calpol six plus","Calpol six plus fastmelts","Child lemsip","Cupanol","Dafalgan","Datril","Disprol","Disprol infant","Disprol jnr","Disprol paed","Fennings","Galpamol","Hedex","Infadrops","Infants' feverall","Injectapap","Junior parapaed","Mandanol","Medinol","Medinol for children","Medinol over 6","Medinol under 6","Medised plain","Miradol","Neopap","Ofirmev","Paldesic","Panadol","Panadol actifast","Panadol actifast solb","Panadol advan","Panadol jnr","Panadol oa","Panaleve","Panaleve 6 plus","Paracetamol","Paramin","Parapaed jnr","Parapaed six plus","Paravict","Perfalgan","Phenaphen","Placidex","Rimadol","Salzone","Tixymol","Tramil 500","Tylenol"],"synonyms":["Acetaminophen","Apap","Biocetamol","Doliprane","Efferalgan","N-acetyl-p-aminophenol","NSC-109028","NSC-3991","P-hydroxy-acetanilid","Paracetamol","Paracetamolum","Vermidon"],"drugType":"Small molecule","mechanismOfAction":"Anandamide amidohydrolase inhibitor","targetName":"Anandamide amidohydrolase"}
{"drugId":"CHEMBL1200409","targetId":"ENSG00000183873","diseaseId":"HP_0003418","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a4eeb3f-ab3d-477c-86d6-f933affb20b4"}],"ancestors":["HP_0025142","EFO_0000651","EFO_0003843","EFO_0003765","HP_0011842","HP_0000118","HP_0000924","HP_0000925"],"label":"Back pain","approvedSymbol":"SCN5A","approvedName":"sodium voltage-gated channel alpha subunit 5","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"LIDOCAINE HYDROCHLORIDE","tradeNames":["Akten","Alphacaine hydrochloride","Anestacon","Anodesyn","Bismodyne","Bradosol plus","Calgel","Co-phenylcaine fte","Denela","Dequaspray","Emla","Germoloids","Germoloids complete","Glydo","Hemocane","Iglu","Instillagel","Laryng-o-jet kit","Laryngojet","Laryngotracheal anesthesia kit","Lido hcl","Lidocaine hydrochloride","Lidocaine hydrochloride preservative free","Lidocaine hydrochloride viscous","Lidocaine viscous","Lidocaton","Lidopen","Lignokent","Lignospan special","Lignostab","Lignostab a 100","Lignostab n","Lignostab-a","Lta ii kit","Medijel","Oragard","Pediatric lta kit","Preparation h","Rexocaine","Versatis","Xylocaine","Xylocaine dental","Xylocaine preservative free","Xylocaine viscous","Xylotox e80","Zingo"],"synonyms":["Lidocaine hcl","Lidocaine hydrochloride","Lidocaine hydrochloride monohydrate","Lidocaine hydrochloride usp","Lidocaini hydrochloridum","Lignocaine (as hydrochloride)","Lignocaine hydrochloride","NSC-757420","Xylocaine hydrochloride"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL134","targetId":"ENSG00000184160","diseaseId":"HP_0003419","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01415895%22"}],"ancestors":["HP_0025142","EFO_0000651","EFO_0003843","EFO_0003765","HP_0011842","HP_0000118","HP_0003418","HP_0000924","HP_0000925"],"label":"Low back pain","approvedSymbol":"ADRA2C","approvedName":"adrenoceptor alpha 2C","targetClass":["Membrane receptor"],"prefName":"CLONIDINE","tradeNames":["Catapres","Catapres-tts-1","Catapres-tts-2","Catapres-tts-3","Clonidine","Nexiclon xr"],"synonyms":["Catapres","Catarpres-tts","Clonidine","Clonidine extended release","Clorpres","Combipres","Duraclon","ST-155-BS","ST-155BS"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor alpha-2 agonist","targetName":"Adrenergic receptor alpha-2"}
{"drugId":"CHEMBL742","targetId":"ENSG00000176884","diseaseId":"HP_0003419","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02154438%22"}],"ancestors":["HP_0025142","EFO_0000651","EFO_0003843","EFO_0003765","HP_0011842","HP_0000118","HP_0003418","HP_0000924","HP_0000925"],"label":"Low back pain","approvedSymbol":"GRIN1","approvedName":"glutamate ionotropic receptor NMDA type subunit 1","targetClass":["Ion channel"],"prefName":"KETAMINE","tradeNames":["Ketalar"],"synonyms":["Anaket v","Calypsol","Clorketam 1000","Dl-ketamine","Imalgene 1000","Ketamine","Ketasol 100","NSC-70151","Narketan","PMI-150","Tekam","Ursotamin","Vetaket"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor negative allosteric modulator","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL2108709","targetId":"ENSG00000108821","diseaseId":"HP_0003549","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03774264%22"}],"ancestors":["EFO_0000651","HP_0000118"],"label":"Abnormality of connective tissue","approvedSymbol":"COL1A1","approvedName":"collagen type I alpha 1 chain","targetClass":["Structural protein"],"prefName":"COLLAGENASE CLOSTRIDIUM HISTOLYTICUM","tradeNames":["Santyl","Xiaflex"],"synonyms":["AA-4500","AA4500","Clostridial collagenase","Clostridium histolyticum enzymes","Collagenase","Collagenase (clostridium histolyticum)","Collagenase clostridium histolyticum","Cordase","Iruxol","MZ-004","Plaquase"],"drugType":"Enzyme","mechanismOfAction":"Collagen hydrolytic enzyme","targetName":"Collagen"}
{"drugId":"CHEMBL605","targetId":"ENSG00000144285","diseaseId":"HP_0004308","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8192d79d-da2b-2532-e053-2991aa0ae8ad"}],"ancestors":["EFO_0000651","HP_0030956","HP_0000118","HP_0011025","HP_0001626"],"label":"Ventricular arrhythmia","approvedSymbol":"SCN1A","approvedName":"sodium voltage-gated channel alpha subunit 1","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"PROCAINAMIDE HYDROCHLORIDE","tradeNames":["Biocoryl","Novocainamid","Procainamide hydrochloride","Procan","Procan sr","Procanbid","Procapan","Pronestyl","Pronestyl-sr"],"synonyms":["Amidoprocaine","Cardiorytmin","NSC-757279","Procainamide HCl","Procainamide hcl","Procainamide hydrochloride","Procainamidi hydrochloridum"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL2103749","targetId":"ENSG00000180210","diseaseId":"HP_0004419","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=911cd48f-01ea-4dec-b30c-95e7e0ea9d2a"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=799d3b00-809b-4abc-989c-05faccec49f8"},{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=B01AE06"}],"ancestors":["HP_0001871","EFO_0000651","HP_0001977","HP_0000118","HP_0004418","HP_0004936"],"label":"Recurrent thrombophlebitis","approvedSymbol":"F2","approvedName":"coagulation factor II, thrombin","targetClass":["Enzyme"],"prefName":"BIVALIRUDIN","tradeNames":["Angiomax","Angiomax rtu","Bivalirudin","Bivalirudin in 0.9% sodium chloride"],"synonyms":["BG-8967","BG8967","Bivalirudin"],"drugType":"Protein","mechanismOfAction":"Thrombin inhibitor","targetName":"Thrombin"}
{"drugId":"CHEMBL1201321","targetId":"ENSG00000112038","diseaseId":"HP_0004798","phase":4,"urls":[{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=A07DA04"}],"ancestors":["HP_0012719","HP_0025031","EFO_0000651","HP_0000118","HP_0002715","HP_0011024","HP_0002719"],"label":"Recurrent infection of the gastrointestinal tract","approvedSymbol":"OPRM1","approvedName":"opioid receptor mu 1","targetClass":["Membrane receptor"],"prefName":"DIFENOXIN","tradeNames":[],"synonyms":["Acscn-9168","Difenoxin","Diphenoxylate related compound a","Diphenoxylic acid","IDS-ND-007","Lyspafen","MCN-JR-15,403-11","Mcn-jr 15403-11","R 15,403 [AS HYDROCHLORIDE]","R-15403"],"drugType":"Small molecule","mechanismOfAction":"Mu opioid receptor agonist","targetName":"Mu opioid receptor"}
{"drugId":"CHEMBL940","targetId":"ENSG00000153956","diseaseId":"HP_0008419","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02120703%22"}],"ancestors":["EFO_0000651","HP_0011842","HP_0000118","HP_0000924","HP_0000925"],"label":"Intervertebral disc degeneration","approvedSymbol":"CACNA2D1","approvedName":"calcium voltage-gated channel auxiliary subunit alpha2delta 1","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"GABAPENTIN","tradeNames":["Gabapentin","Gralise","Neurontin"],"synonyms":["CI-945","DM-1796","GOE 3450","GOE-3450","Gabapentin","NSC-742194","NSC-759254"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated calcium channel modulator","targetName":"Voltage-gated calcium channel"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000130414","diseaseId":"HP_0011015","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01792830%22"}],"ancestors":["EFO_0000651","HP_0000118","HP_0011014","HP_0001939"],"label":"Abnormal blood glucose concentration","approvedSymbol":"NDUFA10","approvedName":"NADH:ubiquinone oxidoreductase subunit A10","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL3188993","targetId":"ENSG00000102468","diseaseId":"HP_0012076","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00254748%22"}],"ancestors":["HP_0000708","HP_0012075","HP_0012638","EFO_0000651","HP_0000118","HP_0000707"],"label":"Borderline personality disorder","approvedSymbol":"HTR2A","approvedName":"5-hydroxytryptamine receptor 2A","targetClass":["Membrane receptor"],"prefName":"QUETIAPINE FUMARATE","tradeNames":["Quetiapine fumarate","Seroquel","Seroquel xr"],"synonyms":["FK-947E","FK947E","ICI 204,636","ICI-204636","Quetiapine (as fumarate)","Quetiapine fumarate","Quetiapine hemifumarate","Utapine","ZD-5077","ZD5077","ZM 204,636","ZM-204636"],"drugType":"Small molecule","mechanismOfAction":"Serotonin 2a (5-HT2a) receptor antagonist","targetName":"Serotonin 2a (5-HT2a) receptor"}
{"drugId":"CHEMBL85","targetId":"ENSG00000149295","diseaseId":"HP_0012076","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00204347%22"}],"ancestors":["HP_0000708","HP_0012075","HP_0012638","EFO_0000651","HP_0000118","HP_0000707"],"label":"Borderline personality disorder","approvedSymbol":"DRD2","approvedName":"dopamine receptor D2","targetClass":["Membrane receptor"],"prefName":"RISPERIDONE","tradeNames":["Perseris kit","Risperdal","Risperdal Consta Long Acting","Risperdal M","Risperdal M-Tab","Risperdal consta","Risperdal quicklet","Risperidone"],"synonyms":["LY-03004","LY03004","N05AX08","NSC-759895","Perseris","R 64 766","R-64,766","R-64-766","R-64766","RCN-3028","RCN3028","Risperidone"],"drugType":"Small molecule","mechanismOfAction":"Dopamine D2 receptor antagonist","targetName":"Dopamine D2 receptor"}
{"drugId":"CHEMBL19019","targetId":"ENSG00000082556","diseaseId":"HP_0012378","phase":2,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05430152%22"}],"ancestors":["HP_0025142","EFO_0000651","EFO_0003765","HP_0000118"],"label":"Fatigue","approvedSymbol":"OPRK1","approvedName":"opioid receptor kappa 1","targetClass":["Membrane receptor"],"prefName":"NALTREXONE","tradeNames":["Celupan","Trexal","Trexan","Vivitrol"],"synonyms":["EN-1639A","EN-1639A FREE BASE","EN-1639A [AS HYDROCHLORIDE]","NSC-758439","Naltrexone","Revia"],"drugType":"Small molecule","mechanismOfAction":"Opioid receptors; mu/kappa/delta antagonist","targetName":"Opioid receptors; mu/kappa/delta"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000148229","diseaseId":"HP_0012410","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04965597%22"}],"ancestors":["HP_0001871","EFO_0000651","HP_0001877","HP_0000118"],"label":"Pure red cell aplasia","approvedSymbol":"POLE3","approvedName":"DNA polymerase epsilon 3, accessory subunit","targetClass":["Unclassified protein"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL656","targetId":"ENSG00000112038","diseaseId":"HP_0012532","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03179475%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01811186%22"}],"ancestors":["HP_0025142","EFO_0000651","EFO_0003843","EFO_0003765","HP_0000118"],"label":"Chronic pain","approvedSymbol":"OPRM1","approvedName":"opioid receptor mu 1","targetClass":["Membrane receptor"],"prefName":"OXYCODONE","tradeNames":["Oxycontin","Proladone","Xtampza er"],"synonyms":["(-)-14-hydroxydihydrocodeinone","14-hydroxydihydrocodeinone","Dihydrone","IDS-NO-002","N02AA05","NSC-19043","Oxicone","Oxycodone","Oxycodone cii","Oxymorphone 3-methyl ether","PF-00345439","PTI-821","Pavinal","Pti 821","Remoxy","Xtampza"],"drugType":"Small molecule","mechanismOfAction":"Mu opioid receptor agonist","targetName":"Mu opioid receptor"}
{"drugId":"CHEMBL1800955","targetId":"ENSG00000078814","diseaseId":"HP_0012664","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02695420%22"}],"ancestors":["EFO_0000651","HP_0000118","HP_0011025","HP_0001626"],"label":"Reduced left ventricular ejection fraction","approvedSymbol":"MYH7B","approvedName":"myosin heavy chain 7B","targetClass":["Unclassified protein"],"prefName":"OMECAMTIV MECARBIL","tradeNames":[],"synonyms":["CK-1827452","Omecamtiv mecarbil"],"drugType":"Small molecule","mechanismOfAction":"Cardiac myosin activator","targetName":"Cardiac myosin"}
{"drugId":"CHEMBL1059","targetId":"ENSG00000153956","diseaseId":"HP_0012735","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02482818%22"}],"ancestors":["EFO_0000651","HP_0000118","HP_0002086"],"label":"Cough","approvedSymbol":"CACNA2D1","approvedName":"calcium voltage-gated channel auxiliary subunit alpha2delta 1","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"PREGABALIN","tradeNames":["Alzain","Axalid","Lecaent","Lyrica","Lyrica cr","Pregabalin","Rewisca"],"synonyms":["CI-1008","NSC-759256","PD-144723","Pregabalin","Pregabalin mylan","Pregabalin sandoz","Pregabalin sandoz gmbh","Pregabalin zentiva","Vronogabic","YNP-1807"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated calcium channel modulator","targetName":"Voltage-gated calcium channel"}
{"drugId":"CHEMBL1215","targetId":"ENSG00000120907","diseaseId":"HP_0012735","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02062710%22"}],"ancestors":["EFO_0000651","HP_0000118","HP_0002086"],"label":"Cough","approvedSymbol":"ADRA1A","approvedName":"adrenoceptor alpha 1A","targetClass":["Membrane receptor"],"prefName":"PHENYLEPHRINE","tradeNames":[],"synonyms":["(-)-phenylephrine","(r)-phenylephrine","AB-101 (PHENYLEPHRINE)","Cyclomydril","Duo-Medihaler","J8.601K","M-oxedrine","M-sympathol","M-sympatol","M-synephrine","Meta-synephrine","Metasynephrine","Phenylephrine","Phenylephrine minims","Phenylephrine, (r)-","R(-)-mezaton"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor alpha-1 agonist","targetName":"Adrenergic receptor alpha-1"}
{"drugId":"CHEMBL1077896","targetId":"ENSG00000183873","diseaseId":"HP_0030834","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04737980%22"}],"ancestors":["HP_0025142","EFO_0003843","EFO_0000651","EFO_0003765","HP_0000118"],"label":"Shoulder pain","approvedSymbol":"SCN5A","approvedName":"sodium voltage-gated channel alpha subunit 5","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"ROPIVACAINE","tradeNames":[],"synonyms":["Ropivacaine","Ropivicaine","TLC-590","TLC590","Tlc590"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL698","targetId":"ENSG00000185313","diseaseId":"HP_0030834","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01544283%22"}],"ancestors":["HP_0025142","EFO_0003843","EFO_0000651","EFO_0003765","HP_0000118"],"label":"Shoulder pain","approvedSymbol":"SCN10A","approvedName":"sodium voltage-gated channel alpha subunit 10","targetClass":["Ion channel"],"prefName":"TETRACAINE","tradeNames":["Ametop","Dicaine","Medihaler-tetracaine","Metraspray","Pontocaine"],"synonyms":["Amethocaine","Tetracaine"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL1437","targetId":"ENSG00000120907","diseaseId":"HP_0031273","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00894621%22"}],"ancestors":["EFO_0000651","HP_0000118","HP_0011025","HP_0001626"],"label":"Shock","approvedSymbol":"ADRA1A","approvedName":"adrenoceptor alpha 1A","targetClass":["Membrane receptor"],"prefName":"NOREPINEPHRINE","tradeNames":[],"synonyms":["(-)-noradrenaline","Levophed","NSC-757246","Nor adrenalin","Norepinephrine","R-norepinephrine"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor agonist","targetName":"Adrenergic receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000170906","diseaseId":"HP_0100543","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04098666%22"}],"ancestors":["HP_0012638","EFO_0000651","HP_0011446","HP_0000118","HP_0000707"],"label":"Cognitive impairment","approvedSymbol":"NDUFA3","approvedName":"NADH:ubiquinone oxidoreductase subunit A3","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198786","diseaseId":"HP_0100543","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02409238%22"}],"ancestors":["HP_0012638","EFO_0000651","HP_0011446","HP_0000118","HP_0000707"],"label":"Cognitive impairment","approvedSymbol":"MT-ND5","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000144285","diseaseId":"HP_0100543","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02884050%22"}],"ancestors":["HP_0012638","EFO_0000651","HP_0011446","HP_0000118","HP_0000707"],"label":"Cognitive impairment","approvedSymbol":"SCN1A","approvedName":"sodium voltage-gated channel alpha subunit 1","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL249856","targetId":"ENSG00000172572","diseaseId":"HP_0100806","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00484133%22"}],"ancestors":["EFO_0000651","HP_0000118","HP_0002715"],"label":"Sepsis","approvedSymbol":"PDE3A","approvedName":"phosphodiesterase 3A","targetClass":["Enzyme"],"prefName":"ENOXIMONE","tradeNames":["Perfan"],"synonyms":["Enoximone","MDL 17,043","MDL-17043"],"drugType":"Small molecule","mechanismOfAction":"Phosphodiesterase 3 inhibitor","targetName":"Phosphodiesterase 3"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000147684","diseaseId":"MONDO_0000396","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03710343%22"}],"ancestors":["EFO_0005774","EFO_1000631","EFO_1000632","EFO_0000618","MONDO_0044996","EFO_0009386"],"label":"spastic cerebral palsy","approvedSymbol":"NDUFB9","approvedName":"NADH:ubiquinone oxidoreductase subunit B9","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1743082","targetId":"ENSG00000104833","diseaseId":"MONDO_0000521","phase":2,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05408845%22"}],"ancestors":["EFO_0005570","MONDO_0002038","MONDO_0004669","EFO_1000384","MONDO_0023370","EFO_0005950","MONDO_0023644","MONDO_0045024","MONDO_0004992","EFO_0008581","EFO_0000313","EFO_0003868","EFO_1000218","MONDO_0044925","EFO_0008549","MONDO_0002516","EFO_0006858","EFO_0006859","EFO_1001047","EFO_0000616","EFO_0010282","EFO_0003826"],"label":"salivary gland carcinoma","approvedSymbol":"TUBB4A","approvedName":"tubulin beta 4A class IVa","targetClass":["Structural protein"],"prefName":"TRASTUZUMAB EMTANSINE","tradeNames":[],"synonyms":["Ado-trastuzumab emtansine","PRO-132365","RG-3502","TRASTUZUMAB-MCC-DM1 T-DM1","Trastuzumab emtansine"],"drugType":"Antibody","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000101162","diseaseId":"MONDO_0000521","phase":2,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05408845%22"}],"ancestors":["EFO_0005570","MONDO_0002038","MONDO_0004669","EFO_1000384","MONDO_0023370","EFO_0005950","MONDO_0023644","MONDO_0045024","MONDO_0004992","EFO_0008581","EFO_0000313","EFO_0003868","EFO_1000218","MONDO_0044925","EFO_0008549","MONDO_0002516","EFO_0006858","EFO_0006859","EFO_1001047","EFO_0000616","EFO_0010282","EFO_0003826"],"label":"salivary gland carcinoma","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1166","targetId":"ENSG00000180210","diseaseId":"MONDO_0000831","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00039858%22"}],"ancestors":["EFO_0004264","EFO_0000319"],"label":"thrombotic disease","approvedSymbol":"F2","approvedName":"coagulation factor II, thrombin","targetClass":["Enzyme"],"prefName":"ARGATROBAN","tradeNames":["Acova","Argatroban","Argatroban in dextrose","Argatroban in sodium chloride"],"synonyms":["Argatroban","Argatroban anhydrous","Argatroban hydrate","Argatroban monohydrate","Argipidine","DK-7419","GN-1600","GN1600","MCI-9038","MD-805"],"drugType":"Small molecule","mechanismOfAction":"Thrombin inhibitor","targetName":"Thrombin"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000062822","diseaseId":"MONDO_0000870","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01529827%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00031655%22"}],"ancestors":["EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0000621","EFO_1000350","EFO_0009119","MONDO_0003659","MONDO_0005374","EFO_0004289","EFO_0002461","EFO_0000220","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0017814","EFO_0003820","MONDO_0015757","MONDO_0023603","EFO_1000068","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","MONDO_0004355","MONDO_0021079","EFO_0002425","MONDO_0017207","EFO_0000540","EFO_0000565","EFO_0005952","EFO_1000654","EFO_0000508","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"childhood acute lymphoblastic leukemia","approvedSymbol":"POLD1","approvedName":"DNA polymerase delta 1, catalytic subunit","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1750","targetId":"ENSG00000198056","diseaseId":"MONDO_0000873","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01451515%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","EFO_0009119","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoblastic lymphoma","approvedSymbol":"PRIM1","approvedName":"DNA primase subunit 1","targetClass":["Enzyme"],"prefName":"CLOFARABINE","tradeNames":["Clolar","Evoltra"],"synonyms":["Clofarabine","Clolar","NSC-759857"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL803","targetId":"ENSG00000077514","diseaseId":"MONDO_0000873","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03817320%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","EFO_0009119","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoblastic lymphoma","approvedSymbol":"POLD3","approvedName":"DNA polymerase delta 3, accessory subunit","targetClass":["Enzyme"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL803","targetId":"ENSG00000106628","diseaseId":"MONDO_0000873","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01363128%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00873093%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00866749%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01451515%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","EFO_0009119","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"lymphoblastic lymphoma","approvedSymbol":"POLD2","approvedName":"DNA polymerase delta 2, accessory subunit","targetClass":["Enzyme"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL2107358","targetId":"ENSG00000258643","diseaseId":"MONDO_0001023","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00612612%22"}],"ancestors":["OTAR_0000006","MONDO_0001014","EFO_0009676","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0002461","EFO_0000220","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","EFO_1000068","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"prolymphocytic leukemia","approvedSymbol":"BCL2L2-PABPN1","approvedName":"BCL2L2-PABPN1 readthrough","targetClass":["Other cytosolic protein"],"prefName":"OBATOCLAX MESYLATE","tradeNames":[],"synonyms":["GX-15-070MS","GX15-070MS","Obatoclax","Obatoclax mesilate","Obatoclax mesylate"],"drugType":"Small molecule","mechanismOfAction":"Apoptosis regulator Bcl-W inhibitor","targetName":"Apoptosis regulator Bcl-W"}
{"drugId":"CHEMBL1773","targetId":"ENSG00000176890","diseaseId":"MONDO_0001056","phase":1,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00845884%22"}],"ancestors":["EFO_0003897","MONDO_0023370","EFO_0008549","MONDO_0002516","MONDO_0045024","MONDO_0004992","EFO_0009608","EFO_0000616","EFO_0010282"],"label":"gastric cancer","approvedSymbol":"TYMS","approvedName":"thymidylate synthetase","targetClass":["Enzyme"],"prefName":"CAPECITABINE","tradeNames":["Capecitabine","Xeloda"],"synonyms":["Capecitabine","Capecitabine accord","Capecitabine medac","Capecitabine sun","Capecitabine teva","Capecitibine","Capecytabine","Capiibine","Captabin","Ecansya","NSC-759853","RO 09-1978/000","RO-09-1978000","RO-091978000","Xeloda"],"drugType":"Small molecule","mechanismOfAction":"Thymidylate synthase inhibitor","targetName":"Thymidylate synthase"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000196230","diseaseId":"MONDO_0001056","phase":3,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01515748%22"}],"ancestors":["EFO_0003897","MONDO_0023370","EFO_0008549","MONDO_0002516","MONDO_0045024","MONDO_0004992","EFO_0009608","EFO_0000616","EFO_0010282"],"label":"gastric cancer","approvedSymbol":"TUBB","approvedName":"tubulin beta class I","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL384467","targetId":"ENSG00000113580","diseaseId":"MONDO_0001056","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04308837%22"}],"ancestors":["EFO_0003897","MONDO_0023370","EFO_0008549","MONDO_0002516","MONDO_0045024","MONDO_0004992","EFO_0009608","EFO_0000616","EFO_0010282"],"label":"gastric cancer","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"DEXAMETHASONE","tradeNames":["Aeroseb-dex","Dalalone","Decaderm","Decadron","Decadron-75","Decaspray","Dexacortisyl","Dexafree","Dexamethasone","Dexamethasone intensol","Dexone","Dexone 0.5","Dexone 0.75","Dexone 1.5","Dexone 4","Dexsol","Dextenza","Dexycu kit","Dropodex","Gppe ear spy","Hemady","Hexadrol","Kortico Injection","Martapan","Maxidex","Maxitrol","Oradexon","Otomize","Ozurdex","Sofradex","Spersadex comp","Tobradex"],"synonyms":["Decadron-LA","Dexacen-4","Dexacort","Dexair","Dexamethasone","Dexamethasone metasulfobenzoate sodium","Dexamethasone palmitate","Dexamethasone valerate","Dexycu","Fluormethylprednisolone","ISV-305","Mymethasone","NSC-34521","Neodecadron","OTO-104"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000104833","diseaseId":"MONDO_0001056","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05171530%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04602117%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04781413%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04683939%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03751761%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04526470%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04182724%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04001569%22"}],"ancestors":["EFO_0003897","MONDO_0023370","EFO_0008549","MONDO_0002516","MONDO_0045024","MONDO_0004992","EFO_0009608","EFO_0000616","EFO_0010282"],"label":"gastric cancer","approvedSymbol":"TUBB4A","approvedName":"tubulin beta 4A class IVa","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000137285","diseaseId":"MONDO_0001056","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05070598%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05427383%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05204173%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04267549%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04195828%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05052931%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05025033%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04563975%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04694183%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03263741%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05190445%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05002686%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04308837%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03322969%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02931890%22"}],"ancestors":["EFO_0003897","MONDO_0023370","EFO_0008549","MONDO_0002516","MONDO_0045024","MONDO_0004992","EFO_0009608","EFO_0000616","EFO_0010282"],"label":"gastric cancer","approvedSymbol":"TUBB2B","approvedName":"tubulin beta 2B class IIb","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL4297440","targetId":"ENSG00000104833","diseaseId":"MONDO_0001056","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00054249%22"}],"ancestors":["EFO_0003897","MONDO_0023370","EFO_0008549","MONDO_0002516","MONDO_0045024","MONDO_0004992","EFO_0009608","EFO_0000616","EFO_0010282"],"label":"gastric cancer","approvedSymbol":"TUBB4A","approvedName":"tubulin beta 4A class IVa","targetClass":["Structural protein"],"prefName":"T-900607","tradeNames":[],"synonyms":["T 900607","T-900607","T900607"],"drugType":"Small molecule","mechanismOfAction":"Tubulin disrupting agent","targetName":"Tubulin"}
{"drugId":"CHEMBL4297440","targetId":"ENSG00000123416","diseaseId":"MONDO_0001056","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00054249%22"}],"ancestors":["EFO_0003897","MONDO_0023370","EFO_0008549","MONDO_0002516","MONDO_0045024","MONDO_0004992","EFO_0009608","EFO_0000616","EFO_0010282"],"label":"gastric cancer","approvedSymbol":"TUBA1B","approvedName":"tubulin alpha 1b","targetClass":["Structural protein"],"prefName":"T-900607","tradeNames":[],"synonyms":["T 900607","T-900607","T900607"],"drugType":"Small molecule","mechanismOfAction":"Tubulin disrupting agent","targetName":"Tubulin"}
{"drugId":"CHEMBL4298024","targetId":"ENSG00000120217","diseaseId":"MONDO_0001056","phase":1,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04835896%22"}],"ancestors":["EFO_0003897","MONDO_0023370","EFO_0008549","MONDO_0002516","MONDO_0045024","MONDO_0004992","EFO_0009608","EFO_0000616","EFO_0010282"],"label":"gastric cancer","approvedSymbol":"CD274","approvedName":"CD274 molecule","targetClass":["Unclassified protein"],"prefName":"BINTRAFUSP ALFA","tradeNames":[],"synonyms":["8L9YQ2N6PA","Bintrafusp alfa","M-7824","M7824","MSB-0011359C","MSB0011359C","Msb0011359c"],"drugType":"Protein","mechanismOfAction":"Programmed cell death 1 ligand 1 binding agent","targetName":"Programmed cell death 1 ligand 1"}
{"drugId":"CHEMBL535","targetId":"ENSG00000128052","diseaseId":"MONDO_0001056","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01238055%22"}],"ancestors":["EFO_0003897","MONDO_0023370","EFO_0008549","MONDO_0002516","MONDO_0045024","MONDO_0004992","EFO_0009608","EFO_0000616","EFO_0010282"],"label":"gastric cancer","approvedSymbol":"KDR","approvedName":"kinase insert domain receptor","targetClass":["Enzyme"],"prefName":"SUNITINIB","tradeNames":["Sutent"],"synonyms":["NSC-736511","NSC-750690","SU-011248","SU-11248","SU011248","Sunitinib","Sutent"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL193","targetId":"ENSG00000157388","diseaseId":"MONDO_0001134","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02357615%22"}],"ancestors":["MONDO_0000473","MONDO_0005044","EFO_0004264","EFO_0000537","EFO_0000319"],"label":"essential hypertension","approvedSymbol":"CACNA1D","approvedName":"calcium voltage-gated channel subunit alpha1 D","targetClass":["Ion channel"],"prefName":"NIFEDIPINE","tradeNames":["Adalat","Adalat a.r.","Adalat cc","Adalat ic","Adalat la 20","Adalat la 30","Adalat la 60","Adalat ret","Adalate lp","Adanif xl","Adipine mr 10","Adipine mr 20","Adipine xl","Afeditab cr","Angiopine 10","Angiopine 40 la","Angiopine 5","Angiopine mr 10","Angiopine mr 20","Calanif","Calchan mr 10","Calchan mr 20","Calcilat","Cardilate mr","Coracten sr","Coracten xl","Coroday mr","Fortipine la40","Genalat 10 ret","Genalat 20 ret","Hypolar ret 10","Hypolar ret 20","Hypolar xl 30","Kentipine","Kentipine mr 10","Kentipine mr 20","Neozipine xl","Nife-wolff","Nifedipine","Nifedipress mr 10","Nifedipress mr 20","Nifedotard 20 mr","Nifelease","Nifensar xl","Nifopress mr","Nifopress ret","Nimodrel mr 10","Nimodrel mr 20","Nimodrel xl","Nivaten ret","Procardia","Procardia xl","Slofedipine xl 30","Slofedipine xl 60","Tensipine mr 10","Tensipine mr 20","Unipine xl","Valni 20 ret","Valni xl","Vasad"],"synonyms":["BAY A 1040","BAY-A-1040","Coracten","NSC-757242","Nifedipine","Nifedipine hydrochloride","Nifedipine slow release","Nifedipinum"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated L-type calcium channel blocker","targetName":"Voltage-gated L-type calcium channel"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000147123","diseaseId":"MONDO_0001187","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03379909%22"}],"ancestors":["MONDO_0023370","EFO_0000294","EFO_0009690","EFO_1000363","MONDO_0045024","MONDO_0004992","EFO_1000018","MONDO_0021066","EFO_0000616"],"label":"urinary bladder cancer","approvedSymbol":"NDUFB11","approvedName":"NADH:ubiquinone oxidoreductase subunit B11","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1637","targetId":"ENSG00000014138","diseaseId":"MONDO_0001187","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00014287%22"}],"ancestors":["MONDO_0023370","EFO_0000294","EFO_0009690","EFO_1000363","MONDO_0045024","MONDO_0004992","EFO_1000018","MONDO_0021066","EFO_0000616"],"label":"urinary bladder cancer","approvedSymbol":"POLA2","approvedName":"DNA polymerase alpha 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"GEMCITABINE HYDROCHLORIDE","tradeNames":["Gemcitabine hydrochloride","Gemzar","Infugem"],"synonyms":["Gemcitabine (as hydrochloride)","Gemcitabine hcl","Gemcitabine hydrochloride","Gemzar","LY-188011","LY-188011 HYDROCHLORIDE","LY188011 HYDROCHLORIDE"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL3833373","targetId":"ENSG00000120217","diseaseId":"MONDO_0001187","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03498196%22"}],"ancestors":["MONDO_0023370","EFO_0000294","EFO_0009690","EFO_1000363","MONDO_0045024","MONDO_0004992","EFO_1000018","MONDO_0021066","EFO_0000616"],"label":"urinary bladder cancer","approvedSymbol":"CD274","approvedName":"CD274 molecule","targetClass":["Unclassified protein"],"prefName":"AVELUMAB","tradeNames":["Bavencio"],"synonyms":["Avelumab","MSB-0010682","MSB0010682","MSB0010718C","Msb-0010718c"],"drugType":"Antibody","mechanismOfAction":"Programmed cell death 1 ligand 1 other","targetName":"Programmed cell death 1 ligand 1"}
{"drugId":"CHEMBL786","targetId":"ENSG00000091831","diseaseId":"MONDO_0001187","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02197897%22"}],"ancestors":["MONDO_0023370","EFO_0000294","EFO_0009690","EFO_1000363","MONDO_0045024","MONDO_0004992","EFO_1000018","MONDO_0021066","EFO_0000616"],"label":"urinary bladder cancer","approvedSymbol":"ESR1","approvedName":"estrogen receptor 1","targetClass":["Transcription factor","Unclassified protein"],"prefName":"TAMOXIFEN CITRATE","tradeNames":["Emblon","Fentamox 10","Fentamox 20","Kentadex","Kessar","Kessar 10","Kessar 20","Noltam","Nolvadex","Nolvadex d","Nolvadex fte","Oestrifen-10","Oestrifen-20","Oestrifen-40","Soltamox","Tamofen","Tamoxifen citrate","Zynoplex"],"synonyms":["I.C.I.46474 CITRATE","ICI 46,474","ICI-46474","Kessar","NSC-180973","NSC-757345","Nourytam","Tamofene","Tamoxifen citrate","Tamoxifeni citras","Tomaxasta","Zemide","Zitazonium"],"drugType":"Small molecule","mechanismOfAction":"Estrogen receptor alpha modulator","targetName":"Estrogen receptor alpha"}
{"drugId":"CHEMBL888","targetId":"ENSG00000062822","diseaseId":"MONDO_0001187","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04947059%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03924856%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03661320%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04700124%22"}],"ancestors":["MONDO_0023370","EFO_0000294","EFO_0009690","EFO_1000363","MONDO_0045024","MONDO_0004992","EFO_1000018","MONDO_0021066","EFO_0000616"],"label":"urinary bladder cancer","approvedSymbol":"POLD1","approvedName":"DNA polymerase delta 1, catalytic subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL939","targetId":"ENSG00000146648","diseaseId":"MONDO_0001187","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00352079%22"}],"ancestors":["MONDO_0023370","EFO_0000294","EFO_0009690","EFO_1000363","MONDO_0045024","MONDO_0004992","EFO_1000018","MONDO_0021066","EFO_0000616"],"label":"urinary bladder cancer","approvedSymbol":"EGFR","approvedName":"epidermal growth factor receptor","targetClass":["Enzyme"],"prefName":"GEFITINIB","tradeNames":["Iressa"],"synonyms":["Gefitinib","Iressa","NSC-759856","ZD-1839","ZD1839"],"drugType":"Small molecule","mechanismOfAction":"Epidermal growth factor receptor erbB1 inhibitor","targetName":"Epidermal growth factor receptor erbB1"}
{"drugId":"CHEMBL70","targetId":"ENSG00000112038","diseaseId":"MONDO_0001208","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04358133%22"}],"ancestors":["EFO_0009686","EFO_0009433","EFO_0000684","OTAR_0000010","EFO_0003818"],"label":"acute respiratory failure","approvedSymbol":"OPRM1","approvedName":"opioid receptor mu 1","targetClass":["Membrane receptor"],"prefName":"MORPHINE","tradeNames":[],"synonyms":["Anhydrous morphine","Avinza","Depodur","Hydromorphone hydrochloride impurity, morphine-","IDS-NM-009","Infumorph","Kadian","Morphia","Morphine","Morphine (anhydrous)","Morphine anhydrous","Morphine extended release","Morphine polistirex","Morphium","N02AA01","Nepenthe","Ospalivina"],"drugType":"Small molecule","mechanismOfAction":"Mu opioid receptor agonist","targetName":"Mu opioid receptor"}
{"drugId":"CHEMBL1096380","targetId":"ENSG00000176014","diseaseId":"MONDO_0001475","phase":3,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03294577%22"}],"ancestors":["EFO_0000540","MONDO_0004805","EFO_0005803"],"label":"neutropenia","approvedSymbol":"TUBB6","approvedName":"tubulin beta 6 class V","targetClass":["Structural protein"],"prefName":"PLINABULIN","tradeNames":[],"synonyms":["NPI-2358","Plinabulin"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1096380","targetId":"ENSG00000101162","diseaseId":"MONDO_0001475","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03102606%22"}],"ancestors":["EFO_0000540","MONDO_0004805","EFO_0005803"],"label":"neutropenia","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"PLINABULIN","tradeNames":[],"synonyms":["NPI-2358","Plinabulin"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000104833","diseaseId":"MONDO_0001475","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02953340%22"}],"ancestors":["EFO_0000540","MONDO_0004805","EFO_0005803"],"label":"neutropenia","approvedSymbol":"TUBB4A","approvedName":"tubulin beta 4A class IVa","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL160","targetId":"ENSG00000196262","diseaseId":"MONDO_0001705","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04470804%22"}],"ancestors":["MONDO_0002280","EFO_0005803"],"label":"pure red-cell aplasia","approvedSymbol":"PPIA","approvedName":"peptidylprolyl isomerase A","targetClass":["Enzyme"],"prefName":"CYCLOSPORINE","tradeNames":["Capimune","Capsorin","Cequa","Cyclosporine","Deximune","Gengraf","Ikervis","Neoral","Optimmune","Restasis","Restasis multidose","Sandimmun","Sandimmune","Sangcya","Vanquoral","Verkazia"],"synonyms":["27-400","ANTIBIOTIC S-7481F1","Atopica","Ciclosporin","Ciclosporin a","Ciclosporinum","Cyclosporin","Cyclosporin a","Cyclosporine","Cyclosporine a","Cyclosporine microemulsion","Cyclosporine, modified","Equoral","Mitogard","NSC-290193","Neoplanta","Neurostat","OL-27-400","Ramihyphin a","SANG-35","SDZ-OXL-400","Zinograf me"],"drugType":"Protein","mechanismOfAction":"Cyclophilin A modulator","targetName":"Cyclophilin A"}
{"drugId":"CHEMBL3301626","targetId":"ENSG00000168959","diseaseId":"MONDO_0001734","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05059327%22"}],"ancestors":["OTAR_0000018","EFO_0005772","MONDO_0023370","MONDO_0021058","EFO_0009690","MONDO_0024237","MONDO_0045024","EFO_0003086","EFO_0009386","MONDO_0042983","MONDO_0015356","MONDO_0016756","MONDO_0000426","EFO_0000508","EFO_0000618","MONDO_0000429","MONDO_0017891","MONDO_0100191"],"label":"tuberous sclerosis","approvedSymbol":"GRM5","approvedName":"glutamate metabotropic receptor 5","targetClass":["Membrane receptor"],"prefName":"BASIMGLURANT","tradeNames":[],"synonyms":["Basimglurant","NOE-101","RG-7090","RO-4917523","RO4917523","Rg7090"],"drugType":"Small molecule","mechanismOfAction":"Metabotropic glutamate receptor 5 modulator","targetName":"Metabotropic glutamate receptor 5"}
{"drugId":"CHEMBL1112","targetId":"ENSG00000102468","diseaseId":"MONDO_0002009","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01123707%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01111565%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01111552%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01111539%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","MONDO_0002050","EFO_0000618","EFO_0009386"],"label":"major depressive disorder","approvedSymbol":"HTR2A","approvedName":"5-hydroxytryptamine receptor 2A","targetClass":["Membrane receptor"],"prefName":"ARIPIPRAZOLE","tradeNames":["Abilify","Abilify maintena","Abilify maintena kit","Abilify mycite kit","Aripiprazole"],"synonyms":["Abilify mycite","Aripiprazole","Aripiprex","NSC-759266","OPC-14597","OPC-31"],"drugType":"Small molecule","mechanismOfAction":"Serotonin 2a (5-HT2a) receptor antagonist","targetName":"Serotonin 2a (5-HT2a) receptor"}
{"drugId":"CHEMBL1276308","targetId":"ENSG00000113580","diseaseId":"MONDO_0002009","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05217758%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","MONDO_0002050","EFO_0000618","EFO_0009386"],"label":"major depressive disorder","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"MIFEPRISTONE","tradeNames":["Korlym","Mifegyne","Mifeprex"],"synonyms":["Mifepristone","NSC-759862","RU 38486","RU 486","RU-38486","RU-486","RU486"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor antagonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL1743034","targetId":"ENSG00000112115","diseaseId":"MONDO_0002009","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04979910%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","MONDO_0002050","EFO_0000618","EFO_0009386"],"label":"major depressive disorder","approvedSymbol":"IL17A","approvedName":"interleukin 17A","targetClass":["Secreted protein"],"prefName":"IXEKIZUMAB","tradeNames":["Taltz"],"synonyms":["Ixekizumab","LY-2439821","LY2439821"],"drugType":"Antibody","mechanismOfAction":"Interleukin 17A inhibitor","targetName":"Interleukin 17A"}
{"drugId":"CHEMBL190","targetId":"ENSG00000163485","diseaseId":"MONDO_0002009","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01263106%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","MONDO_0002050","EFO_0000618","EFO_0009386"],"label":"major depressive disorder","approvedSymbol":"ADORA1","approvedName":"adenosine A1 receptor","targetClass":["Membrane receptor"],"prefName":"THEOPHYLLINE","tradeNames":["Accurbron","Aerolate","Aerolate iii","Aerolate jr","Aerolate sr","Aquaphyllin","Bronkodyl","Duraphyl","Elixicon","Elixomin","Elixophyllin","Elixophyllin sr","Labid","Lanophyllin","Lasma","Nuelin","Nuelin sa","Nuelin sa-250","Pro-vent","Quibron","Quibron-t","Quibron-t/sr","Respbid","Slo-bid","Slo-phyllin","Somophyllin-crt","Somophyllin-t","Sustaire","T-phyl","Theo-24","Theo-dur","Theobid","Theobid jr.","Theochron","Theocin","Theoclear l.a.-130","Theoclear l.a.-260","Theoclear-100","Theoclear-200","Theoclear-80","Theograd","Theolair","Theolair-sr","Theolixir","Theophyl","Theophyl-225","Theophyl-sr","Theophylline","Theophylline-sr","Theovent","Uni-dur","Uniphyl","Uniphyllin continus"],"synonyms":["Dimethylxanthine","Doxophylline metabolite m3","NSC-2066","NSC-757346","Theophylline","Theophylline anhydrous","Theophylline melting point standard","Theophylline monohydrate","Theophylline, anhydrous","Theophylline,anhydrous"],"drugType":"Small molecule","mechanismOfAction":"Adenosine receptor antagonist","targetName":"Adenosine receptor"}
{"drugId":"CHEMBL2103881","targetId":"ENSG00000101204","diseaseId":"MONDO_0002009","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00692445%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","MONDO_0002050","EFO_0000618","EFO_0009386"],"label":"major depressive disorder","approvedSymbol":"CHRNA4","approvedName":"cholinergic receptor nicotinic alpha 4 subunit","targetClass":["Ion channel"],"prefName":"DEXMECAMYLAMINE","tradeNames":[],"synonyms":["Dexmecamylamine","NIH-11008","TC-5214","Tc-5214"],"drugType":"Small molecule","mechanismOfAction":"Neuronal acetylcholine receptor; alpha4/beta2 antagonist","targetName":"Neuronal acetylcholine receptor; alpha4/beta2"}
{"drugId":"CHEMBL3989872","targetId":"ENSG00000273079","diseaseId":"MONDO_0002009","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02366364%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","MONDO_0002050","EFO_0000618","EFO_0009386"],"label":"major depressive disorder","approvedSymbol":"GRIN2B","approvedName":"glutamate ionotropic receptor NMDA type subunit 2B","targetClass":["Ion channel"],"prefName":"APIMOSTINEL","tradeNames":[],"synonyms":["Apimostinel","NRX-1074","Nrx-1074"],"drugType":"Protein","mechanismOfAction":"Glutamate [NMDA] receptor partial agonist","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL742","targetId":"ENSG00000273079","diseaseId":"MONDO_0002009","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03889756%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","MONDO_0002050","EFO_0000618","EFO_0009386"],"label":"major depressive disorder","approvedSymbol":"GRIN2B","approvedName":"glutamate ionotropic receptor NMDA type subunit 2B","targetClass":["Ion channel"],"prefName":"KETAMINE","tradeNames":["Ketalar"],"synonyms":["Anaket v","Calypsol","Clorketam 1000","Dl-ketamine","Imalgene 1000","Ketamine","Ketasol 100","NSC-70151","Narketan","PMI-150","Tekam","Ursotamin","Vetaket"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor negative allosteric modulator","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL1201066","targetId":"ENSG00000103546","diseaseId":"MONDO_0002050","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01114698%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0000618","EFO_0009386"],"label":"depressive disorder","approvedSymbol":"SLC6A2","approvedName":"solute carrier family 6 member 2","targetClass":["Transporter"],"prefName":"VENLAFAXINE HYDROCHLORIDE","tradeNames":["Effexor","Effexor xr","Venlafaxine hydrochloride"],"synonyms":["NSC-745751","Venlafaxine (as hydrochloride)","Venlafaxine hcl","Venlafaxine hydrochloride","WY-45,030","WY-45030"],"drugType":"Small molecule","mechanismOfAction":"Norepinephrine transporter inhibitor","targetName":"Norepinephrine transporter"}
{"drugId":"CHEMBL1201293","targetId":"ENSG00000094755","diseaseId":"MONDO_0002050","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00330174%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0000618","EFO_0009386"],"label":"depressive disorder","approvedSymbol":"GABRP","approvedName":"gamma-aminobutyric acid type A receptor subunit pi","targetClass":["Ion channel"],"prefName":"ACAMPROSATE","tradeNames":[],"synonyms":["Acamprosate"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL190","targetId":"ENSG00000128271","diseaseId":"MONDO_0002050","phase":0,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04309877%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0000618","EFO_0009386"],"label":"depressive disorder","approvedSymbol":"ADORA2A","approvedName":"adenosine A2a receptor","targetClass":["Membrane receptor"],"prefName":"THEOPHYLLINE","tradeNames":["Accurbron","Aerolate","Aerolate iii","Aerolate jr","Aerolate sr","Aquaphyllin","Bronkodyl","Duraphyl","Elixicon","Elixomin","Elixophyllin","Elixophyllin sr","Labid","Lanophyllin","Lasma","Nuelin","Nuelin sa","Nuelin sa-250","Pro-vent","Quibron","Quibron-t","Quibron-t/sr","Respbid","Slo-bid","Slo-phyllin","Somophyllin-crt","Somophyllin-t","Sustaire","T-phyl","Theo-24","Theo-dur","Theobid","Theobid jr.","Theochron","Theocin","Theoclear l.a.-130","Theoclear l.a.-260","Theoclear-100","Theoclear-200","Theoclear-80","Theograd","Theolair","Theolair-sr","Theolixir","Theophyl","Theophyl-225","Theophyl-sr","Theophylline","Theophylline-sr","Theovent","Uni-dur","Uniphyl","Uniphyllin continus"],"synonyms":["Dimethylxanthine","Doxophylline metabolite m3","NSC-2066","NSC-757346","Theophylline","Theophylline anhydrous","Theophylline melting point standard","Theophylline monohydrate","Theophylline, anhydrous","Theophylline,anhydrous"],"drugType":"Small molecule","mechanismOfAction":"Adenosine receptor antagonist","targetName":"Adenosine receptor"}
{"drugId":"CHEMBL2364614","targetId":"ENSG00000142319","diseaseId":"MONDO_0002050","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01369095%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01309945%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0000618","EFO_0009386"],"label":"depressive disorder","approvedSymbol":"SLC6A3","approvedName":"solute carrier family 6 member 3","targetClass":["Transporter"],"prefName":"LIAFENSINE","tradeNames":[],"synonyms":["BMS-820836","Liafensine"],"drugType":"Small molecule","mechanismOfAction":"Monoamine transporter inhibitor","targetName":"Monoamine transporter"}
{"drugId":"CHEMBL243712","targetId":"ENSG00000178394","diseaseId":"MONDO_0002050","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04876521%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0000618","EFO_0009386"],"label":"depressive disorder","approvedSymbol":"HTR1A","approvedName":"5-hydroxytryptamine receptor 1A","targetClass":["Membrane receptor"],"prefName":"AMISULPRIDE","tradeNames":["Barhemsys","Solian","Solian 100","Solian 200","Solian 400","Solian 50"],"synonyms":["APD-421","APD421","Aminosultopride","Amisulpride","DAN-2163","Deniban","NSC-760085","Socian","Sulamid"],"drugType":"Small molecule","mechanismOfAction":"Serotonin (5-HT) receptor antagonist","targetName":"Serotonin (5-HT) receptor"}
{"drugId":"CHEMBL395091","targetId":"ENSG00000198785","diseaseId":"MONDO_0002050","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04476446%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0000618","EFO_0009386"],"label":"depressive disorder","approvedSymbol":"GRIN3A","approvedName":"glutamate ionotropic receptor NMDA type subunit 3A","targetClass":["Ion channel"],"prefName":"ESKETAMINE","tradeNames":[],"synonyms":["(-)-ketamine","Esketamine","Jnj-54135419","Keta-s","Ketamine, (s)-","Ketamine, s-","Ketaved","L-ketamine","S-(-)-ketamine","S-ketamine"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor negative allosteric modulator","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL395091","targetId":"ENSG00000105464","diseaseId":"MONDO_0002050","phase":3,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03852160%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0000618","EFO_0009386"],"label":"depressive disorder","approvedSymbol":"GRIN2D","approvedName":"glutamate ionotropic receptor NMDA type subunit 2D","targetClass":["Ion channel"],"prefName":"ESKETAMINE","tradeNames":[],"synonyms":["(-)-ketamine","Esketamine","Jnj-54135419","Keta-s","Ketamine, (s)-","Ketamine, s-","Ketaved","L-ketamine","S-(-)-ketamine","S-ketamine"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor negative allosteric modulator","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL395091","targetId":"ENSG00000198785","diseaseId":"MONDO_0002050","phase":3,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03852160%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0000618","EFO_0009386"],"label":"depressive disorder","approvedSymbol":"GRIN3A","approvedName":"glutamate ionotropic receptor NMDA type subunit 3A","targetClass":["Ion channel"],"prefName":"ESKETAMINE","tradeNames":[],"synonyms":["(-)-ketamine","Esketamine","Jnj-54135419","Keta-s","Ketamine, (s)-","Ketamine, s-","Ketaved","L-ketamine","S-(-)-ketamine","S-ketamine"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor negative allosteric modulator","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL41","targetId":"ENSG00000108576","diseaseId":"MONDO_0002050","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03390933%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04876521%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0000618","EFO_0009386"],"label":"depressive disorder","approvedSymbol":"SLC6A4","approvedName":"solute carrier family 6 member 4","targetClass":["Transporter"],"prefName":"FLUOXETINE","tradeNames":[],"synonyms":["Fluoxetin ratiopharm","Fluoxetine","Fluval","NSC-283480","NSC-758685","Prozac","Sarafem","Symbyax"],"drugType":"Small molecule","mechanismOfAction":"Serotonin transporter inhibitor","targetName":"Serotonin transporter"}
{"drugId":"CHEMBL894","targetId":"ENSG00000142319","diseaseId":"MONDO_0002050","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00861939%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00864981%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00069459%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0000618","EFO_0009386"],"label":"depressive disorder","approvedSymbol":"SLC6A3","approvedName":"solute carrier family 6 member 3","targetClass":["Transporter"],"prefName":"BUPROPION","tradeNames":[],"synonyms":["Amfebutamone","Bupropion","Bupropion extended release","Bupropion slow release","NSC-758686"],"drugType":"Small molecule","mechanismOfAction":"Dopamine transporter inhibitor","targetName":"Dopamine transporter"}
{"drugId":"CHEMBL1079742","targetId":"ENSG00000146648","diseaseId":"MONDO_0002087","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00030446%22"}],"ancestors":["EFO_0009541","MONDO_0023370","MONDO_0045024","EFO_1001100","MONDO_0004992","EFO_0010282","EFO_0000616"],"label":"peritoneum cancer","approvedSymbol":"EGFR","approvedName":"epidermal growth factor receptor","targetClass":["Enzyme"],"prefName":"ERLOTINIB HYDROCHLORIDE","tradeNames":["Erlotinib hydrochloride","Tarceva"],"synonyms":["CP-358","CP-358,774-01","CP-358774-01","Erlotinib hcl","Erlotinib hydrochloride","OSI-774"],"drugType":"Small molecule","mechanismOfAction":"Epidermal growth factor receptor erbB1 inhibitor","targetName":"Epidermal growth factor receptor erbB1"}
{"drugId":"CHEMBL1201733","targetId":"ENSG00000182866","diseaseId":"MONDO_0002087","phase":1,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01402271%22"}],"ancestors":["EFO_0009541","MONDO_0023370","MONDO_0045024","EFO_1001100","MONDO_0004992","EFO_0010282","EFO_0000616"],"label":"peritoneum cancer","approvedSymbol":"LCK","approvedName":"LCK proto-oncogene, Src family tyrosine kinase","targetClass":["Enzyme"],"prefName":"PAZOPANIB HYDROCHLORIDE","tradeNames":["Votrient"],"synonyms":["GW-786034B","GW786034B","Pazopanib (as hydrochloride)","Pazopanib hcl","Pazopanib hydrochloride","Pazopanib monohydrochloride"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase LCK inhibitor","targetName":"Tyrosine-protein kinase LCK"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000119421","diseaseId":"MONDO_0002087","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02050009%22"}],"ancestors":["EFO_0009541","MONDO_0023370","MONDO_0045024","EFO_1001100","MONDO_0004992","EFO_0010282","EFO_0000616"],"label":"peritoneum cancer","approvedSymbol":"NDUFA8","approvedName":"NADH:ubiquinone oxidoreductase subunit A8","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000151366","diseaseId":"MONDO_0002087","phase":2,"status":"Suspended","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02122185%22"}],"ancestors":["EFO_0009541","MONDO_0023370","MONDO_0045024","EFO_1001100","MONDO_0004992","EFO_0010282","EFO_0000616"],"label":"peritoneum cancer","approvedSymbol":"NDUFC2","approvedName":"NADH:ubiquinone oxidoreductase subunit C2","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL288441","targetId":"ENSG00000186716","diseaseId":"MONDO_0002087","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03023319%22"}],"ancestors":["EFO_0009541","MONDO_0023370","MONDO_0045024","EFO_1001100","MONDO_0004992","EFO_0010282","EFO_0000616"],"label":"peritoneum cancer","approvedSymbol":"BCR","approvedName":"BCR activator of RhoGEF and GTPase","targetClass":["Other cytosolic protein"],"prefName":"BOSUTINIB","tradeNames":["Bosulif"],"synonyms":["Bosutinib","Bosutinib (as monohydrate)","Bosutinib hydrate","Bosutinib monohydrate","SK-606","SKI-606"],"drugType":"Small molecule","mechanismOfAction":"Bcr/Abl fusion protein","targetName":"Bcr/Abl fusion protein"}
{"drugId":"CHEMBL502835","targetId":"ENSG00000134853","diseaseId":"MONDO_0002087","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01669798%22"}],"ancestors":["EFO_0009541","MONDO_0023370","MONDO_0045024","EFO_1001100","MONDO_0004992","EFO_0010282","EFO_0000616"],"label":"peritoneum cancer","approvedSymbol":"PDGFRA","approvedName":"platelet derived growth factor receptor alpha","targetClass":["Enzyme"],"prefName":"NINTEDANIB","tradeNames":["Ofev","Vargatef"],"synonyms":["BIBF 1120","BIBF-1120","BIBF1120","Bibf-1120","Intedanib","Nintedanib"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","targetName":"Platelet-derived growth factor receptor"}
{"drugId":"CHEMBL574737","targetId":"ENSG00000115825","diseaseId":"MONDO_0002087","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00072267%22"}],"ancestors":["EFO_0009541","MONDO_0023370","MONDO_0045024","EFO_1001100","MONDO_0004992","EFO_0010282","EFO_0000616"],"label":"peritoneum cancer","approvedSymbol":"PRKD3","approvedName":"protein kinase D3","targetClass":["Enzyme"],"prefName":"UCN-01","tradeNames":[],"synonyms":["7-hydroxystaurosporine","KRX-0601","KW-2401","NSC-638850","UCN-01","UCN-02","Ucn 01","Ucn-01"],"drugType":"Small molecule","mechanismOfAction":"Protein kinase C (PKC) inhibitor","targetName":"Protein kinase C (PKC)"}
{"drugId":"CHEMBL24828","targetId":"ENSG00000044524","diseaseId":"MONDO_0002108","phase":3,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01876784%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00410761%22"}],"ancestors":["EFO_0003769","EFO_0001379","EFO_0003841","MONDO_0023370","EFO_1000627","MONDO_0021069","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"thyroid cancer","approvedSymbol":"EPHA3","approvedName":"EPH receptor A3","targetClass":["Enzyme"],"prefName":"VANDETANIB","tradeNames":["Caprelsa","Zactima"],"synonyms":["GNF-PF-2188","NSC-744325","NSC-760766","Vandetanib","ZD-64","ZD-6474","ZD6474"],"drugType":"Small molecule","mechanismOfAction":"Ephrin receptor inhibitor","targetName":"Ephrin receptor"}
{"drugId":"CHEMBL24828","targetId":"ENSG00000128052","diseaseId":"MONDO_0002108","phase":3,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00410761%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01876784%22"}],"ancestors":["EFO_0003769","EFO_0001379","EFO_0003841","MONDO_0023370","EFO_1000627","MONDO_0021069","MONDO_0045024","MONDO_0004992","EFO_0000616"],"label":"thyroid cancer","approvedSymbol":"KDR","approvedName":"kinase insert domain receptor","targetClass":["Enzyme"],"prefName":"VANDETANIB","tradeNames":["Caprelsa","Zactima"],"synonyms":["GNF-PF-2188","NSC-744325","NSC-760766","Vandetanib","ZD-64","ZD-6474","ZD6474"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000137267","diseaseId":"MONDO_0002120","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03136055%22"}],"ancestors":["EFO_0003769","EFO_0000313","EFO_0001379","EFO_1001901","MONDO_0023370","MONDO_0021069","MONDO_0045024","MONDO_0004992","EFO_0006858","EFO_0000616"],"label":"neuroendocrine carcinoma","approvedSymbol":"TUBB2A","approvedName":"tubulin beta 2A class IIa","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000062822","diseaseId":"MONDO_0002158","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01312376%22"}],"ancestors":["OTAR_0000017","MONDO_0002149","MONDO_0021092","EFO_0009548","MONDO_0023370","EFO_1000051","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"fallopian tube cancer","approvedSymbol":"POLD1","approvedName":"DNA polymerase delta 1, catalytic subunit","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000100479","diseaseId":"MONDO_0002158","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00652899%22"}],"ancestors":["OTAR_0000017","MONDO_0002149","MONDO_0021092","EFO_0009548","MONDO_0023370","EFO_1000051","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"fallopian tube cancer","approvedSymbol":"POLE2","approvedName":"DNA polymerase epsilon 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000119421","diseaseId":"MONDO_0002158","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02050009%22"}],"ancestors":["OTAR_0000017","MONDO_0002149","MONDO_0021092","EFO_0009548","MONDO_0023370","EFO_1000051","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"fallopian tube cancer","approvedSymbol":"NDUFA8","approvedName":"NADH:ubiquinone oxidoreductase subunit A8","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1607","targetId":"ENSG00000184428","diseaseId":"MONDO_0002158","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003382%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00287859%22"}],"ancestors":["OTAR_0000017","MONDO_0002149","MONDO_0021092","EFO_0009548","MONDO_0023370","EFO_1000051","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"fallopian tube cancer","approvedSymbol":"TOP1MT","approvedName":"DNA topoisomerase I mitochondrial","targetClass":["Enzyme"],"prefName":"TOPOTECAN HYDROCHLORIDE","tradeNames":["Hycamptin","Hycamtin","Topotecan","Topotecan hydrochloride"],"synonyms":["Evotopin","NSC-759263","Nogitecan hydrochloride","SK&F S-104864-A","SK&F-S-104864A","SK-S-104864-A","Topotecan (as hydrochloride)","Topotecan actavis","Topotecan hcl","Topotecan hospira","Topotecan hydrochloride","Topotecan teva"],"drugType":"Small molecule","mechanismOfAction":"DNA topoisomerase I, mitochondrial inhibitor","targetName":"DNA topoisomerase I, mitochondrial"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000101162","diseaseId":"MONDO_0002158","phase":3,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03740165%22"}],"ancestors":["OTAR_0000017","MONDO_0002149","MONDO_0021092","EFO_0009548","MONDO_0023370","EFO_1000051","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"fallopian tube cancer","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL848","targetId":"ENSG00000139842","diseaseId":"MONDO_0002158","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00903630%22"}],"ancestors":["OTAR_0000017","MONDO_0002149","MONDO_0021092","EFO_0009548","MONDO_0023370","EFO_1000051","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"fallopian tube cancer","approvedSymbol":"CUL4A","approvedName":"cullin 4A","targetClass":["Unclassified protein"],"prefName":"LENALIDOMIDE","tradeNames":["Revlimid"],"synonyms":["CC-5013","CDC-501","Lenalidomide","NSC-747972","SYP-1512"],"drugType":"Small molecule","mechanismOfAction":"CRL4(CRBN) E3 ubiquitin ligase inhibitor","targetName":"CRL4(CRBN) E3 ubiquitin ligase"}
{"drugId":"CHEMBL112","targetId":"ENSG00000117480","diseaseId":"MONDO_0002258","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01453400%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01048866%22"}],"ancestors":["EFO_0000684","MONDO_0004867","OTAR_0000010"],"label":"pharyngitis","approvedSymbol":"FAAH","approvedName":"fatty acid amide hydrolase","targetClass":["Enzyme"],"prefName":"ACETAMINOPHEN","tradeNames":["Abdine","Acephen","Acetaminophen","Alvedon","Angiers","Calpol","Calpol six plus","Calpol six plus fastmelts","Child lemsip","Cupanol","Dafalgan","Datril","Disprol","Disprol infant","Disprol jnr","Disprol paed","Fennings","Galpamol","Hedex","Infadrops","Infants' feverall","Injectapap","Junior parapaed","Mandanol","Medinol","Medinol for children","Medinol over 6","Medinol under 6","Medised plain","Miradol","Neopap","Ofirmev","Paldesic","Panadol","Panadol actifast","Panadol actifast solb","Panadol advan","Panadol jnr","Panadol oa","Panaleve","Panaleve 6 plus","Paracetamol","Paramin","Parapaed jnr","Parapaed six plus","Paravict","Perfalgan","Phenaphen","Placidex","Rimadol","Salzone","Tixymol","Tramil 500","Tylenol"],"synonyms":["Acetaminophen","Apap","Biocetamol","Doliprane","Efferalgan","N-acetyl-p-aminophenol","NSC-109028","NSC-3991","P-hydroxy-acetanilid","Paracetamol","Paracetamolum","Vermidon"],"drugType":"Small molecule","mechanismOfAction":"Anandamide amidohydrolase inhibitor","targetName":"Anandamide amidohydrolase"}
{"drugId":"CHEMBL1201231","targetId":"ENSG00000113580","diseaseId":"MONDO_0002280","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e379543-c4cf-4e72-953b-db15b7f0c2a1"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9f4b181e-2675-40c6-a3d7-a8fe671230c1"}],"ancestors":["EFO_0005803"],"label":"anemia","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"PREDNISOLONE PHOSPHORIC ACID","tradeNames":[],"synonyms":["Prednisolone phosphate","Prednisolone phosphoric acid"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000062822","diseaseId":"MONDO_0002367","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00923390%22"}],"ancestors":["EFO_0003865","MONDO_0023370","EFO_0009690","MONDO_0045024","EFO_1000363","MONDO_0004992","MONDO_0021066","EFO_0003086","EFO_0000616"],"label":"kidney cancer","approvedSymbol":"POLD1","approvedName":"DNA polymerase delta 1, catalytic subunit","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1879463","targetId":"ENSG00000198793","diseaseId":"MONDO_0002367","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01453595%22"}],"ancestors":["EFO_0003865","MONDO_0023370","EFO_0009690","MONDO_0045024","EFO_1000363","MONDO_0004992","MONDO_0021066","EFO_0003086","EFO_0000616"],"label":"kidney cancer","approvedSymbol":"MTOR","approvedName":"mechanistic target of rapamycin kinase","targetClass":["Enzyme","Other cytosolic protein"],"prefName":"DACTOLISIB","tradeNames":[],"synonyms":["BEZ-235","BEZ235","Bez-235","Dactolisib","NSC-751249","NVP-BEZ235","NVP-BEZ235-NX","Nvp-bez-235","RTB-101","RTB101","Rtb101"],"drugType":"Small molecule","mechanismOfAction":"Serine/threonine-protein kinase mTOR inhibitor","targetName":"Serine/threonine-protein kinase mTOR"}
{"drugId":"CHEMBL526","targetId":"ENSG00000187730","diseaseId":"MONDO_0002367","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03514550%22"}],"ancestors":["EFO_0003865","MONDO_0023370","EFO_0009690","MONDO_0045024","EFO_1000363","MONDO_0004992","MONDO_0021066","EFO_0003086","EFO_0000616"],"label":"kidney cancer","approvedSymbol":"GABRD","approvedName":"gamma-aminobutyric acid type A receptor subunit delta","targetClass":["Ion channel"],"prefName":"PROPOFOL","tradeNames":["Diprivan","Disoprivan","Propofol","Rapinovet"],"synonyms":["Disoprofol","Fresofol","ICI 35,868","ICI 35-868","ICI-35868","ICI35,868","Lipuro","NSC-5105","Phenol, 2,6-bis(1-methylethyl)","Propofol"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL538943","targetId":"ENSG00000176014","diseaseId":"MONDO_0002367","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003584%22"}],"ancestors":["EFO_0003865","MONDO_0023370","EFO_0009690","MONDO_0045024","EFO_1000363","MONDO_0004992","MONDO_0021066","EFO_0003086","EFO_0000616"],"label":"kidney cancer","approvedSymbol":"TUBB6","approvedName":"tubulin beta 6 class V","targetClass":["Structural protein"],"prefName":"VINORELBINE TARTRATE","tradeNames":["Navelbine","Vinorelbine tartrate"],"synonyms":["Liposomal vinorelbine tartrate","TLC-178","TLC178","Vinorelbine (as tartrate)","Vinorelbine Ditartarate","Vinorelbine ditartrate","Vinorelbine liposomal","Vinorelbine tartrate","Vinorelbine tartrate (1:2)"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL628","targetId":"ENSG00000113448","diseaseId":"MONDO_0002462","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00354198%22"}],"ancestors":["EFO_1002050","EFO_0009690","EFO_0003086","EFO_1002049"],"label":"glomerulonephritis","approvedSymbol":"PDE4D","approvedName":"phosphodiesterase 4D","targetClass":["Enzyme"],"prefName":"PENTOXIFYLLINE","tradeNames":["Neotren mr","Pentoxifylline","Pentoxil","Trental","Trental 100","Trental 400"],"synonyms":["BL 191","BL-191","C04AD03","NSC-637086","NSC-758481","Oxpentifylline","Oxypentifylline","Pentoxifylline","Pentoxiphyllin"],"drugType":"Small molecule","mechanismOfAction":"3',5'-cyclic phosphodiesterase inhibitor","targetName":"3',5'-cyclic phosphodiesterase"}
{"drugId":"CHEMBL3707227","targetId":"ENSG00000120217","diseaseId":"MONDO_0002529","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05085496%22"}],"ancestors":["MONDO_0002532","MONDO_0002898","MONDO_0000653","EFO_0009259","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0004198","EFO_0000313","EFO_0000701","MONDO_0021634","EFO_0000707","EFO_0010285","EFO_0006858","EFO_0000616"],"label":"skin squamous cell carcinoma","approvedSymbol":"CD274","approvedName":"CD274 molecule","targetClass":["Unclassified protein"],"prefName":"ATEZOLIZUMAB","tradeNames":["Tecentriq"],"synonyms":["0ine2sfd9e","Anti-PD-L1","Anti-PDL1","Atezolizumab","MPDL-3280A","MPDL3280A","RG-7446","RG7446"],"drugType":"Antibody","mechanismOfAction":"Programmed cell death 1 ligand 1 inhibitor","targetName":"Programmed cell death 1 ligand 1"}
{"drugId":"CHEMBL225072","targetId":"ENSG00000159131","diseaseId":"MONDO_0002586","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03023319%22"}],"ancestors":["MONDO_0002334","MONDO_0000621","MONDO_0023370","MONDO_0021069","MONDO_0045024","MONDO_0003393","MONDO_0004992","EFO_0002626","EFO_0003769","EFO_0001379","EFO_0000540","EFO_0005803","EFO_0000616"],"label":"thymus cancer","approvedSymbol":"GART","approvedName":"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase","targetClass":["Enzyme"],"prefName":"PEMETREXED","tradeNames":["Alimta","Pemfexy"],"synonyms":["LY-2315","LY-231514","LY231514","NSC-698037","Pemetrexed"],"drugType":"Small molecule","mechanismOfAction":"GAR transformylase inhibitor","targetName":"GAR transformylase"}
{"drugId":"CHEMBL1194","targetId":"ENSG00000136546","diseaseId":"MONDO_0002635","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01591616%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_1001216","EFO_0002461","EFO_1001047","EFO_0010282"],"label":"periodontal disorder","approvedSymbol":"SCN7A","approvedName":"sodium voltage-gated channel alpha subunit 7","targetClass":["Ion channel"],"prefName":"PRILOCAINE","tradeNames":[],"synonyms":["ASTRA-1512","ASTRA-1515","Citanest","NSC-40027","Prilocaine","Propitocaine"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL1200485","targetId":"ENSG00000122025","diseaseId":"MONDO_0002691","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01324076%22"}],"ancestors":["MONDO_0023370","MONDO_0021069","MONDO_0045024","MONDO_0004992","MONDO_0024477","EFO_0008550","EFO_0003769","EFO_0001379","EFO_0001421","EFO_0008549","MONDO_0002516","EFO_0010284","EFO_0000616","EFO_0010282"],"label":"liver cancer","approvedSymbol":"FLT3","approvedName":"fms related receptor tyrosine kinase 3","targetClass":["Enzyme"],"prefName":"SORAFENIB TOSYLATE","tradeNames":["Nexavar"],"synonyms":["BAY 54-9085","BAY-54-9085","Sorafenib tosilate","Sorafenib tosylate"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase receptor FLT3 inhibitor","targetName":"Tyrosine-protein kinase receptor FLT3"}
{"drugId":"CHEMBL1200485","targetId":"ENSG00000165731","diseaseId":"MONDO_0002691","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01324076%22"}],"ancestors":["MONDO_0023370","MONDO_0021069","MONDO_0045024","MONDO_0004992","MONDO_0024477","EFO_0008550","EFO_0003769","EFO_0001379","EFO_0001421","EFO_0008549","MONDO_0002516","EFO_0010284","EFO_0000616","EFO_0010282"],"label":"liver cancer","approvedSymbol":"RET","approvedName":"ret proto-oncogene","targetClass":["Unclassified protein","Enzyme","Other cytosolic protein"],"prefName":"SORAFENIB TOSYLATE","tradeNames":["Nexavar"],"synonyms":["BAY 54-9085","BAY-54-9085","Sorafenib tosilate","Sorafenib tosylate"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase receptor RET inhibitor","targetName":"Tyrosine-protein kinase receptor RET"}
{"drugId":"CHEMBL888","targetId":"ENSG00000101868","diseaseId":"MONDO_0002691","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00020774%22"}],"ancestors":["MONDO_0023370","MONDO_0021069","MONDO_0045024","MONDO_0004992","MONDO_0024477","EFO_0008550","EFO_0003769","EFO_0001379","EFO_0001421","EFO_0008549","MONDO_0002516","EFO_0010284","EFO_0000616","EFO_0010282"],"label":"liver cancer","approvedSymbol":"POLA1","approvedName":"DNA polymerase alpha 1, catalytic subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL888","targetId":"ENSG00000175482","diseaseId":"MONDO_0002691","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00020774%22"}],"ancestors":["MONDO_0023370","MONDO_0021069","MONDO_0045024","MONDO_0004992","MONDO_0024477","EFO_0008550","EFO_0003769","EFO_0001379","EFO_0001421","EFO_0008549","MONDO_0002516","EFO_0010284","EFO_0000616","EFO_0010282"],"label":"liver cancer","approvedSymbol":"POLD4","approvedName":"DNA polymerase delta 4, accessory subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL159","targetId":"ENSG00000137267","diseaseId":"MONDO_0002898","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002882%22"}],"ancestors":["EFO_0000701","MONDO_0000653","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0004198","EFO_0000616"],"label":"skin cancer","approvedSymbol":"TUBB2A","approvedName":"tubulin beta 2A class IIa","targetClass":["Structural protein"],"prefName":"VINBLASTINE","tradeNames":[],"synonyms":["NSC-47842","Velban","Vinblastine","[3H]-Vinblastine"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000065518","diseaseId":"MONDO_0002974","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04275713%22"}],"ancestors":["MONDO_0002256","OTAR_0000017","MONDO_0002654","MONDO_0002149","MONDO_0023370","EFO_1000051","MONDO_0021148","MONDO_0045024","MONDO_0004992","MONDO_0021230","EFO_0000512","MONDO_0002715","EFO_0009549","EFO_1001331","EFO_0000616","EFO_0003859"],"label":"cervical cancer","approvedSymbol":"NDUFB4","approvedName":"NADH:ubiquinone oxidoreductase subunit B4","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1637","targetId":"ENSG00000100479","diseaseId":"MONDO_0002974","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00006224%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00006482%22"}],"ancestors":["MONDO_0002256","OTAR_0000017","MONDO_0002654","MONDO_0002149","MONDO_0023370","EFO_1000051","MONDO_0021148","MONDO_0045024","MONDO_0004992","MONDO_0021230","EFO_0000512","MONDO_0002715","EFO_0009549","EFO_1001331","EFO_0000616","EFO_0003859"],"label":"cervical cancer","approvedSymbol":"POLE2","approvedName":"DNA polymerase epsilon 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"GEMCITABINE HYDROCHLORIDE","tradeNames":["Gemcitabine hydrochloride","Gemzar","Infugem"],"synonyms":["Gemcitabine (as hydrochloride)","Gemcitabine hcl","Gemcitabine hydrochloride","Gemzar","LY-188011","LY-188011 HYDROCHLORIDE","LY188011 HYDROCHLORIDE"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL538943","targetId":"ENSG00000258947","diseaseId":"MONDO_0002974","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002813%22"}],"ancestors":["MONDO_0002256","OTAR_0000017","MONDO_0002654","MONDO_0002149","MONDO_0023370","EFO_1000051","MONDO_0021148","MONDO_0045024","MONDO_0004992","MONDO_0021230","EFO_0000512","MONDO_0002715","EFO_0009549","EFO_1001331","EFO_0000616","EFO_0003859"],"label":"cervical cancer","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"VINORELBINE TARTRATE","tradeNames":["Navelbine","Vinorelbine tartrate"],"synonyms":["Liposomal vinorelbine tartrate","TLC-178","TLC178","Vinorelbine (as tartrate)","Vinorelbine Ditartarate","Vinorelbine ditartrate","Vinorelbine liposomal","Vinorelbine tartrate","Vinorelbine tartrate (1:2)"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL888","targetId":"ENSG00000167325","diseaseId":"MONDO_0002974","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00006224%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00006482%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00421096%22"}],"ancestors":["MONDO_0002256","OTAR_0000017","MONDO_0002654","MONDO_0002149","MONDO_0023370","EFO_1000051","MONDO_0021148","MONDO_0045024","MONDO_0004992","MONDO_0021230","EFO_0000512","MONDO_0002715","EFO_0009549","EFO_1001331","EFO_0000616","EFO_0003859"],"label":"cervical cancer","approvedSymbol":"RRM1","approvedName":"ribonucleotide reductase catalytic subunit M1","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"Ribonucleoside-diphosphate reductase RR1 inhibitor","targetName":"Ribonucleoside-diphosphate reductase RR1"}
{"drugId":"CHEMBL888","targetId":"ENSG00000198056","diseaseId":"MONDO_0002974","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05189028%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04697628%22"}],"ancestors":["MONDO_0002256","OTAR_0000017","MONDO_0002654","MONDO_0002149","MONDO_0023370","EFO_1000051","MONDO_0021148","MONDO_0045024","MONDO_0004992","MONDO_0021230","EFO_0000512","MONDO_0002715","EFO_0009549","EFO_1001331","EFO_0000616","EFO_0003859"],"label":"cervical cancer","approvedSymbol":"PRIM1","approvedName":"DNA primase subunit 1","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1730601","targetId":"ENSG00000188641","diseaseId":"MONDO_0003060","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04027764%22"}],"ancestors":["EFO_0009534","MONDO_0023370","MONDO_0021069","MONDO_0045024","EFO_0003891","MONDO_0004992","MONDO_0024477","MONDO_0002691","EFO_0008550","EFO_0003769","EFO_0001379","EFO_0001421","EFO_0008549","MONDO_0002516","EFO_0010284","EFO_0000616","EFO_0010282"],"label":"biliary tract cancer","approvedSymbol":"DPYD","approvedName":"dihydropyrimidine dehydrogenase","targetClass":["Enzyme"],"prefName":"GIMERACIL","tradeNames":[],"synonyms":["Gimeracil","Gimestat"],"drugType":"Small molecule","mechanismOfAction":"Dihydropyrimidine dehydrogenase inhibitor","targetName":"Dihydropyrimidine dehydrogenase"}
{"drugId":"CHEMBL3545366","targetId":"ENSG00000105647","diseaseId":"MONDO_0003268","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00704080%22"}],"ancestors":["MONDO_0021193","EFO_0005543","MONDO_0023370","EFO_0000618","MONDO_0021248","MONDO_0045024","MONDO_0021043","EFO_0009386","EFO_0000616"],"label":"mixed glioma","approvedSymbol":"PIK3R2","approvedName":"phosphoinositide-3-kinase regulatory subunit 2","targetClass":["Enzyme"],"prefName":"VOXTALISIB","tradeNames":[],"synonyms":["SAR-245409","SAR245409","Voxtalisib","XL-765","XL765"],"drugType":"Small molecule","mechanismOfAction":"PI3-kinase class I inhibitor","targetName":"PI3-kinase class I"}
{"drugId":"CHEMBL803","targetId":"ENSG00000177084","diseaseId":"MONDO_0003541","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00198991%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00198978%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0000220","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","EFO_1000068","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"adult acute lymphoblastic leukemia","approvedSymbol":"POLE","approvedName":"DNA polymerase epsilon, catalytic subunit","targetClass":["Enzyme"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL90555","targetId":"ENSG00000258947","diseaseId":"MONDO_0003541","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00039377%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00873093%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01769209%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01363128%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0000220","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","EFO_1000068","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"adult acute lymphoblastic leukemia","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"VINCRISTINE","tradeNames":[],"synonyms":["22-oxovincaleukoblastine","Leucristine","Leurocristine","Oncotcs","Tecnocris","Vincaleukoblastine, 22-oxo-","Vincristin","Vincristine","Vinkristin"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL941","targetId":"ENSG00000186716","diseaseId":"MONDO_0003541","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00039377%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0009119","MONDO_0005374","EFO_0004289","EFO_0000220","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","EFO_1000068","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","EFO_0002425","EFO_0000540","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044"],"label":"adult acute lymphoblastic leukemia","approvedSymbol":"BCR","approvedName":"BCR activator of RhoGEF and GTPase","targetClass":["Other cytosolic protein"],"prefName":"IMATINIB","tradeNames":[],"synonyms":["Glamox","Gleevec","Imatinib","NSC-743414","NSC-759854","STI-571"],"drugType":"Small molecule","mechanismOfAction":"Bcr/Abl fusion protein","targetName":"Bcr/Abl fusion protein"}
{"drugId":"CHEMBL1201567","targetId":"ENSG00000119535","diseaseId":"MONDO_0003751","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002596%22"}],"ancestors":["EFO_0000514","MONDO_0023370","MONDO_0045024","EFO_0000616","MONDO_0021079"],"label":"childhood germ cell tumor","approvedSymbol":"CSF3R","approvedName":"colony stimulating factor 3 receptor","targetClass":["Membrane receptor"],"prefName":"FILGRASTIM","tradeNames":["Accofil","Neupogen","Neupogen 30","Neupogen 48","Nivestim","Zarzio"],"synonyms":["Filgrastim","Filgrastim for bioassay","Filgrastim-sndz","Granulocyte colony-stimulating factor filgrastim","KRN-8601","MBRI-9901","R-METHUG-CSF","TX-01","TX01","Tbo-filgrastim","XM-02","XM02"],"drugType":"Protein","mechanismOfAction":"Granulocyte colony stimulating factor receptor agonist","targetName":"Granulocyte colony stimulating factor receptor"}
{"drugId":"CHEMBL4297422","targetId":"ENSG00000080815","diseaseId":"MONDO_0003865","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01120275%22"}],"ancestors":["MONDO_0002898","MONDO_0000653","MONDO_0023370","MONDO_0021069","MONDO_0045024","MONDO_0004992","EFO_0004198","MONDO_0021143","MONDO_0021583","EFO_0003769","EFO_0000701","EFO_0000756","EFO_0001379","EFO_1001901","EFO_0000389","EFO_0010285","EFO_0000616"],"label":"acral lentiginous melanoma","approvedSymbol":"PSEN1","approvedName":"presenilin 1","targetClass":["Ion channel"],"prefName":"RG-4733","tradeNames":[],"synonyms":["RO 4929097","RO-4929097","Rg 4733","Rg-4733","Ro4929097"],"drugType":"Small molecule","mechanismOfAction":"Gamma-secretase inhibitor","targetName":"Gamma-secretase"}
{"drugId":"CHEMBL1201733","targetId":"ENSG00000182578","diseaseId":"MONDO_0004192","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00471536%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01031875%22"}],"ancestors":["EFO_0003846","EFO_0009689","MONDO_0023370","EFO_0009690","MONDO_0045024","EFO_1000363","MONDO_0004992","MONDO_0021066","EFO_0000616"],"label":"urethra cancer","approvedSymbol":"CSF1R","approvedName":"colony stimulating factor 1 receptor","targetClass":["Enzyme"],"prefName":"PAZOPANIB HYDROCHLORIDE","tradeNames":["Votrient"],"synonyms":["GW-786034B","GW786034B","Pazopanib (as hydrochloride)","Pazopanib hcl","Pazopanib hydrochloride","Pazopanib monohydrochloride"],"drugType":"Small molecule","mechanismOfAction":"Macrophage colony stimulating factor receptor inhibitor","targetName":"Macrophage colony stimulating factor receptor"}
{"drugId":"CHEMBL24828","targetId":"ENSG00000154928","diseaseId":"MONDO_0004192","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01191892%22"}],"ancestors":["EFO_0003846","EFO_0009689","MONDO_0023370","EFO_0009690","MONDO_0045024","EFO_1000363","MONDO_0004992","MONDO_0021066","EFO_0000616"],"label":"urethra cancer","approvedSymbol":"EPHB1","approvedName":"EPH receptor B1","targetClass":["Enzyme"],"prefName":"VANDETANIB","tradeNames":["Caprelsa","Zactima"],"synonyms":["GNF-PF-2188","NSC-744325","NSC-760766","Vandetanib","ZD-64","ZD-6474","ZD6474"],"drugType":"Small molecule","mechanismOfAction":"Ephrin receptor inhibitor","targetName":"Ephrin receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000023228","diseaseId":"MONDO_0004222","phase":2,"status":"Suspended","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02122185%22"}],"ancestors":["MONDO_0024276","EFO_0005771","EFO_0006387","MONDO_0002149","MONDO_0002229","EFO_1000051","EFO_0003893","EFO_0001075","MONDO_0021148","MONDO_0021144","EFO_0006460","EFO_0000512","EFO_0000313","MONDO_0008170","EFO_0009549","MONDO_0000548","MONDO_0018364","EFO_0006858","EFO_1001331","EFO_0000616","OTAR_0000017","EFO_1000042","MONDO_0002259","MONDO_0023370","MONDO_0045024","MONDO_0004992","MONDO_0021077","EFO_0000228","EFO_0000348","EFO_0001379","EFO_1001962"],"label":"ovarian clear cell cystadenocarcinoma","approvedSymbol":"NDUFS1","approvedName":"NADH:ubiquinone oxidoreductase core subunit S1","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000104833","diseaseId":"MONDO_0004222","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01196429%22"}],"ancestors":["MONDO_0024276","EFO_0005771","EFO_0006387","MONDO_0002149","MONDO_0002229","EFO_1000051","EFO_0003893","EFO_0001075","MONDO_0021148","MONDO_0021144","EFO_0006460","EFO_0000512","EFO_0000313","MONDO_0008170","EFO_0009549","MONDO_0000548","MONDO_0018364","EFO_0006858","EFO_1001331","EFO_0000616","OTAR_0000017","EFO_1000042","MONDO_0002259","MONDO_0023370","MONDO_0045024","MONDO_0004992","MONDO_0021077","EFO_0000228","EFO_0000348","EFO_0001379","EFO_1001962"],"label":"ovarian clear cell cystadenocarcinoma","approvedSymbol":"TUBB4A","approvedName":"tubulin beta 4A class IVa","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL60889","targetId":"ENSG00000186038","diseaseId":"MONDO_0004567","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03477266%22"}],"ancestors":["MONDO_0004565","EFO_0009431","EFO_0010282"],"label":"ileus","approvedSymbol":"HTR3E","approvedName":"5-hydroxytryptamine receptor 3E","targetClass":["Ion channel","Membrane receptor"],"prefName":"MOSAPRIDE","tradeNames":[],"synonyms":["Mosapride","Mosart"],"drugType":"Small molecule","mechanismOfAction":"Serotonin 3 (5-HT3) receptor antagonist","targetName":"Serotonin 3 (5-HT3) receptor"}
{"drugId":"CHEMBL574737","targetId":"ENSG00000149554","diseaseId":"MONDO_0004669","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00031681%22"}],"ancestors":["EFO_0005570","EFO_1000384","MONDO_0023370","EFO_0005950","MONDO_0045024","MONDO_0004992","EFO_0008581","EFO_0003868","EFO_0008549","MONDO_0002516","EFO_0006859","EFO_1001047","EFO_0000616","EFO_0010282","EFO_0003826"],"label":"salivary gland cancer","approvedSymbol":"CHEK1","approvedName":"checkpoint kinase 1","targetClass":["Enzyme"],"prefName":"UCN-01","tradeNames":[],"synonyms":["7-hydroxystaurosporine","KRX-0601","KW-2401","NSC-638850","UCN-01","UCN-02","Ucn 01","Ucn-01"],"drugType":"Small molecule","mechanismOfAction":"Serine/threonine-protein kinase Chk1 inhibitor","targetName":"Serine/threonine-protein kinase Chk1"}
{"drugId":"CHEMBL650","targetId":"ENSG00000113580","diseaseId":"MONDO_0004750","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05487521%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","MONDO_0002182","EFO_0000618","EFO_0005548","MONDO_0000592","EFO_0009386"],"label":"language disorder","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"METHYLPREDNISOLONE","tradeNames":["Medrol","Medrone","Methylprednisolone"],"synonyms":["J3.872E","Methylprednisolone","NSC-19987","U-67,590A"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL3286580","targetId":"ENSG00000158748","diseaseId":"MONDO_0004975","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02006641%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02079246%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01955161%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02006654%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005772","MONDO_0002039","EFO_0005774","EFO_0000618","MONDO_0001627","EFO_0005815","EFO_0009386"],"label":"Alzheimer disease","approvedSymbol":"HTR6","approvedName":"5-hydroxytryptamine receptor 6","targetClass":["Membrane receptor"],"prefName":"IDALOPIRDINE","tradeNames":[],"synonyms":["Idalopirdine","LU AE-58054","LU-AE-58054","LU-AE58054","LY-483518","LY483518","Lu AE58054","Lu-ae58054","SGS-518","SGS518"],"drugType":"Small molecule","mechanismOfAction":"Serotonin 6 (5-HT6) receptor antagonist","targetName":"Serotonin 6 (5-HT6) receptor"}
{"drugId":"CHEMBL807","targetId":"ENSG00000176884","diseaseId":"MONDO_0004975","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00120874%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00401167%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00305903%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00476008%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00469456%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01025466%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00234637%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00862940%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00505167%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00800709%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00933608%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00551161%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02553928%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00334906%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01921972%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005772","MONDO_0002039","EFO_0005774","EFO_0000618","MONDO_0001627","EFO_0005815","EFO_0009386"],"label":"Alzheimer disease","approvedSymbol":"GRIN1","approvedName":"glutamate ionotropic receptor NMDA type subunit 1","targetClass":["Ion channel"],"prefName":"MEMANTINE","tradeNames":[],"synonyms":["D-145","DRG-0267","Memantine","NSC-757843","Namenda"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor negative allosteric modulator","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL1456","targetId":"ENSG00000178035","diseaseId":"MONDO_0004976","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01884571%22"}],"ancestors":["EFO_0009488","EFO_0005772","EFO_1001902","EFO_0004149","MONDO_0003182","EFO_0000618","EFO_0003782","EFO_0009386"],"label":"amyotrophic lateral sclerosis","approvedSymbol":"IMPDH2","approvedName":"inosine monophosphate dehydrogenase 2","targetClass":["Enzyme"],"prefName":"MYCOPHENOLATE MOFETIL","tradeNames":["Arzip","Cellcept","Mycophenolate mofetil","Myfenax"],"synonyms":["Myclausen","Mycophenolate mofetil","Mycophenolic acid 2-(4-morpholinyl)ethyl ester","Mycophenylate mofetil","NSC-724229","NSC-758905","RS-61443"],"drugType":"Small molecule","mechanismOfAction":"Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor","targetName":"Inosine-5'-monophosphate dehydrogenase (IMPDH)"}
{"drugId":"CHEMBL1068","targetId":"ENSG00000007314","diseaseId":"MONDO_0004979","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00142025%22"}],"ancestors":["EFO_0009433","EFO_0000684","EFO_1002018","OTAR_0000010"],"label":"asthma","approvedSymbol":"SCN4A","approvedName":"sodium voltage-gated channel alpha subunit 4","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"OXCARBAZEPINE","tradeNames":["Oxcarbazepine","Oxtellar xr","Trileptal"],"synonyms":["GP-47680","KIN-493","NSC-758693","Oxcarbamazepine","Oxcarbazepine","SPN-804"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL1082607","targetId":"ENSG00000169252","diseaseId":"MONDO_0004979","phase":4,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00273026%22"}],"ancestors":["EFO_0009433","EFO_0000684","EFO_1002018","OTAR_0000010"],"label":"asthma","approvedSymbol":"ADRB2","approvedName":"adrenoceptor beta 2","targetClass":["Membrane receptor"],"prefName":"SALMETEROL XINAFOATE","tradeNames":["Serevent"],"synonyms":["GR 33343 G","GR-33343 G","GR-33343X","LIPO-202","Salmeterol 1-hydroxy-2-naphthoate","Salmeterol xinafoate"],"drugType":"Small molecule","mechanismOfAction":"Beta-2 adrenergic receptor agonist","targetName":"Beta-2 adrenergic receptor"}
{"drugId":"CHEMBL1370561","targetId":"ENSG00000170425","diseaseId":"MONDO_0004979","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00442338%22"}],"ancestors":["EFO_0009433","EFO_0000684","EFO_1002018","OTAR_0000010"],"label":"asthma","approvedSymbol":"ADORA2B","approvedName":"adenosine A2b receptor","targetClass":["Membrane receptor"],"prefName":"AMINOPHYLLINE","tradeNames":["Aminophyllin","Aminophylline","Aminophylline In Sodium Chloride","Aminophylline dye free","Ammophyllin","Amnivent-225 sr","Amnivent-350 sr","Peterphyllin","Phyllocontin","Somophyllin","Somophyllin-df","Truphylline"],"synonyms":["Aminophylline","Aminophyllinum","Cardophyllin","Linampheta","NSC-7919","Syntophyllin","Theophyllamine","Theophylline ethylenediamine","Theophylline-ethylenediamine"],"drugType":"Small molecule","mechanismOfAction":"Adenosine receptor antagonist","targetName":"Adenosine receptor"}
{"drugId":"CHEMBL190","targetId":"ENSG00000113448","diseaseId":"MONDO_0004979","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00252785%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00442338%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00252863%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00000578%22"}],"ancestors":["EFO_0009433","EFO_0000684","EFO_1002018","OTAR_0000010"],"label":"asthma","approvedSymbol":"PDE4D","approvedName":"phosphodiesterase 4D","targetClass":["Enzyme"],"prefName":"THEOPHYLLINE","tradeNames":["Accurbron","Aerolate","Aerolate iii","Aerolate jr","Aerolate sr","Aquaphyllin","Bronkodyl","Duraphyl","Elixicon","Elixomin","Elixophyllin","Elixophyllin sr","Labid","Lanophyllin","Lasma","Nuelin","Nuelin sa","Nuelin sa-250","Pro-vent","Quibron","Quibron-t","Quibron-t/sr","Respbid","Slo-bid","Slo-phyllin","Somophyllin-crt","Somophyllin-t","Sustaire","T-phyl","Theo-24","Theo-dur","Theobid","Theobid jr.","Theochron","Theocin","Theoclear l.a.-130","Theoclear l.a.-260","Theoclear-100","Theoclear-200","Theoclear-80","Theograd","Theolair","Theolair-sr","Theolixir","Theophyl","Theophyl-225","Theophyl-sr","Theophylline","Theophylline-sr","Theovent","Uni-dur","Uniphyl","Uniphyllin continus"],"synonyms":["Dimethylxanthine","Doxophylline metabolite m3","NSC-2066","NSC-757346","Theophylline","Theophylline anhydrous","Theophylline melting point standard","Theophylline monohydrate","Theophylline, anhydrous","Theophylline,anhydrous"],"drugType":"Small molecule","mechanismOfAction":"Phosphodiesterase 4 inhibitor","targetName":"Phosphodiesterase 4"}
{"drugId":"CHEMBL190","targetId":"ENSG00000172572","diseaseId":"MONDO_0004979","phase":4,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03269318%22"}],"ancestors":["EFO_0009433","EFO_0000684","EFO_1002018","OTAR_0000010"],"label":"asthma","approvedSymbol":"PDE3A","approvedName":"phosphodiesterase 3A","targetClass":["Enzyme"],"prefName":"THEOPHYLLINE","tradeNames":["Accurbron","Aerolate","Aerolate iii","Aerolate jr","Aerolate sr","Aquaphyllin","Bronkodyl","Duraphyl","Elixicon","Elixomin","Elixophyllin","Elixophyllin sr","Labid","Lanophyllin","Lasma","Nuelin","Nuelin sa","Nuelin sa-250","Pro-vent","Quibron","Quibron-t","Quibron-t/sr","Respbid","Slo-bid","Slo-phyllin","Somophyllin-crt","Somophyllin-t","Sustaire","T-phyl","Theo-24","Theo-dur","Theobid","Theobid jr.","Theochron","Theocin","Theoclear l.a.-130","Theoclear l.a.-260","Theoclear-100","Theoclear-200","Theoclear-80","Theograd","Theolair","Theolair-sr","Theolixir","Theophyl","Theophyl-225","Theophyl-sr","Theophylline","Theophylline-sr","Theovent","Uni-dur","Uniphyl","Uniphyllin continus"],"synonyms":["Dimethylxanthine","Doxophylline metabolite m3","NSC-2066","NSC-757346","Theophylline","Theophylline anhydrous","Theophylline melting point standard","Theophylline monohydrate","Theophylline, anhydrous","Theophylline,anhydrous"],"drugType":"Small molecule","mechanismOfAction":"Phosphodiesterase 3 inhibitor","targetName":"Phosphodiesterase 3"}
{"drugId":"CHEMBL1908391","targetId":"ENSG00000068078","diseaseId":"MONDO_0004979","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01449162%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03771040%22"}],"ancestors":["EFO_0009433","EFO_0000684","EFO_1002018","OTAR_0000010"],"label":"asthma","approvedSymbol":"FGFR3","approvedName":"fibroblast growth factor receptor 3","targetClass":["Enzyme"],"prefName":"MASITINIB","tradeNames":["Kinavet","Masivet"],"synonyms":["AB-1010","AB1010","Ab-1010","Masican","Masitinib","Masitinib mesilate","Masitinib mesylate","Masitinib methanesulfonate","Masiviera"],"drugType":"Small molecule","mechanismOfAction":"Fibroblast growth factor receptor 3 inhibitor","targetName":"Fibroblast growth factor receptor 3"}
{"drugId":"CHEMBL2134724","targetId":"ENSG00000133019","diseaseId":"MONDO_0004979","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02584738%22"}],"ancestors":["EFO_0009433","EFO_0000684","EFO_1002018","OTAR_0000010"],"label":"asthma","approvedSymbol":"CHRM3","approvedName":"cholinergic receptor muscarinic 3","targetClass":["Membrane receptor"],"prefName":"IPRATROPIUM BROMIDE","tradeNames":["Atrovent","Atrovent aerocaps","Atrovent fte","Atrovent hfa","Atrovent udvs","Ipratrop","Ipratrop steripoule","Ipratropium bromide","Respontin","Rinatec","Tropiovent"],"synonyms":["Ipratropium bromide","Ipratropium bromide anhydrous","Ipratropium bromide hydrate","Ipratropium bromide monohydrate","NSC-759613","SCH 1000-BR-MONOHYDRATE","SCH-1000-BR-"],"drugType":"Small molecule","mechanismOfAction":"Muscarinic acetylcholine receptor M3 antagonist","targetName":"Muscarinic acetylcholine receptor M3"}
{"drugId":"CHEMBL3989798","targetId":"ENSG00000169252","diseaseId":"MONDO_0004979","phase":3,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05292586%22"}],"ancestors":["EFO_0009433","EFO_0000684","EFO_1002018","OTAR_0000010"],"label":"asthma","approvedSymbol":"ADRB2","approvedName":"adrenoceptor beta 2","targetClass":["Membrane receptor"],"prefName":"FORMOTEROL FUMARATE","tradeNames":["Atimos modulite","Foradil","Foradil certihaler","Oxis 12","Oxis 6","Performist","Perforomist"],"synonyms":["Atock","BD 40A","BD-40A","CGP 25827A","CGP-25827A","Eformoterol","Fomoterol fumarate","Foraseq","Formoterol fumarate","Formoterol fumarate (superceded)","Formoterol fumarate anhydrous","Formoterol fumarate dihydrate","Formoterol fumarate hydrate","Formoterol hemifumarate","NSC-299587","Oxeze","YM-08316"],"drugType":"Small molecule","mechanismOfAction":"Beta-2 adrenergic receptor agonist","targetName":"Beta-2 adrenergic receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000166136","diseaseId":"MONDO_0004985","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02519543%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0000618","EFO_0009386"],"label":"bipolar disorder","approvedSymbol":"NDUFB8","approvedName":"NADH:ubiquinone oxidoreductase subunit B8","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1615372","targetId":"ENSG00000149295","diseaseId":"MONDO_0004985","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01986101%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0000618","EFO_0009386"],"label":"bipolar disorder","approvedSymbol":"DRD2","approvedName":"dopamine receptor D2","targetClass":["Membrane receptor"],"prefName":"LURASIDONE HYDROCHLORIDE","tradeNames":["Latuda"],"synonyms":["Lurasidone hcl","Lurasidone hydrochloride","SM-13496"],"drugType":"Small molecule","mechanismOfAction":"Dopamine D2 receptor antagonist","targetName":"Dopamine D2 receptor"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000125675","diseaseId":"MONDO_0004985","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00986128%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00986336%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0000618","EFO_0009386"],"label":"bipolar disorder","approvedSymbol":"GRIA3","approvedName":"glutamate ionotropic receptor AMPA type subunit 3","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"Glutamate receptor ionotropic AMPA antagonist","targetName":"Glutamate receptor ionotropic AMPA"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000171189","diseaseId":"MONDO_0004985","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00986336%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00986128%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0000618","EFO_0009386"],"label":"bipolar disorder","approvedSymbol":"GRIK1","approvedName":"glutamate ionotropic receptor kainate type subunit 1","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"Glutamate receptor ionotropic kainate antagonist","targetName":"Glutamate receptor ionotropic kainate"}
{"drugId":"CHEMBL243712","targetId":"ENSG00000157219","diseaseId":"MONDO_0004985","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00126009%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0000618","EFO_0009386"],"label":"bipolar disorder","approvedSymbol":"HTR5A","approvedName":"5-hydroxytryptamine receptor 5A","targetClass":["Membrane receptor"],"prefName":"AMISULPRIDE","tradeNames":["Barhemsys","Solian","Solian 100","Solian 200","Solian 400","Solian 50"],"synonyms":["APD-421","APD421","Aminosultopride","Amisulpride","DAN-2163","Deniban","NSC-760085","Socian","Sulamid"],"drugType":"Small molecule","mechanismOfAction":"Serotonin (5-HT) receptor antagonist","targetName":"Serotonin (5-HT) receptor"}
{"drugId":"CHEMBL3187365","targetId":"ENSG00000102468","diseaseId":"MONDO_0004985","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17209c32-56eb-4f84-954d-aed7b7a1b18d"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5429f134-839f-4ffc-9944-55f51238def8"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=03c696e9-0e6b-4e5c-be0a-41416f8019be"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0000618","EFO_0009386"],"label":"bipolar disorder","approvedSymbol":"HTR2A","approvedName":"5-hydroxytryptamine receptor 2A","targetClass":["Membrane receptor"],"prefName":"ASENAPINE","tradeNames":["Secuado","Sycrest"],"synonyms":["Asenapine"],"drugType":"Small molecule","mechanismOfAction":"Serotonin 2a (5-HT2a) receptor antagonist","targetName":"Serotonin 2a (5-HT2a) receptor"}
{"drugId":"CHEMBL54","targetId":"ENSG00000069696","diseaseId":"MONDO_0004985","phase":4,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00767715%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0000618","EFO_0009386"],"label":"bipolar disorder","approvedSymbol":"DRD4","approvedName":"dopamine receptor D4","targetClass":["Membrane receptor"],"prefName":"HALOPERIDOL","tradeNames":["Dolpin","Dozic","Fortunan","Haldol","Haldol solutab","Haloperidol","Kentace","Keselen","Serenace"],"synonyms":["Haloperidol","Haloperidol decanoate impurity, haloperidol-","MCN-JR-1625","NSC-170973","NSC-615296","R-1625"],"drugType":"Small molecule","mechanismOfAction":"D2-like dopamine receptor inverse agonist","targetName":"D2-like dopamine receptor"}
{"drugId":"CHEMBL716","targetId":"ENSG00000102468","diseaseId":"MONDO_0004985","phase":4,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01128114%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00139074%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01254721%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01526148%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","EFO_0004247","EFO_0000618","EFO_0009386"],"label":"bipolar disorder","approvedSymbol":"HTR2A","approvedName":"5-hydroxytryptamine receptor 2A","targetClass":["Membrane receptor"],"prefName":"QUETIAPINE","tradeNames":["Atrolak xl","Biquelle xl","Brancico xl","Ebesque xl","Mintreleq xl","Psyquet xl","Seotiapim xl","Seroquel","Seroquel xl","Sondate xl","Tenprolide xl","Zaluron xl"],"synonyms":["NSC-758918","Norsic","Quetiapine","Quetiapine extended release"],"drugType":"Small molecule","mechanismOfAction":"Serotonin 2a (5-HT2a) receptor antagonist","targetName":"Serotonin 2a (5-HT2a) receptor"}
{"drugId":"CHEMBL1200485","targetId":"ENSG00000122025","diseaseId":"MONDO_0004986","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00112905%22"}],"ancestors":["EFO_0000313","MONDO_0023370","EFO_0000294","EFO_0009690","EFO_1000363","MONDO_0045024","MONDO_0004992","EFO_1000018","EFO_0006858","MONDO_0021066","MONDO_0001187","EFO_0000616"],"label":"urinary bladder carcinoma","approvedSymbol":"FLT3","approvedName":"fms related receptor tyrosine kinase 3","targetClass":["Enzyme"],"prefName":"SORAFENIB TOSYLATE","tradeNames":["Nexavar"],"synonyms":["BAY 54-9085","BAY-54-9085","Sorafenib tosilate","Sorafenib tosylate"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase receptor FLT3 inhibitor","targetName":"Tyrosine-protein kinase receptor FLT3"}
{"drugId":"CHEMBL1637","targetId":"ENSG00000175482","diseaseId":"MONDO_0004986","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00028756%22"}],"ancestors":["EFO_0000313","MONDO_0023370","EFO_0000294","EFO_0009690","EFO_1000363","MONDO_0045024","MONDO_0004992","EFO_1000018","EFO_0006858","MONDO_0021066","MONDO_0001187","EFO_0000616"],"label":"urinary bladder carcinoma","approvedSymbol":"POLD4","approvedName":"DNA polymerase delta 4, accessory subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE HYDROCHLORIDE","tradeNames":["Gemcitabine hydrochloride","Gemzar","Infugem"],"synonyms":["Gemcitabine (as hydrochloride)","Gemcitabine hcl","Gemcitabine hydrochloride","Gemzar","LY-188011","LY-188011 HYDROCHLORIDE","LY188011 HYDROCHLORIDE"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL378544","targetId":"ENSG00000261456","diseaseId":"MONDO_0004986","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04383743%22"}],"ancestors":["EFO_0000313","MONDO_0023370","EFO_0000294","EFO_0009690","EFO_1000363","MONDO_0045024","MONDO_0004992","EFO_1000018","EFO_0006858","MONDO_0021066","MONDO_0001187","EFO_0000616"],"label":"urinary bladder carcinoma","approvedSymbol":"TUBB8","approvedName":"tubulin beta 8 class VIII","targetClass":["Structural protein"],"prefName":"VINBLASTINE SULFATE","tradeNames":["Velban","Velbe","Vinblast,lederle","Vinblastine sulfate"],"synonyms":["29060-LE","29060LE","Alkaban-aq","NSC-49842","Vinblastine sulfate","Vinblastine sulphate","Vinblastini sulfas","Vincaleukoblastine sulfate","Vlb monosulfate"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000188229","diseaseId":"MONDO_0004986","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04876313%22"}],"ancestors":["EFO_0000313","MONDO_0023370","EFO_0000294","EFO_0009690","EFO_1000363","MONDO_0045024","MONDO_0004992","EFO_1000018","EFO_0006858","MONDO_0021066","MONDO_0001187","EFO_0000616"],"label":"urinary bladder carcinoma","approvedSymbol":"TUBB4B","approvedName":"tubulin beta 4B class IVb","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000261456","diseaseId":"MONDO_0004986","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04876313%22"}],"ancestors":["EFO_0000313","MONDO_0023370","EFO_0000294","EFO_0009690","EFO_1000363","MONDO_0045024","MONDO_0004992","EFO_1000018","EFO_0006858","MONDO_0021066","MONDO_0001187","EFO_0000616"],"label":"urinary bladder carcinoma","approvedSymbol":"TUBB8","approvedName":"tubulin beta 8 class VIII","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL888","targetId":"ENSG00000014138","diseaseId":"MONDO_0004986","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00005831%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01828736%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00478361%22"}],"ancestors":["EFO_0000313","MONDO_0023370","EFO_0000294","EFO_0009690","EFO_1000363","MONDO_0045024","MONDO_0004992","EFO_1000018","EFO_0006858","MONDO_0021066","MONDO_0001187","EFO_0000616"],"label":"urinary bladder carcinoma","approvedSymbol":"POLA2","approvedName":"DNA polymerase alpha 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1068","targetId":"ENSG00000144285","diseaseId":"MONDO_0004992","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02078089%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"cancer","approvedSymbol":"SCN1A","approvedName":"sodium voltage-gated channel alpha subunit 1","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"OXCARBAZEPINE","tradeNames":["Oxcarbazepine","Oxtellar xr","Trileptal"],"synonyms":["GP-47680","KIN-493","NSC-758693","Oxcarbamazepine","Oxcarbazepine","SPN-804"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000167325","diseaseId":"MONDO_0004992","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02118311%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"cancer","approvedSymbol":"RRM1","approvedName":"ribonucleotide reductase catalytic subunit M1","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"Ribonucleoside-diphosphate reductase RR1 inhibitor","targetName":"Ribonucleoside-diphosphate reductase RR1"}
{"drugId":"CHEMBL1201748","targetId":"ENSG00000104833","diseaseId":"MONDO_0004992","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00925743%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"cancer","approvedSymbol":"TUBB4A","approvedName":"tubulin beta 4A class IVa","targetClass":["Structural protein"],"prefName":"CABAZITAXEL","tradeNames":["Jevtana","Jevtana kit"],"synonyms":["Cabazitaxel","Cabazitaxel acetonate","Jevtana","NSC-761432","TXD 258","TXD-258","XRP 6258","XRP-6258"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1421","targetId":"ENSG00000157404","diseaseId":"MONDO_0004992","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02750514%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"cancer","approvedSymbol":"KIT","approvedName":"KIT proto-oncogene, receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"DASATINIB","tradeNames":["Dasatinib","Sprycel"],"synonyms":["BMS-354825","BMS-354825 HYDRATE","BMS-354825-03","Dasatinib","Dasatinib anhydrous","Dasatinib hydrate","Dasatinib monohydrate","NSC-759877"],"drugType":"Small molecule","mechanismOfAction":"Stem cell growth factor receptor inhibitor","targetName":"Stem cell growth factor receptor"}
{"drugId":"CHEMBL1467","targetId":"ENSG00000158125","diseaseId":"MONDO_0004992","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=10cc918f-aa44-415b-932d-2404695ac449"}],"ancestors":["MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"cancer","approvedSymbol":"XDH","approvedName":"xanthine dehydrogenase","targetClass":["Enzyme"],"prefName":"ALLOPURINOL","tradeNames":["Allopurinol","Aloral","Aluline 100","Aluline 300","Caplenal","Cosuric","Hamarin 100","Hamarin 300","Ledopur","Lopurin","Uricto","Xanthomax-100","Xanthomax-300","Zyloprim","Zyloric","Zyloric-300"],"synonyms":["Allopurinol","Allopurinolum","BW 56-158","BW-56-158","NSC-101655","NSC-1390","Suspendol","Takanarumin"],"drugType":"Small molecule","mechanismOfAction":"Xanthine dehydrogenase inhibitor","targetName":"Xanthine dehydrogenase"}
{"drugId":"CHEMBL1743080","targetId":"ENSG00000120889","diseaseId":"MONDO_0004992","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00320827%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"cancer","approvedSymbol":"TNFRSF10B","approvedName":"TNF receptor superfamily member 10b","targetClass":["Membrane receptor"],"prefName":"TIGATUZUMAB","tradeNames":[],"synonyms":["Anti-dr5 moab","Anti-trail-r2 moab","CS-1008","TRA-8","Tigatuzumab"],"drugType":"Antibody","mechanismOfAction":"Tumor necrosis factor receptor superfamily member 10B agonist","targetName":"Tumor necrosis factor receptor superfamily member 10B"}
{"drugId":"CHEMBL2103884","targetId":"ENSG00000165916","diseaseId":"MONDO_0004992","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02244112%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"cancer","approvedSymbol":"PSMC3","approvedName":"proteasome 26S subunit, ATPase 3","targetClass":["Enzyme"],"prefName":"OPROZOMIB","tradeNames":[],"synonyms":["ONX 0912","ONX-0912","Oprozomib","Pr-047"],"drugType":"Small molecule","mechanismOfAction":"26S proteosome inhibitor","targetName":"26S proteasome"}
{"drugId":"CHEMBL3545085","targetId":"ENSG00000254087","diseaseId":"MONDO_0004992","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00526838%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"cancer","approvedSymbol":"LYN","approvedName":"LYN proto-oncogene, Src family tyrosine kinase","targetClass":["Enzyme"],"prefName":"XL-228","tradeNames":[],"synonyms":["Exel-2280","XL228","Xl-228"],"drugType":"Small molecule","mechanismOfAction":"SRC inhibitor","targetName":"SRC"}
{"drugId":"CHEMBL4297840","targetId":"ENSG00000188389","diseaseId":"MONDO_0004992","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02407990%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"cancer","approvedSymbol":"PDCD1","approvedName":"programmed cell death 1","targetClass":["Surface antigen"],"prefName":"TISLELIZUMAB","tradeNames":[],"synonyms":["BGB-A317","BGN-1","BGN1","Bgb-a317","JHL-2108","JHL2108","Tislelizumab"],"drugType":"Antibody","mechanismOfAction":"Programmed cell death protein 1 inhibitor","targetName":"Programmed cell death protein 1"}
{"drugId":"CHEMBL4650421","targetId":"ENSG00000134470","diseaseId":"MONDO_0004992","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03388632%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"cancer","approvedSymbol":"IL15RA","approvedName":"interleukin 15 receptor subunit alpha","targetClass":["Membrane receptor"],"prefName":"RECOMBINANT HUMAN INTERLEUKIN-15","tradeNames":[],"synonyms":["Recombinant human il-15","Recombinant human interleukin-15","Rhil-15"],"drugType":"Unknown","mechanismOfAction":"Interleukin-15 receptor agonist","targetName":"Interleukin-15 receptor"}
{"drugId":"CHEMBL477772","targetId":"ENSG00000157404","diseaseId":"MONDO_0004992","phase":1,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05210413%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"cancer","approvedSymbol":"KIT","approvedName":"KIT proto-oncogene, receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"PAZOPANIB","tradeNames":["Votrient"],"synonyms":["GW786034","NSC-752782","Pazopanib"],"drugType":"Small molecule","mechanismOfAction":"Stem cell growth factor receptor inhibitor","targetName":"Stem cell growth factor receptor"}
{"drugId":"CHEMBL477772","targetId":"ENSG00000102755","diseaseId":"MONDO_0004992","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01548144%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01542047%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"cancer","approvedSymbol":"FLT1","approvedName":"fms related receptor tyrosine kinase 1","targetClass":["Enzyme"],"prefName":"PAZOPANIB","tradeNames":["Votrient"],"synonyms":["GW786034","NSC-752782","Pazopanib"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL494089","targetId":"ENSG00000142875","diseaseId":"MONDO_0004992","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00666081%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"cancer","approvedSymbol":"PRKACB","approvedName":"protein kinase cAMP-activated catalytic subunit beta","targetClass":["Enzyme"],"prefName":"GSK-690693","tradeNames":[],"synonyms":["GSK 690693","GSK690693","Gsk-690693"],"drugType":"Small molecule","mechanismOfAction":"cAMP-dependent protein kinase (PKA) inhibitor","targetName":"cAMP-dependent protein kinase (PKA)"}
{"drugId":"CHEMBL587723","targetId":"ENSG00000141736","diseaseId":"MONDO_0004992","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00118456%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"cancer","approvedSymbol":"ERBB2","approvedName":"erb-b2 receptor tyrosine kinase 2","targetClass":["Enzyme"],"prefName":"AEE-788","tradeNames":[],"synonyms":["AEE-788","AEE788","Aee 788","Aee-788","GNF-PF-5343","NVP-AEE-788","NVP-AEE788"],"drugType":"Small molecule","mechanismOfAction":"Receptor protein-tyrosine kinase erbB-2 inhibitor","targetName":"Receptor protein-tyrosine kinase erbB-2"}
{"drugId":"CHEMBL1051","targetId":"ENSG00000122420","diseaseId":"MONDO_0005041","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00219596%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02154217%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00051181%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00716859%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01156012%22"}],"ancestors":["EFO_0003966","MONDO_0024458"],"label":"glaucoma","approvedSymbol":"PTGFR","approvedName":"prostaglandin F receptor","targetClass":["Membrane receptor"],"prefName":"LATANOPROST","tradeNames":["Latanoprost","Monopost","Xalatan","Xelpros"],"synonyms":["Latanoprost","Latanoprost (isopropyl ester)","PHXA-41","PHXA41","T-2345","T2345","XA-41","XA41"],"drugType":"Small molecule","mechanismOfAction":"Prostanoid FP receptor agonist","targetName":"Prostanoid FP receptor"}
{"drugId":"CHEMBL679","targetId":"ENSG00000120907","diseaseId":"MONDO_0005041","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3ed35d7d-616c-43cd-9776-705821afc1f0"},{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=S01EA01"},{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=S01EA51"}],"ancestors":["EFO_0003966","MONDO_0024458"],"label":"glaucoma","approvedSymbol":"ADRA1A","approvedName":"adrenoceptor alpha 1A","targetClass":["Membrane receptor"],"prefName":"EPINEPHRINE","tradeNames":["Adren co","Adrenaclick","Adrenalin","Ana-Kit","Ana-guard","Anapen","Anaphylactic shock drug kit","Asma-vydrin","Asthmahaler","Auvi-q","Bronkaid mist","Brovon","Emerade","Epi e z pen jr","Epinephrine","Epinephrine (copackaged)","Epipen","Epipen e z pen","Epipen jr","Epipen jr.","Eppy","Gppe inh soln","Jext","Medihaler-epi","Primatene","Primatene mist","Riddobron","Riddofan","Rybarvin","Simplene","Soln made to rybarvin for","Sus-Phrine","Sus-Phrine Sulfite-Free","Sus-phrine sulfite free","Symjepi","Twinject 0.15","Twinject 0.3"],"synonyms":["(-)-(r)-epinephrine","(-)-epinephrine","Adrenaline","Adrenalinum","Epinephrine","Epinephrine hcl","Epinephrine hydrochloride","Epinephrinum","Glauposine","L-epinephrine hydrochloride","Levo-methylaminoethanolcatechol","NSC-62786","Nephridine","Racepinefrine, (r)-","Sus-phrine sulphite-free","Susphrine","Tonogen","Twinject"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor agonist","targetName":"Adrenergic receptor"}
{"drugId":"CHEMBL839","targetId":"ENSG00000043591","diseaseId":"MONDO_0005041","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00972426%22"}],"ancestors":["EFO_0003966","MONDO_0024458"],"label":"glaucoma","approvedSymbol":"ADRB1","approvedName":"adrenoceptor beta 1","targetClass":["Membrane receptor"],"prefName":"CARTEOLOL","tradeNames":[],"synonyms":["Carteolol","Cartrol","Ocupress"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor beta antagonist","targetName":"Adrenergic receptor beta"}
{"drugId":"CHEMBL1023","targetId":"ENSG00000143171","diseaseId":"MONDO_0005090","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00535574%22"}],"ancestors":["EFO_0000677","MONDO_0002025","MONDO_0002039","EFO_0005774","EFO_0000618","EFO_0005407","EFO_0009386"],"label":"schizophrenia","approvedSymbol":"RXRG","approvedName":"retinoid X receptor gamma","targetClass":["Transcription factor"],"prefName":"BEXAROTENE","tradeNames":["Bexarotene","Targretin","Targretine"],"synonyms":["Bexarotene","LG-100069","LG100069","LGD-1069","LGD1069","NSC-747528"],"drugType":"Small molecule","mechanismOfAction":"Retinoid X receptor agonist","targetName":"Retinoid X receptor"}
{"drugId":"CHEMBL1112","targetId":"ENSG00000149295","diseaseId":"MONDO_0005090","phase":4,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02007928%22"}],"ancestors":["EFO_0000677","MONDO_0002025","MONDO_0002039","EFO_0005774","EFO_0000618","EFO_0005407","EFO_0009386"],"label":"schizophrenia","approvedSymbol":"DRD2","approvedName":"dopamine receptor D2","targetClass":["Membrane receptor"],"prefName":"ARIPIPRAZOLE","tradeNames":["Abilify","Abilify maintena","Abilify maintena kit","Abilify mycite kit","Aripiprazole"],"synonyms":["Abilify mycite","Aripiprazole","Aripiprex","NSC-759266","OPC-14597","OPC-31"],"drugType":"Small molecule","mechanismOfAction":"Dopamine D2 receptor partial agonist","targetName":"Dopamine D2 receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000151366","diseaseId":"MONDO_0005090","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00401973%22"}],"ancestors":["EFO_0000677","MONDO_0002025","MONDO_0002039","EFO_0005774","EFO_0000618","EFO_0005407","EFO_0009386"],"label":"schizophrenia","approvedSymbol":"NDUFC2","approvedName":"NADH:ubiquinone oxidoreductase subunit C2","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000090266","diseaseId":"MONDO_0005090","phase":4,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01654640%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02140788%22"}],"ancestors":["EFO_0000677","MONDO_0002025","MONDO_0002039","EFO_0005774","EFO_0000618","EFO_0005407","EFO_0009386"],"label":"schizophrenia","approvedSymbol":"NDUFB2","approvedName":"NADH:ubiquinone oxidoreductase subunit B2","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL243712","targetId":"ENSG00000178394","diseaseId":"MONDO_0005090","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02051387%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01972711%22"}],"ancestors":["EFO_0000677","MONDO_0002025","MONDO_0002039","EFO_0005774","EFO_0000618","EFO_0005407","EFO_0009386"],"label":"schizophrenia","approvedSymbol":"HTR1A","approvedName":"5-hydroxytryptamine receptor 1A","targetClass":["Membrane receptor"],"prefName":"AMISULPRIDE","tradeNames":["Barhemsys","Solian","Solian 100","Solian 200","Solian 400","Solian 50"],"synonyms":["APD-421","APD421","Aminosultopride","Amisulpride","DAN-2163","Deniban","NSC-760085","Socian","Sulamid"],"drugType":"Small molecule","mechanismOfAction":"Serotonin (5-HT) receptor antagonist","targetName":"Serotonin (5-HT) receptor"}
{"drugId":"CHEMBL715","targetId":"ENSG00000069696","diseaseId":"MONDO_0005090","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01129674%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02462473%22"}],"ancestors":["EFO_0000677","MONDO_0002025","MONDO_0002039","EFO_0005774","EFO_0000618","EFO_0005407","EFO_0009386"],"label":"schizophrenia","approvedSymbol":"DRD4","approvedName":"dopamine receptor D4","targetClass":["Membrane receptor"],"prefName":"OLANZAPINE","tradeNames":["Arkolamyl","Olanzapine","Zalasta","Zyprexa","Zyprexa zydis"],"synonyms":["LY-170053","LY170053","Olansek","Olanzapine","Olanzapine apotex","Olanzapine cipla","Olanzapine glenmark","Olanzapine mylan","Olanzapine teva","Olazax","Olazax disperzi","Zyprexa velotab"],"drugType":"Small molecule","mechanismOfAction":"D2-like dopamine receptor antagonist","targetName":"D2-like dopamine receptor"}
{"drugId":"CHEMBL85","targetId":"ENSG00000149295","diseaseId":"MONDO_0005090","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00857818%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00366704%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00645515%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02374567%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03230864%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00660595%22"}],"ancestors":["EFO_0000677","MONDO_0002025","MONDO_0002039","EFO_0005774","EFO_0000618","EFO_0005407","EFO_0009386"],"label":"schizophrenia","approvedSymbol":"DRD2","approvedName":"dopamine receptor D2","targetClass":["Membrane receptor"],"prefName":"RISPERIDONE","tradeNames":["Perseris kit","Risperdal","Risperdal Consta Long Acting","Risperdal M","Risperdal M-Tab","Risperdal consta","Risperdal quicklet","Risperidone"],"synonyms":["LY-03004","LY03004","N05AX08","NSC-759895","Perseris","R 64 766","R-64,766","R-64-766","R-64766","RCN-3028","RCN3028","Risperidone"],"drugType":"Small molecule","mechanismOfAction":"Dopamine D2 receptor antagonist","targetName":"Dopamine D2 receptor"}
{"drugId":"CHEMBL967","targetId":"ENSG00000182256","diseaseId":"MONDO_0005090","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02374567%22"}],"ancestors":["EFO_0000677","MONDO_0002025","MONDO_0002039","EFO_0005774","EFO_0000618","EFO_0005407","EFO_0009386"],"label":"schizophrenia","approvedSymbol":"GABRG3","approvedName":"gamma-aminobutyric acid type A receptor subunit gamma3","targetClass":["Ion channel"],"prefName":"TEMAZEPAM","tradeNames":["Kentepam","Normison","Restoril","Temaz","Temazepam"],"synonyms":["(rs)-temazepam","NSC-246303","Temazepam","Temazepam civ","WY-3917"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL1152","targetId":"ENSG00000113580","diseaseId":"MONDO_0005129","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04273282%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03578276%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02515045%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00698724%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00758199%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00170729%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00407017%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04631315%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00348244%22"}],"ancestors":["EFO_0009674","OTAR_0000018","EFO_0003966","EFO_0000508","MONDO_0024458"],"label":"cataract","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"PREDNISOLONE ACETATE","tradeNames":["Econopred","Flo-pred","Meticortelone","Omnipred","Pred forte","Pred fte","Pred mild","Prednisolone acetate","Sterane","Ultracortenol"],"synonyms":["NSC-10966","Prednisolone 21-acetate","Prednisolone Acetate","Prednisolone acetate","Prednisoloni acetas"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL1201570","targetId":"ENSG00000115594","diseaseId":"MONDO_0005147","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00711503%22"}],"ancestors":["MONDO_0000588","OTAR_0000020","EFO_0000589","EFO_0005809","EFO_0001379","EFO_0000540","EFO_0000400","MONDO_0000569","MONDO_0001933","EFO_0009605","EFO_0009406","EFO_1002003","EFO_0010282"],"label":"type 1 diabetes mellitus","approvedSymbol":"IL1R1","approvedName":"interleukin 1 receptor type 1","targetClass":["Membrane receptor"],"prefName":"ANAKINRA","tradeNames":["Antril","Kineret"],"synonyms":["AMG-719","Alta-2530","Alta2530","Anakinra","Interleukin-1 receptor antagonist anakinra","Osp-101"],"drugType":"Protein","mechanismOfAction":"Interleukin-1 receptor antagonist","targetName":"Interleukin-1 receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000004779","diseaseId":"MONDO_0005147","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04177303%22"}],"ancestors":["MONDO_0000588","OTAR_0000020","EFO_0000589","EFO_0005809","EFO_0001379","EFO_0000540","EFO_0000400","MONDO_0000569","MONDO_0001933","EFO_0009605","EFO_0009406","EFO_1002003","EFO_0010282"],"label":"type 1 diabetes mellitus","approvedSymbol":"NDUFAB1","approvedName":"NADH:ubiquinone oxidoreductase subunit AB1","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198695","diseaseId":"MONDO_0005147","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03928340%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00118937%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01718093%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02765347%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00145379%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02407899%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01813929%22"}],"ancestors":["MONDO_0000588","OTAR_0000020","EFO_0000589","EFO_0005809","EFO_0001379","EFO_0000540","EFO_0000400","MONDO_0000569","MONDO_0001933","EFO_0009605","EFO_0009406","EFO_1002003","EFO_0010282"],"label":"type 1 diabetes mellitus","approvedSymbol":"MT-ND6","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000160194","diseaseId":"MONDO_0005147","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03513874%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03570632%22"}],"ancestors":["MONDO_0000588","OTAR_0000020","EFO_0000589","EFO_0005809","EFO_0001379","EFO_0000540","EFO_0000400","MONDO_0000569","MONDO_0001933","EFO_0009605","EFO_0009406","EFO_1002003","EFO_0010282"],"label":"type 1 diabetes mellitus","approvedSymbol":"NDUFV3","approvedName":"NADH:ubiquinone oxidoreductase subunit V3","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000160194","diseaseId":"MONDO_0005147","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03639545%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03590262%22"}],"ancestors":["MONDO_0000588","OTAR_0000020","EFO_0000589","EFO_0005809","EFO_0001379","EFO_0000540","EFO_0000400","MONDO_0000569","MONDO_0001933","EFO_0009605","EFO_0009406","EFO_1002003","EFO_0010282"],"label":"type 1 diabetes mellitus","approvedSymbol":"NDUFV3","approvedName":"NADH:ubiquinone oxidoreductase subunit V3","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL4524066","targetId":"ENSG00000112164","diseaseId":"MONDO_0005147","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02351232%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02443155%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01755416%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02898506%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02908087%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01782261%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02617654%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02408705%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01879917%22"}],"ancestors":["MONDO_0000588","OTAR_0000020","EFO_0000589","EFO_0005809","EFO_0001379","EFO_0000540","EFO_0000400","MONDO_0000569","MONDO_0001933","EFO_0009605","EFO_0009406","EFO_1002003","EFO_0010282"],"label":"type 1 diabetes mellitus","approvedSymbol":"GLP1R","approvedName":"glucagon like peptide 1 receptor","targetClass":["Membrane receptor"],"prefName":"LIRAGLUTIDE","tradeNames":["Saxenda","Victoza"],"synonyms":["Liraglutide","Liraglutide (rdna origin)","Liraglutide recombinant","NN-2211","NN-9924","NN2211","NN9924","NNC 90-1170","NNC-90-1170"],"drugType":"Protein","mechanismOfAction":"Glucagon-like peptide 1 receptor agonist","targetName":"Glucagon-like peptide 1 receptor"}
{"drugId":"CHEMBL661","targetId":"ENSG00000186297","diseaseId":"MONDO_0005147","phase":0,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00574639%22"}],"ancestors":["MONDO_0000588","OTAR_0000020","EFO_0000589","EFO_0005809","EFO_0001379","EFO_0000540","EFO_0000400","MONDO_0000569","MONDO_0001933","EFO_0009605","EFO_0009406","EFO_1002003","EFO_0010282"],"label":"type 1 diabetes mellitus","approvedSymbol":"GABRA5","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha5","targetClass":["Ion channel"],"prefName":"ALPRAZOLAM","tradeNames":["Alprazolam","Niravam","Xanax","Xanax xr"],"synonyms":["Alprazolam","Alprazolam civ","NSC-760140","U 31,889","U-31,889","U-31889"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL142703","targetId":"ENSG00000197635","diseaseId":"MONDO_0005148","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02749032%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01582308%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00572650%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"DPP4","approvedName":"dipeptidyl peptidase 4","targetClass":["Enzyme"],"prefName":"VILDAGLIPTIN","tradeNames":["Galvus"],"synonyms":["LAF 237","LAF-237","LAF237","NVP-LAF 237","NVP-LAF237","Vildagliptin","Vitagliptin"],"drugType":"Small molecule","mechanismOfAction":"Dipeptidyl peptidase IV inhibitor","targetName":"Dipeptidyl peptidase IV"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000130414","diseaseId":"MONDO_0005148","phase":0,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03445702%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"NDUFA10","approvedName":"NADH:ubiquinone oxidoreductase subunit A10","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000178127","diseaseId":"MONDO_0005148","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01747083%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01489644%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01557504%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01396564%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02648854%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01786707%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02597400%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00975052%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00897390%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00865033%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01332071%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01546597%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00673465%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01068730%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04065581%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00961857%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01068717%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01002807%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01383356%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03169959%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01941199%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02685774%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00971659%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01089166%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00929201%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01093794%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03138356%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00899470%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00830076%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01365091%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00376038%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01535677%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02722239%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02411825%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02813863%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00519480%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00425009%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01089205%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01755494%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02803918%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01956305%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01089179%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03310749%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01154348%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01302145%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01869621%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00961909%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01490658%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01292993%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04317703%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01728740%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01677299%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01546558%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03061981%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02749032%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02354027%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02565368%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01357876%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00961480%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01780051%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01089192%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00882882%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01068743%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01211197%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02022254%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"NDUFV2","approvedName":"NADH:ubiquinone oxidoreductase core subunit V2","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000186010","diseaseId":"MONDO_0005148","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01305551%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"NDUFA13","approvedName":"NADH:ubiquinone oxidoreductase subunit A13","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000131495","diseaseId":"MONDO_0005148","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00481663%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00672386%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00901979%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00111631%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01729403%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02004886%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02202161%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02205528%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01511198%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02786823%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01111955%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00792935%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00698230%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00328172%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01511172%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03751657%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00290940%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00881530%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01071850%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03230786%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01340664%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01059825%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00734474%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03444584%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00525330%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00631488%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01240759%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01929863%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00263276%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00743002%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00860288%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02973321%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00266253%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00420511%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00971243%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01596504%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03167918%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03416127%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01476475%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01318135%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01969318%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01175473%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02091362%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00605475%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02151461%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02435277%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00871936%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01658501%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00613951%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01117584%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00316758%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02434744%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01217073%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00614055%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00454233%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02119819%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01935804%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00611884%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00789035%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01318109%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00110851%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"NDUFA2","approvedName":"NADH:ubiquinone oxidoreductase subunit A2","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000136521","diseaseId":"MONDO_0005148","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04271189%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05469659%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"NDUFB5","approvedName":"NADH:ubiquinone oxidoreductase subunit B5","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000119013","diseaseId":"MONDO_0005148","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00814372%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00900146%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00868790%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02274740%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02111096%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00698789%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00767000%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02492763%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00263965%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00479466%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"NDUFB3","approvedName":"NADH:ubiquinone oxidoreductase subunit B3","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000099795","diseaseId":"MONDO_0005148","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02064881%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00544518%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"NDUFB7","approvedName":"NADH:ubiquinone oxidoreductase subunit B7","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000170906","diseaseId":"MONDO_0005148","phase":3,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04670666%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05416580%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04373967%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05326490%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04841096%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05345327%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04667143%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"NDUFA3","approvedName":"NADH:ubiquinone oxidoreductase subunit A3","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000140990","diseaseId":"MONDO_0005148","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02429258%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00941148%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00619697%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01087567%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02686177%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01465152%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00318656%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01196546%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00474838%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01917656%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02561130%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00358124%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03819790%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02002221%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02954692%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00913367%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01890629%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00857870%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01919489%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00807092%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00562172%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01181674%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00367055%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00386100%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02338921%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01519674%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03359837%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04916093%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01204580%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01509001%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00815399%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02920801%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01144728%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01720290%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00941161%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00118963%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01842620%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02252965%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00669864%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03361878%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00191464%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00469092%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02235298%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00624364%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04707508%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01966978%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01972724%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00751114%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00491725%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01864174%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03202563%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01341717%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05167513%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01758380%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00964184%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04237493%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00118950%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01512979%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01490918%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00708578%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00778622%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01589445%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03267576%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02050074%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01524705%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01131182%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01438814%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03982238%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01541956%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00653302%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02040246%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01117350%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00780715%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02027753%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00241605%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01278160%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00184626%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00347100%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02836704%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00942318%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01947790%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00035568%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01444248%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01845831%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00819741%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00592969%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01709305%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01123980%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01068652%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00373178%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00121966%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01528254%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02941367%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00360698%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02853630%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01269996%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00993187%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02099838%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00568984%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00612144%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01006590%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01561976%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01518101%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00463502%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00975065%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00951899%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00679939%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03794336%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02526615%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02049814%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"NDUFB10","approvedName":"NADH:ubiquinone oxidoreductase subunit B10","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000140990","diseaseId":"MONDO_0005148","phase":4,"status":"Enrolling by invitation","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01471808%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"NDUFB10","approvedName":"NADH:ubiquinone oxidoreductase subunit B10","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000183648","diseaseId":"MONDO_0005148","phase":4,"status":"Enrolling by invitation","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01471808%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"NDUFB1","approvedName":"NADH:ubiquinone oxidoreductase subunit B1","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198886","diseaseId":"MONDO_0005148","phase":4,"status":"Suspended","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00948324%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"MT-ND4","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1703","targetId":"ENSG00000198886","diseaseId":"MONDO_0005148","phase":1,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05363384%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05415644%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05363592%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"MT-ND4","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4","targetClass":["Enzyme"],"prefName":"METFORMIN HYDROCHLORIDE","tradeNames":["Bolamyn sr","Diagemet xl","Fortamet","Glucamet 500","Glucamet 850","Glucient sr","Glucophage","Glucophage sr","Glucophage xr","Glumetza","Glyformin","Janumet","Ledermetin","Metabet sr","Metformin hydrochloride","Metsol","Milform","Orabet","Riomet","Riomet er","Sukkarto sr"],"synonyms":["Apophage","Benofomin","Diabefagos","Diabex","EX-404","EX404","Glucaminol","LA-6023","Metformin hcl","Metformin hydrochloride","NSC-91485","Neodipa","Siamformet","Walaphage"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1703","targetId":"ENSG00000065518","diseaseId":"MONDO_0005148","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02064881%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"NDUFB4","approvedName":"NADH:ubiquinone oxidoreductase subunit B4","targetClass":["Enzyme"],"prefName":"METFORMIN HYDROCHLORIDE","tradeNames":["Bolamyn sr","Diagemet xl","Fortamet","Glucamet 500","Glucamet 850","Glucient sr","Glucophage","Glucophage sr","Glucophage xr","Glumetza","Glyformin","Janumet","Ledermetin","Metabet sr","Metformin hydrochloride","Metsol","Milform","Orabet","Riomet","Riomet er","Sukkarto sr"],"synonyms":["Apophage","Benofomin","Diabefagos","Diabex","EX-404","EX404","Glucaminol","LA-6023","Metformin hcl","Metformin hydrochloride","NSC-91485","Neodipa","Siamformet","Walaphage"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1703","targetId":"ENSG00000130414","diseaseId":"MONDO_0005148","phase":4,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01510522%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"NDUFA10","approvedName":"NADH:ubiquinone oxidoreductase subunit A10","targetClass":["Enzyme"],"prefName":"METFORMIN HYDROCHLORIDE","tradeNames":["Bolamyn sr","Diagemet xl","Fortamet","Glucamet 500","Glucamet 850","Glucient sr","Glucophage","Glucophage sr","Glucophage xr","Glumetza","Glyformin","Janumet","Ledermetin","Metabet sr","Metformin hydrochloride","Metsol","Milform","Orabet","Riomet","Riomet er","Sukkarto sr"],"synonyms":["Apophage","Benofomin","Diabefagos","Diabex","EX-404","EX404","Glucaminol","LA-6023","Metformin hcl","Metformin hydrochloride","NSC-91485","Neodipa","Siamformet","Walaphage"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1829174","targetId":"ENSG00000126266","diseaseId":"MONDO_0005148","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01414920%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01007097%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"FFAR1","approvedName":"free fatty acid receptor 1","targetClass":["Membrane receptor"],"prefName":"FASIGLIFAM","tradeNames":[],"synonyms":["Fasiglifam","Fasiglifam hemihydrate","TAK-875","Tak-875 anhydrous"],"drugType":"Small molecule","mechanismOfAction":"Free fatty acid receptor 1 positive allosteric modulator","targetName":"Free fatty acid receptor 1"}
{"drugId":"CHEMBL2107841","targetId":"ENSG00000112164","diseaseId":"MONDO_0005148","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02496221%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"GLP1R","approvedName":"glucagon like peptide 1 receptor","targetClass":["Membrane receptor"],"prefName":"ALBIGLUTIDE","tradeNames":["Eperzan"],"synonyms":["Albiglutide","Albiglutide (genetical recombination)","GSK-716155","GSK716155","Tanzeum"],"drugType":"Protein","mechanismOfAction":"Glucagon-like peptide 1 receptor agonist","targetName":"Glucagon-like peptide 1 receptor"}
{"drugId":"CHEMBL3545269","targetId":"ENSG00000215644","diseaseId":"MONDO_0005148","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03376802%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02411825%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03350191%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03414736%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"GCGR","approvedName":"glucagon receptor","targetClass":["Membrane receptor"],"prefName":"SAR425899","tradeNames":[],"synonyms":["Sar425899"],"drugType":"Small molecule","mechanismOfAction":"Glucagon receptor agonist","targetName":"Glucagon receptor"}
{"drugId":"CHEMBL3786673","targetId":"ENSG00000173039","diseaseId":"MONDO_0005148","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01511900%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"RELA","approvedName":"RELA proto-oncogene, NF-kB subunit","targetClass":["Transcription factor"],"prefName":"EDASALONEXENT","tradeNames":[],"synonyms":["CAT 1004","CAT-1004","Cat 1004","Cat-1004","Edasalonexent"],"drugType":"Small molecule","mechanismOfAction":"Nuclear factor NF-kappa-B complex inhibitor","targetName":"Nuclear factor NF-kappa-B complex"}
{"drugId":"CHEMBL4297630","targetId":"ENSG00000112164","diseaseId":"MONDO_0005148","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03555994%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03645421%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03444584%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03235050%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03745937%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03244800%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"GLP1R","approvedName":"glucagon like peptide 1 receptor","targetClass":["Membrane receptor"],"prefName":"COTADUTIDE","tradeNames":[],"synonyms":["Cotadutide","MEDI-0382","MEDI0382","Medi 0382","Medi0382"],"drugType":"Protein","mechanismOfAction":"Glucagon-like peptide 1 receptor agonist","targetName":"Glucagon-like peptide 1 receptor"}
{"drugId":"CHEMBL4594217","targetId":"ENSG00000140675","diseaseId":"MONDO_0005148","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02009488%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01483781%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01273558%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01381887%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01128985%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00707954%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01512849%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02000700%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"SLC5A2","approvedName":"solute carrier family 5 member 2","targetClass":["Transporter"],"prefName":"CANAGLIFLOZIN","tradeNames":["Invokana"],"synonyms":["Canagliflozin","Canagliflozin hemihydrate","Canagliflozin hydrate","JNJ-24831754-ZAE","JNJ-28431754","JNJ-28431754-AAA","TA-7284"],"drugType":"Small molecule","mechanismOfAction":"Sodium/glucose cotransporter 2 inhibitor","targetName":"Sodium/glucose cotransporter 2"}
{"drugId":"CHEMBL660","targetId":"ENSG00000161509","diseaseId":"MONDO_0005148","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01441986%22"}],"ancestors":["EFO_0000589","EFO_0001379","EFO_0000400","MONDO_0001933","EFO_0009605","EFO_0009406","OTAR_0000020","EFO_0010282"],"label":"type 2 diabetes mellitus","approvedSymbol":"GRIN2C","approvedName":"glutamate ionotropic receptor NMDA type subunit 2C","targetClass":["Ion channel"],"prefName":"AMANTADINE","tradeNames":[],"synonyms":["Amantadine","Amantidine","NSC-341865","Symadine","Symmetrel","TCMDC-125869"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor antagonist","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL193","targetId":"ENSG00000157388","diseaseId":"MONDO_0005149","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00519870%22"}],"ancestors":["MONDO_0000473","EFO_0004264","EFO_0000537","EFO_0000319"],"label":"pulmonary hypertension","approvedSymbol":"CACNA1D","approvedName":"calcium voltage-gated channel subunit alpha1 D","targetClass":["Ion channel"],"prefName":"NIFEDIPINE","tradeNames":["Adalat","Adalat a.r.","Adalat cc","Adalat ic","Adalat la 20","Adalat la 30","Adalat la 60","Adalat ret","Adalate lp","Adanif xl","Adipine mr 10","Adipine mr 20","Adipine xl","Afeditab cr","Angiopine 10","Angiopine 40 la","Angiopine 5","Angiopine mr 10","Angiopine mr 20","Calanif","Calchan mr 10","Calchan mr 20","Calcilat","Cardilate mr","Coracten sr","Coracten xl","Coroday mr","Fortipine la40","Genalat 10 ret","Genalat 20 ret","Hypolar ret 10","Hypolar ret 20","Hypolar xl 30","Kentipine","Kentipine mr 10","Kentipine mr 20","Neozipine xl","Nife-wolff","Nifedipine","Nifedipress mr 10","Nifedipress mr 20","Nifedotard 20 mr","Nifelease","Nifensar xl","Nifopress mr","Nifopress ret","Nimodrel mr 10","Nimodrel mr 20","Nimodrel xl","Nivaten ret","Procardia","Procardia xl","Slofedipine xl 30","Slofedipine xl 60","Tensipine mr 10","Tensipine mr 20","Unipine xl","Valni 20 ret","Valni xl","Vasad"],"synonyms":["BAY A 1040","BAY-A-1040","Coracten","NSC-757242","Nifedipine","Nifedipine hydrochloride","Nifedipine slow release","Nifedipinum"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated L-type calcium channel blocker","targetName":"Voltage-gated L-type calcium channel"}
{"drugId":"CHEMBL107","targetId":"ENSG00000137285","diseaseId":"MONDO_0005178","phase":4,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04601883%22"}],"ancestors":["EFO_0004260","OTAR_0000006","EFO_0009676","EFO_1000999","MONDO_0002614","EFO_0005755","EFO_0002461","EFO_1001986","EFO_0005856"],"label":"osteoarthritis","approvedSymbol":"TUBB2B","approvedName":"tubulin beta 2B class IIb","targetClass":["Structural protein"],"prefName":"COLCHICINE","tradeNames":["Colchicine","Colcrys","Gloperba","Mitigare"],"synonyms":["(-)-colchicine","Colchcine","Colchicine","Colchicinum","Colchineos","Colchisol","NSC-757"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL139","targetId":"ENSG00000073756","diseaseId":"MONDO_0005178","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00171678%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02769572%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02596451%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00542087%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01461369%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00171665%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02121002%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00171626%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00171652%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01510912%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00546832%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04421911%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00546507%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00092703%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00171691%22"}],"ancestors":["EFO_0004260","OTAR_0000006","EFO_0009676","EFO_1000999","MONDO_0002614","EFO_0005755","EFO_0002461","EFO_1001986","EFO_0005856"],"label":"osteoarthritis","approvedSymbol":"PTGS2","approvedName":"prostaglandin-endoperoxide synthase 2","targetClass":["Enzyme"],"prefName":"DICLOFENAC","tradeNames":["Cambia","Voltaren","Voltaren Ophthalmic","Voltaren Xr","Zorvolex","Zorvolex capsules"],"synonyms":["Arthrotec","Cataflam","Diclofenac","Diclofenac free acid","LAS-41007","LAS41007","Las41007","Solaraze","Voltaren","Voltaren-XR"],"drugType":"Small molecule","mechanismOfAction":"Cyclooxygenase inhibitor","targetName":"Cyclooxygenase"}
{"drugId":"CHEMBL1504","targetId":"ENSG00000113580","diseaseId":"MONDO_0005178","phase":1,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04863183%22"}],"ancestors":["EFO_0004260","OTAR_0000006","EFO_0009676","EFO_1000999","MONDO_0002614","EFO_0005755","EFO_0002461","EFO_1001986","EFO_0005856"],"label":"osteoarthritis","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"TRIAMCINOLONE ACETONIDE","tradeNames":["Adcortyl","Adcortyl in orabase","Allernaze","Aristocort","Aristocort a","Aristogel","Audicort","Aureocort","Azmacort","Flutex","Gppe ear dps cap","Gppe ear oint","Kenacort","Kenalog","Kenalog in orabase","Kenalog-10","Kenalog-40","Kenalog-80","Kenalog-h","Nasacort","Nasacort allergy 24 hour","Nasacort aq","Nasacort hfa","Nystadermal","Oracort","Oralone","Pevaryl t.c.","Remiderm","Remotic","Silderm","Tri-Nasal","Tri-adcortyl","Triacet","Triacort","Triamcinolone acetonide","Triamcinolone acetonide in absorbase","Triatex","Triderm","Triesence","Trivaris","Trymex","Vetalog","Zilretta"],"synonyms":["FX-006","FX006","Kenacourt","NSC-21916","Triamcinolone Acetonide","Triamcinolone acetonide"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL2103827","targetId":"ENSG00000043591","diseaseId":"MONDO_0005180","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03115827%22"}],"ancestors":["MONDO_0021095","EFO_0009533","OTAR_0000018","EFO_0005774","EFO_0000618","EFO_0000508","EFO_0009386"],"label":"Parkinson disease","approvedSymbol":"ADRB1","approvedName":"adrenoceptor beta 1","targetClass":["Membrane receptor"],"prefName":"DROXIDOPA","tradeNames":["Northera"],"synonyms":["DOPS","Droxidopa","L-DOPS","L-threo-dops"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor agonist","targetName":"Adrenergic receptor"}
{"drugId":"CHEMBL45","targetId":"ENSG00000168412","diseaseId":"MONDO_0005180","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03258294%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02768077%22"}],"ancestors":["MONDO_0021095","EFO_0009533","OTAR_0000018","EFO_0005774","EFO_0000618","EFO_0000508","EFO_0009386"],"label":"Parkinson disease","approvedSymbol":"MTNR1A","approvedName":"melatonin receptor 1A","targetClass":["Membrane receptor"],"prefName":"MELATONIN","tradeNames":["Circadin","General nutrit","Health aid","Heidadouppi","Icenia","Life ext","Melapure","Natrol","Nature's blend","Natures bounty","Quality health","S.gard","Travelag","Vespro","Vytalonin"],"synonyms":["5-methoxy n-acetyl-tryptamine","BCI-049","J5.258B","Melatol","Melatonin","Melatonine","Melovine","N-(2-(5-Methoxy-1H-Indol-3-Yl)Ethyl)Acetamide","N-Acetyl-5-Methoxytryptamine","NSC-113928","NSC-302012","NSC-56423","Regulin","Tartrol"],"drugType":"Small molecule","mechanismOfAction":"Melatonin receptor agonist","targetName":"Melatonin receptor"}
{"drugId":"CHEMBL49","targetId":"ENSG00000178394","diseaseId":"MONDO_0005180","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02617017%22"}],"ancestors":["MONDO_0021095","EFO_0009533","OTAR_0000018","EFO_0005774","EFO_0000618","EFO_0000508","EFO_0009386"],"label":"Parkinson disease","approvedSymbol":"HTR1A","approvedName":"5-hydroxytryptamine receptor 1A","targetClass":["Membrane receptor"],"prefName":"BUSPIRONE","tradeNames":[],"synonyms":["BCI-024","Buspar","Buspirone","Gen-buspirone"],"drugType":"Small molecule","mechanismOfAction":"Serotonin 1a (5-HT1a) receptor partial agonist","targetName":"Serotonin 1a (5-HT1a) receptor"}
{"drugId":"CHEMBL517712","targetId":"ENSG00000181072","diseaseId":"MONDO_0005180","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=350dcd54-857d-4a65-9fd0-ad54f090fd7b"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=559269eb-4a0f-4b38-8d7d-70d419b96a0e"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=78e42769-061f-4973-ac3a-dc3fcc4bf641"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=786b9c9a-8b70-41bb-9ea3-0bf6dd7a06df"}],"ancestors":["MONDO_0021095","EFO_0009533","OTAR_0000018","EFO_0005774","EFO_0000618","EFO_0000508","EFO_0009386"],"label":"Parkinson disease","approvedSymbol":"CHRM2","approvedName":"cholinergic receptor muscarinic 2","targetClass":["Membrane receptor"],"prefName":"ATROPINE","tradeNames":["Atroject","Atropen","Atrophate","Atropine","Atropine (autoinjector)","Isopto Atropine"],"synonyms":["Atropine","Atropinum","Dl-hyoscyamine"],"drugType":"Small molecule","mechanismOfAction":"Muscarinic acetylcholine receptor M2 antagonist","targetName":"Muscarinic acetylcholine receptor M2"}
{"drugId":"CHEMBL660","targetId":"ENSG00000273079","diseaseId":"MONDO_0005180","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01538329%22"}],"ancestors":["MONDO_0021095","EFO_0009533","OTAR_0000018","EFO_0005774","EFO_0000618","EFO_0000508","EFO_0009386"],"label":"Parkinson disease","approvedSymbol":"GRIN2B","approvedName":"glutamate ionotropic receptor NMDA type subunit 2B","targetClass":["Ion channel"],"prefName":"AMANTADINE","tradeNames":[],"synonyms":["Amantadine","Amantidine","NSC-341865","Symadine","Symmetrel","TCMDC-125869"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor antagonist","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL900","targetId":"ENSG00000153253","diseaseId":"MONDO_0005180","phase":4,"urls":[{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=N04AB02"}],"ancestors":["MONDO_0021095","EFO_0009533","OTAR_0000018","EFO_0005774","EFO_0000618","EFO_0000508","EFO_0009386"],"label":"Parkinson disease","approvedSymbol":"SCN3A","approvedName":"sodium voltage-gated channel alpha subunit 3","targetClass":["Ion channel"],"prefName":"ORPHENADRINE","tradeNames":[],"synonyms":["Disipal","Invagesic","Mefenamine","Mialgin","Norflex","Norgesic","Orphenadrin","Orphenadrine","Orphengesic"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL384467","targetId":"ENSG00000113580","diseaseId":"MONDO_0005271","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02349763%22"}],"ancestors":["EFO_0000540","EFO_1002003"],"label":"allergic disease","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"DEXAMETHASONE","tradeNames":["Aeroseb-dex","Dalalone","Decaderm","Decadron","Decadron-75","Decaspray","Dexacortisyl","Dexafree","Dexamethasone","Dexamethasone intensol","Dexone","Dexone 0.5","Dexone 0.75","Dexone 1.5","Dexone 4","Dexsol","Dextenza","Dexycu kit","Dropodex","Gppe ear spy","Hemady","Hexadrol","Kortico Injection","Martapan","Maxidex","Maxitrol","Oradexon","Otomize","Ozurdex","Sofradex","Spersadex comp","Tobradex"],"synonyms":["Decadron-LA","Dexacen-4","Dexacort","Dexair","Dexamethasone","Dexamethasone metasulfobenzoate sodium","Dexamethasone palmitate","Dexamethasone valerate","Dexycu","Fluormethylprednisolone","ISV-305","Mymethasone","NSC-34521","Neodecadron","OTO-104"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL92","targetId":"ENSG00000137285","diseaseId":"MONDO_0005271","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00277043%22"}],"ancestors":["EFO_0000540","EFO_1002003"],"label":"allergic disease","approvedSymbol":"TUBB2B","approvedName":"tubulin beta 2B class IIb","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":[],"synonyms":["RP-56976","Taxotere"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL112","targetId":"ENSG00000073756","diseaseId":"MONDO_0005277","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=775237d0-726a-4892-a993-fced11afce0d"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=856d0894-e840-4b87-95aa-3085d5aed5be"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d63959d5-b1dc-4422-8f69-7599f8b11f4a"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=df9801fc-03fe-41da-a6b3-0f76788217c9"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a753f12-26f2-8870-00ef-810c0f3e0045"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=faf741c4-bfc5-4f52-8773-c50f7b15dd08"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=11690b28-5509-496a-9648-349158770ec2"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8c330933-ee51-4261-917e-155fddf1b711"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a26775c2-cafb-4b13-99ac-d4e8248265fb"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fffd3c9b-d7c8-4ba0-8527-3fdd742c69e6"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f36970e8-9905-43cb-8cfd-693545f183cf"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1434df11-6e37-4722-a4c0-972e5c5899f8"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a04406b8-08fc-4d44-8b3c-63da3d7fb55b"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=86ba6ede-c033-423c-9d3f-045f5efe5bbe"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ed8079a1-670c-48fb-92ff-6e6ad51e6ad3"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7be61442-a0b1-4714-adac-51625e0bbe9e"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cc507320-7673-4abc-ac94-aaab3a9baa7c"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cfa14b4b-94c6-4403-8ff8-0ecdb8c6ff81"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a58819b8-a52c-44a7-9ab0-c74480d98506"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f6e26ba6-2f00-4156-91ad-15bf8597763b"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b2afd18b-02a2-49dc-b059-e551acccdd4a"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8aa576ac-c870-4ac0-a9a5-5539b38f653d"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ea5b9ffe-3cda-405e-8f75-3fd4a64c9a35"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=97c50a3b-f954-46ed-9fa5-b9a45d485f1d"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f8cced0-4749-4a11-8f00-96d8c23c1cfd"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f988e6f2-1e5b-416b-8f2a-aa45a3207945"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1f56c61-1a51-48e2-a2f1-f15926284871"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8e99c982-50ca-49d7-b80a-b60aa18401cb"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=52321fe5-c001-4e2d-8149-3197ddc13764"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42e4219a-a4ef-f090-f6a4-2fd2e213d397"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=418054c3-d8c8-49b0-93a5-a53fd0c5018f"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab907b70-5cdc-49b4-a702-1b14e1351a96"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=611356c6-9cf6-4316-a9cb-e7756955755b"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a81c62d2-8151-42db-bda7-e08578ac5089"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f3a37ce1-5082-4ac4-88a2-c8fadbd0b7b3"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=540dbc71-f279-48f1-b420-b8dc2c21d070"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8328545-437a-4591-8cdc-66d275938024"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9a9fe1f1-eafd-44c9-923b-bea787b5e7e0"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c82c7ea9-0941-4462-ae44-dbc60e76f92c"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3f0f6064-cc9f-491c-a940-3f087abbc774"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=332cec60-efb3-4f24-ac01-fc6769ee02c4"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a6cbc17f-5c60-489c-8029-84b0add556d8"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=736ec64e-088d-4a29-9c06-608dcba482bc"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f8c5c01-5859-4843-adf4-8116ddaedc90"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eb1f2e22-5120-449f-9efb-7ac5a7c06bed"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0a97823-63d5-43fa-862f-2acce3185681"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a03276eb-d435-4159-9cc8-70c2ed132882"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac7e8ce7-088f-4d9c-ad52-2af60436d836"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=71ab0446-3772-4680-93c5-8020d21dc15f"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a330ef47-e23a-4d30-896c-8c5f5a6e79d6"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=692a38bd-4588-4f9c-8def-59484c4ce425"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa88f437-830b-48bc-a44c-fd142963a150"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b151e4eb-bb9a-41b9-98a4-2e12bb4e2e5f"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=85c7db7a-a99a-43ef-9337-9916762ca087"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=919456fe-71e7-4edc-ad4f-2320fb07712e"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8c1edb39-1ae9-44f1-b23b-387b715a3df6"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=41fbd224-1239-4d89-8e19-0a300cd66f38"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=917f576b-ead7-442d-bf90-7fb981210805"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2af36469-aeb0-4d48-92c3-5c11e11fab79"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6dd09be6-a345-4a42-9b64-51b7808ff45f"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e619b656-4123-4878-b601-b0edad3c428b"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8e51a2a-17c9-473a-aff1-dd776006c0a9"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5d248332-87ff-45c2-be92-e9e8386a4749"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be1b8109-725e-4427-9cd9-b468a71a48bd"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c5635b88-c874-417b-aabd-d979c4b13202"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8845dc27-d2b3-4b0c-8fd6-5c3f872ff867"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=720366f1-f2d1-6dd6-7bf1-9fdd9378b073"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c5827155-c339-4f7e-829b-6cf4edc581af"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aedc5167-cc3c-4044-87fa-4ed648c9f23f"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=469779cc-9a1b-470b-b54e-cf30191b97a4"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a41fa5cd-45c2-447b-b35f-aba505a67d98"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d3c69436-a681-4e00-8db0-8cbfaac9627e"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fef4844c-2b44-4e5c-9da3-e5b2214c9e8d"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=87249d21-5729-4d02-9f7f-bdbe75618e58"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7fd761e6-64fe-44cc-8b74-10ce31ccfd66"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42594152-563e-4984-9901-d6ef3b8a6941"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5bbad36-6a0e-3518-3f12-138ae9f63980"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e4a9925-67aa-4be7-8bb7-c8b058ffe223"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d74db417-d2de-495b-bb75-46a83745603d"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab17d24a-57af-4d8d-ae01-7e6846107373"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=07b47cba-fadc-437e-9a9a-845ee1cce591"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4b874a3d-db5a-40dc-a69c-d67c76b82b49"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=09eacd24-d327-4a39-8449-646cd56644ae"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=338b9f27-7097-4675-9ec5-e1eea6898cd5"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=97768690-6a7f-4690-8684-371c89bea71c"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=908bdfc3-ac28-44c9-aa59-39e7b9b28903"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=08442901-bb74-4516-9574-86b3dfeeabb1"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a7e9a136-ee7e-43b9-abb4-a03478f02b30"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8982243-5634-400a-8b23-8029fb4e5e92"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3f0c092b-08db-4e8f-136a-456e0e7bec14"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=669e3bd0-fbd9-423c-8654-a78fe650e3e2"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b7c94695-b5ac-497d-a2de-a336e1c22459"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=30e483da-eaf1-4c73-9fed-333337f9ba86"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dd7b5ba3-652a-443f-b0b9-17abda148e67"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ca8a0862-1956-43ad-844d-77153aa09dfb"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c018be7d-f7b8-45e2-97b8-8e7a71740657"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=410527dc-b93d-4efb-9528-ca58b98d851f"}],"ancestors":["MONDO_0043218","MONDO_0017181","EFO_0005774","EFO_0000618","MONDO_0700057","EFO_0004264","EFO_0009386","EFO_0000319","EFO_0009550"],"label":"migraine disorder","approvedSymbol":"PTGS2","approvedName":"prostaglandin-endoperoxide synthase 2","targetClass":["Enzyme"],"prefName":"ACETAMINOPHEN","tradeNames":["Abdine","Acephen","Acetaminophen","Alvedon","Angiers","Calpol","Calpol six plus","Calpol six plus fastmelts","Child lemsip","Cupanol","Dafalgan","Datril","Disprol","Disprol infant","Disprol jnr","Disprol paed","Fennings","Galpamol","Hedex","Infadrops","Infants' feverall","Injectapap","Junior parapaed","Mandanol","Medinol","Medinol for children","Medinol over 6","Medinol under 6","Medised plain","Miradol","Neopap","Ofirmev","Paldesic","Panadol","Panadol actifast","Panadol actifast solb","Panadol advan","Panadol jnr","Panadol oa","Panaleve","Panaleve 6 plus","Paracetamol","Paramin","Parapaed jnr","Parapaed six plus","Paravict","Perfalgan","Phenaphen","Placidex","Rimadol","Salzone","Tixymol","Tramil 500","Tylenol"],"synonyms":["Acetaminophen","Apap","Biocetamol","Doliprane","Efferalgan","N-acetyl-p-aminophenol","NSC-109028","NSC-3991","P-hydroxy-acetanilid","Paracetamol","Paracetamolum","Vermidon"],"drugType":"Small molecule","mechanismOfAction":"Cyclooxygenase inhibitor","targetName":"Cyclooxygenase"}
{"drugId":"CHEMBL113","targetId":"ENSG00000170425","diseaseId":"MONDO_0005277","phase":3,"status":"Suspended","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02582996%22"}],"ancestors":["MONDO_0043218","MONDO_0017181","EFO_0005774","EFO_0000618","MONDO_0700057","EFO_0004264","EFO_0009386","EFO_0000319","EFO_0009550"],"label":"migraine disorder","approvedSymbol":"ADORA2B","approvedName":"adenosine A2b receptor","targetClass":["Membrane receptor"],"prefName":"CAFFEINE","tradeNames":["Nodoz","Nodoz caplets and chewable tablets","Pro-plus","Yeast-vite","Zanthine"],"synonyms":["Anhydrous caffeine","Cafcit","Caffeine","Caffeine anhydrous","Caffeine melting point standard","Caffeinum","Coffeine","Coffeinum","Durvitan","FEMA NO. 2224","Guaranine","Methyltheobromine","NSC-5036","Synalgos","Theine","Vivarin"],"drugType":"Small molecule","mechanismOfAction":"Adenosine receptor antagonist","targetName":"Adenosine receptor"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000125675","diseaseId":"MONDO_0005277","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00131443%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01799590%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01081795%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00158002%22"}],"ancestors":["MONDO_0043218","MONDO_0017181","EFO_0005774","EFO_0000618","MONDO_0700057","EFO_0004264","EFO_0009386","EFO_0000319","EFO_0009550"],"label":"migraine disorder","approvedSymbol":"GRIA3","approvedName":"glutamate ionotropic receptor AMPA type subunit 3","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"Glutamate receptor ionotropic AMPA antagonist","targetName":"Glutamate receptor ionotropic AMPA"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000109158","diseaseId":"MONDO_0005277","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00210821%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00210873%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00236561%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00236509%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00216606%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00216619%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00253175%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00772031%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00237302%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00210535%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00210860%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00210912%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00231595%22"}],"ancestors":["MONDO_0043218","MONDO_0017181","EFO_0005774","EFO_0000618","MONDO_0700057","EFO_0004264","EFO_0009386","EFO_0000319","EFO_0009550"],"label":"migraine disorder","approvedSymbol":"GABRA4","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha4","targetClass":["Ion channel","Enzyme"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000136546","diseaseId":"MONDO_0005277","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00210496%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02191579%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02424318%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01700387%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02639598%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01060111%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00846495%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03828539%22"}],"ancestors":["MONDO_0043218","MONDO_0017181","EFO_0005774","EFO_0000618","MONDO_0700057","EFO_0004264","EFO_0009386","EFO_0000319","EFO_0009550"],"label":"migraine disorder","approvedSymbol":"SCN7A","approvedName":"sodium voltage-gated channel alpha subunit 7","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL442","targetId":"ENSG00000120907","diseaseId":"MONDO_0005277","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dac9637f-3326-4f25-b7b9-f9f54b738232"},{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=N02CA72"},{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=N02CA52"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b4a06de6-f837-43a8-ae7a-aadb38dd2a7d"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3a31ad0c-7bdd-544b-f5df-a99d04cf541c"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ed1ede57-1317-491a-9ebb-edee9aef5b3b"},{"niceName":"ATC","url":"https://www.whocc.no/atc_ddd_index/?code=N02CA02"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1c066197-dea6-4705-9b4a-8703dd564a2a"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=19479eeb-f507-48a8-bca3-c9cc0a0f6021"}],"ancestors":["MONDO_0043218","MONDO_0017181","EFO_0005774","EFO_0000618","MONDO_0700057","EFO_0004264","EFO_0009386","EFO_0000319","EFO_0009550"],"label":"migraine disorder","approvedSymbol":"ADRA1A","approvedName":"adrenoceptor alpha 1A","targetClass":["Membrane receptor"],"prefName":"ERGOTAMINE","tradeNames":[],"synonyms":["Ergotamine","Ergotamine Tartrate","NSC-95090"],"drugType":"Small molecule","mechanismOfAction":"Adrenergic receptor alpha agonist","targetName":"Adrenergic receptor alpha"}
{"drugId":"CHEMBL454","targetId":"ENSG00000166206","diseaseId":"MONDO_0005277","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be1b8109-725e-4427-9cd9-b468a71a48bd"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c5827155-c339-4f7e-829b-6cf4edc581af"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ca3fe6e9-21ad-4fba-a602-e1c364cf3981"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c018be7d-f7b8-45e2-97b8-8e7a71740657"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8845dc27-d2b3-4b0c-8fd6-5c3f872ff867"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=469779cc-9a1b-470b-b54e-cf30191b97a4"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42594152-563e-4984-9901-d6ef3b8a6941"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f8cced0-4749-4a11-8f00-96d8c23c1cfd"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=657e4c4a-e50c-49f7-99b4-32395ec19bd8"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ace223cc-458e-4455-a64e-83e5cbf95f9a"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8b93fc1-472c-4890-8d02-2ee4f7175c22"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d63959d5-b1dc-4422-8f69-7599f8b11f4a"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa88f437-830b-48bc-a44c-fd142963a150"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=52321fe5-c001-4e2d-8149-3197ddc13764"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8e51a2a-17c9-473a-aff1-dd776006c0a9"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9286d77c-feda-48a0-a04b-5fd9879e5fe0"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1434df11-6e37-4722-a4c0-972e5c5899f8"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8328545-437a-4591-8cdc-66d275938024"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8aa576ac-c870-4ac0-a9a5-5539b38f653d"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ca8a0862-1956-43ad-844d-77153aa09dfb"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aedc5167-cc3c-4044-87fa-4ed648c9f23f"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3f0c092b-08db-4e8f-136a-456e0e7bec14"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a41fa5cd-45c2-447b-b35f-aba505a67d98"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f988e6f2-1e5b-416b-8f2a-aa45a3207945"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7be61442-a0b1-4714-adac-51625e0bbe9e"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b151e4eb-bb9a-41b9-98a4-2e12bb4e2e5f"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8982243-5634-400a-8b23-8029fb4e5e92"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6dd09be6-a345-4a42-9b64-51b7808ff45f"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=540dbc71-f279-48f1-b420-b8dc2c21d070"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ea5b9ffe-3cda-405e-8f75-3fd4a64c9a35"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=df9801fc-03fe-41da-a6b3-0f76788217c9"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=faf741c4-bfc5-4f52-8773-c50f7b15dd08"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8c330933-ee51-4261-917e-155fddf1b711"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a00c6776-e9ef-411b-9396-915c3787559a"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=410527dc-b93d-4efb-9528-ca58b98d851f"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cae6b59d-13dc-49ea-ad4b-2f2bdae23840"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e619b656-4123-4878-b601-b0edad3c428b"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d74db417-d2de-495b-bb75-46a83745603d"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9771b178-cdcd-4992-a066-d7e18e9a5e44"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e10129b-41a3-4572-9564-6f8366b627dc"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f3a37ce1-5082-4ac4-88a2-c8fadbd0b7b3"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=338b9f27-7097-4675-9ec5-e1eea6898cd5"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fffd3c9b-d7c8-4ba0-8527-3fdd742c69e6"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a753f12-26f2-8870-00ef-810c0f3e0045"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c69954d9-9b30-484f-8e4a-5b1fc7dd197d"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=85c7db7a-a99a-43ef-9337-9916762ca087"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a58819b8-a52c-44a7-9ab0-c74480d98506"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a04406b8-08fc-4d44-8b3c-63da3d7fb55b"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a7e9a136-ee7e-43b9-abb4-a03478f02b30"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8e99c982-50ca-49d7-b80a-b60aa18401cb"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c34588ef-a580-4a8b-a525-808e956a4056"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=71ab0446-3772-4680-93c5-8020d21dc15f"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=09eacd24-d327-4a39-8449-646cd56644ae"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f8c5c01-5859-4843-adf4-8116ddaedc90"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8c1edb39-1ae9-44f1-b23b-387b715a3df6"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2ad8bd05-c133-45f5-9100-11660ec40043"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e40e3f1c-ff0e-433d-99e5-8882575fca38"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cc507320-7673-4abc-ac94-aaab3a9baa7c"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eb1f2e22-5120-449f-9efb-7ac5a7c06bed"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a26775c2-cafb-4b13-99ac-d4e8248265fb"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b91dd287-db2b-4c5a-b255-a355bc7ba97a"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=39c7d9f4-9889-4136-bc09-8e5540cd9144"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7fd761e6-64fe-44cc-8b74-10ce31ccfd66"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=919456fe-71e7-4edc-ad4f-2320fb07712e"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=908bdfc3-ac28-44c9-aa59-39e7b9b28903"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e31096f4-162f-44bd-a211-9c2873acfe54"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0a97823-63d5-43fa-862f-2acce3185681"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=917f576b-ead7-442d-bf90-7fb981210805"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa9bfa49-c3b3-419d-a283-5ea0fd6fc3a0"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a330ef47-e23a-4d30-896c-8c5f5a6e79d6"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2ef4b16c-f553-4a79-b5ee-7893aeb0eae3"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5bbad36-6a0e-3518-3f12-138ae9f63980"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=332cec60-efb3-4f24-ac01-fc6769ee02c4"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f6e26ba6-2f00-4156-91ad-15bf8597763b"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9a9fe1f1-eafd-44c9-923b-bea787b5e7e0"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=11690b28-5509-496a-9648-349158770ec2"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=95a33c9b-79a6-47c7-8433-fc217950b88f"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=692a38bd-4588-4f9c-8def-59484c4ce425"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac7e8ce7-088f-4d9c-ad52-2af60436d836"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=07b47cba-fadc-437e-9a9a-845ee1cce591"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5cd45280-2b8c-4ba8-bde9-db687d96847f"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=97768690-6a7f-4690-8684-371c89bea71c"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a6cbc17f-5c60-489c-8029-84b0add556d8"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f36970e8-9905-43cb-8cfd-693545f183cf"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=86ba6ede-c033-423c-9d3f-045f5efe5bbe"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=850bfccf-be34-423a-88d1-eba72f10434b"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=243a6aea-0f48-42a9-a85e-ff247ab94336"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6e0de6e8-e72f-4491-a3f0-657a24c4fc99"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5d248332-87ff-45c2-be92-e9e8386a4749"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab907b70-5cdc-49b4-a702-1b14e1351a96"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a81c62d2-8151-42db-bda7-e08578ac5089"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1f56c61-1a51-48e2-a2f1-f15926284871"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c5635b88-c874-417b-aabd-d979c4b13202"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f93ea649-d127-440a-aa1c-e7ff1db0007a"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bf2b6445-be65-4418-8118-e5a878ad9f41"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d3c69436-a681-4e00-8db0-8cbfaac9627e"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4b874a3d-db5a-40dc-a69c-d67c76b82b49"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ad135f46-5490-40e9-9add-1a953c6d6a9d"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=04bddbc4-86c7-4bac-9327-010568020568"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=669e3bd0-fbd9-423c-8654-a78fe650e3e2"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=166e131d-9c1a-461f-bf33-e45d4ec36ff2"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ed8079a1-670c-48fb-92ff-6e6ad51e6ad3"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=97c50a3b-f954-46ed-9fa5-b9a45d485f1d"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=41fbd224-1239-4d89-8e19-0a300cd66f38"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=418054c3-d8c8-49b0-93a5-a53fd0c5018f"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ba60b130-33cd-4db9-92a7-2cab8ded0737"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cfa14b4b-94c6-4403-8ff8-0ecdb8c6ff81"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a03276eb-d435-4159-9cc8-70c2ed132882"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=856d0894-e840-4b87-95aa-3085d5aed5be"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2af36469-aeb0-4d48-92c3-5c11e11fab79"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e4a9925-67aa-4be7-8bb7-c8b058ffe223"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab17d24a-57af-4d8d-ae01-7e6846107373"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=66305a0c-caf8-414a-a30b-3ab7b73086e1"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fef4844c-2b44-4e5c-9da3-e5b2214c9e8d"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3f0f6064-cc9f-491c-a940-3f087abbc774"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b2afd18b-02a2-49dc-b059-e551acccdd4a"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=30e483da-eaf1-4c73-9fed-333337f9ba86"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=787cda7d-7aa4-4909-8e5c-f2fcf68828e4"},{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=611356c6-9cf6-4316-a9cb-e7756955755b"}],"ancestors":["MONDO_0043218","MONDO_0017181","EFO_0005774","EFO_0000618","MONDO_0700057","EFO_0004264","EFO_0009386","EFO_0000319","EFO_0009550"],"label":"migraine disorder","approvedSymbol":"GABRB3","approvedName":"gamma-aminobutyric acid type A receptor subunit beta3","targetClass":["Ion channel"],"prefName":"BUTALBITAL","tradeNames":["Sandoptal"],"synonyms":["Alisobumal","Allylbarbituric acid","Butalbital","Butalbital ciii","Itobarbital","Tetrallobarbital"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL526","targetId":"ENSG00000163288","diseaseId":"MONDO_0005277","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01604785%22"}],"ancestors":["MONDO_0043218","MONDO_0017181","EFO_0005774","EFO_0000618","MONDO_0700057","EFO_0004264","EFO_0009386","EFO_0000319","EFO_0009550"],"label":"migraine disorder","approvedSymbol":"GABRB1","approvedName":"gamma-aminobutyric acid type A receptor subunit beta1","targetClass":["Ion channel"],"prefName":"PROPOFOL","tradeNames":["Diprivan","Disoprivan","Propofol","Rapinovet"],"synonyms":["Disoprofol","Fresofol","ICI 35,868","ICI 35-868","ICI-35868","ICI35,868","Lipuro","NSC-5105","Phenol, 2,6-bis(1-methylethyl)","Propofol"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL807","targetId":"ENSG00000176884","diseaseId":"MONDO_0005277","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04698525%22"}],"ancestors":["MONDO_0043218","MONDO_0017181","EFO_0005774","EFO_0000618","MONDO_0700057","EFO_0004264","EFO_0009386","EFO_0000319","EFO_0009550"],"label":"migraine disorder","approvedSymbol":"GRIN1","approvedName":"glutamate ionotropic receptor NMDA type subunit 1","targetClass":["Ion channel"],"prefName":"MEMANTINE","tradeNames":[],"synonyms":["D-145","DRG-0267","Memantine","NSC-757843","Namenda"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor negative allosteric modulator","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL831","targetId":"ENSG00000147246","diseaseId":"MONDO_0005277","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00489476%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00825500%22"}],"ancestors":["MONDO_0043218","MONDO_0017181","EFO_0005774","EFO_0000618","MONDO_0700057","EFO_0004264","EFO_0009386","EFO_0000319","EFO_0009550"],"label":"migraine disorder","approvedSymbol":"HTR2C","approvedName":"5-hydroxytryptamine receptor 2C","targetClass":["Ion channel","Membrane receptor"],"prefName":"LOXAPINE","tradeNames":["Adasuve","Loxitane intramuscular [as hydrochloride]","Loxitane-c oral suspension [as hydrochloride]"],"synonyms":["CL 62,362","CL-62362","Loxapac","Loxapine","Loxitane","SUM 3170","SUM-3170"],"drugType":"Small molecule","mechanismOfAction":"Serotonin 2c (5-HT2c) receptor antagonist","targetName":"Serotonin 2c (5-HT2c) receptor"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000022355","diseaseId":"MONDO_0005299","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01241019%22"}],"ancestors":["MONDO_0043218","EFO_0005774","EFO_0003763","EFO_0000618","MONDO_0005053","EFO_0004264","EFO_0009386","EFO_0000319"],"label":"brain ischemia","approvedSymbol":"GABRA1","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha1","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000125675","diseaseId":"MONDO_0005299","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01241019%22"}],"ancestors":["MONDO_0043218","EFO_0005774","EFO_0003763","EFO_0000618","MONDO_0005053","EFO_0004264","EFO_0009386","EFO_0000319"],"label":"brain ischemia","approvedSymbol":"GRIA3","approvedName":"glutamate ionotropic receptor AMPA type subunit 3","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"Glutamate receptor ionotropic AMPA antagonist","targetName":"Glutamate receptor ionotropic AMPA"}
{"drugId":"CHEMBL1569","targetId":"ENSG00000116032","diseaseId":"MONDO_0005301","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03567057%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03436199%22"}],"ancestors":["EFO_0005140","EFO_0005809","EFO_0005772","EFO_0000540","EFO_0005774","MONDO_0002977","MONDO_0000568","EFO_0000618","EFO_1002003","EFO_1000870","EFO_0009386","MONDO_0002562"],"label":"multiple sclerosis","approvedSymbol":"GRIN3B","approvedName":"glutamate ionotropic receptor NMDA type subunit 3B","targetClass":["Ion channel"],"prefName":"AMANTADINE HYDROCHLORIDE","tradeNames":["Amantadine hydrochloride","Gocovri","Lysovir","Mantadine","Osmolex er","Symadine","Symmetrel"],"synonyms":["Adamantanamine hydrochloride","Amantadine hcl","Amantadine hydrochloride","EXP-105-1","Mantadix","NSC-83653","Osmolex"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor antagonist","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL2107762","targetId":"ENSG00000075043","diseaseId":"MONDO_0005301","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00811902%22"}],"ancestors":["EFO_0005140","EFO_0005809","EFO_0005772","EFO_0000540","EFO_0005774","MONDO_0002977","MONDO_0000568","EFO_0000618","EFO_1002003","EFO_1000870","EFO_0009386","MONDO_0002562"],"label":"multiple sclerosis","approvedSymbol":"KCNQ2","approvedName":"potassium voltage-gated channel subfamily Q member 2","targetClass":["Ion channel"],"prefName":"NERISPIRDINE","tradeNames":[],"synonyms":["HP-184","HP184","Nerispirdine","Nerispirdine hydrochloride"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated potassium channel blocker","targetName":"Voltage-gated potassium channel"}
{"drugId":"CHEMBL3707246","targetId":"ENSG00000170989","diseaseId":"MONDO_0005301","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=93ce2fab-edfb-4804-8074-963071de51e4"},{"niceName":"FDA","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209899s000lbl.pdf"}],"ancestors":["EFO_0005140","EFO_0005809","EFO_0005772","EFO_0000540","EFO_0005774","MONDO_0002977","MONDO_0000568","EFO_0000618","EFO_1002003","EFO_1000870","EFO_0009386","MONDO_0002562"],"label":"multiple sclerosis","approvedSymbol":"S1PR1","approvedName":"sphingosine-1-phosphate receptor 1","targetClass":["Membrane receptor"],"prefName":"OZANIMOD HYDROCHLORIDE","tradeNames":["Zeposia"],"synonyms":["Ozanimod hydrochloride","RPC-1063 HCL","RPC1063 HCL"],"drugType":"Small molecule","mechanismOfAction":"Sphingosine 1-phosphate receptor Edg-1 modulator","targetName":"Sphingosine 1-phosphate receptor Edg-1"}
{"drugId":"CHEMBL973","targetId":"ENSG00000102967","diseaseId":"MONDO_0005301","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05147220%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04586023%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04586010%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04338061%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04338022%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05385744%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05156281%22"}],"ancestors":["EFO_0005140","EFO_0005809","EFO_0005772","EFO_0000540","EFO_0005774","MONDO_0002977","MONDO_0000568","EFO_0000618","EFO_1002003","EFO_1000870","EFO_0009386","MONDO_0002562"],"label":"multiple sclerosis","approvedSymbol":"DHODH","approvedName":"dihydroorotate dehydrogenase (quinone)","targetClass":["Enzyme"],"prefName":"TERIFLUNOMIDE","tradeNames":["Aubagio"],"synonyms":["A77 1726","HMR-1726","HMR1726","Leflunomide related compound b","Leflunomide related compound b rs","Teriflunomide"],"drugType":"Small molecule","mechanismOfAction":"Dihydroorotate dehydrogenase inhibitor","targetName":"Dihydroorotate dehydrogenase"}
{"drugId":"CHEMBL973","targetId":"ENSG00000102967","diseaseId":"MONDO_0005301","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02587195%22"}],"ancestors":["EFO_0005140","EFO_0005809","EFO_0005772","EFO_0000540","EFO_0005774","MONDO_0002977","MONDO_0000568","EFO_0000618","EFO_1002003","EFO_1000870","EFO_0009386","MONDO_0002562"],"label":"multiple sclerosis","approvedSymbol":"DHODH","approvedName":"dihydroorotate dehydrogenase (quinone)","targetClass":["Enzyme"],"prefName":"TERIFLUNOMIDE","tradeNames":["Aubagio"],"synonyms":["A77 1726","HMR-1726","HMR1726","Leflunomide related compound b","Leflunomide related compound b rs","Teriflunomide"],"drugType":"Small molecule","mechanismOfAction":"Dihydroorotate dehydrogenase inhibitor","targetName":"Dihydroorotate dehydrogenase"}
{"drugId":"CHEMBL2362016","targetId":"ENSG00000198431","diseaseId":"MONDO_0005341","phase":0,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02699723%22"}],"ancestors":["EFO_0004193","MONDO_0002532","EFO_0010176","MONDO_0002898","MONDO_0000653","EFO_0009259","MONDO_0023370","MONDO_0045024","EFO_0009260","MONDO_0004992","EFO_0004198","EFO_0000313","EFO_0000701","MONDO_0021634","EFO_0000707","MONDO_0002529","EFO_0010285","EFO_0006858","EFO_0000616","EFO_1001763"],"label":"skin basal cell carcinoma","approvedSymbol":"TXNRD1","approvedName":"thioredoxin reductase 1","targetClass":["Enzyme"],"prefName":"ARSENIC TRIOXIDE","tradeNames":["Trisenox"],"synonyms":["Arseneous anhydride","Arseneous oxide","Arsenic oxide","Arsenic oxide (as4o6)","Arsenic sesquioxide","Arsenic trioxide","Arsenicum album","Arsenous oxide","Diarsenic trioxide","NSC-759274","NSC-92859","Tetraarsenic hexaoxide","White arsenic"],"drugType":"Small molecule","mechanismOfAction":"Thioredoxin reductase 1 inhibitor","targetName":"Thioredoxin reductase 1"}
{"drugId":"CHEMBL1637","targetId":"ENSG00000106628","diseaseId":"MONDO_0005411","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02392637%22"}],"ancestors":["OTAR_0000018","EFO_0009534","MONDO_0023370","MONDO_0015509","MONDO_0045024","MONDO_0004992","EFO_0008550","EFO_0004606","EFO_0003832","EFO_0001379","EFO_0001421","EFO_0008549","EFO_0000508","MONDO_0002516","EFO_0010284","EFO_0010282","EFO_0000616"],"label":"gallbladder cancer","approvedSymbol":"POLD2","approvedName":"DNA polymerase delta 2, accessory subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE HYDROCHLORIDE","tradeNames":["Gemcitabine hydrochloride","Gemzar","Infugem"],"synonyms":["Gemcitabine (as hydrochloride)","Gemcitabine hcl","Gemcitabine hydrochloride","Gemzar","LY-188011","LY-188011 HYDROCHLORIDE","LY188011 HYDROCHLORIDE"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL220492","targetId":"ENSG00000022355","diseaseId":"MONDO_0007079","phase":4,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03018704%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","MONDO_0004938","EFO_0000618","MONDO_0021698","EFO_0003890","MONDO_0002494","EFO_0009386"],"label":"alcohol dependence","approvedSymbol":"GABRA1","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha1","targetClass":["Ion channel"],"prefName":"TOPIRAMATE","tradeNames":["Epitomax","Qudexy xr","Topamax","Topamax sprinkle","Topiramate","Trokendi xr"],"synonyms":["(-)-topiramate","Epitoma","MCN-4853","Qudexy","RWJ-17021","RWJ-17021-000","Sincronil","Topamac","Topimax","Topina","Topiramate","Topomax","USL-255","USL255"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL514800","targetId":"ENSG00000105650","diseaseId":"MONDO_0007079","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03175549%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","MONDO_0004938","EFO_0000618","MONDO_0021698","EFO_0003890","MONDO_0002494","EFO_0009386"],"label":"alcohol dependence","approvedSymbol":"PDE4C","approvedName":"phosphodiesterase 4C","targetClass":["Enzyme"],"prefName":"APREMILAST","tradeNames":["Otezla"],"synonyms":["Apremilast","CC-10004","CC10004"],"drugType":"Small molecule","mechanismOfAction":"Phosphodiesterase 4 inhibitor","targetName":"Phosphodiesterase 4"}
{"drugId":"CHEMBL741","targetId":"ENSG00000136546","diseaseId":"MONDO_0007079","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04770493%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","MONDO_0004938","EFO_0000618","MONDO_0021698","EFO_0003890","MONDO_0002494","EFO_0009386"],"label":"alcohol dependence","approvedSymbol":"SCN7A","approvedName":"sodium voltage-gated channel alpha subunit 7","targetClass":["Ion channel"],"prefName":"LAMOTRIGINE","tradeNames":["Lamictal","Lamictal cd","Lamictal odt","Lamictal xr","Lamotrigine"],"synonyms":["BW 430C","BW-430C","Lamotrigine","NSC-759171"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL742","targetId":"ENSG00000176884","diseaseId":"MONDO_0007079","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02649231%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","MONDO_0004938","EFO_0000618","MONDO_0021698","EFO_0003890","MONDO_0002494","EFO_0009386"],"label":"alcohol dependence","approvedSymbol":"GRIN1","approvedName":"glutamate ionotropic receptor NMDA type subunit 1","targetClass":["Ion channel"],"prefName":"KETAMINE","tradeNames":["Ketalar"],"synonyms":["Anaket v","Calypsol","Clorketam 1000","Dl-ketamine","Imalgene 1000","Ketamine","Ketasol 100","NSC-70151","Narketan","PMI-150","Tekam","Ursotamin","Vetaket"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor negative allosteric modulator","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL742","targetId":"ENSG00000273079","diseaseId":"MONDO_0007079","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02649231%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","MONDO_0004938","EFO_0000618","MONDO_0021698","EFO_0003890","MONDO_0002494","EFO_0009386"],"label":"alcohol dependence","approvedSymbol":"GRIN2B","approvedName":"glutamate ionotropic receptor NMDA type subunit 2B","targetClass":["Ion channel"],"prefName":"KETAMINE","tradeNames":["Ketalar"],"synonyms":["Anaket v","Calypsol","Clorketam 1000","Dl-ketamine","Imalgene 1000","Ketamine","Ketasol 100","NSC-70151","Narketan","PMI-150","Tekam","Ursotamin","Vetaket"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor negative allosteric modulator","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL750","targetId":"ENSG00000136546","diseaseId":"MONDO_0007079","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00406692%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","MONDO_0004938","EFO_0000618","MONDO_0021698","EFO_0003890","MONDO_0002494","EFO_0009386"],"label":"alcohol dependence","approvedSymbol":"SCN7A","approvedName":"sodium voltage-gated channel alpha subunit 7","targetClass":["Ion channel"],"prefName":"ZONISAMIDE","tradeNames":["Zonegran","Zonisamide"],"synonyms":["AD-810","CI-912","Excegran","N03AX15","PD-110843","Zonisamide"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL982","targetId":"ENSG00000116329","diseaseId":"MONDO_0007079","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03034408%22"}],"ancestors":["EFO_0000677","MONDO_0002025","EFO_0005774","MONDO_0004938","EFO_0000618","MONDO_0021698","EFO_0003890","MONDO_0002494","EFO_0009386"],"label":"alcohol dependence","approvedSymbol":"OPRD1","approvedName":"opioid receptor delta 1","targetClass":["Membrane receptor"],"prefName":"NALMEFENE","tradeNames":["Selincro"],"synonyms":["JF-1","JKB-121","Nalmefene","Nalmefene hydrochloride hydrate","Nalmetrene","ORF 1167","ORF 11676","ORF-1167","ORF-11676","Revex","SRD-174","SRD174"],"drugType":"Small molecule","mechanismOfAction":"Opioid receptors; mu/kappa/delta antagonist","targetName":"Opioid receptors; mu/kappa/delta"}
{"drugId":"CHEMBL1200485","targetId":"ENSG00000122025","diseaseId":"MONDO_0007254","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00828074%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00217399%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"FLT3","approvedName":"fms related receptor tyrosine kinase 3","targetClass":["Enzyme"],"prefName":"SORAFENIB TOSYLATE","tradeNames":["Nexavar"],"synonyms":["BAY 54-9085","BAY-54-9085","Sorafenib tosilate","Sorafenib tosylate"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase receptor FLT3 inhibitor","targetName":"Tyrosine-protein kinase receptor FLT3"}
{"drugId":"CHEMBL1201179","targetId":"ENSG00000146648","diseaseId":"MONDO_0007254","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00544804%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00379509%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00316875%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01172223%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00753207%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00085020%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"EGFR","approvedName":"epidermal growth factor receptor","targetClass":["Enzyme"],"prefName":"LAPATINIB DITOSYLATE","tradeNames":["Tykerb"],"synonyms":["GW-572016F","GW572016F","Lapatinib","Lapatinib ditoluenesulfonate monohydrate","Lapatinib ditosylate","Lapatinib ditosylate monohydrate","Lapatinib tosilate","Lapatinib tosilate hydrate","Tycerb"],"drugType":"Small molecule","mechanismOfAction":"Epidermal growth factor receptor erbB1 inhibitor","targetName":"Epidermal growth factor receptor erbB1"}
{"drugId":"CHEMBL1201179","targetId":"ENSG00000141736","diseaseId":"MONDO_0007254","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00482391%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00967031%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00820872%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00769470%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01688609%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00436566%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"ERBB2","approvedName":"erb-b2 receptor tyrosine kinase 2","targetClass":["Enzyme"],"prefName":"LAPATINIB DITOSYLATE","tradeNames":["Tykerb"],"synonyms":["GW-572016F","GW572016F","Lapatinib","Lapatinib ditoluenesulfonate monohydrate","Lapatinib ditosylate","Lapatinib ditosylate monohydrate","Lapatinib tosilate","Lapatinib tosilate hydrate","Tycerb"],"drugType":"Small molecule","mechanismOfAction":"Receptor protein-tyrosine kinase erbB-2 inhibitor","targetName":"Receptor protein-tyrosine kinase erbB-2"}
{"drugId":"CHEMBL1201438","targetId":"ENSG00000100385","diseaseId":"MONDO_0007254","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00008203%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"IL2RB","approvedName":"interleukin 2 receptor subunit beta","targetClass":["Membrane receptor"],"prefName":"ALDESLEUKIN","tradeNames":["Proleukin"],"synonyms":["Aldesleukin","Human interleukin-2","Human interleukin-2 125-serine","ILT-101","Ilt-101","Ilt-101 (low dose il-2)","Interleukin 2","Interleukin-2","Interleukin-2 aldesleukin","Interleukin-2(2-133),125-ser","Recombinant interleukin-2 human"],"drugType":"Protein","mechanismOfAction":"Interleukin-2 receptor agonist","targetName":"Interleukin-2 receptor"}
{"drugId":"CHEMBL1336","targetId":"ENSG00000037280","diseaseId":"MONDO_0007254","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00954135%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"FLT4","approvedName":"fms related receptor tyrosine kinase 4","targetClass":["Enzyme"],"prefName":"SORAFENIB","tradeNames":["Nexavar"],"synonyms":["BAY 43-9006","BAY-43-9006","Sorafenib"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000090266","diseaseId":"MONDO_0007254","phase":3,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01101438%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"NDUFB2","approvedName":"NADH:ubiquinone oxidoreductase subunit B2","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1655","targetId":"ENSG00000140009","diseaseId":"MONDO_0007254","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02506790%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02132000%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"ESR2","approvedName":"estrogen receptor 2","targetClass":["Transcription factor"],"prefName":"TOREMIFENE","tradeNames":[],"synonyms":["Acapodene","Chlortamoxifen","Farestone","GTX-006","J33.157K","Toremifene","Toremiphene"],"drugType":"Small molecule","mechanismOfAction":"Estrogen receptor modulator","targetName":"Estrogen receptor"}
{"drugId":"CHEMBL1743082","targetId":"ENSG00000196230","diseaseId":"MONDO_0007254","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04733118%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04675827%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"TUBB","approvedName":"tubulin beta class I","targetClass":["Structural protein"],"prefName":"TRASTUZUMAB EMTANSINE","tradeNames":[],"synonyms":["Ado-trastuzumab emtansine","PRO-132365","RG-3502","TRASTUZUMAB-MCC-DM1 T-DM1","Trastuzumab emtansine"],"drugType":"Antibody","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1773","targetId":"ENSG00000176890","diseaseId":"MONDO_0007254","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=03dd3301-e9ce-40af-84e1-7b70fc6557b0"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"TYMS","approvedName":"thymidylate synthetase","targetClass":["Enzyme"],"prefName":"CAPECITABINE","tradeNames":["Capecitabine","Xeloda"],"synonyms":["Capecitabine","Capecitabine accord","Capecitabine medac","Capecitabine sun","Capecitabine teva","Capecitibine","Capecytabine","Capiibine","Captabin","Ecansya","NSC-759853","RO 09-1978/000","RO-09-1978000","RO-091978000","Xeloda"],"drugType":"Small molecule","mechanismOfAction":"Thymidylate synthase inhibitor","targetName":"Thymidylate synthase"}
{"drugId":"CHEMBL2007641","targetId":"ENSG00000141736","diseaseId":"MONDO_0007254","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05036005%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05420454%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05420467%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"ERBB2","approvedName":"erb-b2 receptor tyrosine kinase 2","targetClass":["Enzyme"],"prefName":"PERTUZUMAB","tradeNames":["Omnitarg","Omnitarg Perjeta","Perjeta"],"synonyms":["Pertuzumab","Pertuzumab-zzxf","RG-1273","RHUMAB 2C4","RHUMAB-2C4"],"drugType":"Antibody","mechanismOfAction":"Receptor protein-tyrosine kinase erbB-2 inhibitor","targetName":"Receptor protein-tyrosine kinase erbB-2"}
{"drugId":"CHEMBL2336325","targetId":"ENSG00000198793","diseaseId":"MONDO_0007254","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02299999%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"MTOR","approvedName":"mechanistic target of rapamycin kinase","targetClass":["Enzyme","Other cytosolic protein"],"prefName":"VISTUSERTIB","tradeNames":[],"synonyms":["AZD-2014","AZD2014","Azd-2014","Vistusertib"],"drugType":"Small molecule","mechanismOfAction":"Serine/threonine-protein kinase mTOR inhibitor","targetName":"Serine/threonine-protein kinase mTOR"}
{"drugId":"CHEMBL27759","targetId":"ENSG00000116478","diseaseId":"MONDO_0007254","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02115594%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"HDAC1","approvedName":"histone deacetylase 1","targetClass":["Epigenetic regulator"],"prefName":"ENTINOSTAT","tradeNames":[],"synonyms":["Entinostat","MS-27-275","MS-275","MS-275-27","SNDX-275"],"drugType":"Small molecule","mechanismOfAction":"Histone deacetylase inhibitor","targetName":"Histone deacetylase"}
{"drugId":"CHEMBL3545110","targetId":"ENSG00000105810","diseaseId":"MONDO_0007254","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03096847%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"CDK6","approvedName":"cyclin dependent kinase 6","targetClass":["Enzyme"],"prefName":"RIBOCICLIB","tradeNames":[],"synonyms":["LEE-011","LEE-011A","LEE011","LEE011A","Lee-011","NVP-LEE011","Ribociclib"],"drugType":"Small molecule","mechanismOfAction":"Cyclin-dependent kinase 6 inhibitor","targetName":"Cyclin-dependent kinase 6"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000258947","diseaseId":"MONDO_0007254","phase":1,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04367090%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00600496%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000176014","diseaseId":"MONDO_0007254","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01876251%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02379585%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00584012%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00531271%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00253318%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02345772%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00864175%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"TUBB6","approvedName":"tubulin beta 6 class V","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000261456","diseaseId":"MONDO_0007254","phase":1,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00074139%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"TUBB8","approvedName":"tubulin beta 8 class VIII","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000188229","diseaseId":"MONDO_0007254","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00408408%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00493870%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01479036%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003679%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00629278%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01354522%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00430001%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00010140%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02393833%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00532727%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01222052%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01622361%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00944424%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02514681%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01642771%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"TUBB4B","approvedName":"tubulin beta 4B class IVb","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL359744","targetId":"ENSG00000131747","diseaseId":"MONDO_0007254","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02393833%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00408408%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00516425%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02214381%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003679%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00629278%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00294996%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"TOP2A","approvedName":"DNA topoisomerase II alpha","targetClass":["Enzyme"],"prefName":"DOXORUBICIN HYDROCHLORIDE","tradeNames":["Adriamycin","Adriamycin Rdf","Adriamycin pfs","Caelyx","Doxil","Doxil (liposomal)","Doxorubicin hydrochloride","Doxorubicin hydrochloride (liposomal)","Myocet","Rubex"],"synonyms":["Adriablastina cs","Adriamycin, hydrochloride","Doxorubicin HCl","Doxorubicin citrate","Doxorubicin citric acid salt","Doxorubicin hcl","Doxorubicin hydrochloride","Doxorubicin liposomal complex of the hydrochloride","Doxorubicini hydrochloridum","Hydroxydaunomycin hydrochloride","Liposomal doxorubicin hydrochloride"],"drugType":"Small molecule","mechanismOfAction":"DNA topoisomerase II alpha inhibitor","targetName":"DNA topoisomerase II alpha"}
{"drugId":"CHEMBL521686","targetId":"ENSG00000041880","diseaseId":"MONDO_0007254","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03742245%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"PARP3","approvedName":"poly(ADP-ribose) polymerase family member 3","targetClass":["Enzyme"],"prefName":"OLAPARIB","tradeNames":["Lynparza"],"synonyms":["AZ-2281","AZ2281","AZD-2281","AZD2281","KEYLYNK-010 COMPONENT OLAPARIB","KU-0059436","KU-59436","NSC-747856","OLAPARIB COMPONENT OF KEYLYNK-010","Olaparib"],"drugType":"Small molecule","mechanismOfAction":"PARP 1, 2 and 3 inhibitor","targetName":"PARP 1, 2 and 3"}
{"drugId":"CHEMBL535","targetId":"ENSG00000102755","diseaseId":"MONDO_0007254","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02790580%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"FLT1","approvedName":"fms related receptor tyrosine kinase 1","targetClass":["Enzyme"],"prefName":"SUNITINIB","tradeNames":["Sutent"],"synonyms":["NSC-736511","NSC-750690","SU-011248","SU-11248","SU011248","Sunitinib","Sutent"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL553025","targetId":"ENSG00000101162","diseaseId":"MONDO_0007254","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02555657%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00776724%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02574455%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01007942%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00103233%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00868634%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02225470%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00146549%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00431106%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"VINORELBINE","tradeNames":[],"synonyms":["NSC-760087","Navelbin","Vinorelbine","Vinorelbine Base"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL888","targetId":"ENSG00000014138","diseaseId":"MONDO_0007254","phase":2,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04517292%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04739670%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05263882%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04143906%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"POLA2","approvedName":"DNA polymerase alpha 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL888","targetId":"ENSG00000148229","diseaseId":"MONDO_0007254","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01352494%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03423849%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00027989%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03025880%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02544243%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01815242%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"POLE3","approvedName":"DNA polymerase epsilon 3, accessory subunit","targetClass":["Unclassified protein"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL92","targetId":"ENSG00000196230","diseaseId":"MONDO_0007254","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00268918%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00705315%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00129896%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00450892%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00086957%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02834403%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00322400%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00169000%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05301530%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002901%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00372424%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01256567%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00645333%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00066443%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00934856%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00020332%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00080665%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02392845%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02027376%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02605915%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01044485%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01862081%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00050167%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00637897%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003103%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00872625%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"TUBB","approvedName":"tubulin beta class I","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":[],"synonyms":["RP-56976","Taxotere"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL92","targetId":"ENSG00000261456","diseaseId":"MONDO_0007254","phase":3,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04024462%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01547741%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01358877%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03493854%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03588091%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00433589%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"TUBB8","approvedName":"tubulin beta 8 class VIII","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":[],"synonyms":["RP-56976","Taxotere"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL92","targetId":"ENSG00000101162","diseaseId":"MONDO_0007254","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04193059%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04540692%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01646034%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05296798%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05159193%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03989037%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05474690%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03671044%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02344472%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04547907%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03949634%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04400695%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03264547%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03926091%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03863223%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":[],"synonyms":["RP-56976","Taxotere"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL940","targetId":"ENSG00000153956","diseaseId":"MONDO_0007254","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03084536%22"}],"ancestors":["EFO_0003869","OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0010285","EFO_0009483","MONDO_0003274","EFO_0000616"],"label":"breast cancer","approvedSymbol":"CACNA2D1","approvedName":"calcium voltage-gated channel auxiliary subunit alpha2delta 1","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"GABAPENTIN","tradeNames":["Gabapentin","Gralise","Neurontin"],"synonyms":["CI-945","DM-1796","GOE 3450","GOE-3450","Gabapentin","NSC-742194","NSC-759254"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated calcium channel modulator","targetName":"Voltage-gated calcium channel"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000258947","diseaseId":"MONDO_0007576","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01704690%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00570531%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00493025%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01372202%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00006472%22"}],"ancestors":["EFO_0009544","MONDO_0021350","MONDO_0023370","MONDO_0021355","EFO_0008549","MONDO_0002516","MONDO_0044991","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0010282","EFO_0000616"],"label":"esophageal cancer","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000168653","diseaseId":"MONDO_0007915","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02741960%22"}],"ancestors":["EFO_0005140","OTAR_0000006","EFO_0009676","EFO_0009314","EFO_0009690","MONDO_0004670","EFO_0002461","EFO_0003086","MONDO_0019737","MONDO_0019724","EFO_0005809","EFO_0000540","EFO_0005755","EFO_1001986","EFO_0005803","EFO_1002003","EFO_1002049"],"label":"systemic lupus erythematosus","approvedSymbol":"NDUFS5","approvedName":"NADH:ubiquinone oxidoreductase subunit S5","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL221959","targetId":"ENSG00000096968","diseaseId":"MONDO_0007915","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02535689%22"}],"ancestors":["EFO_0005140","OTAR_0000006","EFO_0009676","EFO_0009314","EFO_0009690","MONDO_0004670","EFO_0002461","EFO_0003086","MONDO_0019737","MONDO_0019724","EFO_0005809","EFO_0000540","EFO_0005755","EFO_1001986","EFO_0005803","EFO_1002003","EFO_1002049"],"label":"systemic lupus erythematosus","approvedSymbol":"JAK2","approvedName":"Janus kinase 2","targetClass":["Enzyme","Other cytosolic protein"],"prefName":"TOFACITINIB","tradeNames":[],"synonyms":["550","CP 690550","CP- 690 550","CP-690","CP-690,550","CP-690,550 FREE BASE","CP-690-550","CP-690550","CP-690550 FREE BASE","CP690,550","CP690550","Cp-690 free base","Tasocitinib","Tofacitinib"],"drugType":"Small molecule","mechanismOfAction":"Janus Kinase (JAK) inhibitor","targetName":"Janus Kinase (JAK)"}
{"drugId":"CHEMBL101253","targetId":"ENSG00000037280","diseaseId":"MONDO_0008170","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00268918%22"}],"ancestors":["OTAR_0000017","EFO_0005771","MONDO_0002259","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0003893","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0001379","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"ovarian cancer","approvedSymbol":"FLT4","approvedName":"fms related receptor tyrosine kinase 4","targetClass":["Enzyme"],"prefName":"VATALANIB","tradeNames":[],"synonyms":["BAY-86-5127","CGP-79787","K-222584","NVP-PTK787","PTK-787","PTK787","Ptk-787","Vatalanib","Vatalanib succinate","ZK-222584","ZK222584"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000100479","diseaseId":"MONDO_0008170","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03335241%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03412526%22"}],"ancestors":["OTAR_0000017","EFO_0005771","MONDO_0002259","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0003893","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0001379","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"ovarian cancer","approvedSymbol":"POLE2","approvedName":"DNA polymerase epsilon 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1199324","targetId":"ENSG00000115353","diseaseId":"MONDO_0008170","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01432015%22"}],"ancestors":["OTAR_0000017","EFO_0005771","MONDO_0002259","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0003893","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0001379","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"ovarian cancer","approvedSymbol":"TACR1","approvedName":"tachykinin receptor 1","targetClass":["Membrane receptor"],"prefName":"FOSAPREPITANT","tradeNames":["Ivemend"],"synonyms":["Fosaprepitant","L-758298"],"drugType":"Small molecule","mechanismOfAction":"Neurokinin 1 receptor antagonist","targetName":"Neurokinin 1 receptor"}
{"drugId":"CHEMBL1201748","targetId":"ENSG00000137267","diseaseId":"MONDO_0008170","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01747239%22"}],"ancestors":["OTAR_0000017","EFO_0005771","MONDO_0002259","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0003893","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0001379","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"ovarian cancer","approvedSymbol":"TUBB2A","approvedName":"tubulin beta 2A class IIa","targetClass":["Structural protein"],"prefName":"CABAZITAXEL","tradeNames":["Jevtana","Jevtana kit"],"synonyms":["Cabazitaxel","Cabazitaxel acetonate","Jevtana","NSC-761432","TXD 258","TXD-258","XRP 6258","XRP-6258"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1201752","targetId":"ENSG00000101162","diseaseId":"MONDO_0008170","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03093155%22"}],"ancestors":["OTAR_0000017","EFO_0005771","MONDO_0002259","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0003893","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0001379","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"ovarian cancer","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"IXABEPILONE","tradeNames":["Ixempra","Ixempra kit"],"synonyms":["Azaepothilone b","BMS 247550-01","BMS-247550","BMS-247550-01","Ixabepilone","Ixempra","NSC-747973"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198763","diseaseId":"MONDO_0008170","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02312661%22"}],"ancestors":["OTAR_0000017","EFO_0005771","MONDO_0002259","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0003893","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0001379","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"ovarian cancer","approvedSymbol":"MT-ND2","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1444","targetId":"ENSG00000137869","diseaseId":"MONDO_0008170","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00634894%22"}],"ancestors":["OTAR_0000017","EFO_0005771","MONDO_0002259","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0003893","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0001379","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"ovarian cancer","approvedSymbol":"CYP19A1","approvedName":"cytochrome P450 family 19 subfamily A member 1","targetClass":["Enzyme"],"prefName":"LETROZOLE","tradeNames":["Femara","Letrozole"],"synonyms":["CGS 20267","CGS-20267","Letrozole","NSC-759652"],"drugType":"Small molecule","mechanismOfAction":"Cytochrome P450 19A1 inhibitor","targetName":"Cytochrome P450 19A1"}
{"drugId":"CHEMBL1637","targetId":"ENSG00000014138","diseaseId":"MONDO_0008170","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9dc35c59-f4f3-43b4-8251-0cf5c06cdc80"}],"ancestors":["OTAR_0000017","EFO_0005771","MONDO_0002259","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0003893","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0001379","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"ovarian cancer","approvedSymbol":"POLA2","approvedName":"DNA polymerase alpha 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"GEMCITABINE HYDROCHLORIDE","tradeNames":["Gemcitabine hydrochloride","Gemzar","Infugem"],"synonyms":["Gemcitabine (as hydrochloride)","Gemcitabine hcl","Gemcitabine hydrochloride","Gemzar","LY-188011","LY-188011 HYDROCHLORIDE","LY188011 HYDROCHLORIDE"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1946170","targetId":"ENSG00000142627","diseaseId":"MONDO_0008170","phase":2,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05113368%22"}],"ancestors":["OTAR_0000017","EFO_0005771","MONDO_0002259","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0003893","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0001379","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"ovarian cancer","approvedSymbol":"EPHA2","approvedName":"EPH receptor A2","targetClass":["Enzyme"],"prefName":"REGORAFENIB","tradeNames":["Stivarga"],"synonyms":["BAY 73-4506","BAY 73-4506 monohydrate","BAY-73-4506","BAY-734506","Regorafenib"],"drugType":"Small molecule","mechanismOfAction":"Ephrin type-A receptor 2","targetName":"Ephrin type-A receptor 2"}
{"drugId":"CHEMBL1946170","targetId":"ENSG00000111816","diseaseId":"MONDO_0008170","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02278783%22"}],"ancestors":["OTAR_0000017","EFO_0005771","MONDO_0002259","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0003893","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0001379","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"ovarian cancer","approvedSymbol":"FRK","approvedName":"fyn related Src family tyrosine kinase","targetClass":["Enzyme"],"prefName":"REGORAFENIB","tradeNames":["Stivarga"],"synonyms":["BAY 73-4506","BAY 73-4506 monohydrate","BAY-73-4506","BAY-734506","Regorafenib"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase FRK inhibitor","targetName":"Tyrosine-protein kinase FRK"}
{"drugId":"CHEMBL2108581","targetId":"ENSG00000198851","diseaseId":"MONDO_0008170","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01815528%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00377429%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00189345%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00563836%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01246440%22"}],"ancestors":["OTAR_0000017","EFO_0005771","MONDO_0002259","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0003893","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0001379","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"ovarian cancer","approvedSymbol":"CD3E","approvedName":"CD3 epsilon subunit of T-cell receptor complex","targetClass":["Membrane receptor"],"prefName":"CATUMAXOMAB","tradeNames":["Removab"],"synonyms":["Catumaxomab"],"drugType":"Antibody","mechanismOfAction":"T cell surface glycoprotein CD3 cross-linking agent","targetName":"T cell surface glycoprotein CD3"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000104833","diseaseId":"MONDO_0008170","phase":2,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05325229%22"}],"ancestors":["OTAR_0000017","EFO_0005771","MONDO_0002259","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0003893","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0001379","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"ovarian cancer","approvedSymbol":"TUBB4A","approvedName":"tubulin beta 4A class IVa","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000101162","diseaseId":"MONDO_0008170","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00702299%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00825201%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00001383%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01219777%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01649336%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01253681%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01653912%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02121990%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03394885%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02312661%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002734%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00889382%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00005046%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01778803%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00091377%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00228319%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02483104%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00750386%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00672295%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003385%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02092363%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01954355%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00005026%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01711970%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00550784%22"}],"ancestors":["OTAR_0000017","EFO_0005771","MONDO_0002259","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0003893","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0001379","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"ovarian cancer","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL502835","targetId":"ENSG00000128052","diseaseId":"MONDO_0008170","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01485874%22"}],"ancestors":["OTAR_0000017","EFO_0005771","MONDO_0002259","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0003893","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0001379","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"ovarian cancer","approvedSymbol":"KDR","approvedName":"kinase insert domain receptor","targetClass":["Enzyme"],"prefName":"NINTEDANIB","tradeNames":["Ofev","Vargatef"],"synonyms":["BIBF 1120","BIBF-1120","BIBF1120","Bibf-1120","Intedanib","Nintedanib"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL888","targetId":"ENSG00000146143","diseaseId":"MONDO_0008170","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04679064%22"}],"ancestors":["OTAR_0000017","EFO_0005771","MONDO_0002259","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0003893","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0001379","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"ovarian cancer","approvedSymbol":"PRIM2","approvedName":"DNA primase subunit 2","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL92","targetId":"ENSG00000261456","diseaseId":"MONDO_0008170","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003998%22"}],"ancestors":["OTAR_0000017","EFO_0005771","MONDO_0002259","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0003893","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0001379","EFO_0009549","EFO_1001331","EFO_0000616"],"label":"ovarian cancer","approvedSymbol":"TUBB8","approvedName":"tubulin beta 8 class VIII","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":[],"synonyms":["RP-56976","Taxotere"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1201101","targetId":"ENSG00000169083","diseaseId":"MONDO_0008315","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04424654%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02090114%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01750398%22"}],"ancestors":["OTAR_0000017","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","EFO_0000512","EFO_0000616"],"label":"prostate cancer","approvedSymbol":"AR","approvedName":"androgen receptor","targetClass":["Transcription factor","Unclassified protein"],"prefName":"TESTOSTERONE CYPIONATE","tradeNames":["Andro-Cyp","Depandro","Depo-testosterone","Depotest","Testosterone","Testosterone cypionate"],"synonyms":["Depo-Testadiol","NSC-9157","Testosterone 17.beta.-cyclopentanepropionate","Testosterone cipionate","Testosterone cyclopentylpropionate","Testosterone cypionate","Testosterone cypionate ciii"],"drugType":"Small molecule","mechanismOfAction":"Androgen Receptor agonist","targetName":"Androgen Receptor"}
{"drugId":"CHEMBL1201748","targetId":"ENSG00000137267","diseaseId":"MONDO_0008315","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02485691%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02074137%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01649635%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02441894%22"}],"ancestors":["OTAR_0000017","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","EFO_0000512","EFO_0000616"],"label":"prostate cancer","approvedSymbol":"TUBB2A","approvedName":"tubulin beta 2A class IIa","targetClass":["Structural protein"],"prefName":"CABAZITAXEL","tradeNames":["Jevtana","Jevtana kit"],"synonyms":["Cabazitaxel","Cabazitaxel acetonate","Jevtana","NSC-761432","TXD 258","TXD-258","XRP 6258","XRP-6258"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1237024","targetId":"ENSG00000014257","diseaseId":"MONDO_0008315","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8309b497-5d4e-4408-ac0c-2452c11c8a35"}],"ancestors":["OTAR_0000017","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","EFO_0000512","EFO_0000616"],"label":"prostate cancer","approvedSymbol":"ACP3","approvedName":"acid phosphatase 3","targetClass":["Enzyme"],"prefName":"SIPULEUCEL-T","tradeNames":["Provenge"],"synonyms":["APC-8015","APC8015","Sipuleucel-t"],"drugType":"Cell","mechanismOfAction":"Prostatic acid phosphatase binding agent","targetName":"Prostatic acid phosphatase"}
{"drugId":"CHEMBL1421","targetId":"ENSG00000101336","diseaseId":"MONDO_0008315","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00918385%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00860158%22"}],"ancestors":["OTAR_0000017","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","EFO_0000512","EFO_0000616"],"label":"prostate cancer","approvedSymbol":"HCK","approvedName":"HCK proto-oncogene, Src family tyrosine kinase","targetClass":["Enzyme"],"prefName":"DASATINIB","tradeNames":["Dasatinib","Sprycel"],"synonyms":["BMS-354825","BMS-354825 HYDRATE","BMS-354825-03","Dasatinib","Dasatinib anhydrous","Dasatinib hydrate","Dasatinib monohydrate","NSC-759877"],"drugType":"Small molecule","mechanismOfAction":"SRC inhibitor","targetName":"SRC"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000145494","diseaseId":"MONDO_0008315","phase":1,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02339168%22"}],"ancestors":["OTAR_0000017","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","EFO_0000512","EFO_0000616"],"label":"prostate cancer","approvedSymbol":"NDUFS6","approvedName":"NADH:ubiquinone oxidoreductase subunit S6","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1655","targetId":"ENSG00000140009","diseaseId":"MONDO_0008315","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00020735%22"}],"ancestors":["OTAR_0000017","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","EFO_0000512","EFO_0000616"],"label":"prostate cancer","approvedSymbol":"ESR2","approvedName":"estrogen receptor 2","targetClass":["Transcription factor"],"prefName":"TOREMIFENE","tradeNames":[],"synonyms":["Acapodene","Chlortamoxifen","Farestone","GTX-006","J33.157K","Toremifene","Toremiphene"],"drugType":"Small molecule","mechanismOfAction":"Estrogen receptor modulator","targetName":"Estrogen receptor"}
{"drugId":"CHEMBL1703","targetId":"ENSG00000168653","diseaseId":"MONDO_0008315","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02176161%22"}],"ancestors":["OTAR_0000017","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","EFO_0000512","EFO_0000616"],"label":"prostate cancer","approvedSymbol":"NDUFS5","approvedName":"NADH:ubiquinone oxidoreductase subunit S5","targetClass":["Enzyme"],"prefName":"METFORMIN HYDROCHLORIDE","tradeNames":["Bolamyn sr","Diagemet xl","Fortamet","Glucamet 500","Glucamet 850","Glucient sr","Glucophage","Glucophage sr","Glucophage xr","Glumetza","Glyformin","Janumet","Ledermetin","Metabet sr","Metformin hydrochloride","Metsol","Milform","Orabet","Riomet","Riomet er","Sukkarto sr"],"synonyms":["Apophage","Benofomin","Diabefagos","Diabex","EX-404","EX404","Glucaminol","LA-6023","Metformin hcl","Metformin hydrochloride","NSC-91485","Neodipa","Siamformet","Walaphage"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL24828","targetId":"ENSG00000037280","diseaseId":"MONDO_0008315","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00686036%22"}],"ancestors":["OTAR_0000017","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","EFO_0000512","EFO_0000616"],"label":"prostate cancer","approvedSymbol":"FLT4","approvedName":"fms related receptor tyrosine kinase 4","targetClass":["Enzyme"],"prefName":"VANDETANIB","tradeNames":["Caprelsa","Zactima"],"synonyms":["GNF-PF-2188","NSC-744325","NSC-760766","Vandetanib","ZD-64","ZD-6474","ZD6474"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL402548","targetId":"ENSG00000178999","diseaseId":"MONDO_0008315","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00766324%22"}],"ancestors":["OTAR_0000017","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","EFO_0000512","EFO_0000616"],"label":"prostate cancer","approvedSymbol":"AURKB","approvedName":"aurora kinase B","targetClass":["Other nuclear protein","Enzyme"],"prefName":"DANUSERTIB","tradeNames":[],"synonyms":["Danusertib","PHA-739358","Pha-739358"],"drugType":"Small molecule","mechanismOfAction":"Serine/threonine-protein kinase Aurora inhibitor","targetName":"Serine/threonine-protein kinase Aurora"}
{"drugId":"CHEMBL4112930","targetId":"ENSG00000143799","diseaseId":"MONDO_0008315","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05327621%22"}],"ancestors":["OTAR_0000017","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","EFO_0000512","EFO_0000616"],"label":"prostate cancer","approvedSymbol":"PARP1","approvedName":"poly(ADP-ribose) polymerase 1","targetClass":["Enzyme"],"prefName":"PAMIPARIB","tradeNames":[],"synonyms":["BGB-290","Bgb-290","Pamiparib"],"drugType":"Small molecule","mechanismOfAction":"Poly [ADP-ribose] polymerase-1 inhibitor","targetName":"Poly [ADP-ribose] polymerase-1"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000176014","diseaseId":"MONDO_0008315","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00004054%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00030654%22"}],"ancestors":["OTAR_0000017","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","EFO_0000512","EFO_0000616"],"label":"prostate cancer","approvedSymbol":"TUBB6","approvedName":"tubulin beta 6 class V","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL483254","targetId":"ENSG00000171720","diseaseId":"MONDO_0008315","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00667862%22"}],"ancestors":["OTAR_0000017","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","EFO_0000512","EFO_0000616"],"label":"prostate cancer","approvedSymbol":"HDAC3","approvedName":"histone deacetylase 3","targetClass":["Epigenetic regulator"],"prefName":"PANOBINOSTAT","tradeNames":["Farydak"],"synonyms":["LBH-589","LBH589","Panobinostat","Panobinostat hydrate"],"drugType":"Small molecule","mechanismOfAction":"Histone deacetylase inhibitor","targetName":"Histone deacetylase"}
{"drugId":"CHEMBL94657","targetId":"ENSG00000196230","diseaseId":"MONDO_0008315","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00411528%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00407251%22"}],"ancestors":["OTAR_0000017","EFO_0009555","EFO_0007355","MONDO_0024582","MONDO_0002149","MONDO_0023370","EFO_1000051","EFO_0009602","MONDO_0045024","MONDO_0021259","MONDO_0004992","EFO_0000512","EFO_0000616"],"label":"prostate cancer","approvedSymbol":"TUBB","approvedName":"tubulin beta class I","targetClass":["Structural protein"],"prefName":"PATUPILONE","tradeNames":[],"synonyms":["EPO 906","EPO 906A","EPO-906","EPO-906A","Epithilone b","Epo b","Epothilone b","GNF-PF-193","Patupilone"],"drugType":"Small molecule","mechanismOfAction":"Tubulin stabiliser","targetName":"Tubulin"}
{"drugId":"CHEMBL44657","targetId":"ENSG00000077097","diseaseId":"MONDO_0008380","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01899066%22"}],"ancestors":["MONDO_0024341","MONDO_0002236","MONDO_0004338","EFO_0005950","MONDO_0023370","MONDO_0024458","MONDO_0045024","MONDO_0021248","EFO_0007392","MONDO_0004992","EFO_0003824","EFO_1000509","EFO_0003966","EFO_0000618","MONDO_0000649","EFO_0003839","EFO_0006859","EFO_0005716","EFO_0000616"],"label":"retinoblastoma","approvedSymbol":"TOP2B","approvedName":"DNA topoisomerase II beta","targetClass":["Enzyme"],"prefName":"ETOPOSIDE","tradeNames":["Etoposide","Toposar","Vepesid"],"synonyms":["Etoposide","Etoposide resolution mixture","Etoposidum","NSC-141540","Sintopozid","VP-16-213"],"drugType":"Small molecule","mechanismOfAction":"DNA topoisomerase II inhibitor","targetName":"DNA topoisomerase II"}
{"drugId":"CHEMBL888","targetId":"ENSG00000106628","diseaseId":"MONDO_0008627","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01191892%22"}],"ancestors":["EFO_0003844","MONDO_0023370","EFO_0009690","MONDO_0045024","EFO_1000363","MONDO_0001926","MONDO_0004992","EFO_0003086","MONDO_0021066","EFO_0000616"],"label":"ureter cancer","approvedSymbol":"POLD2","approvedName":"DNA polymerase delta 2, accessory subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1567","targetId":"ENSG00000134853","diseaseId":"MONDO_0008667","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00673816%22"}],"ancestors":["EFO_0000618","MONDO_0042983"],"label":"von Hippel-Lindau disease","approvedSymbol":"PDGFRA","approvedName":"platelet derived growth factor receptor alpha","targetClass":["Enzyme"],"prefName":"SUNITINIB MALATE","tradeNames":["Sunitinib malate","Sutent"],"synonyms":["PHA-290940AD","SU-010398","SU-011248 L-MALATE SALT","SU010398","SU011248 L-MALATE SALT","Sunitinib l-malate","Sunitinib malate","Sutent"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","targetName":"Platelet-derived growth factor receptor"}
{"drugId":"CHEMBL477772","targetId":"ENSG00000113721","diseaseId":"MONDO_0008667","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01436227%22"}],"ancestors":["EFO_0000618","MONDO_0042983"],"label":"von Hippel-Lindau disease","approvedSymbol":"PDGFRB","approvedName":"platelet derived growth factor receptor beta","targetClass":["Enzyme"],"prefName":"PAZOPANIB","tradeNames":["Votrient"],"synonyms":["GW786034","NSC-752782","Pazopanib"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","targetName":"Platelet-derived growth factor receptor"}
{"drugId":"CHEMBL628","targetId":"ENSG00000113231","diseaseId":"MONDO_0008867","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01774487%22"}],"ancestors":["MONDO_0015213","OTAR_0000018","MONDO_0001751","MONDO_0002887","EFO_0009534","EFO_0001379","MONDO_0020020","MONDO_0019755","EFO_0010284","EFO_0010282","EFO_1000400"],"label":"biliary atresia","approvedSymbol":"PDE8B","approvedName":"phosphodiesterase 8B","targetClass":["Enzyme"],"prefName":"PENTOXIFYLLINE","tradeNames":["Neotren mr","Pentoxifylline","Pentoxil","Trental","Trental 100","Trental 400"],"synonyms":["BL 191","BL-191","C04AD03","NSC-637086","NSC-758481","Oxpentifylline","Oxypentifylline","Pentoxifylline","Pentoxiphyllin"],"drugType":"Small molecule","mechanismOfAction":"3',5'-cyclic phosphodiesterase inhibitor","targetName":"3',5'-cyclic phosphodiesterase"}
{"drugId":"CHEMBL1200485","targetId":"ENSG00000157764","diseaseId":"MONDO_0008903","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00726986%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0003818","EFO_0000616"],"label":"lung cancer","approvedSymbol":"BRAF","approvedName":"B-Raf proto-oncogene, serine/threonine kinase","targetClass":["Enzyme"],"prefName":"SORAFENIB TOSYLATE","tradeNames":["Nexavar"],"synonyms":["BAY 54-9085","BAY-54-9085","Sorafenib tosilate","Sorafenib tosylate"],"drugType":"Small molecule","mechanismOfAction":"Serine/threonine-protein kinase B-raf inhibitor","targetName":"Serine/threonine-protein kinase B-raf"}
{"drugId":"CHEMBL1637","targetId":"ENSG00000177084","diseaseId":"MONDO_0008903","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00112710%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003447%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00055965%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00006048%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00004100%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0003818","EFO_0000616"],"label":"lung cancer","approvedSymbol":"POLE","approvedName":"DNA polymerase epsilon, catalytic subunit","targetClass":["Enzyme"],"prefName":"GEMCITABINE HYDROCHLORIDE","tradeNames":["Gemcitabine hydrochloride","Gemzar","Infugem"],"synonyms":["Gemcitabine (as hydrochloride)","Gemcitabine hcl","Gemcitabine hydrochloride","Gemzar","LY-188011","LY-188011 HYDROCHLORIDE","LY188011 HYDROCHLORIDE"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL18901","targetId":"ENSG00000244734","diseaseId":"MONDO_0008903","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00004202%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0003818","EFO_0000616"],"label":"lung cancer","approvedSymbol":"HBB","approvedName":"hemoglobin subunit beta","targetClass":["Secreted protein"],"prefName":"EFAPROXIRAL","tradeNames":[],"synonyms":["Efaproxiral","RSR-13","RSR13"],"drugType":"Small molecule","mechanismOfAction":"Hemoglobin HbA negative modulator","targetName":"Hemoglobin HbA"}
{"drugId":"CHEMBL231616","targetId":"ENSG00000048392","diseaseId":"MONDO_0008903","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00064064%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00077415%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0003818","EFO_0000616"],"label":"lung cancer","approvedSymbol":"RRM2B","approvedName":"ribonucleotide reductase regulatory TP53 inducible subunit M2B","targetClass":["Enzyme"],"prefName":"TRIAPINE","tradeNames":[],"synonyms":["3-AP","NSC-663249","OCX-0191","OCX-191","Ocx 191","PAN-811","Triapine"],"drugType":"Small molecule","mechanismOfAction":"Ribonucleotide reductase inhibitor","targetName":"Ribonucleotide reductase"}
{"drugId":"CHEMBL325041","targetId":"ENSG00000100804","diseaseId":"MONDO_0008903","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00388089%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00389805%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0003818","EFO_0000616"],"label":"lung cancer","approvedSymbol":"PSMB5","approvedName":"proteasome 20S subunit beta 5","targetClass":["Enzyme"],"prefName":"BORTEZOMIB","tradeNames":["Velcade"],"synonyms":["Bortezomib","Bortezomib accord","Bortezomib hydrate","LDP-341","NSC-681239","PS-341","Velcade"],"drugType":"Small molecule","mechanismOfAction":"26S proteosome inhibitor","targetName":"26S proteasome"}
{"drugId":"CHEMBL3353410","targetId":"ENSG00000146648","diseaseId":"MONDO_0008903","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04545710%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05215951%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0003818","EFO_0000616"],"label":"lung cancer","approvedSymbol":"EGFR","approvedName":"epidermal growth factor receptor","targetClass":["Enzyme"],"prefName":"OSIMERTINIB","tradeNames":["Tagrisso"],"synonyms":["AZD-9291","AZD-9291 FREE BASE","AZD9291","Azd-9291","Mereletinib","Osimertinib"],"drugType":"Small molecule","mechanismOfAction":"Epidermal growth factor receptor erbB1 inhibitor","targetName":"Epidermal growth factor receptor erbB1"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000104833","diseaseId":"MONDO_0008903","phase":1,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00600496%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0003818","EFO_0000616"],"label":"lung cancer","approvedSymbol":"TUBB4A","approvedName":"tubulin beta 4A class IVa","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL3545252","targetId":"ENSG00000261456","diseaseId":"MONDO_0008903","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00660816%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003900%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00080080%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01443078%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00064012%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00222144%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003762%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01059188%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00281970%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00280735%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00193427%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00075374%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00103389%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00541099%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00030810%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00193245%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003587%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00004139%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00005868%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00970684%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00114192%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00030407%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00030420%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00193453%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00193323%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00449020%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003565%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003231%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00301808%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00227708%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00278460%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00062439%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00026156%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0003818","EFO_0000616"],"label":"lung cancer","approvedSymbol":"TUBB8","approvedName":"tubulin beta 8 class VIII","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel (as trihydrate)","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL378544","targetId":"ENSG00000137267","diseaseId":"MONDO_0008903","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00004887%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003240%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00004209%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0003818","EFO_0000616"],"label":"lung cancer","approvedSymbol":"TUBB2A","approvedName":"tubulin beta 2A class IIa","targetClass":["Structural protein"],"prefName":"VINBLASTINE SULFATE","tradeNames":["Velban","Velbe","Vinblast,lederle","Vinblastine sulfate"],"synonyms":["29060-LE","29060LE","Alkaban-aq","NSC-49842","Vinblastine sulfate","Vinblastine sulphate","Vinblastini sulfas","Vincaleukoblastine sulfate","Vlb monosulfate"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000176014","diseaseId":"MONDO_0008903","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00334763%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00526890%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00459121%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00290537%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00465907%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00063258%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0003818","EFO_0000616"],"label":"lung cancer","approvedSymbol":"TUBB6","approvedName":"tubulin beta 6 class V","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL4297829","targetId":"ENSG00000188389","diseaseId":"MONDO_0008903","phase":1,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04840758%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0003818","EFO_0000616"],"label":"lung cancer","approvedSymbol":"PDCD1","approvedName":"programmed cell death 1","targetClass":["Surface antigen"],"prefName":"SINTILIMAB","tradeNames":["Tyvyt"],"synonyms":["ANTI-PD-1 MONOCLONAL ANTIBODY IBI308","IBI-308","IBI308","Ibi308","Sintilimab"],"drugType":"Antibody","mechanismOfAction":"Programmed cell death protein 1 antagonist","targetName":"Programmed cell death protein 1"}
{"drugId":"CHEMBL491473","targetId":"ENSG00000128052","diseaseId":"MONDO_0008903","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00326599%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00245154%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0003818","EFO_0000616"],"label":"lung cancer","approvedSymbol":"KDR","approvedName":"kinase insert domain receptor","targetClass":["Enzyme"],"prefName":"CEDIRANIB","tradeNames":["Recentin"],"synonyms":["AZD-2171","AZD2171","Azd-2171","Cediranib","ZD-2171"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL501867","targetId":"ENSG00000101162","diseaseId":"MONDO_0008903","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003364%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00002822%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0003818","EFO_0000616"],"label":"lung cancer","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"VINCRISTINE SULFATE","tradeNames":["Kyocristine","Leurocristine Sulfate","Marqibo kit","Oncovin","Vincasar","Vincasar pfs","Vincrex","Vincristine sulfate","Vincristine sulfate pfs"],"synonyms":["37231","Kyocristine","LILLY-37231","Marqibo","NSC-67574","Novopharm","Vincristine sulfate","Vincristine sulfate liposome","Vincristine sulphate","Vincristini sulfas","Vincrisul"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL553025","targetId":"ENSG00000188229","diseaseId":"MONDO_0008903","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003447%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00004100%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00003240%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0003818","EFO_0000616"],"label":"lung cancer","approvedSymbol":"TUBB4B","approvedName":"tubulin beta 4B class IVb","targetClass":["Structural protein"],"prefName":"VINORELBINE","tradeNames":[],"synonyms":["NSC-760087","Navelbin","Vinorelbine","Vinorelbine Base"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL888","targetId":"ENSG00000146143","diseaseId":"MONDO_0008903","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00469976%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00951444%22"}],"ancestors":["MONDO_0000376","MONDO_0021350","EFO_0009433","MONDO_0023370","OTAR_0000010","MONDO_0045024","MONDO_0004992","MONDO_0003274","EFO_0000684","MONDO_0021117","EFO_0003853","EFO_0003818","EFO_0000616"],"label":"lung cancer","approvedSymbol":"PRIM2","approvedName":"DNA primase subunit 2","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL256997","targetId":"ENSG00000149806","diseaseId":"MONDO_0009061","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00234663%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00237380%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00458341%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00351078%22"}],"ancestors":["OTAR_0000018","EFO_0000684","EFO_0000508","OTAR_0000010","MONDO_0000429","EFO_1000017"],"label":"cystic fibrosis","approvedSymbol":"FAU","approvedName":"FAU ubiquitin like and ribosomal protein S30 fusion","targetClass":["Unclassified protein"],"prefName":"ATALUREN","tradeNames":[],"synonyms":["Ataluren","PTC-124","PTC124","Translarna"],"drugType":"Small molecule","mechanismOfAction":"80S Ribosome modulator","targetName":"80S Ribosome"}
{"drugId":"CHEMBL256997","targetId":"ENSG00000231500","diseaseId":"MONDO_0009061","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00351078%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00237380%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00458341%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00234663%22"}],"ancestors":["OTAR_0000018","EFO_0000684","EFO_0000508","OTAR_0000010","MONDO_0000429","EFO_1000017"],"label":"cystic fibrosis","approvedSymbol":"RPS18","approvedName":"ribosomal protein S18","targetClass":["Unclassified protein"],"prefName":"ATALUREN","tradeNames":[],"synonyms":["Ataluren","PTC-124","PTC124","Translarna"],"drugType":"Small molecule","mechanismOfAction":"80S Ribosome modulator","targetName":"80S Ribosome"}
{"drugId":"CHEMBL256997","targetId":"ENSG00000147403","diseaseId":"MONDO_0009061","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02139306%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01140451%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00803205%22"}],"ancestors":["OTAR_0000018","EFO_0000684","EFO_0000508","OTAR_0000010","MONDO_0000429","EFO_1000017"],"label":"cystic fibrosis","approvedSymbol":"RPL10","approvedName":"ribosomal protein L10","targetClass":["Unclassified protein"],"prefName":"ATALUREN","tradeNames":[],"synonyms":["Ataluren","PTC-124","PTC124","Translarna"],"drugType":"Small molecule","mechanismOfAction":"80S Ribosome modulator","targetName":"80S Ribosome"}
{"drugId":"CHEMBL256997","targetId":"ENSG00000131469","diseaseId":"MONDO_0009061","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03256968%22"}],"ancestors":["OTAR_0000018","EFO_0000684","EFO_0000508","OTAR_0000010","MONDO_0000429","EFO_1000017"],"label":"cystic fibrosis","approvedSymbol":"RPL27","approvedName":"ribosomal protein L27","targetClass":["Unclassified protein"],"prefName":"ATALUREN","tradeNames":[],"synonyms":["Ataluren","PTC-124","PTC124","Translarna"],"drugType":"Small molecule","mechanismOfAction":"80S Ribosome modulator","targetName":"80S Ribosome"}
{"drugId":"CHEMBL4297744","targetId":"ENSG00000122026","diseaseId":"MONDO_0009061","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04135495%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04126473%22"}],"ancestors":["OTAR_0000018","EFO_0000684","EFO_0000508","OTAR_0000010","MONDO_0000429","EFO_1000017"],"label":"cystic fibrosis","approvedSymbol":"RPL21","approvedName":"ribosomal protein L21","targetClass":["Unclassified protein"],"prefName":"ELX-02","tradeNames":[],"synonyms":["ELX-02","Elx-02","Exaluren","NB-124"],"drugType":"Unknown","mechanismOfAction":"80S Ribosome modulator","targetName":"80S Ribosome"}
{"drugId":"CHEMBL378544","targetId":"ENSG00000261456","diseaseId":"MONDO_0009348","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03907488%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0005741","MONDO_0044881","MONDO_0045024","EFO_0000183","Orphanet_322126","MONDO_0100336","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0100321","MONDO_0021669","EFO_0000508","MONDO_0019044","MONDO_0017342","MONDO_0017341","EFO_0005803","MONDO_0017343","EFO_0000616"],"label":"classic Hodgkin lymphoma","approvedSymbol":"TUBB8","approvedName":"tubulin beta 8 class VIII","targetClass":["Structural protein"],"prefName":"VINBLASTINE SULFATE","tradeNames":["Velban","Velbe","Vinblast,lederle","Vinblastine sulfate"],"synonyms":["29060-LE","29060LE","Alkaban-aq","NSC-49842","Vinblastine sulfate","Vinblastine sulphate","Vinblastini sulfas","Vincaleukoblastine sulfate","Vlb monosulfate"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL4297584","targetId":"ENSG00000171608","diseaseId":"MONDO_0009348","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03471351%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0005741","MONDO_0044881","MONDO_0045024","EFO_0000183","Orphanet_322126","MONDO_0100336","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0100321","MONDO_0021669","EFO_0000508","MONDO_0019044","MONDO_0017342","MONDO_0017341","EFO_0005803","MONDO_0017343","EFO_0000616"],"label":"classic Hodgkin lymphoma","approvedSymbol":"PIK3CD","approvedName":"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta","targetClass":["Enzyme"],"prefName":"TENALISIB","tradeNames":[],"synonyms":["Tenalisib"],"drugType":"Small molecule","mechanismOfAction":"PI3-kinase p110-delta subunit inhibitor","targetName":"PI3-kinase p110-delta subunit"}
{"drugId":"CHEMBL256997","targetId":"ENSG00000149806","diseaseId":"MONDO_0010311","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01557400%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0004145","MONDO_0016106","MONDO_0015470","EFO_0000618","MONDO_0010542","EFO_0000318","MONDO_0003939","EFO_0000319","MONDO_0016147","OTAR_0000018","EFO_0002970","MONDO_0000591","MONDO_0020120","MONDO_0020121","EFO_0002945","MONDO_0016139","MONDO_0016899","EFO_0003777","EFO_1001902","EFO_0004149","EFO_0000508","MONDO_0016333","EFO_0000407"],"label":"Becker muscular dystrophy","approvedSymbol":"FAU","approvedName":"FAU ubiquitin like and ribosomal protein S30 fusion","targetClass":["Unclassified protein"],"prefName":"ATALUREN","tradeNames":[],"synonyms":["Ataluren","PTC-124","PTC124","Translarna"],"drugType":"Small molecule","mechanismOfAction":"80S Ribosome modulator","targetName":"80S Ribosome"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000125356","diseaseId":"MONDO_0010383","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04141163%22"}],"ancestors":["MONDO_0002025","OTAR_0000018","EFO_0005774","MONDO_0000425","EFO_0009386","EFO_0000677","MONDO_0020606","MONDO_0020119","MONDO_0100284","EFO_0000618","EFO_0000508","EFO_0005548","MONDO_0000508"],"label":"fragile X syndrome","approvedSymbol":"NDUFA1","approvedName":"NADH:ubiquinone oxidoreductase subunit A1","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL256997","targetId":"ENSG00000083845","diseaseId":"MONDO_0010679","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03796637%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00592553%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02819557%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03648827%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00264888%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0004145","MONDO_0024458","MONDO_0016106","EFO_0003966","MONDO_0015470","EFO_0000618","MONDO_0010542","EFO_0000318","MONDO_0003939","EFO_0000319","MONDO_0016147","OTAR_0000018","EFO_0002970","MONDO_0000591","MONDO_0020120","MONDO_0020121","EFO_0002945","MONDO_0015368","MONDO_0016139","MONDO_0016899","EFO_0003777","EFO_1001902","EFO_0004149","EFO_0000508","MONDO_0016333","EFO_0000407"],"label":"Duchenne muscular dystrophy","approvedSymbol":"RPS5","approvedName":"ribosomal protein S5","targetClass":["Unclassified protein"],"prefName":"ATALUREN","tradeNames":[],"synonyms":["Ataluren","PTC-124","PTC124","Translarna"],"drugType":"Small molecule","mechanismOfAction":"80S Ribosome modulator","targetName":"80S Ribosome"}
{"drugId":"CHEMBL256997","targetId":"ENSG00000174444","diseaseId":"MONDO_0010679","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04336826%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0004145","MONDO_0024458","MONDO_0016106","EFO_0003966","MONDO_0015470","EFO_0000618","MONDO_0010542","EFO_0000318","MONDO_0003939","EFO_0000319","MONDO_0016147","OTAR_0000018","EFO_0002970","MONDO_0000591","MONDO_0020120","MONDO_0020121","EFO_0002945","MONDO_0015368","MONDO_0016139","MONDO_0016899","EFO_0003777","EFO_1001902","EFO_0004149","EFO_0000508","MONDO_0016333","EFO_0000407"],"label":"Duchenne muscular dystrophy","approvedSymbol":"RPL4","approvedName":"ribosomal protein L4","targetClass":["Unclassified protein"],"prefName":"ATALUREN","tradeNames":[],"synonyms":["Ataluren","PTC-124","PTC124","Translarna"],"drugType":"Small molecule","mechanismOfAction":"80S Ribosome modulator","targetName":"80S Ribosome"}
{"drugId":"CHEMBL256997","targetId":"ENSG00000130255","diseaseId":"MONDO_0010679","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00759876%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01009294%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00847379%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0004145","MONDO_0024458","MONDO_0016106","EFO_0003966","MONDO_0015470","EFO_0000618","MONDO_0010542","EFO_0000318","MONDO_0003939","EFO_0000319","MONDO_0016147","OTAR_0000018","EFO_0002970","MONDO_0000591","MONDO_0020120","MONDO_0020121","EFO_0002945","MONDO_0015368","MONDO_0016139","MONDO_0016899","EFO_0003777","EFO_1001902","EFO_0004149","EFO_0000508","MONDO_0016333","EFO_0000407"],"label":"Duchenne muscular dystrophy","approvedSymbol":"RPL36","approvedName":"ribosomal protein L36","targetClass":["Unclassified protein"],"prefName":"ATALUREN","tradeNames":[],"synonyms":["Ataluren","PTC-124","PTC124","Translarna"],"drugType":"Small molecule","mechanismOfAction":"80S Ribosome modulator","targetName":"80S Ribosome"}
{"drugId":"CHEMBL256997","targetId":"ENSG00000110700","diseaseId":"MONDO_0010679","phase":3,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03179631%22"}],"ancestors":["OTAR_0000006","EFO_0009676","EFO_0004145","MONDO_0024458","MONDO_0016106","EFO_0003966","MONDO_0015470","EFO_0000618","MONDO_0010542","EFO_0000318","MONDO_0003939","EFO_0000319","MONDO_0016147","OTAR_0000018","EFO_0002970","MONDO_0000591","MONDO_0020120","MONDO_0020121","EFO_0002945","MONDO_0015368","MONDO_0016139","MONDO_0016899","EFO_0003777","EFO_1001902","EFO_0004149","EFO_0000508","MONDO_0016333","EFO_0000407"],"label":"Duchenne muscular dystrophy","approvedSymbol":"RPS13","approvedName":"ribosomal protein S13","targetClass":["Unclassified protein"],"prefName":"ATALUREN","tradeNames":[],"synonyms":["Ataluren","PTC-124","PTC124","Translarna"],"drugType":"Small molecule","mechanismOfAction":"80S Ribosome modulator","targetName":"80S Ribosome"}
{"drugId":"CHEMBL1699","targetId":"ENSG00000161509","diseaseId":"MONDO_0011382","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03247218%22"}],"ancestors":["EFO_0004260","MONDO_0002146","OTAR_0000006","EFO_0009676","EFO_0009555","MONDO_0016072","MONDO_0002280","EFO_0009690","EFO_0002461","MONDO_0044347","MONDO_0044348","EFO_0008560","EFO_0000512","MONDO_0015514","EFO_0004259","EFO_0009549","MONDO_0018384","MONDO_0000429","MONDO_0015770","EFO_0005803","OTAR_0000017","MONDO_0019050","OTAR_0000018","MONDO_0002259","MONDO_0018383","EFO_0003086","MONDO_0019824","EFO_0000545","MONDO_0015127","EFO_0001379","EFO_0004248","MONDO_0018374","EFO_0000508","MONDO_0018373","MONDO_0100191","MONDO_0017146","EFO_1000017","MONDO_0015860","MONDO_0018555"],"label":"sickle cell anemia","approvedSymbol":"GRIN2C","approvedName":"glutamate ionotropic receptor NMDA type subunit 2C","targetClass":["Ion channel"],"prefName":"MEMANTINE HYDROCHLORIDE","tradeNames":["Akatinol","Ebixa","Marixino","Memantine","Memantine hydrochloride","Namenda","Namenda xr","Nemdatine","Valios"],"synonyms":["Acrescent","Auxura","Balaxur","FP-01","Memantine accord","Memantine hcl","Memantine hydrochloride","Memantine lek","Memantine merz","Memantine mylan","Memantine ratiopharm","Memary","NSC-102290","SUN-Y7017"],"drugType":"Small molecule","mechanismOfAction":"Glutamate [NMDA] receptor negative allosteric modulator","targetName":"Glutamate [NMDA] receptor"}
{"drugId":"CHEMBL2103744","targetId":"ENSG00000112038","diseaseId":"MONDO_0011382","phase":4,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00880373%22"}],"ancestors":["EFO_0004260","MONDO_0002146","OTAR_0000006","EFO_0009676","EFO_0009555","MONDO_0016072","MONDO_0002280","EFO_0009690","EFO_0002461","MONDO_0044347","MONDO_0044348","EFO_0008560","EFO_0000512","MONDO_0015514","EFO_0004259","EFO_0009549","MONDO_0018384","MONDO_0000429","MONDO_0015770","EFO_0005803","OTAR_0000017","MONDO_0019050","OTAR_0000018","MONDO_0002259","MONDO_0018383","EFO_0003086","MONDO_0019824","EFO_0000545","MONDO_0015127","EFO_0001379","EFO_0004248","MONDO_0018374","EFO_0000508","MONDO_0018373","MONDO_0100191","MONDO_0017146","EFO_1000017","MONDO_0015860","MONDO_0018555"],"label":"sickle cell anemia","approvedSymbol":"OPRM1","approvedName":"opioid receptor mu 1","targetClass":["Membrane receptor"],"prefName":"MORPHINE SULFATE","tradeNames":["Arymo er","Astramorph pf","Avinza","Depodur","Duramorph","Duramorph pf","Duromorph","Filnarine sr","Infumorph","Kadian","Moraxen","Morcap sr","Morphabond","Morphabond er","Morphgesic sr","Morphine sulfate","Morphine sulfate (autoinjector)","Ms contin","Mst continus","Oramorph","Oramorph sr","Oramorph udv","Rhotard","Sevredol","Srm-rhotard","Zomorph"],"synonyms":["Arymo","Astramorph","Dolcontin","Kapanol","Morcap","Morphine sulfate","Morphine sulfate anhydrous","Morphine sulfate cii","Morphine sulfate hydrate","Morphine sulfate pentahydrate","Morphine sulfate,anhydrous","Morphine sulphate","Morphine sulphate anhydrous","Morphine sulphate pentahydrate","Morphini sulfas","Moscontin","NSC-11441"],"drugType":"Small molecule","mechanismOfAction":"Mu opioid receptor agonist","targetName":"Mu opioid receptor"}
{"drugId":"CHEMBL256147","targetId":"ENSG00000007171","diseaseId":"MONDO_0011382","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00508989%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00009581%22"}],"ancestors":["EFO_0004260","MONDO_0002146","OTAR_0000006","EFO_0009676","EFO_0009555","MONDO_0016072","MONDO_0002280","EFO_0009690","EFO_0002461","MONDO_0044347","MONDO_0044348","EFO_0008560","EFO_0000512","MONDO_0015514","EFO_0004259","EFO_0009549","MONDO_0018384","MONDO_0000429","MONDO_0015770","EFO_0005803","OTAR_0000017","MONDO_0019050","OTAR_0000018","MONDO_0002259","MONDO_0018383","EFO_0003086","MONDO_0019824","EFO_0000545","MONDO_0015127","EFO_0001379","EFO_0004248","MONDO_0018374","EFO_0000508","MONDO_0018373","MONDO_0100191","MONDO_0017146","EFO_1000017","MONDO_0015860","MONDO_0018555"],"label":"sickle cell anemia","approvedSymbol":"NOS2","approvedName":"nitric oxide synthase 2","targetClass":["Enzyme"],"prefName":"TILARGININE","tradeNames":[],"synonyms":[".omega.-n-methylarginine","L-NMMA","Ng-methylarginine","Ng-monomethyl-l-arginine","Omega-n-methylarginine","Omega-n-methylated arginine","Targinine","Tilarginine"],"drugType":"Small molecule","mechanismOfAction":"Nitric oxide synthase inhibitor","targetName":"Nitric oxide synthase"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000077514","diseaseId":"MONDO_0011469","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01529827%22"}],"ancestors":["MONDO_0002245","OTAR_0000018","MONDO_0000577","MONDO_0001713","MONDO_0002280","EFO_0000508","MONDO_0100241","MONDO_0018796","EFO_0005803","MONDO_0009332","MONDO_0015909"],"label":"congenital amegakaryocytic thrombocytopenia","approvedSymbol":"POLD3","approvedName":"DNA polymerase delta 3, accessory subunit","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL92","targetId":"ENSG00000196230","diseaseId":"MONDO_0011719","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00359333%22"}],"ancestors":["EFO_0009431","OTAR_0000018","MONDO_0023370","MONDO_0024635","MONDO_0004251","MONDO_0045024","MONDO_0017128","MONDO_0018506","MONDO_0021118","EFO_0008549","EFO_0000508","EFO_0000616","EFO_0010282"],"label":"gastrointestinal stromal tumor","approvedSymbol":"TUBB","approvedName":"tubulin beta class I","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":[],"synonyms":["RP-56976","Taxotere"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1289601","targetId":"ENSG00000102755","diseaseId":"MONDO_0011962","phase":2,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05106127%22"}],"ancestors":["OTAR_0000017","MONDO_0002654","MONDO_0021251","MONDO_0002149","MONDO_0023370","EFO_1000051","MONDO_0000931","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","MONDO_0002715","EFO_0009549","EFO_1001331","EFO_0000616","EFO_0003859"],"label":"endometrial cancer","approvedSymbol":"FLT1","approvedName":"fms related receptor tyrosine kinase 1","targetClass":["Enzyme"],"prefName":"LENVATINIB","tradeNames":["Kisplyx","Lenvima"],"synonyms":["E-7080","ER-203492-00","Lenvatinib"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL1637","targetId":"ENSG00000100479","diseaseId":"MONDO_0011962","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00004082%22"}],"ancestors":["OTAR_0000017","MONDO_0002654","MONDO_0021251","MONDO_0002149","MONDO_0023370","EFO_1000051","MONDO_0000931","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","MONDO_0002715","EFO_0009549","EFO_1001331","EFO_0000616","EFO_0003859"],"label":"endometrial cancer","approvedSymbol":"POLE2","approvedName":"DNA polymerase epsilon 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"GEMCITABINE HYDROCHLORIDE","tradeNames":["Gemcitabine hydrochloride","Gemzar","Infugem"],"synonyms":["Gemcitabine (as hydrochloride)","Gemcitabine hcl","Gemcitabine hydrochloride","Gemzar","LY-188011","LY-188011 HYDROCHLORIDE","LY188011 HYDROCHLORIDE"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL4303201","targetId":"ENSG00000128052","diseaseId":"MONDO_0011962","phase":2,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05481645%22"}],"ancestors":["OTAR_0000017","MONDO_0002654","MONDO_0021251","MONDO_0002149","MONDO_0023370","EFO_1000051","MONDO_0000931","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","MONDO_0002715","EFO_0009549","EFO_1001331","EFO_0000616","EFO_0003859"],"label":"endometrial cancer","approvedSymbol":"KDR","approvedName":"kinase insert domain receptor","targetClass":["Enzyme"],"prefName":"ANLOTINIB","tradeNames":[],"synonyms":["AL 3818","AL-3818","AL3818","Al-3818","Anlotinib","Catequentinib"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor 2 inhibitor","targetName":"Vascular endothelial growth factor receptor 2"}
{"drugId":"CHEMBL1551","targetId":"ENSG00000012504","diseaseId":"MONDO_0015183","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01974336%22"}],"ancestors":["EFO_0009431","EFO_0010282"],"label":"short bowel syndrome","approvedSymbol":"NR1H4","approvedName":"nuclear receptor subfamily 1 group H member 4","targetClass":["Transcription factor"],"prefName":"URSODIOL","tradeNames":["Actigall","Cholurso","Destolit","Urdox","Urso","Urso 250","Urso forte","Ursodiol","Ursofalk","Ursogal"],"synonyms":["NSC-683769","Ursodeoxycholate","Ursodeoxycholic acid","Ursodesoxycholic acid","Ursodiol","Ursonorm"],"drugType":"Small molecule","mechanismOfAction":"Bile acid receptor FXR agonist","targetName":"Bile acid receptor FXR"}
{"drugId":"CHEMBL2105717","targetId":"ENSG00000105976","diseaseId":"MONDO_0015277","phase":4,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01896479%22"}],"ancestors":["MONDO_0024276","MONDO_0023370","MONDO_0002108","MONDO_0021069","EFO_0002892","MONDO_0024622","MONDO_0045024","MONDO_0002120","MONDO_0004992","EFO_0000501","EFO_0003769","EFO_0000313","EFO_0000228","EFO_0001379","EFO_1001901","EFO_0003841","EFO_1000627","EFO_1002017","EFO_0006858","EFO_0000616"],"label":"medullary thyroid gland carcinoma","approvedSymbol":"MET","approvedName":"MET proto-oncogene, receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"CABOZANTINIB","tradeNames":["Cabometyx","Cometriq"],"synonyms":["BMS-907351","BMS-907351 FREE BASE","Cabozantinib","XL-184","XL-184 FREE BASE","XL184"],"drugType":"Small molecule","mechanismOfAction":"Hepatocyte growth factor receptor inhibitor","targetName":"Hepatocyte growth factor receptor"}
{"drugId":"CHEMBL635","targetId":"ENSG00000113580","diseaseId":"MONDO_0015564","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03043105%22"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0003778","EFO_0005741","MONDO_0023370","MONDO_0021058","MONDO_0045024","MONDO_0009453","MONDO_0015356","MONDO_0100336","MONDO_0016537","MONDO_0100321","MONDO_0015757","EFO_0000540","MONDO_0021669","EFO_0000508","MONDO_0019044","MONDO_0017341","EFO_0005803","MONDO_0015157","EFO_0000616"],"label":"Castleman disease","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"PREDNISONE","tradeNames":["Cortan","Cortancyl","Decortisyl","Delta-dome","Deltasone","Fernisone","Liquid pred","Lodotra","Meticorten","Orasone","Paracort","Prednicen-m","Prednisone","Prednisone intensol","Rayos","Servisone","Sterapred"],"synonyms":["3en3hg4wsw","Decortin","Dehydrocortisone","Metacortandracin","NSC-10023","Prednisone","Prednisone anhydrous","Prednisone tablets","Supercortil"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL2103868","targetId":"ENSG00000128052","diseaseId":"MONDO_0015686","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05092373%22"}],"ancestors":["MONDO_0023370","MONDO_0045024","MONDO_0015682","MONDO_0015683","EFO_0000616"],"label":"primary peritoneal carcinoma","approvedSymbol":"KDR","approvedName":"kinase insert domain receptor","targetClass":["Enzyme"],"prefName":"CABOZANTINIB S-MALATE","tradeNames":["Cabometyx","Cometriq"],"synonyms":["BMS-907351","Cabozantinib s-malate","XL-184","XL184"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor 2 inhibitor","targetName":"Vascular endothelial growth factor receptor 2"}
{"drugId":"CHEMBL98","targetId":"ENSG00000171720","diseaseId":"MONDO_0015760","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092"}],"ancestors":["OTAR_0000018","MONDO_0002334","MONDO_0023370","MONDO_0044881","MONDO_0045024","Orphanet_322126","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","EFO_0005803","EFO_0000616"],"label":"T-cell non-Hodgkin lymphoma","approvedSymbol":"HDAC3","approvedName":"histone deacetylase 3","targetClass":["Epigenetic regulator"],"prefName":"VORINOSTAT","tradeNames":["Zolinza"],"synonyms":["MK-0683","MK0683","NSC-701852","NSC-748799","NSC-759852","Suberoylanilide hydroxamic acid","Vorinostat"],"drugType":"Small molecule","mechanismOfAction":"Histone deacetylase 3 inhibitor","targetName":"Histone deacetylase 3"}
{"drugId":"CHEMBL877","targetId":"ENSG00000122194","diseaseId":"MONDO_0016642","phase":3,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01655927%22"}],"ancestors":["MONDO_0023370","EFO_0003851","EFO_0000618","MONDO_0021248","MONDO_0045024","EFO_0009386","EFO_1000158","EFO_0000616"],"label":"meningioma","approvedSymbol":"PLG","approvedName":"plasminogen","targetClass":["Enzyme"],"prefName":"TRANEXAMIC ACID","tradeNames":["Cyklo-f heavy period relief","Cyklokapron","Exacyl","Lysteda","Menstralite","Tranexamic acid"],"synonyms":["Amcha","CL 65336","CL-65336","Cyclo-f","Cyclocapron","Cyclokapron","Espercil","Femstrual","Haematrix","LB-1148","LB1148","NSC-291305","RP-18429","Rikavarin","TRANS AMCHA","TRANS-AMCHA","Tranexamic acid","Trans AMCHA","Transamin"],"drugType":"Small molecule","mechanismOfAction":"Plasminogen inhibitor","targetName":"Plasminogen"}
{"drugId":"CHEMBL371405","targetId":"ENSG00000154611","diseaseId":"MONDO_0016700","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03727841%22"}],"ancestors":["MONDO_0021193","MONDO_0023370","EFO_0005543","MONDO_0021248","MONDO_0045024","MONDO_0020665","EFO_0007392","MONDO_0004992","EFO_0009386","MONDO_0021640","EFO_0000326","MONDO_0100342","MONDO_0020633","EFO_0000618","EFO_1000027","EFO_1000158","EFO_0000616"],"label":"anaplastic ependymoma","approvedSymbol":"PSMA8","approvedName":"proteasome 20S subunit alpha 8","targetClass":["Enzyme","Unclassified protein"],"prefName":"MARIZOMIB","tradeNames":[],"synonyms":["Marizomib","NPI-0052","Salinosporamide a"],"drugType":"Small molecule","mechanismOfAction":"20S proteosome inhibitor","targetName":"20S proteasome"}
{"drugId":"CHEMBL657","targetId":"ENSG00000196639","diseaseId":"MONDO_0017287","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04918147%22"}],"ancestors":["EFO_0005809","EFO_0000540","EFO_1002003"],"label":"IgG4-related disease","approvedSymbol":"HRH1","approvedName":"histamine receptor H1","targetClass":["Membrane receptor"],"prefName":"DIPHENHYDRAMINE","tradeNames":[],"synonyms":["Antitussive","Beldin","Belix","Benadryl","Benylin","Dibenil","Diphen","Diphenhdyra","Diphenhydramine","Hydramine","Restamin","Silphen"],"drugType":"Small molecule","mechanismOfAction":"Histamine H1 receptor antagonist","targetName":"Histamine H1 receptor"}
{"drugId":"CHEMBL107","targetId":"ENSG00000137285","diseaseId":"MONDO_0018088","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02175589%22"}],"ancestors":["OTAR_0000006","OTAR_0000018","EFO_0009676","MONDO_0003778","EFO_0009690","EFO_0002461","EFO_0003086","MONDO_0009453","MONDO_0017953","MONDO_0015137","MONDO_0019724","MONDO_0023603","EFO_0000540","EFO_0000508","MONDO_0019751","EFO_0005755","EFO_1001986","MONDO_0100191","EFO_1002049","MONDO_0015135"],"label":"familial Mediterranean fever","approvedSymbol":"TUBB2B","approvedName":"tubulin beta 2B class IIb","targetClass":["Structural protein"],"prefName":"COLCHICINE","tradeNames":["Colchicine","Colcrys","Gloperba","Mitigare"],"synonyms":["(-)-colchicine","Colchcine","Colchicine","Colchicinum","Colchineos","Colchisol","NSC-757"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000101162","diseaseId":"MONDO_0018201","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00072215%22"}],"ancestors":["EFO_0000514","MONDO_0023370","MONDO_0045024","EFO_0000616"],"label":"extragonadal germ cell tumor","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000137285","diseaseId":"MONDO_0018364","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01249443%22"}],"ancestors":["OTAR_0000017","EFO_0005771","MONDO_0002259","MONDO_0002149","MONDO_0023370","MONDO_0002229","EFO_1000051","EFO_0003893","MONDO_0021148","MONDO_0045024","MONDO_0004992","EFO_0000512","EFO_0000313","MONDO_0008170","EFO_0001379","EFO_0009549","EFO_0006858","EFO_1001331","EFO_0000616"],"label":"malignant epithelial tumor of ovary","approvedSymbol":"TUBB2B","approvedName":"tubulin beta 2B class IIb","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1614701","targetId":"ENSG00000169032","diseaseId":"MONDO_0018531","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00553332%22"}],"ancestors":["MONDO_0023370","MONDO_0021069","MONDO_0045024","MONDO_0004992","MONDO_0024477","MONDO_0002691","EFO_0008550","EFO_0003769","EFO_0000313","EFO_1000218","EFO_0001379","EFO_0001421","EFO_0008549","MONDO_0002516","EFO_0006858","EFO_0010284","EFO_0000616","EFO_0010282"],"label":"carcinoma of liver and intrahepatic biliary tract","approvedSymbol":"MAP2K1","approvedName":"mitogen-activated protein kinase kinase 1","targetClass":["Enzyme"],"prefName":"SELUMETINIB","tradeNames":[],"synonyms":["ARRY-142886","ARRY-886","AZD-6244","AZD6244","Azd-6244","Selumetinib"],"drugType":"Small molecule","mechanismOfAction":"Dual specificity mitogen-activated protein kinase kinase 1 inhibitor","targetName":"Dual specificity mitogen-activated protein kinase kinase 1"}
{"drugId":"CHEMBL1624","targetId":"ENSG00000151090","diseaseId":"MONDO_0018612","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05371262%22"}],"ancestors":["EFO_0004705","EFO_0001379","EFO_1000627"],"label":"congenital hypothyroidism","approvedSymbol":"THRB","approvedName":"thyroid hormone receptor beta","targetClass":["Transcription factor"],"prefName":"LEVOTHYROXINE","tradeNames":[],"synonyms":["L-thyroxine","Levothyroxin","Levothyroxine","NSC-36397","Synthetic levothyroxine","Thyroxine, l-"],"drugType":"Small molecule","mechanismOfAction":"Thyroid hormone receptor agonist","targetName":"Thyroid hormone receptor"}
{"drugId":"CHEMBL1201573","targetId":"ENSG00000137070","diseaseId":"MONDO_0018906","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00012298%22"}],"ancestors":["EFO_0007352","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0004805","MONDO_0017594","EFO_0005803","EFO_0000616"],"label":"follicular lymphoma","approvedSymbol":"IL11RA","approvedName":"interleukin 11 receptor subunit alpha","targetClass":["Membrane receptor"],"prefName":"OPRELVEKIN","tradeNames":["Neumega"],"synonyms":["Interleukin-11 (2-178)","Oprelvekin"],"drugType":"Protein","mechanismOfAction":"Interleukin 11 receptor alpha agonist","targetName":"Interleukin 11 receptor alpha"}
{"drugId":"CHEMBL2017974","targetId":"ENSG00000105647","diseaseId":"MONDO_0018906","phase":1,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02756247%22"}],"ancestors":["EFO_0007352","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0004805","MONDO_0017594","EFO_0005803","EFO_0000616"],"label":"follicular lymphoma","approvedSymbol":"PIK3R2","approvedName":"phosphoinositide-3-kinase regulatory subunit 2","targetClass":["Enzyme"],"prefName":"BUPARLISIB","tradeNames":[],"synonyms":["BKM-120","BKM-120NX","BKM120-NX","Bkm-120","Buparlisib","NVP-BKM-120","NVP-BKM120"],"drugType":"Small molecule","mechanismOfAction":"PI3-kinase class I inhibitor","targetName":"PI3-kinase class I"}
{"drugId":"CHEMBL2107358","targetId":"ENSG00000258643","diseaseId":"MONDO_0018906","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00538187%22"}],"ancestors":["EFO_0007352","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0004805","MONDO_0017594","EFO_0005803","EFO_0000616"],"label":"follicular lymphoma","approvedSymbol":"BCL2L2-PABPN1","approvedName":"BCL2L2-PABPN1 readthrough","targetClass":["Other cytosolic protein"],"prefName":"OBATOCLAX MESYLATE","tradeNames":[],"synonyms":["GX-15-070MS","GX15-070MS","Obatoclax","Obatoclax mesilate","Obatoclax mesylate"],"drugType":"Small molecule","mechanismOfAction":"Apoptosis regulator Bcl-W inhibitor","targetName":"Apoptosis regulator Bcl-W"}
{"drugId":"CHEMBL343448","targetId":"ENSG00000196591","diseaseId":"MONDO_0018906","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00079443%22"}],"ancestors":["EFO_0007352","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0004805","MONDO_0017594","EFO_0005803","EFO_0000616"],"label":"follicular lymphoma","approvedSymbol":"HDAC2","approvedName":"histone deacetylase 2","targetClass":["Unclassified protein","Epigenetic regulator"],"prefName":"ROMIDEPSIN","tradeNames":["Chromadax","Istodax"],"synonyms":["Depsipeptide","FK-228","FK228","FR-901228","FR901228","NSC-630176","Romidepsin"],"drugType":"Protein","mechanismOfAction":"Histone deacetylase inhibitor","targetName":"Histone deacetylase"}
{"drugId":"CHEMBL3989927","targetId":"ENSG00000113851","diseaseId":"MONDO_0018906","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03310619%22"}],"ancestors":["EFO_0007352","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0004805","MONDO_0017594","EFO_0005803","EFO_0000616"],"label":"follicular lymphoma","approvedSymbol":"CRBN","approvedName":"cereblon","targetClass":["Enzyme","Unclassified protein","Transcription factor","Epigenetic regulator"],"prefName":"IBERDOMIDE","tradeNames":[],"synonyms":["CC-220","Iberdomide"],"drugType":"Small molecule","mechanismOfAction":"CRL4(CRBN) E3 ubiquitin ligase modulator","targetName":"CRL4(CRBN) E3 ubiquitin ligase"}
{"drugId":"CHEMBL888","targetId":"ENSG00000167325","diseaseId":"MONDO_0018906","phase":1,"status":"Suspended","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03321643%22"}],"ancestors":["EFO_0007352","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0004805","MONDO_0017594","EFO_0005803","EFO_0000616"],"label":"follicular lymphoma","approvedSymbol":"RRM1","approvedName":"ribonucleotide reductase catalytic subunit M1","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"Ribonucleoside-diphosphate reductase RR1 inhibitor","targetName":"Ribonucleoside-diphosphate reductase RR1"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000258947","diseaseId":"MONDO_0018944","phase":3,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02639650%22"}],"ancestors":["MONDO_0002872","EFO_0000512","OTAR_0000017","MONDO_0023370","OTAR_0000014","EFO_1000051","EFO_0009549","MONDO_0021148","MONDO_0045024","MONDO_0700003","EFO_0000616","EFO_0009682"],"label":"gestational trophoblastic neoplasm","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL501867","targetId":"ENSG00000196230","diseaseId":"MONDO_0018975","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00846430%22"}],"ancestors":["EFO_0004260","OTAR_0000006","EFO_0009676","EFO_0002461","EFO_0009690","MONDO_0024458","EFO_0004264","MONDO_0042983","MONDO_0015356","EFO_0003966","MONDO_0015512","MONDO_0043218","MONDO_0000426","EFO_0000618","MONDO_0000429","MONDO_0019755","EFO_0000537","EFO_0000319","MONDO_0000473","OTAR_0000018","EFO_0008514","MONDO_0023370","MONDO_0021058","MONDO_0045024","EFO_0003086","MONDO_0800089","MONDO_0016756","EFO_0000508","MONDO_0018230","EFO_1001502","MONDO_0100191"],"label":"neurofibromatosis type 1","approvedSymbol":"TUBB","approvedName":"tubulin beta class I","targetClass":["Structural protein"],"prefName":"VINCRISTINE SULFATE","tradeNames":["Kyocristine","Leurocristine Sulfate","Marqibo kit","Oncovin","Vincasar","Vincasar pfs","Vincrex","Vincristine sulfate","Vincristine sulfate pfs"],"synonyms":["37231","Kyocristine","LILLY-37231","Marqibo","NSC-67574","Novopharm","Vincristine sulfate","Vincristine sulfate liposome","Vincristine sulphate","Vincristini sulfas","Vincrisul"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL90555","targetId":"ENSG00000101162","diseaseId":"MONDO_0019088","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02042391%22"}],"ancestors":["MONDO_0020083","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0005741","MONDO_0044881","MONDO_0045024","Orphanet_322126","MONDO_0100336","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0100321","MONDO_0021669","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0017342","MONDO_0017341","MONDO_0015760","EFO_0005803","MONDO_0017343","EFO_0000616"],"label":"post-transplant lymphoproliferative disease","approvedSymbol":"TUBB1","approvedName":"tubulin beta 1 class VI","targetClass":["Structural protein"],"prefName":"VINCRISTINE","tradeNames":[],"synonyms":["22-oxovincaleukoblastine","Leucristine","Leurocristine","Oncotcs","Tecnocris","Vincaleukoblastine, 22-oxo-","Vincristin","Vincristine","Vinkristin"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL256997","targetId":"ENSG00000142937","diseaseId":"MONDO_0019172","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04117880%22"}],"ancestors":["MONDO_0002289","EFO_0003966","OTAR_0000018","MONDO_0020145","MONDO_0020146","MONDO_0024458","MONDO_0019755","MONDO_0002661"],"label":"aniridia","approvedSymbol":"RPS8","approvedName":"ribosomal protein S8","targetClass":["Unclassified protein"],"prefName":"ATALUREN","tradeNames":[],"synonyms":["Ataluren","PTC-124","PTC124","Translarna"],"drugType":"Small molecule","mechanismOfAction":"80S Ribosome modulator","targetName":"80S Ribosome"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000119421","diseaseId":"MONDO_0019353","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04545736%22"}],"ancestors":["MONDO_0021084","OTAR_0000018","EFO_0008624","MONDO_0004580","MONDO_0024458","MONDO_0002175","MONDO_0020242","MONDO_0019118","EFO_0003966","MONDO_0020238","MONDO_0024417","EFO_0001365","EFO_0000508","EFO_0000618","EFO_0009606","MONDO_0016420","EFO_0003839"],"label":"Stargardt disease","approvedSymbol":"NDUFA8","approvedName":"NADH:ubiquinone oxidoreductase subunit A8","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1703","targetId":"ENSG00000198695","diseaseId":"MONDO_0019391","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03398824%22"}],"ancestors":["EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0019042","OTAR_0000020","MONDO_0002280","EFO_0009690","EFO_0002461","MONDO_0009332","MONDO_0001713","EFO_0005803","MONDO_0019755","OTAR_0000018","EFO_0008499","MONDO_0003225","EFO_0005541","MONDO_0000577","MONDO_0019054","MONDO_0019052","EFO_0003086","MONDO_0015909","EFO_0000589","MONDO_0100137","EFO_0000701","MONDO_0015327","EFO_0000540","MONDO_0015161","MONDO_0019288","EFO_0000508","MONDO_0019289","MONDO_0100191","EFO_0010285","MONDO_0019303","MONDO_0018454","MONDO_0018234"],"label":"Fanconi anemia","approvedSymbol":"MT-ND6","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6","targetClass":["Enzyme"],"prefName":"METFORMIN HYDROCHLORIDE","tradeNames":["Bolamyn sr","Diagemet xl","Fortamet","Glucamet 500","Glucamet 850","Glucient sr","Glucophage","Glucophage sr","Glucophage xr","Glumetza","Glyformin","Janumet","Ledermetin","Metabet sr","Metformin hydrochloride","Metsol","Milform","Orabet","Riomet","Riomet er","Sukkarto sr"],"synonyms":["Apophage","Benofomin","Diabefagos","Diabex","EX-404","EX404","Glucaminol","LA-6023","Metformin hcl","Metformin hydrochloride","NSC-91485","Neodipa","Siamformet","Walaphage"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL3137309","targetId":"ENSG00000171791","diseaseId":"MONDO_0019438","phase":1,"status":"Not yet recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05451771%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05486481%22"}],"ancestors":["OTAR_0000006","EFO_0009676","OTAR_0000020","EFO_0009690","EFO_0002630","EFO_0000618","EFO_1001875","EFO_0000318","EFO_0000538","MONDO_0003939","EFO_0000319","EFO_1002049","EFO_0009387","EFO_1001473","MONDO_0021179","EFO_0002970","EFO_0003100","MONDO_0000591","EFO_0003086","EFO_0000589","EFO_1000639","MONDO_0019724","EFO_0003777","MONDO_0015923","EFO_1001902","EFO_0004149","MONDO_0016330","MONDO_0016179"],"label":"AL amyloidosis","approvedSymbol":"BCL2","approvedName":"BCL2 apoptosis regulator","targetClass":["Ion channel"],"prefName":"VENETOCLAX","tradeNames":["Venclexta"],"synonyms":["ABT-199","GDC-0199","RG-7601","RG7601","Venetoclax"],"drugType":"Small molecule","mechanismOfAction":"Apoptosis regulator Bcl-2 inhibitor","targetName":"Apoptosis regulator Bcl-2"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000106628","diseaseId":"MONDO_0019469","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01529827%22"}],"ancestors":["OTAR_0000006","MONDO_0001475","EFO_0009676","MONDO_0001014","EFO_0004289","MONDO_0005374","EFO_0002461","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0001642","EFO_0000574","MONDO_0015757","MONDO_0024615","MONDO_0004805","EFO_0005803","EFO_0000616","MONDO_0000430","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0023370","MONDO_0045024","EFO_0002426","MONDO_0015822","EFO_0000540","MONDO_0017769","EFO_0000565","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0015760"],"label":"T-cell large granular lymphocyte leukemia","approvedSymbol":"POLD2","approvedName":"DNA polymerase delta 2, accessory subunit","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1201605","targetId":"ENSG00000134460","diseaseId":"MONDO_0019471","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01418430%22"}],"ancestors":["OTAR_0000006","MONDO_0021581","MONDO_0024294","EFO_0004289","MONDO_0005374","EFO_0002461","MONDO_0015817","MONDO_0100329","Orphanet_322126","Orphanet_68336","EFO_0001642","MONDO_0100321","EFO_0003820","MONDO_0023603","MONDO_0021669","MONDO_0004805","EFO_0005803","OTAR_0000018","MONDO_0002334","MONDO_0003225","MONDO_0002898","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0004198","MONDO_0003660","MONDO_0100336","EFO_0000701","EFO_0000540","EFO_0005952","EFO_0000508","EFO_1001303","MONDO_0019044","EFO_1001986","MONDO_0000637","MONDO_0017341","MONDO_0015760","EFO_0005592","EFO_0004260","EFO_0009676","MONDO_0000621","EFO_1000350","MONDO_0044881","EFO_0000574","MONDO_0017814","MONDO_0015757","MONDO_0015758","EFO_0000616","MONDO_0000653","EFO_0005741","MONDO_0021138","MONDO_0018898","MONDO_0017207","EFO_0000565","EFO_0000763","EFO_0007316","EFO_0010285"],"label":"adult T-cell leukemia/lymphoma","approvedSymbol":"IL2RA","approvedName":"interleukin 2 receptor subunit alpha","targetClass":["Membrane receptor"],"prefName":"DACLIZUMAB","tradeNames":["Zenapax","Zinbryta"],"synonyms":["Daclizumab","Daclizumab beta","RO 24-7375","RO-24-7375"],"drugType":"Antibody","mechanismOfAction":"Interleukin-2 receptor inhibitor","targetName":"Interleukin-2 receptor"}
{"drugId":"CHEMBL888","targetId":"ENSG00000167325","diseaseId":"MONDO_0019472","phase":4,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01501149%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01501136%22"}],"ancestors":["MONDO_0015817","MONDO_0044881","Orphanet_322126","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0100321","MONDO_0015757","MONDO_0021669","MONDO_0015758","EFO_0005803","EFO_0000616","OTAR_0000018","MONDO_0002334","MONDO_0002898","MONDO_0000653","EFO_0005741","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0004198","MONDO_0100336","MONDO_0018898","MONDO_0017207","EFO_0000701","EFO_0005952","EFO_0000508","MONDO_0017342","MONDO_0019044","MONDO_0017341","EFO_0010285","MONDO_0017343","MONDO_0015760"],"label":"extranodal nasal NK/T cell lymphoma","approvedSymbol":"RRM1","approvedName":"ribonucleotide reductase catalytic subunit M1","targetClass":["Enzyme"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"Ribonucleoside-diphosphate reductase RR1 inhibitor","targetName":"Ribonucleoside-diphosphate reductase RR1"}
{"drugId":"CHEMBL514800","targetId":"ENSG00000105650","diseaseId":"MONDO_0019558","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00708916%22"}],"ancestors":["EFO_0005140","OTAR_0000006","EFO_0003834","EFO_0009676","EFO_0005809","EFO_0000540","EFO_0005755","MONDO_0004670","EFO_0002461","EFO_1001986","EFO_1002003","MONDO_0015574"],"label":"discoid lupus erythematosus","approvedSymbol":"PDE4C","approvedName":"phosphodiesterase 4C","targetClass":["Enzyme"],"prefName":"APREMILAST","tradeNames":["Otezla"],"synonyms":["Apremilast","CC-10004","CC10004"],"drugType":"Small molecule","mechanismOfAction":"Phosphodiesterase 4 inhibitor","targetName":"Phosphodiesterase 4"}
{"drugId":"CHEMBL2028852","targetId":"ENSG00000168398","diseaseId":"MONDO_0019623","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00517582%22"}],"ancestors":["EFO_0000701","OTAR_0000018","EFO_0005531","EFO_0005532","MONDO_0019293","MONDO_0002406","EFO_0000508","EFO_0010285","EFO_0004264","EFO_0000319"],"label":"hereditary angioedema","approvedSymbol":"BDKRB2","approvedName":"bradykinin receptor B2","targetClass":["Membrane receptor"],"prefName":"ICATIBANT ACETATE","tradeNames":["Firazyr"],"synonyms":["HOE 140","HOE-140","Icatibant acetate"],"drugType":"Protein","mechanismOfAction":"Bradykinin B2 receptor antagonist","targetName":"Bradykinin B2 receptor"}
{"drugId":"CHEMBL4594272","targetId":"ENSG00000164344","diseaseId":"MONDO_0019623","phase":4,"urls":[{"niceName":"FDA","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214094s000lbl.pdf"}],"ancestors":["EFO_0000701","OTAR_0000018","EFO_0005531","EFO_0005532","MONDO_0019293","MONDO_0002406","EFO_0000508","EFO_0010285","EFO_0004264","EFO_0000319"],"label":"hereditary angioedema","approvedSymbol":"KLKB1","approvedName":"kallikrein B1","targetClass":["Enzyme"],"prefName":"BEROTRALSTAT HYDROCHLORIDE","tradeNames":["Orladeyo"],"synonyms":["BCX7353.2HCl","Berotralstat dihydrochloride","Berotralstat hydrochloride"],"drugType":"Small molecule","mechanismOfAction":"Plasma kallikrein inhibitor","targetName":"Plasma kallikrein"}
{"drugId":"CHEMBL1201825","targetId":"ENSG00000112715","diseaseId":"MONDO_0020204","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00456495%22"}],"ancestors":["EFO_0003824","EFO_0003966","EFO_0009546","EFO_0005950","MONDO_0023370","MONDO_0024458","MONDO_0045024","EFO_1000203","EFO_0000616"],"label":"conjunctival tumor","approvedSymbol":"VEGFA","approvedName":"vascular endothelial growth factor A","targetClass":["Secreted protein"],"prefName":"RANIBIZUMAB","tradeNames":["Lucentis"],"synonyms":["BCD-300","FAB-12 VARIANT Y0317","PF-582","Pf-582 (ranibizumab biosimilar)","Pf582","QL-1205","QL1205","RG-3645","RHUFAB","Ranibizumab","Ranibizumab biosimilar pf582","SB-11","SB11 (RANIBIZUMAB BIOSIMILAR)"],"drugType":"Antibody","mechanismOfAction":"Vascular endothelial growth factor A inhibitor","targetName":"Vascular endothelial growth factor A"}
{"drugId":"CHEMBL325041","targetId":"ENSG00000100804","diseaseId":"MONDO_0020547","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00815919%22"}],"ancestors":["EFO_0000540","MONDO_0013730"],"label":"chronic graft versus host disease","approvedSymbol":"PSMB5","approvedName":"proteasome 20S subunit beta 5","targetClass":["Enzyme"],"prefName":"BORTEZOMIB","tradeNames":["Velcade"],"synonyms":["Bortezomib","Bortezomib accord","Bortezomib hydrate","LDP-341","NSC-681239","PS-341","Velcade"],"drugType":"Small molecule","mechanismOfAction":"26S proteosome inhibitor","targetName":"26S proteasome"}
{"drugId":"CHEMBL483254","targetId":"ENSG00000147099","diseaseId":"MONDO_0020547","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01028313%22"}],"ancestors":["EFO_0000540","MONDO_0013730"],"label":"chronic graft versus host disease","approvedSymbol":"HDAC8","approvedName":"histone deacetylase 8","targetClass":["Epigenetic regulator"],"prefName":"PANOBINOSTAT","tradeNames":["Farydak"],"synonyms":["LBH-589","LBH589","Panobinostat","Panobinostat hydrate"],"drugType":"Small molecule","mechanismOfAction":"Histone deacetylase inhibitor","targetName":"Histone deacetylase"}
{"drugId":"CHEMBL1201733","targetId":"ENSG00000157404","diseaseId":"MONDO_0020654","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00471536%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01031875%22"}],"ancestors":["MONDO_0023370","EFO_0009690","MONDO_0024337","MONDO_0045024","MONDO_0004992","MONDO_0021066","MONDO_0037254","EFO_0000313","EFO_0008528","EFO_1000363","EFO_1000601","EFO_0006858","EFO_0000616"],"label":"renal pelvis/ureter urothelial carcinoma","approvedSymbol":"KIT","approvedName":"KIT proto-oncogene, receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"PAZOPANIB HYDROCHLORIDE","tradeNames":["Votrient"],"synonyms":["GW-786034B","GW786034B","Pazopanib (as hydrochloride)","Pazopanib hcl","Pazopanib hydrochloride","Pazopanib monohydrochloride"],"drugType":"Small molecule","mechanismOfAction":"Stem cell growth factor receptor inhibitor","targetName":"Stem cell growth factor receptor"}
{"drugId":"CHEMBL477772","targetId":"ENSG00000157404","diseaseId":"MONDO_0020654","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00471536%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01031875%22"}],"ancestors":["MONDO_0023370","EFO_0009690","MONDO_0024337","MONDO_0045024","MONDO_0004992","MONDO_0021066","MONDO_0037254","EFO_0000313","EFO_0008528","EFO_1000363","EFO_1000601","EFO_0006858","EFO_0000616"],"label":"renal pelvis/ureter urothelial carcinoma","approvedSymbol":"KIT","approvedName":"KIT proto-oncogene, receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"PAZOPANIB","tradeNames":["Votrient"],"synonyms":["GW786034","NSC-752782","Pazopanib"],"drugType":"Small molecule","mechanismOfAction":"Stem cell growth factor receptor inhibitor","targetName":"Stem cell growth factor receptor"}
{"drugId":"CHEMBL803","targetId":"ENSG00000198056","diseaseId":"MONDO_0020743","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02921061%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02212561%22"}],"ancestors":["MONDO_0004643","EFO_0004260","OTAR_0000006","EFO_0009676","MONDO_0021581","MONDO_0019460","MONDO_0000621","EFO_1000350","MONDO_0005374","EFO_0002461","MONDO_0044881","MONDO_0015756","EFO_0003820","EFO_1000068","EFO_0005803","EFO_0000616","MONDO_0003225","MONDO_0002334","MONDO_0023370","MONDO_0045024","MONDO_0021138","MONDO_0004992","EFO_0002427","EFO_0002428","EFO_0000222","EFO_0000540","EFO_0000565","EFO_1001986","MONDO_0000637","MONDO_0019044"],"label":"mixed phenotype acute leukemia","approvedSymbol":"PRIM1","approvedName":"DNA primase subunit 1","targetClass":["Enzyme"],"prefName":"CYTARABINE","tradeNames":["Alexan","Alexan 100","Cytarabine","Cytosar","Cytosar-u","Depocyt","Depocyte","Tarabine Pfs"],"synonyms":["Ara-c","Ara-cytidine","Arabinocytosine","Arabinosyl cytosine","Aracytidine","Aracytin","Aracytine","Cytarabine","Cytarabine liposome","Cytarabinoside","Cytarabinum","NSC-287459","Spongocytidine","U 19920a","U-19,920","U-19920"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000131495","diseaseId":"MONDO_0021063","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01440127%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0023370","EFO_0004288","MONDO_0024634","MONDO_0045024","MONDO_0004992","EFO_0004142","MONDO_0021118","EFO_0008549","EFO_0005842","MONDO_0002516","MONDO_0003409","EFO_0010282","EFO_0000616"],"label":"malignant colon neoplasm","approvedSymbol":"NDUFA2","approvedName":"NADH:ubiquinone oxidoreductase subunit A2","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000198886","diseaseId":"MONDO_0021063","phase":1,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01440127%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0023370","EFO_0004288","MONDO_0024634","MONDO_0045024","MONDO_0004992","EFO_0004142","MONDO_0021118","EFO_0008549","EFO_0005842","MONDO_0002516","MONDO_0003409","EFO_0010282","EFO_0000616"],"label":"malignant colon neoplasm","approvedSymbol":"MT-ND4","approvedName":"mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000004779","diseaseId":"MONDO_0021063","phase":2,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03047837%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0023370","EFO_0004288","MONDO_0024634","MONDO_0045024","MONDO_0004992","EFO_0004142","MONDO_0021118","EFO_0008549","EFO_0005842","MONDO_0002516","MONDO_0003409","EFO_0010282","EFO_0000616"],"label":"malignant colon neoplasm","approvedSymbol":"NDUFAB1","approvedName":"NADH:ubiquinone oxidoreductase subunit AB1","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL1642","targetId":"ENSG00000097007","diseaseId":"MONDO_0021063","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00041340%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0023370","EFO_0004288","MONDO_0024634","MONDO_0045024","MONDO_0004992","EFO_0004142","MONDO_0021118","EFO_0008549","EFO_0005842","MONDO_0002516","MONDO_0003409","EFO_0010282","EFO_0000616"],"label":"malignant colon neoplasm","approvedSymbol":"ABL1","approvedName":"ABL proto-oncogene 1, non-receptor tyrosine kinase","targetClass":["Enzyme"],"prefName":"IMATINIB MESYLATE","tradeNames":["Gleevec","Glivec","Imatinib mesylate"],"synonyms":["Gleevec","Imatinib (as mesilate)","Imatinib accord","Imatinib medac","Imatinib mesilate","Imatinib mesylate","Imatinib methane sulfonate","Imatinib methanesulfonate","NSC-716051","QTI-571","QTI571","Qti571","STI 571","STI-571","STI571"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase ABL inhibitor","targetName":"Tyrosine-protein kinase ABL"}
{"drugId":"CHEMBL2108738","targetId":"ENSG00000188389","diseaseId":"MONDO_0021063","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04123925%22"}],"ancestors":["EFO_0007330","EFO_0009431","MONDO_0023370","EFO_0004288","MONDO_0024634","MONDO_0045024","MONDO_0004992","EFO_0004142","MONDO_0021118","EFO_0008549","EFO_0005842","MONDO_0002516","MONDO_0003409","EFO_0010282","EFO_0000616"],"label":"malignant colon neoplasm","approvedSymbol":"PDCD1","approvedName":"programmed cell death 1","targetClass":["Surface antigen"],"prefName":"NIVOLUMAB","tradeNames":["Opdivo"],"synonyms":["BMS-936558","BMS-986298","MDX-1106","Nivolumab","ONO-4538"],"drugType":"Antibody","mechanismOfAction":"Programmed cell death protein 1 inhibitor","targetName":"Programmed cell death protein 1"}
{"drugId":"CHEMBL1342","targetId":"ENSG00000136928","diseaseId":"MONDO_0021107","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00049803%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00132873%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00066170%22"}],"ancestors":["EFO_0000677","MONDO_0002025","OTAR_0000018","MONDO_0003406","EFO_0005774","EFO_0008568","EFO_0000618","EFO_0000508","EFO_0009386"],"label":"narcolepsy","approvedSymbol":"GABBR2","approvedName":"gamma-aminobutyric acid type B receptor subunit 2","targetClass":["Membrane receptor"],"prefName":"OXYBATE","tradeNames":[],"synonyms":[".gamma.-hydroxybutyrate","Gamma hydroxybutyrate","Gamma-hydroxybutyrate","Oxybate","Xyrem"],"drugType":"Small molecule","mechanismOfAction":"GABA-B receptor agonist","targetName":"GABA-B receptor"}
{"drugId":"CHEMBL428647","targetId":"ENSG00000137285","diseaseId":"MONDO_0021115","phase":1,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03356860%22"}],"ancestors":["OTAR_0000017","MONDO_0021350","MONDO_0023370","MONDO_0007254","MONDO_0045024","MONDO_0004992","EFO_0009483","MONDO_0003274","EFO_0003869","EFO_0000313","EFO_0000305","EFO_1000143","EFO_0010285","EFO_0006858","EFO_0000306","EFO_0000616"],"label":"luminal B breast carcinoma","approvedSymbol":"TUBB2B","approvedName":"tubulin beta 2B class IIb","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1738797","targetId":"ENSG00000143924","diseaseId":"MONDO_0021117","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05081674%22"}],"ancestors":["MONDO_0021350","EFO_0009433","EFO_0000684","EFO_0003853","MONDO_0023370","OTAR_0000010","MONDO_0045024","EFO_0003818","EFO_0000616"],"label":"lung neoplasm","approvedSymbol":"EML4","approvedName":"EMAP like 4","targetClass":["Enzyme"],"prefName":"ALECTINIB","tradeNames":["Alecensa"],"synonyms":["AF-802","AF802","Alectinib","CH-5424802","CH5424802","RO-5424802","RO5424802"],"drugType":"Small molecule","mechanismOfAction":"EML4-ALK","targetName":"EML4-ALK "}
{"drugId":"CHEMBL428647","targetId":"ENSG00000137285","diseaseId":"MONDO_0021148","phase":1,"status":"Unknown status","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02739529%22"}],"ancestors":["EFO_0000512","OTAR_0000017","MONDO_0023370","EFO_1000051","EFO_0009549","MONDO_0045024","EFO_0000616"],"label":"female reproductive system neoplasm","approvedSymbol":"TUBB2B","approvedName":"tubulin beta 2B class IIb","targetClass":["Structural protein"],"prefName":"PACLITAXEL","tradeNames":["Abraxane","Pacitaxel","Paclitaxel","Paxene","Taxol","Taxol 100"],"synonyms":["(-)-paclitaxel","ABI-007","ABI-007 COMPONENT PACLITAXEL","BMS 181339-01","BMS-181339-01","Capxol","Cyclopax","DHP 107","DHP-107","Ebetaxel","Empac","Endotag 1","Genaxol","Genetaxyl","Genexol","Genexol-pm","Intaxel","Lep-etu","MBT 0206","MBT-0206","Mitotax","NK 105","NK-105","NSC-125973","Oncogel","Onxal","Onxol","Pacliex","Paclitaxel","Paclitaxel (taxus canadensis)","Paclitaxol","Plaxicel","QW-8184","Taxalbin","Taxol","Taxol a","Taxus","Taxus liberte","Taxus stent","Tocosol paclitaxel","Yewtaxan"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL269732","targetId":"ENSG00000088832","diseaseId":"MONDO_0021193","phase":0,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02653196%22"}],"ancestors":["MONDO_0023370","EFO_0000618","MONDO_0021248","MONDO_0045024","EFO_0000616"],"label":"neuroepithelial neoplasm","approvedSymbol":"FKBP1A","approvedName":"FKBP prolyl isomerase 1A","targetClass":["Enzyme"],"prefName":"TACROLIMUS","tradeNames":["Prograf","Protopic","Tacrolimus"],"synonyms":["FK-506","FK506","FR-900506","NSC-758659","Tacrolimus monohydrate"],"drugType":"Small molecule","mechanismOfAction":"FK506-binding protein 1A inhibitor","targetName":"FK506-binding protein 1A"}
{"drugId":"CHEMBL159","targetId":"ENSG00000258947","diseaseId":"MONDO_0021637","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01884922%22"}],"ancestors":["MONDO_0021193","EFO_0005543","MONDO_0023370","EFO_0000618","MONDO_0021248","MONDO_0045024","EFO_0009386","EFO_0000616"],"label":"low grade glioma","approvedSymbol":"TUBB3","approvedName":"tubulin beta 3 class III","targetClass":["Structural protein"],"prefName":"VINBLASTINE","tradeNames":[],"synonyms":["NSC-47842","Velban","Vinblastine","[3H]-Vinblastine"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL24","targetId":"ENSG00000043591","diseaseId":"MONDO_0021661","phase":4,"urls":[{"niceName":"DailyMed","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2cc8b659-bd69-4ecc-9b7f-9968ece05357"}],"ancestors":["MONDO_0000473","MONDO_0002277","EFO_0001645","EFO_0003777","EFO_0009085","EFO_0004264","EFO_0009086","EFO_0000319","EFO_0003914"],"label":"coronary atherosclerosis","approvedSymbol":"ADRB1","approvedName":"adrenoceptor beta 1","targetClass":["Membrane receptor"],"prefName":"ATENOLOL","tradeNames":["Antipressan","Atenamin","Atenix-100","Atenix-25","Atenix-50","Atenolol","Ibinolo","Kentol","Tenormin","Tenormin 25","Tenormin l.s.","Totamol","Unibloc","Vasaten"],"synonyms":["Atenolol","Atenololum","Betacard","C07AB03","Corotenol","Duraatenolol","Esatenolol","ICI 66,082","ICI 66082","ICI-66082","Juvental","Myocord","NSC-757832","Novaten","Prenormine","Urosin"],"drugType":"Small molecule","mechanismOfAction":"Beta-1 adrenergic receptor antagonist","targetName":"Beta-1 adrenergic receptor"}
{"drugId":"CHEMBL1980297","targetId":"ENSG00000254087","diseaseId":"MONDO_0024880","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02540876%22"}],"ancestors":["EFO_0009812","MONDO_0023370","MONDO_0045024","MONDO_0004992","MONDO_0024882","EFO_0000616","EFO_0009709"],"label":"metastatic malignant neoplasm","approvedSymbol":"LYN","approvedName":"LYN proto-oncogene, Src family tyrosine kinase","targetClass":["Enzyme"],"prefName":"ILORASERTIB","tradeNames":["Abt-348, a-968660"],"synonyms":["A-968660","A-968660.0","ABBOTT-968660","ABT-348","Abt-348","Ilorasertib"],"drugType":"Small molecule","mechanismOfAction":"SRC inhibitor","targetName":"SRC"}
{"drugId":"CHEMBL477772","targetId":"ENSG00000037280","diseaseId":"MONDO_0024880","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01165385%22"}],"ancestors":["EFO_0009812","MONDO_0023370","MONDO_0045024","MONDO_0004992","MONDO_0024882","EFO_0000616","EFO_0009709"],"label":"metastatic malignant neoplasm","approvedSymbol":"FLT4","approvedName":"fms related receptor tyrosine kinase 4","targetClass":["Enzyme"],"prefName":"PAZOPANIB","tradeNames":["Votrient"],"synonyms":["GW786034","NSC-752782","Pazopanib"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL506871","targetId":"ENSG00000129484","diseaseId":"MONDO_0024880","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02595905%22"}],"ancestors":["EFO_0009812","MONDO_0023370","MONDO_0045024","MONDO_0004992","MONDO_0024882","EFO_0000616","EFO_0009709"],"label":"metastatic malignant neoplasm","approvedSymbol":"PARP2","approvedName":"poly(ADP-ribose) polymerase 2","targetClass":["Enzyme"],"prefName":"VELIPARIB","tradeNames":[],"synonyms":["ABT-888","PARP-1 INHIBITOR ABT-888","Veliparib"],"drugType":"Small molecule","mechanismOfAction":"PARP 1, 2 and 3 inhibitor","targetName":"PARP 1, 2 and 3"}
{"drugId":"CHEMBL535","targetId":"ENSG00000037280","diseaseId":"MONDO_0024880","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00814021%22"}],"ancestors":["EFO_0009812","MONDO_0023370","MONDO_0045024","MONDO_0004992","MONDO_0024882","EFO_0000616","EFO_0009709"],"label":"metastatic malignant neoplasm","approvedSymbol":"FLT4","approvedName":"fms related receptor tyrosine kinase 4","targetClass":["Enzyme"],"prefName":"SUNITINIB","tradeNames":["Sutent"],"synonyms":["NSC-736511","NSC-750690","SU-011248","SU-11248","SU011248","Sunitinib","Sutent"],"drugType":"Small molecule","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","targetName":"Vascular endothelial growth factor receptor"}
{"drugId":"CHEMBL535","targetId":"ENSG00000134853","diseaseId":"MONDO_0024880","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00814021%22"}],"ancestors":["EFO_0009812","MONDO_0023370","MONDO_0045024","MONDO_0004992","MONDO_0024882","EFO_0000616","EFO_0009709"],"label":"metastatic malignant neoplasm","approvedSymbol":"PDGFRA","approvedName":"platelet derived growth factor receptor alpha","targetClass":["Enzyme"],"prefName":"SUNITINIB","tradeNames":["Sutent"],"synonyms":["NSC-736511","NSC-750690","SU-011248","SU-11248","SU011248","Sunitinib","Sutent"],"drugType":"Small molecule","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","targetName":"Platelet-derived growth factor receptor"}
{"drugId":"CHEMBL58323","targetId":"ENSG00000169432","diseaseId":"MONDO_0041052","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00861068%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00238511%22"}],"ancestors":["MONDO_0100336","EFO_0009387","MONDO_0100321","MONDO_0021669","EFO_0005741","EFO_1001902","EFO_0004149","EFO_0000618","MONDO_0700057","EFO_0003100","MONDO_0021677","EFO_0009430"],"label":"postherpetic neuralgia","approvedSymbol":"SCN9A","approvedName":"sodium voltage-gated channel alpha subunit 9","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"ERLOSAMIDE","tradeNames":["Lacosamide","Vimpat"],"synonyms":["(r)-lacosamide 1","ADD 243037","ADD-243037","Erlosamide","Lacosamide","Lacosamide cv","SPM 927","SPM-927"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL698","targetId":"ENSG00000169432","diseaseId":"MONDO_0041052","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00609323%22"}],"ancestors":["MONDO_0100336","EFO_0009387","MONDO_0100321","MONDO_0021669","EFO_0005741","EFO_1001902","EFO_0004149","EFO_0000618","MONDO_0700057","EFO_0003100","MONDO_0021677","EFO_0009430"],"label":"postherpetic neuralgia","approvedSymbol":"SCN9A","approvedName":"sodium voltage-gated channel alpha subunit 9","targetClass":["Auxiliary transport protein","Ion channel"],"prefName":"TETRACAINE","tradeNames":["Ametop","Dicaine","Medihaler-tetracaine","Metraspray","Pontocaine"],"synonyms":["Amethocaine","Tetracaine"],"drugType":"Small molecule","mechanismOfAction":"Sodium channel alpha subunit blocker","targetName":"Sodium channel alpha subunit"}
{"drugId":"CHEMBL526","targetId":"ENSG00000166206","diseaseId":"MONDO_0043510","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00538616%22"}],"ancestors":["EFO_0000546","EFO_0005774","EFO_0009490","EFO_0000618","OTAR_0000009","EFO_0009386"],"label":"brain injury","approvedSymbol":"GABRB3","approvedName":"gamma-aminobutyric acid type A receptor subunit beta3","targetClass":["Ion channel"],"prefName":"PROPOFOL","tradeNames":["Diprivan","Disoprivan","Propofol","Rapinovet"],"synonyms":["Disoprofol","Fresofol","ICI 35,868","ICI 35-868","ICI-35868","ICI35,868","Lipuro","NSC-5105","Phenol, 2,6-bis(1-methylethyl)","Propofol"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL526","targetId":"ENSG00000022355","diseaseId":"MONDO_0043510","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01007773%22"}],"ancestors":["EFO_0000546","EFO_0005774","EFO_0009490","EFO_0000618","OTAR_0000009","EFO_0009386"],"label":"brain injury","approvedSymbol":"GABRA1","approvedName":"gamma-aminobutyric acid type A receptor subunit alpha1","targetClass":["Ion channel"],"prefName":"PROPOFOL","tradeNames":["Diprivan","Disoprivan","Propofol","Rapinovet"],"synonyms":["Disoprofol","Fresofol","ICI 35,868","ICI 35-868","ICI-35868","ICI35,868","Lipuro","NSC-5105","Phenol, 2,6-bis(1-methylethyl)","Propofol"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL897","targetId":"ENSG00000149452","diseaseId":"MONDO_0043510","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01322009%22"}],"ancestors":["EFO_0000546","EFO_0005774","EFO_0009490","EFO_0000618","OTAR_0000009","EFO_0009386"],"label":"brain injury","approvedSymbol":"SLC22A8","approvedName":"solute carrier family 22 member 8","targetClass":["Transporter"],"prefName":"PROBENECID","tradeNames":["Benemid","Benuryl","Probalan","Probampicin","Probecid","Probenecid"],"synonyms":["HC 5006","NSC-18786","Probenate","Probenecid","Probenecidum"],"drugType":"Small molecule","mechanismOfAction":"Solute carrier family 22 member 8 inhibitor","targetName":"Solute carrier family 22 member 8"}
{"drugId":"CHEMBL92","targetId":"ENSG00000196230","diseaseId":"MONDO_0044787","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03493425%22"}],"ancestors":["MONDO_0002532","MONDO_0002038","MONDO_0023370","EFO_0005950","MONDO_0056819","MONDO_0045024","EFO_0000181","MONDO_0004992","EFO_0000313","EFO_0000707","EFO_0006858","MONDO_0056820","EFO_0006859","EFO_0000616"],"label":"nasal cavity and paranasal sinus squamous cell carcinoma","approvedSymbol":"TUBB","approvedName":"tubulin beta class I","targetClass":["Structural protein"],"prefName":"DOCETAXEL","tradeNames":[],"synonyms":["RP-56976","Taxotere"],"drugType":"Small molecule","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL888","targetId":"ENSG00000100479","diseaseId":"MONDO_0044791","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05211323%22"}],"ancestors":["MONDO_0003059","MONDO_0024276","MONDO_0002665","MONDO_0002887","EFO_0009534","MONDO_0021069","MONDO_0003193","EFO_0003891","MONDO_0024477","MONDO_0021385","MONDO_0021662","MONDO_0021321","EFO_0003769","EFO_0000313","MONDO_0003060","EFO_0001421","EFO_0006858","EFO_0000616","EFO_0005540","MONDO_0023370","MONDO_0018918","MONDO_0045024","MONDO_0004992","MONDO_0002691","EFO_0008550","MONDO_0018536","EFO_1000218","EFO_0000228","EFO_0001379","MONDO_0003090","EFO_0008549","MONDO_0002516","MONDO_0018532","EFO_0010284","MONDO_0018531","EFO_0010282"],"label":"combined hepatocellular carcinoma and cholangiocarcinoma","approvedSymbol":"POLE2","approvedName":"DNA polymerase epsilon 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"GEMCITABINE","tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000148229","diseaseId":"MONDO_0044881","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00051311%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01572181%22"}],"ancestors":["MONDO_0002334","MONDO_0023370","MONDO_0045024","EFO_0005803","EFO_0000616"],"label":"hematopoietic and lymphoid cell neoplasm","approvedSymbol":"POLE3","approvedName":"DNA polymerase epsilon 3, accessory subunit","targetClass":["Unclassified protein"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1195136","targetId":"ENSG00000096384","diseaseId":"MONDO_0044881","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00595686%22"}],"ancestors":["MONDO_0002334","MONDO_0023370","MONDO_0045024","EFO_0005803","EFO_0000616"],"label":"hematopoietic and lymphoid cell neoplasm","approvedSymbol":"HSP90AB1","approvedName":"heat shock protein 90 alpha family class B member 1","targetClass":["Unclassified protein","Other cytosolic protein"],"prefName":"SNX 5422","tradeNames":[],"synonyms":["Pf-04929113","Pf-4929113","Snx 5422","Snx-5422"],"drugType":"Small molecule","mechanismOfAction":"Heat shock protein HSP90 inhibitor","targetName":"Heat shock protein HSP90"}
{"drugId":"CHEMBL1489","targetId":"ENSG00000119772","diseaseId":"MONDO_0044881","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01039155%22"}],"ancestors":["MONDO_0002334","MONDO_0023370","MONDO_0045024","EFO_0005803","EFO_0000616"],"label":"hematopoietic and lymphoid cell neoplasm","approvedSymbol":"DNMT3A","approvedName":"DNA methyltransferase 3 alpha","targetClass":["Epigenetic regulator"],"prefName":"AZACITIDINE","tradeNames":["Azacitidine","Onureg","Vidaza"],"synonyms":["5-azacitidine","Azacitidine","Ladakamycin","NSC-102816","U-18,496","U-18496","Vidaza"],"drugType":"Small molecule","mechanismOfAction":"DNA (cytosine-5)-methyltransferase 3A inhibitor","targetName":"DNA (cytosine-5)-methyltransferase 3A"}
{"drugId":"CHEMBL225072","targetId":"ENSG00000228716","diseaseId":"MONDO_0044887","phase":2,"status":"Withdrawn","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00712062%22"}],"ancestors":["EFO_0007352","MONDO_0000621","MONDO_0044881","MONDO_0021248","EFO_0007392","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0100321","MONDO_0021669","EFO_0000618","MONDO_0004805","EFO_0005803","EFO_0000616","MONDO_0003641","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0005741","MONDO_0004095","EFO_0000096","MONDO_0045024","MONDO_0004992","EFO_0009386","MONDO_0100336","MONDO_0017207","EFO_0000326","EFO_0000540","EFO_0005952","EFO_1000157","EFO_0000508","MONDO_0019044","MONDO_0017342","MONDO_0017341","MONDO_0017343","EFO_1000158"],"label":"central nervous system non-hodgkin lymphoma","approvedSymbol":"DHFR","approvedName":"dihydrofolate reductase","targetClass":["Enzyme"],"prefName":"PEMETREXED","tradeNames":["Alimta","Pemfexy"],"synonyms":["LY-2315","LY-231514","LY231514","NSC-698037","Pemetrexed"],"drugType":"Small molecule","mechanismOfAction":"Dihydrofolate reductase inhibitor","targetName":"Dihydrofolate reductase"}
{"drugId":"CHEMBL384467","targetId":"ENSG00000113580","diseaseId":"MONDO_0044887","phase":1,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05036577%22"}],"ancestors":["EFO_0007352","MONDO_0000621","MONDO_0044881","MONDO_0021248","EFO_0007392","MONDO_0044986","Orphanet_322126","EFO_1001938","Orphanet_68336","EFO_0000574","EFO_0001642","MONDO_0015757","MONDO_0100321","MONDO_0021669","EFO_0000618","MONDO_0004805","EFO_0005803","EFO_0000616","MONDO_0003641","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0005741","MONDO_0004095","EFO_0000096","MONDO_0045024","MONDO_0004992","EFO_0009386","MONDO_0100336","MONDO_0017207","EFO_0000326","EFO_0000540","EFO_0005952","EFO_1000157","EFO_0000508","MONDO_0019044","MONDO_0017342","MONDO_0017341","MONDO_0017343","EFO_1000158"],"label":"central nervous system non-hodgkin lymphoma","approvedSymbol":"NR3C1","approvedName":"nuclear receptor subfamily 3 group C member 1","targetClass":["Transcription factor"],"prefName":"DEXAMETHASONE","tradeNames":["Aeroseb-dex","Dalalone","Decaderm","Decadron","Decadron-75","Decaspray","Dexacortisyl","Dexafree","Dexamethasone","Dexamethasone intensol","Dexone","Dexone 0.5","Dexone 0.75","Dexone 1.5","Dexone 4","Dexsol","Dextenza","Dexycu kit","Dropodex","Gppe ear spy","Hemady","Hexadrol","Kortico Injection","Martapan","Maxidex","Maxitrol","Oradexon","Otomize","Ozurdex","Sofradex","Spersadex comp","Tobradex"],"synonyms":["Decadron-LA","Dexacen-4","Dexacort","Dexair","Dexamethasone","Dexamethasone metasulfobenzoate sodium","Dexamethasone palmitate","Dexamethasone valerate","Dexycu","Fluormethylprednisolone","ISV-305","Mymethasone","NSC-34521","Neodecadron","OTO-104"],"drugType":"Small molecule","mechanismOfAction":"Glucocorticoid receptor agonist","targetName":"Glucocorticoid receptor"}
{"drugId":"CHEMBL1637","targetId":"ENSG00000100479","diseaseId":"MONDO_0044889","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03418038%22"}],"ancestors":["EFO_0007352","OTAR_0000018","MONDO_0002334","MONDO_0023370","EFO_0000096","MONDO_0004095","MONDO_0044881","MONDO_0045024","MONDO_0044986","Orphanet_322126","EFO_1001938","EFO_0000403","Orphanet_68336","EFO_0000574","EFO_0001642","EFO_0000540","MONDO_0015757","EFO_0005952","EFO_0000508","MONDO_0019044","MONDO_0017595","MONDO_0004805","EFO_0005803","EFO_0000616"],"label":"high grade B-cell lymphoma","approvedSymbol":"POLE2","approvedName":"DNA polymerase epsilon 2, accessory subunit","targetClass":["Unclassified protein"],"prefName":"GEMCITABINE HYDROCHLORIDE","tradeNames":["Gemcitabine hydrochloride","Gemzar","Infugem"],"synonyms":["Gemcitabine (as hydrochloride)","Gemcitabine hcl","Gemcitabine hydrochloride","Gemzar","LY-188011","LY-188011 HYDROCHLORIDE","LY188011 HYDROCHLORIDE"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1096882","targetId":"ENSG00000101868","diseaseId":"MONDO_0044903","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02167958%22"}],"ancestors":["OTAR_0000006","EFO_0009676","MONDO_0003225","EFO_0000540","EFO_0002461","EFO_0005803"],"label":"myelofibrosis","approvedSymbol":"POLA1","approvedName":"DNA polymerase alpha 1, catalytic subunit","targetClass":["Enzyme"],"prefName":"FLUDARABINE PHOSPHATE","tradeNames":["Fludara","Fludarabine phosphate","Oforta"],"synonyms":["2-f-ara-amp","2-f-araa","2-fluoro ara-a","2-fluorovidarabine","Fludarabine","Fludarabine 5'-monophosphate","Fludarabine monophosphate","Fludarabine phosphate","Fluradosa","NSC-118218","NSC-118218H","NSC-312887","NSC-328002"],"drugType":"Small molecule","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","targetName":"DNA polymerase (alpha/delta/epsilon)"}
{"drugId":"CHEMBL1200694","targetId":"ENSG00000094755","diseaseId":"MONDO_0100096","phase":4,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04359862%22"}],"ancestors":["EFO_0007396","MONDO_0100336","EFO_0007223","MONDO_0100321","EFO_0000763","EFO_0005741","MONDO_0020753","MONDO_0100318","MONDO_0100329"],"label":"COVID-19","approvedSymbol":"GABRP","approvedName":"gamma-aminobutyric acid type A receptor subunit pi","targetClass":["Ion channel"],"prefName":"SEVOFLURANE","tradeNames":["Sevoflurane","Sojourn","Ultane"],"synonyms":["MR-6S4","MR6S4","NSC-760367","Sevocalm","Sevoflo","Sevoflurane","Sevorane"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL1200694","targetId":"ENSG00000166206","diseaseId":"MONDO_0100096","phase":4,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04359862%22"}],"ancestors":["EFO_0007396","MONDO_0100336","EFO_0007223","MONDO_0100321","EFO_0000763","EFO_0005741","MONDO_0020753","MONDO_0100318","MONDO_0100329"],"label":"COVID-19","approvedSymbol":"GABRB3","approvedName":"gamma-aminobutyric acid type A receptor subunit beta3","targetClass":["Ion channel"],"prefName":"SEVOFLURANE","tradeNames":["Sevoflurane","Sojourn","Ultane"],"synonyms":["MR-6S4","MR6S4","NSC-760367","Sevocalm","Sevoflo","Sevoflurane","Sevorane"],"drugType":"Small molecule","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","targetName":"GABA-A receptor; anion channel"}
{"drugId":"CHEMBL1201476","targetId":"ENSG00000117601","diseaseId":"MONDO_0100096","phase":4,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04406389%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04512079%22"}],"ancestors":["EFO_0007396","MONDO_0100336","EFO_0007223","MONDO_0100321","EFO_0000763","EFO_0005741","MONDO_0020753","MONDO_0100318","MONDO_0100329"],"label":"COVID-19","approvedSymbol":"SERPINC1","approvedName":"serpin family C member 1","targetClass":["Enzyme","Secreted protein"],"prefName":"ENOXAPARIN SODIUM","tradeNames":["Clexane","Enoxaparin sodium","Enoxaparin sodium (preservative free)","Lovenox","Lovenox (preservative free)"],"synonyms":["Enoxaparin","Enoxaparin sodium","Enoxaparin sodium salt","Klexane","PK 10169","PK-10169","RP 54563","RP-54563"],"drugType":"Oligosaccharide","mechanismOfAction":"Antithrombin-III activator","targetName":"Antithrombin-III"}
{"drugId":"CHEMBL1237022","targetId":"ENSG00000160712","diseaseId":"MONDO_0100096","phase":3,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04403685%22"}],"ancestors":["EFO_0007396","MONDO_0100336","EFO_0007223","MONDO_0100321","EFO_0000763","EFO_0005741","MONDO_0020753","MONDO_0100318","MONDO_0100329"],"label":"COVID-19","approvedSymbol":"IL6R","approvedName":"interleukin 6 receptor","targetClass":["Membrane receptor","Secreted protein"],"prefName":"TOCILIZUMAB","tradeNames":["Actemra","Actemra roactemra","Roactemra"],"synonyms":["ATLIZUMAB","Actemra","BAT-1806","BAT1806","Bat1806","MRA","MSB-11456","MSB11456","R-1569","RG-1569","RHPM-1","RO-4877533","Tocilizumab"],"drugType":"Antibody","mechanismOfAction":"Interleukin-6 receptor alpha subunit inhibitor","targetName":"Interleukin-6 receptor alpha subunit"}
{"drugId":"CHEMBL163","targetId":"ENSG00000106258","diseaseId":"MONDO_0100096","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04960202%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04303299%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05047601%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04364022%22"}],"ancestors":["EFO_0007396","MONDO_0100336","EFO_0007223","MONDO_0100321","EFO_0000763","EFO_0005741","MONDO_0020753","MONDO_0100318","MONDO_0100329"],"label":"COVID-19","approvedSymbol":"CYP3A5","approvedName":"cytochrome P450 family 3 subfamily A member 5","targetClass":["Enzyme"],"prefName":"RITONAVIR","tradeNames":["Norvir","Ritonavir"],"synonyms":["A-84538","ABBOTT-84538","ABT-538","Empetus","NSC-693184","Norvir","Ritomune","Ritonavir","Ritonavir related compounds mixture","Ritonavirum","Ritovir","Viekirax","Viriton"],"drugType":"Small molecule","mechanismOfAction":"Cytochrome P450 3A inhibitor","targetName":"Cytochrome P450 3A"}
{"drugId":"CHEMBL2103830","targetId":"ENSG00000165025","diseaseId":"MONDO_0100096","phase":2,"status":"Recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT04924660%22"}],"ancestors":["EFO_0007396","MONDO_0100336","EFO_0007223","MONDO_0100321","EFO_0000763","EFO_0005741","MONDO_0020753","MONDO_0100318","MONDO_0100329"],"label":"COVID-19","approvedSymbol":"SYK","approvedName":"spleen associated tyrosine kinase","targetClass":["Enzyme"],"prefName":"FOSTAMATINIB","tradeNames":[],"synonyms":["Fostamatinib","R-788","R-788 FREE ACID","R-935788","R-935788 FREE ACID","R788 FREE ACID","R935788 FREE ACID"],"drugType":"Small molecule","mechanismOfAction":"Tyrosine-protein kinase SYK inhibitor","targetName":"Tyrosine-protein kinase SYK"}
{"drugId":"CHEMBL932","targetId":"ENSG00000133256","diseaseId":"MONDO_0100096","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT05166876%22"}],"ancestors":["EFO_0007396","MONDO_0100336","EFO_0007223","MONDO_0100321","EFO_0000763","EFO_0005741","MONDO_0020753","MONDO_0100318","MONDO_0100329"],"label":"COVID-19","approvedSymbol":"PDE6B","approvedName":"phosphodiesterase 6B","targetClass":["Enzyme"],"prefName":"DIPYRIDAMOLE","tradeNames":["Attia","Cerebrovase 100","Cerebrovase 25","Dipyridamole","Iv persantine","Modaplate","Ofcram pr","Persantin","Persantin ret","Persantine","Pyridantin","Vasyrol"],"synonyms":["B01AC07","Dipyridamole","NSC-515776","RA-8"],"drugType":"Small molecule","mechanismOfAction":"3',5'-cyclic phosphodiesterase inhibitor","targetName":"3',5'-cyclic phosphodiesterase"}
{"drugId":"CHEMBL1089636","targetId":"ENSG00000176014","diseaseId":"MONDO_0100342","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00539344%22"}],"ancestors":["MONDO_0021193","MONDO_0023370","EFO_0005543","MONDO_0021248","MONDO_0045024","MONDO_0020665","EFO_0007392","MONDO_0004992","EFO_0009386","EFO_0000326","EFO_0000618","EFO_1000158","EFO_0000616"],"label":"malignant glioma","approvedSymbol":"TUBB6","approvedName":"tubulin beta 6 class V","targetClass":["Structural protein"],"prefName":"ANG1005","tradeNames":[],"synonyms":["ANG-1005","ANG1005","Ang1005","Paclitaxel trevatide"],"drugType":"Protein","mechanismOfAction":"Tubulin inhibitor","targetName":"Tubulin"}
{"drugId":"CHEMBL1421","targetId":"ENSG00000125508","diseaseId":"MONDO_0100342","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03352427%22"}],"ancestors":["MONDO_0021193","MONDO_0023370","EFO_0005543","MONDO_0021248","MONDO_0045024","MONDO_0020665","EFO_0007392","MONDO_0004992","EFO_0009386","EFO_0000326","EFO_0000618","EFO_1000158","EFO_0000616"],"label":"malignant glioma","approvedSymbol":"SRMS","approvedName":"src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites","targetClass":["Enzyme"],"prefName":"DASATINIB","tradeNames":["Dasatinib","Sprycel"],"synonyms":["BMS-354825","BMS-354825 HYDRATE","BMS-354825-03","Dasatinib","Dasatinib anhydrous","Dasatinib hydrate","Dasatinib monohydrate","NSC-759877"],"drugType":"Small molecule","mechanismOfAction":"SRC inhibitor","targetName":"SRC"}
{"drugId":"CHEMBL1200694","targetId":"ENSG00000171303","diseaseId":"MP_0001914","phase":4,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01048658%22"}],"ancestors":["HP_0001871","EFO_0000651","HP_0000118"],"label":"hemorrhage","approvedSymbol":"KCNK3","approvedName":"potassium two pore domain channel subfamily K member 3","targetClass":["Ion channel"],"prefName":"SEVOFLURANE","tradeNames":["Sevoflurane","Sojourn","Ultane"],"synonyms":["MR-6S4","MR6S4","NSC-760367","Sevocalm","Sevoflo","Sevoflurane","Sevorane"],"drugType":"Small molecule","mechanismOfAction":"Potassium channel subfamily K member 3 opener","targetName":"Potassium channel subfamily K member 3"}
{"drugId":"CHEMBL2103975","targetId":"ENSG00000162009","diseaseId":"MP_0001914","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00331188%22"}],"ancestors":["HP_0001871","EFO_0000651","HP_0000118"],"label":"hemorrhage","approvedSymbol":"SSTR5","approvedName":"somatostatin receptor 5","targetClass":["Membrane receptor"],"prefName":"VAPREOTIDE","tradeNames":["Sanvar"],"synonyms":["BMY-41606","Bmy-41606","DP-05-094","RC-160","Vapreotide","Vapreotide acetate"],"drugType":"Protein","mechanismOfAction":"Somatostatin receptor 5 agonist","targetName":"Somatostatin receptor 5"}
{"drugId":"CHEMBL3137320","targetId":"ENSG00000129484","diseaseId":"Orphanet_145","phase":2,"status":"Active, not recruiting","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02286687%22"}],"ancestors":["EFO_0005771","MONDO_0002149","EFO_1000051","MONDO_0007254","MONDO_0021148","MONDO_0003274","EFO_0000512","EFO_0003869","EFO_0000313","Orphanet_68336","EFO_0009549","EFO_0006858","EFO_1001331","EFO_0000616","OTAR_0000017","OTAR_0000018","MONDO_0021350","Orphanet_183734","MONDO_0002259","MONDO_0023370","MONDO_0045024","MONDO_0004992","EFO_0009483","EFO_0000305","EFO_0001379","MONDO_0016419","EFO_0000508","Orphanet_227535","EFO_0010285"],"label":"Hereditary breast and ovarian cancer syndrome","approvedSymbol":"PARP2","approvedName":"poly(ADP-ribose) polymerase 2","targetClass":["Enzyme"],"prefName":"TALAZOPARIB","tradeNames":[],"synonyms":["BMN 673","BMN-673","LT-673","Talazoparib"],"drugType":"Small molecule","mechanismOfAction":"Poly [ADP-ribose] polymerase 2 inhibitor","targetName":"Poly [ADP-ribose] polymerase 2"}
{"drugId":"CHEMBL112","targetId":"ENSG00000073756","diseaseId":"Orphanet_365","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT02240407%22"}],"ancestors":["OTAR_0000006","OTAR_0000018","Orphanet_98054","EFO_0009676","Orphanet_217572","MONDO_0019052","OTAR_0000020","EFO_0002970","Orphanet_79161","Orphanet_217638","EFO_0000589","Orphanet_71859","EFO_0002945","Orphanet_206634","EFO_0003777","Orphanet_68366","EFO_0000508","Orphanet_217581","EFO_0000318","MONDO_0003939","Orphanet_183497","Orphanet_99739","EFO_0000319"],"label":"Glycogen storage disease due to acid maltase deficiency","approvedSymbol":"PTGS2","approvedName":"prostaglandin-endoperoxide synthase 2","targetClass":["Enzyme"],"prefName":"ACETAMINOPHEN","tradeNames":["Abdine","Acephen","Acetaminophen","Alvedon","Angiers","Calpol","Calpol six plus","Calpol six plus fastmelts","Child lemsip","Cupanol","Dafalgan","Datril","Disprol","Disprol infant","Disprol jnr","Disprol paed","Fennings","Galpamol","Hedex","Infadrops","Infants' feverall","Injectapap","Junior parapaed","Mandanol","Medinol","Medinol for children","Medinol over 6","Medinol under 6","Medised plain","Miradol","Neopap","Ofirmev","Paldesic","Panadol","Panadol actifast","Panadol actifast solb","Panadol advan","Panadol jnr","Panadol oa","Panaleve","Panaleve 6 plus","Paracetamol","Paramin","Parapaed jnr","Parapaed six plus","Paravict","Perfalgan","Phenaphen","Placidex","Rimadol","Salzone","Tixymol","Tramil 500","Tylenol"],"synonyms":["Acetaminophen","Apap","Biocetamol","Doliprane","Efferalgan","N-acetyl-p-aminophenol","NSC-109028","NSC-3991","P-hydroxy-acetanilid","Paracetamol","Paracetamolum","Vermidon"],"drugType":"Small molecule","mechanismOfAction":"Cyclooxygenase inhibitor","targetName":"Cyclooxygenase"}
{"drugId":"CHEMBL1431","targetId":"ENSG00000160194","diseaseId":"Orphanet_733","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01725490%22"}],"ancestors":["Orphanet_271835","OTAR_0000018","Orphanet_68336","MONDO_0023370","EFO_0008549","EFO_0000508","MONDO_0045024","EFO_0000616","EFO_0010282"],"label":"Familial adenomatous polyposis","approvedSymbol":"NDUFV3","approvedName":"NADH:ubiquinone oxidoreductase subunit V3","targetClass":["Enzyme"],"prefName":"METFORMIN","tradeNames":[],"synonyms":["LA-6023","Metformin","Metformin extended release"],"drugType":"Small molecule","mechanismOfAction":"Mitochondrial complex I (NADH dehydrogenase) inhibitor","targetName":"Mitochondrial complex I (NADH dehydrogenase)"}
{"drugId":"CHEMBL256997","targetId":"ENSG00000142937","diseaseId":"Orphanet_79062","phase":2,"status":"Terminated","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01141075%22"}],"ancestors":["EFO_0000589","OTAR_0000018","MONDO_0019052","EFO_0000508","OTAR_0000020"],"label":"Disorder of amino acid and other organic acid metabolism","approvedSymbol":"RPS8","approvedName":"ribosomal protein S8","targetClass":["Unclassified protein"],"prefName":"ATALUREN","tradeNames":[],"synonyms":["Ataluren","PTC-124","PTC124","Translarna"],"drugType":"Small molecule","mechanismOfAction":"80S Ribosome modulator","targetName":"80S Ribosome"}
{"drugId":"CHEMBL46","targetId":"ENSG00000166736","diseaseId":"Orphanet_79292","phase":1,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01578265%22"}],"ancestors":["EFO_0000589","EFO_0003966","MONDO_0018999","OTAR_0000020","EFO_0009690","MONDO_0024458","MONDO_0019743","MONDO_0017773","EFO_0003086"],"label":"Fish-eye disease","approvedSymbol":"HTR3A","approvedName":"5-hydroxytryptamine receptor 3A","targetClass":["Ion channel"],"prefName":"ONDANSETRON","tradeNames":["Ondansetron","Zofran","Zofran odt","Zuplenz"],"synonyms":["A04AA01","Desmethylondansetron","EUR-1025","GR-38032","GR-38032F","NSC-757870","Ondansetron","Zofran"],"drugType":"Small molecule","mechanismOfAction":"Serotonin 3a (5-HT3a) receptor antagonist","targetName":"Serotonin 3a (5-HT3a) receptor"}
{"drugId":"CHEMBL284348","targetId":"ENSG00000185760","diseaseId":"Orphanet_83419","phase":2,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01645787%22"}],"ancestors":["OTAR_0000006","OTAR_0000018","EFO_0009676","EFO_0009488","EFO_0005772","EFO_0008525","MONDO_0003182","EFO_0002970","MONDO_0024237","EFO_0003782","EFO_0004145","MONDO_0024257","EFO_0009386","Orphanet_71859","EFO_1001902","EFO_0004149","EFO_0000508","EFO_0000618","Orphanet_98505","MONDO_0003939","Orphanet_183497"],"label":"Proximal spinal muscular atrophy type 3","approvedSymbol":"KCNQ5","approvedName":"potassium voltage-gated channel subfamily Q member 5","targetClass":["Ion channel"],"prefName":"DALFAMPRIDINE","tradeNames":["Ampyra","Ampyra Extended Release","Fampyra","Neurelan"],"synonyms":["Dalfampridine","EL-970","Fampridine","Fampridine (4-aminopyridine)","NSC-15041"],"drugType":"Small molecule","mechanismOfAction":"Voltage-gated potassium channel blocker","targetName":"Voltage-gated potassium channel"}
{"drugId":"CHEMBL1201574","targetId":"ENSG00000132639","diseaseId":"Orphanet_93955","phase":3,"status":"Completed","urls":[{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT01791881%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT00682760%22"},{"niceName":"ClinicalTrials","url":"https://clinicaltrials.gov/search?id=%22NCT03216473%22"}],"ancestors":["Orphanet_183521","Orphanet_71859","EFO_0004280","OTAR_0000018","Orphanet_391799","EFO_0000618","EFO_0000508"],"label":"Benign essential blepharospasm","approvedSymbol":"SNAP25","approvedName":"synaptosome associated protein 25","targetClass":["Other cytosolic protein"],"prefName":"ONABOTULINUMTOXINA","tradeNames":["Botox","Botox cosmetic","Botox/botox cosmetic"],"synonyms":["Bontoxilysin","Botulin","Botulinum neurotoxin","Botulinum toxin","Botulinum toxin type a purified neurotoxin complex","Onabotulinumtoxina","Onaclostox","RTI-150","RTI150"],"drugType":"Unknown","mechanismOfAction":"Synaptosomal-associated protein 25 inhibitor","targetName":"Synaptosomal nerve-associated protein 25 (SNAP-25)"}